publication_date,compound,headline,neg,neu,pos,label
2015-11-23 22:32:12,-0.3818,Politicians slam tax-avoiding Pfizer-Allergan mega-deal,0.394,0.606,0.0,-1
2015-11-23 23:14:14,0.0,U.S. Republican Trump calls Pfizer deal to move tax base overseas 'disgusting',0.0,1.0,0.0,0
2015-11-24 03:15:02,-0.3818,U.S. politicians slam tax-avoiding Pfizer-Allergan deal,0.342,0.658,0.0,-1
2015-11-24 03:15:02,0.0,Pfizer to buy Allergan in $160 billion deal,0.0,1.0,0.0,0
2015-11-24 18:00:05,0.0,"Pfizer, IIT-Delhi collaborate for healthcare incubation",0.0,1.0,0.0,0
2016-02-02 14:48:58,-0.128,Pfizer 2016 forecasts disappoint; shares fall,0.303,0.449,0.247,-1
2016-03-11 13:19:04,-0.4404,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India,0.195,0.805,0.0,-1
2016-03-14 13:56:07,-0.5574,Delhi High Court stays government ban on Pfizer's Corex cough syrup - TV,0.247,0.753,0.0,-1
2016-03-15 02:34:23,0.1027,Delhi High Court grants Pfizer temporary relief on cough syrup ban,0.217,0.482,0.301,1
2016-04-06 02:52:07,0.0,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says",0.0,1.0,0.0,0
2016-04-06 05:51:34,-0.6908,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal,0.37,0.63,0.0,-1
2016-04-06 12:46:21,-0.6908,Obama's inversion curbs kill Pfizer's $160 bln Allergan deal,0.37,0.63,0.0,-1
2016-04-06 18:20:35,0.0,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",0.0,1.0,0.0,0
2016-04-06 20:57:11,0.0,US STOCKS-Wall St rises with healthcare; oil rallies,0.0,1.0,0.0,0
2016-04-06 21:47:47,0.6808,"US and European stocks gain as oil, pharma shares rally",0.0,0.588,0.412,1
2016-04-07 23:20:27,0.0,Investors stick with Pfizer CEO after Allergan deal scrapped,0.0,1.0,0.0,0
2016-04-08 13:55:38,-0.128,INVESTMENT FOCUS-Investors favour European drug stocks in spite of M&A crackdown,0.222,0.588,0.19,-1
2016-04-27 16:05:59,0.0772,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,0.237,0.576,0.187,0
2016-04-27 18:36:26,-0.1027,Pfizer to pay $785 million for overcharging US government on drugs,0.123,0.877,0.0,-1
2016-04-27 20:07:53,-0.1027,Pfizer to pay $785 mn for overcharging US government on drugs,0.123,0.877,0.0,-1
2016-05-03 12:33:10,0.4939,"Pfizer earnings rise, boosted by Hospira assets",0.0,0.543,0.457,1
2016-05-03 19:26:45,-0.0516,"US STOCKS-Wall St declines on growth fears, oil slide",0.226,0.565,0.21,0
2016-05-04 03:10:49,0.3034,EXCLUSIVE: Pfizer approaches Medivation about potential takeover -sources,0.0,0.758,0.242,1
2016-05-14 20:08:43,-0.3818,Pfizer takes 'significant' move to restrict lethal injection drugs,0.245,0.755,0.0,-1
2016-05-16 13:53:22,0.0,Pfizer to buy eczema specialist for $5.2 billion,0.0,1.0,0.0,0
2016-05-16 17:46:19,0.0,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel,0.0,1.0,0.0,0
2016-05-17 03:36:27,-0.3612,"Asian stocks mixed as crude oil rises, Chinese shares fall",0.266,0.576,0.158,-1
2016-05-17 09:36:21,0.1779,"AstraZeneca asthma drug hits goal, to enter competitive market",0.0,0.825,0.175,1
2016-05-18 06:41:40,0.0,Pascal Soriot's big experiment: reinventing AstraZeneca,0.0,1.0,0.0,0
2016-05-18 20:52:43,-0.4019,U.S. FDA approves Roche's immunotherapy for bladder cancer,0.336,0.458,0.206,-1
2016-05-23 21:53:23,-0.7845,EU lifts suicide warning on Pfizer's smoking-cessation pill,0.535,0.465,0.0,-1
2016-05-26 21:29:00,0.0,Anacor received rival bid before Pfizer deal - filing,0.0,1.0,0.0,0
2016-05-30 13:05:26,0.0,"Pharma sector set for wave of mergers, acquisitions: study",0.0,1.0,0.0,0
2016-06-03 07:22:18,0.0,GSK's modern HIV drug to be rolled out in Botswana,0.0,1.0,0.0,0
2016-06-04 02:28:13,-0.2732,Ex-Oppenheimer & Co. employee faces insider trading charges,0.259,0.741,0.0,-1
2016-06-06 15:28:11,0.0,"Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources",0.0,1.0,0.0,0
2016-06-06 16:00:02,0.0,"Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources",0.0,1.0,0.0,0
2016-06-14 12:57:02,0.0,Shire buys bowel drug rights from Pfizer,0.0,1.0,0.0,0
2016-06-20 19:16:04,0.5106,Rx pizza: 1 free meal can sway doctor prescribing,0.0,0.68,0.32,1
2016-06-28 10:41:04,0.0,Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China,0.0,1.0,0.0,0
2016-06-28 12:51:03,0.5574,Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results,0.0,0.735,0.265,1
2016-07-01 21:51:01,0.5106,BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc.,0.0,0.765,0.235,1
2016-07-04 14:31:10,-0.296,UK plans lower corporation tax to cushion hit from Brexit,0.196,0.804,0.0,-1
2016-07-05 21:24:43,0.2023,Medivation agrees to open its books to Sanofi,0.0,0.795,0.205,1
2016-07-06 12:11:09,-0.6597,Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer,0.227,0.773,0.0,-1
2016-07-06 12:21:02,-0.6597,"Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer",0.196,0.804,0.0,-1
2016-07-06 18:48:20,-0.0772,Pfizer agrees to note addiction risks in opioid marketing,0.193,0.642,0.165,0
2016-07-08 12:11:05,0.3612,Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma,0.073,0.801,0.125,1
2016-07-12 20:33:11,0.4767,Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49,0.0,0.795,0.205,1
2016-07-12 21:39:00,0.0,Lower-cost biotech drug gets thumbs up from FDA panel,0.0,1.0,0.0,0
2016-07-13 12:23:01,0.0,Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis,0.0,1.0,0.0,0
2016-07-25 11:58:08,0.4404,BIND Therapeutics Announces Two Bidders Join Pfizer's Stalking Horse Bid in Auction for BIND's Assets,0.0,0.769,0.231,1
2016-07-25 12:48:02,0.2263,"Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",0.0,0.924,0.076,1
2016-07-25 15:09:25,0.1779,Germany plans to extend price brake for drugs under statutory insurance,0.0,0.855,0.145,1
2016-07-25 23:14:47,0.0,APNewsBreak: Pfizer: Arkansas execution would 'misuse' drug,0.0,1.0,0.0,0
2016-07-26 13:41:56,0.0,"Teva, Mylan eye Pfizer's Brazil venture, sources say",0.0,1.0,0.0,0
2016-07-26 13:51:47,0.128,"Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say",0.0,0.842,0.158,1
2016-07-26 21:48:09,0.7096,BIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND's Assets,0.0,0.753,0.247,1
2016-07-26 23:11:17,0.2755,Legislator: Pfizer can't complain about execution drug,0.0,0.74,0.26,1
2016-07-28 09:43:43,0.0,AstraZeneca a takeover target again? CEO not commenting,0.0,1.0,0.0,0
2016-07-28 14:08:08,0.3182,Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology,0.0,0.85,0.15,1
2016-07-28 20:38:17,0.5574,Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis,0.0,0.825,0.175,1
2016-08-01 14:11:03,0.0,"Pfizer Aims to Become Industry Leader in Gene Therapy with Acquisition of Bamboo Therapeutics, Inc.",0.0,1.0,0.0,0
2016-08-01 14:41:03,0.0,"PFIZER AIMS TO BECOME INDUSTRY LEADER IN GENE THERAPY WITH AQUISITION OF BAMBOO THERAPEUTICS, INC.",0.0,1.0,0.0,0
2016-08-02 11:11:04,0.0,PFIZER REPORTS SECOND-QUARTER 2016 RESULTS,0.0,1.0,0.0,0
2016-08-02 13:23:00,0.2023,Pfizer earnings top estimates on higher sales,0.0,0.769,0.231,1
2016-08-02 17:02:35,0.5739,Pfizer beats Street 2Q forecasts despite big drop in profit,0.0,0.629,0.371,1
2016-08-02 17:06:39,-0.5499,"Pfizer beats estimates, but branded drugs disappoint",0.372,0.628,0.0,-1
2016-08-02 19:15:00,0.4019,CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies,0.0,0.787,0.213,1
2016-08-02 19:44:00,0.4588,Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update,0.0,0.7,0.3,1
2016-08-02 20:32:39,-0.0772,Wall Street falls as weak auto sales spur growth jitters,0.215,0.593,0.193,0
2016-08-03 02:48:00,0.4767,"In Quest to Grow, Rivals Woo Biogen -- WSJ",0.0,0.721,0.279,1
2016-08-03 02:48:00,0.0,Pfizer Hit As Sales Of Older Drugs Fall -- WSJ,0.0,1.0,0.0,0
2016-08-04 13:57:00,0.0,Business Groups Sue U.S. Government Over Tax-Inversion Rules,0.0,1.0,0.0,0
2016-08-04 14:15:00,0.0,U.S. Government Sued Over Tax-Inversion Rules,0.0,1.0,0.0,0
2016-08-04 15:35:00,0.0,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- Update,0.0,1.0,0.0,0
2016-08-04 16:43:00,0.0,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Update,0.0,1.0,0.0,0
2016-08-04 20:00:54,0.0,Business groups sue over new U.S. limit on tax-driven foreign buyouts,0.0,1.0,0.0,0
2016-08-05 01:51:36,0.0,US industry bodies sue over Obama corporate tax rules,0.0,1.0,0.0,0
2016-08-05 02:47:00,0.0,Business Groups Sue Over Inversion Rules -- WSJ,0.0,1.0,0.0,0
2016-08-05 14:50:09,-0.4404,"AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes",0.244,0.756,0.0,-1
2016-08-06 09:08:02,-0.2263,"Pfizer Limited revenue up by 3.4 % for the Quarter ended June 30, 2016",0.137,0.863,0.0,-1
2016-08-08 08:19:00,0.0,Pfizer Announces Publication Of New Data From Studies Of Vyndaqel - Quick Facts,0.0,1.0,0.0,0
2016-08-08 08:35:00,-0.3182,"Allergan Revenue Increases, Though Loss Widens",0.315,0.685,0.0,-1
2016-08-08 12:08:04,0.0,Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease,0.0,1.0,0.0,0
2016-08-08 14:28:55,0.4939,"Health Care Sector Update for 08/08/2016: JNJ, PFE, ABT, MRK, AMGN",0.0,0.758,0.242,1
2016-08-08 15:18:31,0.0,"The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procter & Gamble",0.0,1.0,0.0,0
2016-08-08 16:16:24,0.0,"Dow Movers: MRK, CAT",0.0,1.0,0.0,0
2016-08-08 19:11:53,0.0,Monday's ETF with Unusual Volume: PPH,0.0,1.0,0.0,0
2016-08-09 02:58:00,0.34,"MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals",0.0,0.833,0.167,1
2016-08-09 12:33:02,0.6633,Cardinal Health a Top Ranked SAFE Dividend Stock With 2.1% Yield (CAH),0.0,0.624,0.376,1
2016-08-09 13:18:03,0.0,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 10, 2016",0.0,1.0,0.0,0
2016-08-09 19:56:16,0.0,Gilead Sciences Inc. Stock in 3 Charts,0.0,1.0,0.0,0
2016-08-10 13:27:25,0.0,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 11, 2016",0.0,1.0,0.0,0
2016-08-10 13:29:35,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 11, 2016",0.0,1.0,0.0,0
2016-08-10 14:05:00,-0.4767,"Former Law Partner, Adviser Arrested For Insider Trading",0.307,0.693,0.0,-1
2016-08-10 14:05:00,-0.2023,"Lawyer, Adviser Charged With Insider Trading",0.265,0.735,0.0,-1
2016-08-10 15:53:08,0.3818,Why Ariad Pharmaceuticals Gained 26.9% in July,0.0,0.698,0.302,1
2016-08-10 16:04:05,0.0,Pfizer’s Business Segments and Their Performance,0.0,1.0,0.0,0
2016-08-10 16:52:39,0.296,"IWD, JNJ, JPM, PFE: ETF Inflow Alert",0.0,0.732,0.268,1
2016-08-10 20:41:49,-0.6597,"Lilly Breast Cancer Drug Study Rolls On, Pushing Back Launch Date",0.306,0.694,0.0,-1
2016-08-10 20:58:00,0.0,Mylan's Time Leaning on EpiPens Is Rapidly Approaching an End,0.0,1.0,0.0,0
2016-08-10 23:05:35,-0.2023,Two charged with insider trading over 2010 Pfizer acquisition,0.184,0.816,0.0,-1
2016-08-11 04:51:58,-0.2023,"[$$] Lawyer, Adviser Charged With Insider Trading",0.231,0.769,0.0,-1
2016-08-11 12:54:05,0.4927,More Good News from Ireland,0.0,0.556,0.444,1
2016-08-11 13:06:07,0.3818,Understanding Growth Contributors for Pfizer,0.0,0.606,0.394,1
2016-08-11 13:31:34,0.5106,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox,0.0,0.752,0.248,1
2016-08-11 15:04:54,0.0,Pfizer’s Products with Decreasing Revenues,0.0,1.0,0.0,0
2016-08-11 15:36:53,-0.4404,Put sale sees limited downside for Pfizer,0.438,0.562,0.0,-1
2016-08-11 20:33:59,-0.3597,5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday,0.185,0.815,0.0,-1
2016-08-11 21:03:30,0.0,"PFIZER INC Files SEC form 10-Q, Quarterly Report",0.0,1.0,0.0,0
2016-08-11 23:14:23,0.0,Five Healthcare Stocks Billionaires Are Bullish On,0.0,1.0,0.0,0
2016-08-12 13:04:39,0.0,Pfizer-Anacor Deal Completed in June 2016,0.0,1.0,0.0,0
2016-08-12 16:48:22,0.0,How To YieldBoost PFE To 5.2% Using Options,0.0,1.0,0.0,0
2016-08-12 20:24:46,0.0,Valeant Pharmaceuticals (VRX) Stock: The Philidor Nightmare Isn’t Over,0.0,1.0,0.0,0
2016-08-14 23:51:00,0.0,"Mark Your Calendar For Aug.17, TRIL To Report Data In Q4, FLML Launches Akova",0.0,1.0,0.0,0
2016-08-15 12:51:10,0.4939,"Health Care Sector Update for 08/15/2016: ACRX, ADK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-15 13:04:20,0.0,Recent Corporate and Pipeline Developments for Pfizer,0.0,1.0,0.0,0
2016-08-15 15:04:13,0.2732,Pfizer’s 2Q16 Profitability and Financial Guidance,0.0,0.704,0.296,1
2016-08-15 15:41:00,-0.2263,Rosenstein's Jana Partners: Walgreens Stake Gets Slashed 60%; Trims ConAgra; Adds AutoNation,0.147,0.853,0.0,-1
2016-08-15 16:01:49,0.0,GlycoMimetics Initiated At Outperform By Cowen And Company,0.0,1.0,0.0,0
2016-08-15 16:58:00,-0.296,What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio,0.167,0.833,0.0,-1
2016-08-15 17:05:26,0.5267,Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis,0.0,0.645,0.355,1
2016-08-15 19:35:07,0.0,Why is Time (TIME) Stock Popping Today?,0.0,1.0,0.0,0
2016-08-15 20:25:30,0.0,Hedge funds made big changes at drug companies in 2nd qtr -filings,0.0,1.0,0.0,0
2016-08-15 22:37:07,0.0,"Paulson Shifts Health-Care Stakes, Adds FedEx",0.0,1.0,0.0,0
2016-08-16 13:04:13,0.0,Analyzing the Future Estimates for Pfizer,0.0,1.0,0.0,0
2016-08-16 13:11:28,0.4939,"Health Care Sector Update for 08/16/2016: REPH, OGXI, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-16 13:14:00,0.0,ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment,0.0,1.0,0.0,0
2016-08-16 13:35:00,-0.2023,Ackman: Pershing Square Slashes Zoetis Stake,0.265,0.735,0.0,-1
2016-08-16 15:04:37,-0.6597,Abraxane Still Leads the US Metastatic Pancreatic Cancer Segment,0.355,0.645,0.0,-1
2016-08-16 18:00:00,0.34,"For Value Investors, Arbiter Partners Knows How to Pick 'Em",0.0,0.789,0.211,1
2016-08-16 22:33:06,-0.4215,Pfizer's Bold Bid to Conquer Cancer,0.4,0.364,0.236,-1
2016-08-16 22:48:24,0.0,Novartis Needs to Stem the Bleeding From Gleevec Decline,0.0,1.0,0.0,0
2016-08-16 23:22:50,-0.296,U.S. Market Indexes Lower on Tuesday,0.306,0.694,0.0,-1
2016-08-17 12:13:22,0.0,"With new president and focus on big investors, Cellceutix aims for the Nasdaq",0.0,1.0,0.0,0
2016-08-17 14:57:56,-0.4939,Jason Karp’s Biggest Contributors in Q2 Amid Tourbillon’s Disappointing Performance,0.262,0.738,0.0,-1
2016-08-17 15:33:09,0.0,"Dow Movers: CSCO, PFE",0.0,1.0,0.0,0
2016-08-17 16:03:00,0.0,Billionaire Money Managers Sold off This Stock in the 2nd Quarter,0.0,1.0,0.0,0
2016-08-17 18:45:00,0.0,Court Says Pfizer''s Biosimilar of J&J''s Remicade Doesn''t Infringe Patent,0.0,1.0,0.0,0
2016-08-17 18:45:00,0.0,Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent,0.0,1.0,0.0,0
2016-08-17 19:10:13,0.0,What Are Analysts’ Recommendations for Mylan and Its Peers?,0.0,1.0,0.0,0
2016-08-17 20:01:15,0.0,"3M, Chevron Pull Dow Higher Wednesday",0.0,1.0,0.0,0
2016-08-17 20:11:40,-0.4767,Stocks close slightly higher as Fed rate-hike debate rages on,0.256,0.744,0.0,-1
2016-08-17 20:32:01,0.0,"Merck Among Drug Giants Looking To Buy Medivation, Says Report",0.0,1.0,0.0,0
2016-08-17 22:02:41,-0.2263,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 18, 2016",0.147,0.853,0.0,-1
2016-08-17 22:10:36,0.0,[$$] Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent,0.0,1.0,0.0,0
2016-08-17 22:47:53,0.0,Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study,0.0,1.0,0.0,0
2016-08-17 23:16:25,-0.1531,"Patent for J&J's Remicade invalidated, cheaper version looms",0.186,0.814,0.0,-1
2016-08-18 09:00:00,0.3818,Pfizer’s Lyrica Fuels Endowment Growth at Northwestern: Chart,0.0,0.729,0.271,1
2016-08-18 11:39:11,0.0,"J&J (JNJ) Remicade Patent Invalid, Pfizer to Launch Inflectra?",0.0,1.0,0.0,0
2016-08-18 13:19:20,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 19, 2016",0.0,1.0,0.0,0
2016-08-18 14:47:53,0.765,Why Pfizer's Acquisition of Anacor Is a Great Fit,0.0,0.476,0.524,1
2016-08-18 15:18:00,-0.5719,Why I Hate Johnson & Johnson Right Now (But I'll Never Sell),0.291,0.709,0.0,-1
2016-08-18 16:47:42,0.0,Why Portola Pharmaceuticals Inc Is Plunging Today,0.0,1.0,0.0,0
2016-08-18 16:50:49,0.0,How Much Medivation Can Really Fetch in a Buyout,0.0,1.0,0.0,0
2016-08-18 18:26:20,0.5574,Recent Patent Ruling A Positive For Pfizer,0.0,0.581,0.419,1
2016-08-18 18:34:21,0.0,"Activist Keith Meister Unloads Large Pfizer (PFE) Position, Takes Stakes in B/E Aerospace (BEAV), Johnson Controls (JCI)",0.0,1.0,0.0,0
2016-08-18 18:53:36,-0.4404,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,0.293,0.707,0.0,-1
2016-08-18 19:11:15,0.0,Why Did We Update Our Price Estimate For Bristol-Myers Squibb?,0.0,1.0,0.0,0
2016-08-18 20:21:00,0.0,10 Highest Healthcare Dividend Stocks,0.0,1.0,0.0,0
2016-08-18 20:40:00,-0.5423,"Is It ""Game Over"" After Portola's FDA Rejection?",0.333,0.667,0.0,-1
2016-08-18 22:44:57,0.0,US Stocks Higher after July FOMC Minutes,0.0,1.0,0.0,0
2016-08-18 22:45:51,-0.5423,Is It &quot;Game Over&quot; After Portola's FDA Rejection?,0.333,0.667,0.0,-1
2016-08-19 11:00:00,-0.2732,"No Pain, Potential for Lots of Gain",0.426,0.31,0.264,-1
2016-08-19 12:30:00,0.5719,Employers Slowly Adopt Value-Based Health Benefit Designs,0.0,0.515,0.485,1
2016-08-19 13:19:55,0.4939,"Health Care Sector Update for 08/19/2016: JNJ, PFE, ABT, MRK, AMGN, XLV, ALR, CUTR, CERU",0.0,0.814,0.186,1
2016-08-19 15:25:24,0.0,Teva Pharmaceutical’s 2016 Valuation Compared to Peers,0.0,1.0,0.0,0
2016-08-19 16:45:41,0.0,"Noteworthy ETF Inflows: HDV, PFE, MRK, INTC",0.0,1.0,0.0,0
2016-08-19 19:00:00,0.0,Who Is Driving Pfizer's Management Team? (PFE),0.0,1.0,0.0,0
2016-08-19 21:09:21,0.4576,"After Hours Most Active for Aug 19, 2016 :  LDOS, NI, PFE, YHOO, CMCSA, QQQ, MSFT, PYPL, IDTI",0.0,0.842,0.158,1
2016-08-19 22:41:06,-0.1531,FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse-Deterrent Properties for the Management of Pain,0.137,0.75,0.113,-1
2016-08-19 23:25:00,-0.4939,"Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)",0.286,0.714,0.0,-1
2016-08-21 08:01:23,0.0,Is Pfizer on Its Way Up?,0.0,1.0,0.0,0
2016-08-21 16:04:14,-0.4215,[$$] US doctors waste millions on branded medicines,0.286,0.714,0.0,-1
2016-08-21 16:33:34,0.0,Curbing Excessive Exuberance May be Premature,0.0,1.0,0.0,0
2016-08-21 17:45:12,0.0,3 Reasons Medivation Is the Juiciest Target in Biotech,0.0,1.0,0.0,0
2016-08-21 21:08:00,0.4939,Pfizer Nears Agreement To Buy Medivation -- Sources,0.0,0.686,0.314,1
2016-08-21 21:55:00,0.4939,Pfizer Nears Agreement to Buy Medivation,0.0,0.61,0.39,1
2016-08-21 22:03:06,0.0,Pfizer Said Close to $14 Billion Deal to Acquire Medivation,0.0,1.0,0.0,0
2016-08-21 22:05:00,0.4939,Pfizer Reportedly Nears Agreement To Buy Medivation For About $14 Bln,0.0,0.758,0.242,1
2016-08-21 22:09:41,0.0,Pfizer nears $14 billion deal for Medivation-source,0.0,1.0,0.0,0
2016-08-21 22:39:16,0.0,Pfizer said to be near $14 billion acquisition of Medivation,0.0,1.0,0.0,0
2016-08-21 22:40:00,0.4939,"Pfizer Nears Agreement to Buy Medivation, Sources Say -- Update",0.0,0.738,0.262,1
2016-08-21 23:15:37,0.0,Pfizer nears deal to acquire Medivation for close to $14 bln -sources,0.0,1.0,0.0,0
2016-08-21 23:16:23,0.5859,Pfizer’s Medivation Win; ’Ben-Hur’ Throws a Wheel: Sunday Wrap,0.0,0.648,0.352,1
2016-08-21 23:18:05,0.0,Pfizer nears deal to acquire Medivation for close to $14 billion - sources,0.0,1.0,0.0,0
2016-08-21 23:27:35,0.0,Pfizer nears deal to acquire Medivation for close to $14 billion,0.0,1.0,0.0,0
2016-08-21 23:52:57,-0.6597,Pfizer is reportedly close to spending $14 billion on cancer drugmaker Medivation,0.286,0.714,0.0,-1
2016-08-22 00:09:22,0.0,Pfizer Said to Be Close to $14B Deal for Medivation,0.0,1.0,0.0,0
2016-08-22 01:34:00,0.0,"PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move",0.0,1.0,0.0,0
2016-08-22 01:56:00,0.0,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation,0.0,1.0,0.0,0
2016-08-22 02:48:00,0.0,Pfizer Near $14 Billion Deal for Biotech -- WSJ,0.0,1.0,0.0,0
2016-08-22 04:25:00,0.0,U.S. Stock Futures Slip on Rate Concerns,0.0,1.0,0.0,0
2016-08-22 04:27:50,0.0,PRESS DIGEST - Wall Street Journal - Aug 22,0.0,1.0,0.0,0
2016-08-22 05:42:19,0.4939,Pfizer nears agreement to buy Medivation for $14 bn: reports,0.0,0.738,0.262,1
2016-08-22 06:57:00,0.34,Pfizer To Buy Medivation For Total Enterprise Value Of About $14 Bln,0.0,0.821,0.179,1
2016-08-22 07:16:00,0.4939,[$$] Pfizer Nears Agreement to Buy Medivation,0.0,0.652,0.348,1
2016-08-22 07:24:00,0.0,Pfizer to Buy Medivation for $14 Billion,0.0,1.0,0.0,0
2016-08-22 07:35:00,0.2263,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- Update,0.0,0.84,0.16,1
2016-08-22 07:53:00,0.0,Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln,0.0,1.0,0.0,0
2016-08-22 08:00:00,0.0,Pfizer Investors Conference Call At 9:00 AM ET,0.0,1.0,0.0,0
2016-08-22 08:18:00,0.2263,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update,0.0,0.853,0.147,1
2016-08-22 08:27:00,0.4939,Pfizer Files 8K - Entry Into Definitive Agreement,0.0,0.652,0.348,1
2016-08-22 08:35:00,-0.6597,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal,0.328,0.672,0.0,-1
2016-08-22 08:35:00,-0.6597,Pfizer Adds Key Drug for Cancer in $14 Billion Deal,0.328,0.672,0.0,-1
2016-08-22 08:44:00,0.2263,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 3rd Update,0.0,0.853,0.147,1
2016-08-22 09:40:53,0.0,Pfizer-Medivation Close to Signing $14B Acquisition Deal?,0.0,1.0,0.0,0
2016-08-22 10:03:00,0.0,Pfizer near deal to buy Medivation,0.0,1.0,0.0,0
2016-08-22 10:07:00,0.2263,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 4th Update,0.0,0.853,0.147,1
2016-08-22 10:43:00,0.0,Pfizer buys Medivation for $14B cash,0.0,1.0,0.0,0
2016-08-22 10:45:00,0.0,Pfizer To Acquire Medivation,0.0,1.0,0.0,0
2016-08-22 10:46:00,0.0,Pfizer to Acquire Medivation,0.0,1.0,0.0,0
2016-08-22 10:50:48,-0.7003,Pfizer will pay about $14 billion to acquire the cancer drug company Medivation,0.345,0.655,0.0,-1
2016-08-22 10:54:12,0.0,Pfizer Trumps Sanofi With Medivation Deal for $14 Billion,0.0,1.0,0.0,0
2016-08-22 10:54:39,0.0,Pfizer to buy Medivation in $14 bln deal,0.0,1.0,0.0,0
2016-08-22 10:58:21,-0.5423,Sanofi's Hostility Backfires,0.636,0.364,0.0,-1
2016-08-22 10:58:30,-0.6597,Pfizer has one-upped the competition with a $14 billion bid for a cancer drugmaker,0.286,0.714,0.0,-1
2016-08-22 11:00:20,0.0,Medivation's stock soars after Pfizer buyout deal,0.0,1.0,0.0,0
2016-08-22 11:06:49,0.0,Five Things You Need to Know to Start Your Day,0.0,1.0,0.0,0
2016-08-22 11:20:45,0.2023,[$$] Pfizer agrees $14bn takeover of Medivation,0.0,0.769,0.231,1
2016-08-22 11:25:20,0.5106,Pfizer Tops Sanofi in $14 Billion Medivation Deal,0.0,0.68,0.32,1
2016-08-22 11:38:42,-0.296,"Global stocks, oil turn lower ahead of Fed meeting",0.216,0.784,0.0,-1
2016-08-22 11:38:47,-0.5574,Pfizer agrees to buy cancer behemoth Medivation for $14 billion,0.31,0.563,0.127,-1
2016-08-22 11:41:19,0.4404,Pfizer buying Medivation in deal valued at about $14B,0.0,0.734,0.266,1
2016-08-22 11:48:33,0.0,Pfizer says acquiring Medivation for $14 bn,0.0,1.0,0.0,0
2016-08-22 11:48:54,0.0,"Early movers: MDVN, PFE, CST, ISIL, SYT, FB, VIAB, VLKAY, JPM, MAT & more",0.0,1.0,0.0,0
2016-08-22 11:55:16,0.0,Pfizer Pays a Big Premium for Medivation,0.0,1.0,0.0,0
2016-08-22 12:01:25,0.0,Pfizer says acquiring Medivation for $14 billion,0.0,1.0,0.0,0
2016-08-22 12:13:15,0.4939,"PFIZER INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh",0.0,0.833,0.167,1
2016-08-22 12:14:04,0.0,Pfizer to buy Medivation in $US14b deal,0.0,1.0,0.0,0
2016-08-22 12:28:02,0.0,"Sanofi says talked with Medivation, but will be ""disciplined"" acquirer",0.0,1.0,0.0,0
2016-08-22 12:30:11,0.3818,Pfizer buying biopharm firm focused on oncology for $14B,0.0,0.755,0.245,1
2016-08-22 12:36:00,-0.0516,Morning Movers: Medivation Soars as Pfizer Wins Bidding War; Valeant Jumps,0.235,0.542,0.223,0
2016-08-22 12:37:00,0.0,Pfizer''s Medivation Deal Latest in Long Line of Similar Acquisitions,0.0,1.0,0.0,0
2016-08-22 12:53:32,-0.6597,BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal,0.286,0.714,0.0,-1
2016-08-22 13:07:00,-0.2263,"McDonald's, Verizon And 3 Others That May Drag Down The Dow",0.174,0.826,0.0,-1
2016-08-22 13:09:50,-0.4767,Pfizer boosts cancer drug pipeline with $14 bln Medivation deal,0.299,0.544,0.156,-1
2016-08-22 13:11:00,0.0,Pfizer Is Buying Medivation for $14 Billion,0.0,1.0,0.0,0
2016-08-22 13:16:17,0.0,"Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking",0.0,1.0,0.0,0
2016-08-22 13:17:00,-0.6597,Pfizer To Buy Cancer Drug Firm Medivation For £10bn,0.355,0.645,0.0,-1
2016-08-22 13:20:17,-0.0258,Blog Coverage Pfizer Gets Negative News from UKs MHRA and Positive News from US FDA,0.182,0.64,0.177,0
2016-08-22 13:20:31,0.4939,"Health Care Sector Update for 08/22/2016: FMS, MDVN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-22 13:20:33,-0.296,"Stocks Futures Trade Lower as Fischer, Oil Weighs on Wall Street",0.18,0.82,0.0,-1
2016-08-22 13:20:43,0.4767,"Deals of the Day: Pfizer Nabs Medivation, Syngenta Deal Gets U.S. Approval",0.0,0.78,0.22,1
2016-08-22 13:44:55,-0.2732,"U.S. Futures Defensive on Lower Oil, Hawkish Fed; Pfizer to Buy Medivation for $14 Bln",0.135,0.798,0.067,-1
2016-08-22 13:45:00,0.6408,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Medivation, Inc. to Pfizer Inc. is Fair to Shareholders -- MDVN",0.0,0.808,0.192,1
2016-08-22 13:48:28,-0.0516,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval,0.246,0.522,0.231,0
2016-08-22 13:53:11,-0.6597,Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion,0.355,0.645,0.0,-1
2016-08-22 13:57:25,-0.296,Wall Street opens lower as Pfizer seals Medivation deal,0.216,0.784,0.0,-1
2016-08-22 14:01:02,0.3182,"M&A Boosts Intersil, Syngenta and Medivation in Pre-Market",0.0,0.753,0.247,1
2016-08-22 14:06:00,0.0,Pfizer buys Medivation $14 billion cash,0.0,1.0,0.0,0
2016-08-22 14:10:02,0.0,"Stock Market News for August 22, 2016",0.0,1.0,0.0,0
2016-08-22 14:20:00,0.5984,Pfizer Won the Bidding War for Medivation But Is It Really a Win?,0.188,0.435,0.377,1
2016-08-22 14:21:32,0.0,"Nasdaq Turns Up; Medivation, Syngenta, Intersil Soar On Merger News",0.0,1.0,0.0,0
2016-08-22 14:26:00,0.0,More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion,0.0,1.0,0.0,0
2016-08-22 14:28:39,0.4215,Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game-changer,0.0,0.833,0.167,1
2016-08-22 14:28:48,-0.296,Wall Street lower as investors react to Pfizer deal,0.216,0.784,0.0,-1
2016-08-22 14:39:37,0.0,Understanding Medivation’s Premium Valuation,0.0,1.0,0.0,0
2016-08-22 14:48:45,-0.4019,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise",0.312,0.496,0.191,-1
2016-08-22 14:50:26,0.0,Upstart banks just yanked another big deal away from Wall Street,0.0,1.0,0.0,0
2016-08-22 15:16:00,-0.128,"Crude Selloff, Health Care Rally Split Wall Street",0.287,0.465,0.248,-1
2016-08-22 15:23:36,0.0,Pfizer to acquire Medivation for $14 billion,0.0,1.0,0.0,0
2016-08-22 15:46:02,-0.296,Mid-Morning Market Update: Markets Mostly Lower; Pfizer To Buy Medivation For $14 Billion,0.155,0.845,0.0,-1
2016-08-22 15:46:45,-0.7906,Pfizer spends $14B on Medivation in cancer fight,0.538,0.462,0.0,-1
2016-08-22 15:57:44,0.0,Biotech stocks rally as investors bet on the next big tie-up,0.0,1.0,0.0,0
2016-08-22 16:07:00,0.0,"Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal",0.0,1.0,0.0,0
2016-08-22 16:12:00,0.0,Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back,0.0,1.0,0.0,0
2016-08-22 16:22:00,0.0,The takeover pipeline: Who will be next?,0.0,1.0,0.0,0
2016-08-22 16:22:57,0.0,[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions,0.0,1.0,0.0,0
2016-08-22 16:33:48,0.5106,Pfizer Claims Pharmaceutical's Latest Big Prize,0.0,0.602,0.398,1
2016-08-22 16:36:14,0.0,Monday links: work and drudgery,0.0,1.0,0.0,0
2016-08-22 16:37:05,0.3818,European stocks dip awaiting clear US rate outlook,0.0,0.729,0.271,1
2016-08-22 16:46:16,0.0,Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts,0.0,1.0,0.0,0
2016-08-22 16:52:31,0.3818,[$$] Medivation Ovation: Pfizer Pays the Price for Growth,0.0,0.755,0.245,1
2016-08-22 17:08:00,0.0,Pfizer to buy Medivation,0.0,1.0,0.0,0
2016-08-22 17:14:52,-0.5267,Biotechs Rise on Bet Medivation Losers Will Look to Next Deal,0.254,0.746,0.0,-1
2016-08-22 17:23:15,0.0,[$$] Pfizer/Medivation: combination therapy,0.0,1.0,0.0,0
2016-08-22 17:24:11,-0.6597,[$$] Pfizer makes $14bn bet on cancer drugmaker Medivation,0.355,0.645,0.0,-1
2016-08-22 17:42:49,0.0,ETFs in Focus on Pfizer's Medivation Acquisition,0.0,1.0,0.0,0
2016-08-22 17:47:13,0.296,Medivation's Shares Soar on Confirmation of a Pfizer Buyout,0.0,0.761,0.239,1
2016-08-22 17:54:50,-0.3612,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,0.248,0.604,0.148,-1
2016-08-22 17:57:55,-0.6597,[$$] Pfizer swallows Medivation in effort to conquer cancer,0.355,0.645,0.0,-1
2016-08-22 18:47:00,-0.4404,Stocks Struggle for Direction as Jackson Hole Conference Looms,0.358,0.642,0.0,-1
2016-08-22 18:57:00,0.0,"After Medivation, These 6 Biotech Stocks Could Be M&A Targets Next",0.0,1.0,0.0,0
2016-08-22 19:46:49,0.0,"New Research Reports for Pfizer, Cisco & Visa",0.0,1.0,0.0,0
2016-08-22 20:00:11,0.0,STOCKS SEESAW: Here's what you need to know,0.0,1.0,0.0,0
2016-08-22 20:02:00,0.4019,Stocks Waver as Investors Wait for Fed Clarity,0.0,0.722,0.278,1
2016-08-22 20:05:36,0.4215,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise",0.0,0.763,0.237,1
2016-08-22 20:10:00,0.0,Here's a Reason Why Tesaro (TSRO) Stock Climbed Today,0.0,1.0,0.0,0
2016-08-22 20:26:16,-0.296,Stocks end mostly lower in quiet trade; oil prices decline,0.196,0.804,0.0,-1
2016-08-22 20:27:43,0.0,Pfizer-Medivation Deal Headlines Busy Merger Monday,0.0,1.0,0.0,0
2016-08-22 20:27:59,0.0,Pfizer's Medivation buy seen prescribing more biotech M&A,0.0,1.0,0.0,0
2016-08-22 20:29:12,0.0,Pfizer-Medivation Deal Reignites Biotech Buyout Speculation,0.0,1.0,0.0,0
2016-08-22 20:31:03,0.296,Medivation shares leap on Pfizer's $14 billion offer,0.0,0.761,0.239,1
2016-08-22 20:31:07,0.0,Stocks End Little-Changed; Zoe's Kitchen Plunges After Hours,0.0,1.0,0.0,0
2016-08-22 20:31:54,0.0,Medivation surges on Pfizer takeover as US markets stay flat,0.0,1.0,0.0,0
2016-08-22 20:43:10,0.0,Bernie Sanders Just Called Out Pfizer and Medivation on Twitter,0.0,1.0,0.0,0
2016-08-22 20:56:26,0.0,[$$] Marathon Oil slips on broad sector fall,0.0,1.0,0.0,0
2016-08-22 20:57:17,0.3612,"S&P 500, Dow industrials book a loss as oil snaps win streak",0.152,0.596,0.252,1
2016-08-22 20:58:39,0.4939,What's Driving the M&A in Health Care?,0.0,0.652,0.348,1
2016-08-22 21:01:47,-0.4767,Pfizer boosts cancer drug roster with $14 billion Medivation deal,0.299,0.544,0.156,-1
2016-08-22 21:06:09,0.5927,"Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?",0.0,0.7,0.3,1
2016-08-22 21:20:30,-0.296,"Close Update: Dow, S&P Close Lower On Oil While Nasdaq Buoyed by Biotechs",0.155,0.845,0.0,-1
2016-08-22 21:25:00,0.0,Biotech's next big deal?,0.0,1.0,0.0,0
2016-08-22 21:32:13,0.0,"In possible $14 billion ending, Medivation goes back to early days",0.0,1.0,0.0,0
2016-08-22 21:43:51,0.0,Markets focus on big mergers as global stocks are quiet,0.0,1.0,0.0,0
2016-08-22 21:46:38,0.0,Pfizer Inc. (PFE) Adds Oncology Muscle With Medivation Inc (MDVN),0.0,1.0,0.0,0
2016-08-22 21:59:00,0.0,"Final Trade: PFE, XRT, JCP & TGT",0.0,1.0,0.0,0
2016-08-22 22:46:06,0.0,Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised),0.0,1.0,0.0,0
2016-08-22 22:46:29,0.0,Is Microsoft Corporation (MSFT) the Next Apple?,0.0,1.0,0.0,0
2016-08-22 22:51:11,0.0,Pfizer Acquires Medivation,0.0,1.0,0.0,0
2016-08-22 22:54:24,-0.34,Stocks Calm As Crude Plunges; Busy Day For Medical Sector,0.264,0.571,0.164,-1
2016-08-22 23:01:00,0.0,Cramer: A Bunch of Semis Are Ripe for the Picking,0.0,1.0,0.0,0
2016-08-22 23:02:48,-0.2942,Cramer: Forget biotech! THIS is the next red-hot takeover group,0.196,0.804,0.0,-1
2016-08-22 23:19:00,-0.1027,Pfizer-Medivation cash deal is hard to justify: Analyst,0.167,0.833,0.0,-1
2016-08-23 00:04:30,0.0,PRESS DIGEST- British Business - August 23,0.0,1.0,0.0,0
2016-08-23 00:47:00,0.0,"BPMX Scores A Facelift, MDVN Says ""I Do"" To PFE, Europe Gets Its 1st HIV PrEP",0.0,1.0,0.0,0
2016-08-23 00:56:44,-0.6597,[$$] Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal,0.306,0.694,0.0,-1
2016-08-23 02:48:00,0.0,Deal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ,0.0,1.0,0.0,0
2016-08-23 02:48:00,0.0,Pfizer to Acquire Key Drug -- WSJ,0.0,1.0,0.0,0
2016-08-23 03:05:11,0.1027,The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation,0.177,0.625,0.198,1
2016-08-23 03:36:00,0.3818,M&A is key to Pfizer's sales growth: Strategist,0.0,0.729,0.271,1
2016-08-23 03:45:36,0.1027,Asian stocks in summer lull as markets await Yellen speech,0.0,0.865,0.135,1
2016-08-23 04:09:24,0.0,[$$] Pfizer to Buy Medivation for $14 Billion,0.0,1.0,0.0,0
2016-08-23 04:09:26,0.0,[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions,0.0,1.0,0.0,0
2016-08-23 04:18:41,0.0,PRESS DIGEST - Wall Street Journal - Aug 23,0.0,1.0,0.0,0
2016-08-23 04:23:40,0.0,PRESS DIGEST- New York Times business news - Aug 23,0.0,1.0,0.0,0
2016-08-23 07:53:00,0.5719,Jacobs Wins Contract For Pfizer Global Biotechnology Center In China,0.0,0.709,0.291,1
2016-08-23 08:41:24,0.0,"GLOBAL MARKETS-Stocks creep up amid Fed limbo, dollar dips",0.0,1.0,0.0,0
2016-08-23 08:50:08,-0.4019,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)",0.291,0.53,0.179,-1
2016-08-23 11:45:00,0.4019,Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China,0.0,0.787,0.213,1
2016-08-23 12:08:04,0.0,Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016,0.0,1.0,0.0,0
2016-08-23 12:41:00,0.34,3 Value Stocks Senior Citizens Could Buy Right Now,0.0,0.745,0.255,1
2016-08-23 12:45:57,0.0,What Pfizer Gets in Its $14 Billion Medivation Deal,0.0,1.0,0.0,0
2016-08-23 12:47:00,0.0,Medivation (MDVN) Stock Downgraded After Pfizer Deal,0.0,1.0,0.0,0
2016-08-23 12:58:07,0.0,Pfizer Has Had A Busy M&A Year...Or Has It?,0.0,1.0,0.0,0
2016-08-23 13:00:46,0.4939,"Health Care Sector Update for 08/23/2016: CEMP, BSPM, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-23 13:03:31,0.0,"Your first trade for Tuesday, August 23",0.0,1.0,0.0,0
2016-08-23 13:04:05,0.0,Pfizer’s Medivation Acquisition: What You Need to Know,0.0,1.0,0.0,0
2016-08-23 13:16:18,-0.6124,Pfizer Expands Cancer Drug Portfolio with the Acquisition of Medivation,0.319,0.58,0.101,-1
2016-08-23 13:30:18,0.0,"Deals of the Day: Apple Gets a Gliimpse, Pfizer's Steep Price",0.0,1.0,0.0,0
2016-08-23 13:38:49,-0.1027,"Tiger Cub Lee Ainslie Warns About Valuations, Reveals Major Q2 Moves",0.123,0.877,0.0,-1
2016-08-23 14:00:00,0.2023,Top 10 Shareholders of Pfizer (PFE),0.0,0.735,0.265,1
2016-08-23 14:10:02,0.0,"Stock Market News for August 23, 2016",0.0,1.0,0.0,0
2016-08-23 15:46:54,0.0,"Dow Movers: XOM, PFE",0.0,1.0,0.0,0
2016-08-23 18:39:00,0.8316,Pfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex?,0.0,0.476,0.524,1
2016-08-23 18:51:27,0.3182,"S&P 500, Nasdaq near records as housing data boosts stocks",0.0,0.796,0.204,1
2016-08-23 20:47:40,0.0,Stocks Finish Mixed Amid Summer Doldrums,0.0,1.0,0.0,0
2016-08-23 20:47:44,0.7906,"Why Intersil Corp (ISIL), Medivation Inc (MDVN) and United States Steel Corporation (X) Are 3 of Today’s Best Stocks",0.0,0.696,0.304,1
2016-08-23 20:48:17,0.7959,The 3 Best Fidelity ETFs … No Matter Who Wins the Election!,0.126,0.343,0.531,1
2016-08-23 21:09:46,0.4576,"After Hours Most Active for Aug 23, 2016 :  ESRX, AAPL, LMT, WIX, CSCO, MSFT, EMC, AMAT, WFT, PFE, BAC, C",0.0,0.857,0.143,1
2016-08-23 22:47:32,0.0,"Pfizer Acquires Medivation, Renews Biotech M&A Bets",0.0,1.0,0.0,0
2016-08-23 23:21:31,0.0,U.S. Market Indexes Higher on Tuesday,0.0,1.0,0.0,0
2016-08-24 02:14:00,0.0,Pfizer Acquires Rights Of AstraZeneca's Small Molecule Anti-infectives Business,0.0,1.0,0.0,0
2016-08-24 03:02:00,0.0,AstraZeneca Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Billion,0.0,1.0,0.0,0
2016-08-24 04:15:00,0.0,Pfizer Buys Part of AstraZeneca's Antibiotics Business,0.0,1.0,0.0,0
2016-08-24 04:15:00,0.0,AstraZeneca Sells Part of its Antibiotics Business to Pfizer,0.0,1.0,0.0,0
2016-08-24 04:15:00,0.0,AstraZeneca Sells Part of Antibiotics Business to Pfizer,0.0,1.0,0.0,0
2016-08-24 04:15:00,0.0,Pfizer Buys Part of AstraZeneca''s Antibiotics Business,0.0,1.0,0.0,0
2016-08-24 04:31:00,0.0,AstraZeneca Sells Part of its Antibiotics Business to Pfizer -- Update,0.0,1.0,0.0,0
2016-08-24 05:33:00,0.0,Pfizer Buys Part of AstraZeneca''s Antibiotics Business -- 2nd Update,0.0,1.0,0.0,0
2016-08-24 06:00:00,0.0,Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca,0.0,1.0,0.0,0
2016-08-24 06:09:54,0.0,Pfizer to Buy Antibiotics From AstraZeneca for $725 Million,0.0,1.0,0.0,0
2016-08-24 06:15:05,0.0,AstraZeneca to sell antibiotics business to Pfizer,0.0,1.0,0.0,0
2016-08-24 06:38:01,0.0,Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca,0.0,1.0,0.0,0
2016-08-24 07:48:21,0.0,Pfizer to buy antibiotics business from AstraZeneca,0.0,1.0,0.0,0
2016-08-24 08:32:58,0.0,AstraZeneca sells part of antibiotics unit to Pfizer,0.0,1.0,0.0,0
2016-08-24 09:56:08,0.0,What does AstraZeneca plc’s deal with Pfizer mean for shareholders?,0.0,1.0,0.0,0
2016-08-24 10:50:00,0.0,10 things you need to know today,0.0,1.0,0.0,0
2016-08-24 11:01:00,0.0,Pfizer Picks Up AstraZeneca's Antibiotics Business,0.0,1.0,0.0,0
2016-08-24 11:27:00,0.0,"U.S. stock futures search for firm direction, marooned in wait for Yellen",0.0,1.0,0.0,0
2016-08-24 12:00:23,-0.2263,Forget About That Pfizer Mega-Merger,0.322,0.678,0.0,-1
2016-08-24 12:00:29,0.0,Pfizer: Let's Stay Together,0.0,1.0,0.0,0
2016-08-24 12:08:53,0.4995,"Early movers: FIT, TSLA, PFE, LZB, CLVS, NMBL & more",0.0,0.712,0.288,1
2016-08-24 12:47:16,0.5719,Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract,0.0,0.619,0.381,1
2016-08-24 12:50:11,0.0,AstraZeneca selling antibiotic unit to Pfizer for $725M,0.0,1.0,0.0,0
2016-08-24 12:51:00,0.0,Stock Futures Little Changed in Wait for Friday's Yellen Speech,0.0,1.0,0.0,0
2016-08-24 13:00:22,0.0,"Apple, McDonald’s, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2",0.0,1.0,0.0,0
2016-08-24 13:04:00,0.296,Why Pfizer's Latest Deal Could Send Its Shares Soaring,0.0,0.784,0.216,1
2016-08-24 13:07:02,0.0,"Deals of the Day: Pfizer Does Another Deal, Bracing for a September IPO Spike",0.0,1.0,0.0,0
2016-08-24 13:40:34,-0.296,"Stocks Open Flat To Lower As Oil Dips; Lannett Surges, Intuit, Express Dive",0.155,0.845,0.0,-1
2016-08-24 13:45:18,0.0,AstraZeneca to sell molecule antibiotics business to Pfizer,0.0,1.0,0.0,0
2016-08-24 13:48:20,0.0,Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business,0.0,1.0,0.0,0
2016-08-24 13:56:01,0.0,"Stock Market News for August 24, 2016",0.0,1.0,0.0,0
2016-08-24 14:00:38,0.0,Write A Prescription For More Pharma M&A With This ETF,0.0,1.0,0.0,0
2016-08-24 14:11:02,0.0,"Market News Over Summer Vacation: PFE, AZN, TSLA, LZB",0.0,1.0,0.0,0
2016-08-24 14:19:56,-0.128,[$$] AstraZeneca and Pfizer strike $1.6bn antibiotics deal,0.176,0.824,0.0,-1
2016-08-24 14:56:04,-0.2732,Risk Arbitrage Trading Strategies,0.412,0.588,0.0,-1
2016-08-24 15:04:05,0.0,Medivation: The Latest Analyst Recommendations,0.0,1.0,0.0,0
2016-08-24 15:17:00,0.0,[$$] Smaller Biotech Buyout Targets After Medivation,0.0,1.0,0.0,0
2016-08-24 15:39:54,0.0,[$$] Pfizer Buys Part of AstraZeneca's Antibiotics Business,0.0,1.0,0.0,0
2016-08-24 16:00:00,0.0,Pfizer to Buy Rival's Antibiotics Business (PFN),0.0,1.0,0.0,0
2016-08-24 16:59:00,0.2023,"Top trades for the 2nd half: Lending Club, Amgen & more",0.0,0.833,0.167,1
2016-08-24 17:25:46,0.0,AstraZeneca to sell antibiotic pills business to Pfizer,0.0,1.0,0.0,0
2016-08-24 18:42:24,0.0,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?,0.0,1.0,0.0,0
2016-08-24 18:50:00,-0.6249,Stocks Extend Decline as Crude Falls to One-Week Low,0.43,0.444,0.126,-1
2016-08-24 19:41:00,0.1759,"Dear Pfizer, Stop Overpaying for Acquisitions!",0.242,0.44,0.318,1
2016-08-24 20:03:00,-0.4019,"Crude Oil, Health Care Team Up to Pull Wall Street Lower",0.345,0.468,0.187,-1
2016-08-24 20:50:18,0.0,Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears,0.206,0.588,0.206,0
2016-08-24 20:52:57,0.0,AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit,0.0,1.0,0.0,0
2016-08-24 21:11:59,0.0,Pfizer on buying spree with AstraZeneca antibiotics deal,0.0,1.0,0.0,0
2016-08-24 21:27:00,0.0,Portfolio Manager: Is Pfizer Acquiring Too Quickly?,0.0,1.0,0.0,0
2016-08-24 22:45:51,0.3818,"Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)",0.0,0.776,0.224,1
2016-08-24 22:46:37,0.0,"PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business",0.0,1.0,0.0,0
2016-08-24 22:46:55,0.0,"Trade of the Day: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)",0.0,1.0,0.0,0
2016-08-25 00:41:09,0.836,Which Criteria Best Determine the Success of Mergers?,0.0,0.432,0.568,1
2016-08-25 01:31:00,-0.4215,"HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN",0.189,0.732,0.079,-1
2016-08-25 01:35:00,0.0772,"HEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN",0.168,0.595,0.238,0
2016-08-25 02:48:00,0.0,Pfizer to Buy Some Of Astra's Antibiotics -- WSJ,0.0,1.0,0.0,0
2016-08-25 04:28:34,0.0,[$$] Pfizer Buys Part of AstraZeneca’s Antibiotics Business,0.0,1.0,0.0,0
2016-08-25 12:31:00,0.0,How Mylan And Pfizer Could Cause A Major Biotech Backlash,0.0,1.0,0.0,0
2016-08-25 12:45:54,0.4019,Major Pharma Short Interest Faces Significant Drop,0.193,0.367,0.44,1
2016-08-25 13:30:16,0.4588,"Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3",0.0,0.727,0.273,1
2016-08-25 13:53:01,0.0,"Company News for August 25, 2016",0.0,1.0,0.0,0
2016-08-25 14:35:59,0.2732,Pfizer Can Stall the Decision to Split — Thanks to Medivation,0.142,0.63,0.228,1
2016-08-25 15:04:05,0.0,AstraZeneca’s Recent Product Developments,0.0,1.0,0.0,0
2016-08-25 16:04:30,0.4019,Why Roche Might Be Interested in BioMarin,0.0,0.69,0.31,1
2016-08-25 16:45:49,0.0,"Biotech Funds Bounce After Another Steep, Hillary-Induced Sell-Off",0.0,1.0,0.0,0
2016-08-25 17:18:03,0.0,Pfizer Inks a $1.6 Billion Deal with AstraZeneca,0.0,1.0,0.0,0
2016-08-25 19:18:00,0.0,Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal,0.0,1.0,0.0,0
2016-08-25 19:19:08,0.0,Elliott Management Reduced Its Holding in Interpublic Group of Companies,0.0,1.0,0.0,0
2016-08-25 19:41:06,-0.4588,Will Pfizer Take a Beating After Its Celebrex Settlement?,0.3,0.7,0.0,-1
2016-08-25 19:45:02,0.0,Healthcare Drug Pricing a Factor for the Market on Wednesday,0.0,1.0,0.0,0
2016-08-25 20:47:24,-0.2003,Mylan NV (MYL): Stop Rewarding Big Pharma Greed!,0.382,0.368,0.25,-1
2016-08-25 21:45:41,-0.5267,Biotech Funds Are Routine Casualty As Political Rhetoric Ratchets Up,0.274,0.726,0.0,-1
2016-08-26 12:02:00,0.4019,"Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)",0.0,0.87,0.13,1
2016-08-26 13:20:00,0.2023,3 Top Stocks For Retirees,0.0,0.625,0.375,1
2016-08-26 13:24:01,0.5859,"Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win",0.0,0.703,0.297,1
2016-08-26 17:30:10,0.0,6 More Pharma Companies Selling Overpriced Drugs,0.0,1.0,0.0,0
2016-08-26 22:18:44,-0.6249,Can Novartis Tide Over the Alcon Crisis?,0.406,0.594,0.0,-1
2016-08-27 22:36:10,0.0,Here Are All The Big Biotech Mergers In 2016,0.0,1.0,0.0,0
2016-08-28 10:49:39,0.0,"3 Stocks Up Over 1,000% in the Past 5 Years",0.0,1.0,0.0,0
2016-08-28 18:40:40,-0.1779,[$$] Glaxo Bets It Can Shake Up HIV Treatment,0.175,0.825,0.0,-1
2016-08-29 04:09:48,-0.1779,Glaxo Bets It Can Shake Up HIV Treatment,0.195,0.805,0.0,-1
2016-08-29 12:05:46,0.0,What Investors Should Know about the Pfizer-Anacor Deal,0.0,1.0,0.0,0
2016-08-29 13:12:02,0.4939,"Health Care Sector Update for 08/29/2016: MYL, TNXP, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-29 13:44:00,0.7269,Why Pfizer Remains Attractively Valued With Medivation,0.0,0.45,0.55,1
2016-08-29 14:00:59,0.0,[$$] Mylan to launch cut-price generic version of EpiPen,0.0,1.0,0.0,0
2016-08-29 14:05:17,0.0,What’s the Story behind the Pfizer-Medivation Deal?,0.0,1.0,0.0,0
2016-08-29 15:05:02,0.2023,Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021,0.0,0.87,0.13,1
2016-08-29 15:21:52,0.0,"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated",0.0,1.0,0.0,0
2016-08-29 16:53:26,0.3612,Five Healthcare Stocks Hedge Funds Like,0.0,0.667,0.333,1
2016-08-29 16:55:00,0.0,Mondelez Walks Away After Hershey Spurns Raised Bid,0.0,1.0,0.0,0
2016-08-29 17:28:17,0.4019,Gilead Was Smart to Let Medivation Slip Through its Fingers,0.0,0.769,0.231,1
2016-08-29 19:04:10,0.0,Analyst Recommendations for Akorn in 2016,0.0,1.0,0.0,0
2016-08-29 20:21:43,0.0,Mylan To Launch Its Own EpiPen Generic Rival At Half Price,0.0,1.0,0.0,0
2016-08-30 13:13:12,0.4939,"Health Care Sector Update for 08/30/2016: PTLA, RIGL, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-08-30 14:13:19,0.0,What's Up With Mylan's EpiPen Pricing?,0.0,1.0,0.0,0
2016-08-30 15:08:00,0.7096,3 Bargain Stocks With Great Upside Potential,0.0,0.404,0.596,1
2016-08-30 15:18:58,0.8225,British tech champion ARM's sale to Japan's SoftBank wins shareholder nod,0.0,0.542,0.458,1
2016-08-30 16:11:53,0.0,"XLV, IELG: Big ETF Outflows",0.0,1.0,0.0,0
2016-08-30 16:38:00,0.0,U.S. Chamber of Commerce Files Suit Over Anti-Inversion Regs,0.0,1.0,0.0,0
2016-08-30 17:30:00,0.0,This Pharma Company Is Leading The Race For A Zika Vaccine,0.0,1.0,0.0,0
2016-08-30 18:04:19,0.0,Analyzing Johnson & Johnson’s Business Segments,0.0,1.0,0.0,0
2016-08-30 18:35:00,0.4019,FDA Approves Novartis's Biosimilar to Amgen's Enbrel,0.0,0.69,0.31,1
2016-08-30 18:35:00,0.4019,FDA Approves Novartis''s Biosimilar to Amgen''s Enbrel,0.0,0.69,0.31,1
2016-08-30 19:01:00,0.2732,Could Pfizer Face An Apple-Like Tax Surprise in the EU?,0.0,0.811,0.189,1
2016-08-30 22:04:19,0.4588,How StrataGraft Could Benefit Mallinckrodt’s Hospital Portfolio,0.0,0.667,0.333,1
2016-08-30 22:29:47,0.7672,Novartis wins US OK for biosimilar version of Amgen's Enbrel,0.0,0.547,0.453,1
2016-08-30 23:07:46,0.0,There’s More to Johnson & Johnson (JNJ) Than Meets the Eye,0.0,1.0,0.0,0
2016-08-31 11:00:00,-0.0772,XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer,0.173,0.627,0.2,0
2016-08-31 12:05:39,-0.4767,Why Pfizer’s Valuation Is Suffering,0.437,0.563,0.0,-1
2016-08-31 12:10:09,-0.3182,"Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment",0.284,0.516,0.2,-1
2016-08-31 12:23:00,0.0772,Morning Movers: Clovis Amends Pfizer Agreement; H&R Block Tumbles,0.221,0.534,0.244,0
2016-08-31 12:47:21,0.4939,"Health Care Sector Update for 08/31/2016: VEEV,CLVS,PFE",0.0,0.652,0.348,1
2016-08-31 14:05:13,0.0,Why Pfizer Is Trading at a Discount on an Earnings Basis,0.0,1.0,0.0,0
2016-08-31 15:05:02,0.3818,Will Xtandi Fuel Pfizer’s Top-Line Growth?,0.0,0.658,0.342,1
2016-08-31 15:06:00,0.4215,Here's a Reason Why Clovis Oncology (CLVS) Stock Is Gaining Today,0.0,0.763,0.237,1
2016-08-31 15:15:46,-0.6597,ARIAD Finishes Rolling NDA for Lung Cancer Drug Brigatinib,0.355,0.645,0.0,-1
2016-08-31 15:16:44,0.0,Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel,0.0,1.0,0.0,0
2016-08-31 15:20:36,0.0,3 Dividend Stocks to Make Your Retirement Sweeter,0.0,1.0,0.0,0
2016-08-31 16:25:00,0.3612,"Merck: Lung Cancer Lead Depends On ""How Smart It Plays Its Hand""",0.217,0.394,0.389,1
2016-08-31 16:43:00,-0.296,Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal,0.196,0.804,0.0,-1
2016-08-31 17:28:12,-0.25,[$$] Bidding War for Medivation Is Good News for Biotech,0.264,0.541,0.196,-1
2016-08-31 20:43:44,0.0,Novartis Closing Cell Therapy Unit; CAR-T Stocks Tumble,0.0,1.0,0.0,0
2016-08-31 20:49:40,0.0,Is Pfizer Paying Too Much to Buy Medivation?,0.0,1.0,0.0,0
2016-08-31 22:14:30,0.0299,Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth,0.162,0.667,0.171,0
2016-08-31 23:00:00,0.0,"CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod",0.0,1.0,0.0,0
2016-09-01 12:04:33,0.4404,A Look at Pfizer’s Innovative Health Business,0.0,0.633,0.367,1
2016-09-01 12:06:12,0.0,Is Eli Lilly’s Valuation Higher than Its Peers?,0.0,1.0,0.0,0
2016-09-01 13:17:34,0.4019,Blog Coverage FDA Approves Novartis Erelzi as Biosimilar to Amgens Enbrel,0.0,0.787,0.213,1
2016-09-01 13:19:54,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 02, 2016",0.0,1.0,0.0,0
2016-09-01 13:49:11,0.4939,Options Activity Shows Traders are Betting on a Recovery for This Health Care ETF,0.0,0.789,0.211,1
2016-09-01 14:04:16,0.0,How Pfizer’s Internal Medicine Core Drugs Are Performing,0.0,1.0,0.0,0
2016-09-01 15:04:13,0.0,Why Pfizer’s Vaccines Business Is Declining,0.0,1.0,0.0,0
2016-09-01 15:23:34,-0.4019,"Clovis Oncology Speeds Toward Possible Launch in Ovarian Cancer, but Red Flags Remain",0.184,0.816,0.0,-1
2016-09-01 15:25:15,-0.6597,Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU,0.328,0.672,0.0,-1
2016-09-02 12:04:21,0.0,An Overview of Pfizer’s Oncology Business,0.0,1.0,0.0,0
2016-09-02 14:04:10,-0.296,PFE to Enjoy Being Sole Provider of Key Breast Cancer Treatment,0.265,0.542,0.193,-1
2016-09-02 15:04:05,-0.5719,How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment,0.312,0.567,0.121,-1
2016-09-02 15:19:06,0.0,"Dow Movers: PFE, BA",0.0,1.0,0.0,0
2016-09-02 15:32:16,-0.25,Traders see limit to downside in Pfizer,0.25,0.75,0.0,-1
2016-09-02 17:17:48,-0.1027,"Dow 30 Stock Roundup: EC Asks Apple to Pay $14.5B, Cisco to Buy Software Management Startup, ContainerX",0.08,0.92,0.0,-1
2016-09-05 12:04:05,0.0,Why Pfizer’s Enbrel Faces a Sales Decline,0.0,1.0,0.0,0
2016-09-05 14:04:05,-0.1531,Will Sales of Xeljanz Offset Falling Sales of Enbrel?,0.167,0.833,0.0,-1
2016-09-05 14:04:15,0.0,How Are Eli Lilly’s New Products Performing?,0.0,1.0,0.0,0
2016-09-05 14:09:34,0.0,3 Retirement Stocks to Buy in September,0.0,1.0,0.0,0
2016-09-05 15:04:05,-0.1531,Why Are Revenues from Pfizer’s Rare Disease Portfolio Falling?,0.167,0.833,0.0,-1
2016-09-06 10:28:15,-0.2732,Low taxes at dozens of firms in spotlight after Apple ruling,0.174,0.826,0.0,-1
2016-09-06 11:48:33,0.0,Five Dividend Stocks You Should Look Into,0.0,1.0,0.0,0
2016-09-06 13:21:25,0.0,"Shire plc (SHPG) Ex-Dividend Date Scheduled for September 07, 2016",0.0,1.0,0.0,0
2016-09-06 13:37:23,0.4939,"Health Care Sector Update for 09/06/2016: TNXP, KPTI, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-09-06 14:00:00,0.0,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Morgan Stanley Global Healthcare Conference,0.0,1.0,0.0,0
2016-09-06 14:08:57,0.0,3 Cheap Dividend-Paying Stocks to Buy Now,0.0,1.0,0.0,0
2016-09-06 14:26:59,0.0,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",0.0,1.0,0.0,0
2016-09-06 15:00:00,0.0,Understanding Pfizer's Capital Structure (PFE),0.0,1.0,0.0,0
2016-09-06 20:00:00,-0.6597,3 Hottest Cancer Biotech Acquisition Targets After Medivation,0.423,0.577,0.0,-1
2016-09-07 12:09:10,0.0,Pfizer Appoints Chief Scientific Officer for Neuroscience Research,0.0,1.0,0.0,0
2016-09-07 15:17:13,-0.4019,Volatile September Likely After August Losses,0.351,0.649,0.0,-1
2016-09-07 22:18:08,0.25,Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys,0.161,0.593,0.246,1
2016-09-08 11:15:00,0.25,Pfizer To Present At Wells Fargo Healthcare Conference; Webcast At 12:15 PM ET,0.0,0.857,0.143,1
2016-09-08 12:57:35,0.4939,"Health Care Sector Update for 09/08/2016: BLRX, APRI, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-09-08 13:07:00,0.296,"AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics",0.0,0.896,0.104,1
2016-09-08 13:49:06,0.7245,One Of Forbes' 'Most Innovative Growth Companies' Nears Breakout,0.0,0.536,0.464,1
2016-09-08 14:45:32,0.0,[$$] Funding Snapshot: Immune-Drug Developer AnTolRx Raises $4M Series A,0.0,1.0,0.0,0
2016-09-08 15:39:10,0.0,5 Dividend Stocks to Put on Your Shopping List,0.0,1.0,0.0,0
2016-09-08 16:46:38,0.0,"Clinton’s Drug Proposals ‘Very Negative,’ Pfizer CEO Says",0.0,1.0,0.0,0
2016-09-08 17:08:48,-0.2732,Is Pfizer About to Slash Its Dividend?,0.259,0.741,0.0,-1
2016-09-08 18:17:53,-0.6597,Merck's Lung Cancer Drug Keytruda Under Priority Review,0.386,0.614,0.0,-1
2016-09-08 18:18:29,-0.5267,Pfizer CEO says Clinton plan to curb drug prices would hurt consumers,0.236,0.764,0.0,-1
2016-09-08 19:28:36,0.0,[$$] Chrono Therapeutics Raises $47.6M Series B for Smoking-Cessation Tech,0.0,1.0,0.0,0
2016-09-08 20:49:15,0.0,Clovis Oncology Up As FDA Skips Review Panel For New Drug,0.0,1.0,0.0,0
2016-09-09 13:48:59,0.0,The Biotech ETF With The Unusual Investment Strategy,0.0,1.0,0.0,0
2016-09-09 14:25:02,0.0,Medivation (MDVN) Scales New 52-Week High on Pfizer Deal,0.0,1.0,0.0,0
2016-09-09 14:58:58,-0.2799,Pfizer CEO: Clinton's plan to curb high drug prices would be 'very negative for innovation',0.201,0.655,0.144,-1
2016-09-09 15:28:05,0.0,Clinton spokeswoman defends drug plan after Pfizer comments,0.0,1.0,0.0,0
2016-09-09 19:46:00,0.0,Gilead Sciences: What is PARP?,0.0,1.0,0.0,0
2016-09-09 20:19:00,0.0,Pfizer’s Essential Health Business: What You Need to Know,0.0,1.0,0.0,0
2016-09-09 20:34:00,0.0,Teva Discusses EpiPen Comps as Host of Generics Unveiled,0.0,1.0,0.0,0
2016-09-09 21:00:02,0.3612,Five Dividend Stocks Billionaires Like,0.0,0.615,0.385,1
2016-09-09 21:09:41,0.4576,"After Hours Most Active for Sep 9, 2016 :  BAC, MSFT, T, GE, AAPL, XOM, PFE, JPM, XIV, CSCO, QQQ, FLEX",0.0,0.864,0.136,1
2016-09-09 22:04:32,-0.1531,Why Is Pfizer’s Legacy Brand Portfolio Falling?,0.211,0.789,0.0,-1
2016-09-09 22:32:27,0.0,5 Dow Jones Titans Getting Pulled Into the Selloff,0.0,1.0,0.0,0
2016-09-10 13:30:34,0.0,Pfizer Takes Aim at Johnson & Johnson,0.0,1.0,0.0,0
2016-09-11 16:30:44,0.0,Two Things You Must Understand About Biotech Investing,0.0,1.0,0.0,0
2016-09-11 21:09:48,-0.5719,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",0.291,0.709,0.0,-1
2016-09-12 12:05:10,0.0,Pfizer’s Hospira Deal: Catching Up a Year Later,0.0,1.0,0.0,0
2016-09-12 12:18:06,0.2584,"Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds",0.0,0.844,0.156,1
2016-09-12 13:10:24,0.0,FDA staff flags concerns about Pfizer's quit-smoking drug study,0.0,1.0,0.0,0
2016-09-12 13:28:18,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2016",0.0,1.0,0.0,0
2016-09-12 14:04:53,0.34,How Can Pfizer Revive Its Essential Health Business?,0.0,0.745,0.255,1
2016-09-12 14:13:49,0.0,"2 Biotech Stocks that Turned $8,000 into over $250,000",0.0,1.0,0.0,0
2016-09-12 14:13:50,0.4404,"Better Buy: Merck & Co., Inc. vs. Pfizer",0.0,0.674,0.326,1
2016-09-12 14:29:46,0.0,FDA Staff Question Pfizer’s Psychiatric Data on Chantix,0.0,1.0,0.0,0
2016-09-12 15:26:00,-0.1531,Will Pfizer (PFE) Stock Be Affected by FDA Chantix Study Scrutiny?,0.138,0.862,0.0,-1
2016-09-12 15:49:05,0.7245,This Forbes 'Most Innovative' Growth Stock Remains Near Buy Point,0.0,0.569,0.431,1
2016-09-12 16:33:41,0.5106,Is Clovis Oncology Still a Strong Buy?,0.0,0.602,0.398,1
2016-09-12 17:30:00,0.3818,5 Undervalued Dividend Stocks To Protect Your Portfolio,0.0,0.698,0.302,1
2016-09-13 11:25:00,0.4019,Major Pharma Continues to See Significant Drop in Short Interest,0.151,0.504,0.345,1
2016-09-13 13:47:00,0.0,5 Quality Dividend Names On The Cheap,0.0,1.0,0.0,0
2016-09-13 14:28:04,0.765,"Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression",0.154,0.375,0.471,1
2016-09-13 14:30:00,0.0,Pfizer To Present At Morgan Stanley Conference; Webcast At 3:30 PM ET,0.0,1.0,0.0,0
2016-09-13 14:46:48,-0.6249,Doctors Downplaying Drug’s Suicide Risks Attract FDA’s Scrutiny,0.468,0.355,0.177,-1
2016-09-13 14:48:07,0.0,Why Pfizer's Stock Is a Big Gamble Right Now,0.0,1.0,0.0,0
2016-09-13 15:49:02,0.4215,5 Biotech Stocks That Are Broker Favorites,0.0,0.641,0.359,1
2016-09-13 15:49:53,0.0,Biotech Stocks Bounce Back in Monday Trading: 3 Picks,0.0,1.0,0.0,0
2016-09-13 17:20:00,0.0,Big Pharma Spends Millions to Keep Prices High for California Agencies,0.0,1.0,0.0,0
2016-09-13 17:32:00,0.5719,Why Gilead Sciences Loves PARP…And You Should Too,0.0,0.654,0.346,1
2016-09-13 17:46:23,0.3818,Insight from Ray Dalio and Tim Geithner on the Credit Market,0.0,0.794,0.206,1
2016-09-13 19:01:07,-0.4019,3 Dividend Stocks to Buy in a Market Crash,0.31,0.69,0.0,-1
2016-09-13 19:27:00,0.0,"Pfizer (PFE) Stock Falls, Jefferies Drops Price Target",0.0,1.0,0.0,0
2016-09-13 21:05:28,0.4576,"After Hours Most Active for Sep 13, 2016 :  WFT, ACAS, MSFT, WFC, GE, ARCC, MTU, PFE, AAPL, AMAT, BAC, ON",0.0,0.864,0.136,1
2016-09-14 01:57:03,0.0,[$$] Takeda earmarks $15bn for US pharma acquisitions,0.0,1.0,0.0,0
2016-09-14 09:25:00,0.0,Allergan to Buy Vitae Pharmaceuticals for $639 Million,0.0,1.0,0.0,0
2016-09-14 10:01:00,-0.296,Here's Why Pfizer Is Headed Lower Before It Can Head Higher,0.18,0.82,0.0,-1
2016-09-14 12:25:16,0.0,Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale,0.0,1.0,0.0,0
2016-09-14 20:02:00,-0.7845,Pfizer Moves Closer to FDA Removing Suicide Warning From Smoking Cessation Pill Chantix,0.385,0.615,0.0,-1
2016-09-14 21:15:00,-0.7845,Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix,0.434,0.566,0.0,-1
2016-09-14 22:28:08,0.0258,"FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline)",0.121,0.754,0.126,0
2016-09-14 23:32:31,-0.2023,FDA panel recommends dropping serious warning on Pfizer's Chantix,0.319,0.517,0.164,-1
2016-09-14 23:47:26,-0.7845,[$$] Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix,0.408,0.592,0.0,-1
2016-09-15 02:54:00,-0.2023,"Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz",0.189,0.671,0.14,-1
2016-09-15 08:46:00,0.0,"Merck, Pfizer Announce Ertugliflozin Meets Primary Endpoint In Phase 3 Study",0.0,1.0,0.0,0
2016-09-15 09:13:00,0.5267,OncoImmune Reaches Option And License Agreement With Pfizer,0.0,0.577,0.423,1
2016-09-15 09:48:00,0.0,"Merck, Pfizer Diabetes Therapy Meets Late-Stage Study Goals",0.0,1.0,0.0,0
2016-09-15 11:58:26,0.25,"Wells Fargo, Twitter, Pfizer and More: Why Investors Are Yammering About These 5 Stocks",0.0,0.857,0.143,1
2016-09-15 12:00:37,-0.1779,PARP Wars: Biotech M&A's New Hope,0.343,0.381,0.276,-1
2016-09-15 12:41:12,0.0,Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial,0.0,1.0,0.0,0
2016-09-15 12:56:12,0.0,FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?,0.0,1.0,0.0,0
2016-09-15 13:07:00,-0.34,Pfizer's (PFE) Chantix Warning Could Be Removed After FDA Recommendation,0.211,0.789,0.0,-1
2016-09-15 13:13:22,0.4404,Better Buy: Pfizer Inc. vs. AbbVie Inc.,0.0,0.674,0.326,1
2016-09-15 14:18:09,0.0,Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes,0.0,1.0,0.0,0
2016-09-15 15:20:28,0.5574,Aerie (AERI) Stock Up on Positive Phase III Data on Roclatan,0.0,0.735,0.265,1
2016-09-15 15:32:03,-0.34,FDA Panel Suggests Removing Warning from Pfizer's Chantix,0.255,0.745,0.0,-1
2016-09-15 16:16:19,0.0,"Noteworthy ETF Inflows: IWD, JPM, PFE, MRK",0.0,1.0,0.0,0
2016-09-15 19:39:00,0.0,"Merck (MRK) Stock Higher, Joint Pfizer Diabetes Drug Meets Primary Endpoint",0.0,1.0,0.0,0
2016-09-15 21:06:57,0.4576,"After Hours Most Active for Sep 15, 2016 :  QQQ, MSFT, AAPL, PFE, YHOO, ACAS, FTR, ORCL, FCX, BAC, GE, OXY",0.0,0.864,0.136,1
2016-09-16 02:23:00,0.1779,"ARLZ Gets FDA Nod, ACRX Scores Hat Trick, OTIC On Watch, No Relief For NVAX",0.184,0.649,0.168,1
2016-09-16 07:38:00,0.5574,Pfizer Receives Positive CHMP Opinion For IBRANCE,0.0,0.625,0.375,1
2016-09-16 11:58:03,-0.2023,Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe,0.152,0.724,0.124,-1
2016-09-16 13:10:46,-0.5423,EMA panel recommends nod for Pfizer's breast cancer drug,0.331,0.526,0.143,-1
2016-09-16 13:19:25,0.0,Blog Coverage Aerie Pharma Glaucoma Drug Roclatan Surpasses Primary Goals at End Phase III Trials,0.0,1.0,0.0,0
2016-09-16 15:21:18,0.4417,CEOs say consumers are less confident,0.0,0.632,0.368,1
2016-09-16 15:22:13,0.5574,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data",0.0,0.769,0.231,1
2016-09-16 15:22:15,0.5574,Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III,0.0,0.66,0.34,1
2016-09-16 17:18:36,-0.0516,Pfizer Inc. May Get FDA Ok to Remove ‘Black Box’ Warning From Chantix,0.154,0.705,0.141,0
2016-09-16 17:28:15,-0.34,"Inside the FDA: Why The Pfizer, Inc. (PFE) Boxed Warning On Chantix Is Unlikely To Be Removed",0.13,0.87,0.0,-1
2016-09-16 18:08:10,0.0,"Kahn Brothers Trims Pfizer, Citigroup",0.0,1.0,0.0,0
2016-09-16 20:18:26,0.1531,VLUE: Isolate the Value Factor With This ETF,0.176,0.588,0.235,1
2016-09-16 21:24:00,0.5574,Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab),0.0,0.816,0.184,1
2016-09-16 22:18:02,-0.2263,"Forget Novavax, Buy These 4 Biotech Stocks Instead",0.241,0.759,0.0,-1
2016-09-17 17:20:48,0.0,Is This New Market the Biggest Investment Idea of the Decade?,0.0,1.0,0.0,0
2016-09-18 16:38:49,-0.3535,"GoPro, Oracle, Pfizer, and More: Traders Can’t Stop Watching These Stocks This Weekend",0.17,0.83,0.0,-1
2016-09-18 23:12:56,0.0,GE brings off-the-shelf biotech drug factories to Ireland,0.0,1.0,0.0,0
2016-09-19 08:15:00,0.0,Sanofi Files Suit Against Merck,0.0,1.0,0.0,0
2016-09-19 12:39:08,-0.5267,"GSK cuts vaccine price for refugees, bowing to pressure",0.386,0.614,0.0,-1
2016-09-19 13:25:17,0.0,"Pfizer’s on a Roll, Netflix Earns the Ire of Fox, Plus 2 Other Trending Stories",0.0,1.0,0.0,0
2016-09-19 19:57:45,0.0,Pfizer: Hospira Is Future; Xtandi Is Today's Meal,0.0,1.0,0.0,0
2016-09-19 22:50:37,-0.3089,A Breakdown Here In This Sector Would Not Be Healthy,0.22,0.78,0.0,-1
2016-09-19 22:56:00,0.7845,How To Predict The Next Sarepta (FDA Approval Stock) And Win Big,0.0,0.592,0.408,1
2016-09-19 23:26:08,-0.5574,Stocks Trade Lower Monday With Global Central Bank Uncertainty,0.397,0.603,0.0,-1
2016-09-20 10:50:10,-0.1531,Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing,0.289,0.395,0.316,-1
2016-09-20 12:08:02,0.0,[$$] Big pharma targets drug-resistant superbugs,0.0,1.0,0.0,0
2016-09-20 13:50:16,0.7579,5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November,0.0,0.581,0.419,1
2016-09-20 14:00:00,0.0,Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts,0.0,1.0,0.0,0
2016-09-20 17:30:00,-0.3182,This Hated Pharma Stock Has A Bright Future,0.347,0.413,0.24,-1
2016-09-20 21:09:43,0.0,This ETF bets that companies with female leadership will outperform,0.0,1.0,0.0,0
2016-09-21 14:04:59,0.0,How Procysbi Fits into Horizon’s Existing Orphan Drug Portfolio,0.0,1.0,0.0,0
2016-09-21 17:20:34,-0.4767,Sanofi Sues Merck Over Patent Infringement,0.383,0.617,0.0,-1
2016-09-21 20:32:58,0.7003,"'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs",0.0,0.547,0.453,1
2016-09-22 15:56:00,0.0,Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend,0.0,1.0,0.0,0
2016-09-22 16:22:56,0.0,"Dow Movers: V, UTX",0.0,1.0,0.0,0
2016-09-22 17:43:49,-0.4215,Lundbeck says Alzheimer's late-stage study fails,0.359,0.641,0.0,-1
2016-09-22 21:59:13,0.1027,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,339.52.",0.0,0.896,0.104,1
2016-09-22 23:21:27,-0.6249,"Why Axovant Sciences Ltd (AXON), Jabil Circuit, Inc. (JBL) and Virgin America Inc (VA) Are 3 of Today’s Worst Stocks",0.186,0.814,0.0,-1
2016-09-23 08:38:00,0.4767,Pfizer Gets U.S. Regulatory Approval For Medivation Takeover,0.0,0.693,0.307,1
2016-09-23 11:29:56,0.34,"UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure",0.172,0.547,0.281,1
2016-09-23 12:00:12,0.0,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO",0.0,1.0,0.0,0
2016-09-23 12:42:05,0.0,Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation,0.0,1.0,0.0,0
2016-09-23 13:28:00,0.0,[video]Takeover Chatter Around Clovis May Be Overdone,0.0,1.0,0.0,0
2016-09-23 18:12:06,0.7783,Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract,0.0,0.618,0.382,1
2016-09-23 20:07:24,0.128,Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails,0.214,0.534,0.252,1
2016-09-23 21:25:53,0.0,Teva’s Valuation Multiples Compared to Other Generic Drug Players,0.0,1.0,0.0,0
2016-09-23 22:21:15,0.0,The 5 Highest Dividend Payout Ratios on the Dow,0.0,1.0,0.0,0
2016-09-23 23:04:05,0.1779,Generics or Specialty: Which Mylan Segment Is Growing Fastest?,0.0,0.825,0.175,1
2016-09-25 17:04:26,-0.34,“Don’t fire until you see the whites of their eyes”,0.211,0.789,0.0,-1
2016-09-25 19:20:52,0.6808,Apple iPhone Calling Big Pharma: We Can Help You Develop Better Drugs,0.0,0.641,0.359,1
2016-09-26 06:59:00,0.4404,"Pfizer Says Not To Pursue Splitting Innovative Health, Essential Health Into Two",0.0,0.791,0.209,1
2016-09-26 07:21:00,0.0,Pfizer Won't Pursue a Split,0.0,1.0,0.0,0
2016-09-26 07:52:00,0.0,Pfizer Won''t Pursue a Split of Established and New Medical Lines -- Update,0.0,1.0,0.0,0
2016-09-26 10:45:00,0.0,Pfizer Won't Pursue a Split of Established and New Medical Lines,0.0,1.0,0.0,0
2016-09-26 10:45:00,0.0,Pfizer Throws Out Plan to Split Into Two Companies,0.0,1.0,0.0,0
2016-09-26 11:09:04,0.8271,Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation,0.0,0.535,0.465,1
2016-09-26 11:35:00,0.0,Pfizer Throws Out Plan to Split Into Two Companies -- 2nd Update,0.0,1.0,0.0,0
2016-09-26 12:23:00,-0.128,Stock Futures Fall With Clinton-Trump Showdown Looming,0.2,0.8,0.0,-1
2016-09-26 13:03:17,-0.4215,US STOCKS-Wall St set to open lower as presidential debate looms,0.297,0.703,0.0,-1
2016-09-26 13:20:44,0.0,"Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma",0.0,1.0,0.0,0
2016-09-26 14:05:03,-0.1779,"US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials",0.145,0.855,0.0,-1
2016-09-26 14:08:07,0.0,US shares open lower on profit-taking,0.262,0.476,0.262,0
2016-09-26 14:24:12,0.0,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,0.0,1.0,0.0,0
2016-09-26 14:28:15,0.0,"Why Pfizer, Netflix, Amazon.com, Deutsche Bank, and Cal-Maine Foods Are Trending",0.0,1.0,0.0,0
2016-09-26 14:52:00,0.0,Pfizer Decides Not to Split Business,0.0,1.0,0.0,0
2016-09-26 15:10:22,0.0,Pfizer Decides Against the Split,0.0,1.0,0.0,0
2016-09-26 15:20:00,0.4939,Stocks Fall as Health Care Slumps Ahead of Presidential Debate,0.0,0.738,0.262,1
2016-09-26 15:20:21,0.0,US STOCKS-Wall St drops as Pfizer falls; presidential debate eyed,0.0,1.0,0.0,0
2016-09-26 15:21:07,0.0,"Dow Movers: PFE, AAPL",0.0,1.0,0.0,0
2016-09-26 15:22:36,0.0,Pfizer Can Conquer by Not Dividing,0.0,1.0,0.0,0
2016-09-26 15:24:00,0.0,Pfizer: Split Decision,0.0,1.0,0.0,0
2016-09-26 15:57:00,0.0,"Pfizer (PFE) Stock Declines, Bernstein: More Deals Seem Likely",0.0,1.0,0.0,0
2016-09-26 18:43:56,0.0,US STOCKS-Wall St falls as investors brace for presidential debate,0.0,1.0,0.0,0
2016-09-26 18:46:05,0.4404,"For Pfizer, Bigger as One May Be Better Than Smaller With Two",0.0,0.791,0.209,1
2016-09-26 18:48:00,0.4588,These Investors Are Glad Pfizer Has Decided Not to Split,0.0,0.75,0.25,1
2016-09-26 19:12:06,0.0,Drugmaker Pfizer decides not to break up business,0.0,1.0,0.0,0
2016-09-26 19:39:38,0.0,Pfizer decides against split-up; more deals seen likely,0.0,1.0,0.0,0
2016-09-26 20:01:11,0.0,"Goldman Sachs, JPMorgan Sink DJIA Monday",0.0,1.0,0.0,0
2016-09-26 20:03:00,-0.4215,Wall Street Sells Off on Worries Over Clinton-Trump Showdown,0.259,0.741,0.0,-1
2016-09-26 20:30:48,-0.6486,Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger,0.35,0.65,0.0,-1
2016-09-26 20:32:02,0.0,"Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema",0.0,1.0,0.0,0
2016-09-26 21:15:00,0.0,US STOCKS-Wall St drops as investors brace for presidential debate,0.0,1.0,0.0,0
2016-09-26 22:00:02,0.0,How the Dow Jones industrial average fared on Monday,0.0,1.0,0.0,0
2016-09-26 22:05:00,0.0,[$$] Pfizer Won't Split and Neither Should Investors,0.0,1.0,0.0,0
2016-09-26 22:21:27,0.0,"Regeneron, Sanofi Skin Disease Drug Under Priority Review",0.0,1.0,0.0,0
2016-09-26 23:23:36,0.0,Presidential Debate a Factor for the Market This Week,0.0,1.0,0.0,0
2016-09-27 01:37:49,0.0,[$$] Overheard,0.0,1.0,0.0,0
2016-09-27 04:59:51,0.0,PRESS DIGEST - Wall Street Journal - Sept 27,0.0,1.0,0.0,0
2016-09-27 10:59:22,0.0,[$$] Pfizer Throws Out Plan to Split Into Two Companies,0.0,1.0,0.0,0
2016-09-27 11:40:49,0.4588,Major Pharma Continues to See Rising Tide in Short Interest,0.0,0.75,0.25,1
2016-09-27 13:15:00,0.0,Blog Coverage US Pharma Giant Pfizer to Whole as one Complete Unit,0.0,1.0,0.0,0
2016-09-27 13:21:44,0.6249,Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company,0.0,0.728,0.272,1
2016-09-27 13:49:00,-0.6597,Is This Pfizer's Next Mega-Blockbuster Cancer Drug?,0.423,0.577,0.0,-1
2016-09-27 16:06:27,0.0,Eli Lilly Stock Upgraded: What You Need to Know,0.0,1.0,0.0,0
2016-09-27 16:24:43,0.0,Pfizer (PFE) to Stay Together as a Single Company After All,0.0,1.0,0.0,0
2016-09-27 18:12:22,0.0,Markets In Monotone Mode Despite Post-Debate Rally,0.0,1.0,0.0,0
2016-09-27 18:22:23,0.0,What Gives With Biosimilars?,0.0,1.0,0.0,0
2016-09-27 22:22:18,0.0,Opko Health Has Big News on Deck,0.0,1.0,0.0,0
2016-09-28 09:00:00,0.0,Pfizer Completes Acquisition Of Medivation,0.0,1.0,0.0,0
2016-09-28 10:00:00,0.4215,Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress,0.0,0.851,0.149,1
2016-09-28 11:51:00,0.2023,"Today's Top 5 Stock Picks: Pfizer, Apple, GE, More",0.0,0.795,0.205,1
2016-09-28 13:09:09,0.0,Pfizer Completes Acquisition of Medivation,0.0,1.0,0.0,0
2016-09-28 13:29:00,-0.3818,Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer,0.271,0.729,0.0,-1
2016-09-28 15:43:35,0.0,"Why Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today",0.0,1.0,0.0,0
2016-09-28 22:21:55,0.0,"Why Exelixis, Inc. Got Hammered Today",0.0,1.0,0.0,0
2016-09-29 12:45:06,0.128,Trade extends bearish position in Pfizer,0.0,0.769,0.231,1
2016-09-29 14:03:02,0.0,7 Healthcare Stocks in Focus on World Heart Day,0.0,1.0,0.0,0
2016-09-29 14:24:16,0.0,How Oncology Could Move the Needle for Johnson & Johnson's Stock,0.0,1.0,0.0,0
2016-09-29 15:24:58,0.0,Why Apple Inc. Could Slide 20% This Year (AAPL),0.0,1.0,0.0,0
2016-09-29 16:23:48,0.765,"Dow 30 Stock Roundup: Nike Earnings Impress, Boeing Wins $8B Saudi Order",0.0,0.602,0.398,1
2016-09-29 18:42:36,0.0,How Does Pfizer’s Valuation Compare?,0.0,1.0,0.0,0
2016-09-29 20:01:09,0.0,"Goldman, Merck Lead DJIA Thursday Plunge",0.0,1.0,0.0,0
2016-09-29 20:03:00,-0.4404,"Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street",0.353,0.504,0.144,-1
2016-09-29 20:23:22,-0.2023,"U.S. Stocks Sell Off On Deutsche Bank Worries, But Oil Plays Surge",0.189,0.676,0.135,-1
2016-09-29 21:04:11,0.0,A Look at the Pfizer-Medivation Deal,0.0,1.0,0.0,0
2016-09-29 22:04:12,0.0,The Pfizer-Anacor Deal: A Review,0.0,1.0,0.0,0
2016-09-29 22:59:51,-0.4019,Deutsche Bank's Losses Affecting the Market on Thursday,0.278,0.722,0.0,-1
2016-09-29 23:22:10,0.0,"Why Exelixis, Inc. Continued Its Downfall Today",0.0,1.0,0.0,0
2016-09-30 12:06:02,0.4404,Pfizer’s Innovative Health and Essential Health Businesses,0.0,0.674,0.326,1
2016-09-30 13:41:40,0.4939,"Health Care Sector Update for 09/30/2016: JNJ, PFE, ABT, MRK, AMGN, AUPH, THLD",0.0,0.789,0.211,1
2016-09-30 14:05:31,0.3818,Which Products Were Key Contributors to Pfizer’s Revenue Growth?,0.0,0.755,0.245,1
2016-09-30 15:05:21,0.0,Which Pfizer Products Reported Declining Sales?,0.0,1.0,0.0,0
2016-09-30 16:24:40,0.4767,ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan,0.0,0.721,0.279,1
2016-09-30 16:24:50,-0.4215,"Exelixis, Inc. (EXEL) Crushed on CaboNivo Drug Trial Results",0.259,0.741,0.0,-1
2016-09-30 16:56:03,0.6249,"Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry",0.0,0.579,0.421,1
2016-09-30 17:21:43,-0.296,"Midday Update: Deutsche Bank Takes Pressure off Wall Street, Dow Races Higher",0.167,0.833,0.0,-1
2016-09-30 17:25:20,0.0,The Highest-Yielding Drug Stocks,0.0,1.0,0.0,0
2016-09-30 18:45:00,0.2023,3 Top Healthcare Stocks to Buy Now,0.0,0.735,0.265,1
2016-09-30 23:24:05,0.5267,US Market Indexes Gain on Friday,0.0,0.595,0.405,1
2016-10-01 12:23:00,0.4588,Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors,0.0,0.769,0.231,1
2016-10-01 18:21:11,0.0,Vanguard Windsor II: Vanguard’s Oddball,0.0,1.0,0.0,0
2016-10-03 11:00:00,0.1585,Stock Market Outlook: A Little Too Buoyant?,0.0,0.755,0.245,1
2016-10-03 12:04:58,0.0,Major Product Developments for Pfizer,0.0,1.0,0.0,0
2016-10-03 14:37:07,-0.4228,Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company,0.219,0.781,0.0,-1
2016-10-03 15:05:05,0.0,What’s the Outlook for Pfizer?,0.0,1.0,0.0,0
2016-10-03 15:44:27,0.0,"Dow Movers: PFE, DD",0.0,1.0,0.0,0
2016-10-03 16:44:20,0.0,"Noteworthy ETF Inflows: VLUE, PFE, GM, JPM",0.0,1.0,0.0,0
2016-10-03 19:44:29,-0.4588,Allergan PLC’s Charm-and-Merger Offensive (AGN),0.429,0.571,0.0,-1
2016-10-03 22:15:00,0.4767,Samsung Affiliate Seeks European Approval for Near-Replica of Herceptin,0.0,0.721,0.279,1
2016-10-03 22:45:00,0.34,Samsung BioLogics IPO Could Value Firm at $8.2 Billion,0.0,0.769,0.231,1
2016-10-03 22:45:00,0.4767,Samsung Affiliate Seeks European Approval for Herceptin Copy,0.0,0.693,0.307,1
2016-10-04 01:53:00,0.34,Samsung BioLogics IPO Could Value Firm at $8.2 Billion -- 2nd Update,0.0,0.821,0.179,1
2016-10-04 04:02:37,0.0,Corrections & Amplifications,0.0,1.0,0.0,0
2016-10-04 05:05:00,-0.4215,AstraZeneca's Brilinta Fails Arterial Disease Drug Trial,0.318,0.682,0.0,-1
2016-10-04 05:55:00,0.0,Correction to Samsung BioLogics story,0.0,1.0,0.0,0
2016-10-04 12:42:12,0.0,5 FDA Decisions to Watch Out for in October 2016,0.0,1.0,0.0,0
2016-10-04 13:14:05,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 05, 2016",0.0,1.0,0.0,0
2016-10-04 14:05:02,0.5719,Roche Alecensa Wins Second Breakthrough Status in the U.S.,0.0,0.684,0.316,1
2016-10-04 14:44:14,0.0,"Nope, Gilead Sciences Won’t Get Bought out",0.0,1.0,0.0,0
2016-10-04 16:15:00,-0.3182,J&J Warns Insulin Pump Vulnerable to Cyber Hacking,0.355,0.645,0.0,-1
2016-10-04 20:47:02,-0.2263,Dynavax Technologies Corporation (DVAX) Steals Back Gains on Pending Heplisav Treatment,0.224,0.612,0.163,-1
2016-10-05 02:48:00,0.0,Samsung Group Furthers Drug Push -- WSJ,0.0,1.0,0.0,0
2016-10-05 04:51:45,0.34,[$$] Samsung BioLogics IPO Could Value Firm at $8.2 Billion,0.0,0.789,0.211,1
2016-10-05 12:43:14,0.2023,"How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)",0.0,0.833,0.167,1
2016-10-05 13:30:01,0.0,"The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals",0.0,1.0,0.0,0
2016-10-05 13:49:31,0.0,Biotech Mergers Run the Show: 5 Small-Cap Stocks for Q4,0.0,1.0,0.0,0
2016-10-05 15:22:52,0.0,"If You're in Your 60s, Consider Buying These 3 Stocks",0.0,1.0,0.0,0
2016-10-05 15:45:56,0.4215,3 Insights FuelCell Energy's Management Is Sharing With Investors,0.0,0.714,0.286,1
2016-10-05 16:28:57,0.0,"Pfizer Inc. : PFE-US: Dividend Analysis : August 05th, 2016 (record date) : By the numbers : October 5, 2016",0.0,1.0,0.0,0
2016-10-05 18:42:20,-0.5267,Three Cancer Plays For The Fourth Quarter Of 2016,0.328,0.522,0.149,-1
2016-10-05 20:04:55,0.0,Eli Lilly Looks To Corral More Animal-Health Business Vs. Zoetis,0.0,1.0,0.0,0
2016-10-06 01:57:11,0.1779,3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity,0.176,0.588,0.235,1
2016-10-06 08:05:00,0.0,ICU Medical Investor Conference Call At 8:30 AM ET,0.0,1.0,0.0,0
2016-10-06 08:07:00,0.0,ICU Medical To Acquire Pfizer's Hospira In $1 Bln Deal - Quick Facts,0.0,1.0,0.0,0
2016-10-06 09:34:00,-0.4767,ICU Medical Inc. (ICUI) Has Broken Out To A New High After Acquisition,0.22,0.78,0.0,-1
2016-10-06 10:05:00,0.0,ICU Medical To Buy Pfizer Unit in $1 Billion Deal,0.0,1.0,0.0,0
2016-10-06 11:28:00,0.0,Pfizer To Sell New York City Headquarters By End Of Next Year,0.0,1.0,0.0,0
2016-10-06 11:41:00,0.0,Pfizer To Sell New York City Headquarters By End Of Next Year -- Update,0.0,1.0,0.0,0
2016-10-06 11:45:00,0.0,Pfizer to Sell New York Headquarters By End of 2017,0.0,1.0,0.0,0
2016-10-06 11:54:47,0.0,ICU Medical to Buy Pfizer’s Infusion Unit for $1 Billion,0.0,1.0,0.0,0
2016-10-06 11:59:04,0.0,ICU Medical Inc. to Acquire the Hospira Infusion Systems Business from Pfizer Inc. for $1 Billion in Cash and Stock,0.0,1.0,0.0,0
2016-10-06 12:02:33,0.0,ICU Medical to buy Pfizer's infusion therapy business for $1 bln,0.0,1.0,0.0,0
2016-10-06 12:09:04,0.0,ICU Medical Inc. To Acquire The Hospira Infusion Systems Business From Pfizer Inc. For $1 Billion In Cash And Stock,0.0,1.0,0.0,0
2016-10-06 13:38:07,0.0,[$$] ICU Medical To Buy Pfizer Unit in $1 Billion Deal,0.0,1.0,0.0,0
2016-10-06 13:57:51,-0.2263,US STOCKS-Wall St falls as health stocks drag,0.213,0.787,0.0,-1
2016-10-06 15:03:00,0.0,How Will Pfizer (PFE) Stock React to $1 Billion ICU Medical Deal?,0.0,1.0,0.0,0
2016-10-06 15:24:07,0.0,"Here’s Why Traders Are Watching Tesla, ICU Medical, Pfizer, and Two Other Stocks Today",0.0,1.0,0.0,0
2016-10-06 15:30:26,0.0,Pfizer to sell Hospira infusion therapy business to ICU Medical,0.0,1.0,0.0,0
2016-10-06 16:02:51,0.0,[$$] Pfizer to Sell New York Headquarters By End of 2017,0.0,1.0,0.0,0
2016-10-06 16:03:18,0.0,Pfizer says to seek more modern Manhattan headquarters,0.0,1.0,0.0,0
2016-10-06 17:25:28,0.0,[$$] The Designer Shoebox: Studio Apartments That Use Every Inch,0.0,1.0,0.0,0
2016-10-06 19:22:00,0.0,Pfizer Sells Infusion Therapy Business (PFE),0.0,1.0,0.0,0
2016-10-06 20:01:52,0.0,"American Express, Wal-Mart Weigh on DJIA Thursday",0.0,1.0,0.0,0
2016-10-06 20:23:30,0.4939,"Health Care Sector Update for 10/06/2016: PFE,PHMD,ALNY",0.0,0.652,0.348,1
2016-10-06 20:41:54,0.0,Twitter and Wal-Mart fall; ICU Medical and Lam Research jump,0.0,1.0,0.0,0
2016-10-06 20:43:40,0.2023,7 Top Stocks to Buy in October,0.0,0.735,0.265,1
2016-10-06 20:45:00,0.0,Pfizer to Sell Its Aging Headquarters (PFE),0.0,1.0,0.0,0
2016-10-06 21:11:32,0.0,Pfizer to seek more modern headquarters in Manhattan,0.0,1.0,0.0,0
2016-10-06 21:15:00,0.0,ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal,0.0,1.0,0.0,0
2016-10-06 22:44:07,0.296,Why Opko Health Shares Rallied 14% in September,0.0,0.761,0.239,1
2016-10-06 23:43:37,0.0,"Why ICU Medical, Big 5 Sporting Goods, and Caesars Acquisition Jumped Today",0.0,1.0,0.0,0
2016-10-07 04:11:29,0.0,[$$] Pfizer to Sell New York City Headquarters By End of Next Year,0.0,1.0,0.0,0
2016-10-07 16:44:48,0.0,Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B,0.0,1.0,0.0,0
2016-10-07 18:28:24,0.0,Did Pfizer's No-Split Decision Cost Investors a Lot of Money?,0.0,1.0,0.0,0
2016-10-08 06:15:00,-0.3182,Novartis Targets Breast Cancer Drug Approval to Take on Pfizer,0.284,0.516,0.2,-1
2016-10-08 06:15:01,-0.2023,Novartis challenges Pfizer with strong breast cancer drug data,0.293,0.4,0.307,-1
2016-10-08 15:45:00,-0.2484,The trillion-dollar reason why Wall Street should take gender diversity more seriously,0.153,0.847,0.0,-1
2016-10-09 11:05:06,0.0,3 Tax Loopholes Hillary Clinton Wants to Close,0.0,1.0,0.0,0
2016-10-09 14:53:02,0.5719,Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC),0.0,0.749,0.251,1
2016-10-09 15:13:33,-0.3542,3 Cancer Drugs That Could Get an FDA OK Next Year,0.287,0.522,0.191,-1
2016-10-09 19:30:55,0.0,Mindset Shifts Take Time,0.0,1.0,0.0,0
2016-10-09 20:15:00,0.0,Encouraging Results For Ribociclib In Advanced Breast Cancer,0.297,0.338,0.365,0
2016-10-10 03:01:00,-0.2023,Pfizer: Positive Results From SUTENT Trial As Adjuvant Therapy In Renal Cancer,0.244,0.556,0.2,-1
2016-10-10 06:15:00,0.7845,First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal,0.0,0.734,0.266,1
2016-10-10 06:15:01,-0.6597,Exelixis and Pfizer drugs face off in kidney cancer,0.355,0.645,0.0,-1
2016-10-10 06:53:04,0.7845,First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal,0.0,0.734,0.266,1
2016-10-10 07:08:00,0.128,Pfizer Says Kidney Drug Extends Disease-Free Survival in Adjuvant Setting,0.0,0.857,0.143,1
2016-10-10 07:32:33,-0.6597,Exelixis and Pfizer drugs compete in kidney cancer trial,0.355,0.645,0.0,-1
2016-10-10 11:13:13,0.0,3 Cheap Dividend Stocks That Could Rally Higher,0.0,1.0,0.0,0
2016-10-10 17:18:40,0.0,"Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades",0.0,1.0,0.0,0
2016-10-10 18:19:19,0.0,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here),0.0,1.0,0.0,0
2016-10-10 20:20:21,-0.1531,Merck Topples Bristol-Myers On Lung Cancer Drug Win,0.31,0.423,0.268,-1
2016-10-11 12:04:43,0.0,What Do Analysts Have to Say about Bristol-Myers Squibb?,0.0,1.0,0.0,0
2016-10-11 13:21:06,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2016",0.0,1.0,0.0,0
2016-10-11 13:26:35,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2016",0.0,1.0,0.0,0
2016-10-11 16:05:09,-0.6597,"October 11, 2016 - Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study",0.145,0.855,0.0,-1
2016-10-11 16:18:51,0.296,"VLUE, WMT, PFE, GM: ETF Inflow Alert",0.0,0.732,0.268,1
2016-10-11 17:25:00,0.0,"Pfizer's Kidney Drug Faces a New Rival (EXEL, PFE)",0.0,1.0,0.0,0
2016-10-11 17:36:22,0.5106,Why Doctors Without Borders is turning down a million free pneumonia vaccines from Pfizer,0.0,0.784,0.216,1
2016-10-11 21:17:12,0.0,Investors Are Finally Getting With The Fed's Program — Are You?,0.0,1.0,0.0,0
2016-10-11 21:20:00,0.5499,[$$] The Health-Care Sector Is Anything but Healthy,0.0,0.664,0.336,1
2016-10-12 11:35:07,0.0,Major Pharma Short Sellers Grow More Selective,0.0,1.0,0.0,0
2016-10-12 11:56:00,0.0,Is Biopharma Productivity In A Sharp Decline?,0.0,1.0,0.0,0
2016-10-12 13:07:00,0.0,Is Pfizer Beginning to Hit Bottom?,0.0,1.0,0.0,0
2016-10-12 18:55:49,0.4404,Pfizer Inc. (PFE): Safe And Steady Dividends,0.0,0.674,0.326,1
2016-10-12 20:13:24,0.4215,"Fed Hawks Are Gaining Sway, September Meeting Minutes Show",0.0,0.741,0.259,1
2016-10-13 02:40:41,0.4404,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Roche Holding AG",0.0,0.734,0.266,1
2016-10-13 07:25:00,-0.3182,Pfizer Loses UK Appeal Court Patent Case Over Lyrica,0.223,0.777,0.0,-1
2016-10-13 11:06:38,-0.6808,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,0.318,0.682,0.0,-1
2016-10-13 12:04:00,-0.296,"Pfizer (PFE) Stock Slides, Jefferies Cuts to 'Hold'",0.239,0.761,0.0,-1
2016-10-13 12:10:52,-0.3182,Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug,0.204,0.796,0.0,-1
2016-10-13 12:30:00,0.0,"Morning Movers: WFC, PFE, AMZN, GS, MS",0.0,1.0,0.0,0
2016-10-13 12:30:00,0.0,"This Drug Stock's Pattern Says, 'Sell Now!'",0.0,1.0,0.0,0
2016-10-13 13:21:00,0.4939,"Health Care Sector Update for 10/13/2016: FLKS, TGTX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-10-13 16:08:48,-0.3818,[$$] Pfizer vows to persist in court battle over Lyrica,0.224,0.776,0.0,-1
2016-10-13 16:30:31,0.4404,Does Pfizer Deserve a Better Valuation?,0.0,0.58,0.42,1
2016-10-13 17:49:00,0.0,"Street Talk: AAPL, HCA & more",0.0,1.0,0.0,0
2016-10-13 18:04:00,-0.3182,Lack of Catalysts Keeps Analysts Away From Pfizer,0.247,0.753,0.0,-1
2016-10-13 18:04:14,0.3818,What Are Pfizer’s Major Growth Concerns?,0.0,0.658,0.342,1
2016-10-13 20:04:11,0.5267,Did Pfizer’s Top Line Growth Beat Its Peers?,0.0,0.577,0.423,1
2016-10-13 20:09:21,0.5859,Prothena Slammed On Politics; Could Win Eli Lilly Or Pfizer Partnership,0.0,0.725,0.275,1
2016-10-13 20:17:11,0.0,"Apple Price Target Raised; Gigamon, GrubHub Rated Buys",0.0,1.0,0.0,0
2016-10-13 20:29:13,-0.34,Pfizer Will Likely Overpay For M&A Post-Allergan Breakup Flop: Jeffries,0.211,0.789,0.0,-1
2016-10-13 21:00:03,0.0,Exelixis Goes for It,0.0,1.0,0.0,0
2016-10-13 21:32:36,0.2023,Treasury takes its latest step to keep corporate taxes in the US,0.0,0.859,0.141,1
2016-10-13 22:08:54,-0.296,US Market Indexes Lower on Thursday,0.306,0.694,0.0,-1
2016-10-14 12:04:53,0.3818,Four Key Deals: Analyzing Pfizer’s Impending Growth,0.0,0.698,0.302,1
2016-10-14 13:01:03,0.4939,"Health Care Sector Update for 10/14/2016: NHTC, EGLT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-10-14 13:42:57,0.0258,3 Figures That Matter Most When Johnson & Johnson Reports Its 3rd-Quarter Results,0.0,0.901,0.099,0
2016-10-14 13:43:21,0.0,A Guide to Conservative Income Producing Option Strategies for Dividend Stocks,0.0,1.0,0.0,0
2016-10-14 14:04:37,0.0,Pfizer’s Divestment of Hospira Infusion Systems,0.0,1.0,0.0,0
2016-10-14 15:00:09,0.1779,3 Big-Cap Stocks That Are Growing Again,0.0,0.746,0.254,1
2016-10-14 15:04:38,0.0,How Much Is Pfizer’s Return Potential?,0.0,1.0,0.0,0
2016-10-14 15:43:53,0.0,Merck KGaA Offers Portfolio Updates at Market Day Event,0.0,1.0,0.0,0
2016-10-14 15:44:38,0.0,"Pharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus",0.0,1.0,0.0,0
2016-10-14 22:04:19,0.0,How Will Johnson & Johnson Fare Revenue-Wise in 3Q16?,0.0,1.0,0.0,0
2016-10-14 22:42:05,0.0,Is Opko Health On the Cusp of a Big Year?,0.0,1.0,0.0,0
2016-10-15 14:30:00,0.0,Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016,0.0,1.0,0.0,0
2016-10-17 10:00:00,0.0,Making Sense of Merger-Arbitrage Funds,0.0,1.0,0.0,0
2016-10-17 13:42:57,0.0,What to Expect from J&J's (JNJ) Pharmaceutical Segment in Q3?,0.0,1.0,0.0,0
2016-10-17 13:43:18,-0.5267,Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis,0.236,0.764,0.0,-1
2016-10-17 15:04:21,0.2732,Johnson & Johnson’s Expected Profitability in 3Q16,0.0,0.704,0.296,1
2016-10-17 15:43:53,0.0,"The Zacks Analyst Blog Highlights: Mylan, Pfizer, Roche, Merck and Bristol-Myers",0.0,1.0,0.0,0
2016-10-17 17:56:30,0.0,What to expect from Johnson & Johnson earnings,0.0,1.0,0.0,0
2016-10-17 18:25:00,0.0,Pfizer Plans to Launch Remicade Biosimilar in November,0.0,1.0,0.0,0
2016-10-17 18:58:10,0.0,Pfizer Refuses to Go the Spinoff Route,0.0,1.0,0.0,0
2016-10-17 19:01:00,0.0,Pfizer Plans to Launch Remicade Biosimilar in November -- Update,0.0,1.0,0.0,0
2016-10-17 20:13:21,0.2023,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing",0.0,0.816,0.184,1
2016-10-17 20:33:07,0.0,Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb),0.0,1.0,0.0,0
2016-10-17 20:49:28,0.0,Pfizer set to start shipping Remicade biosimilar next month,0.0,1.0,0.0,0
2016-10-17 21:47:48,0.2023,Alzheimer's Remains a Top Priority for Big Pharma,0.0,0.769,0.231,1
2016-10-17 22:01:14,0.0,Pfizer to start shipping biosimilar version of J&J's Remicade in November,0.0,1.0,0.0,0
2016-10-17 22:16:06,0.296,Pfizer to launch cheaper version of J&J immune drug Remicade,0.0,0.804,0.196,1
2016-10-17 22:50:22,0.0,[$$] Pfizer Plans to Launch Remicade Biosimilar in November,0.0,1.0,0.0,0
2016-10-17 23:07:00,0.0,Pfizer To Begin Shipment Of Biosimilar INFLECTRA To Wholesalers In Nov,0.0,1.0,0.0,0
2016-10-18 07:55:00,-0.128,J&J Brushes Off Looming Biosimilar Competition,0.231,0.769,0.0,-1
2016-10-18 12:31:48,-0.1531,Pharma giants poised for biosimilar battle,0.302,0.465,0.233,-1
2016-10-18 13:56:00,0.6884,"J&J says pharma future bright, despite threat to Remicade",0.0,0.552,0.448,1
2016-10-18 14:42:27,-0.1531,Pharma giants poised to battle over biosimilar medicine,0.245,0.566,0.189,-1
2016-10-18 14:54:45,0.0,"Why Visa, Johnson and Johnson, Pfizer, and Two Other Stocks Are in Spotlight Today",0.0,1.0,0.0,0
2016-10-18 15:49:00,0.0,Why Johnson & Johnson is Tanking,0.0,1.0,0.0,0
2016-10-18 15:50:23,0.5106,J&J (JNJ) Outshines in Q3 Earnings on Strong Pharma Sales,0.0,0.732,0.268,1
2016-10-18 15:50:47,0.0,Pfizer to Launch Remicade Biosimilar in U.S. in November,0.0,1.0,0.0,0
2016-10-18 15:59:10,0.6059,Johnson & Johnson tops 3Q Street view but shares decline,0.0,0.586,0.414,1
2016-10-18 16:06:41,-0.5994,[$$] J&J prepares for drug price war with Pfizer,0.328,0.672,0.0,-1
2016-10-18 16:13:11,-0.128,[$$] J&J Brushes Off Looming Biosimilar Competition,0.2,0.8,0.0,-1
2016-10-18 18:15:00,0.0,Johnson & Johnson: 3 Reasons the Selloff is Overblown,0.0,1.0,0.0,0
2016-10-18 18:15:48,-0.5106,J&J shares lose ground on fears of Pfizer's answer to Remicade,0.35,0.51,0.14,-1
2016-10-18 18:19:01,-0.3612,Pfizer's Remicade Rudeness Shouldn't Faze J&J,0.333,0.667,0.0,-1
2016-10-18 20:47:29,0.4939,"Health Care Sector Update for 10/18/2016: JNJ,PFE,ABEO,ICCC",0.0,0.652,0.348,1
2016-10-18 21:21:03,0.0,Eli Lilly’s 3Q16 Earnings: What to Expect,0.0,1.0,0.0,0
2016-10-19 01:46:43,0.0,How to Trade Stocks in the After-Hours,0.0,1.0,0.0,0
2016-10-19 02:48:00,0.0772,J&J Brushes Off Pfizer's Challenge -- WSJ,0.0,0.822,0.178,0
2016-10-19 04:11:08,0.0258,"[$$] Johnson & Johnson Brushes Off Looming Biosimilar Competition, Posts Solid Results",0.124,0.744,0.132,0
2016-10-19 08:11:00,0.6369,Pfizer Awarded Grant From Bill & Melinda Gates Foundation - Quick Facts,0.0,0.606,0.394,1
2016-10-19 12:00:00,0.7783,Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection,0.0,0.562,0.438,1
2016-10-19 13:47:38,0.4939,Health Care Sector Update for 10/19/2016: PFE,0.0,0.652,0.348,1
2016-10-19 13:49:36,0.0,"Key Takeaways from JNJ's Q3 Call: Remicade, Pipeline, Acquisitions",0.0,1.0,0.0,0
2016-10-19 14:27:59,-0.7351,WHO seeks new mechanism for crisis vaccine supplies at low cost,0.408,0.592,0.0,-1
2016-10-19 16:49:04,0.0,"Noteworthy ETF Inflows: VYM, PFE, WMT, LLY",0.0,1.0,0.0,0
2016-10-19 16:51:09,0.0,"Stock Market News for October 19, 2016",0.0,1.0,0.0,0
2016-10-19 21:38:56,0.0,Seven New Stocks in My Purloined Portfolio,0.0,1.0,0.0,0
2016-10-19 22:18:06,0.3612,CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine),0.0,0.878,0.122,1
2016-10-20 12:00:00,-0.6597,"Debiopharm International SA Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer in Cancer Immunotherapy",0.227,0.773,0.0,-1
2016-10-20 13:50:02,0.0,The 3 Biggest Stories From Johnson & Johnson's Third-Quarter Report,0.0,1.0,0.0,0
2016-10-20 14:24:39,0.4404,Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc,0.0,0.674,0.326,1
2016-10-20 14:29:02,0.0,7 Drug Stocks to Consider as Biosimilars Pick Up Pace,0.0,1.0,0.0,0
2016-10-20 15:30:17,0.0,"Zacks Market Edge Highlights: Pfizer, Netflix, Baidu, Johnson & Johnson and Domino's Pizza",0.0,1.0,0.0,0
2016-10-20 21:05:22,0.4576,"After Hours Most Active for Oct 20, 2016 :  BAC, BBVA, MSFT, CA, CTSH, QQQ, ALKS, PYPL, VZ, PBR, KKR, PFE",0.0,0.864,0.136,1
2016-10-21 14:08:46,0.5267,"Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources",0.0,0.746,0.254,1
2016-10-21 14:10:07,0.5267,"Advent, Bain gain edge in bid for Pfizer's Brazil venture - sources",0.0,0.746,0.254,1
2016-10-21 15:24:21,0.0,"XLV, ZSL: Big ETF Outflows",0.0,1.0,0.0,0
2016-10-21 15:27:08,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals",0.0,1.0,0.0,0
2016-10-21 15:55:00,-0.1779,FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer,0.219,0.547,0.234,-1
2016-10-21 20:26:15,0.5719,Billionaire Ken Fisher Loves These Dividend Stocks,0.0,0.619,0.381,1
2016-10-23 14:23:00,0.0,The Biggest Mergers & Acquisitions In The U.S.,0.0,1.0,0.0,0
2016-10-24 04:00:13,-0.296,[$$] A CEO's primer on how to manage under pressure,0.216,0.784,0.0,-1
2016-10-24 12:06:20,0.0,Analyst Recommendations for Pfizer and Its Peers in 2016,0.0,1.0,0.0,0
2016-10-24 14:05:33,0.6597,Treating Epilepsy Is One of Pfizer’s Solid Growth Prospects,0.0,0.484,0.516,1
2016-10-24 14:28:02,0.0258,Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?,0.241,0.511,0.248,0
2016-10-24 15:04:56,0.3818,Eliquis Proving to Be a Major Growth Driver for Pfizer This Year,0.0,0.794,0.206,1
2016-10-24 18:56:53,0.0,What Presidential Election? Deal Making Has Biggest Week Since 1999,0.0,1.0,0.0,0
2016-10-24 20:19:18,-0.3818,Ariad Could Follow Gilead's — Or Mylan's — Route In Drug Price Battle,0.206,0.794,0.0,-1
2016-10-25 12:04:27,0.296,Toviaz Expected to Report Stable Revenues in 2016,0.0,0.761,0.239,1
2016-10-25 14:04:26,0.4019,Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit,0.0,0.722,0.278,1
2016-10-25 14:04:59,0.0,Update on Roche’s Analyst Recommendations,0.0,1.0,0.0,0
2016-10-25 14:27:25,-0.3182,Merck Keytruda Gets FDA Approval for First-Line Lung Cancer,0.303,0.483,0.214,-1
2016-10-25 15:04:16,0.0,Viagra May Witness a Decline in Revenues in 2016,0.0,1.0,0.0,0
2016-10-25 15:45:42,0.0,Bristol-Myers Squibb’s 3Q16 Earnings: What’s Expected,0.0,1.0,0.0,0
2016-10-25 16:27:14,0.0,5 Healthcare Stocks to Buy Despite a Clinton Victory,0.0,1.0,0.0,0
2016-10-25 16:36:04,0.0,"Analyst Reports for AT&T, Pfizer & General Mills",0.0,1.0,0.0,0
2016-10-25 20:06:17,-0.4215,Ex-Oppenheimer adviser to plead guilty in U.S. to insider trading,0.237,0.763,0.0,-1
2016-10-25 21:04:08,0.4576,"After Hours Most Active for Oct 25, 2016 :  EPD, AAPL, RAI, NRG, ETE, CHK, PFE, QQQ, EBAY, KHC, ADI, MSFT",0.0,0.864,0.136,1
2016-10-25 21:48:55,-0.5994,Ex-Oppenheimer adviser pleads guilty to U.S. insider trading charges,0.412,0.588,0.0,-1
2016-10-25 23:22:08,-0.4215,Ex-Oppenheimer & Co. worker pleads guilty to insider trading,0.286,0.714,0.0,-1
2016-10-26 11:40:58,0.0,Short Sellers Grow More Selective on Major Pharma Stocks,0.0,1.0,0.0,0
2016-10-26 12:04:09,0.4019,Interesting Trend Developing for Pfizer’s Pneumococcal Franchise,0.0,0.69,0.31,1
2016-10-26 14:04:05,0.0,Enbrel Facing Competition from Biosimilar Versions of the Drug,0.0,1.0,0.0,0
2016-10-26 14:52:30,0.0,"The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner",0.0,1.0,0.0,0
2016-10-26 15:04:05,0.3818,Xeljanz ER Is Driving Growth for Pfizer This Year,0.0,0.755,0.245,1
2016-10-26 22:16:12,0.0,How Do Pfizer’s Valuation Multiples Compare with Those of Other Oncology Players in 2016?,0.0,1.0,0.0,0
2016-10-27 10:00:00,0.0258,'Mad Money' Lightning Round: Dollar Tree Has 'Been in Free Fall',0.206,0.581,0.213,0
2016-10-27 11:02:45,0.4404,Better Buy: Eli Lilly and Co vs. Pfizer,0.0,0.707,0.293,1
2016-10-27 12:04:05,0.5994,Pfizer Expects Ibrance to Become a Blockbuster Therapy,0.0,0.606,0.394,1
2016-10-27 12:05:38,0.0,Pfizer Continues to Work on Ibrance Label Expansion in 2016,0.0,1.0,0.0,0
2016-10-27 12:56:00,0.128,Biggest Biotech IPO Of 2016 Is Launched By 31 Year Old,0.0,0.87,0.13,1
2016-10-27 13:45:00,-0.6597,AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials,0.386,0.614,0.0,-1
2016-10-27 14:05:08,0.4019,Xalkori Label Expansion May Boost Pfizer’s Sales in 2016,0.0,0.748,0.252,1
2016-10-27 15:04:51,-0.1531,Inlyta Expected to Witness Competitive Pressures in 2016,0.23,0.6,0.17,-1
2016-10-27 15:37:03,0.0,Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?,0.0,1.0,0.0,0
2016-10-27 15:44:34,0.0,These 3 Dividend Stocks Are the Place To Be Today,0.0,1.0,0.0,0
2016-10-27 16:28:00,0.0,Pfizer Files 8K - Changes Executive Management,0.0,1.0,0.0,0
2016-10-27 17:44:14,0.0,"Bristol-Myers (BMY) Beats on Q3 Earnings, Ups 2016 View",0.0,1.0,0.0,0
2016-10-27 20:08:00,0.0,The Woman At The Center Of The Biggest Biotech IPO Of The Year,0.0,1.0,0.0,0
2016-10-27 20:44:38,0.0,Using VIX In A Stock Portfolio,0.0,1.0,0.0,0
2016-10-28 02:35:00,0.4404,Sanofi Lifts Profit Outlook,0.0,0.508,0.492,1
2016-10-28 12:04:33,0.8481,New Label Expansion May Help Boost Sutent’s Growth Prospects,0.0,0.329,0.671,1
2016-10-28 13:16:06,0.0,Pfizer calls piling up before earnings,0.0,1.0,0.0,0
2016-10-28 14:04:20,0.0,Pfizer Aims to Position Avelumab as Backbone Immuno-Oncology Therapy,0.0,1.0,0.0,0
2016-10-28 14:34:59,0.6705,"Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod",0.0,0.645,0.355,1
2016-10-28 15:04:12,-0.6597,Medivation Adds Leading Prostate Cancer Drug Xtandi to Pfizer’s Oncology Portfolio,0.306,0.694,0.0,-1
2016-10-28 16:07:00,0.0,3 ETFs to Buy if You Think Pfizer Will Beat Earnings,0.0,1.0,0.0,0
2016-10-28 19:34:14,0.0,ARIAD (ARIA): Is a Beat in the Cards this Earnings Season?,0.0,1.0,0.0,0
2016-10-28 22:02:41,0.0,What Can We Expect of Pfizer’s 3Q16 Earnings?,0.0,1.0,0.0,0
2016-10-30 14:05:25,0.2023,8 Top Earnings for the Week Ahead,0.0,0.735,0.265,1
2016-10-30 17:01:15,0.3595,Reflation Alert!,0.0,0.286,0.714,1
2016-10-31 03:41:00,0.0,EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma,0.0,1.0,0.0,0
2016-10-31 06:52:00,0.0,Wall Street May Bounce Back,0.0,1.0,0.0,0
2016-10-31 07:00:00,0.34,European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma,0.0,0.876,0.124,1
2016-10-31 12:04:16,-0.6597,Pfizer’s Xtandi Researched as a Therapy for Early Stage Prostate Cancer,0.328,0.672,0.0,-1
2016-10-31 12:06:08,0.3818,Can Pfizer Recover Growth in 3Q16 Earnings?,0.0,0.698,0.302,1
2016-10-31 14:04:15,0.0,Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs,0.0,1.0,0.0,0
2016-10-31 14:05:17,0.3818,Understanding the Growth Contributors in Pfizer’s 3Q16 Estimates,0.0,0.729,0.271,1
2016-10-31 14:25:49,0.0,What to Expect From Pfizer Earnings,0.0,1.0,0.0,0
2016-10-31 15:04:05,0.0,What Analysts Are Recommending for Pfizer and Other Major Oncology Players in 2016,0.0,1.0,0.0,0
2016-10-31 15:05:14,0.3818,Products Offsetting Growth in Pfizer’s 3Q16 Estimates,0.0,0.698,0.302,1
2016-10-31 15:19:00,0.0,Pfizer Opens The Books And The Medicine Cabinets,0.0,1.0,0.0,0
2016-10-31 20:00:34,0.0,5 Stocks to Watch Before the Market Opens Tomorrow,0.0,1.0,0.0,0
2016-10-31 20:01:58,0.0,"Amgen, Gilead, Eli Lilly Eat Into AbbVie's Humira Sales: Analyst",0.0,1.0,0.0,0
2016-10-31 20:14:26,0.694,"Pre-Market Earnings Report for November 1, 2016 :  PFE, OXY, SHPG, ECL, LYB, BP, EMR, ICE, AEP, TRI, ETN, K",0.0,0.782,0.218,1
2016-10-31 20:19:51,-0.1027,"Pfizer Q3 Sales Challenged By Eli Lilly, Novartis Amid Breakup Bust",0.123,0.877,0.0,-1
2016-10-31 21:01:00,0.25,Win-win election plays,0.0,0.5,0.5,1
2016-11-01 00:14:21,0.2023,3 Top Earnings Charts in a Busy Week,0.0,0.735,0.265,1
2016-11-01 05:05:00,0.5574,Positive China Data Buoys Global Stocks,0.0,0.581,0.419,1
2016-11-01 05:05:00,0.0,Stocks Open Month With a Thud,0.0,1.0,0.0,0
2016-11-01 07:36:00,0.4404,Pfizer Q3 Profit Falls; To Discontinue Bococizumab Development Program,0.0,0.734,0.266,1
2016-11-01 07:38:00,0.0,Pfizer Q3 16 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2016-11-01 07:55:00,-0.296,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",0.239,0.761,0.0,-1
2016-11-01 08:15:00,-0.296,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- Update",0.196,0.804,0.0,-1
2016-11-01 09:05:00,-0.5423,Shire Cuts Guidance After Posting Third-Quarter Loss,0.474,0.526,0.0,-1
2016-11-01 09:22:00,0.0,U.S. Hot Stocks: Hot Stocks to Watch,0.0,1.0,0.0,0
2016-11-01 09:38:00,0.0,Three things to watch in Pfizer's earnings,0.0,1.0,0.0,0
2016-11-01 09:53:00,0.5574,Positive China Data Buoy Global Stocks,0.0,0.581,0.419,1
2016-11-01 10:33:04,-0.0772,"Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor",0.126,0.874,0.0,0
2016-11-01 10:52:00,-0.296,Shire Cuts Guidance After Posting Third-Quarter Loss--Update,0.268,0.732,0.0,-1
2016-11-01 10:54:54,0.0,"Earnings Reaction History: Pfizer Inc, 40.0% Follow-Through Indicator, 1.4% Sensitive",0.0,1.0,0.0,0
2016-11-01 11:03:07,0.0,Pfizer Reports Third-Quarter 2016 Results,0.0,1.0,0.0,0
2016-11-01 11:21:29,0.0,Pfizer third quarter earnings tumble 38% to $1.3 bn,0.0,1.0,0.0,0
2016-11-01 11:32:00,0.0,"Stocks, Bonds Kick Off November With Declines",0.0,1.0,0.0,0
2016-11-01 12:03:00,-0.296,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- 2nd Update",0.18,0.82,0.0,-1
2016-11-01 13:34:40,0.0,Stock Futures Trade Higher on Chinese Manufacturing Data,0.0,1.0,0.0,0
2016-11-01 13:52:27,0.0,US STOCKS-Wall St little changed; Fed in focus,0.0,1.0,0.0,0
2016-11-01 14:04:42,0.2732,What Will Be Pfizer’s Profitability in 3Q16?,0.0,0.741,0.259,1
2016-11-01 14:17:00,-0.5574,"Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab",0.397,0.603,0.0,-1
2016-11-01 14:18:48,-0.34,Pfizer (PFE) Misses on Q3 Earnings and Sales; Lowers View,0.298,0.702,0.0,-1
2016-11-01 14:41:00,0.0,Pfizer Caught In Drug Price Maelstrom (PFE),0.0,1.0,0.0,0
2016-11-01 14:43:00,-0.5096,"Pfizer Q3 'Wasn't Great, Wasn't Bad': More Squawk From Jim Cramer",0.248,0.752,0.0,-1
2016-11-01 14:59:49,0.0,[$$] Big Pharma Sales Need a Booster Shot​,0.0,1.0,0.0,0
2016-11-01 15:14:42,0.296,"Tuesday’s Vital Data: Facebook Inc (FB), Alibaba Group Holding Ltd (BABA) and Pfizer Inc. (PFE)",0.0,0.864,0.136,1
2016-11-01 15:35:00,-0.296,"US STOCKS-Wall St lower amid election jitters, tepid data",0.216,0.784,0.0,-1
2016-11-01 15:48:25,-0.296,"[$$] Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",0.216,0.784,0.0,-1
2016-11-01 15:58:43,0.0,Pfizer Unexpectedly Ends Cholesterol Drug Trial,0.0,1.0,0.0,0
2016-11-01 16:05:00,0.0,Pfizer: It's Never Just the Earnings,0.0,1.0,0.0,0
2016-11-01 16:18:40,-0.34,"Fed Meets, Q3 Earnings Continue, Election Uncertainty Rules",0.255,0.745,0.0,-1
2016-11-01 16:21:00,0.0,Stocks Kick Off November With Declines,0.0,1.0,0.0,0
2016-11-01 16:23:19,-0.3182,"Pfizer earnings tumble on lost patents, higher costs",0.247,0.753,0.0,-1
2016-11-01 17:00:05,-0.4767,[$$] Pfizer cancels cholesterol drug trial and cuts earnings forecast,0.339,0.661,0.0,-1
2016-11-01 17:06:37,-0.296,US STOCKS-Wall St extends losses on election jitters,0.265,0.588,0.147,-1
2016-11-01 17:16:09,-0.7003,PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril,0.459,0.541,0.0,-1
2016-11-01 17:33:07,-0.2263,"Pfizer net plunges 38 pct., misses Street 3Q forecasts",0.192,0.808,0.0,-1
2016-11-01 17:34:25,0.0,[$$] Shire Hit by Fall in Sales of Hemophilia Drugs,0.0,1.0,0.0,0
2016-11-01 17:34:48,-0.5719,"Midday Update: Wall Street Stays Negative as Focus Shifts to Election, NFP",0.252,0.748,0.0,-1
2016-11-01 18:14:09,0.0,Tuesday's ETF with Unusual Volume: DHS,0.0,1.0,0.0,0
2016-11-01 18:16:13,0.2732,Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters,0.0,0.811,0.189,1
2016-11-01 18:29:00,-0.7964,"Stocks Extend Losses Amid Election Uncertainty, Crude Falls",0.607,0.276,0.117,-1
2016-11-01 18:57:28,0.0,3 Things You Really Need to Know About Pfizer's Q3 Results,0.0,1.0,0.0,0
2016-11-01 19:01:29,-0.34,"US STOCKS-Wall St rattled by U.S. election, rate uncertainty",0.231,0.769,0.0,-1
2016-11-01 19:08:00,-0.296,"Pfizer's Ian Read Sees No Size Limit to M&A, But Says Industry Is on Pause",0.136,0.864,0.0,-1
2016-11-01 19:36:02,-0.4019,"US STOCKS-Wall St shaken by U.S. election, rate uncertainty",0.346,0.654,0.0,-1
2016-11-01 19:58:37,0.4404,"Pfizer Bails on Boco, Better Late Than Never",0.0,0.707,0.293,1
2016-11-01 20:06:04,-0.296,Markets Right Now: Stocks end lower ahead of US election,0.196,0.804,0.0,-1
2016-11-01 20:10:41,-0.128,"Pfizer Ends Cholesterol Drug Development, Lowers EPS Guidance",0.176,0.824,0.0,-1
2016-11-01 20:23:51,0.296,"Pfizer cholesterol drug fizzles, hitting shares",0.0,0.694,0.306,1
2016-11-01 20:36:20,-0.34,"US STOCKS-U.S. election, rate uncertainty rattle Wall Street",0.255,0.745,0.0,-1
2016-11-01 20:41:00,-0.6705,"Stocks Drop As Fed Meeting Starts; Apple, Pfizer Biggest Losers On Dow",0.355,0.645,0.0,-1
2016-11-01 20:48:34,0.0,"Market Close Report: NASDAQ Composite index closes at 5,153.58 down -35.56 points",0.0,1.0,0.0,0
2016-11-01 21:04:21,0.4576,"After Hours Most Active for Nov 1, 2016 :  YUMC, QCP, AA, GES, BAC, CSCO, PFE, AAPL, INTC, MENT, MSFT, GILD",0.0,0.864,0.136,1
2016-11-01 21:10:16,0.0,Business Highlights,0.0,1.0,0.0,0
2016-11-01 23:00:00,-0.6115,Cramer Remix: The most negative thing this earnings seaso...,0.333,0.667,0.0,-1
2016-11-02 02:48:00,0.0,Pfizer Ends Cholesterol-Drug Chase -- WSJ,0.0,1.0,0.0,0
2016-11-02 03:08:37,0.296,Asian shares languish as jittery investors eye 2016 election,0.0,0.784,0.216,1
2016-11-02 03:38:30,0.0,Edited Transcript of PFE earnings conference call or presentation 1-Nov-16 2:00pm GMT,0.0,1.0,0.0,0
2016-11-02 04:53:00,-0.4019,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA",0.184,0.816,0.0,-1
2016-11-02 06:22:17,0.6705,Pfizer vaccine Prevenar gains approval in China,0.0,0.476,0.524,1
2016-11-02 07:11:05,0.4019,China approves Pfizer vaccine Prevenar,0.0,0.597,0.403,1
2016-11-02 08:18:59,0.34,Global Blood Therapeutics: Incredible Value At This Price,0.0,0.745,0.255,1
2016-11-02 11:03:00,-0.296,Pfizer Soft Earnings the Latest Reason to Avoid Big Pharma Stocks,0.18,0.82,0.0,-1
2016-11-02 12:04:14,-0.4588,Merck’s 3Q16 Valuation Cheat Sheet,0.429,0.571,0.0,-1
2016-11-02 13:05:42,0.2023,"Top Analyst Upgrades and Downgrades: Brookdale Senior Living, Frontier Communications, Nike, Norfolk Southern, Pfizer, Nucor, Xylem and More",0.0,0.904,0.096,1
2016-11-02 13:16:40,0.0,"Corcept (CORT) Beats on Q3 Earnings, Lifts Sales Guidance",0.0,1.0,0.0,0
2016-11-02 13:17:00,0.0,"Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX",0.0,1.0,0.0,0
2016-11-02 13:20:05,0.4767,Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China,0.0,0.795,0.205,1
2016-11-02 14:04:02,0.0,"Stock Market News for November 02, 2016",0.0,1.0,0.0,0
2016-11-02 15:05:00,-0.296,"Pfizer (PFE) Stock Lower, BMO Capital Downgrades on Q3 Results",0.196,0.804,0.0,-1
2016-11-02 15:09:06,0.4939,Pfizer Delivers Another Solid Quarter Of Organic Growth,0.0,0.588,0.412,1
2016-11-02 15:35:00,0.0,Pfizer: Don't Buy the Dip,0.0,1.0,0.0,0
2016-11-02 15:40:00,0.0,"Pfizer Scraps New Cholesterol Drug (PFE, AMGN)",0.0,1.0,0.0,0
2016-11-02 17:37:03,0.1779,Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer,0.18,0.571,0.249,1
2016-11-02 19:08:22,0.296,"Pfizer Q3 Earnings Review: Performance On Expected Lines, Future Outlook Is Stable",0.0,0.833,0.167,1
2016-11-02 19:22:00,0.6486,"Look to Pfizer (PFE), Church & Dwight if Interest Rates Increase, Stifel Nicolaus' Morganlander Says",0.0,0.694,0.306,1
2016-11-03 11:00:00,0.0,It’s time to prepare your portfolio for the Fed’s next move — here’s how,0.0,1.0,0.0,0
2016-11-03 15:08:02,0.2263,Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity,0.0,0.909,0.091,1
2016-11-03 15:09:00,-0.296,Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge,0.196,0.804,0.0,-1
2016-11-03 15:09:23,0.0,Novartis Takes Aim at Pfizer,0.0,1.0,0.0,0
2016-11-03 15:10:11,0.0,Drug Stocks to Watch for Earnings on Nov 4; REGN & More,0.0,1.0,0.0,0
2016-11-03 16:04:55,-0.4404,Pharma's Woes Go Beyond Election,0.42,0.58,0.0,-1
2016-11-03 20:27:09,0.25,"S&P 500 and Nasdaq Poised for Eighth Day of Declines as Facebook, Election Jitters Weigh",0.0,0.875,0.125,1
2016-11-03 20:34:14,0.2263,Stock market falls for 8th straight session,0.0,0.759,0.241,1
2016-11-03 20:48:52,0.0,"Market Close Report: NASDAQ Composite index closes at 5,058.41 down -47.16 points",0.0,1.0,0.0,0
2016-11-03 21:03:00,0.0,Health Sector Down As Report of Industry Price Collusion Surfaces,0.0,1.0,0.0,0
2016-11-03 21:07:14,0.25,"Close Update: S&P 500 and Nasdaq Poised for Eighth Day of Declines as Facebook, Election Jitters Weigh",0.0,0.889,0.111,1
2016-11-03 21:08:09,0.2263,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why,0.0,0.863,0.137,1
2016-11-04 03:44:00,-0.5994,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark",0.294,0.609,0.096,-1
2016-11-04 08:18:05,0.0,Pharma Industry Outlook - November 2016,0.0,1.0,0.0,0
2016-11-04 08:35:00,0.3818,Regeneron Revenue Growth Slows,0.0,0.536,0.464,1
2016-11-04 12:05:11,0.0,How Does Pfizer's Dividend Stack Up?,0.0,1.0,0.0,0
2016-11-04 14:15:20,0.0,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More",0.0,1.0,0.0,0
2016-11-04 14:26:06,0.0,"Stock Indexes Edge Up, Russell 2000 Up 0.5%; Starbucks Pops 3.5%",0.0,1.0,0.0,0
2016-11-04 15:08:43,0.0,"Noteworthy ETF Inflows: IVE, JPM, WMT, PFE",0.0,1.0,0.0,0
2016-11-04 15:12:54,0.0,"Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen",0.0,1.0,0.0,0
2016-11-04 16:23:24,0.0,"Dow Movers: XOM, NKE",0.0,1.0,0.0,0
2016-11-04 16:26:32,0.0,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies",0.0,1.0,0.0,0
2016-11-04 20:11:12,0.0,Regeneron Bounds On EPS Beat; Stock Muzzled On Amgen Drug Brouhaha,0.0,1.0,0.0,0
2016-11-05 11:23:07,0.4588,Donald Trump's Corporate Tax Repatriation Plan Would Benefit These 5 Companies the Most,0.0,0.786,0.214,1
2016-11-05 17:00:00,-0.5574,Stocks Slip in Uncertain Start to November Amid Election Uncertainty,0.365,0.635,0.0,-1
2016-11-07 07:26:00,0.0,Six Late Stage Drugs That Bit The Dust Recently,0.0,1.0,0.0,0
2016-11-07 11:54:10,0.0,"Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis",0.0,1.0,0.0,0
2016-11-07 13:07:20,0.0,Pfizer’s 3Q16 Earnings: An Overview,0.0,1.0,0.0,0
2016-11-07 13:39:01,-0.296,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure",0.145,0.855,0.0,-1
2016-11-07 15:05:21,0.0,Pfizer’s 3Q16 Earnings: Revenue Stream,0.0,1.0,0.0,0
2016-11-07 15:22:22,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2016",0.0,1.0,0.0,0
2016-11-07 15:57:49,0.296,"Monday’s Vital Data: Apple Inc. (AAPL), Facebook Inc (FB) and Pfizer Inc. (PFE)",0.0,0.845,0.155,1
2016-11-07 16:05:07,0.3818,This Contributed to Pfizer’s Growth in 3Q16,0.0,0.698,0.302,1
2016-11-07 17:22:57,0.0,"The Zacks Analyst Blog Highlights: General Electric, Baker Hughes, Facebook, Pfizer and Procter & Gamble",0.0,1.0,0.0,0
2016-11-07 18:13:28,-0.2732,Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?,0.16,0.84,0.0,-1
2016-11-08 01:25:00,0.5574,"Bonuses on Wall Street to Take a Dive (DOW, PFE)",0.0,0.69,0.31,1
2016-11-08 13:04:37,0.0,Understanding Pfizer’s Products with Declining Sales,0.0,1.0,0.0,0
2016-11-08 13:44:21,0.0,5 Healthcare Stocks Kahn Brothers Is Bullish On,0.0,1.0,0.0,0
2016-11-08 15:04:29,0.2732,Pfizer’s 3Q16 Earnings: Profitability and Financial Guidance,0.0,0.741,0.259,1
2016-11-08 16:04:22,0.0,Pfizer’s 3Q16 Earnings: Changes in Valuations,0.0,1.0,0.0,0
2016-11-08 16:06:40,0.4019,"2 Reasons Exelixis, Inc. Dove 17% in October, and 1 Excuse to Be Excited",0.0,0.73,0.27,1
2016-11-08 17:11:31,0.0,"Pfizer says closing two British sites, not Brexit-related",0.0,1.0,0.0,0
2016-11-08 17:39:00,-0.4215,Pfizer denies Brexit link to two UK site closures,0.259,0.741,0.0,-1
2016-11-08 17:45:00,-0.4215,Viagra maker Pfizer denies Brexit link to two UK site closures,0.219,0.781,0.0,-1
2016-11-08 21:32:26,0.0,"Stock Market News for November 08, 2016",0.0,1.0,0.0,0
2016-11-08 21:48:52,0.0,"Market Close Report: NASDAQ Composite index closes at 5,193.49 up 27.32 points",0.0,1.0,0.0,0
2016-11-08 22:03:50,0.296,Pfizer (PFE) Shares Cross 4% Yield Mark,0.0,0.732,0.268,1
2016-11-08 22:35:00,0.0,California's drug price showdown,0.0,1.0,0.0,0
2016-11-09 05:25:00,0.5423,Corporate Winners and Losers Emerge After Trump Win,0.222,0.327,0.451,1
2016-11-09 08:01:21,-0.4588,California drug pricing initiative headed for defeat,0.333,0.667,0.0,-1
2016-11-09 08:45:00,0.5267,Pharma Stocks Gain on U.S. Election Result,0.0,0.638,0.362,1
2016-11-09 13:52:30,0.6633,Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 3.5% Yield (TEVA),0.0,0.648,0.352,1
2016-11-09 13:53:03,0.4576,"Pre-Market Most Active for Nov 9, 2016 :  BAC, XIV, CX, QQQ, VALE, TVIX, AAPL, VRX, PFE, AZN, ARWR, FB",0.0,0.857,0.143,1
2016-11-09 14:15:59,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for November 10, 2016",0.0,1.0,0.0,0
2016-11-09 14:22:25,0.0,Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?,0.0,1.0,0.0,0
2016-11-09 14:42:41,-0.296,Markets Right Now: US stocks open broadly lower,0.239,0.761,0.0,-1
2016-11-09 14:46:41,0.6369,"Stocks Open Lower After Stunning Trump Win; Drugs Up, Hospitals Dive",0.133,0.482,0.386,1
2016-11-09 14:56:50,0.0,"Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC",0.0,1.0,0.0,0
2016-11-09 15:09:33,-0.3818,Trump’s victory is just the beginning of the shocks for stocks,0.206,0.794,0.0,-1
2016-11-09 15:28:44,0.2732,"Stocks Rethink Trump Win, Pare Losses; Pfizer, CAT Lead Dow",0.186,0.552,0.262,1
2016-11-09 15:33:05,0.0,US stocks mixed in early trade; bond prices tumble,0.0,1.0,0.0,0
2016-11-09 15:36:14,0.0,US STOCKS-Wall St swings in post-U.S. election rollercoaster,0.0,1.0,0.0,0
2016-11-09 16:07:05,0.0,"Pfizer Inc. (PFE) To Close 2 Britain Facilities, To Present New Xeljanz Data",0.0,1.0,0.0,0
2016-11-09 16:55:17,0.0,"Dow Movers: TRV, PFE",0.0,1.0,0.0,0
2016-11-09 17:21:00,-0.4215,Drug stocks rip higher after Trump's upset victory signals easing pressure on prices,0.286,0.595,0.119,-1
2016-11-09 17:23:00,0.7778,"How to Trade the Most Active Stocks After Trump's Win -- Pfizer, BofA, Facebook",0.0,0.639,0.361,1
2016-11-09 17:23:49,0.7096,Stocks Rally As Market Digests Trump's Surprise Win; Why Is Apple Down?,0.0,0.629,0.371,1
2016-11-09 18:13:08,0.0,Midday Update: Stocks Snap Back as Financial and Healthcare Sectors Rally,0.0,1.0,0.0,0
2016-11-09 18:38:25,0.34,Stocks Pare Gains As Market Adjusts To Trump Victory; Banking Stocks Rise,0.0,0.821,0.179,1
2016-11-09 18:47:32,0.0,"Trump Victory, Agenda Likely To Spur Lasting Stock Market Rally",0.0,1.0,0.0,0
2016-11-09 19:36:19,0.8074,"Pharma, biotech shares soar as Trump win calms pricing talk",0.0,0.458,0.542,1
2016-11-09 20:21:00,0.5859,Pharma surges on Trump win,0.0,0.513,0.487,1
2016-11-09 21:19:53,0.0072,Drug Stocks Rally On Relief Clinton Didn't Win White House,0.217,0.564,0.219,0
2016-11-09 21:20:52,0.5994,Health-care stocks skyrocket after Donald Trump stuns market with White House win,0.0,0.671,0.329,1
2016-11-09 21:23:59,0.4404,Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.,0.0,0.707,0.293,1
2016-11-09 21:41:44,0.0,Dow ends near record highs following election of Trump,0.0,1.0,0.0,0
2016-11-09 21:47:38,0.0,Drugmakers soar after Trump victory; hospital operators sink,0.0,1.0,0.0,0
2016-11-09 22:13:02,0.2732,Close Update: Stocks Rally as Wall Street Warms Up to Trump Presidency,0.0,0.84,0.16,1
2016-11-09 22:52:02,-0.3182,[$$] US stocks defy fears of panic after Trump win,0.361,0.414,0.225,-1
2016-11-09 23:46:32,0.128,Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources,0.0,0.87,0.13,1
2016-11-10 00:06:28,0.1027,"Novartis, Pfizer cut prices to win UK approval for cancer drugs",0.319,0.343,0.338,1
2016-11-10 01:18:15,0.5574,Markets Right Now: S&P backs US rating after Trump win,0.092,0.615,0.292,1
2016-11-10 03:05:00,0.743,AstraZeneca Profit Lifted by Tax Gain,0.0,0.388,0.612,1
2016-11-10 06:01:00,0.2023,The top Trump victory trades,0.0,0.69,0.31,1
2016-11-10 07:00:00,-0.3182,IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer,0.196,0.667,0.138,-1
2016-11-10 08:05:47,0.7783,Pfizer wins EU's approval for Ibrance as Novartis readies rival drug,0.0,0.57,0.43,1
2016-11-10 12:40:14,0.6486,Short Interest Bets Increase on Major Pharma,0.0,0.485,0.515,1
2016-11-10 13:21:00,0.4767,Here Are 3 Ways to Play the Growing Market for Vaccines Right Now,0.0,0.709,0.291,1
2016-11-10 13:55:11,0.0,Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH,0.0,1.0,0.0,0
2016-11-10 14:02:03,0.4019,"Trending Stocks: Lockheed Martin to Get Trump Boost? Plus the Latest on ConocoPhillips, Netflix, Pfizer, and More",0.0,0.856,0.144,1
2016-11-10 14:41:03,0.0,Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American Heart Association (AHA) Scientific Sessions 2016,0.0,1.0,0.0,0
2016-11-10 14:44:47,0.0,"Stocks Open With Dow At Record High; Pfizer, Taser, Kohl's Climb",0.0,1.0,0.0,0
2016-11-10 14:46:02,0.0,President-elect Trump puts Obamacare’s future up in the air,0.0,1.0,0.0,0
2016-11-10 14:56:20,0.0,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday",0.0,1.0,0.0,0
2016-11-10 15:11:16,0.0,[$$] AstraZeneca: Trump lifts it up,0.0,1.0,0.0,0
2016-11-10 15:21:57,0.0,Dow hits new record as Trump victory drives up blue chips,0.0,1.0,0.0,0
2016-11-10 15:30:34,0.0,"Dow Hits All-Time High; Financials Lead Again; Macy's, Kohl's Up Big",0.0,1.0,0.0,0
2016-11-10 17:04:00,0.0772,Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit,0.0,0.894,0.106,0
2016-11-10 18:34:18,0.0,"Dow Holds Near Record High But Alphabet, Facebook, Other Techs Sag",0.0,1.0,0.0,0
2016-11-10 21:01:03,0.4019,"Goldman, JPMorgan Boost Dow on Thursday",0.0,0.649,0.351,1
2016-11-10 21:33:03,0.4939,"Health Care Sector Update for 11/10/2016: JNJ, PFE, MRK, ABT, AMGN, VRML, MNKD, ANTH",0.0,0.802,0.198,1
2016-11-10 22:02:34,0.4576,"After Hours Most Active for Nov 10, 2016 :  LW, ASNA, KKR, WFT, CHK, NVDA, SPLS, PFE, BAC, SOXX, QQQ, MSFT",0.0,0.864,0.136,1
2016-11-10 22:17:19,0.0,Trump Election Lights A Firecracker Under Key Stocks,0.0,1.0,0.0,0
2016-11-10 22:19:33,0.4939,Pfizer Spikes On Report It's Mulling $14 Billion Consumer Care Sale,0.0,0.758,0.242,1
2016-11-11 00:13:52,0.0,What's in Store for Merck KGaA (MKGAF) in Q3 Earnings?,0.0,1.0,0.0,0
2016-11-11 06:12:19,0.0,Trump presidency could prove a salve for pharma merger deals,0.0,1.0,0.0,0
2016-11-11 06:17:00,-0.3818,Pfizer: Prevenar 13 To Be Available At Lowest Price For Humanitarian Emergencies,0.191,0.809,0.0,-1
2016-11-11 11:07:09,0.0,Pfizer Announces Major Expansion of Humanitarian Assistance Program,0.0,1.0,0.0,0
2016-11-11 14:06:00,-0.1027,Pfizer Finds Breaking Up Is Hard to Do,0.167,0.833,0.0,-1
2016-11-11 14:16:39,0.0,"Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST",0.0,1.0,0.0,0
2016-11-11 16:14:48,0.0,"Dow Movers: PFE, DIS",0.0,1.0,0.0,0
2016-11-11 16:16:27,0.5859,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?",0.0,0.774,0.226,1
2016-11-11 18:34:41,0.3182,Pfizer lowers cost of Prevnar vaccine for some charity use,0.122,0.65,0.228,1
2016-11-11 19:08:12,0.0,Pfizer offers cut-price pneumonia shot for humanitarian crises,0.0,1.0,0.0,0
2016-11-11 19:09:00,-0.6705,A massive nonprofit rejected a bunch of donated vaccines from Pfizer — and now the drug giant is offering them at a lower price,0.234,0.766,0.0,-1
2016-11-11 20:28:09,0.6369,The 7 Best Dividend Stocks to Buy for 2017,0.0,0.625,0.375,1
2016-11-11 20:30:08,0.296,"Thursday’s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Pfizer Inc. (PFE)",0.0,0.864,0.136,1
2016-11-11 21:49:09,0.0,"Market Close Report: NASDAQ Composite index closes at 5,237.11 up 28.31 points",0.0,1.0,0.0,0
2016-11-11 23:20:00,0.0,"Pfizer May Sell, Spin Off Consumer Health Op (PFE)",0.0,1.0,0.0,0
2016-11-12 14:44:22,0.0,The Shot Heard ‘Round the World: First Inning of Global Reflation,0.0,1.0,0.0,0
2016-11-13 14:27:54,0.3818,Should Biopharma Companies Buy Innovation?,0.0,0.606,0.394,1
2016-11-13 16:20:00,0.0,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally,0.0,1.0,0.0,0
2016-11-13 16:59:00,-0.3103,Study Suggests Celebrex Isn't Riskier Than Rival Pain Drugs,0.268,0.567,0.165,-1
2016-11-13 21:45:02,0.4404,Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen -study,0.0,0.791,0.209,1
2016-11-13 21:57:00,-0.2023,Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen,0.108,0.825,0.067,-1
2016-11-14 00:34:40,-0.7506,[$$] Big pharma is failing to do enough for poor countries,0.416,0.584,0.0,-1
2016-11-14 02:05:00,-0.6908,Study Suggests Celebrex Isn''t Riskier Than Rival Pain Drugs,0.449,0.551,0.0,-1
2016-11-14 05:50:54,-0.6908,Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs,0.449,0.551,0.0,-1
2016-11-14 06:50:15,0.2584,Study Suggests Celebrex Isn't Riskier Than Rivals,0.0,0.747,0.253,1
2016-11-14 10:52:00,0.0,Correction to Celebrex Article on Sunday,0.0,1.0,0.0,0
2016-11-14 13:00:00,-0.6597,Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers,0.239,0.761,0.0,-1
2016-11-14 13:37:22,0.0,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : November 14, 2016",0.0,1.0,0.0,0
2016-11-14 14:19:02,0.0,5 Pharma Stocks in Focus on World Diabetes Day,0.0,1.0,0.0,0
2016-11-14 14:48:44,0.3182,"Dow Hits Fresh High; Early Risers: Harman, Mentor Graphics",0.0,0.777,0.223,1
2016-11-14 15:31:00,0.0,"CORRECTING and REPLACING Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",0.0,1.0,0.0,0
2016-11-14 16:15:00,0.0,Medicare Identifies Which Prescription Drugs Were Costliest in 2015,0.0,1.0,0.0,0
2016-11-14 16:51:38,0.0,Clarification: Pfizer-Vaccine Price story,0.0,1.0,0.0,0
2016-11-14 17:01:00,0.0,"PFIZER INC Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits",0.0,1.0,0.0,0
2016-11-14 17:47:06,0.0,"Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",0.0,1.0,0.0,0
2016-11-14 18:29:17,-0.2732,5 Reasons to Buy 5 Low P/E Biotech ETFs,0.259,0.741,0.0,-1
2016-11-14 20:17:00,0.2263,Pfizer Pneumonia Drug Price Slashed for Charity (PFA),0.178,0.561,0.262,1
2016-11-14 21:25:19,0.0516,Why Is Pfizer Trading at Discounted Valuation Multiples?,0.0,0.854,0.146,0
2016-11-14 21:40:42,0.0,"Go for It, Pfizer -- Sell Your Consumer Healthcare Business",0.0,1.0,0.0,0
2016-11-14 23:04:08,0.0,Analysts’ Recommendations for Pfizer and Its Peers in 2016,0.0,1.0,0.0,0
2016-11-14 23:55:00,-0.3612,"Pfizer Prices $6,000,000,000 Debt Offering",0.385,0.615,0.0,-1
2016-11-15 05:23:10,0.0,[$$] Medicare Identifies Which Prescription Drugs Were Costliest in 2015,0.0,1.0,0.0,0
2016-11-15 08:20:00,0.0,Pfizer Says Phase 3 OPAL Studies For Xeljanz Met Primary Efficacy Endpoints,0.0,1.0,0.0,0
2016-11-15 13:04:58,-0.7096,Ibrance May Continue to Dominate Breast Cancer Space in 2016,0.424,0.576,0.0,-1
2016-11-15 13:05:00,0.0,PRECISION Results Open The Door For OTC Celebrex,0.0,1.0,0.0,0
2016-11-15 13:18:07,0.0,Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ® (Tofacitinib Citrate) for Psoriatic Arthritis,0.0,1.0,0.0,0
2016-11-15 14:31:22,0.0,Pfizer and NCI Ink Research Deal Targeting Multiple Cancers,0.0,1.0,0.0,0
2016-11-15 14:42:50,0.0,"Stocks Open Mixed; Oil Jumps; Airlines, Shipping Fleets Rally",0.0,1.0,0.0,0
2016-11-15 15:04:47,0.7096,Xtandi Is Expected to Witness Strong Growth Trends Going Forward,0.0,0.576,0.424,1
2016-11-15 16:04:41,0.4215,Pfizer Makes Progress with Its 2016 Immuno-Oncology Programs,0.0,0.714,0.286,1
2016-11-15 19:11:21,0.0,"ETFs with exposure to Pfizer Inc. : November 15, 2016",0.0,1.0,0.0,0
2016-11-15 20:06:37,0.0,Pfizer Inc. (PFE) Teams Up With NIH NCI CCR On Immunotherapy,0.0,1.0,0.0,0
2016-11-16 10:43:32,0.0,Macron: the fresh-faced prodigy who would be president,0.0,1.0,0.0,0
2016-11-16 15:41:23,0.4939,Pfizer Inc. (PFE) Signs Agreement With NCI To Explore Immunotherapy,0.0,0.738,0.262,1
2016-11-16 15:52:17,0.3182,Merck KGaA's (MKGAF) Q3 Earnings and Sales Increase Y/Y,0.0,0.777,0.223,1
2016-11-16 15:53:02,0.0,Pfizer Reports Phase III Psoriatic Arthritis Data on Xeljanz,0.0,1.0,0.0,0
2016-11-16 21:59:17,0.4576,"After Hours Most Active for Nov 16, 2016 :  COMT, YHOO, ACWI, VNQI, CSCO, CHK, SYMC, BAC, PFE, DHR, VZ, WFC",0.0,0.864,0.136,1
2016-11-16 22:09:00,-0.34,"PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer’s IBRANCE® (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer",0.145,0.757,0.099,-1
2016-11-16 22:50:17,0.0,The Scariest Thing About Pfizer's Dividend,0.0,1.0,0.0,0
2016-11-17 00:03:17,0.1027,"Roche, Bristol-Myers cut cancer drug prices to win UK approval",0.335,0.309,0.356,1
2016-11-17 14:19:30,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 18, 2016",0.0,1.0,0.0,0
2016-11-17 15:51:44,0.4215,3 Stocks to Add to Your Portfolio as Biotech M&A Hopes Rise,0.0,0.781,0.219,1
2016-11-17 15:52:04,0.0,3 Things Exelixis Must Do to Survive and Thrive in 2017,0.0,1.0,0.0,0
2016-11-17 17:19:00,0.0,Pfizer Files 8K - Other Events,0.0,1.0,0.0,0
2016-11-17 21:01:46,0.7096,Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016,0.0,0.576,0.424,1
2016-11-17 22:51:26,0.0,10 Pharma Stocks That Are Prescribed Under President Trump,0.0,1.0,0.0,0
2016-11-17 23:04:11,0.0,AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio,0.0,1.0,0.0,0
2016-11-18 00:27:41,0.0,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most,0.0,1.0,0.0,0
2016-11-18 03:58:03,-0.2023,Pfizer (PFE) Ibrance Positive in Phase III Breast Cancer Study,0.275,0.5,0.225,-1
2016-11-18 11:22:11,0.0,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal",0.0,1.0,0.0,0
2016-11-18 13:04:47,0.4404,"Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?",0.0,0.734,0.266,1
2016-11-18 15:04:40,0.6808,Innovative Research in Vaccines May Boost Pfizer’s Revenues,0.0,0.517,0.483,1
2016-11-18 16:52:49,0.0,Is Pfizer Rethinking a Company Spin-Off?,0.0,1.0,0.0,0
2016-11-18 21:01:45,-0.2755,"Donald Trump, Republicans Won't Ease Drug-Pricing Debate: Pfizer",0.232,0.768,0.0,-1
2016-11-18 21:50:14,0.6369,The 10 Best Pharma Stocks Under President Donald Trump,0.0,0.656,0.344,1
2016-11-18 22:50:05,0.0,"Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",0.0,1.0,0.0,0
2016-11-20 12:43:34,0.0,"3 Stocks That Turned $7,000 Into $145,600 (or More)",0.0,1.0,0.0,0
2016-11-20 22:06:00,0.4939,3 Stocks You Can Safely Own Until 2030,0.0,0.652,0.348,1
2016-11-21 11:45:00,0.0,"Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019",0.0,1.0,0.0,0
2016-11-21 14:20:29,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 22, 2016",0.0,1.0,0.0,0
2016-11-21 15:11:00,0.0,"Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire",0.0,1.0,0.0,0
2016-11-21 16:45:01,0.4404,How a 15% Decline Is a Gift to Income Investors,0.0,0.707,0.293,1
2016-11-21 18:09:56,0.0,"Notable ETF Outflow Detected - PPH, SNY, BMY, PFE",0.0,1.0,0.0,0
2016-11-21 18:23:24,0.0,"Stock Market News for November 21, 2016",0.0,1.0,0.0,0
2016-11-21 20:57:11,0.0,Cloud M&A: Oracle Corporation (ORCL) to Buy DNS Provider Dyn,0.0,1.0,0.0,0
2016-11-21 21:57:28,0.4576,"After Hours Most Active for Nov 21, 2016 :  PRXL, WMB, C, AAPL, YHOO, PFE, PG, GRPN, IVC, FTR, QQQ, ZAYO",0.0,0.864,0.136,1
2016-11-22 13:26:27,0.0,"Can DJIA Still Rise to 19,700 by End of 2016?",0.0,1.0,0.0,0
2016-11-22 13:27:14,-0.6486,"Currency drop hits Egypt's medicine supplies, angering public",0.469,0.531,0.0,-1
2016-11-22 15:04:52,0.0,"The Latest on Fasinumab, a Teva-Regeneron Collaborative Drug",0.0,1.0,0.0,0
2016-11-22 15:27:18,-0.2263,Pfizer Inc. (PFE) Files Lawsuit Against Texas HHSC,0.213,0.787,0.0,-1
2016-11-22 16:04:18,0.3612,What Do the Analysts Recommend for Bristol-Myers Squibb’s Stock?,0.0,0.762,0.238,1
2016-11-22 16:21:54,0.4767,Novartis Buys Selexys on Favorable Phase II Data on SelG1,0.0,0.744,0.256,1
2016-11-22 16:54:12,0.0,Where Does Eli Lilly’s Valuation Stand Next to Peers?,0.0,1.0,0.0,0
2016-11-22 17:27:40,-0.0772,Is Donald Trump a Blessing or a Curse for Big Pharma?,0.255,0.511,0.234,0
2016-11-22 17:29:19,0.0,Pfizer to consolidate offices at new $200 million Chesterfield campus,0.0,1.0,0.0,0
2016-11-22 19:43:53,-0.34,7 Stocks That Are Ridiculously Cheap Right Now,0.286,0.714,0.0,-1
2016-11-22 20:22:47,-0.743,Small-Cap Biotech Is on Front Lines of Fight Against Depression,0.441,0.559,0.0,-1
2016-11-22 21:01:57,0.25,"Lilly Poised For Big December On Alzheimer's Data, Diabetes Ruling",0.0,0.818,0.182,1
2016-11-22 23:19:10,0.0,What Happened in Biotech in 2016?,0.0,1.0,0.0,0
2016-11-23 07:25:00,-0.1531,Eli Lilly Alzheimer's Drug Fails Trial; Shares Plunge,0.255,0.545,0.2,-1
2016-11-23 07:25:00,-0.1531,Eli Lilly Alzheimer''s Drug Fails Trial; Shares Plunge,0.255,0.545,0.2,-1
2016-11-23 20:05:25,-0.5106,Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question,0.231,0.769,0.0,-1
2016-11-23 21:20:00,0.0,Pfizer Inc. (PFE): Are Hedge Funds Right About This Stock?,0.0,1.0,0.0,0
2016-11-23 21:25:38,-0.4019,Lilly's drug for Alzheimer's fails big trial; shares drop,0.374,0.458,0.168,-1
2016-11-24 13:06:48,-0.4215,"Lilly's Alzheimer Drug Fails Phase III Study, Stock Down",0.259,0.741,0.0,-1
2016-11-24 15:04:17,0.0,A Deeper Look into Eli Lilly’s New Products Portfolio,0.0,1.0,0.0,0
2016-11-25 12:05:00,0.0,J&J Approaches Swiss Firm Actelion About Potential Deal,0.0,1.0,0.0,0
2016-11-25 14:15:14,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 28, 2016",0.0,1.0,0.0,0
2016-11-25 14:50:01,0.0,"Stocks Open Modestly Higher; Early Risers: Wal-Mart, Pfizer, Ctrip.com",0.0,1.0,0.0,0
2016-11-25 18:02:06,0.2023,Top Research Reports for Black Friday 2016,0.0,0.769,0.231,1
2016-11-26 02:47:00,0.0,J&J Stalks Swiss Drug Company -- WSJ,0.0,1.0,0.0,0
2016-11-27 07:14:00,0.0,Drugmakers Find Competition Doesn't Keep a Lid on Prices,0.0,1.0,0.0,0
2016-11-27 07:14:00,0.0,Tandem Drug-Price Increases Take Toll on Some Patients,0.0,1.0,0.0,0
2016-11-27 12:00:04,0.0,[$$] Tandem Drug-Price Increases Take Toll on Some Patients,0.0,1.0,0.0,0
2016-11-27 12:05:39,0.0,[$$] Drugmakers Find Competition Doesn't Keep a Lid on Prices,0.0,1.0,0.0,0
2016-11-27 21:54:53,0.0,Where Else Have We Seen Mallinckrodt’s ‘Acquire to Invest’ Strategy?,0.0,1.0,0.0,0
2016-11-28 05:07:52,0.0,Drugmakers Find Competition Doesn’t Keep a Lid on Prices,0.0,1.0,0.0,0
2016-11-28 12:15:13,0.0,Short Sellers Hike Their Bets in Most Major Pharma Stocks,0.0,1.0,0.0,0
2016-11-28 12:45:18,0.4767,Actelion's ambitious independent-minded CEO will drive up takeover price,0.0,0.721,0.279,1
2016-11-28 14:33:29,0.0,J&J (JNJ) Confirms it Approached Actelion for Possible Deal,0.0,1.0,0.0,0
2016-11-28 16:32:00,0.4215,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Priceline, Expedia and United Continental",0.0,0.797,0.203,1
2016-11-28 16:45:00,-0.4215,Pfizer Nixes 350-Job Expansion After Drug Fails (PFE),0.286,0.714,0.0,-1
2016-11-28 18:11:26,-0.296,5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy,0.385,0.41,0.205,-1
2016-11-28 19:54:53,0.0,"XLV, DXJF: Big ETF Inflows",0.0,1.0,0.0,0
2016-11-28 21:19:00,0.4588,Which companies will benefit from Cuban biotech?,0.0,0.667,0.333,1
2016-11-29 08:30:00,0.3182,Pfizer : FDA Accepts BLA For Avelumab For Treatment Of MMCC For Priority Review,0.0,0.839,0.161,1
2016-11-29 11:16:00,0.0,"Stocks to Watch: November 29, 2016",0.0,1.0,0.0,0
2016-11-29 11:25:00,0.4404,Clifton on Trump trade: Financials good place to be,0.0,0.734,0.266,1
2016-11-29 12:53:54,-0.6597,Merck: Keytruda's Priority Review for New Cancer Indication,0.386,0.614,0.0,-1
2016-11-29 13:06:36,-0.6597,"German Merck, Pfizer get FDA priority review for cancer drug",0.328,0.672,0.0,-1
2016-11-29 13:06:50,0.0,Pfizer’s Valuation Compared to Peers,0.0,1.0,0.0,0
2016-11-29 13:17:13,0.0,"Early movers: TIF, UNH, MNK, PFE, AAPL, T, TIVO, C, ALL & more",0.0,1.0,0.0,0
2016-11-29 14:09:00,0.0,"Stock Futures Turn Mixed as U.S. Economy Grows, Oil Prices Slump",0.0,1.0,0.0,0
2016-11-29 14:28:00,0.3182,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review,0.0,0.887,0.113,1
2016-11-29 14:52:00,0.5719,Pfizer: Be Happy With the Dividend for Now,0.0,0.654,0.346,1
2016-11-29 15:05:42,0.0,Pfizer Divests Hospira’s Infusion System Business to ICU Medical,0.0,1.0,0.0,0
2016-11-29 16:00:00,0.296,Pfizer Shares up in Early Trading (PFE),0.0,0.732,0.268,1
2016-11-29 16:05:15,0.0,"The Pfizer-Medivation Deal, Completed in 3Q16",0.0,1.0,0.0,0
2016-11-29 17:50:29,-0.0516,"Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients Disgruntled",0.079,0.921,0.0,0
2016-11-29 17:56:08,0.0,"VOO, PFE, KO, PEP: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2016-11-29 18:30:58,0.4404,Does Procter & Gamble Co (PG) Represent a Good Addition to Your Portfolio?,0.0,0.775,0.225,1
2016-11-29 18:52:10,-0.296,J&J raises Actelion takeover pressure with higher price - source,0.216,0.784,0.0,-1
2016-11-29 19:18:00,0.0,Pfizer (PFE) Stock Rating Upgraded at Barclays,0.0,1.0,0.0,0
2016-11-29 20:18:00,0.0,Pfizer Upgraded at Barclays,0.0,1.0,0.0,0
2016-11-29 21:01:24,-0.128,"Boeing, UnitedHealth Dominate DJIA Tuesday",0.273,0.727,0.0,-1
2016-11-29 21:17:02,0.0,"Goldman Sachs, Pfizer Are Buys; J&J, Wendy's Downgraded",0.0,1.0,0.0,0
2016-11-29 22:24:00,-0.296,"In Case You Missed It Tuesday: Self-Driving Cars, Soy, Slumping Commodities Take Markets for a Ride",0.136,0.864,0.0,-1
2016-11-30 01:23:00,-0.1779,"Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq",0.208,0.629,0.164,-1
2016-11-30 08:47:00,0.0,Pfizer: PF-05280014 Versus Herceptin Study Meets Primary Endpoint,0.0,1.0,0.0,0
2016-11-30 11:00:00,0.0,10 Cheap High-Quality Dividend Payers,0.0,1.0,0.0,0
2016-11-30 11:17:00,0.2023,"[$$] Pfizer: Easy to Swallow With Low P/E, 3.8% Yield",0.162,0.615,0.223,1
2016-11-30 13:04:47,0.4404,Pfizer’s Innovative and Essential Health Businesses,0.0,0.633,0.367,1
2016-11-30 13:30:00,0.5574,"Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)",0.0,0.833,0.167,1
2016-11-30 13:58:28,-0.296,Pfizer's Herceptin biosimilar succeeds in key breast cancer study,0.301,0.479,0.219,-1
2016-11-30 14:14:06,-0.2263,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for December 01, 2016",0.147,0.853,0.0,-1
2016-11-30 15:04:51,0.3818,Understanding Pfizer’s Growth Contributors,0.0,0.536,0.464,1
2016-11-30 15:22:00,0.5574,Pfizer reports positive REFLECTIONS data (PFE),0.0,0.581,0.419,1
2016-11-30 15:27:00,0.2263,10 Undervalued High-Yield Dividend Stocks Worth Buying Today,0.0,0.787,0.213,1
2016-11-30 15:49:07,0.0,3 High-Yield Dividend Stocks to Buy in December,0.0,1.0,0.0,0
2016-11-30 15:58:47,-0.6597,Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab,0.386,0.614,0.0,-1
2016-11-30 15:59:04,0.0,J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance,0.0,1.0,0.0,0
2016-11-30 16:04:32,-0.1531,These Pfizer Products Saw Falling Revenues in 3Q16,0.186,0.814,0.0,-1
2016-11-30 16:58:15,0.4767,ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.,0.0,0.721,0.279,1
2016-11-30 17:06:00,0.5106,Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock,0.0,0.732,0.268,1
2016-11-30 20:24:13,0.25,Avelumab Granted Priority Review: One Of The Many Milestones That Pfizer Needs,0.0,0.846,0.154,1
2016-11-30 21:01:00,0.0,Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software,0.0,1.0,0.0,0
2016-11-30 23:18:22,0.0772,What's Pfizer's Excuse for Not Buying Exelixis?,0.0,0.822,0.178,0
2016-12-01 00:33:00,-0.5106,"It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC",0.202,0.798,0.0,-1
2016-12-01 08:16:00,0.5574,Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients,0.0,0.735,0.265,1
2016-12-01 13:00:00,-0.6597,Pfizer Partners With IBM Watson To Advance Cancer Drug Discovery,0.328,0.672,0.0,-1
2016-12-01 13:04:22,0.2732,Pfizer’s Profitability and Financial Guidance,0.0,0.656,0.344,1
2016-12-01 13:35:50,0.4939,"Health Care Sector Update for 12/01/2016: JNJ, PFE, ABT, MRK, AMGN, ARDM, HTBX",0.0,0.789,0.211,1
2016-12-01 13:50:08,0.0,Pfizer to use IBM Watson supercomputing to find new drugs,0.0,1.0,0.0,0
2016-12-01 14:21:55,0.2023,Tiger Cub Lee Ainslie’s Top Stock Picks,0.0,0.769,0.231,1
2016-12-01 14:27:00,0.0,Lyrica Showed Efficacy in Children With Epilesey (PFE),0.0,1.0,0.0,0
2016-12-01 15:21:22,0.0,IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery,0.0,1.0,0.0,0
2016-12-01 15:21:25,0.0,LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint,0.0,1.0,0.0,0
2016-12-01 16:04:13,0.0,Inside Pfizer’s Recent Corporate and Pipeline Developments,0.0,1.0,0.0,0
2016-12-01 16:05:29,-0.0772,Recent R&D Developments from Merck You Won’t Want to Miss,0.147,0.734,0.119,0
2016-12-01 16:15:53,0.0,US Market Indexes Higher on Tuesday,0.0,1.0,0.0,0
2016-12-01 16:20:27,0.0,Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study,0.0,1.0,0.0,0
2016-12-01 17:22:11,0.2023,5 Top Performing S&P 500 Stocks of November,0.0,0.769,0.231,1
2016-12-01 20:42:00,0.0,"IBM, Pfizer Announce Partnership (IBM, PFE)",0.0,1.0,0.0,0
2016-12-01 23:36:25,0.0,Pharma execs weigh in on possible changes under Trump,0.0,1.0,0.0,0
2016-12-02 00:18:00,0.0,"ARDM Out Of Orbit, CLSN To Report Data In Q1, MRK Seeks New Use For Old Drug",0.0,1.0,0.0,0
2016-12-02 07:14:00,-0.296,New Tax Rules on Corporate Inversions Face Uncertain Future,0.216,0.784,0.0,-1
2016-12-02 11:40:11,0.0,"Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda",0.0,1.0,0.0,0
2016-12-02 12:15:49,0.0,Coverage initiated on Pfizer by Guggenheim,0.0,1.0,0.0,0
2016-12-02 13:04:11,0.0,The Word on the Street: What Analysts Are Estimating for Pfizer Now,0.0,1.0,0.0,0
2016-12-02 14:15:09,0.6369,5 Best Dividend Stocks To Buy Right Now,0.0,0.588,0.412,1
2016-12-02 14:33:02,0.5574,Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug,0.0,0.714,0.286,1
2016-12-02 16:41:24,-0.296,[$$] Tax Rules on Corporate Inversions Face Uncertain Future,0.216,0.784,0.0,-1
2016-12-02 18:08:00,0.743,"Morgan Stanley Wealth Management: Chevron, Pfizer May be Big Winners in 2017",0.0,0.613,0.387,1
2016-12-02 19:42:53,0.0,The Numbers Behind a Pharma CEO Shouting Match,0.0,1.0,0.0,0
2016-12-02 20:02:00,0.3818,Regeneron's CEO Blasts Peers on Innovation,0.0,0.658,0.342,1
2016-12-02 20:35:20,0.0,$50 Billion Quant Fund Is Making New Bets On These Stocks,0.0,1.0,0.0,0
2016-12-02 21:41:06,0.25,Forget Pfizer: Here Are 3 Better Dividend Stocks,0.194,0.51,0.296,1
2016-12-03 05:03:00,-0.296,[$$] New Tax Rules on Corporate Inversions Face Uncertain Future,0.196,0.804,0.0,-1
2016-12-03 16:00:00,0.2263,Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting,0.0,0.929,0.071,1
2016-12-03 18:00:00,0.4767,New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome,0.0,0.846,0.154,1
2016-12-03 18:04:00,0.2987,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions,0.157,0.584,0.259,1
2016-12-04 14:48:29,0.0,Does Pfizer Pass Warren Buffett’s Test?,0.0,1.0,0.0,0
2016-12-05 08:16:00,0.5574,Pfizer Reports Positive Top-Line Results For Phase 3 BFORE Study Of BOSULIF,0.0,0.735,0.265,1
2016-12-05 13:00:00,0.802,Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia,0.0,0.745,0.255,1
2016-12-05 13:43:25,-0.3182,Pfizer's blood cancer drug Bosulif effective in untreated patients,0.303,0.483,0.214,-1
2016-12-05 14:08:02,0.4767,Pfizer (PFE) Presents Favorable Data on Leukemia Candidate,0.0,0.693,0.307,1
2016-12-05 14:48:38,0.0,2 Stocks That Could Soar Under a Donald Trump Presidency,0.0,1.0,0.0,0
2016-12-05 15:33:23,0.5994,Robust Pipeline Supports 5.5% Dividend Yield,0.0,0.449,0.551,1
2016-12-05 20:51:00,0.0,Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks,0.0,1.0,0.0,0
2016-12-05 21:07:06,0.0,Sanofi to Explore Counterbid for Actelion Amid J&J Talks,0.0,1.0,0.0,0
2016-12-05 22:53:21,0.0,Sanofi exploring bid for Actelion amid J&J talks - Bloomberg,0.0,1.0,0.0,0
2016-12-06 02:35:00,-0.2732,U.S. 'Disappointed' by Japan's Plan to Cut Drug Costs,0.208,0.792,0.0,-1
2016-12-06 06:30:23,-0.5053,Can't buy love? Drug price hikes put sex beyond reach,0.27,0.642,0.088,-1
2016-12-06 08:44:46,0.4019,Dealtalk: Trump's corporate tax holiday could spur pharma M&A,0.0,0.748,0.252,1
2016-12-06 11:00:00,0.0,What a Dividend Payout Ratio Can (and Can't) Tell You,0.0,1.0,0.0,0
2016-12-06 12:05:18,0.4019,Trump's corporate tax holiday could spur pharma M&A,0.0,0.722,0.278,1
2016-12-06 21:19:39,0.4019,Interesting March 2017 Stock Options for PFE,0.0,0.69,0.31,1
2016-12-06 21:26:32,0.0,The Latest Buzz in Biotech,0.0,1.0,0.0,0
2016-12-06 21:27:06,0.0,Pfizer Leukemia Drug Meets Primary Endpoint in Phase III,0.0,1.0,0.0,0
2016-12-06 21:49:03,-0.3818,Sanofi May Battle Johnson & Johnson For European Biotech Actelion,0.245,0.755,0.0,-1
2016-12-07 02:35:00,0.0,Pfizer Fined $107 Million by UK Regulator Over Drug Prices,0.0,1.0,0.0,0
2016-12-07 04:35:00,0.0,Health-Care Stocks Slide,0.0,1.0,0.0,0
2016-12-07 04:35:00,-0.3182,Health-Care Selloff Pressures Stocks,0.434,0.566,0.0,-1
2016-12-07 04:35:00,0.0,U.S. Stocks Post Biggest One-Day Rally Since Election,0.0,1.0,0.0,0
2016-12-07 04:35:00,0.0,"Dow, S&P 500 on Track to Set New Highs",0.0,1.0,0.0,0
2016-12-07 04:35:00,0.296,"Stocks Rise, Despite Slide in Health-Care Shares",0.0,0.732,0.268,1
2016-12-07 04:35:00,0.0,"Dow, S&P 500 Set New Highs",0.0,1.0,0.0,0
2016-12-07 04:35:00,-0.2263,Stocks Pressured by Health-Care Selloff,0.322,0.678,0.0,-1
2016-12-07 05:02:00,0.0,Pfizer Fined $107 Million for Epilepsy Drug Price Hike in UK -- Update,0.0,1.0,0.0,0
2016-12-07 05:34:00,-0.4767,Pfizer Fined In UK For Charging Unfair Prices For Anti-epilepsy Drug,0.237,0.763,0.0,-1
2016-12-07 07:36:22,0.0,"Pfizer, Flynn Pharma Fined Record $106 Million by U.K. Regulator",0.0,1.0,0.0,0
2016-12-07 07:36:22,0.0,"Pfizer, Flynn Fined Record $113 Million Over Epilepsy Drug",0.0,1.0,0.0,0
2016-12-07 08:03:00,0.0,Drug firms fined £90m for 'excessive' price hike to NHS,0.0,1.0,0.0,0
2016-12-07 08:20:00,0.0,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug -- 2nd Update,0.0,1.0,0.0,0
2016-12-07 09:15:00,0.0,"Drug firms fined over 2,600% NHS price hike for epilepsy treatment",0.0,1.0,0.0,0
2016-12-07 09:27:18,0.3182,Britain fines Pfizer record $107 mln for huge drug price hike,0.0,0.813,0.187,1
2016-12-07 10:05:48,0.0,[$$] Pfizer fined £84m for charging 'unfair' price for epilepsy drug,0.0,1.0,0.0,0
2016-12-07 11:33:00,0.0,"MARKET SNAPSHOT: Dow, S&P 500 Set Intraday Records, But Health-care Slumps On Trump",0.0,1.0,0.0,0
2016-12-07 12:06:00,0.0,5 Things You Must Know Before the Market Opens Wednesday,0.0,1.0,0.0,0
2016-12-07 12:56:26,0.0,Pfizer Fined $106 Million For Anti-Epilepsy Drug,0.0,1.0,0.0,0
2016-12-07 13:18:18,0.4404,Better Buy: Amgen Inc. vs. Pfizer,0.0,0.633,0.367,1
2016-12-07 13:28:00,0.0,Britain fines Pfizer $107M for drug price hike,0.0,1.0,0.0,0
2016-12-07 13:29:54,0.0,"Pfizer fined for hiking epilepsy drug price 2,600 pct in UK",0.0,1.0,0.0,0
2016-12-07 13:58:00,0.0,"Pfizer and Flynn Pharma fined over 2,600% NHS price hike",0.0,1.0,0.0,0
2016-12-07 14:00:02,0.5574,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study,0.0,0.69,0.31,1
2016-12-07 14:00:08,0.0,Pfizer fined $107M because of epilepsy drug price hike in U.K.,0.0,1.0,0.0,0
2016-12-07 14:13:00,0.0,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug,0.0,1.0,0.0,0
2016-12-07 14:21:00,0.2023,Pfizer Takes $106 Million Fine From U.K. for Price Hike of Epilepsy Drug,0.0,0.87,0.13,1
2016-12-07 14:22:15,0.3182,Britain fines Pfizer record $107 million for huge drug price hike,0.0,0.813,0.187,1
2016-12-07 14:49:51,0.0,Is Pfizer's New PD-L1 Drug a Game-Changer?,0.0,1.0,0.0,0
2016-12-07 14:57:58,0.0,US STOCKS-Wall St flat as investors test post-election rally,0.0,1.0,0.0,0
2016-12-07 15:36:58,-0.296,Drug Stocks Tumble After Trump Vows to Pressure Prices,0.216,0.784,0.0,-1
2016-12-07 15:37:12,0.0,"Dow, S&P 500 set intraday records, but health-care slumps on Trump",0.0,1.0,0.0,0
2016-12-07 15:52:40,-0.2732,Dividend-paying stocks pull US indexes up; drugmakers drop,0.231,0.769,0.0,-1
2016-12-07 16:26:01,-0.5267,"US STOCKS-Dow, S&P hit highs but Trump comments slam drug stocks",0.254,0.746,0.0,-1
2016-12-07 16:37:00,0.3612,Pfizer at the Mercy of Trump's Tweets: More Squawk From Jim Cramer,0.0,0.815,0.185,1
2016-12-07 16:56:19,0.0,"Notable ETF Inflow Detected - VOO, PFE, KO, PEP",0.0,1.0,0.0,0
2016-12-07 16:58:07,0.0,"Dow Movers: PFE, WMT",0.0,1.0,0.0,0
2016-12-07 17:40:08,0.296,Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares,0.0,0.833,0.167,1
2016-12-07 17:57:15,0.0,"US STOCKS-Dow, S&P hit highs; Trump comment hammers drug stocks",0.0,1.0,0.0,0
2016-12-07 18:13:43,0.3182,Britain fines Pfizer record 84.2 million pounds for huge drug price hike,0.0,0.827,0.173,1
2016-12-07 20:00:00,-0.4767,The UK Has Fined PFE For Unfair Drug Pricing (PFE),0.256,0.744,0.0,-1
2016-12-07 21:07:18,0.0,"Markets Right Now: Dow, S&P 500 surge to record high closes",0.0,1.0,0.0,0
2016-12-07 21:32:38,-0.4588,Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win,0.347,0.459,0.194,-1
2016-12-07 21:33:10,0.0,"Trump Targets Drug Prices And Apple, Seeks '5 Minutes' With Offshoring Firms",0.0,1.0,0.0,0
2016-12-07 21:49:42,0.2263,"NASDAQ Composite Index closes up 24.11 points for the week, rising for the 4th straight day",0.0,0.888,0.112,1
2016-12-07 21:56:04,-0.296,Close Update: Dow Closes At Another Record High as Trump-Rally Continues; Drug Makers Under Pressure,0.136,0.864,0.0,-1
2016-12-07 22:55:36,-0.3182,Dow Jones Industrial Average Jumps 298 Points; Trump Derails Drug Stocks,0.187,0.813,0.0,-1
2016-12-08 03:41:24,0.0,Asian stocks advance ahead of ECB decision,0.0,1.0,0.0,0
2016-12-08 04:05:00,0.4588,Stocks Advance as ECB Extends Asset Purchases,0.0,0.556,0.444,1
2016-12-08 04:05:00,0.0,U.S. Stocks Little Changed; Euro Slides,0.0,1.0,0.0,0
2016-12-08 04:05:00,0.0,U.S. Stocks Climb; Euro Slides,0.0,1.0,0.0,0
2016-12-08 08:13:00,0.0,Stocks Advance After Wall Street Highs,0.0,1.0,0.0,0
2016-12-08 13:10:00,0.0,Pfizer To Present At Citi Global Healthcare Conference; Webcast At 2:10 PM ET,0.0,1.0,0.0,0
2016-12-08 13:15:00,0.0,Patients' Right To Try Should Not Be A License To Fleece Them,0.0,1.0,0.0,0
2016-12-08 13:15:00,0.0,Blog Coverage Pfizer Fined $107 Million for Overcharging Through an Antiepileptic Drug,0.0,1.0,0.0,0
2016-12-08 15:01:05,-0.4404,Should Biotech Investors Worry About Donald Trump?,0.326,0.674,0.0,-1
2016-12-08 16:23:00,0.0,"U.S. Stocks Climb, Extending Rally",0.0,1.0,0.0,0
2016-12-08 16:57:54,0.0,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK,0.0,1.0,0.0,0
2016-12-08 16:59:34,0.0,"Dow Movers: PFE, GS",0.0,1.0,0.0,0
2016-12-08 21:18:00,0.0258,Health care sector suffers: Time to buy the dip?,0.233,0.526,0.241,0
2016-12-08 21:56:57,0.4404,Better Buy: Johnson & Johnson vs. Pfizer Inc.,0.0,0.674,0.326,1
2016-12-09 03:05:17,0.296,Asian shares meander as ECB-inspired rally fades,0.0,0.732,0.268,1
2016-12-09 10:57:00,0.0,Pfizer May Be Setting Up as a Low-Risk Buy,0.0,1.0,0.0,0
2016-12-09 14:35:00,0.0,Drug-Research Firm PPD Explores Sale,0.0,1.0,0.0,0
2016-12-09 14:59:29,-0.2732,"Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs",0.13,0.87,0.0,-1
2016-12-09 15:19:32,-0.2732,Should You Buy Drug Stocks on Their Post-Election Drop?,0.208,0.792,0.0,-1
2016-12-09 16:24:00,0.0516,Listing the Reasons behind Pfizer’s Discounted Price-to-Earnings,0.0,0.833,0.167,0
2016-12-09 16:57:48,-0.2263,Can Trump Solve Pfizer's $80 Billion Problem?,0.284,0.526,0.189,-1
2016-12-09 16:59:37,0.0,"Dow Movers: WMT, KO",0.0,1.0,0.0,0
2016-12-09 17:04:07,0.4588,"Stocks Up Again; Apple Strengthens, Reclaims 50-Day Line",0.0,0.7,0.3,1
2016-12-09 18:05:28,0.0,Understanding Pfizer’s 3Q16 Performance,0.0,1.0,0.0,0
2016-12-09 19:35:28,0.3818,Pfizer’s Eighth Consecutive Quarter of Revenue Growth,0.0,0.698,0.302,1
2016-12-09 19:46:00,0.0,Pfizer Up Along with Other Healthcare Stocks,0.0,1.0,0.0,0
2016-12-09 20:00:43,0.4019,"Stock Market Indexes Rally To New Highs; Apple, Microsoft Boost Dow",0.0,0.787,0.213,1
2016-12-09 20:07:54,0.25,Stocks poised for records as S&P 500 on pace for longest streak since 2014,0.0,0.867,0.133,1
2016-12-09 21:06:45,0.1779,Markets Right Now: Stocks extend rally to new highs,0.0,0.825,0.175,1
2016-12-09 21:57:17,0.0,US Market Indexes End the Week Higher,0.0,1.0,0.0,0
2016-12-09 22:56:54,0.9153,Dow Jones Industrial Average Ends Week With Record Win; S&P Nabs Best Win Streak Since '14,0.0,0.524,0.476,1
2016-12-10 13:06:17,0.3182,Pfizer likely to announce dividend increase,0.0,0.685,0.315,1
2016-12-11 11:50:12,-0.7269,Should Big Pharma Be Worried About a Trump Trade War?,0.466,0.534,0.0,-1
2016-12-11 13:56:57,-0.4215,My Biggest Investing Regret of 2016,0.359,0.641,0.0,-1
2016-12-11 14:18:28,0.0,"Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow",0.0,1.0,0.0,0
2016-12-11 18:54:00,0.0,Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion -- Sources,0.0,1.0,0.0,0
2016-12-11 19:35:00,0.0,Lonza Nears Deal to Buy KKR's Capsugel,0.0,1.0,0.0,0
2016-12-11 23:02:00,0.0,"Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion, Sources Say -- Update",0.0,1.0,0.0,0
2016-12-11 23:59:00,0.0,KKR Reportedly Nears Deal To Sell Capsugel To Lonza Group For More Than $5 Bln,0.0,1.0,0.0,0
2016-12-12 02:47:00,0.0,KKR Closes In on $5 Billion Deal -- WSJ,0.0,1.0,0.0,0
2016-12-12 03:47:34,0.0,[$$] Lonza Nears Deal to Buy KKR's Capsugel,0.0,1.0,0.0,0
2016-12-12 04:09:05,0.0,Asian stocks mixed ahead of Fed rates decision; oil soars,0.0,1.0,0.0,0
2016-12-12 04:15:00,0.0,Lonza Confirms Talks to Buy Capsugel From KKR,0.0,1.0,0.0,0
2016-12-12 04:15:00,0.0,Lonza Confirms Talks to Buy Capsugel,0.0,1.0,0.0,0
2016-12-12 04:22:01,0.0,[$$] Lonza Nears Deal to Buy KKR’s Capsugel,0.0,1.0,0.0,0
2016-12-12 08:15:00,0.3182,Pfizer To Collaborate On IGNITE's Research Program On Novel Vaccinia Viruses,0.0,0.813,0.187,1
2016-12-12 09:49:00,0.4588,Lonza Group Confirms Interest In Capsugel,0.0,0.625,0.375,1
2016-12-12 13:06:15,0.4404,How Did Pfizer’s Innovative Health Business Perform in 3Q16?,0.0,0.734,0.266,1
2016-12-12 13:44:06,0.0,Short Sellers Back Way Off Major Pharma Stocks,0.0,1.0,0.0,0
2016-12-12 14:36:34,-0.6908,Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer,0.388,0.612,0.0,-1
2016-12-12 15:56:49,0.0,Analysts Expect IWY To Hit $63,0.0,1.0,0.0,0
2016-12-12 16:00:18,0.3182,Lilly/AstraZeneca Expand Alzheimer Disease Collaboration,0.0,0.635,0.365,1
2016-12-12 16:06:08,0.3818,How Could Pfizer Drive Growth for Ibrance?,0.0,0.698,0.302,1
2016-12-12 16:10:07,0.0,Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends,0.0,1.0,0.0,0
2016-12-12 16:53:00,0.0,Pfizer Declares First-Quarter 2017 Dividend,0.0,1.0,0.0,0
2016-12-12 16:57:07,-0.0516,"Value Battle: Pfizer Inc. (PFE) vs. Merck & Co., Inc. (MRK)",0.2,0.615,0.185,0
2016-12-12 17:03:23,0.0,Pfizer raises dividend 7%; stock surges,0.0,1.0,0.0,0
2016-12-12 17:35:00,0.2716,"Pfizer's Dividend Rate Hike 'More Important' Than a Trump Tweet, Analyst Says",0.0,0.827,0.173,1
2016-12-12 17:50:17,-0.2732,3 Big Risks for Johnson & Johnson in 2017,0.259,0.741,0.0,-1
2016-12-12 19:56:52,0.0258,Regeneron Pharmaceuticals Inc (REGN) Stock Gains on Opthotech’s Loss,0.197,0.598,0.205,0
2016-12-12 21:01:42,0.0,"J&J, Wal-Mart Lift Dow Higher Monday",0.0,1.0,0.0,0
2016-12-12 21:25:00,0.0,This Isn't a Bearish Pause in the Market,0.0,1.0,0.0,0
2016-12-12 21:56:17,0.0,"Daily Dividend Report: PFE, MORN, STJ, AWK, XHR",0.0,1.0,0.0,0
2016-12-12 21:56:31,0.5267,"Close Update: S&P, Nasdaq Halt Winning Streak But Dow Floats to Record High",0.0,0.779,0.221,1
2016-12-12 21:56:38,0.0,Monday's ETF with Unusual Volume: SPYG,0.0,1.0,0.0,0
2016-12-13 12:18:48,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : December 13, 2016",0.0,1.0,0.0,0
2016-12-13 13:06:09,-0.6597,Avelumab: The First US Treatment for Metastatic Skin Cancer?,0.355,0.645,0.0,-1
2016-12-13 13:56:04,0.0,"China’s Go-Go Momentum Is Pointing to Momo, Inc. (ADR) Stock",0.0,1.0,0.0,0
2016-12-13 14:36:01,0.3818,Exploring Avelumab’s Opportunities in the PD-1/PD-L1 Space,0.0,0.698,0.302,1
2016-12-13 15:11:00,0.0,Pfizer Raises Dividend; Now Yields Near 4%,0.0,1.0,0.0,0
2016-12-13 16:05:57,0.0,How Did Pfizer’s Essential Health Business Perform in 3Q16?,0.0,1.0,0.0,0
2016-12-13 16:58:59,-0.296,3 Tempting Stocks to Avoid,0.423,0.577,0.0,-1
2016-12-13 17:00:27,0.0,Pfizer Just Channeled Its Inner Martin Shkreli (and Paid for It),0.0,1.0,0.0,0
2016-12-13 18:03:00,0.0,Ab Initio Announces Strategic Collaboration with Pfizer to Discover GPCR Activating Antibodies,0.0,1.0,0.0,0
2016-12-13 18:56:11,0.0,US Market Indexes Mixed on Monday,0.0,1.0,0.0,0
2016-12-14 04:01:12,0.0,Asian stocks mostly higher ahead of Fed's rate decision,0.0,1.0,0.0,0
2016-12-14 13:05:41,-0.34,Loss of Patent Protection to Drag Pfizer’s Top Line,0.35,0.5,0.15,-1
2016-12-14 14:35:36,-0.4019,Lyrica to Lose Patent Protection in the US in 2018,0.231,0.769,0.0,-1
2016-12-14 15:01:24,0.5267,J&J (JNJ) Ends Deal Talks with Actelion: Will Sanofi Gain?,0.0,0.726,0.274,1
2016-12-14 16:03:59,0.4019,Blockchain Technology Can Help Reduce Flow Of Counterfeit Drugs,0.0,0.748,0.252,1
2016-12-14 16:05:05,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : December 14, 2016",0.0,0.745,0.255,1
2016-12-14 16:05:37,0.0,How Much Could Pfizer Grow beyond 2016?,0.0,1.0,0.0,0
2016-12-14 16:54:46,0.0,Actelion talking to Sanofi after J&J exit,0.0,1.0,0.0,0
2016-12-14 16:57:52,0.0,"Dow Movers: BA, MRK",0.0,1.0,0.0,0
2016-12-14 17:20:00,0.6115,"How to Trade Wednesday's Most Active Stocks -- Wells Fargo, Apple and More",0.0,0.688,0.312,1
2016-12-14 18:25:40,0.4019,FDA approves Pfizer's eczema ointment,0.0,0.597,0.403,1
2016-12-14 18:50:00,0.0,Eli Lilly In 2017: Boom Or Bust?,0.0,1.0,0.0,0
2016-12-14 20:51:00,0.4019,FDA Approves Pfizer's Eucrisa For Eczema,0.0,0.649,0.351,1
2016-12-14 21:15:00,-0.6597,Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer,0.18,0.82,0.0,-1
2016-12-14 21:30:00,-0.34,Sheridan Memorial Hospital First to Implement Interoperable Alarm Technology Between Cerner and Hospira,0.167,0.833,0.0,-1
2016-12-14 21:49:53,0.4404,Better Buy: Pfizer Inc. vs. Merck,0.0,0.633,0.367,1
2016-12-14 21:56:57,0.4576,"After Hours Most Active for Dec 14, 2016 :  V, ORCL, MDLZ, QQQ, SYF, ITUB, WFC, PFE, MSFT, INTC, MENT, QCOM",0.0,0.864,0.136,1
2016-12-14 21:57:21,0.5267,Will Buyback ETFs Gain Big on Overseas Cash Repatriation?,0.0,0.702,0.298,1
2016-12-14 22:07:59,0.1531,FDA approves Pfizer ointment for chronic itchy skin condition,0.178,0.593,0.229,1
2016-12-14 22:22:32,-0.4215,Pfizer's Xtandi fails in progression trial vs J&J's Zytiga,0.259,0.741,0.0,-1
2016-12-15 02:15:00,0.6597,"CORRECTING and REPLACING Pfizer Receives FDA Approval for EUCRISA™ (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Atopic Dermatitis (Eczema)",0.0,0.779,0.221,1
2016-12-15 09:33:00,0.0,Lonza to Buy Capsugel from KKR in Multibillion-Dollar Deal-- 2nd Update,0.0,1.0,0.0,0
2016-12-15 11:06:42,0.5994,"Drugmakers push profitable, but unproven, opioid solution",0.0,0.505,0.495,1
2016-12-15 11:10:22,0.5267,Drugmakers set to gain as taxpayers foot new opioid costs,0.0,0.726,0.274,1
2016-12-15 12:30:00,0.0,Johnson & Johnson Looks for New Deal That's Just Right,0.0,1.0,0.0,0
2016-12-15 12:58:58,-0.0258,Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study,0.243,0.522,0.235,0
2016-12-15 13:00:00,0.0,Trending: Transportation and Steel Industries Prepare for Trumponomics,0.0,1.0,0.0,0
2016-12-15 13:05:32,0.3612,What Do Analysts Recommend for Pfizer?,0.0,0.667,0.333,1
2016-12-15 13:15:57,0.5106,Pfizer Has Strong Track Record since 2010,0.0,0.645,0.355,1
2016-12-15 14:19:03,0.0,[$$] Drug Company Lonza to Buy Capsule Maker From KKR,0.0,1.0,0.0,0
2016-12-15 15:05:28,0.0,What Were Pfizer’s Major Achievements in 2016?,0.0,1.0,0.0,0
2016-12-15 16:58:19,0.296,"VOO, PFE, BAC, KO: ETF Inflow Alert",0.0,0.732,0.268,1
2016-12-15 19:36:34,0.4939,"Health Care Sector Update for 12/15/2016: FOLD,CBIO,PFE,PACB",0.0,0.652,0.348,1
2016-12-15 21:36:26,0.4939,"Health Care Sector Update for 12/15/2016: ATHN,CBIO,PFE,PACB",0.0,0.652,0.348,1
2016-12-15 22:22:09,0.2023,3 Top Big Pharma Stocks to Buy Now,0.0,0.769,0.231,1
2016-12-15 23:57:50,0.4927,Big Pharma Face Off: Is Merck More Attractive than J&J?,0.0,0.738,0.262,1
2016-12-16 13:04:00,0.0,Mega stocks' mega potential,0.0,1.0,0.0,0
2016-12-16 13:35:00,-0.296,"Firm accused of overcharging NHS by hiking life-saving drug price by 12,000%",0.167,0.833,0.0,-1
2016-12-16 14:03:00,0.0,Stocks With the Potential to Propel Dow Beyond 20K,0.0,1.0,0.0,0
2016-12-16 15:00:51,-0.34,Is This Gilead Sciences' Biggest Mistake in 2016?,0.255,0.745,0.0,-1
2016-12-16 15:08:00,-0.34,FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix,0.255,0.745,0.0,-1
2016-12-16 15:41:00,-0.34,Correction to FDA Chantix Warning Story,0.324,0.676,0.0,-1
2016-12-16 16:28:00,-0.3182,The bizarre connection between Pfizer and the synthetic drug turning people into ‘zombies’,0.161,0.839,0.0,-1
2016-12-16 17:10:28,-0.296,Actavis UK accused of overcharging hydrocortisone drug,0.268,0.732,0.0,-1
2016-12-16 19:20:10,0.0,FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling,0.213,0.632,0.155,0
2016-12-16 19:26:35,-0.34,FDA drops black box warning on Pfizer's anti-smoking drug,0.231,0.769,0.0,-1
2016-12-16 20:12:00,-0.5423,White House Kills Plan for Drug Price Cap,0.333,0.667,0.0,-1
2016-12-16 20:28:17,-0.34,[$$] FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix,0.231,0.769,0.0,-1
2016-12-16 21:20:08,0.1363,Pfizer get OK to remove 'black box' warning on smoking cessation drug,0.157,0.652,0.191,1
2016-12-16 21:56:56,0.0516,"US drops bold warning from anti-smoking pills Chantix, Zyban",0.2,0.583,0.217,0
2016-12-16 21:57:20,0.0,"Dow 30 Stock Roundup: Boeing, GE Raise Dividends; ExxonMobil Gets New CEO",0.0,1.0,0.0,0
2016-12-17 14:23:00,0.0,4 Must-Have Dividend-Growth Stocks For 2017,0.0,1.0,0.0,0
2016-12-19 07:23:00,0.4019,Pfizer Gets EU Nod For Nimenrix To Treat Invasive Meningococcal Disease,0.0,0.787,0.213,1
2016-12-19 12:11:06,0.4767,"Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older",0.0,0.886,0.114,1
2016-12-19 13:00:00,0.4939,Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa™ (andexanet alfa),0.0,0.856,0.144,1
2016-12-19 13:26:01,-0.34,Pfizer Chantix Label Warning Lifted in U.S.; to Add New Data,0.194,0.806,0.0,-1
2016-12-19 13:57:36,0.4939,"Health Care Sector Update for 12/19/2016: BCLI, JNJ, PFE, ABT, MRK, AMGN",0.0,0.775,0.225,1
2016-12-19 13:58:01,0.4019,"Pharma Stock Roundup: Lilly Up on Guidance, Merck Awarded $2.54B in HCV Case",0.0,0.816,0.184,1
2016-12-19 16:02:36,-0.6597,Merck Keytruda Gets CHMP Nod for First-Line Lung Cancer,0.355,0.645,0.0,-1
2016-12-19 17:20:55,0.7845,Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement,0.0,0.504,0.496,1
2016-12-19 17:42:56,0.0,Boom and Bust: The 2016 M&A Deals Report,0.0,1.0,0.0,0
2016-12-19 17:58:26,0.0,4 Stocks Insiders Are Loading Up On – and You Should Too,0.0,1.0,0.0,0
2016-12-19 18:36:53,0.5859,Midday Update: Stocks Hold Gains As Wall Street Waits For Reassurances From Yellen,0.0,0.696,0.304,1
2016-12-19 19:00:00,0.0,Three Appealing Micro-Cap Stocks,0.0,1.0,0.0,0
2016-12-19 19:05:00,0.4019,European Regulator Approves Pfizer Vaccine,0.0,0.597,0.403,1
2016-12-19 19:59:44,0.5719,Pfizer May Be Happy With Anacor,0.0,0.575,0.425,1
2016-12-19 20:03:00,0.0,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch",0.0,1.0,0.0,0
2016-12-19 21:56:55,0.128,"Close Update: Geopolitical Events Trim Early Gains; Dow Misses 20,000 For Fifth Day",0.124,0.719,0.157,1
2016-12-20 02:56:33,0.6514,Surprise! Clovis Oncology Nabs Early OK,0.0,0.429,0.571,1
2016-12-20 12:00:00,0.4019,Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes,0.0,0.816,0.184,1
2016-12-20 14:17:00,0.4939,"Health Care Sector Update for 12/20/2016: BMY, ACAD, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-12-20 15:36:13,0.3612,Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA),0.0,0.872,0.128,1
2016-12-20 16:25:00,-0.5423,Gilead Sciences: How Bad is the Glaxo News?,0.333,0.667,0.0,-1
2016-12-20 19:18:14,0.0,Sanofi's takeover talks with Actelion progressing - source,0.0,1.0,0.0,0
2016-12-20 20:06:10,0.0,3 Dividend Stocks to Put on Your Shopping List,0.0,1.0,0.0,0
2016-12-20 21:10:00,-0.5106,"Cramer: I'm Already Sick of Dow 20,000, and We're Not Even There Yet",0.216,0.784,0.0,-1
2016-12-20 22:31:27,0.7096,Bristol-Myers Squibb Expects Strong Revenue Growth in 2016,0.0,0.504,0.496,1
2016-12-21 07:12:06,0.0,BioInvent announces Cancer Immunotherapy Research Collaboration and License Agreement with Pfizer and issues new shares to Pfizer,0.185,0.588,0.227,0
2016-12-21 08:22:00,-0.0772,Pfizer: FDA To Review SNDA For IBRANCE Inhibitor - Quick Facts,0.126,0.874,0.0,0
2016-12-21 09:39:56,0.8126,Actelion shares gain on report of progress in Sanofi talks,0.0,0.455,0.545,1
2016-12-21 12:00:01,0.0,Artificial leaf copies nature to manufacture medicine,0.0,1.0,0.0,0
2016-12-21 13:12:10,-0.4767,"FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer",0.213,0.676,0.111,-1
2016-12-21 14:59:50,0.4019,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite,0.0,0.748,0.252,1
2016-12-21 17:03:05,-0.296,Markets Right Now: Stock indexes edge lower in midday trade,0.196,0.804,0.0,-1
2016-12-21 21:01:58,0.0,"Merck, Pfizer Weigh on DJIA Wednesday",0.0,1.0,0.0,0
2016-12-21 21:07:36,0.25,Markets Right Now: Health care stocks lead US indexes lower,0.164,0.597,0.239,1
2016-12-21 21:56:35,-0.3182,3 Stocks That Could Get Pounded by Tax Loss Selling,0.223,0.777,0.0,-1
2016-12-21 22:28:00,-0.4588,Dividends key to beating market?,0.429,0.571,0.0,-1
2016-12-21 22:35:10,0.0,"Stock Research Reports for Pfizer, Microsft & Bank of America",0.0,1.0,0.0,0
2016-12-21 23:19:11,0.0,Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU,0.0,1.0,0.0,0
2016-12-21 23:42:55,-0.296,US Market Indexes Lower on Wednesday,0.306,0.694,0.0,-1
2016-12-22 11:40:01,0.0,"5 Stocks That Will Keep the Dow Under 20,000",0.0,1.0,0.0,0
2016-12-22 13:01:01,0.2732,Pfizer Ibrance sNDA Accepted by FDA under Priority Review,0.0,0.792,0.208,1
2016-12-22 15:00:47,-0.4019,J&J Resumes Talks with Actelion: Did Sanofi Just Lose Out?,0.231,0.769,0.0,-1
2016-12-22 17:00:49,0.0,"Dow Movers: PFE, CVX",0.0,1.0,0.0,0
2016-12-22 17:01:14,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Bank of America, Oracle and Nike",0.0,1.0,0.0,0
2016-12-22 18:00:41,-0.128,Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve,0.13,0.87,0.0,-1
2016-12-22 19:02:04,0.2023,FDA Agrees To Review IBRANCE (palbociclib) From Pfizer Inc. (PFE),0.0,0.833,0.167,1
2016-12-22 19:12:00,0.0,Donald Trump's Pick for Health Secretary Traded Medical Stocks While in House,0.0,1.0,0.0,0
2016-12-22 21:57:28,0.4576,"After Hours Most Active for Dec 22, 2016 :  NAVI, BAC, CMCSA, GLW, GNTX, PFE, DOW, MU, MOS, MPEL, TSM, QQQ",0.0,0.864,0.136,1
2016-12-22 21:58:56,0.6369,The 3 Best New ETFs That Will Keep Your Wallet Stuffed,0.0,0.682,0.318,1
2016-12-23 10:08:14,0.0,Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca,0.0,1.0,0.0,0
2016-12-23 14:45:10,0.0,"Stocks Open Tightly Mixed; Pfizer Climbs, Fred's Surges Again",0.0,1.0,0.0,0
2016-12-23 16:19:00,0.4019,Does Pfizer Acquisition From AZN Help The Stock?,0.0,0.722,0.278,1
2016-12-23 16:58:21,0.0,"Noteworthy ETF Inflows: IWD, BAC, PFE, C",0.0,1.0,0.0,0
2016-12-23 19:32:32,0.4939,"Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider",0.0,0.682,0.318,1
2016-12-23 23:57:02,0.0,Why Portola Pharmaceuticals Inc Stock Surged Higher Today,0.0,1.0,0.0,0
2016-12-23 23:57:37,0.0,"Dow 30 Stock Roundup: Nike Beats, Coca-Cola to Buy AB InBev's Stake in CCBA",0.0,1.0,0.0,0
2016-12-25 02:03:00,0.3182,The Year That Was: Novel Drug Approvals Of 2016,0.0,0.777,0.223,1
2016-12-26 12:36:19,0.0,Financial Metrics of Baxter’s Acquisition of Claris Injectables,0.0,1.0,0.0,0
2016-12-26 13:51:58,0.0,"Pfizer Inc. :PFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 26, 2016",0.0,1.0,0.0,0
2016-12-26 17:01:10,-0.5106,How Ugly Can the Bond Rout Get?,0.355,0.645,0.0,-1
2016-12-27 13:57:53,-0.2732,The 3 Biggest Risks for Pfizer in 2017,0.259,0.741,0.0,-1
2016-12-27 14:07:02,0.2732,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up",0.0,0.811,0.189,1
2016-12-27 15:17:19,0.4939,"Health Care Sector Update for 12/27/2016: SGEN, IONS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-12-27 16:01:41,-0.2263,Aerie (AERI) Rhopressa Regulatory Application Delayed Again,0.241,0.759,0.0,-1
2016-12-27 16:13:00,0.0,Donald Trump Dogs Dow Strategy -- Ahead of the Tape,0.0,1.0,0.0,0
2016-12-27 17:24:00,0.0,Halftime traders' 2017 playbook: Jim & Sarat,0.0,1.0,0.0,0
2016-12-27 18:08:51,0.6369,3 Best Stocks for Retirees,0.0,0.417,0.583,1
2016-12-27 18:38:18,0.0,"ETFs with exposure to Pfizer Inc. : December 27, 2016",0.0,1.0,0.0,0
2016-12-27 23:05:35,0.3818,International Segment: Key Driver of VRX’s Revenue Growth in 2016,0.0,0.776,0.224,1
2016-12-28 04:45:04,0.0,[$$] Donald Trump Dogs Dow Strategy,0.0,1.0,0.0,0
2016-12-28 13:35:00,-0.8519,Eight Milestones Of 2016 In The War On Cancer,0.542,0.458,0.0,-1
2016-12-28 13:47:17,0.0,'Dogs of the Dow' unleashed for 2017,0.0,1.0,0.0,0
2016-12-28 14:17:35,0.4939,"Health Care Sector Update for 12/28/2016: SNY, ANTH, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-12-28 15:25:59,0.4588,Short Interest Rises in Major Pharma,0.0,0.625,0.375,1
2016-12-28 15:36:54,0.2716,Why Is Enbrel So Important for Amgen?,0.0,0.741,0.259,1
2016-12-28 20:00:44,0.0,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations,0.0,1.0,0.0,0
2016-12-28 21:30:00,0.0,These 2 'Dogs of Dow' Are Set to Be Unleashed,0.0,1.0,0.0,0
2016-12-28 22:38:11,0.2023,2 Top High-Yield Dividend Stocks to Buy Now,0.0,0.769,0.231,1
2016-12-29 12:35:27,-0.6908,"5 Companies That Will Kill the Dow’s Move to 20,000",0.37,0.63,0.0,-1
2016-12-29 12:36:11,-0.4767,Will Keytruda’s Position Strengthen in the Lung Cancer Market?,0.321,0.511,0.168,-1
2016-12-29 14:37:53,0.4939,"Health Care Sector Update for 12/29/2016: ETRM, CEMP, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2016-12-29 16:46:00,0.0,These 2 'Dogs of the Dow' Will Have Their Day in 2017,0.0,1.0,0.0,0
2016-12-29 17:01:43,0.0,Johnson & Johnson's 4 Biggest Catalysts in 2017,0.0,1.0,0.0,0
2016-12-29 21:00:00,0.0,"Watch Beaten-Down Drug Companies, Hospitals in 2017",0.0,1.0,0.0,0
2016-12-29 23:20:18,0.2023,Kevin O'Leary's Top 10 Quality Dividend Stocks,0.0,0.769,0.231,1
2016-12-30 11:01:50,0.0,[$$] Will 2017 Be the Year of the Deal?,0.0,1.0,0.0,0
2016-12-30 12:38:05,0.0,Exploring GlaxoSmithKline’s Business Segments,0.0,1.0,0.0,0
2016-12-30 14:00:10,0.2732,Merck (MRK) Does Well in 2016: Reasons for Outperformance,0.0,0.792,0.208,1
2016-12-30 14:07:11,0.0,How GlaxoSmithKline’s Pharmaceuticals Segment Has Performed,0.0,1.0,0.0,0
2016-12-30 14:37:49,0.4939,"Health Care Sector Update for 12/30/2016: CO, JNJ, PFE, ABT, MRK, AMGN",0.0,0.775,0.225,1
2016-12-30 15:12:38,0.0,Opko Health's Phase 3 Data Sends Stock Plunging,0.0,1.0,0.0,0
2016-12-30 17:01:55,0.0,Mylan (MYL) Announces Multiple Generic Launches in the U.S.,0.0,1.0,0.0,0
2016-12-30 17:01:58,0.5106,"ARIAD Stock Beats Industry in 2016, Iclusig Sales Strong",0.0,0.708,0.292,1
2016-12-30 17:39:08,-0.0516,Growth hormone deficiency drug from OPKO and Pfizer fails study,0.209,0.597,0.194,0
2016-12-30 18:58:01,0.0,Why Opko Health Inc. Stock Is Sinking Today,0.0,1.0,0.0,0
2016-12-30 19:30:11,0.0,2016: Biotech’s Tumultuous Year,0.0,1.0,0.0,0
2016-12-30 21:58:04,0.4576,"After Hours Most Active for Dec 30, 2016 :  BAC, QQQ, GE, MSFT, AAPL, JPM, T, PFE, CSCO, INTC, WFC, FB",0.0,0.864,0.136,1
2016-12-31 16:14:23,0.0,Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside,0.0,1.0,0.0,0
2017-01-02 21:48:11,0.4576,"After Hours Most Active for Dec 30, 2016 :  CMCSA, BAC, QQQ, GE, MSFT, AAPL, JPM, T, CSCO, PFE, INTC, WFC",0.0,0.864,0.136,1
2017-01-03 13:57:13,0.6633,SNY Named Top 10 SAFE International Dividend Stock,0.0,0.525,0.475,1
2017-01-03 14:19:24,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 04, 2017",0.0,1.0,0.0,0
2017-01-03 14:37:56,0.4939,"Health Care Sector Update for 01/03/2017: AGN, ITEK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2017-01-03 16:00:00,0.0,Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts,0.0,1.0,0.0,0
2017-01-03 17:48:05,0.0,"Stock Research Reports for Pfizer, Lockheed Martin & UnitedHealth",0.0,1.0,0.0,0
2017-01-03 19:09:00,0.0,2017 stock picker's playbook,0.0,1.0,0.0,0
2017-01-03 23:00:08,0.2023,From Bamboo Therapeutics to Undercover Colors: Top Triangle fundraises in 2016,0.0,0.847,0.153,1
2017-01-04 00:37:15,-0.6249,My Worst Predictions for Biotech in 2016,0.406,0.594,0.0,-1
2017-01-04 07:36:00,0.2263,Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts,0.0,0.808,0.192,1
2017-01-04 11:25:11,0.6249,4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017,0.0,0.687,0.313,1
2017-01-04 11:54:29,0.0,The price of a lifesaving drug that reverses opioid overdoses is soaring,0.0,1.0,0.0,0
2017-01-04 12:30:00,0.5719,Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program,0.0,0.749,0.251,1
2017-01-04 14:12:02,0.0,5 Dogs of the Dow Stocks for 2017,0.0,1.0,0.0,0
2017-01-04 14:16:44,0.4939,"Health Care Sector Update for 01/04/2017: NVLS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.775,0.225,1
2017-01-04 14:30:00,0.0,"Pfizer Is Cheap, but Is Still a Dog Stock",0.0,1.0,0.0,0
2017-01-04 14:41:42,-0.4767,Inotek (ITEK) Down on Poor Phase III Glaucoma Drug Data,0.256,0.744,0.0,-1
2017-01-04 16:42:13,0.0,"The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Lockheed Martin, 3M and TripAdvisor",0.0,1.0,0.0,0
2017-01-04 17:56:03,0.4939,Shining A Spotlight On Ailing Health Care ETFs,0.0,0.652,0.348,1
2017-01-04 18:40:14,0.2263,Spark reels in second $15M payment from Pfizer,0.0,0.787,0.213,1
2017-01-04 20:30:01,0.0,3 Reasons to Buy Pfizer Stock for Retirement,0.0,1.0,0.0,0
2017-01-04 21:37:31,0.1779,Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout,0.0,0.841,0.159,1
2017-01-04 21:43:52,0.0,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today,0.0,1.0,0.0,0
2017-01-04 22:37:04,0.0,Exploring an Apple Inc. (AAPL) Takeover of Sirius and Pandora,0.0,1.0,0.0,0
2017-01-04 22:37:48,0.0,What's Next for Opko Health After Its Recent Clinical Setback?,0.0,1.0,0.0,0
2017-01-05 00:37:11,0.0,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today",0.0,1.0,0.0,0
2017-01-05 08:52:00,0.5574,Pfizer's Potential Biosimilar To Humira Reveals Positive Data - Quick Facts,0.0,0.714,0.286,1
2017-01-05 11:00:00,0.0,"For People With Disabilities, ABLE Accounts a Step Toward Independence",0.0,1.0,0.0,0
2017-01-05 11:00:00,0.0,Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer,0.0,1.0,0.0,0
2017-01-05 11:02:00,0.0,"Here's When to Buy Chevron, IBM, 3 More High-Yielding Dow 'Dogs'",0.0,1.0,0.0,0
2017-01-05 13:30:00,0.5574,"Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)",0.0,0.825,0.175,1
2017-01-05 13:30:31,0.0,BAT quits nicotine inhaler to focus on vaping,0.0,1.0,0.0,0
2017-01-05 14:02:01,0.0,AbCellera Announces Multi-Target Research Collaboration with Pfizer,0.0,1.0,0.0,0
2017-01-05 14:37:41,0.4939,"Health Care Sector Update for 01/05/2017: CTIC, HRTX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2017-01-05 14:40:58,0.25,Bayer's sNDA for Stivarga Granted Priority Review in the U.S.,0.0,0.818,0.182,1
2017-01-05 14:41:00,0.4939,What Pharma and Health Care Investors Should Watch for at JPM,0.0,0.758,0.242,1
2017-01-05 15:09:03,0.2263,Spark Therapeutics Gets $15M Milestone Payment from Pfizer,0.0,0.787,0.213,1
2017-01-05 16:05:19,0.4939,"2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth",0.0,0.738,0.262,1
2017-01-05 16:40:26,0.0,"The Zacks Analyst Blog Highlights: Verizon Communications, Pfizer, Chevron, Caterpillar and ExxonMobil",0.0,1.0,0.0,0
2017-01-05 16:44:33,-0.2263,"The 4 Building Blocks That Pushed Exelixis, Inc. Higher by 164% in 2016",0.147,0.853,0.0,-1
2017-01-05 17:36:00,0.0,"Senate Dems, D.C. Watchdog Call for Investigation Into Trump HHS Pick Tom Price's Stock Portfolio",0.0,1.0,0.0,0
2017-01-05 21:05:00,0.0,"ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction",0.0,1.0,0.0,0
2017-01-05 21:39:33,0.2263,Spark Gets A Check From Pfizer And A Downgrade From Vetr,0.0,0.808,0.192,1
2017-01-05 22:26:00,0.5574,Pfizer Unveils Positive Results from Study of Potential Humira Biosimilar,0.0,0.714,0.286,1
2017-01-05 22:37:12,0.0,Bullish Two Hundred Day Moving Average Cross - PFE,0.0,1.0,0.0,0
2017-01-06 13:48:29,0.0,[$$] Carlyle looks to sell health business Nature's Bounty,0.0,1.0,0.0,0
2017-01-06 14:40:03,0.0,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study,0.0,1.0,0.0,0
2017-01-06 14:41:41,-0.0772,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View",0.106,0.894,0.0,0
2017-01-06 16:37:00,0.3818,ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit,0.142,0.608,0.25,1
2017-01-06 17:40:04,0.0,It Was CheckMate for Bristol-Myers Squibb Company in 2016,0.0,1.0,0.0,0
2017-01-06 18:17:02,0.0,Midday Update: Stocks Regain Upward Momentum After Mixed Jobs Report,0.0,1.0,0.0,0
2017-01-06 22:08:22,0.0,Close Update: Labor Market Report Powers S&P 500 and Nasdaq to Record Highs,0.0,1.0,0.0,0
2017-01-07 16:13:00,0.4404,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer",0.0,0.674,0.326,1
2017-01-08 19:18:13,0.0,"5 Trade Ideas for Monday: AIG, CME, Honeywell, McDonald's and Pfizer",0.0,1.0,0.0,0
2017-01-09 12:48:50,0.0,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised),0.0,1.0,0.0,0
2017-01-09 13:51:00,0.0258,This Stock Prevented The Dow From Hitting Key Milestone,0.0,0.879,0.121,0
2017-01-09 14:29:20,0.4939,"Health Care Sector Update for 01/09/2017: ARWR, EXAS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2017-01-09 14:52:07,0.2023,2 Top Stocks in Biotech,0.0,0.625,0.375,1
2017-01-09 14:52:54,0.0,"Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study",0.0,1.0,0.0,0
2017-01-09 15:53:15,0.4215,The FDA Approved Fewer Drugs in 2016: Here's Why,0.0,0.741,0.259,1
2017-01-09 17:24:02,0.0,2 Reasons Pfizer's Stock Beat the Field in 2016,0.0,1.0,0.0,0
2017-01-09 19:19:00,0.0,Piper Bullish On Pfizer and Eli Lilly,0.0,1.0,0.0,0
2017-01-09 21:59:06,0.4576,"After Hours Most Active for Jan 9, 2017 :  BAC, PFE, ELY, ABBV, GE, PENN, MSFT, MPEL, CTXS, AAPL, C, CTSH",0.0,0.864,0.136,1
2017-01-09 23:51:42,0.6369,Cramer names the 'humanization of pets' as the greatest investing theme in the market,0.0,0.756,0.244,1
2017-01-10 12:31:00,0.0,Pfizer To Present At  J.P. Morgan Healthcare Conference; Webcast At 1:30 PM ET,0.0,1.0,0.0,0
2017-01-10 13:24:00,0.0,3 'Dogs of the Dow' Paying Up To 4.3%,0.0,1.0,0.0,0
2017-01-10 14:19:49,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 11, 2017",0.0,1.0,0.0,0
2017-01-10 14:21:51,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 11, 2017",0.0,1.0,0.0,0
2017-01-10 14:29:23,0.4939,"Health Care Sector Update for 01/10/2017: IMNP, VRX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2017-01-10 15:42:00,-0.5267,Pfizer Inc. (PFE) Challenges Businessmen To Come Up With Breast Cancer Solutions,0.268,0.549,0.183,-1
2017-01-10 16:32:56,0.0,"Pfizer Inc. : PFE-US: Dividend Analysis : November 11th, 2016 (record date) : By the numbers : January 10, 2017",0.0,1.0,0.0,0
2017-01-10 16:36:00,0.6369,Best Dividend Stocks For Retirement Income In 2017,0.0,0.625,0.375,1
2017-01-10 16:52:48,0.0,"3 “Dogs of the Dow” Paying Up to 4.3% (CVX, PFE, VZ)",0.0,1.0,0.0,0
2017-01-10 16:55:07,0.0,"The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron Pharmaceuticals",0.0,1.0,0.0,0
2017-01-10 17:53:04,0.0,"Notable ETF Inflow Detected - VOO, BAC, PFE, MRK",0.0,1.0,0.0,0
2017-01-10 17:59:00,0.2023,Todd Hagopian's Top Biotech Takeover Targets For 2017,0.0,0.795,0.205,1
2017-01-10 18:40:27,0.5719,1 Perfect Stock to Invest in the Pharmaceutical Industry,0.0,0.654,0.346,1
2017-01-10 20:41:29,0.296,How a Bust Caused Opko Health Shares to Tumble in 2016,0.0,0.804,0.196,1
2017-01-10 23:15:00,0.5719,Celebrate One Debacle of a Merger With Another -- ICYMI,0.0,0.684,0.316,1
2017-01-11 00:07:19,-0.1027,US warns of unusual cybersecurity flaw in heart devices,0.149,0.851,0.0,-1
2017-01-11 14:56:49,0.0,See Which Of The Latest 13F Filers Holds Pfizer,0.0,1.0,0.0,0
2017-01-11 16:59:59,0.5267,Markets Right Now: US stocks give back most of an early gain,0.0,0.764,0.236,1
2017-01-11 18:41:37,0.0,"Trump Shoots Down Biotechs, Lockheed; Apple, Nvidia Weigh On Nasdaq",0.0,1.0,0.0,0
2017-01-11 20:22:17,0.2023,Wednesday’s Top Biopharma Movers,0.0,0.625,0.375,1
2017-01-11 20:58:00,0.0,Pisani: Market's a tightly-coiled spring right now,0.0,1.0,0.0,0
2017-01-11 21:10:31,0.4588,Markets Right Now: Stocks end a wobbly day with solid gains,0.0,0.667,0.333,1
2017-01-11 21:16:40,-0.4404,Trump Attacks Drugmakers on Pricing,0.42,0.58,0.0,-1
2017-01-11 21:19:08,0.0,"Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, Ford, Fiat",0.0,1.0,0.0,0
2017-01-11 21:48:14,0.1027,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,563.65.",0.0,0.896,0.104,1
2017-01-11 22:56:18,0.0,Dow Jones Industrial Average Ends Choppy Session Higher After Trump,0.0,1.0,0.0,0
2017-01-11 22:56:22,0.0,"Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”",0.0,1.0,0.0,0
2017-01-11 23:57:33,-0.296,Stock Market Roundup Jan. 11: Health Sector Lower on Trump &quot;Murder&quot; Comment,0.167,0.833,0.0,-1
2017-01-12 07:25:51,-0.5719,Most Asia stocks up but Tokyo hit by Trump worries,0.291,0.709,0.0,-1
2017-01-12 08:42:42,-0.4215,"Tokyo stocks, dollar hit as Asia stumbles on Trump woe",0.237,0.763,0.0,-1
2017-01-12 12:37:39,0.0,Understanding Mylan’s Revenues,0.0,1.0,0.0,0
2017-01-12 15:01:19,0.0,Donald Trump Puts Humana Inc (HUM) Stock on My Buy Radar,0.0,1.0,0.0,0
2017-01-12 15:01:27,0.0,Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.,0.0,1.0,0.0,0
2017-01-12 15:57:00,0.34,Analysts Forecast 13% Gains Ahead For The Holdings of FXH,0.0,0.789,0.211,1
2017-01-12 16:01:40,0.0,Double Down on Dividends with These 3 Covered Calls,0.0,1.0,0.0,0
2017-01-12 16:02:30,0.0,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs",0.0,1.0,0.0,0
2017-01-12 16:57:10,0.0,"Stock Market News for January 12, 2017",0.0,1.0,0.0,0
2017-01-12 16:57:29,-0.4404,Trump Attacks Biotech & Pharma: ETFs Bleed,0.367,0.633,0.0,-1
2017-01-12 17:59:56,0.0,Bank of America Corp (BAC) Stock Could Take Flight Tomorrow,0.0,1.0,0.0,0
2017-01-12 20:22:50,0.0,"Investors in big pharma, biotech look to ride out Trump storm",0.0,1.0,0.0,0
2017-01-12 21:01:23,-0.2732,"Disney, Microsoft Lead DJIA Drop Thursday",0.296,0.704,0.0,-1
2017-01-12 21:25:50,0.2263,3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference,0.0,0.826,0.174,1
2017-01-12 21:56:59,0.4576,"After Hours Most Active for Jan 12, 2017 :  PDBC, AKS, PFE, QQQ, SBRA, VNQI, ABEV, GFI, BAC, RF, CTSH, HAIN",0.0,0.864,0.136,1
2017-01-12 22:10:08,0.3612,​Trump’s HHS nominee has promised to divest from these Mass. companies,0.0,0.8,0.2,1
2017-01-13 13:40:06,0.0,5 Stocks With Bigger Dividends Than ExxonMobil,0.0,1.0,0.0,0
2017-01-13 14:40:10,0.0,"ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk",0.206,0.588,0.206,0
2017-01-13 15:39:29,-0.2732,Will This Be a Genius or Foolish Move for Johnson & Johnson?,0.189,0.811,0.0,-1
2017-01-13 16:00:00,0.3182,Versartis' Pipeline Holds Big Promise,0.0,0.635,0.365,1
2017-01-13 20:24:57,0.0,It's Full Speed Ahead for Opko Health After Pipeline Stumble,0.0,1.0,0.0,0
2017-01-13 20:44:14,0.34,Options Insight: How to Play Pfizer,0.0,0.676,0.324,1
2017-01-15 15:20:42,0.4767,[$$] Ireland: Brexit vote forces Dublin to seek new EU friends,0.0,0.763,0.237,1
2017-01-16 12:27:51,-0.6249,Is Donald Trump Big Pharma's Worst Nightmare?,0.406,0.594,0.0,-1
2017-01-16 12:37:38,0.0,How Does Novartis’s Valuation Compare to Peers?,0.0,1.0,0.0,0
2017-01-16 13:38:00,0.0,5 Trump-Proof Pharma Dividends Up To 5.3%,0.0,1.0,0.0,0
2017-01-16 14:39:45,0.0,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended,0.0,1.0,0.0,0
2017-01-16 15:14:00,0.0,These 5 Drug Patents Will Expire in 2017,0.0,1.0,0.0,0
2017-01-17 12:30:06,0.0,[$$] OncoImmune Picks Up $15 Million for Immune-Based Disease Treatments,0.0,1.0,0.0,0
2017-01-17 14:17:26,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 18, 2017",0.0,1.0,0.0,0
2017-01-17 14:38:50,0.4588,One Simple Step to Building a Smarter Portfolio,0.0,0.667,0.333,1
2017-01-17 14:45:41,0.0,Double Down On Dividends With These 2 Covered Calls,0.0,1.0,0.0,0
2017-01-17 14:59:00,0.0,Why Bristol-Myers Squibb May Be a Merger Target Soon,0.0,1.0,0.0,0
2017-01-17 16:38:23,0.0,5 Trump-Proof Pharma Dividend Stocks to Buy,0.0,1.0,0.0,0
2017-01-17 18:37:51,0.0,"Should Pfizer, Inc. Be on Your Stock Watchlist?",0.0,1.0,0.0,0
2017-01-17 21:01:57,0.0,"JPMorgan, Goldman Sachs Sink DJIA on Tuesday",0.0,1.0,0.0,0
2017-01-17 22:33:22,0.0,AARP CEO: Trumpcare needs these 4 basic principles,0.0,1.0,0.0,0
2017-01-17 23:02:55,0.0,Pfizer CEO: This is what Trump doesn’t understand about the pharma industry,0.0,1.0,0.0,0
2017-01-18 10:40:26,0.4939,[$$] Pfizer warns of 'big challenge' ahead from strong dollar,0.108,0.538,0.354,1
2017-01-18 11:00:01,0.0,Trump's health pick set to defend investments at U.S. Senate hearing,0.0,1.0,0.0,0
2017-01-18 11:06:43,-0.4767,Drugmakers in Davos shift focus to chronic diseases of poor,0.256,0.744,0.0,-1
2017-01-18 12:25:00,0.7184,"Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions",0.0,0.5,0.5,1
2017-01-18 14:54:19,0.0,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : January 18, 2017",0.0,1.0,0.0,0
2017-01-18 15:41:08,0.0,What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?,0.0,1.0,0.0,0
2017-01-18 15:45:00,0.7003,There May Be a Buying Opportunity When Pfizer Shares Hit This Important Level,0.0,0.57,0.43,1
2017-01-18 17:37:06,0.0,"Noteworthy ETF Inflows: XLV, PFE, MRK, UNH",0.0,1.0,0.0,0
2017-01-18 21:41:08,0.0,5 Expensive Drugs That Could End Up in Trump's Crosshairs,0.0,1.0,0.0,0
2017-01-18 23:31:40,0.4404,How to improve your sex life without breaking the bank,0.0,0.756,0.244,1
2017-01-18 23:37:43,0.2716,5 Most Important Drugs to Johnson & Johnson in 2017,0.0,0.77,0.23,1
2017-01-19 12:30:09,0.4019,"[$$] Gormley's Take: In Role Reversal, Pharmaceutical Giants Turn to Biotech Startups for Help",0.0,0.828,0.172,1
2017-01-19 13:00:00,0.0,Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer,0.0,1.0,0.0,0
2017-01-19 15:40:17,-0.0516,Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval,0.246,0.522,0.231,0
2017-01-19 15:41:11,0.4019,Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout,0.0,0.748,0.252,1
2017-01-19 16:58:00,0.3612,Pfizer Continues to Tank -- Get Ready to Buy on the Dip,0.0,0.815,0.185,1
2017-01-19 20:36:43,0.2023,"Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works",0.0,0.859,0.141,1
2017-01-19 21:01:32,0.0,"Exxon Mobil, Merck Weigh on DJIA Thursday",0.0,1.0,0.0,0
2017-01-19 21:06:09,-0.4215,What Lies Ahead for Pharma ETFs?,0.359,0.641,0.0,-1
2017-01-20 07:06:06,-0.5994,INSIGHT: Sanofi's M&A misses frustrate some investors in drugmaker,0.412,0.588,0.0,-1
2017-01-20 07:06:38,-0.5994,Sanofi's M&A misses frustrate some investors in drugmaker,0.45,0.55,0.0,-1
2017-01-20 12:38:49,0.0,Why Johnson & Johnson’s 4Q16 Revenues Could Grow,0.0,1.0,0.0,0
2017-01-20 14:40:12,0.0,Are You Undervaluing These 3 Biopharmas' Pipelines?,0.0,1.0,0.0,0
2017-01-20 15:36:41,0.0,"Lawson Kroeker Investment Management Inc Buys Anheuser-Busch InBev SA/NV, Crimson Wine Group ...",0.0,1.0,0.0,0
2017-01-20 16:25:38,-0.6249,5 Worst Performing Dow Stocks of 2017,0.451,0.549,0.0,-1
2017-01-20 16:40:42,0.0,"The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Works, Pfizer and Lockheed Martin",0.0,1.0,0.0,0
2017-01-20 21:30:52,0.2023,Amgen Could Gouge 'Top Pick' AbbVie With Humira Biosimilar: Jefferies,0.0,0.833,0.167,1
2017-01-20 21:57:12,0.4576,"After Hours Most Active for Jan 20, 2017 :  VCIT, CUZ, BAC, TLT, ODP, P, MSFT, PFE, GE, F, QQQ, AAPL",0.0,0.864,0.136,1
2017-01-21 17:12:36,0.0,How Will Pfizer Inc. Fare Under President Trump?,0.0,1.0,0.0,0
2017-01-22 18:13:55,0.0,BioCorRx Receives New Funding for Opioid Drug,0.0,1.0,0.0,0
2017-01-22 21:49:00,0.0,What to Watch for When PFE Reports Q4 Results,0.0,1.0,0.0,0
2017-01-22 22:43:25,0.0,[$$] Theresa May to unveil 10 'pillars' of industrial strategy,0.0,1.0,0.0,0
2017-01-23 12:11:43,0.4404,Better Buy: Merck & Co. Inc. vs. Pfizer,0.0,0.674,0.326,1
2017-01-23 13:31:08,0.0,10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report,0.0,1.0,0.0,0
2017-01-23 15:36:07,0.0,What’s New with Johnson & Johnson?,0.0,1.0,0.0,0
2017-01-23 16:27:28,-0.6597,5 Stupendously Expensive Cancer Drugs,0.595,0.405,0.0,-1
2017-01-23 18:31:04,0.0,Can Q4 Earnings Revitalize Healthcare ETFs?,0.0,1.0,0.0,0
2017-01-23 20:04:00,0.1027,Here's the Price Where Fallen Angel Bristol-Myers Becomes an Attractive Takeover Target,0.162,0.649,0.188,1
2017-01-24 12:36:01,0.3612,What Do Analysts Recommend for Johnson & Johnson?,0.0,0.706,0.294,1
2017-01-24 13:04:00,-0.5106,On Experiencing The Failure Of A Billion-Dollar Clinical Program,0.32,0.68,0.0,-1
2017-01-24 16:35:02,0.2023,J&J (JNJ) Q4 Earnings Top; Seeks Options for Diabetes Unit,0.0,0.833,0.167,1
2017-01-24 17:07:25,0.4215,"Johnson & Johnson cautious in outlook, shops diabetes care",0.132,0.566,0.302,1
2017-01-24 17:17:54,0.1779,[$$] J&J disappoints on 2017 forecasts due to strong dollar,0.187,0.576,0.237,1
2017-01-24 19:30:45,0.3818,"Northeast Financial Consultants Inc Buys Vanguard Growth ETF - DNQ, Vanguard High Dividend ...",0.0,0.822,0.178,1
2017-01-24 20:31:20,0.0,Tuesday's ETF with Unusual Volume: XRLV,0.0,1.0,0.0,0
2017-01-24 22:01:18,0.0,A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield,0.0,1.0,0.0,0
2017-01-24 22:01:55,0.34,Bristol-Myers Squibb Earnings Preview: The Company Has To Reassure Investors,0.0,0.789,0.211,1
2017-01-25 00:31:09,-0.2732,Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017,0.189,0.811,0.0,-1
2017-01-25 11:30:33,-0.296,US Market Indexes Lower on Monday,0.306,0.694,0.0,-1
2017-01-25 14:06:35,0.0,Analyzing Bristol-Myers Squibb’s Other Segments in 4Q16,0.0,1.0,0.0,0
2017-01-25 17:08:05,0.0,"Q4 Earnings Scorecard and Analyst Reports for Tesla, Verizon & Others",0.0,1.0,0.0,0
2017-01-25 17:35:49,-0.4215,What Lies in Store for Pfizer (PFE) this Earnings Season?,0.237,0.763,0.0,-1
2017-01-25 21:34:39,-0.6249,"Eli Lilly, Novartis Challenge Pfizer's Potential $8 Billion Breast Cancer Drug",0.299,0.612,0.088,-1
2017-01-26 08:29:00,0.0,Pfizer Announces Results From Phase 2 Study Of C. Difficile Vaccine,0.0,1.0,0.0,0
2017-01-26 13:00:00,0.5574,Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection,0.0,0.841,0.159,1
2017-01-26 13:13:39,0.5574,Pfizer says mid-stage trial for C. difficile vaccine had positive results,0.0,0.735,0.265,1
2017-01-26 14:28:39,0.0,11 Largest Pharmaceutical Companies In The World,0.0,1.0,0.0,0
2017-01-26 16:47:12,0.0,J&J to spend $30 billion on Swiss drugmaker Actelion,0.0,1.0,0.0,0
2017-01-26 17:25:00,0.4019,Could New Vaccine Help Pfizer Grow its Revenue?,0.0,0.722,0.278,1
2017-01-26 17:32:38,0.0,"Noteworthy ETF Inflows: IWD, BAC, PFE, MRK",0.0,1.0,0.0,0
2017-01-26 17:34:00,0.0,"XLV, MLN: Big ETF Outflows",0.0,1.0,0.0,0
2017-01-26 22:33:22,-0.2263,"Bristol-Myers (BMY) Misses on Q4 Earnings, Beats on Sales",0.192,0.808,0.0,-1
2017-01-26 23:49:00,0.0,"IMGN Marches Forward, FDA Nod For ZLTQ, Knight Lends Shine To PLX",0.0,1.0,0.0,0
2017-01-27 01:55:00,0.0,Earnings Preview: What To Expect From Pfizer,0.0,1.0,0.0,0
2017-01-27 07:08:00,0.5574,Pfizer Gets Positive CHMP Opinion In Europe For XELJANZ,0.0,0.69,0.31,1
2017-01-27 12:00:00,0.5719,Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis,0.097,0.669,0.234,1
2017-01-27 13:15:00,0.5574,Blog Coverage Pfizer Reported Positive Results for Mid-stage Trial for C. difficile Vaccine,0.0,0.769,0.231,1
2017-01-27 13:33:28,-0.8192,"Pharma Stock Roundup: J&J to Buy Actelion, Bristol-Myers' 4Q Results Disappoint",0.456,0.544,0.0,-1
2017-01-27 14:35:02,0.5574,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study,0.0,0.714,0.286,1
2017-01-27 16:35:17,0.5267,Merck (MRK): Stock to Gain on Likely Earnings Beat in Q4?,0.0,0.746,0.254,1
2017-01-27 16:36:36,0.3818,Will Amgen (AMGN) Keep the Earnings Streak Alive in Q4?,0.0,0.776,0.224,1
2017-01-27 17:51:00,0.8126,Will a Pending EU Approval Help XELJANZ Growth?,0.0,0.323,0.677,1
2017-01-27 19:58:14,0.4404,Better Buy: Pfizer Inc. vs. Johnson & Johnson,0.0,0.674,0.326,1
2017-01-28 06:30:41,0.3818,"Earnings Growth Returns, Will it Continue?",0.0,0.658,0.342,1
2017-01-28 16:05:00,0.1999,You Better Not Behave Like an Over-Caffeinated Day Trader Right Now,0.151,0.642,0.207,1
2017-01-28 18:31:41,-0.4019,This Promising Prostate Cancer Treatment Could Be a Game-Changer,0.336,0.458,0.206,-1
2017-01-29 15:43:47,0.0,3 Reasons to Buy Pfizer Stock and Never Sell,0.0,1.0,0.0,0
2017-01-29 23:43:00,0.3182,Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees,0.0,0.839,0.161,1
2017-01-30 05:00:27,-0.25,[$$] Looking for a new chief? Let the office 'Hunger Games' begin,0.167,0.833,0.0,-1
2017-01-30 12:16:54,-0.2732,Can Merck And Pfizer Beat Low Expectations?,0.259,0.741,0.0,-1
2017-01-30 12:37:12,0.5574,Pfizer (PFE) Gets Positive CHMP Opinion for Arthritis Drug,0.0,0.69,0.31,1
2017-01-30 13:22:06,0.2023,3 Top Pharmaceutical Stocks to Buy in February,0.0,0.769,0.231,1
2017-01-30 13:33:37,0.0,Drug Stocks Reporting Q4 Earnings on Jan 31: LLY and PFE,0.0,1.0,0.0,0
2017-01-30 13:44:48,0.0,What to expect from Pfizer earnings: competition on two fronts,0.0,1.0,0.0,0
2017-01-30 14:06:06,0.2732,Exploring JNJ’s 2017 Profitability and Financial Guidance,0.0,0.741,0.259,1
2017-01-30 15:35:59,0.0,What Are Analysts’ Future Estimates for Johnson & Johnson?,0.0,1.0,0.0,0
2017-01-30 16:33:56,0.2732,"Ex-Dividend Reminder: D.R. Horton, CMS Energy Corp and Pfizer",0.0,0.792,0.208,1
2017-01-30 16:45:35,0.2023,Top 7 Earnings Reports to Look For Tuesday,0.0,0.769,0.231,1
2017-01-30 17:26:00,0.0,"A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour",0.0,1.0,0.0,0
2017-01-30 17:33:13,0.4939,"Health Care Sector Update for 01/30/2017: JNJ, PFE, ABT, MRK, AMGN, OCRX, CALA, EYEG",0.0,0.802,0.198,1
2017-01-30 18:31:01,0.4019,Interesting September Stock Options for PFE,0.0,0.649,0.351,1
2017-01-30 18:31:16,0.6124,Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick,0.0,0.667,0.333,1
2017-01-30 18:32:09,0.0,Dow Analyst Moves: PFE,0.0,1.0,0.0,0
2017-01-30 21:11:27,0.0,"Pre-Market Earnings Report for January 31, 2017 :  XOM, PFE, MA, LLY, UPS, TMO, SPG, DHR, AET, S, VLO, HCA",0.0,1.0,0.0,0
2017-01-30 21:52:53,0.0,"Apple, MasterCard, Exxon, EA, AMD, Fed: Investing Action Plan",0.0,1.0,0.0,0
2017-01-30 22:32:08,0.4404,Better Buy: AbbVie Inc. vs. Pfizer,0.0,0.633,0.367,1
2017-01-30 23:40:48,0.0,Apple earnings on deck — What you need to know in markets on Tuesday,0.0,1.0,0.0,0
2017-01-31 00:41:00,0.3818,All Eyes on Growth Plans as Pfizer Gears Up for Fourth Quarter Earnings,0.0,0.822,0.178,1
2017-01-31 06:47:00,0.4404,Pfizer Inc. Q4 Profit Retreats 13%,0.0,0.633,0.367,1
2017-01-31 08:02:00,0.0,Pfizer Q4 16 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2017-01-31 11:38:00,0.0,"Stocks to Watch: January 31, 2017",0.0,1.0,0.0,0
2017-01-31 11:45:00,0.0,PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2016 RESULTS,0.0,1.0,0.0,0
2017-01-31 11:51:31,0.0,"Earnings Reaction History: Pfizer Inc, 45.5% Follow-Through Indicator, 1.3% Sensitive",0.0,1.0,0.0,0
2017-01-31 11:54:21,-0.128,"Pfizer Profit, Forecast Fall Short as Generics to Hurt Sales",0.238,0.559,0.203,-1
2017-01-31 11:57:04,0.0,Pfizer quarterly revenue slips 3 percent,0.0,1.0,0.0,0
2017-01-31 11:57:35,0.3182,"Pfizer's stock drops after profit miss, downbeat sales outlook",0.139,0.609,0.252,1
2017-01-31 12:07:07,0.0,Q4 2016 Pfizer Inc Earnings Release - Time Not Supplied,0.0,1.0,0.0,0
2017-01-31 13:16:01,0.34,Pfizer (PFE) Misses on Q4 Earnings; Tops Sales Estimate,0.156,0.574,0.27,1
2017-01-31 13:25:05,-0.4466,Pfizer swings to a 4Q profit after rough year,0.352,0.437,0.211,-1
2017-01-31 13:30:00,0.0,Pfizer Lets Investors Down in Two New Ways,0.0,1.0,0.0,0
2017-01-31 13:43:00,-0.5574,"Stock Futures Slip as Trump's Travel Ban Continues to Rock Markets, Fed Meets",0.231,0.769,0.0,-1
2017-01-31 13:55:43,0.0,Are Pfizer’s Acquisitions Holding Back Its Bottom Line?,0.0,1.0,0.0,0
2017-01-31 13:57:14,-0.2263,"Healthcare Q4: Eli Lilly Beats, Pfizer Misses",0.241,0.759,0.0,-1
2017-01-31 14:09:12,-0.1027,"Pfizer's profit misses as Prevnar sales lag, costs rise",0.326,0.455,0.22,-1
2017-01-31 14:12:26,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 01, 2017",0.0,1.0,0.0,0
2017-01-31 14:27:00,-0.2263,"Pfizer Misses on Earnings, Forecasts 2017 Sales Below Analysts' Estimates",0.174,0.826,0.0,-1
2017-01-31 14:29:02,-0.1531,"Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft",0.182,0.682,0.136,-1
2017-01-31 14:33:40,0.2023,Top Healthcare Stocks to Buy in 2017,0.0,0.769,0.231,1
2017-01-31 14:48:07,0.0,Trump says drug prices are 'astronomical',0.0,1.0,0.0,0
2017-01-31 15:40:00,0.0,S&P 500 Falls for a Fourth Day as 'Rose-Tinted Glasses' of Trump Presidency Come Off,0.0,1.0,0.0,0
2017-01-31 16:29:00,0.0,Healthcare Names Rally as Pharma Meets with Trump,0.0,1.0,0.0,0
2017-01-31 17:32:07,0.296,"Tuesday’s Vital Data: Rite Aid Corporation (RAD), Bank of America Corp (BAC) and Pfizer Inc. (PFE)",0.0,0.872,0.128,1
2017-01-31 17:35:10,-0.5994,Trade War Concerns Coming Home to Roost,0.394,0.606,0.0,-1
2017-01-31 17:44:35,-0.296,7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip,0.196,0.804,0.0,-1
2017-01-31 18:24:55,0.0,"Early movers: UAA, XOM, UPS, MA, LLY, HOG, PFE & more",0.0,1.0,0.0,0
2017-01-31 19:05:00,0.3818,Pfizer Still Looking For Growth,0.0,0.606,0.394,1
2017-01-31 19:12:00,0.296,Pfizer Shares Look Undervalued,0.0,0.577,0.423,1
2017-01-31 19:31:23,0.0,Tuesday's ETF with Unusual Volume: PPH,0.0,1.0,0.0,0
2017-01-31 19:32:12,-0.1531,Pfizer Inc. (PFE) Stock Makes Big Moves After Q4 Earnings Miss,0.138,0.862,0.0,-1
2017-01-31 20:01:48,-0.296,Pfizer CEO says no need to alter its drug pricing practices,0.18,0.82,0.0,-1
2017-01-31 20:21:45,0.0,[$$] Trump Tells Pharmaceutical CEOs He Wants Prices Down,0.0,1.0,0.0,0
2017-01-31 20:37:31,0.0,Pfizer Needs to Keep Dealing,0.0,1.0,0.0,0
2017-01-31 21:11:40,-0.2732,Pfizer Reports Lagging Q4 EPS; Rebounds On Trump Commentary,0.208,0.792,0.0,-1
2017-01-31 21:17:00,0.0,Fmr. Onyx CEO: Responsibility to find and research cures ...,0.0,1.0,0.0,0
2017-01-31 21:48:13,0.2023,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,614.79",0.0,0.913,0.087,1
2017-01-31 22:08:51,-0.4466,"Pfizer swings to 4Q profit after rough year, hikes 2017 view",0.289,0.538,0.173,-1
2017-01-31 22:32:08,0.0,Pfizer's 3 Fastest-Growing Drugs,0.0,1.0,0.0,0
2017-01-31 22:59:00,0.0,"Final Trade: FDX, FCX & more",0.0,1.0,0.0,0
2017-01-31 23:30:57,0.5859,Dow Jones Industrial Average Nabs Monthly Win,0.0,0.612,0.388,1
2017-01-31 23:47:04,-0.4404,[$$] Trump's Criticism of Imports Adds to Drugmakers' Headaches,0.266,0.734,0.0,-1
2017-02-01 01:49:30,-0.4404,[$$] Trump’s Criticism of Imports Adds to Drugmakers’ Headaches,0.266,0.734,0.0,-1
2017-02-01 02:53:20,0.0,Edited Transcript of PFE earnings conference call or presentation 31-Jan-17 3:00pm GMT,0.0,1.0,0.0,0
2017-02-01 03:57:08,0.0,[$$] Pfizer Revenue Falls As Full-Year Sales Seen Below Wall Street Estimates,0.0,1.0,0.0,0
2017-02-01 04:58:02,0.0,[$$] Trump Inauguration Drew More Than 18 Corporate Donors,0.0,1.0,0.0,0
2017-02-01 13:31:48,-0.3182,Merck Keytruda Gets EU Approval for First-Line Lung Cancer,0.303,0.483,0.214,-1
2017-02-01 13:31:59,0.4215,SanofiRegeneron Sarilumab Approved in Canada for Arthritis,0.0,0.682,0.318,1
2017-02-01 15:34:51,0.0,Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN,0.0,1.0,0.0,0
2017-02-01 18:10:00,0.34,How to Play Pfizer's Fourth-Quarter Results With ETFs,0.0,0.745,0.255,1
2017-02-01 21:00:28,0.0,5 Things Pfizer's Management Wants You to Know,0.0,1.0,0.0,0
2017-02-01 22:01:36,0.4576,"After Hours Most Active for Feb 1, 2017 :  FB, LOGM, TGI, GE, QQQ, PFE, WFT, BIVVV, CSCO, AAPL, ABT, SYF",0.0,0.864,0.136,1
2017-02-01 22:31:21,0.0,3 Big Mergers & Acquisitions That We Could See in 2017,0.0,1.0,0.0,0
2017-02-02 08:55:00,0.0,[$$] Reckitt Benckiser in talks over $16.7bn baby milk deal,0.0,1.0,0.0,0
2017-02-02 12:00:48,0.0,3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson,0.0,1.0,0.0,0
2017-02-02 14:33:51,0.6633,Novartis a Top Ranked SAFE Dividend Stock With 3.7% Yield (NVS),0.0,0.596,0.404,1
2017-02-02 14:53:18,-0.4019,US Market Indexes Regain Some of Their Losses on Wednesday,0.231,0.769,0.0,-1
2017-02-02 15:35:20,0.1027,Ignore Gilead Sciences Inc.: Here Are 2 Better Stocks,0.219,0.526,0.254,1
2017-02-02 16:21:10,0.5563,"The 10 cheapest, fastest-growing and most beloved Dow stocks",0.0,0.69,0.31,1
2017-02-02 16:36:37,0.5106,Merck (MRK) Tops Q4 Earnings; Pharmaceutical Sales Down,0.0,0.68,0.32,1
2017-02-02 17:03:30,0.0,Pfizer Said to Hire JPMorgan to Weigh $2 Billion Portfolio Sale,0.0,1.0,0.0,0
2017-02-02 17:35:49,0.0,Agilent (A) Announces Expanded Use of Diagnostic Assay,0.0,1.0,0.0,0
2017-02-02 17:59:13,0.0,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg,0.0,1.0,0.0,0
2017-02-02 18:03:31,0.0,Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg,0.0,1.0,0.0,0
2017-02-02 20:13:00,0.0,PFE May Reportedly Sell Part of its Portfolio,0.0,1.0,0.0,0
2017-02-03 00:26:05,-0.6597,UK agency says Pfizer breast cancer drug too expensive,0.355,0.645,0.0,-1
2017-02-03 08:28:00,0.6597,Pfizer Enters $5 Bln Accelerated Share Repurchase Agreement With Citibank,0.0,0.597,0.403,1
2017-02-03 13:10:00,0.296,Pfizer Commences $5 Billion Accelerated Share Repurchase,0.0,0.732,0.268,1
2017-02-03 13:16:24,0.0,Pfizer to buyback $5 billion of its common stock,0.0,1.0,0.0,0
2017-02-03 13:33:51,0.0,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling",0.0,1.0,0.0,0
2017-02-03 13:37:00,0.0,"Stock Futures Hold Higher After U.S. Economy Adds 227,000 Jobs",0.0,1.0,0.0,0
2017-02-03 14:48:19,0.0,What Alicia Keys and Daft Punk are bringing home after the Grammys,0.0,1.0,0.0,0
2017-02-03 15:50:31,-0.2185,Pfizer Inc. (PFE)’s Breast Cancer Drug Too Expensive: Says NICE,0.276,0.502,0.222,-1
2017-02-03 16:19:00,0.0,Pfizer Is Returning Even More Cash to Shareholders,0.0,1.0,0.0,0
2017-02-03 17:31:46,0.0,"Notable ETF Inflow Detected - XLV, PFE, MRK, UNH",0.0,1.0,0.0,0
2017-02-03 18:00:59,0.0,MACD: Learn to Recognize Trade Setups,0.0,1.0,0.0,0
2017-02-03 21:57:28,0.4576,"After Hours Most Active for Feb 3, 2017 :  ETE, EPD, PFE, WPZ, ENLK, AAPL, BAC, INTC, MSFT, CTXS, CSCO, YHOO",0.0,0.864,0.136,1
2017-02-03 23:57:17,-0.1531,"Dow 30 Stock Roundup: Apple, Intel, Exxon Beat; Merck, Pfizer, Chevron Miss on Revenues",0.11,0.89,0.0,-1
2017-02-04 12:57:36,0.0,Pfizer's New Biosimilar Is Off and Running,0.0,1.0,0.0,0
2017-02-04 18:57:02,0.0,"Palouse Capital Management, Inc. Buys MetLife, Mattel, Nucor, Sells JPMorgan Chase, Regions ...",0.0,1.0,0.0,0
2017-02-06 12:45:00,0.0,ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer,0.0,1.0,0.0,0
2017-02-06 13:15:00,0.743,Blog Coverage Pfizer Signs Agreement with Citibank to Repurchase $5 Billion Worth of Shares,0.0,0.601,0.399,1
2017-02-06 14:17:58,-0.7131,Merck???s Keytruda Gets Priority Review for Bladder Cancer,0.414,0.586,0.0,-1
2017-02-06 14:18:09,0.0,"Portola, HealthCare Royalty Partners Ink $150 Million Deal",0.0,1.0,0.0,0
2017-02-06 14:55:02,0.2732,Q4 Earnings Faring Well for Pharma ETFs,0.0,0.741,0.259,1
2017-02-06 16:20:26,0.0,"The Zacks Analyst Blog Highlights: Apple, Exxon Mobil, Merck, Pfizer and Intel",0.0,1.0,0.0,0
2017-02-06 16:22:20,0.0,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More",0.0,1.0,0.0,0
2017-02-06 17:56:00,0.0516,Pfizer CEO: 'Misinformation About Drug Pricing Is Far Greater Than I've Ever Seen',0.146,0.696,0.158,0
2017-02-06 23:18:13,0.0,Agilent (A) Announces Expanded Use of Diagnostic Assay (revised),0.0,1.0,0.0,0
2017-02-07 12:22:54,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : February 7, 2017",0.0,1.0,0.0,0
2017-02-07 14:19:54,-0.3182,ARIAD Files for EU Approval of Lung Cancer Drug Brigatinib,0.284,0.516,0.2,-1
2017-02-07 17:16:52,0.0,"Fishman Jay A Ltd Buys Arconic, The Home Depot, Alcoa, Sells Allergan PLC, Level 3 ...",0.0,1.0,0.0,0
2017-02-07 17:28:35,0.296,Pfizer Inc. (PFE) And Citibank To Work Together On $5 Billion Share Repurchase Program,0.0,0.855,0.145,1
2017-02-07 21:17:49,-0.0516,"Model N (MODN) Q1 Loss Narrower than Expected, Guides Well",0.202,0.614,0.184,0
2017-02-07 22:17:25,0.0,"Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",0.0,1.0,0.0,0
2017-02-08 14:17:13,0.0,"Hexavest Inc. Buys Lennar, Bristol-Myers Squibb Company, Apple, Sells Procter & Gamble Co, ...",0.0,1.0,0.0,0
2017-02-08 14:48:04,0.1779,[$$] Sanofi points to lower profit for 2017,0.198,0.541,0.261,1
2017-02-08 18:28:00,0.0,Gilead: Where's the Bottom?,0.0,1.0,0.0,0
2017-02-08 18:30:01,0.0,4 Dow Stocks Every Retiree Should Own,0.0,1.0,0.0,0
2017-02-08 19:30:03,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : February 8, 2017",0.0,0.745,0.255,1
2017-02-08 23:54:16,0.7269,Pfizer Builds Consumer Apps to Improve Patient Care,0.0,0.496,0.504,1
2017-02-09 13:30:00,0.0,Relationship Expert Teams Up with Pfizer to Address Intimacy and Relationship Issues for People Living with Chronic Diseases,0.0,1.0,0.0,0
2017-02-09 13:50:02,0.6369,10 Best Dividend-Paying Stocks for 2017,0.0,0.543,0.457,1
2017-02-09 17:00:01,-0.6597,"Academics call time on $100,000 cancer drugs",0.423,0.577,0.0,-1
2017-02-09 21:57:26,0.4576,"After Hours Most Active for Feb 9, 2017 :  F, BAC, MCHP, AAPL, GGB, QQQ, ABEV, NVDA, PFE, FB, STM, ATVI",0.0,0.864,0.136,1
2017-02-10 13:35:53,-0.34,Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?,0.194,0.806,0.0,-1
2017-02-10 14:23:34,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 13, 2017",0.0,1.0,0.0,0
2017-02-10 16:09:55,0.0,Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017,0.0,1.0,0.0,0
2017-02-10 16:19:42,0.0,Which Of The Latest 13F Filers Holds Pfizer?,0.0,1.0,0.0,0
2017-02-10 17:00:00,-0.3167,Is More Downside Ahead For Teva Pharmaceutical?,0.276,0.724,0.0,-1
2017-02-10 23:18:22,0.0,Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017,0.0,1.0,0.0,0
2017-02-11 00:17:45,0.0,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?,0.0,1.0,0.0,0
2017-02-12 09:17:46,0.0,"Weighing The Week Ahead: Trump Vs. Yellen, Round One",0.0,1.0,0.0,0
2017-02-13 03:10:03,0.0,US issuers rush to sell Formosa bonds before rule change,0.0,1.0,0.0,0
2017-02-13 13:00:07,0.0,3 Stocks You Can Still Buy With the Market at Record Highs,0.0,1.0,0.0,0
2017-02-13 16:22:44,0.0,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More",0.0,1.0,0.0,0
2017-02-13 17:19:17,0.0,"XLV, EFU: Big ETF Inflows",0.0,1.0,0.0,0
2017-02-13 17:19:44,0.0,"SSO, BAC, PFE, MRK: Large Outflows Detected at ETF",0.0,1.0,0.0,0
2017-02-13 19:05:53,0.4466,"Let’s just call it an ‘American Rally,’ OK?",0.0,0.705,0.295,1
2017-02-13 22:11:10,0.296,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%",0.0,0.833,0.167,1
2017-02-13 22:17:20,0.0,"Q4 Scorecard & Analyst Reports for Pfizer, Boeing & Goldman Sachs",0.0,1.0,0.0,0
2017-02-14 05:25:00,0.0,"Luxury, lingerie and...Viagra?",0.0,1.0,0.0,0
2017-02-14 08:52:04,0.5574,Gilead challenges GSK with strong HIV drug data,0.0,0.566,0.434,1
2017-02-14 14:21:36,0.0,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 15, 2017",0.0,1.0,0.0,0
2017-02-14 15:18:51,0.0,Investing Rookie? Start With These 3 Stocks,0.0,1.0,0.0,0
2017-02-14 15:45:13,0.0,Three Stocks To Buy For Valentines Day,0.0,1.0,0.0,0
2017-02-14 16:21:15,0.0,"The Zacks Analyst Blog Highlights: Boeing, Pfizer, Goldman Sachs, NVIDIA and Twitter",0.0,1.0,0.0,0
2017-02-14 20:33:00,0.0,Bristol-Myers Squibb: Takeover Target?,0.0,1.0,0.0,0
2017-02-14 22:32:36,0.0,David Tepper Increases Wagers on Drug Companies,0.0,1.0,0.0,0
2017-02-15 10:17:18,0.7269,"Lord, Abbett & Co. Llc Buys KeyCorp, PowerShares Exchange-Traded Fund Trust, United States ...",0.0,0.643,0.357,1
2017-02-15 13:06:01,0.296,Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip,0.0,0.784,0.216,1
2017-02-15 14:25:05,0.0,4 High-Yield Dividend Stocks You Don't Have to Babysit,0.0,1.0,0.0,0
2017-02-15 17:38:00,0.0,Bristol-Myers: Don't Bet on a Pfizer Acquisition,0.0,1.0,0.0,0
2017-02-15 19:18:00,0.0,Tepper's Appaloosa triples stake in Allergan,0.0,1.0,0.0,0
2017-02-15 19:54:33,0.0,Roche's Herceptin And Perjeta Combination Trials Beg A Larger Question,0.0,1.0,0.0,0
2017-02-15 20:03:00,0.0,5 Ways Allergan Can Keep Up Momentum,0.0,1.0,0.0,0
2017-02-15 21:01:35,0.0,"Pfizer, Cisco Push DJIA Higher Wednesday",0.0,1.0,0.0,0
2017-02-15 21:53:20,0.2263,Close Update: Wall Street Sets Records for Fifth Straight Day as Trump Talks Taxes,0.0,0.872,0.128,1
2017-02-15 22:03:14,0.4576,"After Hours Most Active for Feb 15, 2017 :  CSCO, WFC, XOM, PFE, TMUS, MSFT, VZ, EMR, SXL, QQQ, AMAT, TRIP",0.0,0.864,0.136,1
2017-02-15 22:53:21,0.5267,Stock Index ETFs Nail Another Gain; Health Stocks Lead,0.0,0.702,0.298,1
2017-02-16 06:53:16,0.5106,"Ajo, Lp Buys Wal-Mart Stores, Hospitality Properties Trust, Applied Materials, Sells Symantec, ...",0.0,0.784,0.216,1
2017-02-16 08:15:00,0.0,Pfizer Reports Results From Oral Strategy Trial Of XELJANZ Compared To Humira,0.0,1.0,0.0,0
2017-02-16 13:00:00,0.0,Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ® (tofacitinib citrate) Compared to Humira® (adalimumab),0.0,1.0,0.0,0
2017-02-16 13:16:19,0.2755,Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone,0.0,0.869,0.131,1
2017-02-16 14:00:16,0.0,Washington University to collaborate with Pfizer on drug discovery,0.0,1.0,0.0,0
2017-02-16 14:19:00,0.4215,Here Comes Pfizer's Powerful Breakout,0.0,0.588,0.412,1
2017-02-16 15:46:52,0.34,"Procter & Gamble, Pfizer Lead Market Gains",0.0,0.676,0.324,1
2017-02-16 16:41:06,0.5267,How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners,0.0,0.764,0.236,1
2017-02-16 17:06:55,0.0,David Tepper Invests Heavily in Pharma in 4th Quarter,0.0,1.0,0.0,0
2017-02-16 20:57:23,0.3818,3 Dividend Stocks That Prove Boring Is Beautiful,0.205,0.446,0.348,1
2017-02-16 21:55:01,0.0,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,0.0,1.0,0.0,0
2017-02-17 11:55:07,0.0,Santhera opens Mass. office as local Duchenne ecosystem grows,0.0,1.0,0.0,0
2017-02-17 12:21:12,0.0,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ",0.0,1.0,0.0,0
2017-02-17 14:58:22,0.0,Pfizer's Xeljanz Combo Comparable to AbbVie's Humira,0.0,1.0,0.0,0
2017-02-17 15:53:08,0.0,The Math Shows XLV Can Go To $81,0.0,1.0,0.0,0
2017-02-17 17:00:00,0.4215,New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a,0.0,0.843,0.157,1
2017-02-17 21:31:05,-0.6597,"AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink",0.306,0.694,0.0,-1
2017-02-17 22:01:00,0.4767,Trade or fade this week's Dow winners?,0.0,0.659,0.341,1
2017-02-17 22:01:22,0.4576,"After Hours Most Active for Feb 17, 2017 :  PFE, NI, PGNX, CSCO, ORCL, WFC, SPLS, PEG, QQQ, BAC, SBUX, MSFT",0.0,0.864,0.136,1
2017-02-17 23:41:03,0.296,Momenta Pharma shares halted as drug application hits speed bump,0.0,0.804,0.196,1
2017-02-18 10:53:47,-0.4404,Roche says Phase II trial supports twin treatment for kidney cancer,0.277,0.566,0.157,-1
2017-02-18 13:52:35,0.6369,The Best Investments for an IRA,0.0,0.543,0.457,1
2017-02-18 22:41:56,0.4404,"Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.",0.0,0.707,0.293,1
2017-02-19 12:54:19,0.0,A Billionaire Recently Bought Pfizer Stock -- and So Did I,0.0,1.0,0.0,0
2017-02-20 19:45:22,-0.7184,Collapse of Kraft-Unilever tie-up extends run of failed mega-deals,0.464,0.429,0.107,-1
2017-02-20 21:52:12,0.4576,"After Hours Most Active for Feb 17, 2017 :  PFE, NI, HPQ, PGNX, CSCO, QQQ, WFT, ORCL, BAC, SPLS, SBUX, MSFT",0.0,0.864,0.136,1
2017-02-21 08:10:00,0.3182,Pfizer Says FDA Accepts BLA For Inotuzumab Ozogamicin - Quick Facts,0.0,0.796,0.204,1
2017-02-21 13:00:00,0.4588,Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and Drug Administration,0.0,0.833,0.167,1
2017-02-21 15:47:00,0.0258,"Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan",0.0,0.901,0.099,0
2017-02-21 15:57:00,0.4019,"Boeing, GE and Oracle CEOs Support Border Adjustment Tax in Letter to Congress",0.0,0.816,0.184,1
2017-02-21 16:11:43,-0.5106,"Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means",0.268,0.732,0.0,-1
2017-02-21 16:35:28,-0.0516,Momenta shares plunge after supplier receives warning letter from FDA on multiple sclerosis drug,0.145,0.723,0.133,0
2017-02-21 17:07:51,0.296,"XLV, PFE, MRK, LLY: ETF Outflow Alert",0.0,0.732,0.268,1
2017-02-21 17:37:27,0.0,"Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug",0.0,1.0,0.0,0
2017-02-21 19:07:08,0.5106,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Looks Strong,0.0,0.732,0.268,1
2017-02-21 21:56:18,0.4576,"After Hours Most Active for Feb 21, 2017 :  ODP, GE, AKS, AAPL, BX, F, PFE, AME, MSFT, INTC, CMCSA, TVIX",0.0,0.864,0.136,1
2017-02-21 23:06:32,0.6908,"Dow Jones Industrial Average Scores New High, 8th Straight Win",0.0,0.584,0.416,1
2017-02-22 06:57:19,0.4404,Better Buy: Pfizer Inc. vs. Merck & Co. Inc.,0.0,0.707,0.293,1
2017-02-22 07:07:45,0.5859,Factor Xa's Win Billions of Dollars in Sales From Warfarin,0.0,0.703,0.297,1
2017-02-22 08:33:00,-0.2263,"Pfizer Quits London and Swiss Listings, Says 'Limited Liquidity' in European Trading",0.147,0.853,0.0,-1
2017-02-22 10:39:00,-0.4767,Viagra maker Pfizer cites poor performance for stock de-listing,0.279,0.721,0.0,-1
2017-02-22 12:54:03,0.0,"Early movers: TOL, DISH, SIX, TRCO, FSLR, & more",0.0,1.0,0.0,0
2017-02-22 13:23:00,0.0,World's Biggest Drugmaker Quits London and Swiss Listings,0.0,1.0,0.0,0
2017-02-22 14:08:26,0.0,Merck & Co.’s Segment-Wise Revenues for 4Q16,0.0,1.0,0.0,0
2017-02-22 17:25:09,0.0,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company,0.0,1.0,0.0,0
2017-02-22 18:51:42,0.0,"Goldman Says Buy Health-Care, Retail Volatility Before Trump Address",0.0,1.0,0.0,0
2017-02-22 19:02:19,0.2023,Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA),0.113,0.735,0.152,1
2017-02-22 21:41:05,0.4404,Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield,0.0,0.791,0.209,1
2017-02-22 21:58:55,0.4576,"After Hours Most Active for Feb 22, 2017 :  CUZ, VMBS, AAPL, PFE, AMAT, PHM, QQQ, VER, MSFT, SQ, CSX, FCX",0.0,0.864,0.136,1
2017-02-23 00:50:21,0.0,Who Could Buy Bristol-Myers Squibb?,0.0,1.0,0.0,0
2017-02-23 00:50:49,0.0,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,0.0,1.0,0.0,0
2017-02-23 08:49:33,0.0,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast,0.0,1.0,0.0,0
2017-02-23 14:20:44,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 24, 2017",0.0,1.0,0.0,0
2017-02-23 14:20:58,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 24, 2017",0.0,1.0,0.0,0
2017-02-23 14:50:38,-0.3182,Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca,0.204,0.796,0.0,-1
2017-02-23 15:51:43,0.4019,Seeking Alpha Interviews: Bret Jensen On Promising Drugs And Acquisition Targets,0.0,0.787,0.213,1
2017-02-23 16:53:03,0.6705,Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems,0.0,0.56,0.44,1
2017-02-23 16:53:26,0.0,"Dow Movers: GS, CVX",0.0,1.0,0.0,0
2017-02-23 19:49:59,0.0,Thursday's ETF with Unusual Volume: PPH,0.0,1.0,0.0,0
2017-02-23 21:01:35,0.0,"Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday",0.0,1.0,0.0,0
2017-02-23 21:15:00,0.0,Ronald E. Blaylock Elected to Pfizer’s Board of Directors,0.0,1.0,0.0,0
2017-02-23 21:36:24,0.1154,"Dow logs 10th straight record, but Nasdaq stumbles a second day",0.0,0.861,0.139,1
2017-02-23 21:54:41,0.0,"PFIZER INC Files SEC form 10-K, Annual Report",0.0,1.0,0.0,0
2017-02-23 22:06:00,0.0,"PFIZER INC Files SEC form 8-K, Financial Statements and Exhibits",0.0,1.0,0.0,0
2017-02-23 22:39:20,0.5994,United Therapeutics feels squeeze from increased pulmonary hypertension competition,0.0,0.588,0.412,1
2017-02-23 23:29:57,0.34,Dow Jones Leads Market Gains on Thursday,0.0,0.714,0.286,1
2017-02-24 12:27:12,0.0,"Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs",0.0,1.0,0.0,0
2017-02-24 12:39:01,0.0,Performance of Eli Lilly & Co.’s Business Segments in 4Q16,0.0,1.0,0.0,0
2017-02-24 13:45:03,0.296,Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; stable outlook,0.0,0.82,0.18,1
2017-02-24 14:20:57,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for February 27, 2017",0.0,1.0,0.0,0
2017-02-24 16:05:00,-0.6597,Novartis Cancer Drug Zykadia Gets Priority Review,0.423,0.577,0.0,-1
2017-02-24 18:09:00,-0.3612,"Pfizer Prices $1,065,000,000 Debt Offering",0.385,0.615,0.0,-1
2017-02-24 21:53:02,0.0,Pfizer’s Valuation after Its 4Q16 Earnings Release,0.0,1.0,0.0,0
2017-02-24 21:59:31,0.4576,"After Hours Most Active for Feb 24, 2017 :  SE, F, CSCO, MT, PFE, MGM, KMI, QQQ, EBAY, ELNK, HOLX, STX",0.0,0.864,0.136,1
2017-02-24 22:30:21,0.4215,Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections,0.0,0.741,0.259,1
2017-02-24 23:43:23,0.0,Pfizer subpoenaed in U.S. over patient assistance plans,0.0,1.0,0.0,0
2017-02-24 23:49:28,0.5719,"Dow 30 Stock Roundup: Wal-Mart, Home Depot Beat on Earnings, Boeing Wins $1.32B Order from Juneyao",0.0,0.802,0.198,1
2017-02-25 00:50:01,0.0,3 Biotech Long Shots: Boom Or Bust?,0.0,1.0,0.0,0
2017-02-25 14:25:00,-0.296,Details Still Missing on Republicans' 'Once in a Generation' Tax Plan,0.196,0.804,0.0,-1
2017-02-27 12:15:08,0.0258,"Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer",0.0,0.916,0.084,0
2017-02-27 12:35:53,0.0,Merck & Co.’s Valuation after Its 4Q16 Earnings,0.0,1.0,0.0,0
2017-02-27 12:38:10,0.4404,Pfizer’s Innovative Health and Essential Health in 4Q16,0.0,0.707,0.293,1
2017-02-27 14:08:22,0.3818,Understanding Pfizer’s Growth Contributors in 4Q16,0.0,0.658,0.342,1
2017-02-27 14:19:58,-0.2263,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 28, 2017",0.147,0.853,0.0,-1
2017-02-27 15:38:09,-0.1531,Pfizer’s Products with Falling Revenues in 4Q16,0.211,0.789,0.0,-1
2017-02-27 16:50:56,0.0,"Dow Movers: MSFT, CVX",0.0,1.0,0.0,0
2017-02-27 18:22:00,-0.5106,Why You Shouldn't Look Down On Your Depressed Colleagues,0.292,0.708,0.0,-1
2017-02-27 21:46:19,0.0,Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study,0.0,1.0,0.0,0
2017-02-27 21:50:02,-0.7506,"No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed",0.444,0.556,0.0,-1
2017-02-27 22:12:26,0.0,"Drugmakers pledge restraint, but prices will still soar",0.0,1.0,0.0,0
2017-02-28 06:50:22,0.0,Pharma Industry Outlook - February/March 2017,0.0,1.0,0.0,0
2017-02-28 07:17:00,0.3182,"Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts",0.0,0.827,0.173,1
2017-02-28 11:15:00,0.3182,"Merck KGaA, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts",0.0,0.839,0.161,1
2017-02-28 11:15:08,0.0,The 6 Most Shorted NYSE Stocks,0.0,1.0,0.0,0
2017-02-28 12:00:00,0.3182,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review,0.0,0.881,0.119,1
2017-02-28 12:38:38,-0.6597,"Merck KGaA, Pfizer get priority review for bladder cancer drug",0.328,0.672,0.0,-1
2017-02-28 13:51:16,0.0,Pfizer Stock History: How the Drugmaker Became an Industry Giant,0.0,1.0,0.0,0
2017-02-28 14:06:24,0.0,Pfizer’s Major Product Developments in 4Q16,0.0,1.0,0.0,0
2017-02-28 14:20:47,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2017",0.0,1.0,0.0,0
2017-02-28 15:35:48,0.0,Eli Lilly & Co.’s Valuation after Its 4Q16 Earnings Report,0.0,1.0,0.0,0
2017-02-28 15:35:59,0.0,Pfizer’s Recent Corporate and Pipeline Developments,0.0,1.0,0.0,0
2017-02-28 16:52:40,0.0,"Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly",0.0,1.0,0.0,0
2017-02-28 17:35:25,-0.34,Pfizer Gets FDA Warning Over Contaminated Drugs at Hospira Plant,0.211,0.789,0.0,-1
2017-02-28 18:35:48,0.0,Results In For Pfizer Inc. (PFE) Rheumatoid Arthritis Study,0.0,1.0,0.0,0
2017-02-28 19:43:13,-0.1027,FDA warns Pfizer over contaminated drugs at Kansas plant,0.149,0.851,0.0,-1
2017-02-28 23:18:44,0.0,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",0.0,1.0,0.0,0
2017-02-28 23:53:00,-0.3612,"Pfizer Prices €4,000,000,000 Debt Offering",0.385,0.615,0.0,-1
2017-03-01 00:14:33,-0.7184,[$$] OrbiMed Logs Two Decades of Novel Attacks on Cancer,0.44,0.422,0.139,-1
2017-03-01 11:54:50,0.0,Short Sellers Pile On Pfizer After Buyout Rumors,0.0,1.0,0.0,0
2017-03-01 12:35:47,0.0,Analyzing Pfizer’s Estimates for the Future,0.0,1.0,0.0,0
2017-03-01 12:36:19,0.4019,Label Expansion Expected to Boost Keytruda’s 2017 Revenue,0.0,0.722,0.278,1
2017-03-01 12:37:46,0.6369,AstraZeneca’s New Products May Offer 2017 Growth Opportunities,0.0,0.536,0.464,1
2017-03-01 18:04:11,0.0,PFIZER INC Financials,0.0,1.0,0.0,0
2017-03-01 21:15:00,0.4404,"Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency",0.0,0.86,0.14,1
2017-03-01 22:07:00,-0.4404,Drug Companies Block Shareholder Votes on Price Transparency Proposals,0.266,0.734,0.0,-1
2017-03-01 22:07:10,-0.4404,[$$] Drug Companies Block Shareholders' Voting on Price Transparency,0.266,0.734,0.0,-1
2017-03-01 22:15:00,-0.34,Drugs stocks shrug off Trump warning,0.324,0.676,0.0,-1
2017-03-01 23:14:14,0.0,"M&As, Pipeline Catalysts to Drive Pharma Sector",0.0,1.0,0.0,0
2017-03-01 23:36:07,0.3612,Cramer’s charts uncover 4 pharma stocks ready to explode higher,0.0,0.762,0.238,1
2017-03-01 23:42:00,0.3612,Cramer’s charts uncover 4 pharma stocks ready to explode ...,0.0,0.762,0.238,1
2017-03-01 23:47:00,0.0,Could pharma sector roar even higher? Cramer checks the c...,0.0,1.0,0.0,0
2017-03-01 23:58:00,-0.5719,Cramer Remix: Investors are too negative about fast-growi...,0.346,0.654,0.0,-1
2017-03-02 02:40:25,-0.2263,[$$] ICU Medical Outlook Misses Wall Street Targets,0.213,0.787,0.0,-1
2017-03-02 11:11:00,-0.4939,Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1),0.176,0.824,0.0,-1
2017-03-02 17:15:27,0.0,"Dow Movers: AXP, XOM",0.0,1.0,0.0,0
2017-03-02 18:10:00,0.4215,[$$] The Biotech Stock Safety Net,0.0,0.641,0.359,1
2017-03-02 19:09:00,0.0,How To Trade The 8 'Dogs Of The Dow',0.0,1.0,0.0,0
2017-03-03 12:53:00,0.0,70 or Older? 3 Stocks You Should Consider Buying,0.0,1.0,0.0,0
2017-03-03 13:07:48,-0.5719,Corporates break new ground to cope with negative rates,0.316,0.684,0.0,-1
2017-03-03 13:33:01,-0.7034,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug",0.271,0.729,0.0,-1
2017-03-03 17:42:49,0.4939,Health Care Dividend Stock Showdown,0.0,0.556,0.444,1
2017-03-03 19:46:00,0.0,Here's Why Pfizer Rallied 7.7% in February,0.0,1.0,0.0,0
2017-03-03 20:35:43,0.0,How Mylan’s Europe Segment Performed,0.0,1.0,0.0,0
2017-03-04 05:01:00,-0.7184,[$$] AstraZeneca Struggles to Justify Rejection of Pfizer,0.5,0.5,0.0,-1
2017-03-06 13:30:00,0.0,Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session,0.0,1.0,0.0,0
2017-03-06 14:19:17,-0.296,Germany to scrap plan to lower prices of new drugs-lawmakers,0.196,0.804,0.0,-1
2017-03-06 14:50:08,0.0,Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here,0.0,1.0,0.0,0
2017-03-06 14:52:41,0.4939,Health Care Sector Update for 03/06/2017: MRK,0.0,0.652,0.348,1
2017-03-06 16:17:27,0.0,What's in Store for Merck KGaA (MKGAF) in Q4 Earnings?,0.0,1.0,0.0,0
2017-03-06 18:29:00,-0.3252,Bristol-Myers Squibb: Don't Get Your Hopes Up,0.28,0.72,0.0,-1
2017-03-07 10:19:00,0.0,Pfizer To Present At Cowen And Co Healthcare Conference; Webcast At 11:20 AM ET,0.0,1.0,0.0,0
2017-03-07 12:54:21,0.0,"Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more",0.0,1.0,0.0,0
2017-03-07 14:17:16,0.0,"Shire plc (SHPG) Ex-Dividend Date Scheduled for March 08, 2017",0.0,1.0,0.0,0
2017-03-07 14:21:00,0.4404,Is Portola Pharmaceuticals Balance Sheet Safe?,0.0,0.633,0.367,1
2017-03-07 14:48:55,0.0,Trump's Latest Drug Pricing Tweet Hits Biotech Stocks,0.0,1.0,0.0,0
2017-03-07 15:36:03,0.0,"Ten stocks to watch with focus on Obamacare, drug prices; Dow Jones dips; Snap slides 10 percent early",0.0,1.0,0.0,0
2017-03-07 16:37:14,0.2023,"Stock market fights for altitude, but health-care, energy slide weigh",0.148,0.64,0.212,1
2017-03-07 16:51:54,0.0,"GLOBAL MARKETS-Wall Street slips, U.S. dollar firm on Fed outlook",0.0,1.0,0.0,0
2017-03-07 17:14:53,0.0,"Trump Tweets, Drug Stocks Tank",0.0,1.0,0.0,0
2017-03-07 18:13:13,0.0,Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M,0.0,1.0,0.0,0
2017-03-07 18:13:27,0.296,Midday Update: Wall Street Remains Cautious as Global Growth Weighs,0.117,0.667,0.217,1
2017-03-07 18:14:44,0.0,"Dow Movers: MRK, WMT",0.0,1.0,0.0,0
2017-03-07 18:30:00,-0.0772,Trump's Tax Plans: Biggest Winners and Losers,0.296,0.435,0.27,0
2017-03-07 20:30:18,0.0,Sources: Pfizer considering $100M plant expansion in the Triangle,0.0,1.0,0.0,0
2017-03-07 21:01:54,0.0,"Chevron, Verizon Sink DJIA on Tuesday",0.0,1.0,0.0,0
2017-03-07 21:05:00,0.4939,Stocks Fall for Day Two as Trump Targets Health Care Sector,0.0,0.758,0.242,1
2017-03-07 21:55:44,-0.296,"Stocks today: Dow, S&P 500 slip as rally pauses on Obamacare repeal; Trump talks tax cuts right before closing bell",0.104,0.896,0.0,-1
2017-03-07 22:02:53,0.4576,"After Hours Most Active for Mar 7, 2017 :  FMBI, XRX, CSCO, SWN, PFE, HBI, F, MSFT, YHOO, FIG, CMCSA, TLT",0.0,0.864,0.136,1
2017-03-07 22:12:50,-0.0258,Close Update: Wall Street Trades Lower as Energy and Healthcare Stocks Wilt,0.154,0.699,0.147,0
2017-03-07 22:20:06,-0.5267,Drugmakers fall as investors see pricing threat from Trump,0.298,0.702,0.0,-1
2017-03-07 23:13:52,0.3818,"Trump's Tweet Hits Pharma Stocks, Promises Decreased Drug Prices",0.0,0.755,0.245,1
2017-03-07 23:41:00,-0.3612,Cramer: Why Trump’s Twitter tantrums on pharma are your b...,0.217,0.783,0.0,-1
2017-03-08 00:12:14,-0.296,3 Drug Stocks Hit by Trump’s Call for Lower Prices,0.216,0.784,0.0,-1
2017-03-08 00:13:34,0.0,"Stock Market Roundup, March 7: SNAP Falls Again, Drug Stocks Dip",0.0,1.0,0.0,0
2017-03-08 01:25:00,0.0772,Trump's Twitter tantrums a pharma buying opportunity,0.269,0.43,0.301,0
2017-03-08 10:37:24,0.34,"FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)",0.0,0.844,0.156,1
2017-03-08 12:25:02,0.0,Are Hedge Funds Turning Bearish on Healthcare Stocks?,0.0,1.0,0.0,0
2017-03-08 13:04:00,-0.2732,Forget the Distractions: Bristol-Myers Squibb Is a Bargain,0.402,0.412,0.186,-1
2017-03-08 13:35:00,0.0,State Street Calls for More Women on Boards,0.0,1.0,0.0,0
2017-03-08 15:46:00,-0.7964,Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare,0.47,0.53,0.0,-1
2017-03-08 16:01:02,0.3182,Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County,0.0,0.827,0.173,1
2017-03-08 16:16:58,0.0,"J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day",0.0,1.0,0.0,0
2017-03-08 17:14:58,0.2732,"Merck/Pfizer's Diabetes Drug Accepted for Review by FDA, EMA",0.0,0.792,0.208,1
2017-03-08 17:16:00,0.0,Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs,0.0,1.0,0.0,0
2017-03-08 18:43:06,-0.7351,Caterpillar Stock Slides After Report Accuses It of Tax Fraud,0.437,0.563,0.0,-1
2017-03-08 21:22:43,-0.4588,This Pharma Firm Is Beating The Pack In Getting Drugs To Market,0.214,0.786,0.0,-1
2017-03-08 21:23:00,0.0,"1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking",0.0,1.0,0.0,0
2017-03-08 22:13:32,-0.3182,"Aerie (AERI) Q4 Loss Widens, Rhopressa NDA Resubmitted",0.247,0.753,0.0,-1
2017-03-08 22:39:00,0.296,Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk,0.0,0.845,0.155,1
2017-03-09 07:00:00,0.0,Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia,0.0,1.0,0.0,0
2017-03-09 08:12:17,-0.4215,US Indexes Lower on Energy Stock Losses,0.445,0.364,0.191,-1
2017-03-09 13:12:41,0.0,"Retirees, Maximize Your Income From Dividends",0.0,1.0,0.0,0
2017-03-09 13:59:14,0.0,Pharma says high prices fund drug development — but this study finds otherwise,0.0,1.0,0.0,0
2017-03-09 16:16:40,0.0,"The Zacks Analyst Blog Highlights: Caterpillar, Apple and Pfizer",0.0,1.0,0.0,0
2017-03-09 21:03:42,0.0,"Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?",0.0,1.0,0.0,0
2017-03-10 13:00:33,0.0,Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs,0.0,1.0,0.0,0
2017-03-10 14:17:30,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 13, 2017",0.0,1.0,0.0,0
2017-03-10 17:36:00,0.0,Jobs report beats expectations,0.0,1.0,0.0,0
2017-03-11 17:04:00,0.4404,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",0.0,0.734,0.266,1
2017-03-12 12:42:00,0.2716,The 3 Most Important Numbers for Johnson & Johnson,0.0,0.741,0.259,1
2017-03-12 15:41:00,0.0,3 Big Pharma Stocks To Buy in Your 401(k),0.0,1.0,0.0,0
2017-03-12 19:40:00,0.4391,The 10 Most Important Tips for Playing the Stock Market in March,0.0,0.72,0.28,1
2017-03-13 11:14:08,0.5267,Is this top FTSE 100 income stock a clear takeover candidate?,0.0,0.645,0.355,1
2017-03-13 11:37:58,0.0,Johnson & Johnson’s Valuation Compared to Its Peers,0.0,1.0,0.0,0
2017-03-13 13:00:38,0.4576,"Pre-Market Most Active for Mar 13, 2017 :  MBLY, INTC, MT, STM, GE, MSFT, T, PFE, AAPL, CSCO, CMCSA, ASML",0.0,0.857,0.143,1
2017-03-13 13:53:30,0.0,The 19 Best-Selling Prescription Drugs of All-Time,0.0,1.0,0.0,0
2017-03-13 14:07:43,0.34,"Aerie Resubmits Rhopressa NDA, Roclatan Gains Traction",0.0,0.714,0.286,1
2017-03-13 14:30:49,0.0,"Pfizer Inc. :PFE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017",0.0,1.0,0.0,0
2017-03-13 14:37:11,0.0,Johnson & Johnson’s Business Segment Performance,0.0,1.0,0.0,0
2017-03-13 15:18:39,0.3182,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks,0.0,0.796,0.204,1
2017-03-13 17:08:09,0.0,Trefis Market Diagnosis: What Are Market Participants Thinking About Pfizer?,0.0,1.0,0.0,0
2017-03-13 18:06:54,0.4019,Interesting April Stock Options for PFE,0.0,0.649,0.351,1
2017-03-13 19:05:48,0.2023,Why AbbVie Inc Was a Named Top Dividend Stock (ABBV),0.0,0.816,0.184,1
2017-03-13 19:45:02,0.0,Intrexon executive out less than a year after joining the company,0.0,1.0,0.0,0
2017-03-13 20:23:00,0.4404,Better Buy: Eli Lilly and Company vs. Pfizer,0.0,0.707,0.293,1
2017-03-14 05:07:00,0.0,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts,0.0,1.0,0.0,0
2017-03-14 08:20:00,0.2023,Wall Street Cautious Amid Rate Hike Prospects,0.163,0.581,0.256,1
2017-03-14 09:00:00,0.4019,"Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria",0.0,0.87,0.13,1
2017-03-14 12:31:00,0.0,[$$] Don't Expect Pfizer to Make a Mega Acquisition,0.0,1.0,0.0,0
2017-03-14 14:13:56,0.34,Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance,0.208,0.472,0.321,1
2017-03-14 19:05:00,0.0,"Pfizer Unveils Zavicefta Antibiotic in Germany, UK",0.0,1.0,0.0,0
2017-03-14 19:43:00,-0.6124,AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results,0.384,0.463,0.153,-1
2017-03-14 20:14:17,-0.7906,Novartis Breast Cancer Drug Just OK'd — And Already Losing?,0.5,0.5,0.0,-1
2017-03-14 21:49:51,0.2023,Unilever CEO urges UK to provide 'level playing field' after Kraft bid,0.0,0.859,0.141,1
2017-03-14 23:06:54,-0.6597,Novartis Takes Aim at Pfizer in Breast Cancer,0.386,0.614,0.0,-1
2017-03-15 12:09:00,-0.25,Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco,0.182,0.818,0.0,-1
2017-03-15 14:37:17,0.0,David Tepper on Allergan: Does It Look Cheap?,0.0,1.0,0.0,0
2017-03-15 15:07:00,0.4404,3 Safe Stocks to Invest In for an Aging Bull Market,0.0,0.756,0.244,1
2017-03-15 16:40:00,0.0,Bernie Sanders Slams Sanofi Zika Vaccine Deal,0.0,1.0,0.0,0
2017-03-15 17:08:37,0.0,Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication,0.0,1.0,0.0,0
2017-03-15 18:13:12,0.6486,Pfizer’s Cash Flow Stamina versus Merck’s Ambitious R&D,0.0,0.531,0.469,1
2017-03-15 21:05:58,0.1926,"After Hours Most Active for Mar 15, 2017 :  SNPS, RIG, GEO, KOS, YPF, TNGO, LYG, PFE, MCHI, MSFT, GRPN, AAPL",0.096,0.775,0.129,1
2017-03-15 21:06:46,-0.7003,Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?,0.435,0.412,0.153,-1
2017-03-15 21:23:00,0.4767,Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz,0.0,0.763,0.237,1
2017-03-15 21:46:40,0.0,Ex-Oppenheimer adviser gets six months in U.S. insider trading case,0.0,1.0,0.0,0
2017-03-15 22:29:37,0.5267,US Market Indexes Gain and Fed Raises Rate,0.0,0.673,0.327,1
2017-03-16 01:00:00,0.3612,"Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis",0.13,0.695,0.175,1
2017-03-16 12:02:50,0.0,Dividend Stocks Hedge Funds Are Betting On,0.0,1.0,0.0,0
2017-03-16 15:09:28,0.0,Roche Holding Ltd. (ADR) (RHHBY) Stock Is Weathering the Healthcare Storm,0.0,1.0,0.0,0
2017-03-16 15:10:05,0.0,Glaxo Files for Label Expansion of Influenza Vaccine in US,0.0,1.0,0.0,0
2017-03-16 17:07:40,0.0,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China,0.0,1.0,0.0,0
2017-03-16 19:07:36,0.4404,Biogen Inc (BIIB): Profit From the BIIB Stock Bears,0.0,0.734,0.266,1
2017-03-16 20:25:52,-0.0258,"Wall Street Poised for Weaker Finish as Utilities, Health Care Lag",0.303,0.4,0.297,0
2017-03-16 20:45:44,-0.2732,"Close Update: Wall Street Posts Mostly Weaker Finish as Utilities, Health Care Lag",0.286,0.541,0.173,-1
2017-03-16 21:00:00,0.0,How to trade deregulation: 6 stocks,0.0,1.0,0.0,0
2017-03-16 21:58:00,0.0,"Final Trade: BAC, COH & more",0.0,1.0,0.0,0
2017-03-17 13:05:25,0.0,Valeant: It's Not a Game of Chess- Part I,0.0,1.0,0.0,0
2017-03-17 15:15:00,0.4215,Bristol-Myers Squibb and Pfizer Present Large Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Non-Valvular Atrial Fibrillation,0.0,0.903,0.097,1
2017-03-17 16:03:00,0.6369,3 Best Pharmaceutical Stocks for Long-Term Investors,0.0,0.543,0.457,1
2017-03-17 17:03:00,0.0,"Amgen Blew It…For Medicines Co., Esperion Too",0.0,1.0,0.0,0
2017-03-17 20:03:00,-0.5574,Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report,0.247,0.753,0.0,-1
2017-03-17 20:59:00,-0.5267,The Biggest Loser: Amgen Drops 6.4%,0.405,0.595,0.0,-1
2017-03-17 21:06:16,0.4576,"After Hours Most Active for Mar 17, 2017 :  FTR, DNR, LYG, URBN, RJF, PG, PFE, ARE, TTWO, FSLR, HBAN, SGYP",0.0,0.864,0.136,1
2017-03-17 22:06:50,0.0,"Dow 30 Stock Roundup: Boeing Inks $3.3B U.S. Army Deal, Intel Buys Mobileye",0.0,1.0,0.0,0
2017-03-18 22:28:36,0.0,"Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans",0.0,1.0,0.0,0
2017-03-19 11:22:00,0.6369,3 Best Stocks for Your Roth IRA,0.0,0.543,0.457,1
2017-03-20 13:41:00,-0.7717,"Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome",0.489,0.511,0.0,-1
2017-03-20 14:07:00,-0.296,Lilly's breast cancer drug combination succeeds key study,0.324,0.441,0.235,-1
2017-03-20 16:08:51,0.0,"Trump, Biogen and Amgen Hammer Healthcare ETFs",0.0,1.0,0.0,0
2017-03-20 16:09:10,0.0,"Noteworthy ETF Inflows: IUSV, CVX, PG, PFE",0.0,1.0,0.0,0
2017-03-20 17:16:00,-0.5106,Eli Lilly Breast Cancer Combo Does Well In Trial,0.326,0.519,0.156,-1
2017-03-20 20:12:08,0.0,"Anatomy Of A Decision, Part 1: The C-Suite",0.0,1.0,0.0,0
2017-03-21 01:56:50,0.0,[$$] White House Set to Announce Head of Senate Legislative Affairs Team,0.0,1.0,0.0,0
2017-03-21 11:00:00,0.2023,Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks,0.0,0.769,0.231,1
2017-03-21 11:30:04,0.0,[$$] SutroVax Set for Vaccine Trials After $64 Million Financing,0.0,1.0,0.0,0
2017-03-21 14:00:02,0.7579,Is Pfizer (PFE) a Great Stock for Value Investors?,0.0,0.48,0.52,1
2017-03-21 14:08:38,-0.4549,IBM's Watson Is Tackling Medicine's Most Complex Problems,0.298,0.702,0.0,-1
2017-03-21 14:09:50,-0.2023,Lilly's Breast Cancer Combo Drug Phase III Results Positive,0.293,0.467,0.24,-1
2017-03-21 16:13:00,0.25,7 Pharma Plays With Emerging Market Potential,0.0,0.714,0.286,1
2017-03-21 16:49:00,0.4939,"4 Health Care Charts Signaling Buys: Pfizer, Amgen Included",0.0,0.686,0.314,1
2017-03-21 17:09:33,0.7096,Nektar's Pain Drug Positive in Phase III Study; Shares Gain,0.178,0.324,0.497,1
2017-03-21 18:07:05,-0.0516,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk?,0.175,0.667,0.158,0
2017-03-21 22:05:43,0.7096,Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017,0.0,0.629,0.371,1
2017-03-22 13:16:49,0.0,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 23, 2017",0.0,1.0,0.0,0
2017-03-22 14:30:00,0.0,Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts,0.0,1.0,0.0,0
2017-03-22 18:47:00,0.0,Can Abbott Outperform Despite Alere?,0.0,1.0,0.0,0
2017-03-22 20:01:55,0.3034,EXCLUSIVE: Advent pulls bid for Pfizer's Brazil venture - sources,0.0,0.782,0.218,1
2017-03-23 12:33:00,-0.5859,Pfizer’s Lyrica Ineffective for Sciatica Pain (PFE),0.49,0.51,0.0,-1
2017-03-23 16:02:14,0.6908,Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse,0.0,0.551,0.449,1
2017-03-23 19:02:05,0.0,Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power,0.0,1.0,0.0,0
2017-03-23 19:10:41,-0.4019,"FDA approves Pfizer, German Merck immunotherapy for skin cancer",0.312,0.496,0.191,-1
2017-03-23 20:28:21,0.34,"Pfizer, Merck KGaA's $13,000-a-Month Cancer Drug Wins Approval",0.272,0.309,0.42,1
2017-03-23 21:30:00,0.7783,"FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma",0.0,0.606,0.394,1
2017-03-24 01:11:00,0.4019,"FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars",0.0,0.803,0.197,1
2017-03-24 06:33:00,0.0,Biotech Stocks Facing FDA Decision In April,0.0,1.0,0.0,0
2017-03-24 07:40:49,-0.6597,"Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month",0.355,0.645,0.0,-1
2017-03-24 09:50:00,-0.6597,"Pfizer, Merck KGaA Get FDA Nod for Skin Cancer Drug (PFE)",0.306,0.694,0.0,-1
2017-03-24 10:26:00,0.5574,Pfizer Gets Positive CHMP Opinion For TRUMENBA,0.0,0.625,0.375,1
2017-03-24 10:46:00,-0.128,Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment,0.27,0.429,0.301,-1
2017-03-24 11:58:30,0.4939,20 Questions With Tom Vilord of Vilord Wealth Advisors,0.0,0.714,0.286,1
2017-03-24 14:01:47,0.4215,"Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved",0.0,0.797,0.203,1
2017-03-24 14:18:00,0.5574,Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease,0.0,0.769,0.231,1
2017-03-24 15:41:00,-0.128,Mylan Hit After Abbott Dumps Shares,0.303,0.449,0.247,-1
2017-03-24 16:01:45,0.0,"Dow Movers: PFE, INTC",0.0,1.0,0.0,0
2017-03-24 16:58:00,0.0,Healthcare: Will They or Won't They?,0.0,1.0,0.0,0
2017-03-24 16:58:16,-0.4215,US Market Indexes Lower With Losses Led by Energy Stocks,0.35,0.5,0.15,-1
2017-03-24 17:00:21,0.4767,Amgen's (AMGN) Humira Biosimilar Receives Approval in EU,0.0,0.693,0.307,1
2017-03-24 17:00:39,-0.3182,Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval,0.326,0.444,0.23,-1
2017-03-24 19:07:07,0.0,Novartis’s Valuation Compared to Its Peers’,0.0,1.0,0.0,0
2017-03-24 20:51:00,0.4939,"Trump, Ryan Spike Health Care Vote in Setback for President, GOP",0.0,0.758,0.242,1
2017-03-24 21:47:15,-0.1027,Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty,0.333,0.435,0.232,-1
2017-03-24 22:57:41,-0.6705,Here's how stocks could react now that the GOP health-care bill has been killed,0.257,0.743,0.0,-1
2017-03-25 10:43:00,0.2023,1 Top Stock in Big Pharma,0.0,0.69,0.31,1
2017-03-25 15:58:17,0.25,"Pioneer Investments Exits Wells Fargo, Coca-Cola, Buys Walt Disney",0.0,0.8,0.2,1
2017-03-25 18:01:00,-0.4201,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),0.189,0.811,0.0,-1
2017-03-26 13:03:00,0.4576,3 Tremendously Promising Diabetes Drugs Potentially on the Way,0.0,0.7,0.3,1
2017-03-26 23:03:00,-0.5267,"XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod",0.276,0.647,0.076,-1
2017-03-27 05:16:00,0.4767,Pfizer: XELJANZ In Combination With Methotrexate Gets EC Approval For RA,0.0,0.763,0.237,1
2017-03-27 07:20:52,0.4215,Chinese drug approval boosts AstraZeneca's lung cancer hopes,0.265,0.241,0.494,1
2017-03-27 09:00:00,0.0258,XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the Treatment of Moderate to Severe Active Rheumatoid Arthritis (RA),0.107,0.782,0.111,0
2017-03-27 14:02:00,0.0,3 Big Pharma Stocks You Don't Have to Babysit,0.0,1.0,0.0,0
2017-03-27 14:22:00,0.0,Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?,0.0,1.0,0.0,0
2017-03-27 15:03:22,0.5574,Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma,0.0,0.66,0.34,1
2017-03-27 15:45:00,0.4215,Pfizer Rheumatoid Arthritis Drug Approved in EU,0.0,0.682,0.318,1
2017-03-27 16:55:00,0.0,Pfizer Stock Rises on Bristol-Myers Takeover Talk,0.0,1.0,0.0,0
2017-03-27 18:01:02,0.4019,Interesting January 2018 Stock Options for PFE,0.0,0.69,0.31,1
2017-03-27 18:29:48,0.34,Bristol-Myers Squibb's Motivation Behind CytomX Deal,0.0,0.676,0.324,1
2017-03-27 19:23:00,0.7783,A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd.,0.0,0.541,0.459,1
2017-03-27 20:13:27,0.6249,Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol?,0.0,0.662,0.338,1
2017-03-27 20:29:00,-0.5574,3 Top Cancer Drug Stocks to Buy in 2017,0.361,0.492,0.148,-1
2017-03-28 02:58:17,0.4404,"The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement",0.0,0.756,0.244,1
2017-03-28 11:36:38,0.0,How Decline in Remicade Is Affecting Merck’s Immunology Revenues,0.0,1.0,0.0,0
2017-03-28 13:06:21,0.0,This Is Driving Merck’s Vaccines Business,0.0,1.0,0.0,0
2017-03-28 15:31:00,0.0,[$$] Could Pfizer Make Cash Bid for Bristol-Myers?,0.0,1.0,0.0,0
2017-03-28 16:59:19,0.0,"Noteworthy ETF Inflows: IWB, BAC, PG, PFE",0.0,1.0,0.0,0
2017-03-28 17:58:53,0.0,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe,0.0,1.0,0.0,0
2017-03-28 19:42:00,0.5994,Could Real-World Studies Boost These 3 Big Pharma Stocks' Prospects?,0.0,0.588,0.412,1
2017-03-28 22:51:16,0.4404,Cramer's lightning round: Stick with this 'terrific' defense play,0.0,0.642,0.358,1
2017-03-29 02:47:00,0.34,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data",0.0,0.862,0.138,1
2017-03-29 11:36:09,0.3612,What Wall Street Analysts Recommend for Merck,0.0,0.706,0.294,1
2017-03-29 17:59:15,0.2732,AstraZeneca's (AZN) Lynparza NDA Accepted for Review by FDA,0.0,0.792,0.208,1
2017-03-29 19:42:00,0.0,3 Drugmakers With Boatloads of Cash to Spend,0.0,1.0,0.0,0
2017-03-29 20:01:00,0.5106,VBI Vaccines Emerges as Strong Biotech Stock,0.0,0.645,0.355,1
2017-03-29 20:50:35,0.0,Eli Lilly’s Valuation Compared to Its Peers’,0.0,1.0,0.0,0
2017-03-30 11:36:52,0.3818,Why Entresto Could Become Key Growth Driver for Novartis in 2017,0.0,0.794,0.206,1
2017-03-30 13:06:41,0.296,What Could Boost Medicare Demand for Novartis’s Entresto?,0.147,0.588,0.265,1
2017-03-30 13:16:00,0.0,Viagra May Be Soon Be Sold Without a Prescription in the UK,0.0,1.0,0.0,0
2017-03-30 14:36:43,0.296,Reduced Co-pays May Boost Demand for Entresto,0.163,0.543,0.293,1
2017-03-30 20:30:58,0.0,These 5 Dow Stocks Are Near Buy Points: Investing Action Plan,0.0,1.0,0.0,0
2017-03-31 12:21:00,0.0,Could Pfizer Buy Esperion Therapeutics?,0.0,1.0,0.0,0
2017-03-31 14:35:57,0.5106,Entresto Could See Strong Uptake in European Markets in 2017,0.0,0.732,0.268,1
2017-03-31 16:48:00,-0.4767,"Merck, Incyte Expand Cancer Collaboration",0.454,0.309,0.237,-1
2017-03-31 18:04:00,-0.3182,"IBRANCE® (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer",0.205,0.651,0.144,-1
2017-03-31 19:29:18,0.0,Understanding Sanofi’s Valuation Compared to Peers,0.0,1.0,0.0,0
2017-03-31 19:32:00,0.6808,3 Attractive Healthy Dividend-Paying Market Gems,0.0,0.349,0.651,1
2017-03-31 21:55:08,0.0,How Does Pfizer’s Valuation Compare to Peers?,0.0,1.0,0.0,0
2017-03-31 22:59:24,0.5719,"Dow 30 Stock Roundup: Apple Buys Workflow, J&J Wins European Label Expansion",0.0,0.748,0.252,1
2017-04-01 07:10:58,0.4939,White House wealth: Trump employees disclose their finances,0.0,0.686,0.314,1
2017-04-02 18:05:00,0.3612,"2:05 pm Pfizer confirms that the FDA has approved a supplemental New Drug Application for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, IBRANCE",0.05,0.843,0.107,1
2017-04-03 06:00:00,-0.1779,The cost of cancer: new drugs show success at a steep price,0.257,0.526,0.216,-1
2017-04-03 11:38:04,0.4404,How Pfizer’s Innovative and Essential Health Segments Performed,0.0,0.707,0.293,1
2017-04-03 12:49:00,-0.3182,Pfizer's Ibrance Gets FDA Approval for Breast Cancer,0.326,0.444,0.23,-1
2017-04-03 13:08:10,0.0,Analyzing Pfizer’s Geographical Performance in 2016,0.0,1.0,0.0,0
2017-04-03 13:15:18,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 04, 2017",0.0,1.0,0.0,0
2017-04-03 13:39:01,-0.3182,Pfizer Gets Regular Approval for Breast Cancer Drug Ibrance,0.303,0.483,0.214,-1
2017-04-03 14:10:00,0.1027,Mylan Expands EpiPen Recall,0.0,0.682,0.318,1
2017-04-03 14:41:55,0.3818,What Contributed to Pfizer’s Growth in 2016?,0.0,0.698,0.302,1
2017-04-03 16:36:38,0.0,Pfizer Inc. (PFE) Stock Could Be a Second-Quarter Star,0.0,1.0,0.0,0
2017-04-03 17:36:00,0.296,"Monday’s Vital Data: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN) and Comcast Corporation (CMCSA)",0.0,0.845,0.155,1
2017-04-03 17:38:05,0.0,Mylan's EpiPen Recall Expanded to U.S.,0.0,1.0,0.0,0
2017-04-04 13:06:40,0.0,What’s Pfizer’s Financial Guidance for 2017?,0.0,1.0,0.0,0
2017-04-04 13:08:40,-0.2023,Onconova Therapeutics stock surges 18% on positive pre-clinical data for cancer drugs,0.244,0.556,0.2,-1
2017-04-04 13:15:00,0.0,Today's Research Reports on Stocks to Watch: Mylan and Pfizer,0.0,1.0,0.0,0
2017-04-04 13:16:42,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 05, 2017",0.0,1.0,0.0,0
2017-04-04 14:36:41,0.4019,These Key Product Developments Could Help Pfizer,0.0,0.69,0.31,1
2017-04-04 16:24:00,0.34,There's Value in Healthcare ETFs,0.0,0.625,0.375,1
2017-04-04 16:25:00,-0.2023,Onconova Reports Positive Data for 2 Cancer Drugs,0.338,0.385,0.277,-1
2017-04-04 18:23:01,0.0,How Walgreens Boots Alliance Inc (WBA) Stock Will Trade After Earnings,0.0,1.0,0.0,0
2017-04-05 11:36:02,0.0,Must-Know Corporate and Pipeline Developments for Pfizer,0.0,1.0,0.0,0
2017-04-05 13:06:09,0.3612,What Wall Street Analysts Recommend for Pfizer,0.0,0.706,0.294,1
2017-04-05 15:56:01,0.296,"IWB, BAC, PFE, C: ETF Outflow Alert",0.0,0.732,0.268,1
2017-04-05 18:53:19,-0.2023,Roche Announces Positive Data on Lung Cancer Drug Alecensa,0.293,0.467,0.24,-1
2017-04-05 19:36:28,-0.3612,Advertisers flee Bill O'Reilly's show but impact unclear,0.263,0.737,0.0,-1
2017-04-05 20:44:00,0.2716,The 3 Most Important Numbers for Pfizer Inc.,0.0,0.741,0.259,1
2017-04-05 21:00:00,0.0,"DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control",0.0,1.0,0.0,0
2017-04-06 17:53:30,-0.5719,Allergan (AGN) Presents Mixed Depression Data on Botox,0.346,0.654,0.0,-1
2017-04-06 17:53:57,0.5574,Paratek (PRTK) Stock Continues to Rise on Positive Results,0.0,0.69,0.31,1
2017-04-07 15:57:50,0.0,How Pharmaceutical ETFs Performed during 1Q17,0.0,1.0,0.0,0
2017-04-07 16:25:07,-0.5423,FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements,0.31,0.69,0.0,-1
2017-04-07 16:53:13,0.0,"Boltwood Capital Management Buys iShares Core S&P Small-Cap, Allergan PLC, ...",0.0,1.0,0.0,0
2017-04-07 22:54:57,0.0,"Dow 30 Stock Roundup: Boeing Bags Air Force Orders, DuPont to Sell Part of Crop Protection Biz",0.0,1.0,0.0,0
2017-04-10 05:38:51,0.5859,Roche's Alecensa notches trial win against Pfizer's Xalkori,0.0,0.648,0.352,1
2017-04-10 11:36:42,0.0,How Pfizer Stock Performed in 1Q17,0.0,1.0,0.0,0
2017-04-10 12:15:00,0.0,Medivation Founder David Hung Becomes CEO Of Axovant Sciences,0.0,1.0,0.0,0
2017-04-10 12:50:00,-0.1027,3 Dividend Stocks That Should Pay for the Rest of Your Life,0.123,0.877,0.0,-1
2017-04-10 13:14:28,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 11, 2017",0.0,1.0,0.0,0
2017-04-10 13:15:47,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 11, 2017",0.0,1.0,0.0,0
2017-04-10 14:11:00,0.2023,3 Top Dividend Stocks to Put on Your Shopping List,0.0,0.816,0.184,1
2017-04-10 15:37:00,-0.6597,Roche Cancer Drug Beats Pfizer's Xalkori in Study,0.386,0.614,0.0,-1
2017-04-10 23:54:07,-0.6597,Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint,0.386,0.614,0.0,-1
2017-04-11 11:53:32,0.0,"Lawson Kroeker Investment Management Inc Buys Opus Bank, Gilead Sciences, Crimson Wine Group, ...",0.0,1.0,0.0,0
2017-04-11 12:08:00,0.2023,The 3 Top Dividend Stocks in the Healthcare Sector,0.0,0.795,0.205,1
2017-04-11 15:09:00,0.0,Jim Cramer -- Eli Lilly Is the New 'Darling' of Big Pharma,0.0,1.0,0.0,0
2017-04-11 15:45:08,0.0,​Boston biotech Rhythm elevates Genzyme head Meeker to board chairman,0.0,1.0,0.0,0
2017-04-11 16:53:43,0.5106,"Dynamic Advisors Solutions LLC Buys Ventas, Las Vegas Sands, Crown Castle International, Sells ...",0.0,0.736,0.264,1
2017-04-11 20:29:00,0.0,What&apos;s Got Axovant Sciences Jumping 10% Today?,0.0,1.0,0.0,0
2017-04-11 21:54:58,0.0,What's Got Axovant Sciences Jumping 10% Today?,0.0,1.0,0.0,0
2017-04-12 14:53:35,0.0,"Foundation Resource Management Inc Buys Johnson & Johnson, Sells SPDR S&P 500, Vectrus, ...",0.0,1.0,0.0,0
2017-04-12 15:46:38,0.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,0.0,1.0,0.0,0
2017-04-12 18:55:04,0.0,Here's Why Wave Life Sciences Fell as Much as 12.1% This Morning,0.0,1.0,0.0,0
2017-04-12 21:04:02,0.4576,"After Hours Most Active for Apr 12, 2017 :  F, T, INTC, PFE, CSCO, GM, XOM, KO, MAT, QCOM, JD, SIRI",0.0,0.864,0.136,1
2017-04-13 13:58:43,0.5574,Aerie Reports Positive Data on Ophthalmic Drug Rhopressa,0.0,0.66,0.34,1
2017-04-13 13:58:48,-0.2732,"Pharma Stock Roundup: Merck Gets CRL for Label Expansion Effort, Roche Cancer Drug Tops",0.223,0.609,0.168,-1
2017-04-13 14:22:02,0.0,J&J (JNJ) to Kick Off Pharma Q1 Earnings: Will it Beat?,0.0,1.0,0.0,0
2017-04-13 15:00:00,0.34,A Direct Approach to Value Stocks,0.0,0.625,0.375,1
2017-04-13 16:55:24,0.0,"Noteworthy ETF Outflows: IWB, BAC, PG, PFE",0.0,1.0,0.0,0
2017-04-13 17:54:47,-0.6597,Roche Launches Antibody Test to Diagnose Prostate Cancer,0.386,0.614,0.0,-1
2017-04-13 18:53:35,0.4939,"Edge Wealth Management LLC Buys Gilead Sciences, Qualcomm, Apollo Commercial Real Estate ...",0.0,0.789,0.211,1
2017-04-13 22:17:57,0.0,Pfizer Says Execution Drugs Sold to Arkansas Without Knowing,0.0,1.0,0.0,0
2017-04-14 01:38:38,0.0258,2 firms seek to prevent drugs' use in Arkansas executions,0.0,0.879,0.121,0
2017-04-14 14:54:59,0.0,Analysts Expect 10% Upside For XLV,0.0,1.0,0.0,0
2017-04-15 12:53:38,0.765,"Town & Country Bank & Trust CO dba First Bankers Trust CO Buys Enbridge, TJX, Royal ...",0.0,0.663,0.337,1
2017-04-17 01:33:00,0.1779,Lilly and Incyte Fall After FDA Rejects Potential Blockbuster for Rheumatoid Arthritis,0.187,0.585,0.228,1
2017-04-17 07:30:28,0.0,Overcoming Opioids: The quest for less addictive drugs,0.0,1.0,0.0,0
2017-04-17 13:20:01,0.4767,5 Drug Stocks That Could Be Big Winners this Earnings Season,0.0,0.744,0.256,1
2017-04-17 13:46:05,0.0,"Stocks Open Higher: McDonald&apos;s, Apple Rise On The Dow",0.0,1.0,0.0,0
2017-04-17 14:51:00,0.3612,"Gilead, Pfizer, AbbVie Win From Lilly's Loss",0.207,0.45,0.342,1
2017-04-17 14:58:01,0.296,Why Shares of Portola Pharmaceuticals Are Up Over 60% in 2017,0.0,0.82,0.18,1
2017-04-17 16:47:00,0.0,Why Incyte Corporation Stock Is Plunging Today,0.0,1.0,0.0,0
2017-04-17 20:13:20,-0.7783,Can Lilly Survive Rheumatoid Arthritis Flop With Breast Cancer Drug?,0.459,0.541,0.0,-1
2017-04-17 21:43:00,0.0,Billion dollar drug bust,0.0,1.0,0.0,0
2017-04-17 21:54:46,0.0,How Pfizer Inc. Makes Most of Its Money,0.0,1.0,0.0,0
2017-04-17 23:54:07,0.0,5 Things You Should Expect When Johnson & Johnson Reports Its Q1 Results Tomorrow,0.0,1.0,0.0,0
2017-04-18 00:30:00,0.4404,5 Stocks To Profit From The Canadian Marijuana Boom,0.0,0.707,0.293,1
2017-04-18 00:43:00,-0.3818,The makers of a lethal-injection drug have become leaders in Arkansas' death-penalty battle,0.191,0.809,0.0,-1
2017-04-18 00:54:44,0.5574,Roche's Hemophilia A Drug Positive in Second Phase III Study,0.0,0.69,0.31,1
2017-04-18 03:24:00,0.4939,"HitGen, Pfizer Enter Research Collaboration & License Agreement - Quick Facts",0.0,0.714,0.286,1
2017-04-18 03:56:25,-0.3612,[$$] Papua New Guinea struggles to eradicate yaws disease,0.238,0.762,0.0,-1
2017-04-18 12:33:43,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : April 18, 2017",0.0,1.0,0.0,0
2017-04-18 15:02:54,0.0,"J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down",0.0,1.0,0.0,0
2017-04-18 15:04:00,0.6369,The 4 Best Dividend Stocks in Pharmaceuticals,0.0,0.543,0.457,1
2017-04-18 15:08:47,0.0,Did Pharma & Biotech M&As Pick Pace in Q1?,0.0,1.0,0.0,0
2017-04-18 15:19:31,0.0,Johnson & Johnson says pricing competition squeezed 1Q sales,0.0,1.0,0.0,0
2017-04-18 17:05:12,0.0,High-Yield Healthcare Investments You Can Buy Right Now,0.0,1.0,0.0,0
2017-04-18 17:05:26,-0.6597,Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion,0.328,0.672,0.0,-1
2017-04-18 18:11:00,0.0,Johnson & Johnson Sees Little Impact In Key Area Despite Pfizer Competition,0.0,1.0,0.0,0
2017-04-19 13:05:41,0.0,Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?,0.0,1.0,0.0,0
2017-04-19 14:57:09,0.3182,Pfizer receives subpoenas in U.S. intravenous saline solution probe,0.0,0.777,0.223,1
2017-04-19 15:05:19,0.0,"Billionaires, companies power Trump's record inaugural haul",0.0,1.0,0.0,0
2017-04-19 15:42:00,-0.5267,Gilead Sciences: Who's Frustrated Now?,0.459,0.541,0.0,-1
2017-04-19 17:04:22,0.0,Lackluster J&J Q1 Pushes Healthcare ETFs Down,0.0,1.0,0.0,0
2017-04-19 19:05:29,0.3182,Pfizer subpoenaed in U.S. intravenous saline solution probe,0.0,0.753,0.247,1
2017-04-19 19:13:12,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : April 19, 2017",0.0,0.745,0.255,1
2017-04-19 19:33:03,0.0772,Johnson & Johnson's Pharma Business To See Challenges In The Near Term,0.0,0.885,0.115,0
2017-04-19 20:03:01,0.5267,Pfizer is latest to get Justice Department subpoena in intravenous saline investigation,0.0,0.764,0.236,1
2017-04-19 20:17:08,-0.34,Is J&J&apos;s Pharma Sales Slowdown a Warning for Other Players?,0.231,0.769,0.0,-1
2017-04-19 21:02:38,-0.25,"Pfizer Follows Baxter, Gets Slammed With Subpoena Related To Saline Shortage",0.167,0.833,0.0,-1
2017-04-19 21:02:47,0.4576,"After Hours Most Active for Apr 19, 2017 :  GE, EBAY, LC, PFE, SWNC, GIMO, QCOM, WLL, ARRY, YHOO, MSFT, CMCSA",0.0,0.864,0.136,1
2017-04-19 22:03:44,-0.34,Is J&J's Pharma Sales Slowdown a Warning for Other Players?,0.231,0.769,0.0,-1
2017-04-19 23:11:00,0.0,Pfizer Gets US DoJ Subpoena In Intravenous Saline Investigation,0.0,1.0,0.0,0
2017-04-20 16:04:21,0.0,Bristol-Myers Squibb Co: Buy the Dip?,0.0,1.0,0.0,0
2017-04-20 16:05:32,0.2023,3 Top High-Yield Dividend Stocks to Buy Now,0.0,0.769,0.231,1
2017-04-20 16:05:55,-0.802,AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies,0.507,0.493,0.0,-1
2017-04-20 19:00:00,0.0,Pfizer Invites Public To Listen To Webcast Of April 27 Annual Meeting Of Shareholders,0.0,1.0,0.0,0
2017-04-21 12:36:00,0.0,"Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries",0.0,1.0,0.0,0
2017-04-21 16:00:26,0.6249,Making Drug Manufacturing Great Again,0.0,0.494,0.506,1
2017-04-21 16:04:16,0.0,"Noteworthy ETF Inflows: VTV, BAC, PG, PFE",0.0,1.0,0.0,0
2017-04-21 17:02:21,0.0,"Hexavest Inc. Buys VanEck Vectors Gold Miners, Ventas, Tyson Foods, Sells Citigroup, Coca-Cola ...",0.0,1.0,0.0,0
2017-04-21 19:05:00,0.5574,Pfizer Receives Positive CHMP Opinion for BESPONSA® (Inotuzumab Ozogamicin) for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia,0.0,0.833,0.167,1
2017-04-21 21:03:22,0.0,FDA OKs Samsung Bioepis's Biosimilar Version Of J&J's Remicade,0.0,1.0,0.0,0
2017-04-22 04:08:23,0.0,FDA OKs Samsung Bioepis’s Biosimilar Version Of J&J’s Remicade,0.0,1.0,0.0,0
2017-04-22 05:24:00,0.0,"Hospira Recalls One Lot Of 25% Dextrose Injection, USP (Infant)",0.0,1.0,0.0,0
2017-04-23 10:42:00,0.0,"If You&apos;re in Your 50s, Consider Buying These 3 Stocks",0.0,1.0,0.0,0
2017-04-23 12:02:48,0.0,"If You're in Your 50s, Consider Buying These 3 Stocks",0.0,1.0,0.0,0
2017-04-24 05:40:00,0.5574,Pfizer Announces Positive Results Of REPROVE Study,0.0,0.625,0.375,1
2017-04-24 07:21:00,0.0,Street To Open In Greener Zone,0.0,1.0,0.0,0
2017-04-24 09:30:00,0.0,"Pivotal Phase III Study Underscores Efficacy Of Zavicefta™ (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals",0.0,1.0,0.0,0
2017-04-24 11:58:00,-0.4767,Hiding Data And Other Criticisms Of Big Pharma,0.406,0.594,0.0,-1
2017-04-24 14:06:02,-0.7351,Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?,0.437,0.563,0.0,-1
2017-04-24 17:10:00,0.34,Trump Executive Order Could Revive Allergan-Pfizer Merger,0.0,0.714,0.286,1
2017-04-24 20:14:13,0.2263,"How Lilly&apos;s New Drug Could Spark A Deeper Rivalry With Pfizer, Novartis",0.0,0.84,0.16,1
2017-04-24 21:02:44,0.3182,CEO Gassner Makes Sure Veeva Has A 'Second Act'  — And More,0.0,0.796,0.204,1
2017-04-24 21:03:03,0.4576,"After Hours Most Active for Apr 24, 2017 :  INTC, F, SBGL, HPE, CMCSA, NKE, GE, PFE, YHOO, AAOI, QCOM, SBUX",0.0,0.864,0.136,1
2017-04-25 12:00:00,0.0,Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease,0.0,1.0,0.0,0
2017-04-25 12:04:00,0.4404,3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb,0.0,0.734,0.266,1
2017-04-25 12:04:21,0.4576,America's 12 Most Charitable Companies,0.0,0.572,0.428,1
2017-04-25 13:04:42,0.4939,"Health Care Sector Update for 04/25/2017: BIIB, ESRX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2017-04-25 17:00:00,-0.296,Chill Pill: Eli Lilly Cuts Guidance with Earnings,0.239,0.761,0.0,-1
2017-04-25 19:43:00,0.0,Tesaro Inc Bulls Need a Reality Check,0.0,1.0,0.0,0
2017-04-26 15:09:03,0.2732,Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?,0.0,0.792,0.208,1
2017-04-26 16:03:28,0.0,"John G Ullman & Associates Inc Buys Exxon Mobil, Flowserve, Abbott Laboratories, Sells St ...",0.0,1.0,0.0,0
2017-04-26 16:05:02,0.0,"XLV, SVXY: Big ETF Outflows",0.0,1.0,0.0,0
2017-04-26 20:46:57,0.0,Roche Should Remain Resilient And Grow Moderately In Q1,0.0,1.0,0.0,0
2017-04-26 20:56:11,0.4576,"After Hours Most Active for Apr 26, 2017 :  BAC, QQQ, NRG, MPW, GE, PFE, GM, MCHI, GILD, SIRI, MU, MSFT",0.0,0.864,0.136,1
2017-04-27 11:04:01,0.1779,AstraZeneca aims to escape drug sales trough in second half,0.0,0.841,0.159,1
2017-04-27 12:00:00,-0.5719,"Pfizer’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough Therapy Designation from FDA for ALK-Positive Metastatic Non-Small Cell Lung Cancer",0.251,0.661,0.088,-1
2017-04-27 12:27:56,0.3182,Will Apple Increase Its Dividend Next Week?,0.0,0.723,0.277,1
2017-04-27 13:08:40,0.4019,InSphero Announces Agreement with Pfizer to Develop Novel Assays for Predicting Drug-induced Liver Injury,0.145,0.57,0.285,1
2017-04-27 13:25:39,0.0,"Hamlin Capital Management, LLC Buys Exxon Mobil, American Eagle Outfitters, First American ...",0.0,1.0,0.0,0
2017-04-27 16:30:00,0.0,Pfizer Hosts Annual Meeting of Shareholders,0.0,1.0,0.0,0
2017-04-27 17:31:57,0.0,"Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View",0.0,1.0,0.0,0
2017-04-27 18:48:00,0.0,Rutgers All-Stars Round 2 pick: PFE,0.0,1.0,0.0,0
2017-04-28 13:29:47,0.3818,These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016,0.0,0.833,0.167,1
2017-04-28 14:30:46,0.0,Should You Buy Pfizer (PFE) Ahead of Earnings?,0.0,1.0,0.0,0
2017-04-28 14:31:13,0.0,"Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More",0.0,1.0,0.0,0
2017-04-28 15:31:50,0.6249,"Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong",0.0,0.579,0.421,1
2017-04-28 19:25:43,0.0,"Capital Insight Partners, Llc Buys Medtronic PLC, PepsiCo, Mitsubishi UFJ Financial Group, ...",0.0,1.0,0.0,0
2017-04-29 19:26:23,0.0,Amgen: The Bear Case From a Bull,0.0,1.0,0.0,0
2017-04-29 19:31:00,0.6369,The 3 Best Pharmaceutical Stocks to Buy in 2017,0.0,0.625,0.375,1
2017-04-30 11:08:57,0.4588,"[$$] French back at polls, US pharma results, Fed sets interest rates",0.0,0.786,0.214,1
2017-04-30 11:41:00,0.0,3 Key Things to Watch in Pfizer&apos;s Q1 Results,0.0,1.0,0.0,0
2017-04-30 13:25:50,0.0,"Facebook, Tesla and More Major Earnings Coming Out This Week",0.0,1.0,0.0,0
2017-04-30 13:27:00,0.0,3 Key Things to Watch in Pfizer's Q1 Results,0.0,1.0,0.0,0
2017-05-01 04:10:09,-0.2732,Drug Makers Take Page From Hollywood to Spread the Risk,0.189,0.811,0.0,-1
2017-05-01 12:42:00,0.0,3 Big Drugmakers That Could Make Billions Under Trump&apos;s Tax Plan,0.0,1.0,0.0,0
2017-05-01 13:36:00,0.4215,"'Dogs Of The Dow' Chevron, Verizon And Exxon Need To Be Rescued By Investors",0.0,0.823,0.177,1
2017-05-01 14:30:55,0.0,3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan,0.0,1.0,0.0,0
2017-05-01 14:56:05,0.0,"Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week",0.0,1.0,0.0,0
2017-05-01 15:30:41,0.0,What to Expect From Apple and More Dow Stocks Reporting on Tuesday,0.0,1.0,0.0,0
2017-05-01 15:31:37,0.0,"Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD",0.0,1.0,0.0,0
2017-05-01 17:21:19,0.0,Pfizer’s 1Q17 Earnings: Analysts’ Estimates,0.0,1.0,0.0,0
2017-05-01 19:05:49,0.0,Why Pfizer’s 1Q17 Revenue Is Expected to Rise,0.0,1.0,0.0,0
2017-05-01 20:35:44,0.0,Analysts’ Ratings and Recommendations for Pfizer,0.0,1.0,0.0,0
2017-05-01 23:28:23,0.0,What To Expect From Merck's Q1 Earnings,0.0,1.0,0.0,0
2017-05-02 02:28:31,0.0,"Earnings Calendar, Analyst Estimates And Stocks To Watch",0.0,1.0,0.0,0
2017-05-02 04:47:12,0.0,Stock Futures: These 10 Big-Cap Earnings Are On Tap Tuesday,0.0,1.0,0.0,0
2017-05-02 06:51:00,0.0,Pfizer Inc. Q1 Income Advances 0%,0.0,1.0,0.0,0
2017-05-02 07:15:00,0.4404,"Pfizer Q1 Profit Beats Estimates, Revenues Up 1% Excl. HIS; Reaffirms Guidance",0.0,0.791,0.209,1
2017-05-02 07:36:00,0.0,Street Aims For Mixed Opening Ahead Of FOMC Meeting,0.0,1.0,0.0,0
2017-05-02 09:00:00,0.0,Pfizer Q1 17 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2017-05-02 10:45:00,0.0,PFIZER REPORTS FIRST-QUARTER 2017 RESULTS,0.0,1.0,0.0,0
2017-05-02 10:46:17,0.0,"Earnings Reaction History: Pfizer Inc, 41.7% Follow-Through Indicator, 1.3% Sensitive",0.0,1.0,0.0,0
2017-05-02 10:55:05,0.4404,Pfizer's quarterly profit rises 2.7 pct,0.0,0.633,0.367,1
2017-05-02 11:01:15,0.3182,"Pfizer reports Q1 profit beat, revenue miss",0.168,0.526,0.305,1
2017-05-02 11:06:06,0.4404,Pfizer beats 1Q profit forecasts,0.0,0.58,0.42,1
2017-05-02 11:11:30,0.0,Pfizer's Lackluster Sales May Fuel Speculation for Deals,0.0,1.0,0.0,0
2017-05-02 11:14:00,-0.0516,Pfizer Tops Earnings Estimates but Revenue Misses as Prevnar 13 Sales Slide,0.162,0.69,0.148,0
2017-05-02 12:25:12,0.34,"Pfizer (PFE) Tops Q1 Earnings Estimates, Misses Sales",0.17,0.536,0.295,1
2017-05-02 12:50:35,0.0,Pfizer Sinks on Mixed Q1 Earnings,0.0,1.0,0.0,0
2017-05-02 13:18:50,0.0,"Stocks to Watch: Aetna, Pfizer, Apple",0.0,1.0,0.0,0
2017-05-02 14:03:29,0.0,US STOCKS-Wall St flat as Fed meet kicks off; Nasdaq hits record,0.0,1.0,0.0,0
2017-05-02 14:20:02,0.0,On Pfizer and Apple: 2 Titanic Stocks Reporting Earnings Today,0.0,1.0,0.0,0
2017-05-02 14:48:00,0.0,Pfizer Sill Desperately Seeking Revenue Growth,0.283,0.435,0.283,0
2017-05-02 15:32:08,-0.1531,"Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact",0.197,0.656,0.148,-1
2017-05-02 15:32:32,0.0,"Zacks Investment Ideas feature highlights: Tesla, Pfizer, Apple and Facebook",0.0,1.0,0.0,0
2017-05-02 15:36:15,0.4404,Mid-Morning Market Update: Markets Mostly Flat; Pfizer Profit Beats Views,0.0,0.756,0.244,1
2017-05-02 15:37:42,-0.4019,[$$] Pfizer Revenue Falls as Drugs Lose Exclusivity,0.278,0.722,0.0,-1
2017-05-02 15:58:16,0.5267,Dow Higher On Intel Gain; Apple Q2 Earnings After The Close,0.0,0.746,0.254,1
2017-05-02 15:59:00,0.0,Pfizer: We Could Be Here a While,0.0,1.0,0.0,0
2017-05-02 16:00:00,-0.4404,"Patent Losses, Prevnar Weakness Weigh on Pfizer Growth",0.42,0.382,0.198,-1
2017-05-02 16:02:19,0.0,Slowing auto sales weigh on US stocks as indexes wobble,0.0,1.0,0.0,0
2017-05-02 16:37:00,0.0,Four CNBC IQ 100 components are down big today,0.0,1.0,0.0,0
2017-05-02 16:58:09,0.3818,Prescription for growth at Pfizer? Analysts say deals,0.0,0.729,0.271,1
2017-05-02 17:06:56,0.2382,"Pfizer beats 1Q profit forecasts, but sales slip",0.0,0.782,0.218,1
2017-05-02 17:26:10,0.0,Pfizer Enters Oversold Territory,0.0,1.0,0.0,0
2017-05-02 17:27:29,0.4019,Trump's 'tax holiday' could be a windfall for these stocks,0.0,0.748,0.252,1
2017-05-02 17:29:14,0.0,Pfizer and Apple In Focus,0.0,1.0,0.0,0
2017-05-02 17:46:22,0.34,"Midday Update: Stocks Hold Slim Gains as Wait Begins for FOMC, Apple Results",0.0,0.833,0.167,1
2017-05-02 18:27:25,0.0,"Merck (MRK) Beats on Q1 Earnings & Sales, Ups Annual View",0.0,1.0,0.0,0
2017-05-02 18:27:44,0.0,Buy Pfizer Inc. (PFE) Stock While Its Dividend Is on Sale,0.0,1.0,0.0,0
2017-05-02 20:06:24,-0.5719,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher,0.291,0.709,0.0,-1
2017-05-02 20:27:58,0.5106,"Dow&apos;s Pfizer Tops Earnings Views, But Sales Come Up Short",0.0,0.732,0.268,1
2017-05-02 22:29:07,0.0,"3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip",0.0,1.0,0.0,0
2017-05-03 07:07:11,-0.296,Asian stocks lower ahead of US Federal Reserve meeting,0.216,0.784,0.0,-1
2017-05-03 11:30:00,0.5423,Investors Rest Easy After Pfizer and Merck Release Solid Q1 Earnings Reports,0.0,0.69,0.31,1
2017-05-03 12:25:43,-0.0516,5 Best Stocks for Investing in Cancer Treatments,0.324,0.368,0.309,0
2017-05-03 12:58:29,0.0,Dow Jones Industrial Average And Dow Stocks: News And Analysis,0.0,1.0,0.0,0
2017-05-03 13:00:00,0.6908,Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritis,0.0,0.801,0.199,1
2017-05-03 13:30:00,0.0,"Drug Stock Q1 Earnings Releases on May 4: ZTS, REGN & More",0.0,1.0,0.0,0
2017-05-03 14:33:00,0.0,Bristol-Myers: Going Stag to the Ball?,0.0,1.0,0.0,0
2017-05-03 18:02:28,-0.34,Pfizer Must Learn to Live With Uncertainty,0.286,0.714,0.0,-1
2017-05-03 19:44:05,0.6249,"Advisors Asset Management, Inc. Buys Alpine Total Dynamic Dividend Fund, Colony NorthStar Inc, ...",0.0,0.702,0.298,1
2017-05-03 19:51:59,-0.3182,"Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat",0.223,0.777,0.0,-1
2017-05-03 20:31:58,-0.296,"Bristol-Myers &apos;Too Risky&apos; To Acquire As Merck, Roche Pile On Pressure",0.18,0.82,0.0,-1
2017-05-03 20:50:49,-0.3182,"Aerie (AERI) Posts Wider-Than-Expected Q1 Loss, Expenses Up",0.247,0.753,0.0,-1
2017-05-03 21:25:00,0.0,Phase 3 OCTAVE Studies of Oral Tofacitinib in Ulcerative Colitis Results Published in The New England Journal of Medicine,0.0,1.0,0.0,0
2017-05-04 03:43:00,0.0,"BPMX Craters, KPTI Surges On Deal With Anivive, PFE Seeks New Use For Old Drug",0.0,1.0,0.0,0
2017-05-04 20:59:34,0.4576,"After Hours Most Active for May 4, 2017 :  BAC, JNPR, PFE, GM, FCX, CF, SBUX, CMCSA, YHOO, QCOM, STX, AMAG",0.0,0.864,0.136,1
2017-05-05 18:17:07,0.0,Analyzing Pfizer’s 1Q17 Earnings,0.0,1.0,0.0,0
2017-05-05 19:34:56,0.5267,U.S. chief justice taps New York judge to handle Puerto Rico bankruptcy,0.0,0.764,0.236,1
2017-05-05 19:56:00,0.4019,Deals of the Week: Waiting for Clarity,0.0,0.69,0.31,1
2017-05-05 20:05:43,0.0,Pfizer’s 1Q17 Earnings: A Look at Revenues by Segment,0.0,1.0,0.0,0
2017-05-05 22:25:18,0.4404,Merck vs. Pfizer: Which Stock Looks Better Post-Earnings?,0.0,0.707,0.293,1
2017-05-05 23:24:50,-0.2263,"Dow 30 Stock Roundup: Apple, Merck Beat; Pfizer Misses on Revenues",0.16,0.84,0.0,-1
2017-05-08 11:37:17,0.3818,Pfizer: Understanding Growth Drivers in 1Q17,0.0,0.658,0.342,1
2017-05-08 13:06:28,0.0,Pfizer: Why Revenues Fell in 1Q17 for Some Products,0.0,1.0,0.0,0
2017-05-08 13:34:00,0.0,J&J: What's In Store At Next Week's Analyst Meeting,0.0,1.0,0.0,0
2017-05-08 14:00:00,-0.2263,"Collaboration Helps Broaden Access to Pfizer’s Contraceptive, Sayana® Press (medroxyprogesterone acetate), for Women in Some of the World’s Poorest Countries",0.145,0.747,0.108,-1
2017-05-08 14:36:15,0.0,Pfizer’s Key Product Developments in 1Q17,0.0,1.0,0.0,0
2017-05-08 14:48:44,-0.2263,"Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit",0.147,0.853,0.0,-1
2017-05-08 15:02:35,0.2732,"Ex-Dividend Reminder: WEC Energy Group, Pfizer and Union Bankshares",0.0,0.792,0.208,1
2017-05-08 18:03:29,0.4019,Interesting June Stock Options for PFE,0.0,0.649,0.351,1
2017-05-08 19:21:00,-0.3182,"Allergan Must Show Mergers, Drug Pipeline Can Make Up For Lost Sales",0.173,0.827,0.0,-1
2017-05-08 20:00:00,0.0,M&A Talks May Take Center Stage in Allergan's 1Q Earnings Call,0.0,1.0,0.0,0
2017-05-08 21:00:43,0.4576,"After Hours Most Active for May 8, 2017 :  XRX, PFE, YHOO, SRC, DDR, KO, JNPR, AAPL, MSFT, MNST, ADI, CSX",0.0,0.864,0.136,1
2017-05-09 11:35:57,0.0,Pfizer’s Corporate and Pipeline Developments in 1Q17,0.0,1.0,0.0,0
2017-05-09 13:06:19,0.0,Comparing Pfizer’s Valuation to Peers after 1Q17 Earnings,0.0,1.0,0.0,0
2017-05-09 16:01:22,0.296,"IVW, PFE, PG, ACN: ETF Outflow Alert",0.0,0.732,0.268,1
2017-05-09 16:47:19,0.34,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,0.256,0.349,0.395,1
2017-05-09 17:00:23,0.0516,"Buy 'repatriation stocks' because that is sure to make the cut in the final tax bill, UBS says",0.103,0.784,0.113,0
2017-05-09 17:00:23,0.0516,"Buy &apos;repatriation stocks&apos; because that is sure to make the cut in the final tax bill, UBS says",0.103,0.784,0.113,0
2017-05-09 19:53:00,0.1531,FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer,0.227,0.412,0.361,1
2017-05-09 21:03:00,0.1531,FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer,0.227,0.412,0.361,1
2017-05-09 21:12:00,0.1531,Pfizer : FDA Grants BAVENCIO Approval For Common Type Of Advanced Bladder Cancer,0.227,0.412,0.361,1
2017-05-10 01:31:06,0.0,Edited Transcript of PFE earnings conference call or presentation 2-May-17 2:00pm GMT,0.0,1.0,0.0,0
2017-05-10 08:56:16,-0.765,"Roche's star cancer drug stumbles in study, raising doubts about future",0.423,0.577,0.0,-1
2017-05-10 13:00:50,0.6633,Why Teva Pharmaceutical Industries is a Top 10 SAFE International Dividend Stock (TEVA),0.0,0.648,0.352,1
2017-05-10 13:30:02,0.3818,[$$] Going public benefits workers and investors,0.0,0.698,0.302,1
2017-05-10 17:01:42,0.0,"Pfizer Inc. : PFE-US: Dividend Analysis : May 12th, 2017 (record date) : By the numbers : May 10, 2017",0.0,1.0,0.0,0
2017-05-10 19:28:00,0.0,"Allergan Starts 'Pivotal' 2017 With a Beat, Plus Jim Cramer's Take",0.0,1.0,0.0,0
2017-05-10 20:01:00,0.0,Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2017-05-10 20:03:19,-0.0516,"Model N (MODN) Q2 Loss Narrower than Expected, Guides Well",0.202,0.614,0.184,0
2017-05-10 21:00:54,0.4576,"After Hours Most Active for May 10, 2017 :  SNAP, PFE, MT, ETP, EPD, RF, INTC, QQQ, NVDA, RCII, VIAV, AMAG",0.0,0.864,0.136,1
2017-05-10 21:18:02,0.296,"Sangamo shares jump on Pfizer collaboration, quarterly results",0.0,0.761,0.239,1
2017-05-10 23:43:31,-0.8271,"Why Roche&apos;s Cancer Failure Might Tank Bristol, Pfizer — But Not Merck",0.461,0.539,0.0,-1
2017-05-11 02:03:00,0.0,"FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes",0.0,1.0,0.0,0
2017-05-11 14:30:38,0.0,Why Sangamo Therapeutics Is Surging,0.0,1.0,0.0,0
2017-05-11 17:20:47,0.0,Midday Update: Retail Earnings Weigh Down Wall Street,0.0,1.0,0.0,0
2017-05-11 18:01:11,0.4939,"Health Care Sector Update for 05/11/2017: MNKD,SGMO,PFE,ITUS",0.0,0.652,0.348,1
2017-05-11 19:03:12,0.0,Here's Why Sangamo Therapeutics Rocketed Up to 56.3% Higher Today,0.0,1.0,0.0,0
2017-05-11 20:20:41,0.4939,"Health Care Sector Update for 05/11/2017: CNAT,SGMO,PFE,ITUS",0.0,0.652,0.348,1
2017-05-11 21:00:54,0.4576,"After Hours Most Active for May 11, 2017 :  PFE, SNAP, BAC, JWN, CSCO, ETE, ETP, MSFT, MU, AAPL, ODP, FB",0.0,0.864,0.136,1
2017-05-12 12:06:32,0.0,The 7 Biggest Mergers of All Time (Exxon Didn't Even Make the List),0.0,1.0,0.0,0
2017-05-12 14:29:42,-0.2263,"Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study",0.137,0.863,0.0,-1
2017-05-12 17:24:44,0.0,"Boston Financial Mangement Inc  Buys Luxottica Group SpA, Air Products & Chemicals Inc, ...",0.0,1.0,0.0,0
2017-05-12 17:43:59,0.0,These guys put the 'activist' in activist investing,0.0,1.0,0.0,0
2017-05-12 17:43:59,0.0,These guys put the &apos;activist&apos; in activist investing,0.0,1.0,0.0,0
2017-05-12 20:20:00,0.0,Why Sangamo Therapeutics Inc. Jumped Higher Today,0.0,1.0,0.0,0
2017-05-12 20:25:18,0.0,What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?,0.0,1.0,0.0,0
2017-05-12 21:00:00,0.0,Johnson & Johnson Analyst Day,0.0,1.0,0.0,0
2017-05-12 21:19:38,0.0,Tepper's Appaloosa Trims Bets on Pharmaceuticals,0.0,1.0,0.0,0
2017-05-12 22:01:53,-0.5423,What happens to corporate crime cases with the FBI in flux?,0.259,0.741,0.0,-1
2017-05-13 09:14:28,0.3612,"Investec Asset Management (PTY) Ltd Buys Microsoft Corp, Alphabet Inc, Bank of Nova Scotia, ...",0.0,0.848,0.152,1
2017-05-14 15:01:00,0.6369,Here&apos;s Why the Best Is Yet to Come for Pfizer Inc.,0.0,0.704,0.296,1
2017-05-14 16:14:58,0.6369,Here's Why the Best Is Yet to Come for Pfizer Inc.,0.0,0.704,0.296,1
2017-05-15 13:17:54,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for May 16, 2017",0.0,1.0,0.0,0
2017-05-15 20:17:24,0.0,7 Dogs of the Dow to Trade Now for Income,0.0,1.0,0.0,0
2017-05-15 21:04:44,0.4576,"After Hours Most Active for May 15, 2017 :  NE, ZNGA, MU, SNAP, PFE, VVV, MGM, DDR, MSFT, YHOO, AGNC, QQQ",0.0,0.864,0.136,1
2017-05-16 07:40:00,0.0,Sangamo Gets Fast Track Designation For SB-525 Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2017-05-16 11:30:00,0.0,Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2017-05-16 12:13:47,0.0,"Early movers: HD, PFE, BABA, DKS, YHOO, F, VOD, FB, JNJ & more",0.0,1.0,0.0,0
2017-05-16 13:48:02,0.34,"US STOCKS-S&P, Nasdaq hit record highs on gains in tech, consumer staples",0.0,0.821,0.179,1
2017-05-16 13:57:00,-0.3182,Pfizer Posting Notable Loss After Downgrade By Citi,0.247,0.753,0.0,-1
2017-05-16 14:47:00,0.0,Jim Cramer -- Citi's Downgrade of Pfizer Not Totally Reasonable,0.0,1.0,0.0,0
2017-05-16 15:15:54,0.0,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,0.0,1.0,0.0,0
2017-05-16 15:39:41,0.0,"US STOCKS-Wall St retreats after S&P, Nasdaq hit record highs",0.0,1.0,0.0,0
2017-05-16 16:17:00,0.0,Eli Lilly: Has This Bloom Begun To Wilt?,0.0,1.0,0.0,0
2017-05-16 16:19:54,0.0,"Dow Movers: NKE, HD",0.0,1.0,0.0,0
2017-05-16 16:34:00,0.0,"Jim Cramer Talks Home Depot, TJX Companies, Ford, Apple, Pfizer, Nike, Target and Alibaba",0.0,1.0,0.0,0
2017-05-16 17:07:00,0.0,Pfizer: Is It Time To Sell?,0.0,1.0,0.0,0
2017-05-16 17:15:38,0.0,"US STOCKS-Wall St flat after S&P, Nasdaq hit record highs",0.0,1.0,0.0,0
2017-05-16 19:05:51,0.0,"US STOCKS-S&P 500 falls on mixed data, Nasdaq helped by tech stocks",0.0,1.0,0.0,0
2017-05-16 20:04:51,-0.2732,"Yum Brands, Intuitive Surgical Called Buys; Pfizer Cut To Sell",0.189,0.811,0.0,-1
2017-05-16 20:13:19,-0.2023,"Dow&apos;s Pfizer, Eli Lilly Topple To 3-Month Lows On Downgrades",0.167,0.833,0.0,-1
2017-05-16 20:35:43,0.3182,"US STOCKS-S&P 500, Dow end session flat, tech boosts Nasdaq",0.0,0.796,0.204,1
2017-05-16 20:37:01,0.128,[$$] US retail real estate extends its bruising slide,0.0,0.842,0.158,1
2017-05-16 21:04:50,0.4576,"After Hours Most Active for May 16, 2017 :  CMCSA, PSXP, BAC, PFE, KEY, KATE, KIM",0.0,0.824,0.176,1
2017-05-17 00:15:40,0.0,Aerie's (AERI) Rhopressa NDA Sufficient for FDA Review,0.0,1.0,0.0,0
2017-05-17 11:53:11,0.4019,"Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal",0.0,0.828,0.172,1
2017-05-17 12:00:00,0.0,Today's Research Reports on Stocks to Watch: BlackBerry and Pfizer,0.0,1.0,0.0,0
2017-05-17 13:42:00,0.5719,3 Dividend Stocks Perfect for Senior Citizens,0.0,0.575,0.425,1
2017-05-17 14:13:48,0.0,The Implied Analyst 12-Month Target For PPH,0.0,1.0,0.0,0
2017-05-17 15:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of June 9 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations,0.0,1.0,0.0,0
2017-05-17 16:13:39,0.296,"IVW, PFE, PG, MMM: ETF Inflow Alert",0.0,0.732,0.268,1
2017-05-17 16:17:51,0.4404,5 Reasons Why Merck (MRK) is a Good Stock to Buy Now,0.0,0.756,0.244,1
2017-05-17 16:39:00,-0.6597,Eli Lilly: Worries Ahead In Patent Fight,0.519,0.481,0.0,-1
2017-05-17 17:11:24,0.0,Nasdaq Reports Another New High,0.0,1.0,0.0,0
2017-05-17 17:25:05,0.0,"Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports",0.0,1.0,0.0,0
2017-05-17 20:13:27,0.7096,Vanguard Health Care ETF (VHT): A Healthy Long-Term Investment,0.0,0.504,0.496,1
2017-05-17 21:00:00,-0.4767,Pfizer drug from Medivation deal shows promise in breast cancer -study,0.28,0.573,0.146,-1
2017-05-17 21:01:12,0.4576,"After Hours Most Active for May 17, 2017 :  CSCO, ODP, PFE, QQQ, PTEN, CMCSA, MSFT, BAC, RF, UAL, DOW, GE",0.0,0.864,0.136,1
2017-05-18 00:00:00,0.0,Astellas Announces Oncology Portfolio Updates,0.0,1.0,0.0,0
2017-05-18 00:00:00,-0.6597,Pfizer Oncology to Present Data Across 13 Different Types of Cancer at ASCO 2017 Annual Meeting,0.227,0.773,0.0,-1
2017-05-18 00:11:46,0.0,Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status,0.0,1.0,0.0,0
2017-05-18 11:30:16,-0.2732,[$$] Some Biotech Companies Making the Cut in Narrower IPO Market,0.174,0.826,0.0,-1
2017-05-18 11:37:00,-0.836,A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks,0.497,0.503,0.0,-1
2017-05-18 13:00:00,0.2732,The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis,0.0,0.905,0.095,1
2017-05-18 13:30:01,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Home Depot, ConocoPhillips, Prudential Financial and Canadian Pacific",0.0,1.0,0.0,0
2017-05-18 13:36:41,0.0,"Pfizer Inc. :PFE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017",0.0,1.0,0.0,0
2017-05-18 16:14:17,0.4767,J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021,0.0,0.78,0.22,1
2017-05-18 19:44:45,-0.6597,Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments,0.386,0.614,0.0,-1
2017-05-18 23:12:21,0.3818,Endocyte (ECYT) Focused on Two Lead Pipeline Candidates,0.0,0.729,0.271,1
2017-05-19 02:28:00,0.0,Company Spotlight: GlycoMimetics,0.0,1.0,0.0,0
2017-05-19 12:05:40,0.2023,7 Top Dividend Stocks to Buy for Every Kind of Investor,0.0,0.833,0.167,1
2017-05-19 12:38:44,-0.6808,CHMP backs Novartis's Zykadia for first-line use in lung cancer,0.412,0.588,0.0,-1
2017-05-19 15:17:31,0.3182,"Merck KGaA (MKGAF) Q1 Earnings Fall Y/Y, Revenues Increase",0.0,0.777,0.223,1
2017-05-19 16:12:00,0.1531,Billionaire George Soros Is Warming Up to This Big Pharma Stock. Should You?,0.0,0.882,0.118,1
2017-05-19 16:13:23,0.0,Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications,0.0,1.0,0.0,0
2017-05-19 18:05:38,0.0,"ETFs with exposure to Pfizer Inc. : May 19, 2017",0.0,1.0,0.0,0
2017-05-19 21:01:35,0.4576,"After Hours Most Active for May 19, 2017 :  SNAP, PFE, QCOM, CNP, LNT, T, MSFT, QQQ, EGO, CMCSA, HMHC, CBOE",0.0,0.864,0.136,1
2017-05-19 21:47:04,0.0,[$$] Iterum Therapeutics Lines Up Funding Ahead of Trials,0.0,1.0,0.0,0
2017-05-19 23:11:17,0.5574,Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug,0.0,0.753,0.247,1
2017-05-20 11:22:00,0.34,3 Stocks to Supplement Your Social Security Income,0.0,0.714,0.286,1
2017-05-21 11:41:00,0.0,3 Ways Johnson & Johnson&apos;s Pharmaceutical Business Plans to Beat the Market,0.0,1.0,0.0,0
2017-05-21 13:12:32,0.0,3 Ways Johnson & Johnson's Pharmaceutical Business Plans to Beat the Market,0.0,1.0,0.0,0
2017-05-21 20:11:37,0.4939,Health Care SPDR (ETF) (XLV): The Quick Guide to XLV,0.0,0.738,0.262,1
2017-05-22 12:42:00,0.6369,The 3 Best Dividend Stocks in Arthritis Medication,0.0,0.588,0.412,1
2017-05-22 14:15:21,0.0,"These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?",0.0,1.0,0.0,0
2017-05-22 20:48:26,0.2263,"NASDAQ Composite Index closes up 28.57 points for the week, rising for the 3rd straight day",0.0,0.888,0.112,1
2017-05-22 21:01:49,0.4576,"After Hours Most Active for May 22, 2017 :  PFE, HPE, QCOM, MSFT, CVS, INTC, BAC, ORCL, FOXA, ETE, CSCO, AAPL",0.0,0.864,0.136,1
2017-05-22 21:12:38,0.0,"3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)",0.0,1.0,0.0,0
2017-05-23 10:05:00,0.0,Merck & Co Faces Financial Hit From U.K. Regulator Over Drug Pricing,0.0,1.0,0.0,0
2017-05-23 12:59:04,-0.6597,The Current State Of The Breast Cancer Treatment Space,0.355,0.645,0.0,-1
2017-05-23 16:11:43,0.0,"NWQ Managers Sells Pfizer, Viacom, Edison",0.0,1.0,0.0,0
2017-05-23 16:16:29,0.4767,Sanofi/Regeneron's Kevzara Gets FDA Approval for Arthritis,0.0,0.659,0.341,1
2017-05-23 17:14:38,0.3412,"What's Your Flavor? Don't Worry, There's An ETF For That",0.0,0.789,0.211,1
2017-05-23 21:13:49,0.0258,Can These 3 High-Flying Healthcare Stocks Reach the Clouds?,0.0,0.864,0.136,0
2017-05-23 21:47:00,-0.5267,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE...",0.274,0.726,0.0,-1
2017-05-24 07:19:00,-0.2023,Pfizer Recommends Stockholders To Reject TRC Capital's Mini-tender Offer,0.233,0.603,0.164,-1
2017-05-24 10:45:00,-0.2023,Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation,0.185,0.685,0.13,-1
2017-05-24 13:12:57,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2017",0.0,1.0,0.0,0
2017-05-24 14:36:50,0.0,Performance of Merck’s Diabetes Portfolio in 1Q17,0.0,1.0,0.0,0
2017-05-24 16:33:31,0.0,"XLV, ULE: Big ETF Outflows",0.0,1.0,0.0,0
2017-05-24 20:32:20,0.0,PFE Crosses Above 4% Yield Territory,0.0,1.0,0.0,0
2017-05-24 20:59:58,0.8189,"After Hours Most Active for May 24, 2017 :  INTC, PFE, WY, F, WIN, MRO, OAS, JCP, MSFT, IMGN, BRCD, EBAY",0.0,0.705,0.295,1
2017-05-25 11:35:53,0.0,Merck’s Immunology and Cardiovascular Franchise in 1Q17,0.0,1.0,0.0,0
2017-05-25 12:10:37,0.4767,Drug approvals bounce back as R&D labs churn out new winners,0.0,0.763,0.237,1
2017-05-25 16:32:39,0.3818,iShares S&P 500 Growth ETF Experiences Big Inflow,0.0,0.729,0.271,1
2017-05-25 17:16:00,0.6124,FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications,0.0,0.706,0.294,1
2017-05-25 18:01:28,-0.3875,TrumpCare isn't moving health care stocks because it won't pass: NYSE trader,0.193,0.807,0.0,-1
2017-05-25 18:13:06,0.5574,Aerie&apos;s Ophthalmic Candidate Positive in Registration Trial,0.0,0.625,0.375,1
2017-05-25 20:32:30,0.5574,Aerie's Ophthalmic Candidate Positive in Registration Trial,0.0,0.625,0.375,1
2017-05-25 21:49:00,0.6124,FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications,0.0,0.643,0.357,1
2017-05-25 23:32:32,0.2023,The Top 10 S&P 500 Dividend Stocks to Buy Now,0.0,0.833,0.167,1
2017-05-26 11:37:49,0.0,Changes in Sanofi’s Valuation after Its 1Q17 Earnings,0.0,1.0,0.0,0
2017-05-26 12:08:12,0.0,"Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data",0.0,1.0,0.0,0
2017-05-26 12:15:00,0.3818,Blog Coverage: Pfizer Cautions Shareholders Against Accepting TRC Capital Corporation's Mini-Tender Offer,0.0,0.809,0.191,1
2017-05-26 13:36:01,0.5574,Pfizer&apos;s Epogen Biosimilar Gets Positive FDA Committee Vote,0.0,0.66,0.34,1
2017-05-26 15:36:29,0.5574,Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote,0.0,0.66,0.34,1
2017-05-26 15:36:41,0.4404,Celldex's Immuno-Oncology Pipeline Continues to Impress,0.0,0.633,0.367,1
2017-05-26 20:20:20,0.0,"Are Regeneron, Sanofi Treading On Pfizer In Eczema?",0.0,1.0,0.0,0
2017-05-26 20:23:23,0.3818,Genvoya Could Drive Gilead Sciences’ Revenue Growth in 2017,0.0,0.755,0.245,1
2017-05-26 20:31:52,0.2023,3 Top Dividend Stocks in Generic Drugs,0.0,0.735,0.265,1
2017-05-27 12:00:55,0.6124,Which Biotechs Benefit Most Under Trump&apos;s Tax Reform Vision?,0.0,0.583,0.417,1
2017-05-27 12:40:04,0.2023,Top Presentations to Look for at ASCO,0.0,0.769,0.231,1
2017-05-28 16:30:54,-0.5574,3 Top Dividend Stocks in Cancer Drugs,0.431,0.392,0.176,-1
2017-05-29 14:33:15,-0.6597,Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year's End,0.216,0.784,0.0,-1
2017-05-30 10:29:00,0.0,Pfizer: EC Oks TRUMENBA For Prevention Of Invasive Meningococcal Disease,0.0,1.0,0.0,0
2017-05-30 11:23:00,0.6369,The 5 Best Dividend Stocks in Cholesterol Drugs,0.0,0.588,0.412,1
2017-05-30 14:00:00,0.6705,European Commission Approves Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults,0.0,0.649,0.351,1
2017-05-30 20:32:26,0.4939,"Health Care Sector Update for 05/30/2017: PFE,PTGX,JNJ,CYCC",0.0,0.652,0.348,1
2017-05-31 12:30:00,0.2263,Pfizer Announces Acceptance of Regulatory Submissions by U.S. FDA and European Medicines Agency for SUTENT® (sunitinib) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma After Surgery,0.06,0.855,0.085,1
2017-05-31 13:22:38,-0.2263,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for June 01, 2017",0.147,0.853,0.0,-1
2017-05-31 15:33:34,0.0,"Dow Movers: GS, PFE",0.0,1.0,0.0,0
2017-05-31 15:48:03,0.4215,Pfizer&apos;s Trumenba Vaccine Approved by European Commission,0.0,0.682,0.318,1
2017-05-31 17:32:51,0.4215,Pfizer's Trumenba Vaccine Approved by European Commission,0.0,0.682,0.318,1
2017-05-31 19:44:00,0.2023,3 Top Dividend Stocks in Diabetes Treatment,0.0,0.735,0.265,1
2017-05-31 20:46:03,0.0,Stocks Close In The Red; Banks Crumble On Slow JPMorgan Trade Revenue,0.0,1.0,0.0,0
2017-05-31 20:49:40,0.0,"Market Close Report: NASDAQ Composite index closes at 6,198.52 down -4.67 points",0.0,1.0,0.0,0
2017-06-01 05:19:00,0.296,European Shares Broadly Higher; Banks Underperform,0.0,0.694,0.306,1
2017-06-01 12:00:00,-0.3818,European Markets Put An End To Their Recent Losing Streak,0.224,0.776,0.0,-1
2017-06-01 15:35:59,0.5106,Icon Plc (ICLR) Stock is Cultivating a Strong Business,0.0,0.68,0.32,1
2017-06-01 16:25:00,0.3612,"AT&T, Pfizer, Taiwan Semi Ready to Rip Higher: Must-See Charts",0.0,0.783,0.217,1
2017-06-01 20:07:28,0.0,"How Clovis, AstraZeneca Could &apos;Muddy&apos; A Potential Deal For Tesaro",0.0,1.0,0.0,0
2017-06-02 02:17:00,0.0,GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts,0.0,1.0,0.0,0
2017-06-02 14:36:32,0.5574,"Pharma Stock Roundup: Positive Data from Lilly & Teva, BMY's Deals & More",0.0,0.735,0.265,1
2017-06-02 15:42:03,-0.34,Pfizer&apos;s Kidney Cancer Drug Gets Acceptance in the U.S. & EU,0.286,0.519,0.195,-1
2017-06-02 16:32:46,0.0,"ITOT, PG, PFE, MMM: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2017-06-02 16:48:31,0.0,[$$] Pfizer raises US prices of 91 drugs by 20% in 2017,0.0,1.0,0.0,0
2017-06-02 17:27:09,0.6249,Portola Pharmaceuticals Could Be a Great June Trade,0.0,0.594,0.406,1
2017-06-02 17:31:52,-0.34,Pfizer's Kidney Cancer Drug Gets Acceptance in the U.S. & EU,0.286,0.519,0.195,-1
2017-06-02 18:38:36,-0.6124,Pfizer defeats appeals linking Zoloft to birth defects,0.455,0.545,0.0,-1
2017-06-02 18:54:22,0.0,Pfizer hikes U.S. prices of 91 drugs by average 20 pct in 2017-FT,0.0,1.0,0.0,0
2017-06-02 22:31:43,0.2263,"Dow 30 Stock Roundup: GE Inks Deals Worth $5.58B in Vietnam, Merck Buys Rights to Alzheimer Antibody",0.0,0.894,0.106,1
2017-06-03 20:30:00,-0.5719,Pfizer Presents Final Phase 2 Data on Investigational PARP Inhibitor Talazoparib in Patients with Germline BRCA-Positive Advanced Breast Cancer,0.251,0.661,0.088,-1
2017-06-05 02:42:00,-0.6486,"AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce",0.346,0.654,0.0,-1
2017-06-05 10:01:17,0.0,Pfizer (PFE) Down 2.5% Since Earnings Report: Can It Rebound?,0.0,1.0,0.0,0
2017-06-05 11:30:00,-0.4215,Pfizer drug delays lung cancer growth longer than Astra's Iressa-study,0.293,0.533,0.173,-1
2017-06-05 11:30:00,-0.6597,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial,0.355,0.645,0.0,-1
2017-06-05 12:47:00,0.6369,Here&apos;s the Best Dividend Stock in Big Pharma,0.0,0.625,0.375,1
2017-06-05 12:52:00,-0.1531,Will Pfizer Be Affected By Trump Administration Tax Reform?,0.167,0.833,0.0,-1
2017-06-05 13:30:01,0.0,"The Zacks Analyst Blog Highlights: General Electric, Walt Disney, Merck, Pfizer and Chevron",0.0,1.0,0.0,0
2017-06-05 14:53:02,0.0,Pfizer Provides Final Update on Phase II Talazoparib Study,0.0,1.0,0.0,0
2017-06-05 15:06:00,0.0,"How To Trade 'Dogs Of The Dow' Chevron, IBM, Verizon And Exxon In Correction Territory",0.0,1.0,0.0,0
2017-06-05 16:04:42,0.4019,Interesting September 2018 Stock Options for PFE,0.0,0.69,0.31,1
2017-06-05 16:40:17,0.4939,"Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, CLSN, MBOT, LOXO",0.0,0.802,0.198,1
2017-06-05 17:04:15,0.0,Here's Why Opko Health Inc. Slipped 18.8% in May,0.0,1.0,0.0,0
2017-06-05 20:01:43,0.4939,"Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, NLNK, RDUS, BPMC",0.0,0.802,0.198,1
2017-06-05 20:51:00,0.2023,Top Stocks Billionaires Are Buying Now,0.0,0.735,0.265,1
2017-06-05 21:14:00,0.357,Tesaro Crashes Despite Beating AstraZeneca With &apos;Stronger&apos; Data,0.0,0.738,0.262,1
2017-06-06 08:08:00,0.0,Pfizer Gets FDA Fast Track Designation For Tafamidis For TTR-CM,0.0,1.0,0.0,0
2017-06-06 12:00:00,0.0,Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy,0.0,1.0,0.0,0
2017-06-06 16:36:13,0.4939,"Health Care Sector Update for 06/06/2017: JNJ, PFE, ABT, MRK, AMGN, CTIC, PTCT, CLDX",0.0,0.802,0.198,1
2017-06-06 18:18:00,-0.8271,Johnson & Johnson's New Prostate Cancer Drug Might Make Pfizer Sick,0.49,0.51,0.0,-1
2017-06-06 20:17:42,0.4939,"Health Care Sector Update for 06/06/2017: JNJ, PFE, ABT, MRK, AMGN, NOVT, SNOA, EGLT",0.0,0.802,0.198,1
2017-06-07 00:16:32,0.0,"Roche Announces Data on Perjeta, Alecensa and Tecentriq",0.0,1.0,0.0,0
2017-06-07 00:18:01,-0.2023,Merck's Cancer Drug Keytruda Positive in Clinical Studies,0.314,0.429,0.257,-1
2017-06-07 07:43:00,0.0,Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA,0.0,1.0,0.0,0
2017-06-07 11:30:00,0.0,Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency,0.0,1.0,0.0,0
2017-06-07 14:16:02,0.0,Pfizer&apos;s (PFE) Tafamidis Gets Fast Track Status in the U.S.,0.0,1.0,0.0,0
2017-06-07 15:28:23,0.0,Pfizer's (PFE) Tafamidis Gets Fast Track Status in the U.S.,0.0,1.0,0.0,0
2017-06-07 16:46:16,0.4939,"Health Care Sector Update for 06/07/2017: JNJ, PFE, ABT, MRK, AMGN, CALA, ALOG, CERS",0.0,0.802,0.198,1
2017-06-07 18:22:31,0.0,What Happened to Pfizer’s Valuation after 1Q17?,0.0,1.0,0.0,0
2017-06-07 20:05:57,0.0,Inside Pfizer’s 1Q17 Revenues,0.0,1.0,0.0,0
2017-06-07 20:06:29,0.4939,"Health Care Sector Update for 06/07/2017: JNJ, PFE, ABT, MRK, AMGN, KMDA, JAZZ, EXAS",0.0,0.802,0.198,1
2017-06-07 20:25:12,-0.1531,"Dow&apos;s Pfizer Faces Challenges As Roche, J&J, Lilly Loom",0.186,0.686,0.127,-1
2017-06-07 21:35:58,0.0,Behind Pfizer’s Business Segments in 1Q17,0.0,1.0,0.0,0
2017-06-08 11:36:38,0.0,Understanding Pfizer’s 1Q17 Performance by Geography,0.0,1.0,0.0,0
2017-06-08 11:46:25,-0.7964,Johnson & Johnson’s new prostate cancer advances could signal trouble for Pfizer,0.441,0.559,0.0,-1
2017-06-08 12:56:13,0.4576,"Pre-Market Most Active for Jun 8, 2017 :  BABA, SMFG, YHOO, GE, MSFT, F, T, PFE, AAPL, CSCO, INTC, CMCSA",0.0,0.857,0.143,1
2017-06-08 13:06:56,0.0,What Drove Pfizer in 1Q17?,0.0,1.0,0.0,0
2017-06-08 14:36:19,-0.0258,Why Pfizer’s Products Lost Market Share in 1Q17,0.219,0.571,0.21,0
2017-06-08 16:31:37,0.5574,AbbVie (ABBV) Announced Positive Phase III RA Candidate Data,0.0,0.69,0.31,1
2017-06-08 16:46:27,0.4939,"Health Care Sector Update for 06/08/2017: JNJ, PFE, ABT, MRK, AMGN, CYTR, TGTX, QGEN",0.0,0.802,0.198,1
2017-06-08 20:56:19,0.4576,"After Hours Most Active for Jun 8, 2017 :  YHOO, GE, CSCO, BAX, FB, F, AAPL, MU, QQQ, HPQ, PFE, SBGL",0.0,0.864,0.136,1
2017-06-08 21:26:50,0.0,Pfizer Becomes Oversold,0.0,1.0,0.0,0
2017-06-09 07:23:00,0.0,Pfizer Investor Conference Call At 11:00 AM ET,0.0,1.0,0.0,0
2017-06-09 09:30:07,0.6808,[$$] U.S. Probe Sheds Light on Charities' Role in Boosting Drug Sales,0.0,0.641,0.359,1
2017-06-09 10:00:00,0.0,Pfizer  Investor Conference Call At 11:00 AM ET,0.0,1.0,0.0,0
2017-06-09 11:28:36,0.0,7 Reasons Why Prescription Drug Prices Are Extremely Expensive,0.0,1.0,0.0,0
2017-06-09 12:00:00,-0.6597,Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer,0.173,0.827,0.0,-1
2017-06-09 12:40:10,0.3291,"Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got",0.2,0.539,0.261,1
2017-06-09 16:46:39,0.4939,"Health Care Sector Update for 06/09/2017: JNJ, PFE, ABT, MRK, AMGN, ENDP, LXRX, MBOT",0.0,0.802,0.198,1
2017-06-09 19:28:09,0.1139,Don't Miss These 3 Breakouts; What's Taking Tech Stocks Down?,0.0,0.847,0.153,1
2017-06-09 19:32:00,-0.5106,Prostate Cancer Drug Sales Drop as Feds Investigate Charities,0.414,0.382,0.204,-1
2017-06-09 20:06:40,0.4939,"Health Care Sector Update for 06/09/2017: JNJ, PFE, ABT, MRK, AMGN, ENZ, BNTC, SNSS",0.0,0.802,0.198,1
2017-06-09 20:48:42,0.2023,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 6,207.92",0.0,0.913,0.087,1
2017-06-09 22:27:31,0.0,Dow Jones Industrial Average Nabs Record Close; Nasdaq Retreats as Tech Stocks Spiral,0.0,1.0,0.0,0
2017-06-10 17:00:00,-0.0772,Merck and Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies,0.08,0.92,0.0,0
2017-06-11 21:22:00,0.5106,"LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite",0.148,0.529,0.323,1
2017-06-12 04:00:42,-0.2732,[$$] Big US pharma dealmaking plunges to five-year low,0.208,0.792,0.0,-1
2017-06-12 04:00:42,-0.6486,[$$] Washington turmoil is proving a bitter pill for Pfizer,0.431,0.569,0.0,-1
2017-06-12 04:50:21,0.34,[$$] U.S. Probe Sheds Light on Charities’ Role in Boosting Drug Sales,0.0,0.821,0.179,1
2017-06-12 08:00:00,0.0,"Trump's Offshore Tax Plan May Mean Extra Perk for Apple, Pfizer",0.0,1.0,0.0,0
2017-06-12 12:43:12,0.0,Merck&apos;s Diabetes Drug Meets Primary Endpoint in Key Studies,0.0,1.0,0.0,0
2017-06-12 13:06:51,0.4939,"Health Care Sector Update for 06/12/2017: JNJ, PFE, ABT, MRK, AMGN,CHRS, NVO, AZN",0.0,0.789,0.211,1
2017-06-12 13:17:46,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 13, 2017",0.0,1.0,0.0,0
2017-06-12 13:23:10,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for June 13, 2017",0.0,1.0,0.0,0
2017-06-12 14:32:22,0.0,Merck's Diabetes Drug Meets Primary Endpoint in Key Studies,0.0,1.0,0.0,0
2017-06-12 16:27:03,0.0,"IVE, PFE, ABT, CVS: Large Outflows Detected at ETF",0.0,1.0,0.0,0
2017-06-12 16:29:41,-0.3182,PFE Makes Bullish Cross Above Critical Moving Average,0.247,0.753,0.0,-1
2017-06-12 17:27:53,0.4019,Interesting March 2018 Stock Options for PFE,0.0,0.69,0.31,1
2017-06-12 18:21:31,0.4767,The Winners of Trump's Offshore Tax Plan,0.0,0.659,0.341,1
2017-06-13 08:06:00,0.0,Pfizer And Lilly Gets FDA Fast Track Designation For Tanezumab,0.0,1.0,0.0,0
2017-06-13 10:00:00,0.0,Apple and Pfizer's Tax Windfall,0.0,1.0,0.0,0
2017-06-13 12:00:00,0.0,Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab,0.0,1.0,0.0,0
2017-06-13 12:06:00,-0.2263,Former Pfizer Scientist Is Resurrecting Projects To Solve The Multidrug Resistant Bacteria Problem,0.174,0.71,0.116,-1
2017-06-13 12:53:50,-0.5106,Eli Lilly stock rises 1.5% after pain drug gets fast track designation from FDA,0.202,0.798,0.0,-1
2017-06-13 13:00:00,0.0,Nearly One in Four New and Expectant Parents Have Never Heard of Invasive Pneumococcal Disease According to a New Survey,0.0,1.0,0.0,0
2017-06-13 13:18:00,0.0,Merck: A Speed Bump For Keytruda?,0.0,1.0,0.0,0
2017-06-13 13:46:58,0.4939,"Health Care Sector Update for 06/13/2017: JNJ, PFE, ABT, MRK, AMGN, CHRS, IMNP",0.0,0.789,0.211,1
2017-06-13 15:06:46,0.0,General Electric Company (GE) Stock: Immelt’s Departure Is Just the Start,0.0,1.0,0.0,0
2017-06-13 16:16:00,0.2023,"Pfizer, Eli Lilly Granted Accelerated Review for Non-Opiod Pain Relief Drug",0.201,0.488,0.311,1
2017-06-13 16:27:44,-0.6597,"Pfizer, Roche and Aspen face South African probe into cancer drug prices",0.286,0.714,0.0,-1
2017-06-13 22:28:04,-0.5994,Will Tesaro Be the Focus of the Next Biotech Bidding War?,0.281,0.719,0.0,-1
2017-06-14 10:00:00,0.0,Pfizer To Participate In Goldman Sachs Healthcare Conference At 11:00 AM ET,0.0,1.0,0.0,0
2017-06-14 13:46:34,0.4939,"Health Care Sector Update for 06/14/2017: JNJ, PFE, ABT, MRK, AMGN, ALDX, NDRM, LOXO",0.0,0.802,0.198,1
2017-06-14 13:59:07,-0.802,Pfizer denies over-charging for cancer drugs in South Africa,0.507,0.493,0.0,-1
2017-06-14 16:09:11,0.0,"Company News for June 14, 2017",0.0,1.0,0.0,0
2017-06-14 17:08:44,-0.5106,Pfizer & Lilly Get Fast Track Designation for Pain Candidate,0.292,0.708,0.0,-1
2017-06-14 17:16:02,0.4939,"Basilea announces license agreement with Pfizer for antifungal Cresemba® (isavuconazole) for Europe, Russia, Turkey and Israel",0.0,0.824,0.176,1
2017-06-14 17:20:00,0.4215,"Pfizer Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a Novel Treatment for Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients",0.0,0.817,0.183,1
2017-06-14 20:43:00,0.0,Johnson & Johnson: The Bear Case From a Bull,0.0,1.0,0.0,0
2017-06-14 21:09:09,-0.802,Acceleron (XLRN) Kidney Cancer Candidate Fails in Phase II,0.507,0.493,0.0,-1
2017-06-15 02:26:00,0.0,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar",0.0,1.0,0.0,0
2017-06-15 13:26:43,0.4939,"Health Care Sector Update for 06/15/2017: JNJ, PFE, ABT, MRK, AMGN, CRBP, LNTH",0.0,0.789,0.211,1
2017-06-15 13:40:48,-0.4404,Don’t Be Scared of Biogen Inc (BIIB) Stock,0.293,0.707,0.0,-1
2017-06-15 14:43:00,0.4404,3 Stocks With Better Dividends Than CVS Health Corporation,0.0,0.707,0.293,1
2017-06-15 15:12:04,0.128,Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug,0.0,0.842,0.158,1
2017-06-15 16:15:33,0.0,Mylan In FDA Limbo On Generic Multiple Sclerosis Drug,0.0,1.0,0.0,0
2017-06-15 17:08:58,0.1531,[$$] European takeover rules merit a sceptical response,0.22,0.5,0.28,1
2017-06-16 05:22:00,0.4215,Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study,0.0,0.741,0.259,1
2017-06-16 08:35:00,0.0,Pfizer Announces Results from XELJANZ® (tofacitinib citrate) ORAL Strategy Study Published in The Lancet and Presented at the EULAR Annual Congress,0.0,1.0,0.0,0
2017-06-16 11:37:00,0.6369,5 best bets in biotech: Expert,0.0,0.488,0.512,1
2017-06-16 12:27:12,0.0,"Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused",0.0,1.0,0.0,0
2017-06-16 13:07:28,0.4939,"Health Care Sector Update for 06/16/2017: JNJ, PFE, ABT, MRK, AMGN, GSK, PFE, LLY",0.0,0.802,0.198,1
2017-06-16 17:49:54,0.0,2 Incredibly Cheap Biotech Stocks,0.0,1.0,0.0,0
2017-06-16 20:41:01,0.5994,"Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?",0.0,0.698,0.302,1
2017-06-16 22:19:23,0.0,"Dow 30 Stock Roundup: GE Appoints Flannery as CEO; UTX, CAT Hike Dividends",0.0,1.0,0.0,0
2017-06-17 15:42:00,0.5859,3 Dividend Stocks for Successful Investors,0.0,0.513,0.487,1
2017-06-18 18:03:00,-0.2732,Could Legalized Marijuana Be Making Big Pharma Nervous?,0.231,0.769,0.0,-1
2017-06-19 12:00:00,0.0,Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine,0.0,1.0,0.0,0
2017-06-19 12:00:05,-0.1531,[$$] Can AstraZeneca Thrive on Its Own? Big Test Looms,0.151,0.849,0.0,-1
2017-06-19 12:53:12,0.0,3 Biotech Stocks That More than Doubled Year to Date,0.0,1.0,0.0,0
2017-06-19 13:08:16,0.3818,Eylea Continues to Be a Key Growth Driver for Regeneron in 2017,0.0,0.794,0.206,1
2017-06-19 13:20:17,0.4939,"Health Care Sector Update for 06/19/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, MACK, MDT",0.0,0.802,0.198,1
2017-06-19 14:37:08,0.2263,FDA Grants Fast-Track Designation to Tanezumab,0.0,0.725,0.275,1
2017-06-19 18:18:44,0.0,Biotech Stocks To Watch And Pharma Industry News,0.0,1.0,0.0,0
2017-06-19 20:59:14,0.4576,"After Hours Most Active for Jun 19, 2017 :  AABA, INTC, T, ETE, QQQ, CSCO, PFE, C, BABA, LC, MSFT, AAPL",0.0,0.864,0.136,1
2017-06-19 21:21:00,0.0,"Why Exelixis, Inc. Zoomed Higher Today",0.0,1.0,0.0,0
2017-06-19 23:19:23,0.2023,"Top Stock Reports for Chevron, Pfizer & Boeing",0.0,0.769,0.231,1
2017-06-20 04:36:49,-0.1531,Can AstraZeneca Thrive on Its Own? Big Test Looms,0.167,0.833,0.0,-1
2017-06-20 10:00:00,0.2023,Top 10 Holdings of Our Ultimate Stock-Pickers' Index,0.0,0.795,0.205,1
2017-06-20 11:36:13,0.2023,Regeneron’s Praluent May See Gradual Increase in 2017 Demand,0.139,0.648,0.213,1
2017-06-20 12:28:17,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : June 20, 2017",0.0,1.0,0.0,0
2017-06-20 13:20:38,0.4939,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, LPCN, PRXL, MD",0.0,0.802,0.198,1
2017-06-20 13:30:01,0.0,"The Zacks Analyst Blog Highlights: Chevron, Pfizer, Boeing, 3M and Citigroup",0.0,1.0,0.0,0
2017-06-20 13:55:50,-0.3182,Worldwide drug sale forecasts fall as pricing pressures mount,0.223,0.777,0.0,-1
2017-06-20 14:00:00,0.0,Pfizer Invites Public To View And Listen To Webcast Of August 1 Conference Call With Analysts,0.0,1.0,0.0,0
2017-06-20 16:22:13,0.0,"IUSG, PG, PFE, VZ: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2017-06-20 16:59:37,0.4939,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, EGLT, NVIV, VAR",0.0,0.802,0.198,1
2017-06-20 17:19:52,0.5574,J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study,0.0,0.625,0.375,1
2017-06-20 17:26:00,0.0,Today's iQ100 leaders,0.0,1.0,0.0,0
2017-06-20 17:35:49,0.0,"Is Ford Motor Company (F) Stock Undervalued, Or Cheap for a Reason?",0.0,1.0,0.0,0
2017-06-20 20:20:26,0.4939,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, NEOS, IMNP, GLPG",0.0,0.802,0.198,1
2017-06-20 23:19:51,-0.2023,Exelixis's Cabometyx Positive for First-Line Kidney Cancer,0.338,0.385,0.277,-1
2017-06-21 12:54:02,0.0,"3 Stocks to Watch on Wednesday: Carmax, Inc (KMX), Adobe Systems Incorporated (ADBE) and Sangamo Therapeutics Inc (SGMO)",0.0,1.0,0.0,0
2017-06-21 13:21:06,0.4939,"Health Care Sector Update for 06/21/2017: JNJ, PFE, ABT, MRK, AMGN, RXII, PSTI, CARA",0.0,0.802,0.198,1
2017-06-21 14:00:00,0.0,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,0.0,1.0,0.0,0
2017-06-21 15:25:06,-0.6597,"Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More",0.328,0.672,0.0,-1
2017-06-21 16:22:00,-0.34,Pfizer Firing on All Cylinders,0.375,0.625,0.0,-1
2017-06-21 17:08:00,0.0,Pfizer: Time to Sell the Consumer Biz?,0.0,1.0,0.0,0
2017-06-21 17:24:52,0.4767,Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US,0.0,0.721,0.279,1
2017-06-21 17:29:23,0.0,Traders take bullish position on Pfizer,0.0,1.0,0.0,0
2017-06-21 17:50:00,0.0,Dems Roast Trump for Leaving Medicare Out of Drug Price Order,0.0,1.0,0.0,0
2017-06-21 18:29:00,0.0,Will Pfizer Reexamine a Sale of its Consumer Division?,0.0,1.0,0.0,0
2017-06-21 19:21:46,0.0,"Notable Wednesday Option Activity: WDC, BBY, PFE",0.0,1.0,0.0,0
2017-06-22 13:20:29,0.4939,"Health Care Sector Update for 06/22/2017: JNJ, PFE, ABT, MRK, AMGN, KMDA, NVS, OTIC",0.0,0.802,0.198,1
2017-06-22 15:27:00,0.6249,10 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer,0.0,0.76,0.24,1
2017-06-22 16:24:17,0.0,Merck's Keytruda on a Roll: Can it Retain the Momentum?,0.0,1.0,0.0,0
2017-06-22 16:33:00,0.0,Here&apos;s Why Sangamo Therapeutics Rose as Much as 11.7% Today,0.0,1.0,0.0,0
2017-06-22 17:21:18,0.0,"Stock Market News for June 22, 2017",0.0,1.0,0.0,0
2017-06-22 18:21:02,0.0,Here's Why Sangamo Therapeutics Rose as Much as 11.7% Today,0.0,1.0,0.0,0
2017-06-22 20:05:00,0.0,Pfizer Declares 32-Cent Third-Quarter 2017 Dividend,0.0,1.0,0.0,0
2017-06-22 20:22:21,0.0,"3 Big Stock Charts for Thursday: Pfizer Inc. (PFE), Wal-Mart Stores Inc (WMT) and Costco Wholesale Corporation (COST)",0.0,1.0,0.0,0
2017-06-22 21:05:29,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : June 22, 2017",0.0,0.745,0.255,1
2017-06-22 22:19:26,-0.7906,Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger,0.538,0.462,0.0,-1
2017-06-23 09:10:03,-0.1779,Novartis breast cancer drug Kisqali wins European panel nod,0.291,0.464,0.245,-1
2017-06-23 13:06:47,0.0,Vertex on the Street: Analysts’ Recommendations in June 2017,0.0,1.0,0.0,0
2017-06-23 13:29:27,0.4939,"Health Care Sector Update for 06/23/2017: JNJ, PFE, ABT, MRK, AMGN, CARA, BLCM, NVS",0.0,0.802,0.198,1
2017-06-23 14:08:00,0.34,Biotech Movers: Regeneron Slides Back After Big Gains,0.0,0.745,0.255,1
2017-06-23 14:28:54,-0.5106,Healthcare Stocks Make a Dumb Move on ‘Trumpcare’,0.355,0.645,0.0,-1
2017-06-23 15:57:12,0.0,Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonobos,0.0,1.0,0.0,0
2017-06-24 12:03:00,0.5994,Portola Pharmaceuticals&apos; FDA Nod Could Spark M&A Interest,0.0,0.55,0.45,1
2017-06-24 13:51:23,0.5994,Portola Pharmaceuticals' FDA Nod Could Spark M&A Interest,0.0,0.55,0.45,1
2017-06-25 12:50:27,0.7096,3 Stocks to Help You Build Retirement Wealth,0.0,0.459,0.541,1
2017-06-25 13:32:00,0.0,How To Find Dividend Payers With 100%+ Upside To Boot,0.0,1.0,0.0,0
2017-06-26 11:18:00,0.6597,Trader shares top health-care play,0.0,0.238,0.762,1
2017-06-26 12:40:31,0.4215,Pfizer’s Progress on Its Group B Streptococcus Vaccine,0.0,0.682,0.318,1
2017-06-26 13:29:43,0.4939,"Health Care Sector Update for 06/26/2017: JNJ, PFE, ABT, MRK, AMGN",0.0,0.758,0.242,1
2017-06-26 14:24:00,0.6808,After health care gains eight percent in one quarter,0.0,0.556,0.444,1
2017-06-26 14:38:16,0.0,Pfizer’s Xeljanz: Results from the ORAL Strategy,0.0,1.0,0.0,0
2017-06-26 14:50:00,0.4939,Pfizer Stock Looks Pretty Bullish for the Long Term,0.0,0.714,0.286,1
2017-06-26 14:55:36,0.2732,Epizyme Progressing Well on Two Lead Pipeline Candidates,0.0,0.769,0.231,1
2017-06-26 16:05:43,0.0,Pfizer Has Received Commercial Rights for Cresemba in Europe,0.0,1.0,0.0,0
2017-06-26 18:51:38,0.0,How to Find Cheap Stocks With 5%+ Dividends,0.0,1.0,0.0,0
2017-06-26 20:26:00,0.0,"How Things Look for Opko Health, Inc. in 3 Charts",0.0,1.0,0.0,0
2017-06-27 11:38:11,0.0,Tanezumab Receives FDA Fast Track Designation,0.0,1.0,0.0,0
2017-06-27 12:01:00,0.3818,Pfizer Fueling Growth Of Competitors' Pipelines,0.0,0.658,0.342,1
2017-06-27 12:08:00,0.2732,2 Pharma Buyout Targets That May Surprise You,0.0,0.741,0.259,1
2017-06-27 12:38:00,-0.5574,The Forgotten $35 Billion U.S. Healthcare Problem,0.479,0.521,0.0,-1
2017-06-27 12:50:41,0.2023,Pfizer a Top 25 Dividend Giant With 3.77% Yield (PFE),0.0,0.816,0.184,1
2017-06-27 13:00:00,0.0,"Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri",0.0,1.0,0.0,0
2017-06-27 13:03:00,-0.2263,Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed,0.353,0.432,0.216,-1
2017-06-27 13:07:04,0.0,"Pfizer’s Valuation as of June 22, 2017",0.0,1.0,0.0,0
2017-06-27 14:36:38,0.0,A Look at Pfizer’s Revenue for 1Q17,0.0,1.0,0.0,0
2017-06-27 15:55:28,0.4767,Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU,0.0,0.659,0.341,1
2017-06-27 16:52:57,0.2023,AstraZeneca's Faslodex Recommended by CHMP for 1st Line Use,0.0,0.816,0.184,1
2017-06-27 20:03:00,0.6249,[$$] Merck Cholesterol Drug Could Help Unlock Value,0.0,0.541,0.459,1
2017-06-28 10:15:03,-0.6597,[$$] Cancer Drug Startup Vivace Therapeutics Raises $40 Million,0.355,0.645,0.0,-1
2017-06-28 11:36:35,0.0,Pfizer’s Segment Performance in 1Q17,0.0,1.0,0.0,0
2017-06-28 13:06:20,0.0,Pfizer’s Geographical Performance in 1Q17,0.0,1.0,0.0,0
2017-06-28 13:29:51,0.4939,"Health Care Sector Update for 06/28/2017: JNJ, PFE, ABT, MRK, AMGN, GMRE, BLUE, FOLD",0.0,0.802,0.198,1
2017-06-28 14:06:23,-0.34,Merck's CETP Inhibitor Reduces CV Risk in Phase III Study,0.298,0.702,0.0,-1
2017-06-28 14:36:01,0.2732,Pfizer’s Profitability in 1Q17,0.0,0.588,0.412,1
2017-06-28 15:07:01,0.0,Is This the Next Home-Run Biotech Stock?,0.0,1.0,0.0,0
2017-06-28 22:03:29,0.4404,Better Days Ahead for the Pharma Sector?,0.0,0.674,0.326,1
2017-06-29 00:48:00,0.0,Biotech Stocks Facing FDA Decision In July,0.0,1.0,0.0,0
2017-06-29 12:30:00,0.4767,Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders,0.061,0.787,0.152,1
2017-06-29 13:03:00,0.0,Merck & Co. Inc.: The Bear Case from a Bull,0.0,1.0,0.0,0
2017-06-29 13:22:49,0.4939,"Health Care Sector Update for 06/29/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, SRPT, NVS",0.0,0.802,0.198,1
2017-06-29 14:55:19,0.0,The Real Impact Of The Walgreens And Rite Aid Saga,0.0,1.0,0.0,0
2017-06-29 15:08:33,0.0,"Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca",0.0,1.0,0.0,0
2017-06-29 19:50:11,0.296,"FDA, Pfizer, Merck join WHO in Memphis for global drug conference",0.0,0.82,0.18,1
2017-06-29 22:02:36,0.802,"M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks",0.0,0.526,0.474,1
2017-06-29 22:03:56,0.0,Is It Too Late to Buy Portola Pharmaceuticals Stock?,0.0,1.0,0.0,0
2017-06-30 07:44:00,0.4767,Pfizer Reports European Commission's Approval Of BESPONSA - Quick Facts,0.0,0.721,0.279,1
2017-06-30 10:00:00,0.0,The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion),0.0,1.0,0.0,0
2017-06-30 11:30:00,0.4215,BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia,0.0,0.851,0.149,1
2017-06-30 11:43:49,0.0,InPlay from Briefing.com,0.0,1.0,0.0,0
2017-06-30 13:23:05,0.4939,"Health Care Sector Update for 06/30/2017: JNJ, PFE, ABT, MRK, AMGN, SKLN, AMGN. CARA",0.0,0.802,0.198,1
2017-06-30 14:39:18,0.0,"Merck’s Valuation on June 28, 2017",0.0,1.0,0.0,0
2017-06-30 16:44:18,0.0,Sarepta Looks to Focus on Exondys 51 & DMD Pipeline in 2017,0.0,1.0,0.0,0
2017-06-30 17:42:02,0.0,Arena Ends Study on Extended Release Formulation of PAH Drug,0.0,1.0,0.0,0
2017-06-30 23:42:23,0.0,"3 Stocks That Turned $7,000 Into As Much As $37,000 So Far in 2017",0.0,1.0,0.0,0
2017-07-01 18:04:00,0.4404,Better Buy: Pfizer Inc. vs. Eli Lilly and Company,0.0,0.734,0.266,1
2017-07-02 11:21:00,0.0,"The CBO Trips Up Trumpcare, Plus a Biotech &quot;Spiffy-Pop",0.0,1.0,0.0,0
2017-07-03 13:04:00,0.4939,"Health Care Sector Update for 07/03/2017: JNJ, PFE, ABT, MRK, AMGN, OPXA, PTCT. KND",0.0,0.802,0.198,1
2017-07-03 13:14:13,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 05, 2017",0.0,1.0,0.0,0
2017-07-03 14:01:02,0.4767,Pfizer&apos;s (PFE) Leukemia Candidate Receives Approval in EU,0.0,0.693,0.307,1
2017-07-03 15:48:32,0.4767,Pfizer's (PFE) Leukemia Candidate Receives Approval in EU,0.0,0.693,0.307,1
2017-07-03 15:49:07,0.0,Why is Corcept's Stock Up More Than 60% So Far This Year?,0.0,1.0,0.0,0
2017-07-03 15:55:00,0.2023,Why Investment In Biosimilars Is Important For Pfizer,0.0,0.795,0.205,1
2017-07-03 15:55:32,0.4215,Long-Term Performance of Hedge Funds’ Popular Picks,0.0,0.682,0.318,1
2017-07-04 17:44:52,0.0,"Pfizer receives token payment to exit Brazil venture, sources say",0.0,1.0,0.0,0
2017-07-05 10:21:56,0.0,Mixed open seen as shortened trading week resumes; Fed minutes in focus,0.0,1.0,0.0,0
2017-07-05 11:59:39,0.0,"Early movers: VNTV, CAB, PFE, AAPL, INTC, WMT, DIS, BMY & more",0.0,1.0,0.0,0
2017-07-05 13:24:05,0.4939,"Health Care Sector Update for 07/05/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, BGNE, EVHC",0.0,0.802,0.198,1
2017-07-05 14:20:24,0.0,"Bank on Gilead Sciences, Inc. (GILD) Stock Getting Its Mojo Back",0.0,1.0,0.0,0
2017-07-06 07:43:18,0.0,"Pensionfund DSM Netherlands Buys Procter & Gamble Co, McDonald's Corp, PepsiCo Inc, Sells ...",0.0,1.0,0.0,0
2017-07-06 08:43:18,0.0,"Pensionfund Sabic Buys Procter & Gamble Co, McDonald's Corp, PepsiCo Inc, Sells Facebook ...",0.0,1.0,0.0,0
2017-07-06 13:11:00,0.0772,In Your 70s? 3 Stocks You Might Want to Buy,0.0,0.86,0.14,0
2017-07-06 13:22:00,0.0,"Despite This Happening, Sangamo Therapeutics Inc. Surged 31% in June",0.0,1.0,0.0,0
2017-07-06 13:24:15,0.4939,"Health Care Sector Update for 07/06/2017: JNJ, PFE, ABT, MRK, AMGN, EGLT, TNXP, NVS",0.0,0.802,0.198,1
2017-07-06 13:30:10,0.0,5 Dow Jones Stocks Every Investor Should Own,0.0,1.0,0.0,0
2017-07-06 16:47:57,0.296,"IYH, PFE, MDT, CELG: ETF Inflow Alert",0.0,0.732,0.268,1
2017-07-06 17:43:57,0.2023,See How Pfizer Ranks Among Analysts' Top Dow 30 Picks,0.0,0.833,0.167,1
2017-07-06 20:14:00,0.0,Pfizer Exits Brazil Venture,0.0,1.0,0.0,0
2017-07-07 12:25:12,0.0,"Pharma Stock Roundup: MRK&apos;s Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise Outlook",0.0,1.0,0.0,0
2017-07-07 13:24:23,0.4939,"Health Care Sector Update for 07/07/2017: JNJ, PFE, ABT, MRK, AMGN, NVS, DXTR, CNAT, ADXS",0.0,0.814,0.186,1
2017-07-07 13:47:47,0.296,"The Cabosun Shone on Exelixis in June, Sending Its Shares Up 32%",0.0,0.833,0.167,1
2017-07-07 13:49:00,0.0,"Pharma Stock Roundup: MRK's Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise Outlook",0.0,1.0,0.0,0
2017-07-07 14:46:58,-0.6597,This Biotech Finds Its Stride With Kidney Cancer Treatment,0.355,0.645,0.0,-1
2017-07-07 15:51:17,-0.6597,Puma (PBYI) Ends Patient Enrollment in Phase III Cancer Trial,0.328,0.672,0.0,-1
2017-07-07 16:05:00,0.6249,15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer,0.0,0.76,0.24,1
2017-07-10 11:39:04,0.0,How 2Q17 Is Shaping Up for Pfizer,0.0,1.0,0.0,0
2017-07-10 13:38:00,0.6369,"Boeing Best In Show Among 8 'Dogs Of The Dow,' Here's How To Trade Them Now",0.0,0.769,0.231,1
2017-07-10 14:45:25,-0.6249,The Worst Place to Invest Now (and 2 Buys for Quick 100%+ Gains),0.272,0.728,0.0,-1
2017-07-10 19:47:13,-0.2924,Wall Street Opens Without a Clear Direction,0.304,0.696,0.0,-1
2017-07-10 20:22:00,-0.3182,These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now,0.267,0.545,0.188,-1
2017-07-10 20:44:56,0.0,The 10 largest pharmaceutical companies in the world,0.0,1.0,0.0,0
2017-07-11 11:18:00,0.0,How Portola Is Looking to Change the Anticoagulant Game,0.0,1.0,0.0,0
2017-07-11 11:24:00,-0.3182,"NFL loses Viagra, Cialis advertising: Report",0.315,0.685,0.0,-1
2017-07-11 13:04:00,0.0,Here’s how much the 10 largest pharmaceutical companies spend on R&D,0.0,1.0,0.0,0
2017-07-11 13:14:06,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2017",0.0,1.0,0.0,0
2017-07-11 13:17:04,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2017",0.0,1.0,0.0,0
2017-07-11 15:49:23,-0.6597,Lilly's Breast Cancer Drug Gets Priority Review Status by FDA,0.328,0.672,0.0,-1
2017-07-11 16:47:05,0.7003,"Arena's Ralinepag Positive in Phase II PAH Study, Shares Up",0.0,0.58,0.42,1
2017-07-11 18:52:00,0.0951,Pfizer's Exit From Brazil Generics Market Is Not Alarming,0.0,0.854,0.146,0
2017-07-11 20:32:00,0.4019,FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia,0.0,0.838,0.162,1
2017-07-11 22:44:39,0.0,Exelixis & Bristol-Myers Initiate Trial on Opdivo-Cabometyx,0.0,1.0,0.0,0
2017-07-11 22:45:44,0.2023,3 Top Healthcare Stocks to Buy Today,0.0,0.735,0.265,1
2017-07-12 01:48:00,0.0772,"ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE",0.199,0.643,0.158,0
2017-07-12 10:33:00,0.1779,Will Pfizer Keep Growing Its Dividend?,0.0,0.746,0.254,1
2017-07-12 14:24:02,0.2023,Pfizer&apos;s Mylotarg Recommended by FDA Advisory Committee,0.0,0.769,0.231,1
2017-07-12 14:50:45,0.0,J&J (JNJ) to Commence Pharma Q2 Earnings Season: What's Up?,0.0,1.0,0.0,0
2017-07-12 15:49:07,0.0,Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label,0.0,1.0,0.0,0
2017-07-12 16:48:37,0.2023,Pfizer's Mylotarg Recommended by FDA Advisory Committee,0.0,0.769,0.231,1
2017-07-13 08:11:00,0.3182,Pfizer: FDA Accepts SNDA For Xeljanz For Treatment Of Ulcerative Colitis,0.0,0.813,0.187,1
2017-07-13 12:00:00,0.25,Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis,0.1,0.733,0.167,1
2017-07-13 13:02:00,0.0,3 Dividend Stocks That Are Minting Money,0.0,1.0,0.0,0
2017-07-13 23:24:45,0.25,Tata Consultancy Profit Misses Estimates,0.244,0.385,0.372,1
2017-07-13 23:47:00,0.0,Corcept Therapeutics Focuses on Korlym's Label Expansion,0.0,1.0,0.0,0
2017-07-13 23:47:28,0.0,Clovis (CLVS) Focuses on Rubraca Launch and Label Expansion,0.0,1.0,0.0,0
2017-07-14 00:45:39,0.296,Why Are Shares of Exelixis (EXEL) Up 77% So Far in 2017?,0.0,0.833,0.167,1
2017-07-14 02:31:00,-0.0516,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%",0.107,0.893,0.0,0
2017-07-14 11:28:11,0.0,"Pharma Stock Roundup: FDA Panel Votes for Novartis CAR-T Drug, SNY to Buy Vaccines Co.",0.0,1.0,0.0,0
2017-07-14 11:40:11,0.0,What Allergan’s Valuation as of July 13 Tells Us,0.0,1.0,0.0,0
2017-07-14 13:01:00,-0.431,Why Healthcare Funds Are Not Sickened By GOP Bid To Kill Obamacare,0.268,0.57,0.162,-1
2017-07-14 15:59:00,0.0,"Kevin O'Leary: Own big, quality names",0.0,1.0,0.0,0
2017-07-14 16:45:30,0.2732,Pfizer Xeljanz Label Expansion Application Accepted by FDA,0.0,0.769,0.231,1
2017-07-14 16:47:28,0.0,"Notable ETF Inflow Detected - VHT, PFE, MDT, ABBV",0.0,1.0,0.0,0
2017-07-14 18:07:22,0.0,AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet,0.0,1.0,0.0,0
2017-07-14 20:05:00,0.0,Potential AstraZeneca C-Suite Shuffle Rekindles Takeover Chatter,0.0,1.0,0.0,0
2017-07-14 23:01:00,-0.4939,"How to Use Technical Analysis to Make Money: Cramer's 'Mad Money' Recap (Friday, 7/14/17)",0.198,0.802,0.0,-1
2017-07-15 04:01:00,0.6249,"[$$] ""A Great Time"" to Invest in the Health-Care Sector",0.0,0.687,0.313,1
2017-07-16 14:45:00,0.0,Roundtable: 1 Stock I&apos;m Never Selling,0.0,1.0,0.0,0
2017-07-16 19:03:00,-0.5859,Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here&apos;s Why It Doesn&apos;t Matter,0.272,0.667,0.061,-1
2017-07-16 20:45:14,-0.609,Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter,0.332,0.668,0.0,-1
2017-07-16 22:46:22,0.0,Roundtable: 1 Stock I'm Never Selling,0.0,1.0,0.0,0
2017-07-17 12:49:58,0.4767,3 Small Biotech Stocks Being Run by Proven Winners,0.0,0.693,0.307,1
2017-07-17 15:26:53,0.0,How to Identify Economic Moats,0.0,1.0,0.0,0
2017-07-17 15:26:59,0.7351,How Bayer Is Creating Value through Innovation,0.0,0.357,0.643,1
2017-07-18 13:02:07,0.6633,JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades,0.0,0.624,0.376,1
2017-07-18 14:08:09,0.4767,Paratek Antibiotic Candidate's Phase III Data Favorable,0.0,0.659,0.341,1
2017-07-18 16:08:06,-0.3612,"J&J (JNJ) Beats on Q2 Earnings, Lags Sales, Ups 2017 View",0.2,0.8,0.0,-1
2017-07-19 03:02:21,0.6124,Does Puma Biotechnology's Approval Make It Worth More?,0.0,0.545,0.455,1
2017-07-19 13:04:06,0.4939,"Health Care Sector Update for 07/19/2017: JNJ, PFE, ABT, MRK, AMGN, MDGS, GSK, INO",0.0,0.802,0.198,1
2017-07-19 15:08:14,0.0,Is a Beat in the Cards for Eli Lilly (LLY) in Q2 Earnings?,0.0,1.0,0.0,0
2017-07-19 16:08:09,0.3818,Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?,0.0,0.776,0.224,1
2017-07-19 20:03:31,0.0,5 Off-the-Radar Numbers to Take Note of in Johnson & Johnson's Second-Quarter Report,0.0,1.0,0.0,0
2017-07-19 20:58:08,0.0,4 Healthcare Megatrends for Investors,0.0,1.0,0.0,0
2017-07-19 21:02:07,0.4576,"After Hours Most Active for Jul 19, 2017 :  INTC, PFE, QQQ, CAG, T, RF, MGM, KO, ROST, ERIC, TMUS, AAPL",0.0,0.864,0.136,1
2017-07-19 22:48:26,0.0,Cramer&apos;s lightning round: GameStop just can&apos;t seem to go higher,0.0,1.0,0.0,0
2017-07-19 22:48:26,0.0,Cramer's lightning round: GameStop just can't seem to go higher,0.0,1.0,0.0,0
2017-07-19 22:59:00,0.0,Cramer's lightning round: GameStop just can't seem to go ...,0.0,1.0,0.0,0
2017-07-20 01:50:00,0.128,Pfizer Obtains Exclusive Commercialization Rights In Europe To CRESEMBA,0.0,0.842,0.158,1
2017-07-20 05:17:00,0.4939,"Basilea announces completion of the license agreement with Pfizer for antifungal Cresemba® for Europe, Russia, Turkey and Israel",0.0,0.842,0.158,1
2017-07-20 05:23:00,0.7184,"Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients",0.0,0.75,0.25,1
2017-07-20 11:58:51,0.296,Pfizer shares downgraded because Viagra patent is expiring later this year,0.0,0.82,0.18,1
2017-07-20 13:35:00,0.3612,Pfizer: We Still Like You But…,0.0,0.667,0.333,1
2017-07-20 13:43:05,0.4939,"Health Care Sector Update for 07/20/2017: JNJ, PFE, ABT, MRK, AMGN, BVXV, GSK, PFE",0.0,0.802,0.198,1
2017-07-20 14:57:34,0.296,Analyst Prescribes Neutral Rating For Pfizer Shares,0.0,0.732,0.268,1
2017-07-20 16:41:00,0.3818,Pfizer Downgraded on Patent Expiration for Viagra: Credit Suisse,0.0,0.755,0.245,1
2017-07-20 17:04:51,-0.4215,What Lies in Store for Glaxo (GSK) this Earnings Season?,0.237,0.763,0.0,-1
2017-07-20 19:17:00,0.0,Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging,0.0,1.0,0.0,0
2017-07-20 19:53:27,0.0,"Merck, Pfizer CEOs talk 'Made in America' week",0.0,1.0,0.0,0
2017-07-20 20:02:40,0.0,Trump unveils companies' $500 million U.S. drug packaging project,0.0,1.0,0.0,0
2017-07-20 20:06:15,-0.1027,"Tesla Started At Neutral, High Risk; Amazon Gets Price Target Hike",0.164,0.703,0.133,-1
2017-07-20 23:30:00,0.0,5 New Breast Cancer Treatments That Are Helping to Save Lives,0.262,0.417,0.321,0
2017-07-21 03:02:51,0.0,3 Hottest Biotech Stocks of 2017 -- Are They Still Buys Now?,0.0,1.0,0.0,0
2017-07-21 11:00:00,0.4767,Cleaner Exposure to Value Stocks,0.0,0.423,0.577,1
2017-07-21 11:50:00,0.5574,EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma,0.0,0.795,0.205,1
2017-07-21 12:00:00,0.0,Today's Research Reports on Stocks to Watch: Abbott Laboratories and Pfizer Inc.,0.0,1.0,0.0,0
2017-07-21 12:52:12,0.2732,Can Merck (MRK) Pull Off a Surprise this Earnings Season?,0.0,0.792,0.208,1
2017-07-21 13:04:03,0.4939,"Health Care Sector Update for 07/21/2017: JNJ, PFE, ABT, MRK, AMGN, AEZS, BCLI, RH",0.0,0.802,0.198,1
2017-07-21 14:41:27,0.0,A Look at Johnson & Johnson’s Segment-Wise Performance,0.0,1.0,0.0,0
2017-07-21 16:02:58,0.2732,"Capital Insight Partners, Llc Buys LafargeHolcim, NextEra Energy Inc, EQT Corp, Sells Walt ...",0.0,0.861,0.139,1
2017-07-21 17:11:10,0.0,HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?,0.0,1.0,0.0,0
2017-07-21 22:03:29,-0.5106,AbbVie Inc's. (ABBV) Q2 Earnings: Disappointment in Store?,0.32,0.68,0.0,-1
2017-07-21 23:04:05,0.4767,Merck's Biosimilar Insulin Gets Tentative FDA Approval,0.0,0.659,0.341,1
2017-07-22 16:05:04,0.4404,Better Buy: AbbVie Inc. vs. Johnson & Johnson,0.0,0.674,0.326,1
2017-07-23 15:01:00,0.0,5 Things You Probably Didn&apos;t Know About Pfizer Inc.,0.0,1.0,0.0,0
2017-07-23 17:04:52,0.0,5 Things You Probably Didn't Know About Pfizer Inc.,0.0,1.0,0.0,0
2017-07-23 23:21:00,0.0,One Step Closer To EU Approval...,0.0,1.0,0.0,0
2017-07-24 04:33:00,0.0,GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study,0.0,1.0,0.0,0
2017-07-24 08:42:00,0.0,Pfizer Says REFLECTIONS B7391003 Study Met Primary Objective - Quick Facts,0.0,1.0,0.0,0
2017-07-24 11:20:00,0.5574,Featured Company News - Pfizer and Merck Announce EMA'S CHMP Positive Opinion for Avelumab,0.0,0.769,0.231,1
2017-07-24 12:30:00,0.5574,"Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)",0.0,0.825,0.175,1
2017-07-24 13:14:01,0.0,Centene (CNC) to Report Q2 Earnings: What&apos;s in the Cards?,0.0,1.0,0.0,0
2017-07-24 14:03:48,0.4939,"Health Care Sector Update for 07/24/2017: JNJ, PFE, ABT, MRK, AMGN, WBMD, BMY, SRPT",0.0,0.802,0.198,1
2017-07-24 14:07:42,0.0,Universal Health (UHS) Q2 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2017-07-24 15:10:45,0.0,What to Expect from Anthem (ANTM) this Earnings Season?,0.0,1.0,0.0,0
2017-07-24 15:11:06,0.0,Centene (CNC) to Report Q2 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2017-07-24 16:02:36,0.0,"Noteworthy ETF Inflows: VYM, PFE, MMM, ABBV",0.0,1.0,0.0,0
2017-07-24 16:10:14,0.2732,Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs,0.0,0.811,0.189,1
2017-07-24 17:06:36,0.4019,Interesting January 2019 Stock Options for PFE,0.0,0.69,0.31,1
2017-07-24 17:09:02,0.0,What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings?,0.0,1.0,0.0,0
2017-07-24 18:26:49,0.0,How Pfizer Is Expected to Perform in 2017,0.0,1.0,0.0,0
2017-07-24 18:37:41,-0.5994,"Merck, Samsung Accelerate a Biosimilar Price War",0.438,0.562,0.0,-1
2017-07-24 20:06:09,0.3818,Why Ibrance Could Drive Pfizer’s Revenue Growth,0.0,0.698,0.302,1
2017-07-24 21:35:58,0.3818,Why Ibrance Could Be Pfizer’s Long-Term Growth Driver,0.0,0.729,0.271,1
2017-07-25 02:57:05,0.0,Corning Looks to Sustain Its Momentum,0.0,1.0,0.0,0
2017-07-25 08:50:00,0.5766,GSK : ViiV Healthcare Announces Results From NEAT 022 Study,0.0,0.682,0.318,1
2017-07-25 08:56:00,0.5574,ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts,0.0,0.714,0.286,1
2017-07-25 11:35:43,0.0,Analysts’ Recommendations for Merck in July 2017,0.0,1.0,0.0,0
2017-07-25 11:40:13,0.6486,Why Xeljanz Could Boost Pfizer’s Revenue Growth,0.0,0.485,0.515,1
2017-07-25 13:11:41,0.0,How Pfizer’s Vaccine Franchise Is Positioned in 2017,0.0,1.0,0.0,0
2017-07-25 13:17:24,0.4939,"Health Care Sector Update for 07/25/2017: JNJ, PFE, ABT, MRK, AMGN, NVAX, BIIB, LLY",0.0,0.802,0.198,1
2017-07-25 13:56:00,0.5423,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings,0.0,0.811,0.189,1
2017-07-25 14:40:30,0.0,Why Pfizer’s Sutent Could Witness a Modest Decline in 2017,0.0,1.0,0.0,0
2017-07-25 21:36:13,-0.5574,Adviser charged with insider trading on Pfizer-King deal pleads guilty,0.365,0.635,0.0,-1
2017-07-25 21:53:09,0.2023,"Top Analyst Reports for Oracle, Pfizer & Abbott",0.0,0.769,0.231,1
2017-07-26 11:15:00,0.0,These 2 Pharma Giants May Be on Pfizer&apos;s M&A Radar Right Now,0.0,1.0,0.0,0
2017-07-26 12:11:00,0.0,3 Charts Suggesting Traders Are Bullish on Healthcare,0.0,1.0,0.0,0
2017-07-26 13:00:00,0.0,These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now,0.0,1.0,0.0,0
2017-07-26 13:06:55,0.0,How Is Pfizer’s Lyrica Expected to Perform in 2017?,0.0,1.0,0.0,0
2017-07-26 13:29:01,-0.6597,"Key Takeaways from Lilly&apos;s (LLY) Q2 Call: Baricitinib, Cancer Pipeline",0.328,0.672,0.0,-1
2017-07-26 13:37:18,0.4939,"Health Care Sector Update for 07/26/2017: JNJ, PFE, ABT, MRK, AMGN, TTPH, BMY, RETA",0.0,0.802,0.198,1
2017-07-26 14:09:12,0.0,"Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios",0.0,1.0,0.0,0
2017-07-26 14:37:03,0.0,Understanding Pfizer’s Sterile Injection Pharmaceuticals Position in 2017,0.0,1.0,0.0,0
2017-07-26 15:03:50,0.0,"The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger",0.0,1.0,0.0,0
2017-07-26 15:04:03,-0.6597,"Key Takeaways from Lilly's (LLY) Q2 Call: Baricitinib, Cancer Pipeline",0.328,0.672,0.0,-1
2017-07-26 16:04:12,0.0,Is a Beat in the Cards for Pfizer (PFE) in Q2 Earnings?,0.0,1.0,0.0,0
2017-07-26 16:43:00,0.34,S&P 500 stocks to find value,0.0,0.676,0.324,1
2017-07-26 17:01:38,0.5106,Corning (GLW) Beats Q2 Earnings Estimates on Strong Revenues,0.0,0.708,0.292,1
2017-07-26 20:57:15,0.4576,"After Hours Most Active for Jul 26, 2017 :  FB, BTI, BAC, T, CSCO, F, AUY, AAPL, MU, PFE, JBLU, WFM",0.0,0.864,0.136,1
2017-07-27 00:57:49,0.0,"Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense",0.0,1.0,0.0,0
2017-07-27 02:57:23,0.4939,Corning Exceeds Expectations on Optical and Gorilla Glass Strength,0.0,0.714,0.286,1
2017-07-27 06:22:08,0.0,AstraZeneca Plunges After Setback in Crucial Lung-Cancer Drug Trial,0.0,1.0,0.0,0
2017-07-27 11:10:34,-0.1779,AstraZeneca's Missing Takeover Defense,0.386,0.351,0.263,-1
2017-07-27 11:36:11,0.7351,Pfizer Sees a Significant Opportunity in This for Revenue Growth,0.0,0.455,0.545,1
2017-07-27 11:56:43,0.0,"Argyle Capital Management Inc. Buys DXC Technology Co, CVS Health Corp, C.R. ...",0.0,1.0,0.0,0
2017-07-27 12:57:49,-0.7184,Shares in AstraZeneca dive as key cancer drug trial fails,0.439,0.427,0.134,-1
2017-07-27 13:06:45,0.0,What to Expect from Pfizer’s Rare Disease Franchise in 2017,0.0,1.0,0.0,0
2017-07-27 13:09:03,0.0,What Led the Rise in GE’s Healthcare Revenue in 2Q17?,0.0,1.0,0.0,0
2017-07-27 13:16:03,0.0,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : July 27, 2017",0.0,1.0,0.0,0
2017-07-27 13:29:00,0.5574,Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers,0.0,0.795,0.205,1
2017-07-27 13:37:17,0.4939,"Health Care Sector Update for 07/27/2017: JNJ, PFE, ABT, MRK, AMGN, BMY, EW, VAR",0.0,0.802,0.198,1
2017-07-27 14:07:29,0.0,"Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally",0.0,1.0,0.0,0
2017-07-27 16:24:47,-0.25,[$$] AstraZeneca: transcendental agitation,0.4,0.6,0.0,-1
2017-07-27 17:03:03,0.0,"Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View",0.0,1.0,0.0,0
2017-07-28 01:15:00,-0.5106,Mighty AstraZeneca Takes a Lickin&apos; on Failed Mystic Trial,0.32,0.68,0.0,-1
2017-07-28 02:58:25,-0.5106,Mighty AstraZeneca Takes a Lickin' on Failed Mystic Trial,0.32,0.68,0.0,-1
2017-07-28 06:04:12,0.7351,[$$] United Therapeutics in Settlement Talks With Justice Department,0.0,0.53,0.47,1
2017-07-28 11:36:15,0.0,Behind Pfizer’s Legacy Established Products Performance in 2017,0.0,1.0,0.0,0
2017-07-28 12:35:12,0.2732,Why Pfizer Inc. (PFE) Might Surprise This Earnings Season,0.0,0.792,0.208,1
2017-07-28 13:06:15,0.0,Pfizer on the Street: Inside the Analysts’ Recommendations,0.0,1.0,0.0,0
2017-07-28 13:17:24,0.4939,"Health Care Sector Update for 07/28/2017: JNJ, PFE, ABT, MRK, AMGN, ABBV, NUVA",0.0,0.789,0.211,1
2017-07-28 13:48:32,0.6369,AbbVie Inc (ABBV) Q2 Beat Fueled by Best World’s Best-Selling Drug,0.0,0.704,0.296,1
2017-07-28 14:50:00,0.34,3 Value Stocks Senior Citizens Should Consider Buying Today,0.0,0.745,0.255,1
2017-07-28 14:54:02,0.0,"Merck (MRK) Beats on Q2 Earnings and Sales, Keeps 2017 View",0.0,1.0,0.0,0
2017-07-28 19:45:39,0.0,"Earnings Watch: Apple, Tesla, Pfizer, Activision-Blizzard On Tap For Next Week",0.0,1.0,0.0,0
2017-07-28 21:58:28,0.0,"Upcoming Earnings Reports to Watch: AAPL, PFE, TWX, KHC",0.0,1.0,0.0,0
2017-07-28 23:56:47,0.0,Q2 Earnings Season Past the Halfway Mark,0.0,1.0,0.0,0
2017-07-29 15:57:56,0.0,What's Next for AstraZeneca and Its Dividend?,0.0,1.0,0.0,0
2017-07-29 23:32:00,0.2263,Company Spotlight: Spark Therapeutics,0.0,0.612,0.388,1
2017-07-30 11:43:00,0.0,3 Things You Can Expect With Pfizer&apos;s Q2 Results,0.0,1.0,0.0,0
2017-07-30 12:54:41,0.0,3 Things You Can Expect With Pfizer's Q2 Results,0.0,1.0,0.0,0
2017-07-30 13:05:00,0.0,Earnings Preview: What To Expect From Pfizer On Tuesday,0.0,1.0,0.0,0
2017-07-30 14:25:46,0.0,"Apple, Tesla and More Companies Reporting This Week",0.0,1.0,0.0,0
2017-07-31 01:47:00,0.0,Biotech Stocks Facing FDA Decision In August,0.0,1.0,0.0,0
2017-07-31 06:30:00,0.0,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection,0.0,1.0,0.0,0
2017-07-31 12:06:12,0.0,"Pharma Stock Roundup: Q2 Earnings Results from Merck, Lilly, Bristol-Myers & More",0.0,1.0,0.0,0
2017-07-31 14:11:02,0.0,"Apple, Pfizer and Yum Brands are part of Zacks Earnings Preview",0.0,1.0,0.0,0
2017-07-31 14:30:02,0.0,"Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY",0.0,1.0,0.0,0
2017-07-31 14:46:01,0.0,Earnings Preview: Pharma Giant Pfizer Reports Q2 Results Tomorrow Morning,0.0,1.0,0.0,0
2017-07-31 15:00:54,0.2732,Can Cardinal Health (CAH) Pull a Surprise in Q4 Earnings?,0.0,0.792,0.208,1
2017-07-31 15:57:57,0.4939,"Ex-Dividend Reminder: Dominion Energy Midstream Partners LP, CMS Energy Corp and Pfizer",0.0,0.704,0.296,1
2017-07-31 16:56:53,0.0,Allergan (AGN) to Report Q2 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2017-07-31 16:58:27,0.296,What's in the Cards for Immune Design (IMDZ) in Q2 Earnings?,0.0,0.82,0.18,1
2017-07-31 17:51:00,0.3818,Pfizer Earnings: Drug Growth And Pipeline In Focus For Q2,0.0,0.776,0.224,1
2017-07-31 20:03:00,0.0,"Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff",0.0,1.0,0.0,0
2017-07-31 20:13:30,0.0,"Pre-Market Earnings Report for August 1, 2017 :  PFE, SPG, PSX, CME, EMR, ECL, ETN, TRI, S, BP, APD, CMI",0.0,1.0,0.0,0
2017-07-31 20:24:06,0.0,Inside Pfizer’s 2Q17 Earnings: Analyst Estimates,0.0,1.0,0.0,0
2017-07-31 20:56:45,0.2263,"Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out",0.0,0.853,0.147,1
2017-07-31 21:14:09,-0.6124,Close Update: Dow Closes At Record High While Nasdaq and S&P Struggle Under Tech Losses,0.278,0.722,0.0,-1
2017-07-31 22:06:05,-0.296,Why Pfizer Expects Lower Revenues for 2Q17,0.268,0.732,0.0,-1
2017-08-01 06:47:00,0.0,Pfizer Inc. Reports 3% Rise In Q2 Earnings,0.0,1.0,0.0,0
2017-08-01 07:14:00,0.0,Wall Street Aims For A Racing Start,0.0,1.0,0.0,0
2017-08-01 07:23:00,0.6808,"Pfizer Q2 Profit Tops Estimates, Revenues Miss; Lifts FY17 Earnings View",0.101,0.506,0.392,1
2017-08-01 08:34:25,-0.7184,AstraZeneca a tricky takeover target after big cancer drug blow,0.462,0.538,0.0,-1
2017-08-01 09:01:00,0.0,Pfizer Q2 17 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2017-08-01 10:45:00,0.0,Pfizer Reports Second-Quarter 2017 Results,0.0,1.0,0.0,0
2017-08-01 10:54:51,0.0,"Earnings Reaction History: Pfizer Inc, 36.4% Follow-Through Indicator, 1.1% Sensitive",0.0,1.0,0.0,0
2017-08-01 11:02:40,0.3182,"Pfizer reports Q2 profit beat, revenue miss",0.168,0.526,0.305,1
2017-08-01 11:04:53,-0.296,Pfizer Sales Shortfall Highlights Pressure to Make a Deal,0.239,0.761,0.0,-1
2017-08-01 11:11:00,0.0,"Pfizer reports mixed quarter, increases midrange 2017 EPS...",0.0,1.0,0.0,0
2017-08-01 11:29:11,0.0,Key FDA Events to Watch Out for in Aug 2017,0.0,1.0,0.0,0
2017-08-01 11:32:50,0.5106,US STOCKS-Futures higher on strong earnings season; Apple in focus,0.0,0.732,0.268,1
2017-08-01 11:41:38,0.0,Pfizer on the Street: Analyst Recommendations after 2Q17,0.0,1.0,0.0,0
2017-08-01 11:55:16,0.4939,Why Pfizer Earnings Aren’t Exciting Investors,0.0,0.61,0.39,1
2017-08-01 12:00:00,0.0,Investor Network: Pfizer Inc. to Host Earnings Call,0.0,1.0,0.0,0
2017-08-01 12:05:58,0.0,"Early movers: UAA, PFE, ADM, P, TXRH, AN, HMC, LVS, WYNN, SNAP & more",0.0,1.0,0.0,0
2017-08-01 12:10:26,0.0,"3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Pfizer Inc. (PFE) and Texas Roadhouse Inc (TXRH)",0.0,1.0,0.0,0
2017-08-01 12:10:46,-0.4767,"Pfizer revenue misses on lower Prevnar, Enbrel sales",0.406,0.594,0.0,-1
2017-08-01 12:28:12,0.0,"Becton, Dickinson (BDX) Q2 Earnings: What&apos;s in the Cards?",0.0,1.0,0.0,0
2017-08-01 12:41:00,0.0772,Dow Set to Open at All-Time High as Wall Street Awaits Apple,0.0,0.894,0.106,0
2017-08-01 13:15:17,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2017",0.0,1.0,0.0,0
2017-08-01 13:25:20,0.0,"Stocks to Watch: Sprint, Pfizer, Pandora, Under Armour, Lumber Liquidators",0.0,1.0,0.0,0
2017-08-01 13:37:50,0.4404,Key drug sales push Pfizer profit up 50 percent,0.0,0.734,0.266,1
2017-08-01 13:59:02,0.0,"Becton, Dickinson (BDX) Q2 Earnings: What's in the Cards?",0.0,1.0,0.0,0
2017-08-01 13:59:31,0.34,"Pfizer (PFE) Tops Q2 Earnings Estimates, Misses Sales",0.17,0.536,0.295,1
2017-08-01 14:36:13,0.0,Eli Lilly’s Major Developments in 2Q17,0.0,1.0,0.0,0
2017-08-01 14:36:42,0.0,Pfizer's revenue falls again,0.0,1.0,0.0,0
2017-08-01 14:46:00,0.2023,"Dow Secures All-Time Trading High, Weak Auto Sales Cap Broader Gains",0.186,0.513,0.301,1
2017-08-01 15:00:00,0.0,Pfizer Looks Undervalued,0.0,1.0,0.0,0
2017-08-01 15:25:03,0.0,"Q2 Earnings From UA, PFE And ADM",0.0,1.0,0.0,0
2017-08-01 15:54:00,0.3818,The 8 'Dogs Of The Dow' Gained Ground On The Dow 30,0.0,0.794,0.206,1
2017-08-01 15:55:47,0.0,"Dow Movers: MCD, JPM",0.0,1.0,0.0,0
2017-08-01 15:58:47,-0.2263,"Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales",0.213,0.787,0.0,-1
2017-08-01 16:13:20,-0.34,Why Garmin Ltd. (GRMN) Stock Should Still Be Avoided,0.231,0.769,0.0,-1
2017-08-01 16:38:47,-0.34,[$$] Pfizer hits pause on deals amid US tax reform uncertainty,0.194,0.806,0.0,-1
2017-08-01 16:53:53,0.0,Sky-High Boeing Co (BA) Stock Is Bleeding Fuel,0.0,1.0,0.0,0
2017-08-01 17:01:14,0.0,Q2 Earnings Tuesday: Mixed Bag for Most,0.0,1.0,0.0,0
2017-08-01 17:19:20,0.0,[$$] Pfizer Waiting for Cues on Tax Reform to Pursue Deals,0.0,1.0,0.0,0
2017-08-01 17:26:00,0.0,Big movers in the blitz,0.0,1.0,0.0,0
2017-08-01 17:33:07,0.0,Pfizer Remains Underappreciated,0.0,1.0,0.0,0
2017-08-01 17:36:44,0.4588,Pfizer delays major M&A as it awaits U.S. tax reform clarity,0.0,0.692,0.308,1
2017-08-01 18:15:00,0.0,"Dow on Track for Fifth Record Close in a Row, Wall Street Rises",0.0,1.0,0.0,0
2017-08-01 18:32:15,-0.34,Pfizer's New Tax Obsession Shouldn't Paralyze It,0.286,0.714,0.0,-1
2017-08-01 19:02:00,0.2716,12 Numbers in Pfizer&apos;s Q2 Update More Important Than Its Revenue Decline,0.0,0.84,0.16,1
2017-08-01 20:11:48,-0.6597,"Generics Chip Away At Dow Stock Pfizer, But Cancer Unit &apos;Stabilizing&apos;",0.306,0.694,0.0,-1
2017-08-01 20:22:57,-0.4019,Will Pfizer&apos;s Cancer Drugs Help It Grow Without A Merger?,0.312,0.496,0.191,-1
2017-08-01 20:30:00,-0.34,"Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products",0.296,0.556,0.148,-1
2017-08-01 20:55:52,0.2716,12 Numbers in Pfizer's Q2 Update More Important Than Its Revenue Decline,0.0,0.84,0.16,1
2017-08-01 23:30:00,0.4215,"How Snap May Have Dashed Uber's IPO Hopes; Intel CEO on Autonomy, Tech Rally -- ICYMI Tuesday",0.0,0.851,0.149,1
2017-08-02 00:00:00,0.0,"Dow Enters August With a Bang, New Records for Day Five",0.0,1.0,0.0,0
2017-08-02 01:33:23,0.7351,Pfizer tops 2Q profit forecasts,0.0,0.326,0.674,1
2017-08-02 02:54:05,0.25,Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo,0.0,0.75,0.25,1
2017-08-02 11:35:56,0.0,Eli Lilly’s Valuation after 2Q17 Earnings Release,0.0,1.0,0.0,0
2017-08-02 11:37:01,0.4404,How BMY Is Valued following Its 2Q17 Earnings,0.0,0.707,0.293,1
2017-08-02 12:00:00,0.0,Earnings Preview: What To Expect From Regeneron Pharmaceuticals On Thursday,0.0,1.0,0.0,0
2017-08-02 13:08:52,0.4215,Pfizer upgraded to outperform at BMO Capital Markets on drug pipeline progress,0.0,0.797,0.203,1
2017-08-02 13:34:31,0.4939,"Health Care Sector Update for 08/02/2017: JNJ, PFE, ABT, MRK, AMGN, EYES, OCUL",0.0,0.789,0.211,1
2017-08-02 14:00:00,0.6705,"Pfizer Stock Upgraded at BMO on Attractive Risk/Reward, Growth Outlook",0.0,0.593,0.407,1
2017-08-02 14:00:03,0.0,Can DENTSPLY Sirona (XRAY) Deliver a Beat in Q2 Earnings?,0.0,1.0,0.0,0
2017-08-02 14:05:10,0.0,"With 22K in the books, here are the stocks Wall Street believes will lead the Dow to 23,000",0.0,1.0,0.0,0
2017-08-02 14:09:02,0.0,"Company News For August 02, 2017",0.0,1.0,0.0,0
2017-08-02 15:15:00,0.0,A Large-Scale Acquisition Is Unlikely for Pfizer Until This Happens,0.0,1.0,0.0,0
2017-08-02 15:56:44,0.0,Wednesday's ETF with Unusual Volume: ACWV,0.0,1.0,0.0,0
2017-08-02 16:00:18,-0.3182,Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2,0.277,0.723,0.0,-1
2017-08-03 12:00:00,0.0,Today's Research Reports on Stocks to Watch: Pfizer and Procter & Gamble,0.0,1.0,0.0,0
2017-08-03 13:19:22,0.4939,"Health Care Sector Update for 08/03/2017: JNJ, PFE, ABT, MRK, AMGN, REGN, TEVA",0.0,0.789,0.211,1
2017-08-03 14:01:05,0.6633,Novartis a Top Ranked SAFE Dividend Stock With 3.2% Yield (NVS),0.0,0.596,0.404,1
2017-08-03 15:59:04,0.0,"Keystone Financial Planning, Inc. Buys British American Tobacco PLC, Procter & Gamble Co, ...",0.0,1.0,0.0,0
2017-08-03 16:03:41,0.0,"Dow Movers: V, PFE",0.0,1.0,0.0,0
2017-08-03 18:10:00,0.6597,FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate) for the Treatment of Active Psoriatic Arthritis,0.0,0.735,0.265,1
2017-08-03 20:48:39,0.0,"Market Close Report: NASDAQ Composite index closes at 6,340.34 down -22.31 points",0.0,1.0,0.0,0
2017-08-03 21:04:09,-0.3182,"Momenta (MNTA) Q2 Loss In Line with Estimates, Sales Beat",0.204,0.796,0.0,-1
2017-08-03 21:19:06,0.4767,"Dow bags 7th straight record, but energy slump weighs on broader stock market",0.0,0.728,0.272,1
2017-08-04 01:59:12,0.0,AstraZeneca plc: Buy the Dip?,0.0,1.0,0.0,0
2017-08-04 02:47:00,0.2023,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar",0.125,0.707,0.168,1
2017-08-04 03:39:42,0.0,"Asian stocks mixed as US jobs, politics in focus",0.0,1.0,0.0,0
2017-08-04 12:47:12,0.0,"Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals",0.0,1.0,0.0,0
2017-08-04 13:19:34,0.4939,"Health Care Sector Update for 08/04/2017: JNJ, PFE, ABT, MRK, AMGN, MDRX, CFRX",0.0,0.789,0.211,1
2017-08-04 14:55:31,0.0516,"Dow Jones Reaches Another New High, Closes at 22,026.10",0.0,0.87,0.13,0
2017-08-04 15:13:00,-0.1779,"[$$] CVS Formulary Changes Boost JNJ, Pfizer; Hurt Lilly",0.26,0.534,0.206,-1
2017-08-04 16:03:50,0.0,"Dow Movers: DIS, JPM",0.0,1.0,0.0,0
2017-08-04 16:04:08,0.0,"Market News For August 04, 2017",0.0,1.0,0.0,0
2017-08-04 20:58:54,0.7028,"After Hours Most Active for Aug 4, 2017 :  PFE, QQQ, TWTR, BAC, M, GIS, VZ, GT, AMAT, MDLZ, BRCD, TTPH",0.0,0.755,0.245,1
2017-08-04 22:59:37,0.4767,"Dow 30 Stock Roundup: Apple Impresses, Pfizer Beats on Earnings",0.0,0.744,0.256,1
2017-08-05 15:52:00,0.0,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,0.0,1.0,0.0,0
2017-08-06 05:59:02,0.0,9 Stocks That Have Paid Dividends for More Than a Century,0.0,1.0,0.0,0
2017-08-07 13:45:01,-0.1531,Q2 Earnings Fail to Impress Pharma ETF,0.307,0.439,0.254,-1
2017-08-07 15:36:48,0.0,"Dow Movers: UTX, MCD",0.0,1.0,0.0,0
2017-08-07 15:41:43,0.0,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Intel, Chevron and Exxon Mobil",0.0,1.0,0.0,0
2017-08-07 16:13:00,-0.6705,Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire,0.478,0.522,0.0,-1
2017-08-08 12:45:11,0.0,"Pfizer investing $100M in Sanford plant expansion, adding jobs",0.0,1.0,0.0,0
2017-08-08 13:17:52,0.0,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2017",0.0,1.0,0.0,0
2017-08-08 16:37:47,0.0,Why Martin Shkreli Won’t Be the Last Pharma Bro,0.0,1.0,0.0,0
2017-08-08 16:41:35,0.2023,"Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View",0.0,0.816,0.184,1
2017-08-08 21:03:33,0.4576,"After Hours Most Active for Aug 8, 2017 :  BAC, PFE, CMCSA, FIG, APO, DIS, INTC, QCOM, CSCO, MSFT, MRK, QQQ",0.0,0.864,0.136,1
2017-08-08 22:06:47,0.0,[$$] Aclaris Therapeutics Buys Confluence Life Sciences in $100 Million Deal,0.0,1.0,0.0,0
2017-08-09 01:00:38,0.0,Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher,0.0,1.0,0.0,0
2017-08-09 11:00:00,0.5106,Earnings Review and Free Research Report: Johnson Controls’ Adjusted Net Income Soared 69.4%,0.0,0.784,0.216,1
2017-08-09 15:47:32,-0.296,Mexico watchdog finds big pharma faces no competition on some drugs,0.18,0.82,0.0,-1
2017-08-09 16:37:02,0.0,Vanguard High Dividend Yield ETF Experiences Big Inflow,0.0,1.0,0.0,0
2017-08-09 17:02:23,0.0,Analysts’ Recommendations for Celgene in August 2017,0.0,1.0,0.0,0
2017-08-09 17:05:14,0.5994,Pfizer: Some Near Term Challenges May Mute Positive Triggers,0.0,0.588,0.412,1
2017-08-10 12:40:22,0.0,Short Sellers Hike Bets in Major Pharma,0.0,1.0,0.0,0
2017-08-10 14:03:30,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 11, 2017",0.0,1.0,0.0,0
2017-08-10 23:36:00,0.4466,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,0.0,0.827,0.173,1
2017-08-11 05:51:22,0.0,Pfizer Alum's China Startup Is Said to Select Banks for IPO,0.0,1.0,0.0,0
2017-08-11 12:00:33,0.6486,IHS Markit Score Update: Rise in demand for ETFs holding Pfizer Inc is a positive for its shares,0.07,0.657,0.272,1
2017-08-11 13:06:04,0.6597,Luspatercept: Opportunity for Celgene’s Long-Term Growth?,0.0,0.426,0.574,1
2017-08-11 15:46:28,-0.3182,"On earnings calls, corporate leaders openly bemoan DC's lack of direction",0.187,0.813,0.0,-1
2017-08-11 19:59:09,0.0,Pfizer’s Valuation after 2Q17 Earnings,0.0,1.0,0.0,0
2017-08-11 21:35:43,0.0,Pfizer’s 2Q17 Earnings: What You Need to Know,0.0,1.0,0.0,0
2017-08-12 00:26:36,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : August 12, 2017",0.0,0.745,0.255,1
2017-08-12 01:36:08,0.0,Edited Transcript of PFE earnings conference call or presentation 1-Aug-17 2:00pm GMT,0.0,1.0,0.0,0
2017-08-12 16:13:17,-0.5719,Video games could soon replace pills in treating Alzheimer's disease and depression,0.252,0.748,0.0,-1
2017-08-13 18:03:00,-0.5423,Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?,0.259,0.741,0.0,-1
2017-08-14 11:37:44,0.4404,Pfizer’s Innovative and Essential Health Businesses in 2Q17,0.0,0.707,0.293,1
2017-08-14 13:07:11,0.0,Understanding Pfizer’s Geographical Performance in 2Q17,0.0,1.0,0.0,0
2017-08-14 14:37:38,0.3818,Pfizer’s Major Growth Drivers in 2Q17,0.0,0.658,0.342,1
2017-08-14 19:34:53,0.0,"Alnylam Pharmaceuticals, Inc. Earnings: Waiting for Apollo",0.0,1.0,0.0,0
2017-08-15 09:00:00,0.0,What’s Harder Than Making Copycat Biotech Drugs? Selling Them,0.0,1.0,0.0,0
2017-08-15 11:36:43,0.0,Pfizer’s Declining-Revenue Products in 2Q17,0.0,1.0,0.0,0
2017-08-15 13:06:11,0.2023,Pfizer’s Important Product Developments in 2Q17,0.0,0.735,0.265,1
2017-08-15 13:13:27,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : August 15, 2017",0.0,1.0,0.0,0
2017-08-15 13:16:21,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for August 16, 2017",0.0,1.0,0.0,0
2017-08-15 14:36:03,0.0,Pfizer’s Corporate and Pipeline Developments in 2Q17,0.0,1.0,0.0,0
2017-08-15 15:42:15,0.4767,"Clovis (CLVS) Focuses on Label Expansion, Rubraca Impresses",0.0,0.693,0.307,1
2017-08-15 16:39:35,0.3818,Catalyst (CPRX) Focused on Development of Pipeline Candidates,0.0,0.729,0.271,1
2017-08-15 21:04:16,0.4576,"After Hours Most Active for Aug 15, 2017 :  MSFT, MU, FOXA, URBN, ORCL, WMB, QQQ, PFE, CMCSA, EXC, CHK, XOM",0.0,0.864,0.136,1
2017-08-16 02:01:00,0.7184,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",0.0,0.6,0.4,1
2017-08-16 13:17:11,0.0,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 17, 2017",0.0,1.0,0.0,0
2017-08-16 13:35:35,0.0,"Cypress Capital Management Llc Buys iShares International Select Dividend, SPDR DJ STOXX 50 ...",0.0,1.0,0.0,0
2017-08-16 14:16:55,-0.4404,The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak,0.209,0.791,0.0,-1
2017-08-16 17:35:17,0.0,"First Fiduciary Investment Counsel, Inc. Buys Capital One Financial Corp, Intel Corp, Sells ...",0.0,1.0,0.0,0
2017-08-17 11:36:17,0.0,How Amgen’s Nephrology Drugs Are Positioned after 2Q17?,0.0,1.0,0.0,0
2017-08-17 14:06:02,0.3818,Can Pfizer Bank on New Immunotherapy Bavencio for Growth?,0.0,0.755,0.245,1
2017-08-17 16:34:19,0.0,"Notable ETF Inflow Detected - VT, GE, CVX, PFE",0.0,1.0,0.0,0
2017-08-17 17:57:00,0.4767,Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin),0.0,0.721,0.279,1
2017-08-17 19:59:14,-0.4019,FDA approves Pfizer's drug for rare blood cancer,0.336,0.458,0.206,-1
2017-08-17 21:19:00,-0.3182,Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa,0.284,0.516,0.2,-1
2017-08-17 21:36:35,0.0,"FDA OKs Pfizer drug for rare, fast-killing type of leukemia",0.0,1.0,0.0,0
2017-08-17 23:38:11,-0.6597,Exelixis Submits sNDA for Kidney Cancer Drug Cabometyx,0.386,0.614,0.0,-1
2017-08-18 01:11:00,-0.6597,"FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal",0.239,0.761,0.0,-1
2017-08-18 05:37:50,0.2023,"Top Analyst Reports for Pfizer, TJX Companies & Honda",0.0,0.795,0.205,1
2017-08-18 10:59:00,0.4404,Bristol-Myers Squibb and Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation (NVAF) and Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) at ESC Congress 2017,0.062,0.792,0.147,1
2017-08-18 11:09:11,0.0,"Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY&apos;s Opdivo",0.0,1.0,0.0,0
2017-08-18 11:39:11,0.0,Analysts’ Recommendations for Bristol-Myers Squibb in August 2017,0.0,1.0,0.0,0
2017-08-18 13:18:01,-0.34,Pfizer&apos;s (PFE) Besponsa Gets FDA Nod with a Boxed Warning,0.231,0.769,0.0,-1
2017-08-18 13:41:51,0.0,"The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk",0.0,1.0,0.0,0
2017-08-18 13:42:33,0.0,"Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY's Opdivo",0.0,1.0,0.0,0
2017-08-18 14:39:55,0.5267,IWX's Underlying Holdings Could Mean 10% Gain Potential,0.0,0.673,0.327,1
2017-08-18 15:35:20,-0.6249,"The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia",0.369,0.481,0.15,-1
2017-08-18 15:43:40,-0.34,Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning,0.231,0.769,0.0,-1
2017-08-18 16:40:22,0.0,Notable Two Hundred Day Moving Average Cross - PFE,0.0,1.0,0.0,0
2017-08-19 05:01:00,0.4019,[$$] Healthy Dividends,0.0,0.426,0.574,1
2017-08-19 15:38:14,0.0,These Stocks Have Tripled This Year,0.0,1.0,0.0,0
2017-08-20 11:43:00,0.2263,"Here&apos;s How Much $10,000 Invested in Pfizer in 1977 Is Worth Now",0.0,0.853,0.147,1
2017-08-20 12:15:00,0.5859,Pfizer&apos;s Besponsa Is Yet Another Win for the Biopharma Giant,0.0,0.703,0.297,1
2017-08-20 13:37:46,0.5859,Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant,0.0,0.703,0.297,1
2017-08-20 13:38:22,0.2263,"Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth Now",0.0,0.853,0.147,1
2017-08-21 12:21:00,0.4404,Better Buy: AbbVie Inc. vs. Pfizer Inc.,0.0,0.674,0.326,1
2017-08-21 13:18:00,0.4939,"Health Care Sector Update for 08/21/2017: JNJ, PFE, ABT, MRK, AMGN, AZN, NVS, TNXP",0.0,0.802,0.198,1
2017-08-21 14:37:24,0.0,"Pfizer Inc. :PFE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017",0.0,1.0,0.0,0
2017-08-21 20:57:37,0.4576,"After Hours Most Active for Aug 21, 2017 :  GE, INTC, PFE, RAD, CMCSA, TGT, F, BAC, AAPL, QQQ, AMAT, EMB",0.0,0.864,0.136,1
2017-08-22 01:38:39,0.5719,3 Dividend Stocks Perfect for Retirement,0.0,0.519,0.481,1
2017-08-22 12:00:00,-0.6597,"Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer",0.239,0.761,0.0,-1
2017-08-22 13:07:36,0.0,How Allergan’s US Specialized Therapeutics Segment Performed in 2Q17,0.0,1.0,0.0,0
2017-08-22 13:18:03,0.4939,"Health Care Sector Update for 08/22/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, PFE, MDT",0.0,0.802,0.198,1
2017-08-22 13:18:08,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 23, 2017",0.0,1.0,0.0,0
2017-08-22 13:47:07,0.2263,India grants Pfizer patent on pneumonia vaccine in blow to aid group,0.0,0.853,0.147,1
2017-08-22 14:44:02,0.2023,Immunomedics&apos; Progress in Phase II Cancer Study Encouraging,0.282,0.321,0.397,1
2017-08-22 16:41:40,0.2023,Immunomedics' Progress in Phase II Cancer Study Encouraging,0.282,0.321,0.397,1
2017-08-22 19:47:00,0.0,What&apos;s Next for Bristol-Myers Squibb After Its Opdivo Setback?,0.0,1.0,0.0,0
2017-08-22 21:39:32,0.0,What's Next for Bristol-Myers Squibb After Its Opdivo Setback?,0.0,1.0,0.0,0
2017-08-23 11:37:09,0.0,How Allergan’s International Segment Performed in 2Q17,0.0,1.0,0.0,0
2017-08-23 13:18:25,0.4939,"Health Care Sector Update for 08/23/2017: JNJ, PFE, ABT, MRK, AMGN, PRTK, NVAX, RARE",0.0,0.802,0.198,1
2017-08-23 13:39:55,0.0,How Johnson & Johnson Makes Most of Its Money,0.0,1.0,0.0,0
2017-08-23 14:03:42,0.0,U.S. appeals court upholds insider trading conviction of SAC's Martoma,0.0,1.0,0.0,0
2017-08-23 14:10:02,-0.6597,Pfizer&apos;s Ibrance in First-Line Combo Breast Cancer Study,0.386,0.614,0.0,-1
2017-08-23 16:40:41,-0.6597,Pfizer's Ibrance in First-Line Combo Breast Cancer Study,0.386,0.614,0.0,-1
2017-08-23 17:38:09,-0.4215,SAC Capital's Martoma fails to overturn U.S. insider trading conviction,0.237,0.763,0.0,-1
2017-08-23 19:37:25,0.6249,30 Great Stocks of All Time,0.0,0.549,0.451,1
2017-08-23 20:58:01,0.4576,"After Hours Most Active for Aug 23, 2017 :  T, QQQ, CAG, PFE, ENZY, CTL, VWR, F, GE, MSFT, MU, CSCO",0.0,0.864,0.136,1
2017-08-23 22:37:44,0.0,Here's Why Clovis Stock Is Up Almost 60% So Far in 2017,0.0,1.0,0.0,0
2017-08-23 23:37:35,0.0,3 High-Yield Dividend Stocks for Conservative Investors,0.0,1.0,0.0,0
2017-08-24 12:00:00,0.4404,Pfizer Rare Disease Launches Two First-of-Its-Kind Innovative Technologies for People Living with Hemophilia at National Hemophilia Foundation Annual Meeting,0.0,0.861,0.139,1
2017-08-24 13:17:40,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 25, 2017",0.0,1.0,0.0,0
2017-08-24 13:18:15,-0.2263,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 25, 2017",0.147,0.853,0.0,-1
2017-08-24 13:18:22,0.4939,"Health Care Sector Update for 08/24/2017: JNJ, PFE, ABT, MRK, AMGN, CO, ENZY, MYL",0.0,0.802,0.198,1
2017-08-24 15:07:32,0.0,Florida set to carry out execution with drug not previously used in lethal injections,0.0,1.0,0.0,0
2017-08-24 17:30:00,-0.5267,Candida Auris: A New Fungal Superbug Emerging As A Global Threat,0.298,0.702,0.0,-1
2017-08-24 23:11:52,0.0,Florida executes man with drug not previously used in lethal injections,0.0,1.0,0.0,0
2017-08-25 12:00:00,0.0,Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A,0.0,1.0,0.0,0
2017-08-25 13:41:04,0.4939,"Health Care Sector Update for 08/25/2017: JNJ, PFE, ABT, MRK, AMGN, XOMA, VEEV, ADMS, NVS",0.0,0.814,0.186,1
2017-08-25 16:41:55,0.0,"XLV, GNRX: Big ETF Outflows",0.0,1.0,0.0,0
2017-08-25 16:45:04,0.0,"Noteworthy ETF Inflows: VT, GE, CVX, PFE",0.0,1.0,0.0,0
2017-08-25 20:58:21,0.4576,"After Hours Most Active for Aug 25, 2017 :  WLL, PFE, ROST, MU, EBAY, QQQ, DAL, KO, CSCO, AXL, CPN, WFM",0.0,0.864,0.136,1
2017-08-26 17:37:41,-0.3612,Is the System Rigged Against Biosimilars?,0.333,0.667,0.0,-1
2017-08-27 13:49:53,0.0,Here Are the Big Pharma Stocks to Own Based on R&D Spending,0.0,1.0,0.0,0
2017-08-27 20:48:33,0.5574,Can Buying Exelixis Stock Still Make You Rich?,0.0,0.66,0.34,1
2017-08-28 02:47:00,-0.5106,Bristol-Myers: Eliquis Shows Lower Risk Of Stroke In NVAF Patient Subgroups,0.323,0.677,0.0,-1
2017-08-28 05:26:00,0.0,"Bristol-Myers, Pfizer Report Investigational Eliquis Data - Quick Facts",0.0,1.0,0.0,0
2017-08-28 06:30:00,0.4215,Bristol-Myers Squibb and Pfizer Present Observational Real-World Data Analysis on the Effectiveness and Safety of Eliquis® (apixaban) Compared to Warfarin in Select High-Risk Patients with Non-Valvular Atrial Fibrillation,0.0,0.906,0.094,1
2017-08-28 09:00:00,0.0,Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion,0.0,1.0,0.0,0
2017-08-28 12:09:12,0.0,Sangamo Therapeutics Initiates Dosing in Hemophilia A Study,0.0,1.0,0.0,0
2017-08-28 12:50:45,0.0,AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting,0.0,1.0,0.0,0
2017-08-28 12:51:26,0.0772,In Your 60s? 3 Stocks You Might Want to Buy,0.0,0.86,0.14,0
2017-08-28 13:07:40,0.0,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : August 28, 2017",0.0,1.0,0.0,0
2017-08-28 13:29:03,0.4939,"Health Care Sector Update for 08/28/2017: JNJ, PFE, ABT, MRK, AMGN, KITE, GILD, AVEO, NVS",0.0,0.814,0.186,1
2017-08-28 15:49:52,0.0,"Dow Movers: TRV, HD",0.0,1.0,0.0,0
2017-08-28 20:49:33,0.0,3 High-Yield Dividend Aristocrat Stocks,0.0,1.0,0.0,0
2017-08-28 22:10:34,0.0,"ETFs with exposure to Pfizer Inc. : August 28, 2017",0.0,1.0,0.0,0
2017-08-28 23:45:00,-0.4767,We Got It Wrong With OPKO Health -- Now What?,0.256,0.744,0.0,-1
2017-08-29 08:23:00,0.0,Biotech Stocks Facing FDA Decision In September,0.0,1.0,0.0,0
2017-08-29 09:00:15,-0.7003,Medical Journals Have a Fake News Problem,0.592,0.408,0.0,-1
2017-08-29 11:00:00,0.3818,U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia,0.0,0.898,0.102,1
2017-08-29 11:30:33,0.0,[$$] Pfizer to test drug for liver disease linked to rising obesity,0.0,1.0,0.0,0
2017-08-29 12:21:00,0.4215,Bristol-Myers Squibb and Pfizer Alliance Announce Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Elderly Patients with Non-Valvular Atrial Fibrillation,0.0,0.906,0.094,1
2017-08-29 13:29:03,0.4939,"Health Care Sector Update for 08/29/2017: JNJ, PFE, ABT, MRK, AMGN, IMGN, ETRM",0.0,0.789,0.211,1
2017-08-29 13:51:10,0.0,3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%,0.0,1.0,0.0,0
2017-08-29 14:58:18,0.0,"Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow",0.0,1.0,0.0,0
2017-08-29 15:29:03,0.3182,Biogen Alzheimer&apos;s Drug Shows Promise in Long-Term Study,0.0,0.753,0.247,1
2017-08-29 15:45:03,0.5267,Pfizer Presents Encouraging Eliquis Results in NVAF Patients,0.0,0.673,0.327,1
2017-08-29 16:48:22,0.0,"David Tepper Reduces General Motors, Allergan Positions, Exits Pfizer",0.0,1.0,0.0,0
2017-08-29 17:12:58,0.0,Bristol-Myers Squibb’s Valuation after 2Q17 Earnings,0.0,1.0,0.0,0
2017-08-29 17:51:47,0.0,Why Catalent Inc. Rose as Much as 17% This Morning,0.0,1.0,0.0,0
2017-08-29 17:52:09,0.3182,Biogen Alzheimer's Drug Shows Promise in Long-Term Study,0.0,0.753,0.247,1
2017-08-29 20:14:52,0.0,Analysts’ Recommendations for Pfizer in August 2017,0.0,1.0,0.0,0
2017-08-29 22:06:51,0.0,How Did Pfizer Perform in 2Q17?,0.0,1.0,0.0,0
2017-08-29 23:49:36,0.0,"Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today",0.0,1.0,0.0,0
2017-08-30 02:31:00,0.0772,"APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision",0.0,0.909,0.091,0
2017-08-30 11:37:38,0.3818,Pfizer’s Immuno-Oncology Clinical Program’s Long-Term Growth Potential,0.0,0.698,0.302,1
2017-08-30 13:08:25,0.5267,Talazoparib Could Be a Significant Long-Term Growth Driver for Pfizer,0.0,0.614,0.386,1
2017-08-30 13:13:01,-0.34,Merck&apos;s CETP Inhibitor Reduces Cardiovascular Risk by 9%,0.362,0.638,0.0,-1
2017-08-30 13:17:01,0.2732,Pfizer&apos;s sNDA for Bosulif Accepted in the U.S. and Europe,0.0,0.811,0.189,1
2017-08-30 13:29:17,0.4939,"Health Care Sector Update for 08/30/2017: JNJ, PFE, ABT, MRK, AMGN, MDCO, OTIC",0.0,0.789,0.211,1
2017-08-30 14:01:00,0.0,Gilead-Kite: A New Transformative Deal For Biotech,0.0,1.0,0.0,0
2017-08-30 14:37:15,0.6124,Pfizer’s Ibrance Could See Robust Growth in 2H17,0.0,0.545,0.455,1
2017-08-30 14:52:01,-0.34,Merck's CETP Inhibitor Reduces Cardiovascular Risk by 9%,0.362,0.638,0.0,-1
2017-08-30 15:46:00,-0.5719,Merck: Heartbreak Over A Cholesterol Drug,0.481,0.519,0.0,-1
2017-08-30 15:54:39,0.2732,Pfizer's sNDA for Bosulif Accepted in the U.S. and Europe,0.0,0.811,0.189,1
2017-08-30 20:48:16,0.6369,5 Greatest Health-Care Stocks of All Time,0.0,0.543,0.457,1
2017-08-31 03:06:00,0.0,"Hospira Recalls 1 Lot Of Vancomycin Hydrochloride For Injection, USP,750 Mg/vial",0.0,1.0,0.0,0
2017-08-31 11:37:14,0.0,How Pfizer’s Prevnar 13 and Lyrica Stand after 2Q17,0.0,1.0,0.0,0
2017-08-31 12:54:00,0.0,"Amyloid Publishes Long-Term Data Analysis from Pfizer Suggesting Tafamidis Delays Progression of TTR-FAP, a Rare Disease",0.0,1.0,0.0,0
2017-08-31 13:06:45,0.0,How Pfizer’s Rare Disease Franchise Stands after 2Q17,0.0,1.0,0.0,0
2017-08-31 13:18:32,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 01, 2017",0.0,1.0,0.0,0
2017-08-31 13:26:01,0.0,The Medicines Company&apos;s Infection Drug Vabomere Gets FDA Nod,0.0,1.0,0.0,0
2017-08-31 13:29:27,0.4939,"Health Care Sector Update for 08/31/2017: JNJ, PFE, MRK, ABT, AMGN, APRI, BVXV, AMGN",0.0,0.802,0.198,1
2017-08-31 14:36:32,0.0,"A Post-2Q17 Update on Pfizer’s Oncology Drugs: Sutent, Xalkori, and Inlyta",0.0,1.0,0.0,0
2017-08-31 15:56:17,0.0,The Medicines Company's Infection Drug Vabomere Gets FDA Nod,0.0,1.0,0.0,0
2017-08-31 16:34:10,0.0,Changes in GlaxoSmithKline’s Valuation after 2Q17,0.0,1.0,0.0,0
2017-08-31 20:29:25,0.4939,"Health Care Sector Update for 08/31/2017: JNJ, PFE, ABT, MRK, AMGN, IPXL, INSY",0.0,0.789,0.211,1
2017-08-31 20:58:52,0.4576,"After Hours Most Active for Aug 31, 2017 :  DOW, DD, SBAC, BAC, QQQ, MSFT, TEVA, PFE, GE, AMAT, GILD, INTC",0.0,0.864,0.136,1
2017-09-01 00:11:00,0.0,"Bristol-Myers Squibb, Pfizer, Abbott Are on the Move: Buy These Target Prices",0.0,1.0,0.0,0
2017-09-01 10:51:03,0.0,Why Is Pfizer (PFE) Up 2.5% Since the Last Earnings Report?,0.0,1.0,0.0,0
2017-09-01 11:36:25,0.0,A Post-2Q17 Look at Pfizer’s Internal Medicines,0.0,1.0,0.0,0
2017-09-01 13:06:18,0.0,Pfizer’s Sterile Injection Pharmaceuticals in 2Q17 and 1H17,0.0,1.0,0.0,0
2017-09-01 13:50:47,0.4939,"Health Care Sector Update for 09/01/2017: JNJ, PFE, ABT, MRK, AMGN, IOVA, APVO, PGNX",0.0,0.802,0.198,1
2017-09-01 14:36:14,0.0,How Pfizer’s Enbrel and Xeljanz Are Positioned after 2Q17,0.0,1.0,0.0,0
2017-09-01 15:38:00,0.4767,Pfizer Receives FDA Approval for MYLOTARG™ (gemtuzumab ozogamicin),0.0,0.693,0.307,1
2017-09-01 18:40:00,-0.1027,3 Stocks That Pay You,0.318,0.682,0.0,-1
2017-09-01 18:41:00,0.4404,Better Buy: Eli Lilly and Company vs. Pfizer Inc.,0.0,0.734,0.266,1
2017-09-01 19:21:46,0.4019,FDA approves Pfizer's leukemia drug,0.0,0.597,0.403,1
2017-09-01 20:30:57,0.0,"Pfizer Inc. : PFE-US: Dividend Analysis : August 04th, 2017 (record date) : By the numbers : September 1, 2017",0.0,1.0,0.0,0
2017-09-01 20:34:59,0.4019,FDA Approves Pfizer's Leukemia Drug,0.0,0.597,0.403,1
2017-09-02 01:15:03,0.296,Pfizer Inc (PFE) Chairman & CEO Ian C Read Sold $6.7 million of Shares,0.0,0.833,0.167,1
2017-09-02 09:48:36,0.0,US Market Indexes End the Month Higher,0.0,1.0,0.0,0
2017-09-03 12:49:29,0.6369,Here's the Best Dividend Stock in Big Pharma,0.0,0.625,0.375,1
2017-09-04 11:36:07,0.0,An Update on Pfizer’s Legacy Established Products after 2Q17,0.0,1.0,0.0,0
2017-09-04 13:06:07,0.0,What to Expect from Pfizer’s Biosimilars Business,0.0,1.0,0.0,0
2017-09-04 13:50:40,0.0,Key FDA Regulatory Events to Watch Out for in Sep 2017,0.0,1.0,0.0,0
2017-09-04 13:54:01,0.4215,Pfizer&apos;s Acute Leukemia Drug Mylotarg Approved by the FDA,0.0,0.741,0.259,1
2017-09-04 15:49:21,0.4215,Pfizer's Acute Leukemia Drug Mylotarg Approved by the FDA,0.0,0.741,0.259,1
2017-09-05 16:51:52,0.4939,Health Care Select Sector SPDR Fund Experiences Big Outflow,0.0,0.714,0.286,1
2017-09-06 11:50:01,0.0,7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020,0.0,1.0,0.0,0
2017-09-06 13:23:24,0.0,"Shire plc (SHPG) Ex-Dividend Date Scheduled for September 07, 2017",0.0,1.0,0.0,0
2017-09-06 16:52:54,-0.3182,Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer,0.303,0.483,0.214,-1
2017-09-06 16:53:48,0.0,MEI Pharma-Presage Biosciences on License Deal for Voruciclib,0.0,1.0,0.0,0
2017-09-06 16:55:11,-0.2023,4 Drug Stocks Worth a Look on Promising Cancer Pipeline,0.314,0.357,0.329,-1
2017-09-06 22:50:34,0.2263,Here's Why Spark Therapeutics Inc. Surged 23.5% in August,0.0,0.808,0.192,1
2017-09-07 01:15:00,0.0,Genentech Recalls Three Lots Of Activase (alteplase) 100mg Vials,0.0,1.0,0.0,0
2017-09-07 05:49:00,0.4215,New Drugs Approved In August,0.0,0.588,0.412,1
2017-09-07 13:53:40,0.2023,3 Top Stocks for Retirees,0.0,0.625,0.375,1
2017-09-07 15:43:03,0.0,3 Alternative Mutual Funds to Ride Out a Spooky September,0.0,1.0,0.0,0
2017-09-07 15:58:12,0.0,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,0.0,1.0,0.0,0
2017-09-07 16:54:35,0.0,J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use,0.0,1.0,0.0,0
2017-09-07 19:23:31,-0.8316,EpiPen Maker Neglected ‘Hundreds’ of Complaints About Defects,0.638,0.362,0.0,-1
2017-09-07 19:32:05,-0.4019,"FDA says there have been 'hundreds of complaints' about EpiPen misfires, some patient deaths followed",0.162,0.838,0.0,-1
2017-09-07 21:20:21,-0.4767,U.S. FDA warns of problems with EpiPen manufacturing plant,0.369,0.631,0.0,-1
2017-09-07 23:15:17,-0.1027,"[$$] FDA Warns Pfizer's Meridian Unit on EpiPen Oversight, Quality Issues",0.123,0.877,0.0,-1
2017-09-08 00:19:00,-0.5859,FDA Warns Of Manufacturing Violations To EpiPen Plant,0.444,0.556,0.0,-1
2017-09-08 03:58:57,0.0,PRESS DIGEST - Wall Street Journal - Sept 8,0.0,1.0,0.0,0
2017-09-08 04:15:23,0.0,PRESS DIGEST- New York Times business news - Sept 8,0.0,1.0,0.0,0
2017-09-08 05:05:00,-0.1027,"[$$] FDA Warns Pfizer’s Meridian Unit on EpiPen Oversight, Quality Issues",0.123,0.877,0.0,-1
2017-09-08 10:32:33,-0.34,Pfizer’s Meridian Hit With FDA Warning Over EpiPen Flaws,0.231,0.769,0.0,-1
2017-09-08 10:53:10,-0.6249,FDA warns of serious manufacturing violations in letter to EpiPen manufacturing facility,0.404,0.596,0.0,-1
2017-09-08 11:38:13,0.0,Understanding Merck’s Valuation after 2Q17,0.0,1.0,0.0,0
2017-09-08 11:49:00,0.0,"[$$] Pfizer CEO, CFO Sell $13 Million in Stock",0.0,1.0,0.0,0
2017-09-08 13:23:29,0.0,"Stocks to Watch: Equifax, Pfizer, Kroger, Southwest, Kura Oncology, American Outdoor Brands",0.0,1.0,0.0,0
2017-09-08 15:35:45,0.0721,Pfizer Accused of Not Investigating EpiPen Failures,0.227,0.517,0.256,0
2017-09-08 15:55:33,0.5719,"Bristol-Myers' Opdivo Study Meets Early Success, Stock Up",0.0,0.654,0.346,1
2017-09-08 15:55:36,0.6597,"Dow 30 Stock Roundup: UTX to Buy Rockwell Collins, Merck Secures EU Keytruda Approval",0.0,0.69,0.31,1
2017-09-08 17:17:55,-0.2732,Feds want to deny Martin Shkreli bail,0.276,0.575,0.149,-1
2017-09-08 23:51:09,0.5719,3 Excellent Dividend ETFs for Turbulent Times,0.0,0.575,0.425,1
2017-09-09 22:05:00,-0.6249,Lilly Breast Cancer Drug Results May Challenge Pfizer Pill,0.346,0.551,0.102,-1
2017-09-10 07:15:00,0.5574,"Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin® (trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congress",0.0,0.859,0.141,1
2017-09-10 08:19:36,-0.6597,"Lilly takes on Pfizer, Novartis with new breast cancer drug data",0.306,0.694,0.0,-1
2017-09-11 00:58:00,0.4404,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch",0.0,0.805,0.195,1
2017-09-11 11:00:00,-0.5267,Pfizer Presents Overall Survival Data of XALKORI in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer,0.216,0.686,0.098,-1
2017-09-11 11:17:00,0.6369,Allergan&apos;s Patent Loophole Could Be a Huge Gift for Pfizer,0.0,0.574,0.426,1
2017-09-11 11:40:00,-0.6249,Featured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for Anaphylaxis,0.242,0.758,0.0,-1
2017-09-11 12:51:40,0.6369,Allergan's Patent Loophole Could Be a Huge Gift for Pfizer,0.0,0.574,0.426,1
2017-09-11 13:20:24,0.0,"Forward Pharma A/S (FWP) Ex-Dividend Date Scheduled for September 12, 2017",0.0,1.0,0.0,0
2017-09-11 13:55:00,0.4168,FDA's Letter To Pfizer Won't Hurt EpiPen Market,0.0,0.716,0.284,1
2017-09-11 15:16:49,0.0,AbbVie says deaths in arthritis trial not linked to drug,0.0,1.0,0.0,0
2017-09-12 14:15:02,-0.6597,Pfizer Lung Cancer Drug&apos;s Overall Survival Data Unfavorable,0.386,0.614,0.0,-1
2017-09-12 14:25:16,0.4215,Is There Now An Opportunity In Pfizer Inc (PFE)?,0.0,0.741,0.259,1
2017-09-12 15:13:26,0.0,"Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock",0.0,1.0,0.0,0
2017-09-12 16:38:18,0.0,AbbVie's RA Candidate Meets Primary Endpoint in Phase III,0.0,1.0,0.0,0
2017-09-12 16:39:56,-0.6597,Pfizer Lung Cancer Drug's Overall Survival Data Unfavorable,0.386,0.614,0.0,-1
2017-09-12 17:11:00,0.6908,"Teva Pharma showing strong gains, IQ100 up 22%",0.0,0.513,0.487,1
2017-09-12 20:48:48,0.1027,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,454.28.",0.0,0.896,0.104,1
2017-09-12 20:54:54,0.0,"Close Update: Wall Street Hits Record Highs as Telecoms, Financials Lead",0.0,1.0,0.0,0
2017-09-12 21:34:53,0.0,Dow Jumps Again; Apple Stock Falls After iPhone X,0.0,1.0,0.0,0
2017-09-12 23:34:48,0.5574,Bristol-Myers Reports Positive Results from Melanoma Study,0.0,0.625,0.375,1
2017-09-13 11:41:04,0.0,Teva Pharmaceutical on the Street: Analysts’ Recommendations in September,0.0,1.0,0.0,0
2017-09-13 11:59:47,0.0258,US Market Indexes Reach New Highs on Tuesday,0.0,0.864,0.136,0
2017-09-13 13:34:16,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2017",0.0,1.0,0.0,0
2017-09-13 16:38:33,0.0,"XLV, PFE, MDT, AGN: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2017-09-13 21:23:09,0.2023,"Top Analyst Reports for Apple, Pfizer & Carnival",0.0,0.769,0.231,1
2017-09-14 01:36:47,0.0,3 Biotech Stocks That Have Already Quadrupled in 2017,0.0,1.0,0.0,0
2017-09-14 05:10:00,0.5574,"Pfizer, Astellas Report Positive Results From XTANDI Phase 3 Trial - Quick Facts",0.0,0.735,0.265,1
2017-09-14 09:00:00,-0.2023,Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer,0.163,0.704,0.133,-1
2017-09-14 09:54:45,-0.6249,"Pfizer, Astellas prostate cancer drug clears late-stage trial",0.376,0.513,0.111,-1
2017-09-14 11:32:00,0.6369,Here&apos;s Why the Best Is Yet to Come for Opko Health Inc.,0.0,0.724,0.276,1
2017-09-14 11:40:30,0.0,US STOCKS-Futures flat ahead of key inflation data,0.0,1.0,0.0,0
2017-09-14 12:16:09,0.1027,Pfizer shares rise 1.4% after news of positive late-stage cancer trial,0.242,0.44,0.319,1
2017-09-14 13:21:01,0.0,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk",0.0,1.0,0.0,0
2017-09-14 13:41:48,0.6369,Here's Why the Best Is Yet to Come for Opko Health Inc.,0.0,0.724,0.276,1
2017-09-14 13:51:08,-0.296,"UPDATE 2-Pfizer, Astellas prostate cancer drug succeeds key trial",0.301,0.479,0.219,-1
2017-09-14 14:18:00,0.0,Dow Hits Intraday Record but Rest of Market Falters After Inflation Reading,0.0,1.0,0.0,0
2017-09-14 14:18:00,-0.2023,Pfizer Announces Positive Late Stage Trial of Cancer Treatment,0.293,0.467,0.24,-1
2017-09-14 15:29:00,-0.4019,"Pfizer, Astellas prostate cancer drug promising in late-stage trial",0.312,0.496,0.191,-1
2017-09-14 15:51:03,0.0,Why Did Pfizer (PFE) Stock Pop Today?,0.0,1.0,0.0,0
2017-09-14 16:20:14,0.2732,"US stocks are mixed as energy companies rise, retailers dip",0.0,0.811,0.189,1
2017-09-14 17:16:27,0.4939,"Health Care Sector Update for 09/14/2017: JNJ, PFE, ABT, MRK, AMGN, GKOS, PFE, BVXV",0.0,0.802,0.198,1
2017-09-14 19:06:00,0.2263,"Boeing, United Tech Lead Dow to Records but Rest of Market Flounders",0.0,0.853,0.147,1
2017-09-14 19:19:00,-0.7906,"Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale",0.318,0.682,0.0,-1
2017-09-14 20:05:00,0.1655,"Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall",0.0,0.879,0.121,1
2017-09-14 20:05:37,0.0,How This Dow Component Could Double Its Prostate-Cancer Market,0.0,1.0,0.0,0
2017-09-14 20:11:55,0.0,Markets Right Now: Dow ekes out another high in mixed day,0.0,1.0,0.0,0
2017-09-14 20:37:41,0.4939,"Health Care Sector Update for 09/14/2017: JNJ, PFE, ABT, MRK, AMGN, EKSO, RARE, CRIS",0.0,0.802,0.198,1
2017-09-14 21:37:06,0.0,"Noteworthy Thursday Option Activity: MCD, MO, PFE",0.0,1.0,0.0,0
2017-09-15 10:52:10,0.0,"Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO",0.0,1.0,0.0,0
2017-09-15 11:37:06,-0.4939,Who Will Win the Kidney Cancer Battle Between Bristol-Myers Squibb and Exelixis?,0.354,0.455,0.192,-1
2017-09-15 12:02:53,0.0,Dow Jones Closes at New High,0.0,1.0,0.0,0
2017-09-15 13:37:25,-0.6597,Pfizer Punches Back at Johnson & Johnson in Prostate Cancer,0.355,0.645,0.0,-1
2017-09-15 15:38:55,0.0,"Dow Movers: GS, BA",0.0,1.0,0.0,0
2017-09-15 16:38:20,0.0,Oncology Space in Focus this Week on ESMO Presentations,0.0,1.0,0.0,0
2017-09-15 16:39:27,-0.296,Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study,0.301,0.479,0.219,-1
2017-09-15 19:34:43,0.0,"Levin Capital Strategies, L.p. Buys Tyson Foods Inc, General Electric Co, Qualcomm Inc, Sells ...",0.0,1.0,0.0,0
2017-09-16 19:25:00,0.0,3 Stocks to Buy and Hold for Decades,0.0,1.0,0.0,0
2017-09-17 11:03:00,0.4404,Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb,0.0,0.674,0.326,1
2017-09-17 14:35:49,0.4404,10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright,0.0,0.734,0.266,1
2017-09-18 14:00:02,0.4767,Neos Therapeutics ADHD Drug Adzenys Receives Approval in US,0.0,0.721,0.279,1
2017-09-18 14:19:26,-0.6597,Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear,0.435,0.565,0.0,-1
2017-09-18 14:30:00,0.0,3 High-Yield Healthcare Stocks,0.0,1.0,0.0,0
2017-09-18 16:40:38,0.3818,Catalyst (CPRX) Focused on Two Lead Pipeline Candidates,0.0,0.729,0.271,1
2017-09-18 17:35:09,0.4019,Interesting October Stock Options for PFE,0.0,0.649,0.351,1
2017-09-18 18:19:40,0.3612,What Analysts Recommend for Novartis in September 2017,0.0,0.737,0.263,1
2017-09-18 20:56:11,0.4576,"After Hours Most Active for Sep 18, 2017 :  MSFT, LC, CERN, BAC, MU, PFE, BABA, GE, CPN, AAPL, ISBC, ETFC",0.0,0.864,0.136,1
2017-09-19 11:34:00,0.0,3 Stocks to Buy with Dividend Yields Above 3%,0.0,1.0,0.0,0
2017-09-19 14:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts,0.0,1.0,0.0,0
2017-09-19 17:15:00,-0.2732,Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery,0.091,0.909,0.0,-1
2017-09-19 20:56:17,0.4576,"After Hours Most Active for Sep 19, 2017 :  BAC, T, INTC, APD, KEY, Z, PFE, GE, FOXA, BBBY, QQQ, ETFC",0.0,0.864,0.136,1
2017-09-20 09:22:00,0.4019,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra,0.0,0.803,0.197,1
2017-09-20 11:52:57,0.0,"Early movers: FDX, WMT, AMZN, BBB, PFE, LB & more",0.0,1.0,0.0,0
2017-09-20 13:10:00,0.4939,Pfizer Goes to Court to Allow Competition for Biologics and Expand Options for Patients,0.0,0.741,0.259,1
2017-09-20 13:39:00,0.5859,"Investors Await Fed Move; Amazon To Link Alexa, Smart Glasses",0.0,0.547,0.453,1
2017-09-20 13:45:03,0.0,"Pfizer Should Outperform, Morgan Stanley Upgrades",0.0,1.0,0.0,0
2017-09-20 13:52:24,0.0,Pfizer's stock jumps to 13-month high to lead Dow gainers after analyst upgrade,0.0,1.0,0.0,0
2017-09-20 13:56:45,0.0,US STOCKS-Wall St opens little changed; Fed takes center stage,0.0,1.0,0.0,0
2017-09-20 14:12:02,0.0,Pfizer&apos;s Sutent Label Expansion Gets Mixed FDA Committee View,0.0,1.0,0.0,0
2017-09-20 16:38:58,0.0,"Dow Movers: MMM, PFE",0.0,1.0,0.0,0
2017-09-20 16:42:35,0.0,Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View,0.0,1.0,0.0,0
2017-09-20 17:39:00,0.0,Pfizer: Is It Time To Buy?,0.0,1.0,0.0,0
2017-09-20 17:48:42,0.0,Behind Pfizer’s Product Developments after 2Q17,0.0,1.0,0.0,0
2017-09-20 18:17:31,-0.2263,[$$] Murky World of Drug Rebates Gets Airing in Lawsuit,0.174,0.826,0.0,-1
2017-09-20 19:23:59,0.0,Pfizer files suit against J&J over Remicade contracts,0.0,1.0,0.0,0
2017-09-20 19:37:53,0.0,Inside Pfizer’s Post-2Q17 Pipeline Developments,0.0,1.0,0.0,0
2017-09-20 19:42:19,-0.2263,[$$] Pfizer takes on J&J with antitrust lawsuit,0.213,0.787,0.0,-1
2017-09-20 20:56:22,0.4576,"After Hours Most Active for Sep 20, 2017 :  INTC, GE, F, BAC, PFE, ZNGA, AAPL, JPM, CSCO, HPE, QQQ, CDNS",0.0,0.864,0.136,1
2017-09-20 21:06:05,0.0,Pfizer’s Revenues in Review: PFE’s Quarterly Performance,0.0,1.0,0.0,0
2017-09-20 22:46:51,0.1027,"[$$] Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies",0.075,0.822,0.103,1
2017-09-21 00:46:00,0.0,Pfizer and Johnson & Johnson&apos;s Brewing Brawl Gets Real,0.0,1.0,0.0,0
2017-09-21 01:01:00,0.0,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ",0.0,1.0,0.0,0
2017-09-21 01:34:57,-0.5423,Mylan Down 24% Year to Date: What's Troubling the Stock?,0.28,0.72,0.0,-1
2017-09-21 02:35:37,0.0,Pfizer and Johnson & Johnson's Brewing Brawl Gets Real,0.0,1.0,0.0,0
2017-09-21 03:39:00,0.0,"Merck, Pfizer Report EU Marketing Authorization For BAVENCIO - Quick Facts",0.0,1.0,0.0,0
2017-09-21 04:41:51,0.0,PRESS DIGEST - Wall Street Journal - Sept 21,0.0,1.0,0.0,0
2017-09-21 04:44:03,-0.2263,[$$] The Murky World of Drug Rebates Gets Airing in Lawsuit,0.16,0.84,0.0,-1
2017-09-21 06:34:00,0.3182,Pfizer is taking its fight with J&J over a blockbuster drug to court,0.158,0.606,0.236,1
2017-09-21 07:19:24,-0.6597,"Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod",0.355,0.645,0.0,-1
2017-09-21 07:28:00,0.4019,European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma,0.0,0.769,0.231,1
2017-09-21 10:00:29,0.0,Big Pharma Turns to Blockchain to Track Meds,0.0,1.0,0.0,0
2017-09-21 10:48:23,0.4939,This squabble between two big drugmakers could have major implications for the U.S. health care system,0.0,0.824,0.176,1
2017-09-21 10:59:00,-0.4939,New Global Report Finds Majority of People at High Risk of Stroke Not Being Screened for Common Risk Factors,0.198,0.802,0.0,-1
2017-09-21 11:37:00,0.0,3 Ways AI Is Changing Medicine,0.0,1.0,0.0,0
2017-09-21 11:40:09,0.0,Assessing Pfizer’s Performance by Business Segment in 2Q17,0.0,1.0,0.0,0
2017-09-21 13:09:50,0.0,Understanding Pfizer’s Performance in US and International Markets,0.0,1.0,0.0,0
2017-09-21 13:35:08,-0.4019,Pharma giants' to clash in court over biosimilar product dispute,0.231,0.769,0.0,-1
2017-09-21 13:45:01,0.34,Can Pfizer (PFE) Prove to be an Apt Value Investment?,0.0,0.789,0.211,1
2017-09-21 14:00:00,0.0,National Sickle Cell Disease Poll of African Americans Dispels Long-Held Views,0.0,1.0,0.0,0
2017-09-21 14:25:02,-0.3612,"Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake",0.333,0.667,0.0,-1
2017-09-21 14:30:00,0.0,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,0.0,1.0,0.0,0
2017-09-21 14:38:04,0.3818,These Key Pfizer Products Contributed to Growth in 2Q17,0.0,0.755,0.245,1
2017-09-21 16:40:32,0.0,"Stock Market News For Sep 21, 2017",0.0,1.0,0.0,0
2017-09-21 17:33:00,0.4215,[$$] Pfizer's Underappreciated Global Opportunity,0.0,0.588,0.412,1
2017-09-21 19:39:30,0.0,"XLV, JNJ, PFE, MDT: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2017-09-21 21:59:28,0.25,"Versartis growth hormone drug fails key study, shares sink",0.206,0.441,0.353,1
2017-09-22 00:54:00,-0.3182,Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week?,0.187,0.813,0.0,-1
2017-09-22 08:35:02,0.5267,US Market Indexes Gain on Wednesday,0.0,0.595,0.405,1
2017-09-22 11:37:29,-0.1027,These Pfizer’s Products Are Now Losing Market Share,0.241,0.556,0.204,-1
2017-09-22 12:42:12,0.0,"Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update",0.0,1.0,0.0,0
2017-09-22 12:58:12,-0.6597,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters",0.355,0.645,0.0,-1
2017-09-22 13:07:08,0.0,What Pfizer’s Valuation Changes after 2Q17 Tell Us,0.0,1.0,0.0,0
2017-09-22 14:39:03,0.5719,"Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com",0.0,0.778,0.222,1
2017-09-22 15:39:17,-0.3182,Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval,0.303,0.483,0.214,-1
2017-09-22 17:08:19,0.0,AstraZeneca Stock Upgraded: What You Need to Know,0.0,1.0,0.0,0
2017-09-22 18:44:00,-0.5106,This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%,0.231,0.769,0.0,-1
2017-09-22 19:17:15,-0.4939,Healthcare Stocks Soar After McCain Rejects Obamacare Repeal,0.314,0.686,0.0,-1
2017-09-23 15:48:32,0.0,3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?,0.0,1.0,0.0,0
2017-09-23 16:40:00,0.0,The 6 Medications Being Used to Tackle the Opioid Epidemic,0.0,1.0,0.0,0
2017-09-25 04:01:00,0.0,[$$] Gene Therapy Is Nearing a Major Breakthrough,0.0,1.0,0.0,0
2017-09-25 11:00:00,0.0,Pfizer Spins Off New Firm for Some Rare Disease Drugs,0.0,1.0,0.0,0
2017-09-25 11:02:46,0.0,[$$] Pfizer tests new way of putting more drugs on trial,0.0,1.0,0.0,0
2017-09-25 15:03:58,0.0,Pfizer Channels Its Inner Biotech,0.0,1.0,0.0,0
2017-09-25 16:15:08,-0.4215,Pfizer helps pump $103M into startup to develop new cancer therapies,0.275,0.562,0.163,-1
2017-09-25 16:52:04,-0.5267,Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer,0.328,0.522,0.149,-1
2017-09-25 17:47:05,0.0,"One Put, One Call Option To Know About for Pfizer",0.0,1.0,0.0,0
2017-09-25 20:57:25,0.4576,"After Hours Most Active for Sep 25, 2017 :  T, ON, QQQ, BAC, SBUX, ADP, INTC, IBB, GE, TPRE, PFE, F",0.0,0.857,0.143,1
2017-09-26 12:50:58,0.0,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",0.0,1.0,0.0,0
2017-09-26 13:21:00,-0.2732,Patti LaBelle and Pfizer Work Together to Educate Baby Boomers About the Risk of Pneumococcal Pneumonia,0.123,0.877,0.0,-1
2017-09-26 23:52:12,-0.2023,Axovant Sciences' Alzheimer's Disease Trial Comes Up Empty -- What Now?,0.153,0.847,0.0,-1
2017-09-27 04:26:00,0.4215,Bavencio Approved For Merkel Cell Carcinoma In Japan,0.0,0.714,0.286,1
2017-09-27 07:48:00,0.0,Wall Street Might Open Higher,0.0,1.0,0.0,0
2017-09-27 08:00:00,0.4215,Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan,0.0,0.741,0.259,1
2017-09-27 12:30:00,0.0,Pfizer Declares 32-Cent Fourth-Quarter 2017 Dividend,0.0,1.0,0.0,0
2017-09-27 15:59:00,-0.2263,Agilent Boosts Market Share With FDA Nod to New Cancer Test,0.26,0.473,0.266,-1
2017-09-27 16:54:08,-0.4019,3 High-Yield Stocks to Own in a Market Crash,0.31,0.69,0.0,-1
2017-09-27 18:53:42,0.0,3 Dividend Stocks to Buy and Hold Forever,0.0,1.0,0.0,0
2017-09-27 20:58:47,0.4576,"After Hours Most Active for Sep 27, 2017 :  CNDT, AABA, CSCO, QQQ, T, HPQ, MDLZ, IEF, PFE, F, SYF, EBAY",0.0,0.864,0.136,1
2017-09-28 15:56:05,0.0,Moody's: Biosimilars Market Adoption Faces Hurdles But Development Continues Apace,0.0,1.0,0.0,0
2017-09-28 19:41:10,0.0,This Drug Pricing Scheme Could Be Making Your Medicine More Expensive,0.0,1.0,0.0,0
2017-09-28 20:41:36,0.34,Eli Lilly wins U.S. approval for breast cancer drug,0.256,0.349,0.395,1
2017-09-28 21:27:00,0.2263,Tax reform could spark a wave of biopharma M&A,0.0,0.787,0.213,1
2017-09-28 21:34:30,0.5859,Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere,0.0,0.703,0.297,1
2017-09-28 22:26:52,0.0,Pfizer Announces Fourth-Quarter Dividend,0.0,1.0,0.0,0
2017-09-28 22:51:56,0.0,Cramer's lightning round: Re-pounding the table on DowDuPont,0.0,1.0,0.0,0
2017-09-28 23:08:00,0.0,Cramer's lightning round: Re-pounding the table on DowDuP...,0.0,1.0,0.0,0
2017-09-29 00:10:14,0.0,Is Pfizer Inc (PFE) A Buy At Its Current Price?,0.0,1.0,0.0,0
2017-09-29 12:28:08,0.4019,Could Tax Reform Boost the Healthcare Sector?,0.0,0.69,0.31,1
2017-09-29 14:40:15,0.0,Must-Know Changes to Bristol-Myers Squibb’s Valuation,0.0,1.0,0.0,0
2017-09-29 16:35:23,0.296,"VYM, PFE, BMY, CB: ETF Outflow Alert",0.0,0.732,0.268,1
2017-09-29 16:36:08,0.0,"XLV, HEWW: Big ETF Outflows",0.0,1.0,0.0,0
2017-10-01 11:31:00,-0.128,Pfizer Exposes the Sordid Underbelly of Drug Prices,0.176,0.824,0.0,-1
2017-10-02 00:28:27,0.6369,"Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences?",0.0,0.625,0.375,1
2017-10-02 13:01:29,0.0,Quality Dividend ETFs for Turbulent Times,0.0,1.0,0.0,0
2017-10-02 13:36:23,0.4939,"Health Care Sector Update for 10/02/2017: JNJ, PFE, ABT, MRK, AMGN, KTOV, MNKD, AEMD",0.0,0.802,0.198,1
2017-10-02 13:45:23,0.0,3 Crash-Survival Tips Every Investor Should Know,0.0,1.0,0.0,0
2017-10-02 14:50:23,0.4404,"Better Buy: Gilead Sciences, Inc. vs. Pfizer",0.0,0.674,0.326,1
2017-10-02 15:14:00,0.0,"[$$] Lilly Faces Off With Pfizer, Novartis",0.0,1.0,0.0,0
2017-10-02 16:38:00,0.0,"How To Trade The 8 'Dogs Of The Dow,' Which Outperformed The Dow In September",0.0,1.0,0.0,0
2017-10-02 17:50:35,0.4019,Interesting November Stock Options for PFE,0.0,0.649,0.351,1
2017-10-02 18:48:28,0.4767,Merck's Keytruda Continues To Roll With Another FDA Approval,0.0,0.721,0.279,1
2017-10-02 20:49:21,-0.2023,"AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk",0.167,0.833,0.0,-1
2017-10-03 00:28:00,0.0,Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI,0.0,1.0,0.0,0
2017-10-03 12:36:00,0.5267,3 Winning Dividend Strategies To Survive The Next Pullback,0.0,0.673,0.327,1
2017-10-03 13:26:29,0.4939,"Health Care Sector Update for 10/03/2017: JNJ, PFE, ABT, MRK, AMGN, DMPI, RDHL, RIGL",0.0,0.802,0.198,1
2017-10-03 14:05:00,0.5267,Gender Focus Proves Rewarding for This ETF,0.0,0.638,0.362,1
2017-10-03 14:19:00,0.0,[$$] Big Questions for Big Pharma,0.0,1.0,0.0,0
2017-10-03 14:54:50,-0.6908,Is This How Drugmakers Will Kill Biosimilars?,0.439,0.561,0.0,-1
2017-10-03 21:43:09,0.2023,"Top Research Reports for Pfizer, AT&T & BlackRock",0.0,0.769,0.231,1
2017-10-04 12:29:54,0.2023,Why Pfizer is the 'Top Dividend Stock of the Dow' With 3.5% Yield (PFE),0.0,0.878,0.122,1
2017-10-04 13:15:01,0.0,Allergan&apos;s Botox Gets FDA Nod for Forehead Line Treatment,0.0,1.0,0.0,0
2017-10-04 13:21:24,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 05, 2017",0.0,1.0,0.0,0
2017-10-04 14:10:19,0.0,"S.Africa watchdog drops over-charging probe into Aspen, Equity",0.0,1.0,0.0,0
2017-10-04 14:37:58,0.0,"The Zacks Analyst Blog Highlights: Pfizer, AT&T, BlackRock U.S. Bancorp and Walt Disney",0.0,1.0,0.0,0
2017-10-04 15:36:15,0.0,Allergan's Botox Gets FDA Nod for Forehead Line Treatment,0.0,1.0,0.0,0
2017-10-04 20:32:57,0.4767,"How Mylan's MS-Generic Approval Caused Teva, Momenta To Plunge",0.0,0.721,0.279,1
2017-10-05 00:47:39,0.0,3 High-Yield Billionaire Stocks,0.0,1.0,0.0,0
2017-10-05 07:47:09,0.0,"Pensionfund DSM Netherlands Buys General Electric Co, CVS Health Corp, Time Warner Inc, Sells ...",0.0,1.0,0.0,0
2017-10-05 12:00:00,0.1027,Pfizer Launches Novel Programs to Put Important Support Services at the Fingertips of Cancer Patients,0.198,0.495,0.306,1
2017-10-05 13:27:23,0.4939,"Health Care Sector Update for 10/05/2017: JNJ, PFE, ABT, MRK, AMGN, DXTR, NBIX, RIGL",0.0,0.802,0.198,1
2017-10-05 14:37:00,-0.0516,"The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September",0.202,0.614,0.184,0
2017-10-05 15:13:20,0.5719,"New Research: Key Drivers of Growth for Sprint, Pfizer, Oracle, Chesapeake Energy, Ford, and Verizon - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production",0.0,0.856,0.144,1
2017-10-05 20:37:08,0.1531,4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3,0.0,0.862,0.138,1
2017-10-06 13:46:59,0.4939,"Health Care Sector Update for 10/06/2017: JNJ, PFE, ABT, MRK, AMGN, KDMN",0.0,0.775,0.225,1
2017-10-06 16:38:00,-0.296,"Missing Link: Long Capital One, Bristol-Myers",0.306,0.694,0.0,-1
2017-10-06 22:27:58,-0.1531,FDA: Drug shortages possible due to Puerto Rico power outage,0.151,0.849,0.0,-1
2017-10-07 15:51:37,0.5994,3 Blockbuster Drugs That Still Cost More Than They Should,0.0,0.672,0.328,1
2017-10-09 05:48:00,0.4215,New Drugs Approved In September,0.0,0.588,0.412,1
2017-10-09 11:22:06,0.25,This Dow stock looks poised to ‘pull an Intel’ and break out to a multi-year high,0.0,0.875,0.125,1
2017-10-09 11:44:10,0.0,Analysts’ Recommendations for Amgen in October 2017,0.0,1.0,0.0,0
2017-10-09 13:51:02,0.0,These 5 Dow Stocks Are Near Buy Zones As Earnings Season Begins,0.0,1.0,0.0,0
2017-10-09 14:35:00,0.296,"Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer",0.0,0.833,0.167,1
2017-10-09 16:53:49,0.0,"Notable ETF Outflow Detected - XLV, JNJ, PFE, MDT",0.0,1.0,0.0,0
2017-10-09 16:54:05,-0.2263,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",0.213,0.787,0.0,-1
2017-10-09 17:52:50,0.0,AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation,0.0,1.0,0.0,0
2017-10-10 07:05:00,0.0,"Pfizer Reviews Strategic Alternatives For Consumer Healthcare Unit, Incl Sale",0.0,1.0,0.0,0
2017-10-10 10:04:00,0.5267,3 Healthcare Dividend Stocks Ideal for Retirees,0.0,0.595,0.405,1
2017-10-10 10:32:00,0.4404,2 Big Safe Havens if the Stock Rally Crashes,0.0,0.707,0.293,1
2017-10-10 10:45:00,0.0,Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business,0.0,1.0,0.0,0
2017-10-10 10:47:00,0.0,CNBC poll shows 64% of households own Apple products,0.0,1.0,0.0,0
2017-10-10 10:58:10,0.0,"Pfizer is exploring sale, spin-off of its consumer health-care business",0.0,1.0,0.0,0
2017-10-10 11:02:10,0.0,Pfizer Is Weighing Sale of $17 Billion Consumer Health Unit,0.0,1.0,0.0,0
2017-10-10 11:08:56,0.0,"Pfizer to explore potential sale, spinoff of consumer healthcare business",0.0,1.0,0.0,0
2017-10-10 11:51:51,0.0,Pfizer may sell consumer unit,0.0,1.0,0.0,0
2017-10-10 12:07:00,0.0,Pfizer Could Fall By 9% Or More,0.0,1.0,0.0,0
2017-10-10 12:14:00,0.0,Pfizer Pops in Pre-Market After Group Considers Consumer Healthcare Sale,0.0,1.0,0.0,0
2017-10-10 12:15:28,0.0,"Stocks making the biggest moves premarket: HON, PFE, WMT, AIG, MSFT & more",0.0,1.0,0.0,0
2017-10-10 12:30:02,0.0,[$$] Pfizer weighs sale of consumer health business,0.0,1.0,0.0,0
2017-10-10 13:00:00,-0.296,Pfizer's Divestiture Plan No Big Deal,0.306,0.694,0.0,-1
2017-10-10 13:23:30,0.4215,"Stocks to Watch: AIG, Wal-Mart, Honeywell, Pfizer, P&G, United Continental, Microsoft",0.0,0.781,0.219,1
2017-10-10 13:30:36,0.4939,"Health Care Sector Update for 10/10/2017: JNJ, PFE, ABT, MRK, AMGN, ANAB, VICL, LLY",0.0,0.802,0.198,1
2017-10-10 13:59:00,0.0,News Update – Market Open,0.0,1.0,0.0,0
2017-10-10 14:01:02,0.4767,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,0.0,0.763,0.237,1
2017-10-10 15:15:35,-0.3818,Honeywell To Spin Off 2 Units; Pfizer Mulls Consumer Sale; P&G-Peltz Proxy Fight Today,0.178,0.822,0.0,-1
2017-10-10 15:15:50,0.0,"Stocks Climb; Wal-Mart Takes Buy Point, Tesla Gets Price Hike",0.0,1.0,0.0,0
2017-10-10 15:43:11,0.0382,This Pfizer Disposal Won't Leave Investors Hanging,0.0,0.839,0.161,0
2017-10-10 16:43:27,0.0,[$$] Pfizer Reviews Options for Consumer Healthcare Business,0.0,1.0,0.0,0
2017-10-10 16:52:56,0.0,[$$] Pfizer: shelf medication,0.0,1.0,0.0,0
2017-10-10 16:57:59,0.0,Pfizer weighs $15 bln sale of consumer healthcare business,0.0,1.0,0.0,0
2017-10-10 16:58:14,0.0,Pfizer weighs $15 billion sale of consumer healthcare business,0.0,1.0,0.0,0
2017-10-10 17:35:07,0.5574,Pfizer Inc. -- Moody's: Sale of Pfizer consumer products would be positive for liquidity,0.0,0.783,0.217,1
2017-10-10 18:07:00,0.4939,Pfizer weighing sale of consumer health care business,0.0,0.686,0.314,1
2017-10-10 19:10:27,0.4404,Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow,0.0,0.791,0.209,1
2017-10-10 19:13:25,0.6369,Healthcare: Are These the Best Dividend Stocks to Buy Now?,0.0,0.682,0.318,1
2017-10-10 20:14:30,0.0,Pfizer considers consumer business sale,0.0,1.0,0.0,0
2017-10-10 20:54:10,0.4215,Wal-Mart and United climb while Procter & Gamble slumps,0.0,0.714,0.286,1
2017-10-10 21:11:19,0.0,Dow Component Pfizer Mulls Over-The-Counter Spinoff Or Sale,0.0,1.0,0.0,0
2017-10-10 22:10:28,0.6369,10 Best Stocks to Buy and Hold for the Next Decade,0.0,0.704,0.296,1
2017-10-11 00:00:44,0.0,[$$] Spinoffs Juice Investor Returns,0.0,1.0,0.0,0
2017-10-11 03:10:38,0.0,Pfizer Inc. (PFE) May Spin Off Consumer Health Biz,0.0,1.0,0.0,0
2017-10-11 04:00:16,-0.25,The Pharma Chief Who Sees Profit Where Skeptics See Lousy Odds,0.31,0.506,0.184,-1
2017-10-11 04:19:48,0.296,Asian shares higher after Wall Street sets new record high,0.0,0.804,0.196,1
2017-10-11 07:00:27,0.0,[$$] Pfizer Considers a Sale or Spinoff of Its Consumer Healthcare Business,0.0,1.0,0.0,0
2017-10-11 07:02:07,0.6369,[$$] The Reason Investors Love Spinoffs: Juicier Returns,0.0,0.625,0.375,1
2017-10-11 11:45:14,0.0,"$100 Billion Question: Will Trump Let Alphabet, Pfizer Keep Tax Havens?",0.0,1.0,0.0,0
2017-10-11 12:04:00,0.5859,3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff,0.0,0.743,0.257,1
2017-10-11 13:20:44,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2017",0.0,1.0,0.0,0
2017-10-11 13:23:04,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2017",0.0,1.0,0.0,0
2017-10-11 14:22:02,0.0,Pfizer Considering Sale/Spin-Off of Consumer Healthcare Unit,0.0,1.0,0.0,0
2017-10-11 16:17:33,0.0,"Stock Market News For Oct 11, 2017",0.0,1.0,0.0,0
2017-10-11 17:13:25,-0.802,Lilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study,0.474,0.526,0.0,-1
2017-10-11 17:40:00,-0.1027,Pfizer: Who Will Pay $14B for Advil?,0.189,0.811,0.0,-1
2017-10-11 18:10:55,0.3818,"Boltwood Capital Management Buys DowDuPont Inc, iShares Intermediate Credit Bond ETF, iShares ...",0.0,0.822,0.178,1
2017-10-11 19:03:00,0.0,"Three blue-chip US companies are on the verge of breaking apart, prodded by short-term investors",0.0,1.0,0.0,0
2017-10-11 19:05:09,0.0,"Pfizer considers selling unit that includes Advil, ChapStick",0.0,1.0,0.0,0
2017-10-11 20:48:00,0.6369,Is Pfizer the Best Dividend Stock in Healthcare?,0.0,0.625,0.375,1
2017-10-12 21:13:30,-0.296,Breakout Watch: No. 1-Ranked Medical Research Stock Tests Buy Zone,0.196,0.804,0.0,-1
2017-10-13 02:01:00,0.7003,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS",0.0,0.633,0.367,1
2017-10-13 05:35:00,0.0,2 Reasons Pfizer Is on Our Minds Today,0.0,1.0,0.0,0
2017-10-13 12:06:12,0.0,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY&apos;s Pipeline Setback",0.0,1.0,0.0,0
2017-10-13 13:32:00,0.0,Pfizer: Could a Big Merger Move the Needle?,0.0,1.0,0.0,0
2017-10-13 14:10:48,0.1027,"Koshinski Asset Management, Inc. Buys PowerShares S&P 500 Low Volatility Portfolio, Pfizer ...",0.135,0.705,0.16,1
2017-10-13 14:20:36,0.0,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback",0.0,1.0,0.0,0
2017-10-13 14:47:00,-0.4939,Pharma Sales Could Be Chilled by Hurricane Damage,0.314,0.686,0.0,-1
2017-10-13 15:17:03,0.0,"Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy",0.0,1.0,0.0,0
2017-10-13 15:42:53,0.0,Behind Eli Lilly’s October Analyst Recommendations,0.0,1.0,0.0,0
2017-10-13 18:12:08,0.0,Spin-Off ETF: Can the Outperformance Continue?,0.0,1.0,0.0,0
2017-10-13 20:14:08,0.4767,5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings,0.0,0.661,0.339,1
2017-10-13 20:20:35,0.0,4 Blue-Chip Stocks to Sell and 4 Stocks to Buy Right Now,0.0,1.0,0.0,0
2017-10-13 22:18:22,-0.296,This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due,0.167,0.833,0.0,-1
2017-10-14 04:05:00,0.0,Pfizer Says It&apos;s Pondering a Big Sale,0.0,1.0,0.0,0
2017-10-14 05:15:54,0.0,Earnings Season Preview: 2 Things to Watch For in Healthcare,0.0,1.0,0.0,0
2017-10-14 05:16:01,0.0,Pfizer Says It's Pondering a Big Sale,0.0,1.0,0.0,0
2017-10-15 20:40:00,0.2263,Pfizer Consumer Unit Worth as Much as $14 Billion,0.0,0.808,0.192,1
2017-10-16 07:29:00,0.3182,Pfizer: Trial Of ALK-Inhibitor Lorlatinib Shows Clinically Meaningful Activity,0.0,0.777,0.223,1
2017-10-16 10:49:33,0.4215,[$$] Drugstore Favorites May Be Catching the Common Consumer Cold,0.0,0.763,0.237,1
2017-10-16 11:00:00,-0.5267,Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigational ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer,0.173,0.748,0.079,-1
2017-10-16 14:58:00,-0.7351,The Cost Of Developing Drugs Is Insane. That Paper That Says Otherwise Is Insanely Bad,0.323,0.677,0.0,-1
2017-10-16 18:00:00,0.4404,How Stock Investors Can Profit Big From Spinoffs,0.0,0.707,0.293,1
2017-10-16 19:59:07,0.0,Pharma Industry Outlook - October 2017,0.0,1.0,0.0,0
2017-10-17 12:09:00,0.6276,The Blockbuster That Wasn't -- A CETP Inhibitor Post-Mortem,0.0,0.539,0.461,1
2017-10-17 13:49:51,0.0,"Clark Estates Inc Buys Fluor Corp, Allergan PLC, GlaxoSmithKline PLC, Sells Scripps Networks ...",0.0,1.0,0.0,0
2017-10-17 14:37:02,0.0,"J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales",0.0,1.0,0.0,0
2017-10-17 15:51:48,0.0,3 Dividend Healthcare Stocks,0.0,1.0,0.0,0
2017-10-17 15:56:29,0.0,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen",0.0,1.0,0.0,0
2017-10-17 16:52:53,0.0,"Notable ETF Outflow Detected - XLV, JNJ, PFE, CELG",0.0,1.0,0.0,0
2017-10-17 21:00:00,0.0,This hot trade is about to get even hotter: Trader,0.0,1.0,0.0,0
2017-10-17 22:52:16,0.4404,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks,0.0,0.707,0.293,1
2017-10-17 23:49:36,0.0,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,0.0,1.0,0.0,0
2017-10-18 02:55:00,-0.4767,Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure?,0.235,0.642,0.123,-1
2017-10-18 06:14:57,-0.6249,"Reckitt CEO Focuses on Health, Looking Beyond Worst Year",0.339,0.661,0.0,-1
2017-10-18 06:24:50,0.4404,Reckitt Benckiser to form two business units for better focus,0.0,0.756,0.244,1
2017-10-18 11:03:36,0.0,Pfizer's Advil May Be Just the Thing for Sickly Reckitt,0.0,1.0,0.0,0
2017-10-18 13:12:00,0.4019,[$$] Reckitt Benckiser: fission for compliments,0.0,0.649,0.351,1
2017-10-18 13:54:51,0.0,Eli Lilly (LLY) to Report Q3 Earnings: What's in Store?,0.0,1.0,0.0,0
2017-10-18 14:04:43,0.3818,Reckitt to reshape as sales growth evaporates,0.0,0.698,0.302,1
2017-10-18 15:55:58,0.0,Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?,0.0,1.0,0.0,0
2017-10-18 16:30:21,0.0,"Dow Jones Industrial Average Hits 23,000. Now What?",0.0,1.0,0.0,0
2017-10-18 17:35:57,0.0,Here&apos;s Why Ignyta Stock Soared as Much as 27.5% Today,0.0,1.0,0.0,0
2017-10-18 18:19:36,0.1531,Johnson & Johnson Posts Solid Q3 Numbers Led By Ramp Up In Oncology Drugs,0.0,0.882,0.118,1
2017-10-18 18:50:05,0.7269,"Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company, Hanesbrands Inc, ...",0.0,0.663,0.337,1
2017-10-18 18:50:55,0.0,Here's Why Ignyta Stock Soared as Much as 27.5% Today,0.0,1.0,0.0,0
2017-10-18 20:21:08,0.1531,What to Expect from Big Pharmas After J&J&apos;s Solid Q3 Results?,0.0,0.862,0.138,1
2017-10-18 22:52:36,0.1531,What to Expect from Big Pharmas After J&J's Solid Q3 Results?,0.0,0.862,0.138,1
2017-10-18 23:49:59,0.0,"5 Blue-Chip Stocks That “Dow 23,000” Left in the Dust",0.0,1.0,0.0,0
2017-10-19 04:03:24,0.0772,[$$] Reckitt Makeover Clears Way for Pfizer Bid,0.0,0.843,0.157,0
2017-10-19 10:11:00,0.6249,2 Great Stocks For Retirees,0.0,0.423,0.577,1
2017-10-19 11:39:48,0.0,Inside Pfizer’s Performance in 3Q17,0.0,1.0,0.0,0
2017-10-19 11:51:55,0.0,3 High-Yield Stocks for Conservative Investors,0.0,1.0,0.0,0
2017-10-19 12:37:00,-0.296,4 Cheap Stock Picks for the Impatient,0.306,0.694,0.0,-1
2017-10-19 12:43:52,0.0,"Howe & Rusling Inc Buys DowDuPont Inc, JPMorgan Chase, iShares Intermediate ...",0.0,1.0,0.0,0
2017-10-19 12:44:23,0.1027,Trump Tax Cuts Clear First Hurdle; Now Comes A Wrestling Match,0.172,0.625,0.203,1
2017-10-19 13:36:01,0.0,Conatus Entrusts Keith W. Marshall With Key Management Roles,0.0,1.0,0.0,0
2017-10-19 15:47:35,0.0,3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock,0.0,1.0,0.0,0
2017-10-19 17:15:20,0.0,I'm bullish on American Express and Verizon: NYSE trader,0.0,1.0,0.0,0
2017-10-19 17:15:21,-0.5719,Buyers never came in that Monday in '87—it was chaos: NYSE trader,0.252,0.748,0.0,-1
2017-10-19 17:15:21,-0.296,There's no reason for investors to sell stocks now: NYSE trader,0.18,0.82,0.0,-1
2017-10-19 18:48:31,0.0,Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings,0.0,1.0,0.0,0
2017-10-19 19:20:07,0.0,Healthcare ETFs Head to Head: XLV vs. VHT,0.0,1.0,0.0,0
2017-10-19 21:03:31,0.4576,"After Hours Most Active for Oct 19, 2017 :  V, AAPL, CMCSA, BABA, PYPL, PFE, T, KW, GE, QQQ, ADBE, GILD",0.0,0.864,0.136,1
2017-10-20 02:47:20,0.1779,"Senate OKs Budget Resolution, The Easy Part Of Passing Trump Tax Cuts",0.146,0.662,0.192,1
2017-10-20 11:45:09,0.0,What’s Driving Economic Moats,0.0,1.0,0.0,0
2017-10-20 14:00:00,0.0,3 High-Yield Pharmaceutical Stocks,0.0,1.0,0.0,0
2017-10-20 14:55:02,0.0,Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again?,0.0,1.0,0.0,0
2017-10-21 00:59:20,0.0,Healthcare ETF (VHT) Hits New 52-Week High,0.0,1.0,0.0,0
2017-10-21 05:59:34,0.0,Dow Jones and S&P 500 Close at New Highs,0.0,1.0,0.0,0
2017-10-23 13:20:13,0.4939,"Health Care Sector Update for 10/23/2017: JNJ, PFE, ABT, MRK, AMGN, TIG, AZN",0.0,0.789,0.211,1
2017-10-24 13:04:13,0.3818,Will Merck (MRK) Keep the Earnings Streak Alive in Q3?,0.0,0.776,0.224,1
2017-10-24 15:07:13,0.0,Healthcare ETFs Set to Soar as Q3 Earnings Unfold,0.0,1.0,0.0,0
2017-10-24 17:06:55,0.2732,Can AbbVie (ABBV) Spring a Surprise this Earnings Season?,0.0,0.769,0.231,1
2017-10-24 19:00:55,-0.128,Corning (GLW) Beats Q3 Earnings on High Gorilla Glass Demand,0.143,0.857,0.0,-1
2017-10-24 21:02:59,0.34,3 Value Stocks for Retirement,0.0,0.556,0.444,1
2017-10-25 13:03:46,0.0,Is Pfizer Inc. a Buy?,0.0,1.0,0.0,0
2017-10-25 13:06:27,0.0,Is a Beat Likely for Pfizer (PFE) This Earnings Season?,0.0,1.0,0.0,0
2017-10-25 13:24:29,0.296,GSK to study consumer health buys but pharma top priority,0.0,0.804,0.196,1
2017-10-25 14:44:54,0.0,[$$] GSK draws up shopping list for Pfizer and Merck consumer units,0.0,1.0,0.0,0
2017-10-25 15:00:53,0.0,[$$] Glaxo Will Consider Bid for Pfizer's Consumer-Health Unit,0.0,1.0,0.0,0
2017-10-25 16:54:34,-0.2732,GlaxoSmithKline stock plummets 6% after concerns about dividend risk,0.208,0.792,0.0,-1
2017-10-25 18:31:15,0.3818,Expect Bristol-Myers Squibb To Post Steady Growth In Q3 Led By Opdivio And Eliquis,0.0,0.833,0.167,1
2017-10-25 18:39:54,0.128,Exclusive: Pfizer to launch consumer health sale in November - sources,0.0,0.857,0.143,1
2017-10-25 19:30:00,0.0,Pfizer to Sell Consumer Healthcare Business Next Month,0.0,1.0,0.0,0
2017-10-25 19:50:22,0.128,Exclusive: Pfizer to launch consumer health sale in November: sources,0.0,0.857,0.143,1
2017-10-25 20:20:28,0.1531,Could GlaxoSmithKline Scoop Up Pfizer&apos;s Over-The-Counter Unit?,0.0,0.789,0.211,1
2017-10-25 21:04:01,0.1531,Could GlaxoSmithKline Scoop Up Pfizer's Over-The-Counter Unit?,0.0,0.789,0.211,1
2017-10-25 23:36:00,0.0,"Warren Prods AIG Non-SIFI Label, GSK Joins List of Pfizer Consumer Beaus--ICYMI",0.0,1.0,0.0,0
2017-10-26 00:14:37,0.0,PRESS DIGEST- British Business - Oct 26,0.0,1.0,0.0,0
2017-10-26 05:34:11,0.128,Exclusive: Pfizer to launch consumer health sale in November -sources,0.0,0.857,0.143,1
2017-10-26 07:39:40,0.0,Pfizer sets date for auction of consumer healthcare unit: Reuters,0.0,1.0,0.0,0
2017-10-26 09:59:54,0.0,"New England Research & Management, Inc. ...",0.0,1.0,0.0,0
2017-10-26 10:37:00,0.0,5 Products You Didn't Know Were Made By Pfizer,0.0,1.0,0.0,0
2017-10-26 12:26:12,0.4404,Merck vs. Pfizer: Which is Better Ahead of Q3 Earnings?,0.0,0.756,0.244,1
2017-10-26 13:00:48,0.0,"Meyer Handelman Co Buys DowDuPont Inc, Micro Focus International PLC, Cigna Corp, Sells E.I. ...",0.0,1.0,0.0,0
2017-10-26 15:58:16,-0.4215,"Buy the Dip in Amgen, Inc. While Wall Street Fears It",0.219,0.781,0.0,-1
2017-10-26 16:31:04,0.296,"Glaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down",0.0,0.804,0.196,1
2017-10-26 18:15:10,0.0,"Will P&G bite on Pfizer sale of brands such as Chapstick, Centrum?",0.0,1.0,0.0,0
2017-10-26 20:00:25,-0.4588,Here's Why Trump's Tax Cuts Could Easily Collapse,0.422,0.391,0.187,-1
2017-10-26 20:20:43,0.4939,"Health Care Sector Update for 10/26/2017: JNJ, PFE, ABT, MRK, AMGN, INSY, ABMD, THC",0.0,0.802,0.198,1
2017-10-26 20:59:48,0.4576,"After Hours Most Active for Oct 26, 2017 :  QQQ, MSFT, MAT, SQ, CMCSA, GE, INTC, RF, LMOS, F, PFE, HPQ",0.0,0.864,0.136,1
2017-10-27 10:08:00,0.0,3 Key Things to Watch in Pfizer&apos;s Q3 Results,0.0,1.0,0.0,0
2017-10-27 11:59:50,0.0,"Argyle Capital Management Inc. Buys DowDuPont Inc, W.W. Grainger Inc, CVS Health Corp, Sells E. ...",0.0,1.0,0.0,0
2017-10-27 12:02:56,0.0,3 Key Things to Watch in Pfizer's Q3 Results,0.0,1.0,0.0,0
2017-10-27 12:50:12,0.5106,"Pharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers",0.0,0.769,0.231,1
2017-10-27 14:09:57,0.0,"The Zacks Analyst Blog Highlights: Merck, Pfizer, Aetna and Electronic Arts",0.0,1.0,0.0,0
2017-10-27 20:41:31,0.0,"Close Update: U.S. Stocks Rally With Nasdaq, S&P 500 at Record Highs on Tech Sector Surge",0.0,1.0,0.0,0
2017-10-27 22:00:26,0.0,3 Key Earnings Reports to Watch Next Week,0.0,1.0,0.0,0
2017-10-28 11:07:00,-0.4939,Tech Bulls Can't Be Contained: Cramer's 'Mad Money' Recap (Friday 10/27/17),0.242,0.758,0.0,-1
2017-10-29 23:01:00,0.4019,One Year Maintenance and Switching Data in Patients with Crohn’s Disease Support the Use of INFLECTRA®* (infliximab CT-P13) in IBD1,0.0,0.876,0.124,1
2017-10-30 14:27:00,0.2023,2 Top Pharma Stocks on Sale This Week,0.0,0.769,0.231,1
2017-10-30 14:41:02,0.0,"What&apos;s in the Cards for PFE, INCY and ACOR in Q3 Earnings?",0.0,1.0,0.0,0
2017-10-30 15:48:00,0.0,Pfizer Earnings Preview: Management Exploring Alternatives For Consumer Unit Ahead Of Q3 Report,0.0,1.0,0.0,0
2017-10-30 16:17:05,0.0,"Dow Movers: MRK, AAPL",0.0,1.0,0.0,0
2017-10-30 17:09:00,0.0,Trading Strategies For Pharma Giants Merck And Pfizer,0.0,1.0,0.0,0
2017-10-30 17:18:41,0.0,"What's in the Cards for PFE, INCY and ACOR in Q3 Earnings?",0.0,1.0,0.0,0
2017-10-30 17:32:17,0.0,Upcoming Earnings: Pfizer Reports Tomorrow As Management Explores Alternatives For Consumer Healthcare,0.0,1.0,0.0,0
2017-10-30 17:52:00,0.0,"Bulls pile into 2 healthcare names, a gaming stock, and a...",0.0,1.0,0.0,0
2017-10-30 17:55:55,0.0,[$$] Merck starts consumer unit disposal process,0.0,1.0,0.0,0
2017-10-30 18:16:29,0.0,Inside Pfizer’s 3Q17 Estimates,0.0,1.0,0.0,0
2017-10-30 19:50:18,0.3818,Why Some Expect Growth in Pfizer’s 3Q17 Revenues,0.0,0.729,0.271,1
2017-10-30 20:16:35,0.0,"Noteworthy Monday Option Activity: MDLZ, KSU, PFE",0.0,1.0,0.0,0
2017-10-30 20:20:55,0.0,"Pre-Market Earnings Report for October 31, 2017 :  PFE, MA, AMT, AET, ECL, BP, ETN, FIS, CMI, HCA, PEG, ADM",0.0,1.0,0.0,0
2017-10-30 21:00:29,0.4576,"After Hours Most Active for Oct 30, 2017 :  ABEV, INTC, MSFT, DVN, ITUB, QQQ, SKX, PFE, DIS, PYPL, WBA, MDLZ",0.0,0.864,0.136,1
2017-10-30 21:11:33,0.5267,"Close Update: Wall Street's Winning Streak Snapped by Drug Sector, Tax Reform",0.0,0.764,0.236,1
2017-10-30 21:20:11,0.0,Pfizer on the Street: Analyst Ratings and Recommendations,0.0,1.0,0.0,0
2017-10-30 22:39:10,0.25,Is Aerie (AERI) Poised for a Beat This Earnings Season?,0.0,0.8,0.2,1
2017-10-31 06:49:00,0.0,Pfizer Inc. Q3 Earnings Rise 8%,0.0,1.0,0.0,0
2017-10-31 07:37:00,0.7351,Pfizer Lifts FY17 Adj. EPS View Above Market As Q2 Profit Tops Estimates,0.0,0.64,0.36,1
2017-10-31 07:49:00,0.25,Wall Street Poised For A Bounce Back,0.0,0.714,0.286,1
2017-10-31 09:00:00,0.0,Pfizer Q3 17 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2017-10-31 10:45:00,0.0,PFIZER REPORTS THIRD-QUARTER 2017 RESULTS,0.0,1.0,0.0,0
2017-10-31 10:55:07,0.4404,Pfizer's quarterly profit more than doubles,0.0,0.633,0.367,1
2017-10-31 11:01:29,0.6249,"Pfizer shares surge on Q3 profit beat, raised 2017 earnings outlook",0.0,0.638,0.362,1
2017-10-31 11:12:43,0.0,"Earnings Reaction History: Pfizer Inc, 27.3% Follow-Through Indicator, 1.1% Sensitive",0.0,1.0,0.0,0
2017-10-31 11:46:00,-0.4215,Pfizer posts earnings beat but doubts remain about organi...,0.259,0.741,0.0,-1
2017-10-31 12:00:00,0.0,Pfizer Inc. to Host Earnings Call,0.0,1.0,0.0,0
2017-10-31 12:13:12,0.5106,"Pfizer (PFE) Tops Q3 Earnings Estimates, Sales In Line",0.0,0.708,0.292,1
2017-10-31 12:29:39,0.0,[$$] Pfizer Expects Wave of New Launches,0.0,1.0,0.0,0
2017-10-31 12:34:43,0.0,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : October 31, 2017",0.0,1.0,0.0,0
2017-10-31 12:42:00,0.0,Stock Futures Suggest a Wall Street Rebound as Fed Meeting Begins,0.0,1.0,0.0,0
2017-10-31 13:28:33,0.0,"Stocks to Watch: Apple, Qualcomm, Facebook, Aetna, Under Armour, Pfizer, Mastercard",0.0,1.0,0.0,0
2017-10-31 14:02:13,0.0,"US STOCKS-Mondelez, tech stocks lift S&P, Nasdaq",0.0,1.0,0.0,0
2017-10-31 14:06:00,0.2732,"Big Pharma: Win Some, Lose Some",0.257,0.381,0.362,1
2017-10-31 14:26:05,0.4404,Pfizer raises profit outlook,0.0,0.508,0.492,1
2017-10-31 14:47:27,0.0,Stocks Open Slightly Higher; Chip Giant Hit On Apple News,0.0,1.0,0.0,0
2017-10-31 15:14:27,0.5106,U.S. stocks rise on earnings; October set to be a strong month,0.0,0.752,0.248,1
2017-10-31 15:53:03,0.0,"Pfizer (PFE) Beats on Q3 Earnings, Raises 2017 EPS View",0.0,1.0,0.0,0
2017-10-31 16:19:17,-0.3612,Dow&apos;s Pfizer Falls To 7-Week Low As Legacy Medicines Challenged,0.304,0.696,0.0,-1
2017-10-31 16:22:00,0.3182,Pfizer CEO: Optimistic on tax reform this year,0.0,0.753,0.247,1
2017-10-31 16:49:50,0.0,Stocks Mixed Early As Tech Leads; Apple Rises Again On Upgrade,0.0,1.0,0.0,0
2017-10-31 16:51:43,0.0,Stocks To Watch Out For This Halloween,0.0,1.0,0.0,0
2017-10-31 16:52:00,0.0,Pfizer's New Drugs Offset Generic Competition,0.0,1.0,0.0,0
2017-10-31 16:52:04,0.0,Will Markets Stay Spooked This Halloween?,0.0,1.0,0.0,0
2017-10-31 17:22:49,0.4588,Pfizer expects broad interest for consumer health business,0.0,0.7,0.3,1
2017-10-31 17:44:00,0.0,Nasdaq on Track to Finish October With New Record as Tech Rises,0.0,1.0,0.0,0
2017-10-31 17:48:29,0.2716,Pfizer Inc. Q3 Earnings: The Most Important Things to Know,0.0,0.811,0.189,1
2017-10-31 17:49:02,-0.3612,Dow's Pfizer Falls To 7-Week Low As Legacy Medicines Challenged,0.304,0.696,0.0,-1
2017-10-31 19:05:13,0.2023,Former Pfizer property among the top real estate deals of October,0.0,0.847,0.153,1
2017-10-31 19:15:15,-0.3252,Why Pfizer Inc (PFE) May Not Be As Efficient As Its Industry,0.175,0.825,0.0,-1
2017-10-31 20:02:00,0.34,Nasdaq Closes at a Record as Wall Street Seals October Gains,0.0,0.789,0.211,1
2017-10-31 20:25:20,-0.5106,"Pfizer beats 3Q net forecasts on lower charges, higher sales",0.35,0.65,0.0,-1
2017-11-01 14:23:02,0.0,"Company News For Nov 1, 2017",0.0,1.0,0.0,0
2017-11-01 14:48:00,-0.34,The 8 'Dogs Of The Dow' Continue To Lag The Dow This Year,0.179,0.821,0.0,-1
2017-11-01 15:34:54,0.0,Allergan Shouldn't Break Up,0.0,1.0,0.0,0
2017-11-01 17:17:38,0.34,"Pfizer Inc. – Value Analysis (NYSE:PFE) : November 1, 2017",0.0,0.745,0.255,1
2017-11-01 17:33:00,0.6705,Prevnar Helps Pfizer Post Better Than Expected Q3 Results,0.0,0.56,0.44,1
2017-11-01 18:46:32,0.4404,Pfizer Inc. Stock Earnings Were a Snooze — But That’s Good,0.0,0.734,0.266,1
2017-11-01 19:55:47,0.0,Edited Transcript of PFE earnings conference call or presentation 31-Oct-17 2:00pm GMT,0.0,1.0,0.0,0
2017-11-01 20:47:50,0.0,Pfizer Inc. (PFE) Q3 2017 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2017-11-02 03:37:43,0.2023,AP Top Extended Financial Headlines at 11:36 p.m. EDT,0.0,0.816,0.184,1
2017-11-02 08:00:11,0.0,Pfizer Inc. May Be About to Turn the Corner With Likely Consumer Unit Sale,0.0,1.0,0.0,0
2017-11-02 08:00:18,-0.4588,"EpiPen Failures Cited in Seven Deaths This Year, FDA Files Show",0.231,0.769,0.0,-1
2017-11-02 13:01:00,-0.0772,5 Things Pfizer&apos;s Management Just Said That You Don&apos;t Want to Miss,0.134,0.756,0.109,0
2017-11-02 15:01:30,0.0572,5 Things Pfizer's Management Just Said That You Don't Want to Miss,0.105,0.771,0.124,0
2017-11-02 15:58:42,0.743,"House GOP Tax Bill Looks Like A Winner For Apple, U.S. Multinationals",0.0,0.588,0.412,1
2017-11-02 17:03:49,0.0,"AmerisourceBergen (ABC) Beats Q4 Earnings, Issues FY18 View",0.0,1.0,0.0,0
2017-11-02 18:58:02,0.0,House GOP Tax Bill Takes Aim At Big Tech And Big Pharma,0.0,1.0,0.0,0
2017-11-02 18:59:06,-0.6249,"Momenta&apos;s (MNTA) Biosimilar Study Fails, Q3 Loss Narrows",0.459,0.541,0.0,-1
2017-11-02 21:07:08,-0.6249,"Momenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows",0.459,0.541,0.0,-1
2017-11-02 21:09:11,0.4576,"After Hours Most Active for Nov 2, 2017 :  INTC, F, AAPL, GE, SBUX, PFE, KO, HPQ, NAVI, GM, BTEC, QQQ",0.0,0.864,0.136,1
2017-11-03 14:38:22,0.0,3 Reasons Behind Exelixis Stock's Big Bounce,0.0,1.0,0.0,0
2017-11-03 15:40:36,0.0,"Key Predictions for Q3 Earnings Reports of MYL, HZNP & KERX",0.0,1.0,0.0,0
2017-11-03 17:38:54,0.4404,"Dow 30 Stock Roundup: Chevron, Exxon, Apple Earnings Impress",0.0,0.734,0.266,1
2017-11-06 13:32:01,0.0,"Pharma Stock Roundup: Pfizer, Teva&apos;s Q3 Earnings, Novartis Seeks New Indication for Kymriah",0.0,1.0,0.0,0
2017-11-06 14:00:39,0.0,Bristol-Myers Squibb’s Valuations after Its 3Q17 Earnings,0.0,1.0,0.0,0
2017-11-06 15:08:15,0.5106,Go Long Mylan N.V. After Earnings With Confidence,0.0,0.68,0.32,1
2017-11-06 15:12:25,0.0,"Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah",0.0,1.0,0.0,0
2017-11-06 18:33:14,0.4019,"FDA approves Roche drugs for rare types of blood, lung cancers",0.0,0.787,0.213,1
2017-11-06 21:17:01,0.0,Inside Pfizer’s 3Q17 Earnings: An Overview,0.0,1.0,0.0,0
2017-11-06 21:19:56,0.4404,How Pfizer’s Innovative Health and Essential Health Business Performed in 3Q17,0.0,0.775,0.225,1
2017-11-06 22:50:09,0.0,Understanding Pfizer’s Geographical Performance in 3Q17,0.0,1.0,0.0,0
2017-11-07 12:02:00,0.4404,"Better Buy: Novavax, Inc. vs. Pfizer Inc.",0.0,0.674,0.326,1
2017-11-07 12:15:00,0.6249,Spark Therapeutics and Pfizer Amend License Agreement for Investigational SPK-9001 in Hemophilia B,0.0,0.662,0.338,1
2017-11-07 12:33:33,0.3818,These Key Products Contributed to Pfizer’s Growth in 3Q17,0.0,0.755,0.245,1
2017-11-07 14:02:27,-0.0258,These Pfizer Products Lost Market Share in 3Q17,0.219,0.571,0.21,0
2017-11-07 14:16:22,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for November 08, 2017",0.0,1.0,0.0,0
2017-11-07 15:31:46,0.0,Inside Pfizer’s Product Developments in 3Q17,0.0,1.0,0.0,0
2017-11-07 17:00:16,0.6249,"Spark, Pfizer amend agreement for experimental hemophilia gene therapy",0.0,0.579,0.421,1
2017-11-07 18:06:58,0.0,"Flippin Bruce & Porter Inc Buys Nucor Corp, Williams-Sonoma Inc, Compass Minerals ...",0.0,1.0,0.0,0
2017-11-07 20:46:08,0.0,What&apos;s in the Cards for Merck KGaA (MKGAF) in Q3 Earnings?,0.0,1.0,0.0,0
2017-11-07 21:24:00,0.2263,"Here's Why Spark Therapeutics, Inc. Fell 9.3% in October",0.0,0.808,0.192,1
2017-11-07 23:09:05,0.0,What's in the Cards for Merck KGaA (MKGAF) in Q3 Earnings?,0.0,1.0,0.0,0
2017-11-08 09:42:08,-0.3818,Novartis takes fight to Pfizer's Ibrance with new Kisqali data,0.224,0.776,0.0,-1
2017-11-08 12:32:42,0.0,Behind Pfizer’s Corporate and Pipeline Developments in 3Q17,0.0,1.0,0.0,0
2017-11-08 14:01:32,0.0,Understanding Pfizer’s Valuation after the 3Q17 Results,0.0,1.0,0.0,0
2017-11-08 14:20:19,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 09, 2017",0.0,1.0,0.0,0
2017-11-08 15:17:58,0.0,"Key Predictions for Q3 Earnings Reports of PBYI, XON, LGND",0.0,1.0,0.0,0
2017-11-08 15:39:00,0.0,Here&apos;s What Cost GlaxoSmithKline PLC Nearly $10 Billion in Market Cap in October,0.0,1.0,0.0,0
2017-11-08 16:14:10,0.0,The Implied Analyst 12-Month Target For MOAT,0.0,1.0,0.0,0
2017-11-08 17:15:09,0.0,Here's What Cost GlaxoSmithKline PLC Nearly $10 Billion in Market Cap in October,0.0,1.0,0.0,0
2017-11-08 18:12:32,0.25,There's About 0% Chance Of A Permanent 20% Corporate Tax Rate,0.0,0.818,0.182,1
2017-11-08 19:55:00,0.0,"Wall Street dealmaking is heating up, but it's not a sign stocks are topping: NYSE trader",0.0,1.0,0.0,0
2017-11-08 21:15:42,0.0,"Noteworthy Wednesday Option Activity: QCOM, RHT, PFE",0.0,1.0,0.0,0
2017-11-08 23:27:42,0.0,"ETFs with exposure to Pfizer Inc. : November 8, 2017",0.0,1.0,0.0,0
2017-11-09 00:43:52,0.0,Arkansas got execution drug made by resistant manufacturer,0.0,1.0,0.0,0
2017-11-09 14:15:13,-0.3182,"Aerie (AERI) Q3 Loss Wider Than Expected, Pipeline in Focus",0.204,0.796,0.0,-1
2017-11-09 16:10:04,0.0,Pharma ETFs Down Post Q3 Earnings,0.0,1.0,0.0,0
2017-11-09 17:14:15,0.0,"Notable ETF Inflow Detected - VYM, JNJ, WFC, PFE",0.0,1.0,0.0,0
2017-11-09 22:12:11,-0.5267,Senate GOP To Delay Corporate Cut As House Takes Aim At Apple,0.306,0.694,0.0,-1
2017-11-10 00:16:00,-0.0572,Cramer's lightning round: You don't want to touch Pandora...,0.133,0.867,0.0,0
2017-11-10 17:01:26,0.0,"Pfizer Sells Stake in China's Hisun, Ending Drugs Joint Venture",0.0,1.0,0.0,0
2017-11-10 18:12:06,0.0,"Merck KGaA (MKGAF) Q3 Earnings Decline Y/Y, Revenues Flat",0.0,1.0,0.0,0
2017-11-10 18:48:09,0.0,Pfizer exits China joint venture for generic drugs,0.0,1.0,0.0,0
2017-11-10 21:13:00,0.4215,"BMS-Pfizer Alliance to Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation",0.0,0.877,0.123,1
2017-11-13 09:29:00,0.0,Pfizer Appoints Albert Bourla As COO,0.0,1.0,0.0,0
2017-11-13 10:27:15,0.3182,Bill Gates Is Now Tackling Alzheimer’s With a Huge Investment in Dementia Research,0.0,0.827,0.173,1
2017-11-13 14:00:00,0.0,Can Marijuana Cure Alzheimer&apos;s Disease?,0.0,1.0,0.0,0
2017-11-13 14:20:00,0.0,Pfizer Names Albert Bourla Chief Operating Officer,0.0,1.0,0.0,0
2017-11-13 14:34:18,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for November 14, 2017",0.0,1.0,0.0,0
2017-11-13 14:49:17,0.0,Pfizer names Bourla as chief operating officer,0.0,1.0,0.0,0
2017-11-13 15:08:00,0.0,Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb,0.0,1.0,0.0,0
2017-11-13 15:11:31,0.0,Can Marijuana Cure Alzheimer's Disease?,0.0,1.0,0.0,0
2017-11-13 15:43:02,0.0,"Pfizer Inc. : PFE-US: Dividend Analysis : November 10th, 2017 (record date) : By the numbers : November 13, 2017",0.0,1.0,0.0,0
2017-11-13 16:23:24,-0.4019,Analyst: Is The Street Ignoring Pfizer And Its Upcoming Catalysts?,0.231,0.769,0.0,-1
2017-11-13 16:33:57,0.4404,[$$] Pfizer Sets Up Succession Plan With Creation of Operating Chief Role,0.0,0.719,0.281,1
2017-11-13 16:59:52,0.2732,Pfizer creates chief operating officer role for Bourla,0.0,0.769,0.231,1
2017-11-13 17:16:25,0.0,Arena (ARNA) Completes Enrolment in Etrasimod Phase II Study,0.0,1.0,0.0,0
2017-11-13 18:12:00,0.4019,Interesting January 2020 Stock Options for PFE,0.0,0.69,0.31,1
2017-11-13 21:58:18,0.4576,"After Hours Most Active for Nov 13, 2017 :  GE, PFE, VZ, F, MSFT, JBLU, CSCO, ON, DYN, JBL, MU, FITB",0.0,0.864,0.136,1
2017-11-13 22:57:38,0.2023,"Top Analyst Reports for Pfizer, Occidental Petroleum & Charles Schwab",0.0,0.816,0.184,1
2017-11-14 08:57:39,0.3612,"Investec Asset Management (PTY) Ltd Buys Honeywell International Inc, DowDuPont Inc, Citigroup ...",0.0,0.828,0.172,1
2017-11-14 11:00:15,0.0,"This Simple, Lifesaving Liquid Is Suddenly in Short Supply",0.0,1.0,0.0,0
2017-11-14 14:01:38,0.2023,3 Top Big Pharma Dividend Stocks You Can Buy Right Now,0.0,0.833,0.167,1
2017-11-14 15:35:00,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Occidental Petroleum, Charles Schwab, Prudential and S&P Global",0.0,1.0,0.0,0
2017-11-14 16:28:43,0.0,"Dow Movers: GE, CAT",0.0,1.0,0.0,0
2017-11-14 16:33:42,0.0,Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day,0.0,1.0,0.0,0
2017-11-14 16:34:14,0.0,Merck (MRK) Gets CHMP Nod for Infection Candidate Prevymis,0.0,1.0,0.0,0
2017-11-14 23:54:32,0.0,"How to Know if You Should Buy, Sell or Hold Pfizer Inc.",0.0,1.0,0.0,0
2017-11-15 12:32:32,0.0,Inside Novartis’s Ophthalmology Drugs Now,0.0,1.0,0.0,0
2017-11-15 13:59:58,0.0,"Pfizer Inc. :PFE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 15, 2017",0.0,1.0,0.0,0
2017-11-15 14:12:22,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for November 16, 2017",0.0,1.0,0.0,0
2017-11-15 14:45:00,0.7269,3 Value Stocks Perfect for Retirement,0.0,0.33,0.67,1
2017-11-15 15:57:15,0.0,Why Pfizer Inc (PFE) Could Be A Buy,0.0,1.0,0.0,0
2017-11-15 16:10:00,0.0,GOP tax plan takes aim at Obamacare,0.0,1.0,0.0,0
2017-11-15 18:56:59,-0.357,"Despite Valeant Improvement, VRX Stock Price Is Still Too High",0.216,0.784,0.0,-1
2017-11-15 23:23:55,0.0,How to Invest in Companies That Place Women in Senior Leadership Roles,0.0,1.0,0.0,0
2017-11-16 00:01:00,-0.6249,"Pfizer, Novartis agree UK price cuts for new breast cancer drugs",0.386,0.468,0.146,-1
2017-11-16 07:18:34,0.0,"Avalon Advisors, Llc Buys DowDuPont Inc, Berkshire Hathaway Inc, Chevron Corp, Sells ...",0.0,1.0,0.0,0
2017-11-16 11:18:31,0.0,"Two Sigma Advisers, Llc Buys DowDuPont Inc, Pfizer Inc, Caterpillar Inc, Sells E.I. ...",0.0,1.0,0.0,0
2017-11-16 12:32:52,0.0,Which Products Are Driving Revenues for Antares Pharma in 2017?,0.0,1.0,0.0,0
2017-11-16 16:10:01,0.0,AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio,0.0,1.0,0.0,0
2017-11-16 16:26:22,0.0,AstraZeneca’s Valuation after 3Q17 Earnings,0.0,1.0,0.0,0
2017-11-16 16:52:56,0.0,Obamacare enrollment soars in first 11 days,0.0,1.0,0.0,0
2017-11-16 19:03:56,0.0,"Charles Brandes Buys YPF SA, Cardinal Health Inc, HCA Healthcare Inc, Sells State Street ...",0.0,1.0,0.0,0
2017-11-16 21:58:00,0.25,Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma,0.074,0.816,0.11,1
2017-11-16 23:03:19,0.0,"Partner Fund Management, L.P. Buys Portola Pharmaceuticals Inc, Centene Corp, Allergan PLC, ...",0.0,1.0,0.0,0
2017-11-16 23:26:00,-0.4588,Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning,0.325,0.45,0.225,-1
2017-11-17 00:13:00,0.4939,"FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche",0.0,0.789,0.211,1
2017-11-17 11:02:00,0.2732,These 3 Stocks Might as Well Not Even Be in the Dow Jones Industrials,0.0,0.851,0.149,1
2017-11-17 14:53:02,-0.6597,Cancer Space Update: Label Expansion for Three Major Drugs,0.355,0.645,0.0,-1
2017-11-17 15:12:28,0.0,Why It’s Time to Put Pfizer Inc. Stock on Your Watchlist,0.0,1.0,0.0,0
2017-11-17 15:30:19,0.0,Novartis on the Street: Analysts’ Recommendations in November,0.0,1.0,0.0,0
2017-11-17 17:05:47,0.0,"Notable ETF Inflow Detected - XLV, JNJ, PFE, ABBV",0.0,1.0,0.0,0
2017-11-17 22:09:10,-0.6597,Pfizer&apos;s Cancer Drug Sutent Gets FDA Nod for Label Expansion,0.328,0.672,0.0,-1
2017-11-17 23:55:07,0.0,The Latest: Nevada won't return execution drug to Pfizer,0.0,1.0,0.0,0
2017-11-18 00:03:40,-0.6597,Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion,0.328,0.672,0.0,-1
2017-11-18 01:16:21,-0.2732,Nevada wants to use untried execution drugs that pose risks,0.189,0.811,0.0,-1
2017-11-18 01:26:03,-0.4939,Nevada refusing Pfizer demand for return of execution drugs,0.375,0.625,0.0,-1
2017-11-18 19:58:19,0.0,"Tax reform could come before 2018, so a strategist says buy these 2 stocks",0.0,1.0,0.0,0
2017-11-20 13:30:00,0.0,ImmunoPrecise Realigns Senior Management,0.0,1.0,0.0,0
2017-11-20 14:06:34,0.4939,"Health Care Sector Update for 11/20/2017: JNJ, PFE, ABT, MRK, AMGN, DBVT, EGLT, ACOR",0.0,0.802,0.198,1
2017-11-20 16:40:19,0.0,Trump may eliminate health provision in tax bill,0.0,1.0,0.0,0
2017-11-20 17:14:08,0.0,Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US,0.0,1.0,0.0,0
2017-11-20 18:04:46,0.0,"ETFs with exposure to Pfizer Inc. : November 20, 2017",0.0,1.0,0.0,0
2017-11-20 19:09:08,0.4019,Interesting December Stock Options for PFE,0.0,0.649,0.351,1
2017-11-20 22:06:24,0.4576,"After Hours Most Active for Nov 20, 2017 :  ACM, QQQ, BAC, LC, EUFN, PFE, WFC, T, URBN, FITB, GILD, AAPL",0.0,0.864,0.136,1
2017-11-20 22:26:00,0.0,Stay away from big pharma?,0.0,1.0,0.0,0
2017-11-20 23:41:39,-0.6597,Roche Sues Pfizer to Bar Biosimilar of Cancer Drug Herceptin,0.328,0.672,0.0,-1
2017-11-21 09:47:32,0.0,Britain says Canada's Concordia overcharging health service for thyroid drug,0.0,1.0,0.0,0
2017-11-21 10:36:09,0.0,"Drug firm Concordia overcharged Britain's health service with 6,000 pct price rise",0.0,1.0,0.0,0
2017-11-21 10:38:42,0.0,"Drug firm Concordia overcharged Britain's health service with 6,000 percent price rise",0.0,1.0,0.0,0
2017-11-21 13:03:25,0.0,November Pharma And Biotech Dividend Stocks To Look Out For,0.0,1.0,0.0,0
2017-11-21 13:39:04,0.0,Is Merck & Co. Inc. a Buy?,0.0,1.0,0.0,0
2017-11-21 14:34:05,0.4939,"Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO",0.0,0.802,0.198,1
2017-11-21 17:33:02,0.0,"Patent Expiry, Competition Will Continue To Weigh On Bristol-Myers Squibb's Virology Portfolio",0.0,1.0,0.0,0
2017-11-21 20:13:00,0.6369,ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV,0.0,0.658,0.342,1
2017-11-22 00:45:00,0.4215,"Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection",0.0,0.896,0.104,1
2017-11-22 01:19:00,0.0,"First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675",0.0,1.0,0.0,0
2017-11-22 14:35:42,0.4939,"Health Care Sector Update for 11/22/2017: JNJ, PFE, ABT, MRK, AMGN, EXEL, PBMD, SSY",0.0,0.802,0.198,1
2017-11-22 14:55:43,0.0,The Outlook For Merck’s Anti-Infectives Drug Business,0.0,1.0,0.0,0
2017-11-22 17:02:17,0.0,"Stock Market News For Nov 22, 2017",0.0,1.0,0.0,0
2017-11-22 17:03:00,0.4767,J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen,0.0,0.744,0.256,1
2017-11-22 19:30:10,0.0,How Teva’s Generic Medicines Business Is Positioned after 3Q17,0.0,1.0,0.0,0
2017-11-23 14:00:14,0.2023,Top 10 Largest Pharmaceutical Companies By Revenue in 2017,0.0,0.816,0.184,1
2017-11-23 15:32:14,0.0,Teva on the Street: Analyst Recommendations in November 2017,0.0,1.0,0.0,0
2017-11-24 13:02:22,0.0,Value-Adding Dividend Stocks To Buy Now,0.0,1.0,0.0,0
2017-11-24 14:16:16,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 27, 2017",0.0,1.0,0.0,0
2017-11-24 14:36:27,0.4939,"Health Care Sector Update for 11/24/2017: JNJ, PFE, ABT, MRK, AMGN, TEVA, NKTR",0.0,0.789,0.211,1
2017-11-24 18:30:56,0.0,What’s Johnson & Johnson’s Valuation?,0.0,1.0,0.0,0
2017-11-24 18:57:10,-0.25,3 Companies Competing to Gain Lead in Ovarian Cancer Market,0.297,0.473,0.23,-1
2017-11-27 13:10:00,0.0,"Investor Expectations to Drive Momentum within Intel, Pfizer, CenturyLink, Marathon Oil, Applied Materials, and AK Steel Holding — Discovering Underlying Factors of Influence",0.0,1.0,0.0,0
2017-11-27 15:37:00,0.4404,"Why Pfizer, Applied Materials And Three Other GARP Stocks Look Attractive",0.0,0.775,0.225,1
2017-11-27 17:07:20,0.0,SPDR Portfolio Total Stock Market ETF Experiences Big Inflow,0.0,1.0,0.0,0
2017-11-27 17:10:45,0.0,"XLV, SZK: Big ETF Outflows",0.0,1.0,0.0,0
2017-11-27 23:06:51,-0.4767,Chip Stocks Drag Nasdaq Lower,0.577,0.423,0.0,-1
2017-11-27 23:45:46,-0.0772,Cramer admits his biggest investing mistakes,0.287,0.46,0.253,0
2017-11-28 00:10:00,-0.3612,Cramer's biggest investing mistakes,0.455,0.545,0.0,-1
2017-11-28 08:19:00,0.0,"Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint",0.0,1.0,0.0,0
2017-11-28 13:10:00,-0.5267,"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients with Pre-Treated Advanced Gastric Cancer",0.167,0.758,0.076,-1
2017-11-28 13:12:24,-0.743,"Merck KGaA, Pfizer's avelumab misses goal in gastric cancer trial",0.441,0.559,0.0,-1
2017-11-28 13:12:36,-0.743,"Pfizer, Germany's Merck cancer treatment trial misses primary endpoint",0.474,0.526,0.0,-1
2017-11-28 13:16:43,0.296,BRIEF-Zhejiang Hisun Pharmaceutical's share trade to resume after Pfizer exited China JV,0.0,0.833,0.167,1
2017-11-28 13:25:00,-0.5267,Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer,0.188,0.726,0.085,-1
2017-11-28 14:27:03,0.4939,"Health Care Sector Update for 11/28/2017: JNJ, PFE, ABT, MRK, AMGN, EARS, EGLT, AZN",0.0,0.802,0.198,1
2017-11-28 15:30:32,-0.802,"Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial",0.507,0.493,0.0,-1
2017-11-28 16:04:22,0.4767,UK gives Pfizer world's first over-the-counter Viagra approval,0.0,0.693,0.307,1
2017-11-28 16:10:42,-0.296,2 Large-Cap Drug Stocks Missing Out on Industry Rally in '17,0.196,0.804,0.0,-1
2017-11-28 16:47:23,-0.5046,Brace for More Cancer-Drug Trial Failures,0.395,0.605,0.0,-1
2017-11-28 18:08:53,0.4939,"Health Care Sector Update for 11/28/2017: COOL,PZRX,PETX, MDT,GILD,PFE",0.0,0.686,0.314,1
2017-11-28 20:00:00,0.4215,How Large Is Pfizer's Biosimilar Opportunity?,0.0,0.641,0.359,1
2017-11-28 21:11:14,-0.2732,3 Dividend Stocks That Cut Bigger Checks Than Chevron,0.231,0.769,0.0,-1
2017-11-28 21:53:09,0.0,"Glaxo, Pfizer&apos;s ViiV Healthcare Begins HIV Drug Combo Study",0.0,1.0,0.0,0
2017-11-28 22:11:04,0.0,How Did Pfizer Perform in 3Q17?,0.0,1.0,0.0,0
2017-11-29 00:21:12,0.0,"Glaxo, Pfizer's ViiV Healthcare Begins HIV Drug Combo Study",0.0,1.0,0.0,0
2017-11-29 02:05:00,-0.2263,"EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark",0.128,0.872,0.0,-1
2017-11-29 07:09:00,0.0,Biotech Stocks Facing FDA Decision In December,0.0,1.0,0.0,0
2017-11-29 12:35:02,0.3818,Could Lorlatinib Be a Long-Term Growth Driver for Pfizer?,0.0,0.729,0.271,1
2017-11-29 14:04:27,0.0,How Is Pfizer’s Xtandi Positioned after 3Q17?,0.0,1.0,0.0,0
2017-11-29 14:26:08,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 30, 2017",0.0,1.0,0.0,0
2017-11-29 14:39:24,0.4939,"Health Care Sector Update for 11/29/2017: JNJ, PFE, ABT, MRK, AMGN, KOOL, CAPR, RXII",0.0,0.802,0.198,1
2017-11-29 15:34:38,0.0,How Are Pfizer’s Vaccines and Biosimilars Positioned after 3Q17?,0.0,1.0,0.0,0
2017-11-29 16:11:04,-0.802,Pfizer/Merck KGaA&apos;s Bavencio Fails in Gastric Cancer Study,0.545,0.455,0.0,-1
2017-11-29 18:23:57,-0.802,Pfizer/Merck KGaA's Bavencio Fails in Gastric Cancer Study,0.545,0.455,0.0,-1
2017-11-29 19:10:44,0.7096,"U.S. says patient charity helped drugmakers, revokes approval",0.0,0.504,0.496,1
2017-11-29 19:10:46,-0.1027,"GOP Corporate Tax Cuts Take Friendly Fire From Corker, Rubio",0.311,0.473,0.216,-1
2017-11-29 23:53:58,-0.3182,APNewsBreak: Doctor: Lack of drugs led to new execution plan,0.204,0.796,0.0,-1
2017-11-30 12:21:46,0.4404,Better Buy: GlaxoSmithKline plc vs. Pfizer,0.0,0.633,0.367,1
2017-11-30 12:33:54,0.0,How Have Pfizer’s Ibrance and Sutent Performed in 2017?,0.0,1.0,0.0,0
2017-11-30 13:19:13,0.0,Bank of America Acts on Bristol-Myers Squibb and Pfizer,0.0,1.0,0.0,0
2017-11-30 14:01:55,0.0,An Update on Pfizer’s Xalkori and Inlyta,0.0,1.0,0.0,0
2017-11-30 14:19:02,0.0,Glaxo Stock Down So Far This Year: Is a Reversal in Store?,0.0,1.0,0.0,0
2017-11-30 15:31:42,0.0,How Has Pfizer’s Internal Medicine Portfolio Performed in 2017?,0.0,1.0,0.0,0
2017-11-30 21:59:43,0.4576,"After Hours Most Active for Nov 30, 2017 :  WFT, F, AUY, ACWI, NAVI, NUAN, MSFT, NUE, V, FWONK, MU, PFE",0.0,0.864,0.136,1
2017-11-30 22:49:01,0.4404,Why Pfizer And Four More GARP Stocks Look Good,0.0,0.734,0.266,1
2017-12-01 01:39:00,0.5719,"Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific",0.0,0.657,0.343,1
2017-12-01 06:22:00,0.4939,Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region,0.0,0.824,0.176,1
2017-12-01 11:00:11,-0.4215,"Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Changes",0.189,0.811,0.0,-1
2017-12-01 12:31:31,0.0,How Pfizer’s Established Products Have Performed,0.0,1.0,0.0,0
2017-12-01 14:01:20,0.0,Understanding Eli Lilly’s Valuation This November,0.0,1.0,0.0,0
2017-12-01 14:01:37,0.0,How Is Pfizer’s Immunology and Inflammation Portfolio Positioned Now?,0.0,1.0,0.0,0
2017-12-01 14:33:02,-0.802,Cancer Space Update: Pfizer&apos;s Bavencio Fails in Phase III,0.507,0.493,0.0,-1
2017-12-01 15:25:51,0.0,Gilead & 3 Other Drug Stocks in Focus this World AIDS Day,0.0,1.0,0.0,0
2017-12-01 15:27:06,0.0258,Glaxo Begins Phase III Study on Injection to Prevent HIV,0.0,0.891,0.109,0
2017-12-01 15:31:43,0.0,How Pfizer’s Premarin and Other Legacy Established Products Performed,0.0,1.0,0.0,0
2017-12-01 16:23:56,-0.802,Cancer Space Update: Pfizer's Bavencio Fails in Phase III,0.507,0.493,0.0,-1
2017-12-01 19:13:44,0.0,"Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources",0.0,1.0,0.0,0
2017-12-02 01:20:57,0.0,3 Drug/Biotech Stocks in Focus on World AIDS Day,0.0,1.0,0.0,0
2017-12-02 13:11:25,0.0,The 15 All-Time Best-Selling Prescription Drugs,0.0,1.0,0.0,0
2017-12-02 15:36:00,-0.2732,Is a Dividend Cut Coming From GlaxoSmithKline plc?,0.259,0.741,0.0,-1
2017-12-04 08:29:00,0.0,"BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS",0.0,1.0,0.0,0
2017-12-04 12:10:00,0.4939,Wired News – Pfizer Announced an Agreement to Develop and Commercialize Basilea’s Antifungal CRESEMBA in China and the Asia/ Pacific Region,0.0,0.856,0.144,1
2017-12-04 12:30:38,0.0,How Is Pfizer’s Sterile Injection Pharmaceuticals Business Positioned?,0.0,1.0,0.0,0
2017-12-04 13:32:00,0.0,3 Reasons Pfizer Should Buy Celgene in 2018,0.0,1.0,0.0,0
2017-12-04 14:03:02,0.5719,Pfizer Wins China & Asia-Pacific Rights to Anti-Fungal Drug,0.0,0.654,0.346,1
2017-12-04 14:16:50,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for December 05, 2017",0.0,1.0,0.0,0
2017-12-04 14:27:19,0.5574,Why the &apos;gay wedding cake&apos; Supreme Court case is really about corporate governance,0.0,0.769,0.231,1
2017-12-04 15:30:13,0.0,A Look at How These Pfizer Drugs Have Performed in 2017,0.0,1.0,0.0,0
2017-12-04 16:10:46,0.0,3 Stocks That Quadrupled,0.0,1.0,0.0,0
2017-12-04 19:00:00,0.0,"Regardless of the 'palace intrigue' at the White House, stocks will probably go up: NYSE trader",0.0,1.0,0.0,0
2017-12-05 12:30:02,0.3612,What Analysts Recommend for Pfizer in November 2017,0.0,0.737,0.263,1
2017-12-05 13:00:00,0.0,"Bristol-Myers Squibb and Pfizer Alliance Urge People to ‘Tune in to AFib, Take Note of Stroke Risk’",0.0,1.0,0.0,0
2017-12-05 14:08:24,0.4215,5 Top-Ranked Drug Stocks that are Broker Favorites,0.0,0.682,0.318,1
2017-12-05 15:23:19,0.0,Have you been 'pwned' in a data breach? Troy Hunt can tell,0.0,1.0,0.0,0
2017-12-05 17:12:35,0.0,"Noteworthy ETF Inflows: VYM, JNJ, WFC, PFE",0.0,1.0,0.0,0
2017-12-05 17:15:00,0.0,Biotech Stocks May See a New M&A Wave in 2018,0.0,1.0,0.0,0
2017-12-05 18:13:43,0.0,"ETFs with exposure to Pfizer Inc. : December 5, 2017",0.0,1.0,0.0,0
2017-12-06 05:00:00,0.0,Frayed Gasket Delaying Astra's ZS-9 Shows Pharma M&A Perils,0.0,1.0,0.0,0
2017-12-06 10:00:50,0.0,"Sex, Drugs and That Little Blue Pill",0.0,1.0,0.0,0
2017-12-06 12:30:00,-0.34,"Updated Data from Phase 3 Trial of IBRANCE® (palbociclib) Plus Letrozole in ER+, HER2- Metastatic Breast Cancer Confirm Improvement in Progression-Free Survival",0.167,0.72,0.114,-1
2017-12-06 12:47:22,0.0,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : December 6, 2017",0.0,1.0,0.0,0
2017-12-06 16:11:10,0.0,Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?,0.0,1.0,0.0,0
2017-12-06 18:07:02,-0.296,US Market Indexes Lower on Tuesday,0.306,0.694,0.0,-1
2017-12-06 22:00:00,0.2263,Spark Therapeutics and Pfizer Announce Publication in The New England Journal of Medicine of Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Hemophilia B,0.0,0.932,0.068,1
2017-12-06 22:16:18,0.6808,"Gene-therapy approach to hemophilia finds success in study, Spark stock surges",0.0,0.616,0.384,1
2017-12-06 23:49:01,0.0,Pfizer is releasing its own generic Viagra to stay relevant,0.0,1.0,0.0,0
2017-12-06 23:49:32,0.0,Viagra goes generic: Pfizer to launch own little white pill,0.0,1.0,0.0,0
2017-12-07 01:11:31,0.0,10 Things to Know for Thursday,0.0,1.0,0.0,0
2017-12-07 13:00:00,0.4767,Pfizer Inc. Announces (i) Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors and (ii) Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents,0.0,0.911,0.089,1
2017-12-07 14:35:00,0.0,Regulations And Politics Rain On Pharma M&A Parade,0.0,1.0,0.0,0
2017-12-07 16:16:08,0.6705,CWABS Asset-Backed Certificates Trust 2007-6 -- Moody's assigns A1 to Pfizer's new sterling notes; stable outlook,0.0,0.718,0.282,1
2017-12-07 17:08:40,0.0,"Levin Capital Strategies, L.p. Buys DowDuPont Inc, Walt Disney Co, Treehouse Foods Inc, Sells ...",0.0,1.0,0.0,0
2017-12-07 18:53:00,0.2263,[$$] Lighting a Spark for Gene Therapy,0.0,0.725,0.275,1
2017-12-07 20:27:08,0.0,Pfizer Reports Updated Data from Phase III Study on Ibrance,0.0,1.0,0.0,0
2017-12-07 20:57:52,0.0,Understanding Allergan’s Valuation in December 2017,0.0,1.0,0.0,0
2017-12-08 08:43:00,0.128,Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial,0.0,0.824,0.176,1
2017-12-08 12:32:58,0.0,How Eli Lilly’s Endocrinology Drugs Are Performing,0.0,1.0,0.0,0
2017-12-08 13:30:00,-0.5994,Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer,0.233,0.688,0.079,-1
2017-12-08 13:30:01,-0.2263,Pfizer breast cancer drug superior to chemotherapy in Phase III study,0.26,0.533,0.207,-1
2017-12-08 15:13:34,0.0,A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients,0.0,1.0,0.0,0
2017-12-08 17:13:46,0.4576,A Cancer-Drug Pricing Experiment Just Got More Interesting,0.0,0.667,0.333,1
2017-12-08 17:43:09,0.0,An Irish Town That Manufactures Viagra Boasts of ‘Love Fumes’ in the Air,0.0,1.0,0.0,0
2017-12-09 17:00:00,-0.4215,Six Off the Beaten Path Healthcare Stock Gems,0.286,0.714,0.0,-1
2017-12-10 15:29:01,0.4404,Better Buy: Pfizer (PFE) vs. AbbVie (ABBV),0.0,0.674,0.326,1
2017-12-11 07:00:00,0.3182,Eli Lily: FDA Accepts BLA To Review Galcanezumab For Prevention Of Migraine,0.0,0.827,0.173,1
2017-12-11 07:38:00,0.2263,"Spark, Pfizer Record Sustained Factor IX Activity Levels In SPK-9001 Trial",0.0,0.84,0.16,1
2017-12-11 10:00:22,0.0,The Little Blue Pill: An Oral History of Viagra,0.0,1.0,0.0,0
2017-12-11 12:00:00,0.2263,Spark Therapeutics and Pfizer Announce Longer-term Preliminary Data Showing Consistent and Sustained Factor IX Levels in Hemophilia B at 59th American Society of Hematology (ASH) Annual Meeting and Exposition,0.0,0.934,0.066,1
2017-12-11 12:55:48,0.4767,"Republican tax bill makes big winners of Amgen, Gilead and other drugmakers",0.0,0.78,0.22,1
2017-12-11 14:31:38,0.4404,Teva's stock gains after exclusive launch of generic Viagra,0.0,0.642,0.358,1
2017-12-11 14:40:00,0.0,Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers,0.0,1.0,0.0,0
2017-12-11 14:54:02,0.0,"Sex, Drugs, and Teva Pharmaceutical Industries (TEVA)",0.0,1.0,0.0,0
2017-12-11 15:36:03,0.5423,Pfizer&apos;s (PFE) Talazoparib Emerges Superior in EMBRACA Study,0.0,0.667,0.333,1
2017-12-11 15:37:20,0.0,4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018,0.0,1.0,0.0,0
2017-12-11 16:33:12,0.0,3 High-Yield Dividend Stocks to Buy in 2018,0.0,1.0,0.0,0
2017-12-11 17:32:29,0.5423,Pfizer's (PFE) Talazoparib Emerges Superior in EMBRACA Study,0.0,0.667,0.333,1
2017-12-11 18:05:00,0.2263,[$$] Spark Therapeutics Selloff Looks Overdone,0.0,0.725,0.275,1
2017-12-11 18:28:00,0.0,Teva Stock Rises After Announcing Launch of Generic Viagra Competitor,0.0,1.0,0.0,0
2017-12-11 19:31:04,0.2263,"Here's Why Spark Therapeutics, Inc. Is Getting Hammered Today",0.0,0.808,0.192,1
2017-12-11 20:55:00,-0.3818,Roche's Fight With Pfizer May Be Just The Beginning,0.245,0.755,0.0,-1
2017-12-11 22:42:00,0.2382,"Merck lagging this year, but charts show it's poised for ...",0.119,0.69,0.192,1
2017-12-12 07:26:00,0.0,Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib,0.0,1.0,0.0,0
2017-12-12 13:18:00,0.0,3 Dividend Stocks to Buy on Sale,0.0,1.0,0.0,0
2017-12-12 13:31:51,0.5719,3 Dividend Stocks Perfect for Retirees,0.0,0.519,0.481,1
2017-12-12 15:15:03,0.2263,Spark Therapeutics Stock Plunges on Hemophilia Therapy Data,0.0,0.787,0.213,1
2017-12-12 15:30:17,0.3612,What Analysts Recommend for Eli Lilly in December 2017,0.0,0.762,0.238,1
2017-12-12 16:34:09,0.2023,3 Top Healthcare Stocks to Buy in December,0.0,0.769,0.231,1
2017-12-12 21:52:00,0.128,U.S. Food And Drug Administration Extends Action Date For XELJANZ® (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months,0.0,0.93,0.07,1
2017-12-12 21:58:48,0.4576,"After Hours Most Active for Dec 12, 2017 :  F, CLF, NI, MDLZ, BABA, PFE, BAC, CZR, CMCSA, JBLU, RIGL, INTC",0.0,0.864,0.136,1
2017-12-12 22:37:22,-0.2023,3 Reasons Spark Therapeutics Is a Buy After Its Crash,0.255,0.566,0.179,-1
2017-12-13 02:38:00,0.3612,"ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use",0.16,0.533,0.308,1
2017-12-13 09:53:00,0.0,Cellectis SA (CLLS) Is Sharply Higher On Study Results,0.0,1.0,0.0,0
2017-12-13 11:33:00,-0.2263,Why 2017 Was a Year to Forget for Pfizer Inc.,0.192,0.808,0.0,-1
2017-12-13 12:02:17,0.0,US Market Indexes Higher on Monday,0.0,1.0,0.0,0
2017-12-13 12:31:00,0.0,5 Biotech Buyout Candidates for 2018,0.0,1.0,0.0,0
2017-12-13 14:29:32,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for December 14, 2017",0.0,1.0,0.0,0
2017-12-13 16:05:58,0.5267,Why Cellectis Is Winning Big With Its Pfizer Partnership,0.0,0.702,0.298,1
2017-12-13 18:05:15,0.0,"Notable ETF Outflow Detected - IVW, GOOG, JNJ, PFE",0.0,1.0,0.0,0
2017-12-13 20:17:00,0.0,"OCUL Catches Eyes, IMGN, CLLS Rise After ASH Data, Catalyst Ahead For RETA",0.0,1.0,0.0,0
2017-12-13 21:03:00,0.4767,Pfizer Biosimilar Medicine IXIFI Gets FDA Approval For All Eligible Indications,0.0,0.763,0.237,1
2017-12-13 22:06:00,0.0,Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Data Published in New England Journal of Medicine Demonstrate the Vaccine’s Immunogenicity,0.0,1.0,0.0,0
2017-12-13 23:01:00,0.4019,FDA Approves New Pfizer Biosimilar,0.0,0.597,0.403,1
2017-12-13 23:06:50,-0.6597,This Biotech Stock Rocketed On Human Trials For New Cancer Drug,0.306,0.694,0.0,-1
2017-12-14 01:09:58,0.7783,Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval,0.0,0.541,0.459,1
2017-12-14 07:40:00,0.0,Pfizer Initiates Phase 3 Program For PF-04965842 - Quick Facts,0.0,1.0,0.0,0
2017-12-14 12:00:00,-0.2023,Wired News – Myriad Genetics' EMBRACA Trials Show Positive Results for BRACAnalysis CDx(R) Test on Patients with Metastatic Breast Cancer Responding to Pfizer's Talazoparib,0.152,0.724,0.124,-1
2017-12-14 12:30:00,-0.0772,"Pfizer Initiates Phase 3 Program for PF-04965842, a JAK1 Inhibitor in Development for Moderate-to-Severe Atopic Dermatitis",0.091,0.909,0.0,0
2017-12-14 14:51:50,0.0,10 Biggest Antidepressant Drug Companies In 2017,0.0,1.0,0.0,0
2017-12-14 15:27:00,0.2732,Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors,0.0,0.93,0.07,1
2017-12-14 19:15:00,0.0,Teva Options Jump to Record Amid New CEO's Latest Bid for Turnaround,0.0,1.0,0.0,0
2017-12-14 19:58:00,0.8176,Pfizer Says FDA Okays XELJANZ And XELJANZ XR To Treat Active Psoriatic Arthritis,0.0,0.541,0.459,1
2017-12-14 20:34:08,0.4767,Pfizer&apos;s Second Biosimilar of Remicade Receives FDA Approval,0.0,0.693,0.307,1
2017-12-14 20:44:00,0.0,Pfizer's Bet On Oncology,0.0,1.0,0.0,0
2017-12-14 20:51:00,0.0,Valeant: Down It Goes!,0.0,1.0,0.0,0
2017-12-14 23:07:14,0.4767,Pfizer's Second Biosimilar of Remicade Receives FDA Approval,0.0,0.693,0.307,1
2017-12-15 00:26:00,0.7003,Pfizer Announces FDA Approval of XELJANZ® (tofacitinib) and XELJANZ® XR for the Treatment of Active Psoriatic Arthritis,0.0,0.721,0.279,1
2017-12-15 01:13:33,0.0,Pfizer's Xeljanz gets FDA nod as joint disease treatment,0.0,1.0,0.0,0
2017-12-15 02:03:24,-0.0772,ASH 2017 Recap: These Were the Big Winners and Losers,0.234,0.552,0.214,0
2017-12-15 12:20:45,0.0,Pfizer Headed for New High After FDA Nod for Joint Disease Treatment,0.0,1.0,0.0,0
2017-12-15 13:03:00,0.0,Pfizer Inc. Announces Expiration and Results of its Private Exchange Offer for its 6.500 per cent. Notes due 2038 and Related Tender Offer,0.0,1.0,0.0,0
2017-12-15 14:05:43,0.4767,AbbVie a Top Socially Responsible Dividend Stock With 3.0% Yield (ABBV),0.0,0.661,0.339,1
2017-12-15 14:37:10,0.4939,"Dow Stocks Lead Early Surge; Costco Gains, Top Railroad Sells Off",0.0,0.682,0.318,1
2017-12-15 17:07:49,0.0,"Dow Movers: IBM, PFE",0.0,1.0,0.0,0
2017-12-15 19:05:07,-0.6597,"Cancer Space Update: Roche, Pfizer & Regeneron Make Data Presentations",0.355,0.645,0.0,-1
2017-12-15 19:37:07,0.0,Pfizer&apos;s Arthritis Drug Gets FDA Nod for Label Expansion,0.0,1.0,0.0,0
2017-12-15 20:06:06,0.0,"S&P 500 Hits New High, As Stock Market Surges",0.0,1.0,0.0,0
2017-12-15 21:03:57,0.0,Can Teva Jump-Start Its Restructuring By Swiping Some Of Gilead's Sales?,0.0,1.0,0.0,0
2017-12-15 22:03:45,0.4576,"After Hours Most Active for Dec 15, 2017 :  BAC, GE, CMCSA, T, VZ, CSCO, INTC, CDNS, MU, QCOM, FBP, PFE",0.0,0.864,0.136,1
2017-12-15 22:05:11,-0.743,Merck's Keytruda Misses Primary End Point for Gastric Cancer,0.474,0.526,0.0,-1
2017-12-15 22:05:34,0.0,Pfizer's Arthritis Drug Gets FDA Nod for Label Expansion,0.0,1.0,0.0,0
2017-12-17 14:00:00,0.0,Here&apos;s Why GlycoMimetics Could Become a Takeover Target,0.0,1.0,0.0,0
2017-12-17 15:07:34,0.0,Here's Why GlycoMimetics Could Become a Takeover Target,0.0,1.0,0.0,0
2017-12-17 16:07:54,0.6369,The 3 Best Biotech Stocks of 2017,0.0,0.543,0.457,1
2017-12-17 16:33:00,0.2023,3 Top Stocks That Are Cash Cows,0.0,0.735,0.265,1
2017-12-17 22:06:21,0.0,Apple Just Carved A Base; These Three Dow Stocks Are New Buys,0.0,1.0,0.0,0
2017-12-18 11:00:00,-0.4199,A New PARP Drug For Breast Cancer? I'm Thrilled!,0.345,0.441,0.213,-1
2017-12-18 12:03:00,0.0,The 5 Best-Selling Drugs of 2017,0.0,1.0,0.0,0
2017-12-18 13:01:00,0.6369,The 3 Best Dow Dividend Stocks for 2018,0.0,0.588,0.412,1
2017-12-18 14:11:07,0.4767,Bristol-Myers Squibb a Top Socially Responsible Dividend Stock With 2.6% Yield (BMY),0.0,0.687,0.313,1
2017-12-18 15:06:47,0.0,Apple Just Carved A Base; These 3 Dow Stocks Are New Buys,0.0,1.0,0.0,0
2017-12-18 15:14:13,0.0,"Apple Just Hit A Buy Point, Joining These 3 Dow Stocks",0.0,1.0,0.0,0
2017-12-18 16:44:00,0.0,Pfizer Declares First-Quarter 2018 Dividend,0.0,1.0,0.0,0
2017-12-18 16:58:22,0.0,"Pfizer sets new $10 billion stock buyback program, bumps up dividend by 6.3%",0.0,1.0,0.0,0
2017-12-18 17:07:24,0.0,US Market Indexes Higher on Friday,0.0,1.0,0.0,0
2017-12-18 17:07:36,0.0,"Dow Movers: DIS, AXP",0.0,1.0,0.0,0
2017-12-18 17:32:27,0.296,"Pfizer announces new $10 billion share buyback, hikes dividend",0.0,0.784,0.216,1
2017-12-18 20:17:00,0.5994,Pfizer Board Approves New $10 Bln Share Buy-back; Hikes Dividend,0.0,0.62,0.38,1
2017-12-19 00:30:00,0.4767,The 5 Winners Of Canada’s Cannabis Boom,0.0,0.617,0.383,1
2017-12-19 08:12:00,0.4939,Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer,0.0,0.738,0.262,1
2017-12-19 11:02:00,0.0,Why 2017 Was a Year to Remember for Johnson & Johnson,0.0,1.0,0.0,0
2017-12-19 14:01:00,0.4576,This Possible Dog of the Dow Just Got Even More Interesting,0.0,0.77,0.23,1
2017-12-19 15:30:03,0.296,"Pfizer Hikes Dividend, Announces $10B Share Buyback Plan",0.0,0.761,0.239,1
2017-12-19 16:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts,0.0,1.0,0.0,0
2017-12-19 17:13:52,0.2732,AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA,0.0,0.769,0.231,1
2017-12-19 18:24:01,0.296,Pfizer Shareholders Are Already Enjoying the Fruits of Tax Cuts,0.162,0.588,0.25,1
2017-12-19 21:06:19,0.0,"Daily Dividend Report: T, PFE, ROP, USB, TWX",0.0,1.0,0.0,0
2017-12-19 21:11:00,0.4019,U.S. FDA Approves Pfizer’s BOSULIF® (bosutinib) for the Treatment of Patients with Newly-Diagnosed Ph+ Chronic Myelogenous Leukemia (CML),0.0,0.863,0.137,1
2017-12-19 21:50:10,-0.3182,"Pfizer, Exelixis cancer drugs get FDA approval for wider use",0.284,0.516,0.2,-1
2017-12-19 22:10:47,0.0,New Gene Therapies Could Change Hemophilia Forever,0.0,1.0,0.0,0
2017-12-20 00:11:00,0.0,"EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours",0.0,1.0,0.0,0
2017-12-20 14:01:02,-0.6597,Exelixis&apos; Cabometyx Gets FDA Nod for First-Line Kidney Cancer,0.355,0.645,0.0,-1
2017-12-20 15:09:48,0.2023,3 Top Generic Drug Stocks to Consider Buying Now,0.0,0.795,0.205,1
2017-12-20 16:12:40,-0.6597,Exelixis' Cabometyx Gets FDA Nod for First-Line Kidney Cancer,0.355,0.645,0.0,-1
2017-12-20 16:40:11,0.0,Pfizer: Analysts’ Recommendations for December 2017,0.0,1.0,0.0,0
2017-12-20 18:15:03,-0.228,Pfizer Expects to Report Slightly Lower Revenues in 2017,0.192,0.808,0.0,-1
2017-12-20 19:00:00,-0.6597,Exelixis&apos; Cabometyx Takes Aim at Sutent in Kidney Cancer,0.355,0.645,0.0,-1
2017-12-20 19:21:07,0.0,Pfizer&apos;s Leukemia Drug Gets FDA Nod in First-Line Setting,0.0,1.0,0.0,0
2017-12-20 19:45:02,0.7351,Pfizer Expects to Report Strong Net Profit Margins in 2017,0.0,0.563,0.437,1
2017-12-20 20:08:49,-0.6597,Exelixis' Cabometyx Takes Aim at Sutent in Kidney Cancer,0.355,0.645,0.0,-1
2017-12-20 21:08:33,-0.296,Markets Right Now: US stock indexes close mostly lower,0.216,0.784,0.0,-1
2017-12-20 21:09:00,0.0,Pfizer's Leukemia Drug Gets FDA Nod in First-Line Setting,0.0,1.0,0.0,0
2017-12-20 21:40:48,0.4019,U.S. FDA approves new diabetes drug from Merck and Pfizer,0.0,0.769,0.231,1
2017-12-20 22:07:20,-0.3182,Wall Street Weakens for Second Day With Tax Bill Rally on Pause,0.173,0.827,0.0,-1
2017-12-21 00:10:20,0.2732,"Apple, Diamondback Energy Breakouts Show Why Volume Key: S&P 500 Futures",0.0,0.826,0.174,1
2017-12-21 04:57:22,0.0,This Group Leader&apos;s Breakout Speaks Volumes,0.0,1.0,0.0,0
2017-12-21 05:09:32,0.0,This Group Leader's Breakout Speaks Volumes: S&P 500 Futures,0.0,1.0,0.0,0
2017-12-21 11:35:00,0.25,Pfizer Inc. Announces Pricing and Early Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents,0.0,0.92,0.08,1
2017-12-21 12:32:09,0.3818,Ibrance: Major Growth Driver for Pfizer in 2017,0.0,0.729,0.271,1
2017-12-21 13:52:01,0.25,What&apos;s Happening in Advanced Renal Cell Carcinoma Space?,0.0,0.778,0.222,1
2017-12-21 15:41:28,0.4767,"Aeterna Zentaris jumps on FDA approval, Honda bets on solid-state battery, Rolling Stone is sold",0.0,0.819,0.181,1
2017-12-21 16:10:23,0.3832,Why Owning Pfizer Inc. Stock Is Little Better Than Cash,0.0,0.775,0.225,1
2017-12-21 16:12:21,0.3818,"Why Exelixis, Inc. Could Be a Gold Mine for Growth Investors",0.0,0.776,0.224,1
2017-12-21 16:15:00,0.25,What's Happening in Advanced Renal Cell Carcinoma Space?,0.0,0.778,0.222,1
2017-12-21 16:43:21,0.0,"ETFs with exposure to Pfizer Inc. : December 21, 2017",0.0,1.0,0.0,0
2017-12-21 17:11:46,0.0,"Dow Movers: INTC, GS",0.0,1.0,0.0,0
2017-12-21 18:07:00,0.4404,FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma,0.0,0.782,0.218,1
2017-12-21 18:37:49,0.2247,Be Extremely Careful With Valeant Pharmaceuticals Intl Inc Stock Price,0.0,0.826,0.174,1
2017-12-21 23:11:33,0.2023,"Top Research Reports for Pfizer, FedEx & Abbott",0.0,0.769,0.231,1
2017-12-21 23:59:00,0.34,3 Value Stocks for Conservative Investors,0.0,0.625,0.375,1
2017-12-22 07:13:00,0.4019,"Merck, Pfizer: FDA Approves Steglatro And Fixed-dose Combination Steglujan",0.0,0.748,0.252,1
2017-12-22 12:00:00,0.34,FDA Approves SGLT2 Inhibitor STEGLATRO™ (ertugliflozin) and Fixed-Dose Combination STEGLUJAN™ (ertugliflozin and sitagliptin) for Adults with Type 2 Diabetes,0.065,0.8,0.135,1
2017-12-22 12:15:00,0.0,"If I Could Only Buy 1 Healthcare Stock in January, It Would Be This One",0.0,1.0,0.0,0
2017-12-22 12:15:30,0.4215,Merck and Pfizer diabetes drug approved by the FDA,0.0,0.741,0.259,1
2017-12-22 13:02:01,0.4215,"Pharma Stock Roundup: Aerie&apos;s Rhopressa Approved, Label Expansion for BMY, Pfizer Drugs",0.0,0.797,0.203,1
2017-12-22 13:25:00,0.0,3 High-Yield Healthcare Dividend Stocks to Buy in 2018,0.0,1.0,0.0,0
2017-12-22 13:48:01,0.0,"The Zacks Analyst Blog Highlights: Pfizer, FedEx, Abbott, Biogen and Marathon Petroleum",0.0,1.0,0.0,0
2017-12-22 14:07:02,-0.2263,Biogen&apos;s Alzheimer&apos;s Drug Misses Goal in Interim Analysis,0.213,0.787,0.0,-1
2017-12-22 14:57:02,0.0,"Dow 30 Stock Roundup: Nike Beats, Pfizer Hikes Dividend",0.0,1.0,0.0,0
2017-12-22 15:00:00,0.0,3 Reasons to Own Pfizer&apos;s Stock in 2018,0.0,1.0,0.0,0
2017-12-22 15:12:20,0.4404,Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb,0.0,0.674,0.326,1
2017-12-22 15:15:12,0.4215,"Pharma Stock Roundup: Aerie's Rhopressa Approved, Label Expansion for BMY, Pfizer Drugs",0.0,0.797,0.203,1
2017-12-22 16:13:22,-0.2263,Biogen's Alzheimer's Drug Misses Goal in Interim Analysis,0.213,0.787,0.0,-1
2017-12-22 17:09:28,0.0,"Notable ETF Outflow Detected - HDV, PFE, PG, MRK",0.0,1.0,0.0,0
2017-12-22 17:10:21,-0.4019,Cancer Space Update: FDA Approves Label Expansion of 4 Drugs,0.312,0.496,0.191,-1
2017-12-22 17:11:14,0.0,3 Reasons to Own Pfizer's Stock in 2018,0.0,1.0,0.0,0
2017-12-22 18:09:30,0.0,Why 2017 Was a Year to Remember for Corning Inc.,0.0,1.0,0.0,0
2017-12-22 18:10:13,0.0,How Big Is J&J's Phase 3 Drug Pipeline?,0.0,1.0,0.0,0
2017-12-24 00:17:00,-0.4588,"It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again",0.231,0.769,0.0,-1
2017-12-25 11:00:00,0.2023,3 Top Dividend Stocks for 2018,0.0,0.69,0.31,1
2017-12-25 14:00:02,0.0,Analysts’ Recommendations for AstraZeneca in December 2017,0.0,1.0,0.0,0
2017-12-26 14:45:02,0.0,Merck&apos;s Diabetes Drugs Get FDA Nod as Adjunct Therapies,0.0,1.0,0.0,0
2017-12-26 15:07:26,-0.0258,2 Overlooked Dividend Stocks to Buy for 2018,0.155,0.845,0.0,0
2017-12-26 17:11:22,0.0,Merck's Diabetes Drugs Get FDA Nod as Adjunct Therapies,0.0,1.0,0.0,0
2017-12-26 20:37:06,0.34,Why Oncology Accounts For 65% Of Bristol-Myers Squibb's Value,0.0,0.769,0.231,1
2017-12-26 20:37:09,0.0,A Quick Look At Merck & Pfizer's New Diabetes Drug,0.0,1.0,0.0,0
2017-12-26 21:07:39,0.7579,Here’s Why Pfizer Inc. Stock Is a Great Tax Plan Play,0.0,0.552,0.448,1
2017-12-26 23:06:13,0.4404,Why Pfizer Inc. Stock Is One of the Few Safe Drug Stocks,0.0,0.791,0.209,1
2017-12-27 06:00:14,-0.1779,A $17 Billion Dilemma for Reckitt's CEO,0.254,0.746,0.0,-1
2017-12-27 11:00:00,0.2023,4 Top Pharmaceutical Stocks for 2018,0.0,0.69,0.31,1
2017-12-27 15:08:48,0.0,These 3 Stocks Just Raised Their Dividends,0.0,1.0,0.0,0
2017-12-27 15:13:01,0.0,Why is Corcept's Stock Up More Than 150% So Far This Year?,0.0,1.0,0.0,0
2017-12-27 17:08:59,0.0,"Dow Movers: NKE, GE",0.0,1.0,0.0,0
2017-12-27 17:25:07,0.34,An Intrinsic Value Calculation For Pfizer Inc (NYSE:PFE) Shows It’s 30.53% Undervalued,0.0,0.821,0.179,1
2017-12-28 14:21:32,0.0,5 of the Best-Performing Biotech Stocks of 2017,0.0,1.0,0.0,0
2017-12-28 14:48:00,0.4939,How Pfizer Inc. Stock Is Positioning for Solid Growth Ahead,0.0,0.656,0.344,1
2017-12-28 16:14:08,0.0,Protalix (PLX) Fabry Disease Candidate Gets Orphan Status,0.0,1.0,0.0,0
2017-12-28 16:16:38,0.0,Will Exelixis (EXEL) be Able to Carry '17 Momentum in 2018?,0.0,1.0,0.0,0
2017-12-28 16:36:07,0.0,Xtandi’s Prescription Volumes Continue to Rise in 2017,0.0,1.0,0.0,0
2017-12-28 16:36:14,0.0,Xeljanz Sees Rapid Adoption in 2017,0.0,1.0,0.0,0
2017-12-28 17:23:02,0.0,Array BioPharma spins off cardiovascular myopathy drug research into new subsidiary,0.0,1.0,0.0,0
2017-12-28 18:01:16,0.7184,5 Best Quant Hedge Funds’ 5 Top Picks,0.0,0.4,0.6,1
2017-12-28 18:10:02,0.0,Pfizer Expects Eucrisa to Report Sales of ~$2.0 Billion,0.0,1.0,0.0,0
2017-12-28 18:43:00,0.0,"Countdown to 2018: Pfizer's Making a Shopping List, Checking It Twice",0.0,1.0,0.0,0
2017-12-28 19:40:02,0.3818,Biosimilars Expected to Be a Major Growth Driver for Pfizer,0.0,0.755,0.245,1
2017-12-29 14:02:16,0.0772,Challenges for Pfizer’s Essential Health Segment in 2017,0.0,0.843,0.157,0
2017-12-29 14:12:41,0.0,"Dow 30 Stock Roundup: UnitedHealth Arm to Buy Chile Company, FDA OKs Merck Diabetes Drugs",0.0,1.0,0.0,0
2017-12-29 16:18:16,0.0,Eli Lilly’s Valuation in December 2017,0.0,1.0,0.0,0
2017-12-29 19:11:12,0.0,How Large Is Merck's Phase 3 Drug Pipeline?,0.0,1.0,0.0,0
2017-12-29 19:11:21,0.0,A Closer Look At Roche's Phase 3 Drug Pipeline,0.0,1.0,0.0,0
2017-12-30 05:01:00,0.0,[$$] Glaxo: Expect a Speedy Recovery,0.0,1.0,0.0,0
2018-01-02 11:02:22,0.2023,Top Equities To Buy On The GOP Tax Plan (VIG),0.0,0.833,0.167,1
2018-01-02 14:25:00,0.0,Should You Buy Bristol-Myers Squibb Stock in 2018?,0.0,1.0,0.0,0
2018-01-02 16:04:22,0.0,Is Pfizer Still a No-Brainer?,0.0,1.0,0.0,0
2018-01-02 16:10:22,0.4767,3 GOP Tax Plan Winners to Buy Now – and 1 to Watch,0.0,0.744,0.256,1
2018-01-02 17:10:17,0.34,Vanguard Value ETF Experiences Big Outflow,0.0,0.676,0.324,1
2018-01-02 21:04:00,0.0,The 8 'Dogs Of The Dow' Selections For 2018,0.0,1.0,0.0,0
2018-01-02 21:57:05,0.4576,"After Hours Most Active for Jan 2, 2018 :  SFUN, LC, SGMS, HII, CHD, JD, INTC, BAC, QQQ, LX, PFE, MSFT",0.0,0.864,0.136,1
2018-01-03 01:08:15,0.2732,3 Dividend Stocks That Cut Bigger Checks Than Kinder Morgan,0.171,0.569,0.26,1
2018-01-03 07:40:00,0.0,"Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS",0.0,1.0,0.0,0
2018-01-03 12:31:00,0.0,Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS,0.0,1.0,0.0,0
2018-01-03 12:35:02,0.0,Johnson & Johnson’s Valuation in December 2017,0.0,1.0,0.0,0
2018-01-03 12:51:33,0.296,Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer,0.0,0.845,0.155,1
2018-01-03 13:09:00,-0.3182,Trump's Tax Law Could Lead To Loss Of Biopharma Jobs,0.204,0.796,0.0,-1
2018-01-03 13:26:36,0.0,Sangamo partners with Pfizer to develop gene therapy for ALS,0.0,1.0,0.0,0
2018-01-03 14:18:28,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 04, 2018",0.0,1.0,0.0,0
2018-01-03 15:45:58,0.0,Sangamo Jumps on Newest Pfizer Collaboration,0.0,1.0,0.0,0
2018-01-03 17:14:42,0.0,Achaogen's NDA for Plazomicin Gets Priority Review From FDA,0.0,1.0,0.0,0
2018-01-03 20:07:14,0.8519,The Vanguard Health Care ETF Is a Strong Buy After Its Powerful Rally,0.0,0.492,0.508,1
2018-01-04 00:20:00,0.0,"Arvinas Sees $830 Mln Upfront, Potential Milestone Payments In Deal With Pfizer",0.0,1.0,0.0,0
2018-01-04 05:01:00,-0.0516,Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates,0.138,0.732,0.13,0
2018-01-04 12:37:24,0.0,What Were the Key Developments in Pfizer’s Research Pipeline in 2017?,0.0,1.0,0.0,0
2018-01-04 12:56:32,0.3818,Healthcare Stocks: Year In Review; Your Growth Prescriptions For 2018,0.0,0.776,0.224,1
2018-01-04 13:00:00,0.4939,Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer,0.0,0.738,0.262,1
2018-01-04 13:04:01,0.0,"Biotech Stock Roundup: GWPH Submits Epidiolex in the EU, Sangamo Inks Deal with Pfizer",0.0,1.0,0.0,0
2018-01-04 14:06:55,0.7096,Bavencio May Prove to Be a Strong Growth Driver for Pfizer,0.0,0.576,0.424,1
2018-01-04 14:08:38,0.2023,PFE Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.7% Yield,0.0,0.878,0.122,1
2018-01-04 15:34:23,0.0,"Pfizer Is Pursuing Oncology, Inflammation, and Immunology Research",0.0,1.0,0.0,0
2018-01-04 17:14:33,0.0,Pfizer (PFE) Collaborates With Sangamo for Gene Therapy,0.0,1.0,0.0,0
2018-01-04 19:11:03,0.0,How Will Pfizer's Oncology Segment Shape Up In The Coming Years?,0.0,1.0,0.0,0
2018-01-04 19:21:00,0.0,"The Secret Sauce Behind Exelixis, Inc.&apos;s 12% Move Higher in December",0.0,1.0,0.0,0
2018-01-04 20:43:04,0.0772,[$$] The Dow Has What Investors Want,0.0,0.822,0.178,0
2018-01-04 21:08:45,0.5994,Biggest Blockbuster Drugs of All Time,0.0,0.562,0.438,1
2018-01-04 21:13:12,0.0,"The Secret Sauce Behind Exelixis, Inc.'s 12% Move Higher in December",0.0,1.0,0.0,0
2018-01-05 12:20:12,-0.296,"Pharma Stock Roundup: Allergan Announces Job Cuts, Pfizer Inks Deals",0.196,0.804,0.0,-1
2018-01-05 13:12:00,0.4767,"Tax Reform Winners: 3 Stocks To Buy, 1 To Watch",0.0,0.693,0.307,1
2018-01-05 15:12:27,0.0,"Why 2017 Was a Year to Remember for Gilead Sciences, Inc.",0.0,1.0,0.0,0
2018-01-05 15:13:27,0.4215,Key Biosimilar Approvals in 2017: Progress Report,0.0,0.682,0.318,1
2018-01-05 15:35:35,0.0,How Novo Nordisk’s Biopharmaceuticals Segment Performed in 3Q17,0.0,1.0,0.0,0
2018-01-05 20:19:59,0.0,A Look at Pfizer’s Valuation,0.0,1.0,0.0,0
2018-01-05 21:10:49,0.0,Exelixis Amends Cabozantinib-Tecentriq Phase Ib Trial,0.0,1.0,0.0,0
2018-01-05 21:50:02,0.0,Pfizer’s Revenue and Earnings in 3Q17,0.0,1.0,0.0,0
2018-01-06 16:36:00,0.0,3 Scorching-Hot Healthcare Stocks -- Are They Buys?,0.0,1.0,0.0,0
2018-01-06 19:40:57,0.4019,[$$] Pfizer Ends Hunt for Drugs to Treat Alzheimer's and Parkinson's,0.0,0.787,0.213,1
2018-01-07 09:50:00,0.4215,New Drugs Approved In December,0.0,0.588,0.412,1
2018-01-07 21:05:00,-0.2732,Pfizer Ends Alzheimer's And Parkinson's Research; To Cut 300 Jobs,0.189,0.811,0.0,-1
2018-01-08 00:44:40,-0.2732,"Pfizer to Cut 300 Jobs as Alzheimer's, Parkinson's Research Ends",0.189,0.811,0.0,-1
2018-01-08 05:11:03,0.0,What’s News: Business & Finance,0.0,1.0,0.0,0
2018-01-08 05:12:38,0.4019,[$$] Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s,0.0,0.787,0.213,1
2018-01-08 10:30:00,0.0,Pfizer To Present At J.P. Morgan Healthcare Conference; Webcast At 11:30 AM ET,0.0,1.0,0.0,0
2018-01-08 12:07:00,0.6369,3 Soaring Gene-Editing Biotech Stocks: Which Is the Best Buy?,0.0,0.656,0.344,1
2018-01-08 12:08:22,0.0,Be afraid? Investors are eating up stocks at the fastest pace in years,0.0,1.0,0.0,0
2018-01-08 12:20:00,0.4939,Wired News – Pfizer Signs SuperHuman Platform License Agreement with Distributed Bio,0.0,0.758,0.242,1
2018-01-08 12:34:03,0.0,How Did Valeant’s Branded Rx Segment Perform in 3Q17?,0.0,1.0,0.0,0
2018-01-08 12:36:57,0.0,How Pfizer’s Business Segments Performed in 3Q17,0.0,1.0,0.0,0
2018-01-08 12:59:12,0.0,Alzheimer&apos;s takes Another Hit as Pfizer Ends Research in this Area,0.0,1.0,0.0,0
2018-01-08 13:00:00,0.0,Pfizer Establishes New Partnering Model for Early-Stage Academic Research,0.0,1.0,0.0,0
2018-01-08 13:30:00,0.25,Pfizer Inc. Announces Expiration and Results of its Tender Offer for its 5.750 per cent. Notes due 2021 and Related Solicitation of Consents,0.0,0.917,0.083,1
2018-01-08 14:04:16,0.0,Pfizer’s Performance across Geographies in 3Q17,0.0,1.0,0.0,0
2018-01-08 14:51:02,0.0,"Stocks to Watch: Apple, Nvidia, Celgene, Caterpillar, Snap, Pandora, GoPro, Kohl's, Lululemon",0.0,1.0,0.0,0
2018-01-08 14:56:02,-0.4404,"Pfizer to Stall R&D for Alzheimer&apos;s/Parkinson&apos;s, Cut Jobs",0.394,0.606,0.0,-1
2018-01-08 15:11:08,0.0,Alzheimer's takes Another Hit as Pfizer Ends Research in this Area,0.0,1.0,0.0,0
2018-01-08 15:31:56,0.0,Behind Valeant’s Branded Drugs: Other 3Q17 Performances,0.0,1.0,0.0,0
2018-01-08 15:33:23,0.3818,What Drove Pfizer’s Growth in 3Q17,0.0,0.658,0.342,1
2018-01-08 16:05:38,0.5574,"Stocks Slip; Caterpillar, United Tech Climb; This Top Chip Stock Breaks Out",0.0,0.685,0.315,1
2018-01-08 16:52:07,0.296,Celgene deal could be the first of many for biopharma as new tax law frees up cash,0.0,0.879,0.121,1
2018-01-08 17:08:08,-0.4404,"Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs",0.394,0.606,0.0,-1
2018-01-08 18:18:00,0.2732,"Pfizer to Exit Neuro Research, May Create Finance Arm",0.0,0.792,0.208,1
2018-01-08 19:30:18,0.0,"Pfizer ends research for new Alzheimer's, Parkinson's drugs",0.0,1.0,0.0,0
2018-01-09 01:13:00,0.0772,GSK's Redfern Says Pharma Remains Number One Priority,0.0,0.843,0.157,0
2018-01-09 11:09:00,0.3818,The 1 Word That Explains Why Pfizer&apos;s Future Looks Brighter Than Its Past,0.0,0.809,0.191,1
2018-01-09 13:05:22,0.3818,The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past,0.0,0.809,0.191,1
2018-01-09 14:12:06,0.0,Moody's: US pharmaceutical companies' cash holdings set to decline under new tax law,0.0,1.0,0.0,0
2018-01-09 15:07:44,0.2023,3 Top Healthcare Stocks to Buy in January,0.0,0.769,0.231,1
2018-01-09 15:48:52,0.6369,7 Best Healthcare ETFs for 2018,0.0,0.488,0.512,1
2018-01-09 16:04:00,0.0,Here&apos;s Why Sangamo Therapeutics Inc. Stock Soared 438% in 2017,0.0,1.0,0.0,0
2018-01-09 16:07:36,0.0,2018 J.P. Morgan Healthcare Conference Roundup,0.0,1.0,0.0,0
2018-01-09 17:08:59,0.3182,"Regeneron, Sanofi Expand Investment in Cemiplimab & Dupilumab",0.0,0.723,0.277,1
2018-01-09 17:32:54,0.0,Analysts’ Recommendations for Mylan,0.0,1.0,0.0,0
2018-01-09 17:41:28,0.0,Analyst Recommendations for Ignyta and Its Peers in January 2018,0.0,1.0,0.0,0
2018-01-09 17:55:23,0.0,2018 Could Be Hallmark Year For These Two Antifungal Companies,0.0,1.0,0.0,0
2018-01-09 18:05:49,0.4939,Merck's (MRK) Keytruda Succeeds in High-Risk Melanoma Study,0.0,0.686,0.314,1
2018-01-09 18:07:09,0.0,Here's Why Sangamo Therapeutics Inc. Stock Soared 438% in 2017,0.0,1.0,0.0,0
2018-01-09 19:05:08,0.0,Exploring Mylan’s Diversified Portfolio of Brands,0.0,1.0,0.0,0
2018-01-09 19:15:03,0.4939,A Close Look at Ignyta’s Licensing Agreement,0.0,0.61,0.39,1
2018-01-09 20:35:03,0.0,What Mylan Expects for Fiscal 2017,0.0,1.0,0.0,0
2018-01-09 20:36:41,0.0,"GSK CEO says looking at Pfizer consumer business, but not a priority",0.0,1.0,0.0,0
2018-01-09 22:05:38,-0.1027,3 Dividend Stocks That Pay You More Than ExxonMobil Does,0.149,0.851,0.0,-1
2018-01-09 22:15:02,-0.25,AbbVie Rapidly Advancing Its 2018 Solid Tumor Portfolio,0.255,0.588,0.157,-1
2018-01-09 23:00:00,-0.2732,3 Dividend Stocks That Cut Bigger Checks Than McDonald&apos;s,0.231,0.769,0.0,-1
2018-01-09 23:08:50,-0.4767,Teacher arrested after speaking out at school board meeting,0.279,0.721,0.0,-1
2018-01-10 00:04:17,-0.2732,3 Dividend Stocks That Cut Bigger Checks Than McDonald's,0.231,0.769,0.0,-1
2018-01-10 06:16:01,0.4939,Basilea announces completion of the license agreement extension with Pfizer for antifungal Cresemba® for China and Asia Pacific,0.0,0.842,0.158,1
2018-01-10 11:30:01,0.0,7 Stocks With ‘Tax Cut’ Dividend Increases on Tap,0.0,1.0,0.0,0
2018-01-10 12:31:11,0.1779,AbbVie’s Position in the Growing Oncology Market in 2018,0.0,0.825,0.175,1
2018-01-10 12:36:17,0.0,How Incyte’s Jakafi Performed in 3Q17,0.0,1.0,0.0,0
2018-01-10 12:37:25,0.0,Mylan’s Renaissance and Agila Acquisitions,0.0,1.0,0.0,0
2018-01-10 12:37:55,0.0,Inside Ignyta’s Financial Performance,0.0,1.0,0.0,0
2018-01-10 12:38:17,0.4939,AbbVie’s Rova-T: Solid Growth Driver for the Future?,0.0,0.588,0.412,1
2018-01-10 14:05:02,-0.2732,Key Risks Facing Mylan in January 2018,0.259,0.741,0.0,-1
2018-01-10 14:05:20,-0.2732,Ignyta and Its Key Risks in 2018,0.259,0.741,0.0,-1
2018-01-10 14:05:59,-0.6597,AbbVie’s Rova-T and the Treatment of Small Cell Lung Cancer,0.328,0.672,0.0,-1
2018-01-10 15:33:58,0.5994,AbbVie’s Rova-T: Can Label Expansion Make It a Blockbuster Drug?,0.0,0.672,0.328,1
2018-01-10 16:12:43,0.0,Merck's Keytruda Combo Gets Breakthrough Therapy Status,0.0,1.0,0.0,0
2018-01-10 17:06:35,0.0,Why Nestle Is Eyeing Merck's Consumer Health Unit,0.0,1.0,0.0,0
2018-01-10 17:09:00,0.0,"4 Reasons Exelixis, Inc. More Than Doubled in 2017",0.0,1.0,0.0,0
2018-01-10 18:04:33,0.0,5 ETFs to Bet on 2018 Dogs of the Dow,0.0,1.0,0.0,0
2018-01-10 20:05:02,0.0,How Mylan’s North America Segment Performed in 3Q17,0.0,1.0,0.0,0
2018-01-10 20:23:10,-0.2023,Teva Stock Has Risen Significantly since November Lows: What’s Next?,0.167,0.833,0.0,-1
2018-01-10 21:08:42,0.0772,Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know,0.0,0.894,0.106,0
2018-01-10 21:40:02,0.0,What to Expect from Roche’s Investigational Drug Polatuzumab Vedotin,0.0,1.0,0.0,0
2018-01-10 21:55:02,0.3612,What Analysts Recommend for Teva Pharmaceuticals,0.0,0.667,0.333,1
2018-01-11 01:12:00,0.0,"Novartis Names Elizabeth Barrett CEO, Novartis Oncology - Quick Facts",0.0,1.0,0.0,0
2018-01-11 12:30:22,0.3818,Miles White&apos;s Bold Moves Made Abbott Laboratories A Global Force,0.0,0.755,0.245,1
2018-01-11 12:35:11,0.0,How Is Bioverativ’s Eloctate Positioned Now?,0.0,1.0,0.0,0
2018-01-11 14:02:50,0.3818,Miles White's Bold Moves Made Abbott Laboratories A Global Force,0.0,0.755,0.245,1
2018-01-11 14:03:12,0.0,What to Expect from Roche’s Tecentriq and Avastin in 2018,0.0,1.0,0.0,0
2018-01-11 14:04:29,0.0,How Is Bioverativ’s Alprolix Positioned Now?,0.0,1.0,0.0,0
2018-01-11 15:08:39,-0.0516,Valeant Pharmaceuticals Intl Inc Stock Is Worth the Risk,0.191,0.636,0.173,0
2018-01-11 15:32:59,0.8126,Approval of Alecensa in Europe Could Boost Roche’s Revenue Growth,0.0,0.455,0.545,1
2018-01-11 15:33:29,0.0,What Does Teva’s Recently Announced Restructuring Plan Entail?,0.0,1.0,0.0,0
2018-01-11 15:40:15,0.0,Trump looks to revamp major Medicaid requirements,0.0,1.0,0.0,0
2018-01-11 16:12:17,0.0,Key Takeaways from Pfizer & 3 Other Drug Stocks at Healthcare Conference,0.0,1.0,0.0,0
2018-01-11 20:49:00,0.34,A Look At Big Pharma's Value Sensitivity To Changes In Tax Rates,0.0,0.806,0.194,1
2018-01-11 21:18:09,0.0,Parkinson&apos;s Disease Space Again Under Spotlight This Week,0.0,1.0,0.0,0
2018-01-11 23:04:31,0.0,Parkinson's Disease Space Again Under Spotlight This Week,0.0,1.0,0.0,0
2018-01-12 10:00:00,-0.2732,Where’s Mine? Workers Wonder If Trump Tax Cut Will Trickle Down,0.174,0.826,0.0,-1
2018-01-12 12:41:12,0.0,"Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference",0.0,1.0,0.0,0
2018-01-12 13:37:01,0.2263,Merck&apos;s Keytruda on a Roll: Can it Retain the Spark in 2018?,0.0,0.84,0.16,1
2018-01-12 14:01:22,0.3612,What Analysts Recommend for Roche in January 2018,0.0,0.737,0.263,1
2018-01-12 16:07:34,0.0,Ligand (LGND) Inks Deal With Glenmark for OmniAb Platform,0.0,1.0,0.0,0
2018-01-12 16:09:42,0.5719,"Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo",0.0,0.778,0.222,1
2018-01-12 16:10:44,0.0,3 Reasons Dividend-Monster Pfizer Inc. Could Explode Higher,0.0,1.0,0.0,0
2018-01-12 16:12:10,0.2263,Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?,0.0,0.84,0.16,1
2018-01-12 16:20:02,0.0772,The Key Challenges Teva Pharmaceutical Is Facing,0.0,0.822,0.178,0
2018-01-12 17:50:02,-0.5859,"Teva to Lose 20–25 Sites, Cut 14,000 Workers in Next 2 Years",0.348,0.652,0.0,-1
2018-01-12 19:49:53,0.0,Here's another reason to get more bullish on stocks: NYSE trader,0.0,1.0,0.0,0
2018-01-12 22:04:33,0.4576,"After Hours Most Active for Jan 12, 2018 :  F, GE, CLNS, S, VIPS, QQQ, PFE, CTRP, CELG, CENX, CSCO, FB",0.0,0.864,0.136,1
2018-01-13 03:08:00,0.0,"Momenta Pharmaceuticals, Inc. Continues Its Rollercoaster Ride",0.0,1.0,0.0,0
2018-01-14 15:07:03,0.0,5 Biotech Stocks That Could Be Bought Out in 2018,0.0,1.0,0.0,0
2018-01-14 15:07:49,0.6369,"Will 2018 Be Alnylam Pharmaceuticals, Inc.'s Best Year Yet?",0.0,0.656,0.344,1
2018-01-15 12:34:02,-0.3612,Can Teva’s Debt Repayment Plan Deleverage Its Balance Sheet?,0.238,0.762,0.0,-1
2018-01-15 14:02:42,0.4404,Teva Pharmaceutical Focusing on Per Product Operating Profits,0.0,0.707,0.293,1
2018-01-15 15:11:04,0.0,Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion,0.0,1.0,0.0,0
2018-01-16 01:03:00,0.0,The Race To Find A Treatment For NASH,0.0,1.0,0.0,0
2018-01-16 07:18:00,0.0,"Foundation Medicine, Pfizer Enter Into Broad Tie-up For Companion Diagnostics",0.0,1.0,0.0,0
2018-01-16 12:31:24,0.4939,How Teva Pharmaceutical Plans to Optimize Global Generics,0.0,0.686,0.314,1
2018-01-16 17:12:26,0.3818,Will Amgen (AMGN) Continue to Tread Growth Path This Year?,0.0,0.776,0.224,1
2018-01-16 21:56:46,0.6933,"After Hours Most Active for Jan 16, 2018 :  GE, PFE, INTC, GNTX, WP, NFLX, TVPT, QCOM, BAC, F, CSCO, AAPL",0.0,0.759,0.241,1
2018-01-17 12:31:25,0.34,Vertex Pharmaceuticals Has Robust Late-Stage Research Pipeline,0.0,0.714,0.286,1
2018-01-17 13:29:00,0.25,Pfizer Looks Poised for a Breakout,0.0,0.667,0.333,1
2018-01-17 14:01:18,0.0,Vertex Pharmaceuticals to Target 90% of Cystic Fibrosis Patients,0.0,1.0,0.0,0
2018-01-17 14:03:23,0.3818,Repatha Could Significantly Drive Amgen’s Revenue Growth in 2018,0.0,0.755,0.245,1
2018-01-17 15:14:40,-0.2023,"Exelixis, Ipsen Report Positive Results on Lead Cancer Drug",0.293,0.467,0.24,-1
2018-01-17 18:08:23,0.4404,The Dogs of the Dow: Investing Made Easy,0.0,0.707,0.293,1
2018-01-17 21:11:09,0.2023,"Top Stock Reports for Pfizer, Chevron & Cisco",0.0,0.769,0.231,1
2018-01-17 23:11:04,0.3612,Buy These 3 Stocks to Trade Like An Institutional Investor,0.0,0.762,0.238,1
2018-01-18 12:32:18,0.0,How Amgen’s Enbrel and Nplate Are Positioned for 2018,0.0,1.0,0.0,0
2018-01-18 13:29:25,0.0,How Opdivo Is Positioned at the Beginning of 2018,0.0,1.0,0.0,0
2018-01-18 14:54:47,0.0258,"Biogen, Pfizer vets launch autoimmune disease startup backed by $58M",0.0,0.891,0.109,0
2018-01-18 16:11:14,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Chevron, Cisco, Las Vegas Sands and Dominion Resources",0.0,1.0,0.0,0
2018-01-18 16:12:35,0.0,J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?,0.0,1.0,0.0,0
2018-01-18 16:30:02,0.3818,Why Opdivo Could Continue to Be Growth Driver beyond 2018,0.0,0.776,0.224,1
2018-01-18 19:11:08,0.3612,Buy These 3 Stocks to Trade Like an Institutional Investor,0.0,0.762,0.238,1
2018-01-18 20:01:27,0.0,"IOO, PG, PFE, BMY: Large Outflows Detected at ETF",0.0,1.0,0.0,0
2018-01-18 21:00:03,0.0,Merck & Co.’s Quarterly Revenue Trend,0.0,1.0,0.0,0
2018-01-18 22:30:03,0.0,Merck & Co.’s Business Segments and Performance in 3Q17,0.0,1.0,0.0,0
2018-01-19 12:30:57,0.3818,Amgen’s Aimovig is Expected to Witness Steady Growth in 2018,0.0,0.776,0.224,1
2018-01-19 12:33:12,0.0,How Is Bristol-Myers Squibb’s Sprycel Positioned for 2018?,0.0,1.0,0.0,0
2018-01-19 12:34:45,0.5994,Keytruda: Merck & Co.’s Immuno-Oncology Blockbuster Drug,0.0,0.562,0.438,1
2018-01-19 13:00:00,0.34,6 Drug Stocks With Robust Dividend Payouts,0.0,0.676,0.324,1
2018-01-19 13:01:05,0.0,"Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion",0.0,1.0,0.0,0
2018-01-19 13:05:02,0.0,Johnson & Johnson’s 4Q17 Earnings on January 23: What to Expect,0.0,1.0,0.0,0
2018-01-19 14:22:00,0.2023,Here Are My 3 Top Trades for 2018,0.0,0.769,0.231,1
2018-01-19 15:34:52,0.0,Merck & Co.’s Diabetes Products in 3Q17,0.0,1.0,0.0,0
2018-01-19 16:05:02,0.0,Johnson & Johnson’s Pharmaceutical Segment: 4Q17 Estimates,0.0,1.0,0.0,0
2018-01-19 17:01:28,0.4404,3 Dividend Stocks With Better Yields Than PepsiCo,0.0,0.674,0.326,1
2018-01-19 21:58:19,0.6933,"After Hours Most Active for Jan 19, 2018 :  MSFT, PFE, AAPL, HES, WP, MCHP, GE, JNJ, EBAY, JPM, CSCO, NKTR",0.0,0.759,0.241,1
2018-01-20 00:58:23,0.0,Gilead Collaborates with Pfizer for Yescarta Combo Study,0.0,1.0,0.0,0
2018-01-21 16:07:34,0.5574,5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them,0.0,0.753,0.247,1
2018-01-22 02:59:00,0.0,Some Branded Drugs Going Generic In 2018,0.0,1.0,0.0,0
2018-01-22 12:31:47,0.3612,What Analysts Recommend for Bristol-Myers Squibb in January 2018,0.0,0.762,0.238,1
2018-01-22 12:34:15,0.0,Johnson & Johnson’s Consumer Segment: 4Q17 Estimates,0.0,1.0,0.0,0
2018-01-22 12:34:21,0.0,Johnson & Johnson Is Trading at an All-Time High—What’s Next?,0.0,1.0,0.0,0
2018-01-22 13:17:00,0.0,Whom Will Pfizer Buy in 2018?,0.0,1.0,0.0,0
2018-01-22 14:02:24,0.0,Johnson & Johnson’s Medical Devices Segment: 4Q17 Estimates,0.0,1.0,0.0,0
2018-01-22 15:09:03,0.2023,How Important Is Keytruda To Merck?,0.0,0.735,0.265,1
2018-01-22 15:31:20,0.0,Analysts’ Future Estimates for Merck & Co.,0.0,1.0,0.0,0
2018-01-22 15:32:18,0.0,Analyst Ratings and Recommendations for Johnson & Johnson,0.0,1.0,0.0,0
2018-01-22 18:06:29,0.0,Healthcare ETFs to Watch As Q4 Earnings Unfold,0.0,1.0,0.0,0
2018-01-22 18:06:42,-0.2023,Merck Reports Positive Phase III Liver Cancer Data on Keytruda,0.275,0.5,0.225,-1
2018-01-23 12:31:29,0.0,Analyst Recommendations for Merck & Co. in January 2018,0.0,1.0,0.0,0
2018-01-23 14:06:32,0.4767,Merck a Top Socially Responsible Dividend Stock With 3.1% Yield (MRK),0.0,0.661,0.339,1
2018-01-23 14:58:06,-0.3182,Johnson & Johnson Loses Remicade Patent in Appeal Ruling,0.247,0.753,0.0,-1
2018-01-23 15:50:47,0.0,U.S. appeals court invalidates J&J patent on Remicade,0.0,1.0,0.0,0
2018-01-23 16:14:29,0.0,U.S. appeals court upholds ruling invalidating J&J patent on Remicade,0.0,1.0,0.0,0
2018-01-23 19:09:27,0.0,Should J&J Spin Off Its Consumer Business?,0.0,1.0,0.0,0
2018-01-23 22:08:41,0.5994,Dow's J&J Topples After Judge Tosses Patent On Blockbuster Drug,0.0,0.698,0.302,1
2018-01-24 08:45:00,0.0,Pfizer: Potential Biosimilar To Rituxan Meets Primary Endpoint - Quick Facts,0.0,1.0,0.0,0
2018-01-24 11:34:00,-0.1027,3 Stocks That Pay You to Own Them,0.189,0.811,0.0,-1
2018-01-24 12:35:45,0.5574,Novartis’s Crizanlizumab Demonstrates Positive Results in Trials,0.0,0.625,0.375,1
2018-01-24 13:30:00,0.5574,Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®,0.0,0.714,0.286,1
2018-01-24 13:54:59,0.4939,"Pfizer's biosimilar of Biogen, Roche's lymphoma drug succeeds in study",0.0,0.738,0.262,1
2018-01-24 14:02:37,0.0,How Is Kisqali Positioned for 2018?,0.0,1.0,0.0,0
2018-01-24 14:08:15,0.4767,Why Amgen is a Top Socially Responsible Dividend Stock (AMGN),0.0,0.631,0.369,1
2018-01-24 16:05:12,0.4939,Pfizer's biosimilar of Roche's Rituxan succeeds in study,0.0,0.686,0.314,1
2018-01-24 16:12:16,0.0,Is a Beat in the Cards for AbbVie (ABBV) in Q4 Earnings?,0.0,1.0,0.0,0
2018-01-24 22:16:20,-0.296,Why Valeant's 162% Climb Over Nine Months 'Makes No Sense',0.196,0.804,0.0,-1
2018-01-25 12:34:20,0.0,A Look at Apple’s US Investment Plans,0.0,1.0,0.0,0
2018-01-25 13:54:30,0.0,"Cerus, Pfizer Both Just Put Out Key Late Stage Data",0.0,1.0,0.0,0
2018-01-25 14:00:49,0.6486,Tasigna Could Boost Novartis’s Revenue Growth in 2018,0.0,0.531,0.469,1
2018-01-25 14:38:21,0.0,Analysts’ Estimates for Pfizer’s 4Q17 Earnings,0.0,1.0,0.0,0
2018-01-25 14:38:49,-0.0258,Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms,0.106,0.795,0.099,0
2018-01-25 15:33:50,0.0,How the White House Reacted to Apple’s US Investment Plan,0.0,1.0,0.0,0
2018-01-25 15:47:03,0.0,Pfizer&apos;s Rituxan Biosimilar Meets Endpoint in Phase III,0.0,1.0,0.0,0
2018-01-25 16:10:08,0.3818,Pfizer: Revenue Growth Is Expected in 4Q17,0.0,0.698,0.302,1
2018-01-25 17:13:44,0.0,Analysts’ Ratings for Radius Health and Its Peers in January,0.0,1.0,0.0,0
2018-01-25 17:40:02,0.0,Pfizer in 4Q17: Revenue Estimates Based on Geographies,0.0,1.0,0.0,0
2018-01-25 18:01:44,0.0,Pfizer's Rituxan Biosimilar Meets Endpoint in Phase III,0.0,1.0,0.0,0
2018-01-25 18:45:02,0.6597,A Strong Pipeline of Drugs Bodes Well for Radius Health,0.0,0.565,0.435,1
2018-01-25 20:15:03,0.2732,Taking Stock of Radius Health’s Licensing Agreements,0.0,0.741,0.259,1
2018-01-25 20:51:08,0.0,Will Pfizer (PFE) Surpass Estimates This Earnings Season?,0.0,1.0,0.0,0
2018-01-25 21:04:03,0.3612,What Analysts Recommend for GlaxoSmithKline in January 2018,0.0,0.737,0.263,1
2018-01-25 22:35:11,0.0,GlaxoSmithKline Could Witness Modest Rise in Revenues in 2017,0.0,1.0,0.0,0
2018-01-26 12:33:53,0.7351,What Are Pfizer’s Positive Growth Contributors?,0.0,0.392,0.608,1
2018-01-26 12:34:29,0.0,Taking Stock of Radius Health’s Financial Performance,0.0,1.0,0.0,0
2018-01-26 12:57:19,0.2263,"EMA panel recommends Merck, Pfizer's diabetes drug",0.0,0.759,0.241,1
2018-01-26 14:02:57,-0.296,Pfizer’s 4Q17 Estimates: Products with Lower Sales,0.268,0.732,0.0,-1
2018-01-26 15:32:12,0.0,Pfizer: Analysts’ Ratings and Recommendations for 4Q17,0.0,1.0,0.0,0
2018-01-26 16:42:04,0.0,"Dow Movers: CAT, INTC",0.0,1.0,0.0,0
2018-01-26 17:03:54,-0.25,Health care costs are still a crushing problem,0.419,0.323,0.258,-1
2018-01-26 17:40:06,0.0,"Notable ETF Outflow Detected - IHE, PFE, PRGO, JAZZ",0.0,1.0,0.0,0
2018-01-26 17:58:18,0.0,Midday Update: Stocks Climb to Record Highs Despite Slower-Than-Expected GDP,0.0,1.0,0.0,0
2018-01-26 18:05:00,0.0,Pfizer's Q4 Earnings Preview: Watching Ibrance And Prevnar Sales,0.0,1.0,0.0,0
2018-01-26 19:39:46,-0.34,"Stocks Climb, But 2 Key Industry Groups Come Under Fire",0.231,0.769,0.0,-1
2018-01-26 19:40:12,0.0,"Blue-Chip Drug Stock, Dow Jones Name Boasts Big Yield, Hits 13-Year High",0.0,1.0,0.0,0
2018-01-26 20:39:24,0.25,Stock Market Poised To End Week On High Note; These 2 Blue Chips Shine,0.0,0.857,0.143,1
2018-01-26 20:40:31,0.0,"Noteworthy Friday Option Activity: TAP, TSCO, PFE",0.0,1.0,0.0,0
2018-01-26 22:02:21,0.4576,"After Hours Most Active for Jan 26, 2018 :  PFE, LC, FE, CTL, GE, EPD",0.0,0.813,0.187,1
2018-01-26 23:26:00,0.5994,Cramer breaks down the Super Bowl of earnings,0.0,0.642,0.358,1
2018-01-26 23:31:00,0.7845,Cramer's game plan: Welcome to the Super Bowl of earnings,0.0,0.537,0.463,1
2018-01-26 23:32:06,-0.6486,"Pfizer Inc. Stock Rises From the Dead, Deserves to Be in Your Portfolio",0.264,0.736,0.0,-1
2018-01-27 00:31:23,0.0,5 Biotech and Pharmaceutical Stocks Going Bonkers,0.0,1.0,0.0,0
2018-01-28 12:00:00,0.0,Is GlaxoSmithKline plc a Buy in 2018?,0.0,1.0,0.0,0
2018-01-29 12:07:00,0.0,What to Expect in Pfizer&apos;s Q4 Earnings Results,0.0,1.0,0.0,0
2018-01-29 13:10:00,0.0,Today’s Research Reports on Stocks to Watch: AbbVie Inc. and Pfizer Inc.,0.0,1.0,0.0,0
2018-01-29 14:03:14,0.0,What to Expect in Pfizer's Q4 Earnings Results,0.0,1.0,0.0,0
2018-01-29 15:05:32,0.0,AbbVie (ABBV) Soars on Q4 Results: Key Takeaways from the Earnings Call,0.0,1.0,0.0,0
2018-01-29 15:42:00,0.0,"Pfizer, Eli Lilly, Merck Earnings Preview: Big Pharma On Docket This Week",0.0,1.0,0.0,0
2018-01-29 15:52:35,0.0,"PFE, LLY, MRK Write Up 'Scripts For Q4",0.0,1.0,0.0,0
2018-01-29 15:59:45,0.4019,You Definitely Should Buy Celgene Corporation Stock After Earnings Beat,0.0,0.769,0.231,1
2018-01-29 20:38:00,0.0,Will Pfizer Get Big Bucks for Advil and Other Household Names?,0.0,1.0,0.0,0
2018-01-29 21:12:01,0.0,"Pre-Market Earnings Report for January 30, 2018 :  PFE, MCD, DHR, AET, HCA, GLW, TROW, PCAR, ZBH, BEN, NUE, CNHI",0.0,1.0,0.0,0
2018-01-30 06:49:00,0.0,Pfizer Inc. Earnings Climb In Q4,0.0,1.0,0.0,0
2018-01-30 07:26:00,0.0,Pfizer Q4 Results Beat Estimates; Issues Upbeat FY18 Outlook,0.0,1.0,0.0,0
2018-01-30 09:00:00,0.0,Pfizer Q4 17 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2018-01-30 11:45:00,0.0,PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS,0.0,1.0,0.0,0
2018-01-30 11:53:04,0.0,Pfizer exceeds Street expectations and divulges plan for tax law windfall,0.0,1.0,0.0,0
2018-01-30 11:55:18,-0.7034,Pfizer beats Street 4Q forecasts,0.547,0.453,0.0,-1
2018-01-30 12:05:49,0.6249,"Pfizer shares rise after Q4 profit, revenue beats; upbeat guidance",0.0,0.611,0.389,1
2018-01-30 12:31:00,0.0,Could Opko Health Inc. Be a Millionaire-Maker Stock?,0.0,1.0,0.0,0
2018-01-30 12:31:14,0.5106,Does Pfizer Inc’s (NYSE:PFE) Recent Track Record Look Strong?,0.0,0.708,0.292,1
2018-01-30 12:50:12,-0.1613,"Pfizer, riding tax changes, puts up huge 4Q profit",0.301,0.374,0.324,-1
2018-01-30 12:55:50,0.0,"Pfizer Earnings, Guidance May Not Be Enough for Investors",0.0,1.0,0.0,0
2018-01-30 13:02:01,0.2023,"Pfizer (PFE) Q4 Earnings & Sales Top, 2018 View Upbeat",0.0,0.816,0.184,1
2018-01-30 14:19:56,0.0,Benzinga Pro's 7 Stocks To Watch Today,0.0,1.0,0.0,0
2018-01-30 14:34:53,0.1779,"Stocks to Watch: Apple, MetLife, Amazon, Aetna, Wal-Mart, McDonald's, Maxim, Callidus, Reuters, Pfizer",0.0,0.876,0.124,1
2018-01-30 15:10:03,0.0,Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat,0.0,1.0,0.0,0
2018-01-30 15:23:00,-0.7783,Rate Fears Could Keep Pressure On Stocks After Yesterday's Weakness,0.527,0.473,0.0,-1
2018-01-30 15:23:03,0.4019,"Markets Deeper in the Red, Q4 Reports Stay Healthy",0.0,0.748,0.252,1
2018-01-30 15:25:00,0.4404,Pfizer profit surges due to tax law,0.0,0.674,0.326,1
2018-01-30 15:32:03,0.5574,"Q4 Results Remain Positive, Market Dips",0.0,0.581,0.419,1
2018-01-30 16:44:04,-0.296,Mid-Morning Market Update: Markets Open Lower; Pfizer Beats Q4 Expectations,0.196,0.804,0.0,-1
2018-01-30 16:44:22,0.0,"Dow Movers: UNH, NKE",0.0,1.0,0.0,0
2018-01-30 16:44:37,0.2023,3 Top Dividend Stocks With Yields Over 2%,0.0,0.769,0.231,1
2018-01-30 16:47:53,0.0,"Ex-Dividend Reminder: Siemens, Signet Jewelers and Pfizer",0.0,1.0,0.0,0
2018-01-30 16:59:02,0.6486,"Pfizer touts drug sales, credits tax savings for surge in Q4 profit",0.071,0.581,0.348,1
2018-01-30 17:49:18,0.0,Johnson & Johnson’s Revenues Rose 11.5% in 4Q17,0.0,1.0,0.0,0
2018-01-30 18:22:20,0.0,"Midday Update: Wall Street Unhinged By Bond Rout, Healthcare Sector Sell-Off",0.0,1.0,0.0,0
2018-01-30 18:33:00,0.0,What You Should Really Examine in Pfizer&apos;s Q4 Earnings Results,0.0,1.0,0.0,0
2018-01-30 19:00:53,0.4019,[$$] Pfizer Plans $5 Billion Boost in U.S. Manufacturing From Tax-Law Changes,0.0,0.803,0.197,1
2018-01-30 19:20:03,0.3818,Johnson & Johnson’s Growth Rate for 4Q17,0.0,0.658,0.342,1
2018-01-30 19:44:21,0.0,What You Should Really Examine in Pfizer's Q4 Earnings Results,0.0,1.0,0.0,0
2018-01-30 19:44:46,0.5859,"Pfizer's new tax rate higher than investors hoped, shares fall",0.0,0.625,0.375,1
2018-01-30 20:00:49,-0.296,GLOBAL MARKETS-Stocks tumble anew amid bond yield pressure,0.239,0.761,0.0,-1
2018-01-30 20:43:27,0.0,Pfizer Inc. Stock Falls Despite Q4 Earnings Beat,0.0,1.0,0.0,0
2018-01-30 20:46:00,0.0,Technician: Buy these market laggards during the selloff,0.0,1.0,0.0,0
2018-01-30 20:50:02,0.0,Johnson & Johnson’s Segment-Wise Performance in 4Q17,0.0,1.0,0.0,0
2018-01-30 21:16:00,-0.296,Dow Tumbles 362 Points; S&P 500 and Nasdaq Also Finish Lower,0.18,0.82,0.0,-1
2018-01-30 21:32:38,-0.296,GLOBAL MARKETS-Stocks slide again on rising bond yield pressure,0.216,0.784,0.0,-1
2018-01-30 22:02:04,0.0,"Close Update: Crypto Rout, Healthcare Sell-Off Rattles Wall Street",0.0,1.0,0.0,0
2018-01-30 22:44:57,0.0,"Here's Why Momenta Pharmaceuticals, Inc. Jumped 12% Today",0.0,1.0,0.0,0
2018-01-31 02:42:47,-0.5106,Stocks Hit Hard Amid Harsh Headwinds,0.518,0.482,0.0,-1
2018-01-31 12:18:12,0.0,Momenta Up on FDA&apos;s Amendment of McPherson Compliance Status,0.0,1.0,0.0,0
2018-01-31 12:33:00,0.6369,The Best Arthritis Drug/Treatment Stocks on the Market Right Now,0.0,0.682,0.318,1
2018-01-31 12:34:51,0.0,Johnson & Johnson’s Pharmaceuticals Business in 4Q17,0.0,1.0,0.0,0
2018-01-31 12:35:41,0.0,Eli Lilly’s 4Q17 Estimates: New Products Portfolio,0.0,1.0,0.0,0
2018-01-31 12:35:59,0.0,Dolutegravir Franchise to Drive GlaxoSmithKline’s HIV Portfolio,0.0,1.0,0.0,0
2018-01-31 13:00:00,0.0,Today’s Research Reports on Trending Tickers: McDonald's and Pfizer,0.0,1.0,0.0,0
2018-01-31 13:25:00,0.0,"Investor Expectations to Drive Momentum within QCR, Bridge, Enterprise Financial Services, Hewlett Packard Enterprise, Pfizer, and The Finish Line — Discovering Underlying Factors of Influence",0.0,1.0,0.0,0
2018-01-31 13:45:15,0.0,Momenta Up on FDA's Amendment of McPherson Compliance Status,0.0,1.0,0.0,0
2018-01-31 13:57:26,0.3804,Wall Street Is More Optimistic about JNJ Stock after 4Q17 Results,0.0,0.794,0.206,1
2018-01-31 14:02:52,0.0,Johnson & Johnson’s Medical Devices Business in 4Q17,0.0,1.0,0.0,0
2018-01-31 14:03:17,0.0,Eli Lilly’s 4Q17 Estimates: Elanco,0.0,1.0,0.0,0
2018-01-31 14:03:32,-0.128,GlaxoSmithKline Projects Tough Environment for Triumeq and Tivicay,0.176,0.824,0.0,-1
2018-01-31 14:13:55,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 01, 2018",0.0,1.0,0.0,0
2018-01-31 15:33:30,0.0,Johnson & Johnson’s Consumer Business in 4Q17,0.0,1.0,0.0,0
2018-01-31 15:34:33,0.4019,2-Drug HIV Regimens Expected to Boost GlaxoSmithKline’s Revenues,0.0,0.722,0.278,1
2018-01-31 16:48:27,0.0,"Stock Market News for Jan 31, 2018",0.0,1.0,0.0,0
2018-01-31 16:54:49,0.0,Merck’s 4Q17 Earnings: Analysts’ Estimates,0.0,1.0,0.0,0
2018-01-31 17:41:59,-0.25,AbbVie Is Ruining Pharma Earnings Season,0.286,0.714,0.0,-1
2018-01-31 18:25:02,0.3818,Merck’s 4Q17 Estimates: Revenue Growth Expected,0.0,0.658,0.342,1
2018-01-31 22:08:20,0.0,Lilly Issues Beat-And-Raise But Dives Alongside Other Drug Stocks,0.0,1.0,0.0,0
2018-01-31 23:08:19,0.3818,Dow Leads In Tight Finish; Video Gamers Clear Buy Points,0.0,0.776,0.224,1
2018-01-31 23:08:53,0.0,Mnuchin Met With Apple’s Cook Ahead of First Tax Plan Release,0.0,1.0,0.0,0
2018-02-01 06:28:42,0.6908,"Like Pfizer, Roche Sees U.S. Tax Cut Boosting 2018 Profit",0.132,0.377,0.491,1
2018-02-01 12:31:44,0.0,Vaccines Segment Continues to Be Differentiator for GlaxoSmithKline,0.0,1.0,0.0,0
2018-02-01 12:33:05,0.0,Merck’s 4Q17 Estimates: Vaccines,0.0,1.0,0.0,0
2018-02-01 14:01:32,0.4019,Meningitis Vaccines Portfolio Could Boost GSK’s Revenues in 2018,0.0,0.748,0.252,1
2018-02-01 14:02:03,0.0,How Tax Reforms Could Affect J&J’s 4Q17 Earnings Results,0.0,1.0,0.0,0
2018-02-01 14:02:43,0.0,Merck’s 4Q17 Estimates: Animal Health,0.0,1.0,0.0,0
2018-02-01 15:31:14,0.3818,GSK Projects Modest Long-Term Revenue Growth for Vaccines Portfolio,0.0,0.755,0.245,1
2018-02-01 15:32:48,0.0,Analyst Ratings and Recommendations for Merck & Co.,0.0,1.0,0.0,0
2018-02-01 19:50:08,0.0,How’s Celgene’s Abraxane Positioned after 4Q17?,0.0,1.0,0.0,0
2018-02-01 22:45:02,0.0,A Look at Cara Therapeutics’ Intravenous CR845,0.0,1.0,0.0,0
2018-02-01 23:57:19,0.2023,"Top Analyst Reports for Pfizer, PayPal & Raytheon",0.0,0.769,0.231,1
2018-02-02 12:31:05,0.1027,Flu Season Expected to Benefit GlaxoSmithKline’s 4Q17 Revenues,0.224,0.517,0.259,1
2018-02-02 12:31:29,0.0,How Has Johnson & Johnson Stock Performed Recently?,0.0,1.0,0.0,0
2018-02-02 14:00:19,0.0,Wall Street Analysts’ Recommendations for JNJ in January 2018,0.0,1.0,0.0,0
2018-02-02 14:00:29,0.3818,Shingrix Could Be a Long-Term Growth Driver for GlaxoSmithKline,0.0,0.729,0.271,1
2018-02-02 15:10:00,0.0,Here&apos;s What Pfizer&apos;s Saying About Its Future,0.0,1.0,0.0,0
2018-02-02 16:22:47,0.4404,"Dow 30 Stock Roundup: BA, MSFT, AAPL, MCD, PFE, V Earnings Impress",0.0,0.775,0.225,1
2018-02-02 16:23:31,0.4939,"The Zacks Analyst Blog Highlights: Pfizer, PayPal, Raytheon, Aetna and Kinder Morgan",0.0,0.775,0.225,1
2018-02-02 17:00:18,0.0,Here's What Pfizer's Saying About Its Future,0.0,1.0,0.0,0
2018-02-02 17:59:35,0.0,Allergan's Anti-Infective Drug Avycaz Receives Third FDA Nod,0.0,1.0,0.0,0
2018-02-02 18:54:00,0.3818,"[$$] Big, Bold Blue-Chip Buys: GE, Pfizer, Disney, Apple",0.0,0.755,0.245,1
2018-02-02 19:00:49,0.0,Novartis’s 4Q17 Revenues and Fiscal 2017 Revenues,0.0,1.0,0.0,0
2018-02-02 19:58:37,0.3818,Roche's New Drugs Aid Growth While Rituxan Continues To Slide In Europe,0.0,0.809,0.191,1
2018-02-02 21:48:54,0.2023,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 7,240.95",0.0,0.913,0.087,1
2018-02-02 22:05:03,0.4404,Novartis’s 4Q17 Earnings: Innovative Medicines Business,0.0,0.633,0.367,1
2018-02-03 13:00:00,-0.3182,"Pharma Execs Talk M&A, Drug Pricing Pressures on Earnings Calls",0.204,0.796,0.0,-1
2018-02-03 15:11:48,0.0,"Glaxo, Reckitt Submit Only Bids for Pfizer's Consumer Unit",0.0,1.0,0.0,0
2018-02-03 17:07:01,0.2023,The Dow Crashes 665 Points -- Here Are 3 Top Stocks to Buy,0.0,0.859,0.141,1
2018-02-04 15:07:25,0.0,3 Headwinds in Q4 Earnings Results That Make Merck a Mediocre Stock,0.0,1.0,0.0,0
2018-02-05 06:35:00,0.0,"Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit",0.0,1.0,0.0,0
2018-02-05 09:12:55,0.0,"Glaxo, Reckitt Are Said to Be Only Suitors for Pfizer's Division",0.0,1.0,0.0,0
2018-02-05 11:52:34,0.0,5 Opioid Treatment Stocks,0.0,1.0,0.0,0
2018-02-05 15:30:02,0.0,GlaxoSmithKline Is Global Leader in Consumer Healthcare Business,0.0,1.0,0.0,0
2018-02-05 15:33:27,0.0,Novartis’s Valuations after Its 4Q17 Earnings,0.0,1.0,0.0,0
2018-02-05 16:48:00,-0.1027,The 8 'Dogs Of The Dow' Bitten Hard By Friday's Market Slump,0.123,0.877,0.0,-1
2018-02-05 17:10:20,0.0,"Noteworthy ETF Inflows: OEF, PFE, HON, BMY",0.0,1.0,0.0,0
2018-02-05 17:55:31,0.4939,Will Tax Reform Affect Health Care Sector Earnings in 2018?,0.0,0.738,0.262,1
2018-02-05 21:01:33,0.0,"Stocks Dive In Broad, Fierce Selling After Dow Plunges 1,600 Points",0.0,1.0,0.0,0
2018-02-05 21:07:21,0.4767,"Bristol-Myers (BMY) Beats on Q4 Earnings, Eliquis Impresses",0.0,0.693,0.307,1
2018-02-05 22:00:00,-0.6597,Pfizer's Xtandi delays prostate cancer spread in early stage disease,0.328,0.672,0.0,-1
2018-02-05 22:00:21,-0.6597,Early Prostate Cancer Kept at Bay in Two Studies for High-Risk Men,0.286,0.714,0.0,-1
2018-02-05 22:12:00,-0.886,Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer,0.331,0.669,0.0,-1
2018-02-06 01:35:00,0.0,"Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall",0.0,1.0,0.0,0
2018-02-06 12:30:14,0.0,GSK Has Emerged as Leading Player in Over-the-Counter Market,0.0,1.0,0.0,0
2018-02-06 13:53:30,0.0,Analysts Predict 13% Upside For The Holdings of DJD,0.0,1.0,0.0,0
2018-02-06 14:39:33,0.3818,Worst Day In 6 Years Offers 8 Great Buying Opportunities,0.259,0.316,0.424,1
2018-02-06 15:00:03,-0.6597,Pfizer Files for Xtandi in Early Stage Prostate Cancer,0.355,0.645,0.0,-1
2018-02-06 15:24:42,0.0,"The Future of Merck & Co., Inc. Stock Is With Keytruda",0.0,1.0,0.0,0
2018-02-06 15:26:06,0.6249,3 Great Stocks for Your IRA,0.0,0.494,0.506,1
2018-02-06 20:20:27,0.0,8 Great Stocks to Buy After the Worst Market Day in 6 Years,0.238,0.523,0.238,0
2018-02-07 12:30:00,0.0,Wired News – Bristol-Myers Squibb’s Phase-3 CheckMate-227 Study Met its Co-Primary Endpoint,0.0,1.0,0.0,0
2018-02-07 12:33:57,-0.296,Tax Cuts and Jobs Act Has Proven a Major Boon for AbbVie in 2018,0.155,0.845,0.0,-1
2018-02-07 14:59:51,0.0,Sanofi’s $11.6 Billion Bioverativ Acquisition: Highlights,0.0,1.0,0.0,0
2018-02-07 15:32:08,0.3818,Humira Will Remain a Key Growth Driver for AbbVie in 2018,0.0,0.776,0.224,1
2018-02-07 20:48:22,0.1027,Pfizer Inc. Stock Hurt by Dwindling Revenue Growth Prospects,0.239,0.423,0.338,1
2018-02-07 20:49:16,0.0,Wednesday's ETF with Unusual Volume: PPH,0.0,1.0,0.0,0
2018-02-08 02:17:09,0.2023,"U.S. FDA approves Gilead triple HIV drug, rival files lawsuit",0.151,0.635,0.214,1
2018-02-08 02:33:00,-0.6124,ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir,0.385,0.615,0.0,-1
2018-02-08 11:05:00,0.2023,3 Top Dividend Stocks to Buy in February,0.0,0.769,0.231,1
2018-02-08 12:31:11,0.0,ABBV to Focus on Advancing Late-Stage Immunology Research in 2018,0.0,1.0,0.0,0
2018-02-08 12:37:37,-0.3818,"Analysis: Reckitt, GSK balance risk-reward in high-stakes Pfizer fight",0.245,0.755,0.0,-1
2018-02-08 12:39:53,-0.3818,"Reckitt, GSK balance risk-reward in high-stakes Pfizer fight",0.271,0.729,0.0,-1
2018-02-08 14:09:00,0.2278,Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices,0.116,0.697,0.186,1
2018-02-08 16:20:58,0.4019,"FDA Approves Gilead (GILD) HIV Triple Therapy, Stock Up",0.0,0.748,0.252,1
2018-02-08 16:21:50,0.4019,Wall Street See-Saws on Spike in Bond Yields: 5 Safest Bets,0.0,0.769,0.231,1
2018-02-08 20:48:45,0.3818,Pfizer Reports Revenue Growth in 4Q17,0.0,0.658,0.342,1
2018-02-08 22:20:02,0.0,How Pfizer’s Business Segments Performed in 4Q17,0.0,1.0,0.0,0
2018-02-09 10:11:00,0.8957,Best In Show: 2018 Power Of The Profession Award Winners,0.0,0.393,0.607,1
2018-02-09 11:00:00,0.2023,7 Stocks Top Managers Have Been Buying,0.0,0.735,0.265,1
2018-02-09 12:37:58,0.0,How Did Pfizer’s Geographical Regions Perform in 4Q17?,0.0,1.0,0.0,0
2018-02-09 14:04:29,0.3818,What Drove Pfizer’s 4Q17 Growth?,0.0,0.606,0.394,1
2018-02-09 15:02:03,0.0,Glaxo&apos;s (GSK) Begins Phase III HIV Two-Drug Regimen Study,0.0,1.0,0.0,0
2018-02-09 15:35:37,-0.1027,Pfizer’s 4Q17 Results: These Products Are Losing Market Share,0.22,0.593,0.186,-1
2018-02-09 16:00:04,0.1531,Solid Q4 Earnings Drive Pharma ETF Outlook,0.0,0.789,0.211,1
2018-02-09 16:22:05,0.4215,"The Zacks Analyst Blog Highlights: CA, Quest Diagnostics, Pfizer, United Parcel and U.S. Bancorp",0.0,0.823,0.177,1
2018-02-09 17:20:59,0.0,Glaxo's (GSK) Begins Phase III HIV Two-Drug Regimen Study,0.0,1.0,0.0,0
2018-02-09 18:15:35,-0.3182,FDA Okays J&J's Prostate Cancer Drug in First-Line Setting,0.303,0.483,0.214,-1
2018-02-09 18:19:56,0.0,Novartis and Peers in February 2018: Analyst Recommendations,0.0,1.0,0.0,0
2018-02-09 19:50:10,0.3818,Why Novartis Is Expected to Report Modest Revenue Growth in 2018,0.0,0.794,0.206,1
2018-02-09 21:20:10,0.0,What’s Expected of Novartis’s Core Operating Income in 2018?,0.0,1.0,0.0,0
2018-02-09 21:55:40,0.4576,"After Hours Most Active for Feb 8, 2018 :  NVDA, BAC, GE, QQQ, USMC, F, CMCSA, T, MSFT, CAR, SQ, PFE",0.0,0.864,0.136,1
2018-02-09 22:08:00,0.0,Getting technical: How the bears are shorting the S&P 500 vis-à-vis SPY,0.0,1.0,0.0,0
2018-02-12 05:06:16,0.4404,Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY),0.0,0.734,0.266,1
2018-02-12 08:20:00,0.3818,"U.S., EU, Japan Accept Regulatory Submissions For Review Of Pfizer's Lorlatinib",0.0,0.794,0.206,1
2018-02-12 12:31:45,0.0,"Amgen’s Nephrology Drugs: Aranesp, Epogen, Sensipar in 4Q17",0.0,1.0,0.0,0
2018-02-12 12:33:17,0.0,What Investors Should Know about Pfizer’s Recent Developments,0.0,1.0,0.0,0
2018-02-12 12:37:08,0.4404,What’s Expected of Novartis’s Net Profit Margin in 2018?,0.0,0.734,0.266,1
2018-02-12 13:00:00,0.3182,"U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib",0.069,0.794,0.138,1
2018-02-12 13:20:00,0.0,Today’s Research Reports on Trending Tickers: Eli Lilly and Company and Pfizer,0.0,1.0,0.0,0
2018-02-12 14:02:50,0.0,What’s Pfizer’s Valuation after 4Q17 Earnings?,0.0,1.0,0.0,0
2018-02-12 15:32:30,0.3612,What Analysts Recommend for Pfizer after 4Q17,0.0,0.706,0.294,1
2018-02-12 16:06:47,0.0,How’s Pfizer’s Oncology Business Positioned after 2017?,0.0,1.0,0.0,0
2018-02-12 17:40:02,0.0,Pfizer’s Inlyta: Analyzing Revenue Trends,0.0,1.0,0.0,0
2018-02-12 19:10:02,0.5106,Pfizer’s Bosulif Had a Strong Performance in 4Q17 and 2017,0.0,0.708,0.292,1
2018-02-12 20:31:35,0.0,Bristol-Myers Squibb’s 4Q17 Earnings Performance,0.0,1.0,0.0,0
2018-02-12 22:25:15,-0.5106,U.S. investment adviser gets prison for insider trading on Pfizer-King deal,0.248,0.752,0.0,-1
2018-02-13 11:30:00,0.0,Visiting Puerto Rico After Hurricane Maria: What You Need To Know,0.0,1.0,0.0,0
2018-02-13 12:34:43,0.0,What to Expect from Pfizer’s Xtandi in 2018,0.0,1.0,0.0,0
2018-02-13 12:37:16,0.5994,Opdivo: Bristol-Myers Squibb’s Oncology Blockbuster Drug in 4Q17,0.0,0.642,0.358,1
2018-02-13 13:10:00,0.0,Today’s Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Pfizer Inc.,0.0,1.0,0.0,0
2018-02-13 14:03:16,0.0,Pfizer’s Sutent Generated Higher Revenues in 4Q17,0.0,1.0,0.0,0
2018-02-13 14:53:45,0.5574,Novartis gains U.S. approval for delayed MS drug,0.153,0.403,0.444,1
2018-02-13 15:09:00,0.3818,3 Selloff Bargains for 100% Dividend Growth and 40% Upside,0.0,0.755,0.245,1
2018-02-13 15:09:14,0.4404,Better Buy: Eli Lilly and Company vs. Johnson & Johnson,0.0,0.734,0.266,1
2018-02-13 15:32:20,0.0,Analyzing Pfizer’s Ibrance and Xalkori after 2Q17,0.0,1.0,0.0,0
2018-02-13 15:33:38,0.5994,Eliquis: Bristol-Myers Squibb’s Cardiovascular Blockbuster in 4Q17,0.0,0.606,0.394,1
2018-02-13 17:01:28,0.0,The Quest to Develop the First Alzheimer's Disease Treatment,0.0,1.0,0.0,0
2018-02-13 18:07:51,0.4588,Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate,0.0,0.727,0.273,1
2018-02-13 19:01:13,0.0,How Pfizer Performed Overall in 4Q17 and 2017,0.0,1.0,0.0,0
2018-02-13 20:35:03,0.0,Inside Pfizer’s Vaccines Performance in 4Q17 and 2017,0.0,1.0,0.0,0
2018-02-13 22:04:00,0.0,Merck scraps another late-stage Alzheimer's drug study,0.0,1.0,0.0,0
2018-02-13 22:05:03,0.0,Where Pfizer Stands in Biosimilars after 2017,0.0,1.0,0.0,0
2018-02-14 08:40:00,0.0,Pfizer Receives Breakthrough Therapy Designation For PF-04965842 - Quick Facts,0.0,1.0,0.0,0
2018-02-14 12:31:38,0.0,Bristol-Myers Squibb’s Orencia and Other Brands in 4Q17,0.0,1.0,0.0,0
2018-02-14 12:33:17,0.0,Behind Pfizer’s Internal Medicines in 2017,0.0,1.0,0.0,0
2018-02-14 13:21:00,0.0,"[$$] Pimco's Big Buys: Apple, Intel, Merck, Pfizer, GE",0.0,1.0,0.0,0
2018-02-14 13:30:00,-0.0772,"Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842, an oral JAK1 Inhibitor, for the Treatment of Patients with Moderate-to-Severe Atopic Dermatitis",0.058,0.942,0.0,0
2018-02-14 13:33:00,0.2023,3 Urgent Buys For 8.9% Dividends And 40% Upside,0.0,0.795,0.205,1
2018-02-14 14:01:23,0.2732,Changes in Bristol-Myers Squibb’s 4Q17 Profitability,0.0,0.704,0.296,1
2018-02-14 14:02:47,0.0,How Did Pfizer’s Viagra and Lyrica Perform in 2017?,0.0,1.0,0.0,0
2018-02-14 14:38:02,0.4767,5 Low Leverage Stocks You Will Love on Valentine&apos;s Day,0.158,0.526,0.316,1
2018-02-14 14:47:02,0.0,Merck (MRK) Halts Another Late Stage Study on Alzheimer&apos;s,0.0,1.0,0.0,0
2018-02-14 15:31:22,0.0,Bristol-Myers Squibb’s Valuation after Its 4Q17 Earnings,0.0,1.0,0.0,0
2018-02-14 15:32:13,0.0,Inside Pfizer’s Inflammation and Immunology Portfolio Performances in 2017,0.0,1.0,0.0,0
2018-02-14 17:11:32,0.0,Merck (MRK) Halts Another Late Stage Study on Alzheimer's,0.0,1.0,0.0,0
2018-02-14 17:12:07,0.4767,5 Low Leverage Stocks You Will Love on Valentine's Day,0.158,0.526,0.316,1
2018-02-14 18:37:24,0.0,What To Expect From Roche In 2018,0.0,1.0,0.0,0
2018-02-14 18:43:06,0.5574,Exelixis Reports Positive Data From Thyroid Carcinoma Trial,0.0,0.66,0.34,1
2018-02-14 19:45:00,0.0,"With the Correction In Pfizer Behind Us, Traders Can Go Long Again",0.0,1.0,0.0,0
2018-02-14 21:22:05,0.0,3 Reasons to Be Bullish on Pfizer Inc. Stock,0.0,1.0,0.0,0
2018-02-14 21:42:21,0.0,Merck & Co.’s Revenues in 4Q17,0.0,1.0,0.0,0
2018-02-14 22:21:43,0.4767,5 Low Leverage Stocks You Will Love on Valentine’s Day,0.158,0.526,0.316,1
2018-02-15 08:50:00,-0.4215,Merck: Phase III JAVELIN Lung 200 Trial With Avelumab Fails To Meet Endpoint,0.189,0.811,0.0,-1
2018-02-15 12:31:36,0.0,Where Pfizer’s Xeljanz Is Positioned for 2018,0.0,1.0,0.0,0
2018-02-15 13:30:00,-0.5267,"Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer",0.136,0.802,0.062,-1
2018-02-15 14:00:45,0.0,How Pfizer’s Peri-LOE Products Performed in 2017,0.0,1.0,0.0,0
2018-02-15 14:30:12,-0.802,"Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial",0.507,0.493,0.0,-1
2018-02-15 15:30:19,0.0,Behind Pfizer’s Sterile Injection Pharmaceutical Performance in 2017,0.0,1.0,0.0,0
2018-02-15 18:27:00,0.0,6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One&apos;s a Marijuana Stock),0.0,1.0,0.0,0
2018-02-15 20:22:36,0.0,6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock),0.0,1.0,0.0,0
2018-02-16 12:00:15,0.25,New Tax Cuts Will Save Billions. But for Whom?,0.177,0.565,0.258,1
2018-02-16 12:17:12,0.0,FDA Sets the Stage for Earlier-Stage Alzheimer&apos;s Treatments,0.0,1.0,0.0,0
2018-02-16 12:30:18,0.0,How Did Pfizer’s Legacy Established Products Segment Perform in 2017?,0.0,1.0,0.0,0
2018-02-16 12:32:32,0.0,Merck’s Diabetes Products in 4Q17,0.0,1.0,0.0,0
2018-02-16 14:01:13,0.0,Inside Pfizer’s Rare Disease Segment Performance in 2017,0.0,1.0,0.0,0
2018-02-16 14:02:38,0.0,Merck’s Immunology and Cardiovascular Products in 4Q17,0.0,1.0,0.0,0
2018-02-16 14:25:24,0.0,FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments,0.0,1.0,0.0,0
2018-02-16 15:30:18,0.0,Pfizer on the Street: Analyst Recommendations in February 2018,0.0,1.0,0.0,0
2018-02-16 15:31:05,0.0,Merck’s Human Vaccines Business in 4Q17,0.0,1.0,0.0,0
2018-02-16 15:55:00,0.0772,3 Reasons Pfizer May Want to Buy Bristol-Myers Squibb,0.0,0.843,0.157,0
2018-02-16 16:23:08,0.0,"Dow Movers: MCD, CSCO",0.0,1.0,0.0,0
2018-02-16 16:28:23,0.0,Bristol-Myers Squibb (BMY) in Focus: Stock Moves 5.6% Higher,0.0,1.0,0.0,0
2018-02-16 17:00:57,0.0,Analyst Ratings for AMAG Pharmaceuticals and Peers in February,0.0,1.0,0.0,0
2018-02-16 17:00:58,0.2732,Label Expansion of Ferahame Bodes Well for AMAG Pharmaceuticals,0.0,0.792,0.208,1
2018-02-16 17:02:13,0.0,Exploring AMAG Pharmaceuticals’ Financial Performance,0.0,1.0,0.0,0
2018-02-16 18:11:00,0.0,"[$$] Big Stock Buys in GE, Citi, DowDuPont, Merck",0.0,1.0,0.0,0
2018-02-16 20:51:25,0.2263,How Much Is Roche's Phase 3 Drug Pipeline Worth?,0.0,0.787,0.213,1
2018-02-16 21:40:59,0.34,Wall Street Pares Gains But Markets Head for First Weekly Advance in Three,0.0,0.833,0.167,1
2018-02-16 21:48:55,0.0,"Market Close Report: NASDAQ Composite index closes at 7,239.47 down -16.96 points",0.0,1.0,0.0,0
2018-02-16 22:00:45,0.34,Close Update: Wall Street Pares Gains But Markets Post First Weekly Advance in Three,0.0,0.844,0.156,1
2018-02-16 23:21:42,0.6369,Stocks Wrap Up Best Week in Years,0.0,0.588,0.412,1
2018-02-16 23:48:23,0.0,How Did Pfizer Inc’s (NYSE:PFE) 34.94% ROE Fare Against The Industry?,0.0,1.0,0.0,0
2018-02-17 17:08:12,0.4767,This High-Yielding Dividend Stock Deserves a Gold Medal,0.0,0.659,0.341,1
2018-02-18 16:47:00,0.0,Why Healthcare Stocks Soared in Trump&apos;s First Year in Office,0.0,1.0,0.0,0
2018-02-18 18:06:30,0.0,Why Healthcare Stocks Soared in Trump's First Year in Office,0.0,1.0,0.0,0
2018-02-18 23:06:37,0.2023,Validea's Top Five Healthcare Stocks Based On David Dreman - 2/18/2018,0.0,0.833,0.167,1
2018-02-19 12:36:03,0.0,GlaxoSmithKline’s Business Segments in 4Q17,0.0,1.0,0.0,0
2018-02-19 14:00:14,0.0,Merck’s Valuations after Its 4Q17 Earnings,0.0,1.0,0.0,0
2018-02-19 14:04:43,0.0,GlaxoSmithKline’s Pharmaceuticals Business in 4Q17,0.0,1.0,0.0,0
2018-02-19 15:18:46,0.0,[$$] Is Reckitt's Deal Machine Still Up to Snuff?,0.0,1.0,0.0,0
2018-02-19 15:30:14,0.0,Analysts’ Recommendations for Merck & Co. after 4Q17,0.0,1.0,0.0,0
2018-02-19 15:31:51,0.34,Kymriah May Emerge as a Robust Treatment Option in DLBCL Indication,0.0,0.789,0.211,1
2018-02-19 15:32:54,0.0,GlaxoSmithKline’s HIV Business in 4Q17,0.0,1.0,0.0,0
2018-02-20 14:02:40,0.0,GlaxoSmithKline’s Vaccines Business in 4Q17,0.0,1.0,0.0,0
2018-02-20 17:11:49,0.0,"Stock Market News For Feb 20, 2018",0.0,1.0,0.0,0
2018-02-20 19:37:35,0.0,How Are Roche's Revenues And Earnings Likely To Change Over The Next Five Years?,0.0,1.0,0.0,0
2018-02-20 21:56:32,0.4576,"After Hours Most Active for Feb 20, 2018 :  MSFT, QQQ, GE, EXC, PFE, T, F, EBAY, QCOM, MDT, CSCO, FB",0.0,0.864,0.136,1
2018-02-21 04:33:52,0.0,[$$] Novartis CEO Steers Drug Maker Back to R&D,0.0,1.0,0.0,0
2018-02-21 12:31:44,0.0,Novartis Expects FDA and EMA Approvals for Aimovig in 2018,0.0,1.0,0.0,0
2018-02-21 12:32:46,0.0,GlaxoSmithKline’s Valuations after Its 4Q17 Earnings,0.0,1.0,0.0,0
2018-02-21 13:08:13,-0.128,3 Growth Stocks That Could Put Netflix's Returns to Shame,0.244,0.551,0.205,-1
2018-02-21 14:18:14,0.1531,Solid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular Dystrophy,0.0,0.882,0.118,1
2018-02-22 11:04:00,0.5859,Would Pfizer Investors Win With a Bristol-Myers Squibb Acquisition?,0.0,0.648,0.352,1
2018-02-22 14:11:03,0.0,Momenta's (MNTA) Earnings & Revenues Surpass Estimates in Q4,0.0,1.0,0.0,0
2018-02-22 16:47:29,0.0,How Johnson & Johnson Performed in 4Q17 and Fiscal 2017,0.0,1.0,0.0,0
2018-02-22 17:56:07,0.0,Comparing Eli Lilly’s Business Segments in 4Q17,0.0,1.0,0.0,0
2018-02-22 17:56:18,0.0,How Eli Lilly’s Cardiovascular Portfolio Performed in 4Q17,0.0,1.0,0.0,0
2018-02-22 17:56:35,0.0,Eli Lilly’s Oncology Portfolio in 4Q17,0.0,1.0,0.0,0
2018-02-22 18:36:05,0.0,Analyst Ratings for Regeneron Pharmaceuticals and Its Peers,0.0,1.0,0.0,0
2018-02-22 18:36:06,0.0,Regeneron Pharmaceuticals and Its Financial Performance,0.0,1.0,0.0,0
2018-02-22 18:36:06,0.0,A Look at Regeneron Pharmaceuticals’ Product Pipeline,0.0,1.0,0.0,0
2018-02-22 18:37:44,0.0,How Much Has Roche Paid In Dividends Over The Last Five Years?,0.0,1.0,0.0,0
2018-02-22 19:25:02,0.0,A Look at Eli Lilly’s Neuroscience Portfolio in 4Q17,0.0,1.0,0.0,0
2018-02-22 20:55:31,0.0,Eli Lilly’s New Product Portfolio in 4Q17,0.0,1.0,0.0,0
2018-02-23 08:40:00,0.0,Pfizer Updates On EMA Application For SUTENT,0.0,1.0,0.0,0
2018-02-23 09:16:00,0.5574,Pfizer Gets Positive CHMP Opinion For Mylotarg And Bosulif - Quick Facts,0.0,0.735,0.265,1
2018-02-23 12:08:42,0.2023,3 Top Healthcare Stocks to Buy Right Now,0.0,0.769,0.231,1
2018-02-23 13:00:00,0.0,Albert Bourla Elected to Pfizer’s Board of Directors,0.0,1.0,0.0,0
2018-02-23 13:00:00,0.0,12 Dividend Stocks for Bull and Bear Markets,0.0,1.0,0.0,0
2018-02-23 13:30:00,-0.2732,Pfizer Announces Update on European Marketing Authorization Application for SUTENT® (sunitinib) in Adult Patients at High Risk of Recurrent Renal Cell Carcinoma,0.091,0.909,0.0,-1
2018-02-23 14:00:00,0.5574,"Pfizer Receives Positive CHMP Opinion for Two Hematology Medicines, MYLOTARG™ and BOSULIF®",0.0,0.753,0.247,1
2018-02-23 14:17:34,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 26, 2018",0.0,1.0,0.0,0
2018-02-23 14:47:18,0.4939,"Health Care Sector Update for 02/23/2018: BLCM, PFE, PBYI, AMGN, 4507:JP",0.0,0.758,0.242,1
2018-02-23 15:12:13,0.4767,Can Rhopressa's Approval Drive Aerie (AERI) in Q4 Earnings?,0.0,0.721,0.279,1
2018-02-23 15:40:45,0.0,Analysts’ Post-4Q17 Recommendations for Eli Lilly,0.0,1.0,0.0,0
2018-02-23 18:45:00,0.4939,"Health Care Sector Update for 02/23/2018: PBYI, BLCM, PFE",0.0,0.714,0.286,1
2018-02-23 21:24:31,0.4939,"Health Care Sector Update for 02/23/2018: AMGN,PBYI,BLCM,PFE",0.0,0.652,0.348,1
2018-02-23 22:17:06,0.0,Analyst Ratings for Vanda Pharmaceuticals and Peers in February,0.0,1.0,0.0,0
2018-02-23 22:17:07,0.0,What Investors Can Expect from Vanda Pharmaceuticals in 2018,0.0,1.0,0.0,0
2018-02-26 14:01:34,0.0,How JNJ’s Hypertension Segment Performed in 4Q17,0.0,1.0,0.0,0
2018-02-26 15:20:52,0.0,Blue Chips Lead Market; 2 Dow Stocks Retake 50-Day Line,0.0,1.0,0.0,0
2018-02-26 17:24:26,0.0,Analysts’ Recommendations for Novo Nordisk and Peers in 2018,0.0,1.0,0.0,0
2018-02-26 18:55:02,0.0,Novo Nordisk Expected to Report Flat Revenue in 2018,0.0,1.0,0.0,0
2018-02-26 20:25:02,0.0,What’s Expected for Novo Nordisk’s Net Income Margin in 2018,0.0,1.0,0.0,0
2018-02-26 21:35:46,0.0,Biogen&apos;s Multiple Sclerosis Drug Franchise Takes Another Hit,0.0,1.0,0.0,0
2018-02-26 22:06:44,0.6597,5 Best GARP Stocks Based on Discounted PEG,0.0,0.481,0.519,1
2018-02-26 22:51:22,0.0,Analysts’ Ratings for Alkermes and Its Peers in February 2018,0.0,1.0,0.0,0
2018-02-27 02:41:00,0.0,Biotech Stocks Facing FDA Decision In March,0.0,1.0,0.0,0
2018-02-27 12:30:02,0.0,[$$] WeWork Competitor Industrious Raises $80 Million,0.0,1.0,0.0,0
2018-02-27 13:07:48,0.0,"This could be the next $1 billion drug, if patients get on board",0.0,1.0,0.0,0
2018-02-27 14:00:18,0.0,How Did Johnson & Johnson’s Zytiga Perform in 2017?,0.0,1.0,0.0,0
2018-02-27 14:08:03,0.5267,3 Dividend Stocks Ideal for Retirees,0.0,0.541,0.459,1
2018-02-27 14:08:27,0.0,5 Things Exelixis Inc. Management Wants You to Know About the Biotech's Future,0.0,1.0,0.0,0
2018-02-27 14:09:59,0.0,"Zacks.com highlights: Pfizer, Laboratory Corporation of America Holdings, Hill-Rom Holdings, HCA Healthcare and Terex",0.0,1.0,0.0,0
2018-02-27 14:38:02,-0.6597,Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP,0.355,0.645,0.0,-1
2018-02-27 14:53:02,-0.1779,Lilly&apos;s Verzenio Wins FDA Nod for First Line Breast Cancer,0.273,0.497,0.23,-1
2018-02-27 15:30:02,0.0,JNJ’s Cardiovascular Segment’s Performance in 4Q17 and 2017,0.0,1.0,0.0,0
2018-02-27 17:11:49,-0.1779,Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer,0.273,0.497,0.23,-1
2018-02-28 00:07:07,0.2023,3 Top Pharma Stocks With Dividend Yields Over 3%,0.0,0.795,0.205,1
2018-02-28 12:30:02,0.0,Analysts’ Recommendations for Johnson & Johnson in February 2018,0.0,1.0,0.0,0
2018-02-28 16:10:02,0.6249,5 Reasons Why Pfizer (PFE) Could be a Great Pick in 2018,0.0,0.687,0.313,1
2018-02-28 16:19:00,0.0,This doctor says his test could decrease opioid addiction,0.0,1.0,0.0,0
2018-02-28 22:08:00,0.4019,4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio,0.0,0.748,0.252,1
2018-03-01 11:00:00,0.2023,Bet on Big Pharma: A Six-Pack of Top Tier Drug Stocks,0.0,0.833,0.167,1
2018-03-01 13:22:00,0.0,"[$$] Selling Nvidia, GE, Applied Materials, Buying Pfizer",0.0,1.0,0.0,0
2018-03-01 16:11:31,0.0,Intangibles Hold the Key to Valeant Pharmaceuticals Intl Inc Stock,0.0,1.0,0.0,0
2018-03-01 19:07:54,0.296,"IVW, NVDA, CSCO, PFE: ETF Inflow Alert",0.0,0.732,0.268,1
2018-03-01 19:53:00,-0.1027,"How To Trade The 8 'Dogs Of The Dow,' Which Were Hit Hard In February",0.097,0.903,0.0,-1
2018-03-02 06:17:00,0.0,Neofluidics Enters Collaboration With Pfizer - Quick Facts,0.0,1.0,0.0,0
2018-03-02 11:00:00,0.0,Neofluidics Announces Collaboration with Pfizer Inc.,0.0,1.0,0.0,0
2018-03-02 20:25:14,0.3804,Wall Street More Optimistic about Johnson & Johnson after 4Q17,0.0,0.755,0.245,1
2018-03-03 04:06:39,0.2023,Here’s Why Gilead Sciences' Jump Into Gene Editing Is Important,0.0,0.833,0.167,1
2018-03-03 21:19:00,0.0,An Ear To The Pharma: 7 Stocks To Watch This Week,0.0,1.0,0.0,0
2018-03-04 08:00:31,0.0,[$$] Saline investigation highlights the cost of American healthcare,0.0,1.0,0.0,0
2018-03-05 12:32:21,0.0,Sanofi Pasteur’s 4Q17 Performance,0.0,1.0,0.0,0
2018-03-05 12:34:01,0.0,Johnson & Johnson Stock: What’s behind the Recent Decline?,0.0,1.0,0.0,0
2018-03-05 14:01:54,0.0,Sanofi’s Valuations in February 2018,0.0,1.0,0.0,0
2018-03-05 16:20:12,0.0,Fretting Over Trump Tariffs? Buy 5 Ultra-Safe Stocks Now,0.0,1.0,0.0,0
2018-03-05 17:00:00,0.5574,ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis,0.0,0.825,0.175,1
2018-03-05 18:14:52,0.0,What's in the Cards for Merck KGaA (MKGAF) in Q4 Earnings?,0.0,1.0,0.0,0
2018-03-05 19:34:53,0.0,Where Are Biotech Industry Vets Taking a Seat at the Table Right Now?,0.0,1.0,0.0,0
2018-03-05 20:00:00,0.0,Dan R. Littman Elected to Pfizer’s Board of Directors,0.0,1.0,0.0,0
2018-03-05 23:22:00,-0.2732,Senator Asks Drug Companies What They'll Do With Extra Cash From Big Tax Cut,0.139,0.861,0.0,-1
2018-03-06 14:00:31,0.0,A Look into the Performance of AZN’s Nexium and Synagis in 2017,0.0,1.0,0.0,0
2018-03-06 14:18:51,0.5267,Glaxo's Encouraging Asthma & HIV Data at Medical Meetings,0.0,0.673,0.327,1
2018-03-06 15:20:41,0.5106,"The Zacks Analyst Blog Highlights: Pfizer, Verizon, Altria, Occidental Petroleum and Community Trust",0.0,0.784,0.216,1
2018-03-06 18:15:03,0.0,Johnson & Johnson’s Revenues in 4Q17,0.0,1.0,0.0,0
2018-03-06 18:55:02,-0.296,Gilead Sciences Reported Lower Revenues in 4Q17,0.268,0.732,0.0,-1
2018-03-07 00:15:45,0.2732,AstraZeneca's Forxiga Label Expansion Filing Accepted in EU,0.0,0.769,0.231,1
2018-03-07 00:39:21,-0.4019,Pfizer Inc (NYSE:PFE): Are Analysts’ Earnings Forecast Signalling Trouble Ahead?,0.231,0.769,0.0,-1
2018-03-07 12:33:01,0.0,Johnson & Johnson’s Pharmaceutical Segment in 4Q17,0.0,1.0,0.0,0
2018-03-07 15:30:30,-0.1779,Will Recent Trade War Talk Affect the Health Care Sector in March?,0.228,0.585,0.187,-1
2018-03-07 15:31:17,0.0,How BMY’s Baraclude and Sustiva Franchise Performed,0.0,1.0,0.0,0
2018-03-07 18:30:30,0.0,Depomed versus Peers in March 2018: Analyst Ratings,0.0,1.0,0.0,0
2018-03-07 21:00:09,0.0,Pharmaceutical Industry Outlook - March 2018,0.0,1.0,0.0,0
2018-03-08 14:01:09,0.0,Analysts’ Recommendations for Gilead Sciences in March,0.0,1.0,0.0,0
2018-03-08 14:02:00,0.0772,"Quest for the blockbuster Alzheimer’s drug is failing, but there&apos;s another option",0.147,0.685,0.168,0
2018-03-08 14:02:00,0.0772,"Quest for the blockbuster Alzheimer’s drug is failing, but there's another option",0.147,0.685,0.168,0
2018-03-08 14:30:00,0.3818,2 Cheap Growth Stocks to Buy Right Now,0.0,0.698,0.302,1
2018-03-08 16:03:36,0.4939,The company that’s trying to change archaic methods within health care,0.0,0.758,0.242,1
2018-03-08 16:54:24,0.0258,How to Invest in ETFs Backed by Women Power,0.0,0.879,0.121,0
2018-03-08 17:01:00,-0.0516,FDA Panel Backs Pfizer's Xeljanz For Ulcerative Colitis,0.146,0.854,0.0,0
2018-03-08 19:20:18,0.0,Masimo and Its Peers: Analysts’ Ratings in March 2018,0.0,1.0,0.0,0
2018-03-08 19:20:19,0.0,Masimo’s Geographic Segments in Fiscal 2017,0.0,1.0,0.0,0
2018-03-08 19:53:14,-0.0516,FDA panel backs Pfizer's Xeljanz as bowel disease treatment,0.13,0.87,0.0,0
2018-03-08 21:51:00,0.4215,Pfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on XELJANZ® (tofacitinib) for Moderately to Severely Active Ulcerative Colitis,0.121,0.645,0.234,1
2018-03-08 22:00:10,0.3818,"M&A, Innovation & New Drugs to Drive Pharma Stocks",0.0,0.729,0.271,1
2018-03-09 02:04:00,0.0258,"FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month",0.089,0.815,0.096,0
2018-03-09 12:43:12,-0.296,Is Big Pharma Using Corporate Tax Savings to Lower Drug Costs?,0.18,0.82,0.0,-1
2018-03-09 12:45:12,-0.802,"Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM&apos;s Acne Candidate Fails",0.419,0.581,0.0,-1
2018-03-09 14:50:54,-0.802,"Pharma Stock Roundup: MRK Signs New Cancer Deal, DERM's Acne Candidate Fails",0.419,0.581,0.0,-1
2018-03-09 15:49:46,0.0,Peek Under The Hood: IWL Has 11% Upside,0.0,1.0,0.0,0
2018-03-09 16:53:27,0.0258,Pfizer Gets FDA Panel Backing for New Indication for Xeljanz,0.0,0.891,0.109,0
2018-03-09 19:45:00,0.0,How Will Pfizer Perform In 2018?,0.0,1.0,0.0,0
2018-03-09 20:14:12,0.0,What’s AstraZeneca’s Valuation in March 2018?,0.0,1.0,0.0,0
2018-03-09 21:47:26,-0.296,"Pharma Stocks Weighed Down by Competition, Generic Pressure",0.239,0.761,0.0,-1
2018-03-10 15:48:31,0.0,"Reckitt CEO stands by Mead Johnson deal, despite Pfizer option",0.0,1.0,0.0,0
2018-03-11 12:00:00,0.0,Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral Anticoagulants,0.0,1.0,0.0,0
2018-03-11 17:06:36,0.0,Here's What Lifted Sangamo Therapeutics Inc. in February,0.0,1.0,0.0,0
2018-03-12 07:42:00,0.6124,Biogen To Acquire Phase 2b Ready Asset For Schizophrenia,0.0,0.583,0.417,1
2018-03-12 11:40:13,0.0,Biogen to buy schizophrenia treatment from Pfizer for up to $590 million,0.0,1.0,0.0,0
2018-03-12 12:07:17,0.0,Biogen to buy Pfizer's neurology drug in deal nearing $600 mln,0.0,1.0,0.0,0
2018-03-12 13:02:16,0.3818,What Were AstraZeneca’s Growth Platforms in 4Q17?,0.0,0.698,0.302,1
2018-03-12 15:11:18,0.0,Pfizer Stock Split History,0.0,1.0,0.0,0
2018-03-12 19:28:45,0.0,Analysts’ Ratings for Tenet Healthcare and Its Peers in March,0.0,1.0,0.0,0
2018-03-12 20:26:50,0.4939,"Health Care Sector Update for 03/12/2018: SRPT,BIIB,PFE,SVRA,ALNY,SNY",0.0,0.652,0.348,1
2018-03-12 21:06:40,0.4576,"After Hours Most Active for Mar 12, 2018 :  PFE, QCOM, F, CBS, BAC, QQQ, CELG, HST, SOHU, GE, CTSH, GILD",0.0,0.864,0.136,1
2018-03-13 11:31:14,0.0,How AstraZeneca’s Oncology Products Performed in 4Q17,0.0,1.0,0.0,0
2018-03-13 12:10:00,0.0,Today’s Research Reports on Stocks to Watch: Teva and Pfizer,0.0,1.0,0.0,0
2018-03-13 13:00:46,0.0,How AstraZeneca’s CVMD Segment Products Performed in 4Q17,0.0,1.0,0.0,0
2018-03-13 15:09:03,0.3612,Biogen to Buy Mid-Stage Neuropsychiatry Asset From Pfizer,0.0,0.737,0.263,1
2018-03-13 16:40:16,0.0,Pfizer could score $515 million from the sale of a schizophrenia drug,0.0,1.0,0.0,0
2018-03-13 20:07:13,0.0,What’s Novartis’s Valuation in March 2018?,0.0,1.0,0.0,0
2018-03-13 20:56:36,0.4576,"After Hours Most Active for Mar 13, 2018 :  ENDP, DWDP, NWL, INTC, PFE, HPQ, ZNGA, FOLD, SWN, QQQ, CBS, STLD",0.0,0.864,0.136,1
2018-03-13 21:00:02,0.0,How Merck’s Diabetes Portfolio Performed in 2017,0.0,1.0,0.0,0
2018-03-14 13:03:03,0.0,Behind Merck’s Virology Business: A Post-4Q17 Update,0.0,1.0,0.0,0
2018-03-14 14:12:02,-0.6597,Cancer Space Takes Giant Strides: Are Patients Benefiting?,0.386,0.614,0.0,-1
2018-03-14 17:08:32,0.296,"Commit To Purchase Pfizer At $35, Earn 6% Annualized Using Options",0.0,0.82,0.18,1
2018-03-14 17:11:06,-0.296,"Biotech Stock Roundup: REGN Cuts Praluent Price, OREX to File for Bankruptcy",0.167,0.833,0.0,-1
2018-03-14 17:57:00,-0.4019,NYSE trader: Out of control deficit spending will come to bite us someday,0.184,0.816,0.0,-1
2018-03-14 18:34:00,0.0,"[$$] Big Stock Sales: GE, P&G, Pfizer, Bristol-Myers",0.0,1.0,0.0,0
2018-03-15 12:47:00,-0.6597,How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment,0.286,0.714,0.0,-1
2018-03-15 14:30:47,0.4939,Understanding the Performance of Merck’s Hospital Acute Care Drugs Noxafil and Cubicin,0.0,0.775,0.225,1
2018-03-15 17:47:07,0.0,Pfizer’s Valuation Post-4Q17 Earnings,0.0,1.0,0.0,0
2018-03-15 19:20:02,0.0,Assessing Pfizer’s 4Q17 Quarterly Revenue Trend,0.0,1.0,0.0,0
2018-03-15 20:08:18,0.3818,Pfizer (PFE) and Delta Air Lines (DAL): Growth & Income Stocks,0.0,0.776,0.224,1
2018-03-15 20:21:43,0.4767,Pfizer Lifts CEO's Pay 61% to $27.9 Million With Retention Bonus,0.101,0.647,0.252,1
2018-03-15 20:50:02,0.0,Pfizer’s Segment-by-Segment Performance in 4Q17,0.0,1.0,0.0,0
2018-03-16 11:30:41,0.0,How Did Merck’s Invanz and Cancidas Perform in 2017?,0.0,1.0,0.0,0
2018-03-16 11:33:03,0.0,How Pfizer Performed across Geographies during 4Q17,0.0,1.0,0.0,0
2018-03-16 12:08:44,0.0,3 Reasons CRISPR Stocks Could Keep Soaring,0.0,1.0,0.0,0
2018-03-16 13:00:32,0.0,How Merck’s Bridion and Primaxin Performed in 2017,0.0,1.0,0.0,0
2018-03-16 13:02:38,0.3818,A Closer Look at Pfizer’s 4Q17 Growth Drivers,0.0,0.698,0.302,1
2018-03-16 13:10:48,0.0,J&J's (JNJ) Erdafitinib Gets Breakthrough Therapy Status,0.0,1.0,0.0,0
2018-03-16 14:30:20,0.0,"Behind Merck’s Vaccines Gardasil, Pneumovax 23, and ProQuad: A Post-4Q17 Performance Update",0.0,1.0,0.0,0
2018-03-16 15:13:37,0.5719,"Dow 30 Stock Roundup: Boeing JV Wins $354M Satellite Contract, Merck's Keytruda Gets Priority Review",0.0,0.791,0.209,1
2018-03-16 16:23:09,0.0,"Why A Biopharma Buying Spree May Target AstraZeneca, Bristol",0.0,1.0,0.0,0
2018-03-16 19:15:00,0.0,Pfizer CEO Ian Read Gets 61% Raise to Keep Him From Considering Retirement,0.0,1.0,0.0,0
2018-03-19 11:00:00,0.2732,BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent,0.0,0.84,0.16,1
2018-03-19 11:31:25,0.0,Analysts’ Recommendations for Pfizer in March 2018,0.0,1.0,0.0,0
2018-03-19 13:40:01,0.34,Should Value Investors Pick Pfizer (PFE) Stock Now?,0.0,0.745,0.255,1
2018-03-19 14:30:22,0.0,Merck on the Street: Analyst Recommendations in March 2017,0.0,1.0,0.0,0
2018-03-19 14:41:02,0.0,J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit,0.0,1.0,0.0,0
2018-03-19 16:08:11,0.0,"Notable ETF Inflow Detected - XLV, PFE, TMO, LLY",0.0,1.0,0.0,0
2018-03-19 16:26:14,0.0,GlaxoSmithKline’s Valuation in March 2018,0.0,1.0,0.0,0
2018-03-19 17:19:00,0.2944,Is Pfizer&apos;s CEO Ian Read Really Worth 61% More?,0.0,0.785,0.215,1
2018-03-19 19:08:17,0.2944,Is Pfizer's CEO Ian Read Really Worth 61% More?,0.0,0.785,0.215,1
2018-03-19 20:15:00,-0.5423,U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC),0.181,0.741,0.078,-1
2018-03-20 03:16:00,0.4767,"ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch",0.0,0.78,0.22,1
2018-03-20 07:01:17,-0.4019,"China's Aim to Remove Cancer Drug Taxes May Boost Pfizer, Glaxo",0.273,0.559,0.168,-1
2018-03-20 10:00:00,0.2023,Our Ultimate Stock-Pickers’ Top 10 Dividend-Yielding Stocks,0.0,0.769,0.231,1
2018-03-20 14:00:00,0.0,Pfizer Invites Public To View And Listen To Webcast Of May 1 Conference Call With Analysts,0.0,1.0,0.0,0
2018-03-20 15:36:03,0.0,Pfizer&apos;s Xtandi Label Expansion Filing Gets Priority Review,0.0,1.0,0.0,0
2018-03-20 17:07:18,0.0,Analyst Ratings for Nektar Therapeutics and Peers in March 2018,0.0,1.0,0.0,0
2018-03-20 17:47:03,0.4939,"Health Care Sector Update for 03/20/2018: PFE,CRME,CPH.TO,AFMD",0.0,0.652,0.348,1
2018-03-20 18:09:56,0.0,Pfizer's Xtandi Label Expansion Filing Gets Priority Review,0.0,1.0,0.0,0
2018-03-20 20:27:00,0.4939,"Health Care Sector Update for 03/20/2018: TRIL,TRIL.TO,PFE,CRME,CPH.TO,AFMD",0.0,0.652,0.348,1
2018-03-20 20:56:41,0.4576,"After Hours Most Active for Mar 20, 2018 :  F, BAC, SAN, EXC, CSCO, MU, PFE, JD, MDLZ, V, QQQ, QCOM",0.0,0.864,0.136,1
2018-03-20 22:06:56,0.6369,Dow Nets Triple-Digit Win As Markets Await Rate Hike,0.0,0.574,0.426,1
2018-03-21 00:07:23,0.2023,3 Top Stocks With High Dividend Yields,0.0,0.735,0.265,1
2018-03-21 09:03:11,0.0,[$$] Reckitt ends pursuit for part of Pfizer’s consumer healthcare unit,0.0,1.0,0.0,0
2018-03-21 09:15:42,0.0,[$$] GlaxoSmithKline in pole position for $20bn Pfizer unit,0.0,1.0,0.0,0
2018-03-21 11:21:00,0.0,Wired News – Pfizer Signs Collaboration Deal with BioDuro to Develop Shelf-Stable Fluorosulfation Reagent,0.0,1.0,0.0,0
2018-03-21 16:59:35,0.0,Latest Stock Recommendations on TEVA: Mostly ‘Holds’,0.0,1.0,0.0,0
2018-03-21 17:33:34,-0.3612,Britain's use of copycat biotech drugs takes off while U.S. lags,0.2,0.8,0.0,-1
2018-03-21 20:24:14,0.296,Reckitt Shares Jump as It Passes on Pfizer Consumer Auction,0.0,0.804,0.196,1
2018-03-21 20:27:10,-0.2732,Drug companies are beginning to wake up to this new risk factor,0.16,0.84,0.0,-1
2018-03-21 20:56:17,0.0,Reckitt Benckiser pulls out of Pfizer consumer health auction,0.0,1.0,0.0,0
2018-03-21 21:30:02,0.4939,Could Gilead Sciences’ Biktarvy Witness Solid Growth in 2018?,0.0,0.625,0.375,1
2018-03-22 03:04:43,0.0,"[$$] Stocks to watch: Ted Baker, Interserve, Vectura, Facebook, AbbVie",0.0,1.0,0.0,0
2018-03-22 03:21:00,0.0,Reckitt Benckiser Ends Discussions With Pfizer On Consumer Health Deal,0.0,1.0,0.0,0
2018-03-22 03:34:30,0.0,[$$] GSK’s move for Pfizer’s consumer arm divides market,0.0,1.0,0.0,0
2018-03-22 07:58:51,0.0,[$$] Reckitt Benckiser Ends Talks to Buy Pfizer Unit,0.0,1.0,0.0,0
2018-03-22 09:14:59,0.0,GSK's bid in focus as Reckitt quits Pfizer consumer health auction,0.0,1.0,0.0,0
2018-03-22 09:22:23,0.0,[$$] Reckitt rises after exiting talks to buy Pfizer consumer health unit ,0.0,1.0,0.0,0
2018-03-22 10:03:02,0.0258,UPDATE 1-Trade jitters send European shares to two-week low,0.186,0.619,0.195,0
2018-03-22 10:47:05,0.0,The Drugs Didn't Work for Reckitt,0.0,1.0,0.0,0
2018-03-22 11:09:10,0.0,[$$] GlaxoSmithKline leads race to buy $20bn Pfizer unit,0.0,1.0,0.0,0
2018-03-22 11:33:13,0.0,How Gilead Sciences’ TAF-Containing HIV Drugs Performed,0.0,1.0,0.0,0
2018-03-22 13:00:00,0.4939,Allergan's Battered Shares Are Poised To Rise Over 35%,0.0,0.625,0.375,1
2018-03-22 13:37:06,-0.1779,[$$] Durex-Maker Reckitt Avoids $20 Billion Headache,0.221,0.779,0.0,-1
2018-03-22 14:26:53,0.0,Deals of the day-Mergers and acquisitions,0.0,1.0,0.0,0
2018-03-22 15:15:00,0.0,GlaxoSmithKline Now Front-Runner for Pfizer Unit,0.0,1.0,0.0,0
2018-03-22 15:31:03,0.6249,4 Reasons Why Glaxo (GSK) Stock Can be a Great Pick in &apos;18,0.0,0.709,0.291,1
2018-03-22 15:37:03,0.0,Merck Gets European Committee Vote for Veterinary Product,0.0,1.0,0.0,0
2018-03-22 15:44:30,0.5106,LIVE MARKETS-A question of trust,0.0,0.548,0.452,1
2018-03-22 15:46:06,-0.0772,Biotech Winners And Losers From Congress' Latest Funding Bill,0.252,0.519,0.23,0
2018-03-22 15:49:50,0.0,GSK advances in Pfizer consumer health auction as Reckitt quits,0.0,1.0,0.0,0
2018-03-22 15:55:36,0.0,Back to the drawing board for Reckitt after dropping Pfizer bid,0.0,1.0,0.0,0
2018-03-22 16:57:26,-0.25,Pfizer Doesn't Have to Be Stuck With Its Consumer Business,0.182,0.818,0.0,-1
2018-03-22 17:36:00,0.2263,How Much Is Pfizer's Consumer Healthcare Business Worth?,0.0,0.787,0.213,1
2018-03-22 17:40:46,-0.6369,"European shares suffer as trade jitters, weak data weigh",0.438,0.411,0.151,-1
2018-03-22 18:08:58,0.6249,4 Reasons Why Glaxo (GSK) Stock Can be a Great Pick in '18,0.0,0.709,0.291,1
2018-03-22 19:32:00,0.4588,Small-Cap Biotech and Tech Names Part of Our Latest 'Sweet 16' Stock Picks,0.0,0.8,0.2,1
2018-03-22 21:28:00,0.0,"New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores",0.0,1.0,0.0,0
2018-03-22 22:08:58,0.296,4 ETFs to Join The Sustainable Investing Trend,0.0,0.732,0.268,1
2018-03-23 04:40:00,0.0,GSK Withdraws From Process For Pfizer's Consumer Healthcare Unit; Stock Up,0.0,1.0,0.0,0
2018-03-23 05:26:00,0.128,FTSE 100 Extends Slide Amid Global Selloff,0.0,0.8,0.2,1
2018-03-23 05:59:00,-0.3818,European Shares Extend Losses As Trade Fears Mount,0.41,0.299,0.291,-1
2018-03-23 07:40:00,0.5574,ViiV Healthcare: CHMP Issues Positive Opinion For Juluca - Quick Facts,0.0,0.714,0.286,1
2018-03-23 07:58:25,0.0,Glaxo Surges After Withdrawing Bid for Pfizer Consumer-Health Unit,0.0,1.0,0.0,0
2018-03-23 07:59:41,0.0,"[$$] First Reckitt, now GSK pulls out of Pfizer consumer unit auction",0.0,1.0,0.0,0
2018-03-23 08:09:00,0.0,Pfizer Reports Results From Phase 4 Study With CHANTIX/CHAMPIX - Quick Facts,0.0,1.0,0.0,0
2018-03-23 08:29:18,0.0,[$$] Glaxo Ends Talks for Pfizer Unit,0.0,1.0,0.0,0
2018-03-23 09:19:00,0.6486,Sandoz: CHMP Adopts Positive Opinion For Infliximab - Quick Facts,0.0,0.569,0.431,1
2018-03-23 10:10:32,0.0,[$$] GSK pulls out of auction to buy $20bn Pfizer business,0.0,1.0,0.0,0
2018-03-23 10:47:00,0.296,GSK Shares Jump After Pfizer Talks End,0.0,0.732,0.268,1
2018-03-23 11:27:00,0.7184,ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe,0.0,0.6,0.4,1
2018-03-23 11:31:03,0.0,Discussing Teva’s Recent Stock Performance,0.0,1.0,0.0,0
2018-03-23 11:31:11,0.0,"How Gilead’s Viread, Complera, and Letairis Performed",0.0,1.0,0.0,0
2018-03-23 11:59:10,0.1779,GSK pulls out of $20 billion race for Pfizer consumer assets,0.0,0.855,0.145,1
2018-03-23 12:00:00,0.0,Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX® (varenicline) in Adolescent Smokers,0.0,1.0,0.0,0
2018-03-23 12:10:00,0.0,Today’s Research Reports on Stocks to Watch: AbbVie and Pfizer,0.0,1.0,0.0,0
2018-03-23 12:20:55,-0.4215,Pfizer's quit-smoking Chantix fails study in adolescent smokers,0.286,0.714,0.0,-1
2018-03-23 12:21:00,0.0,"Stocks making the biggest moves premarket: NKE, MU, CSCO, PFE, DBX, WYNN & more",0.0,1.0,0.0,0
2018-03-23 12:21:54,0.4939,GSK withdraws from bidding for Pfizer&apos;s consumer health care unit,0.0,0.738,0.262,1
2018-03-23 12:40:19,0.3612,Glaxo's Boss Looks Ready to Loosen the Straitjacket,0.0,0.737,0.263,1
2018-03-23 12:58:00,-0.7717,European Markets Tumbled Further On Trade War Fears,0.528,0.472,0.0,-1
2018-03-23 13:26:04,0.0,"Stocks to Watch: Dropbox, Boeing, Alphabet, Facebook, Kroger, Nike, Micron, Pfizer, KB Home",0.0,1.0,0.0,0
2018-03-23 13:27:48,0.4939,"Health Care Sector Update for 03/23/2018: PACB, PGNX, PFE, GSK, VTVT",0.0,0.758,0.242,1
2018-03-23 14:01:33,0.4215,Key Updates on Teva’s Restructuring Plan Progress,0.0,0.682,0.318,1
2018-03-23 14:28:02,-0.6597,Cancer Space Roundup: NVS&apos; Tasigna & SGEN&apos;s Adcetris Label Expansions in Focus,0.306,0.694,0.0,-1
2018-03-23 14:28:19,0.0,Pfizer Inc (NYSE:PFE): Time For A Financial Health Check,0.0,1.0,0.0,0
2018-03-23 16:19:12,0.1779,GSK pulls out of race for Pfizer consumer assets,0.0,0.825,0.175,1
2018-03-23 17:05:02,0.0,Teva Is Implementing This Strategy as Part of Its Restructuring,0.0,1.0,0.0,0
2018-03-23 17:12:12,-0.6597,Cancer Space Roundup: NVS' Tasigna & SGEN's Adcetris Label Expansions in Focus,0.306,0.694,0.0,-1
2018-03-23 18:08:53,0.4019,Pfizer is having a tough time selling its consumer health care business,0.109,0.657,0.234,1
2018-03-23 18:10:40,0.1779,GSK pulls out of £14.2 billion race for Pfizer consumer assets,0.0,0.855,0.145,1
2018-03-23 18:47:29,-0.836,"European Equity Benchmarks Close Lower on Trade War Fears; Industrials, Steel Stocks Down",0.471,0.529,0.0,-1
2018-03-23 19:46:14,0.0,Pfizer in a Quandary Over Consumer-Health Business,0.0,1.0,0.0,0
2018-03-23 20:06:33,0.0,Pfizer Breaks Below 200-Day Moving Average - Notable for PFE,0.0,1.0,0.0,0
2018-03-23 20:22:08,-0.3818,"Pharma Stock Roundup: ABBV&apos;s Rova-T Disappoints, J&J Unit Gets Buyout Offer",0.206,0.794,0.0,-1
2018-03-23 20:27:36,0.4939,"Health Care Sector Update for 03/23/2018: PFE,GSK,PGNX,PACB,VTVT.ONT",0.0,0.652,0.348,1
2018-03-23 21:01:59,0.0,GSK Spikes After Dropping Bid For Pfizer&apos;s Over-The-Counter Unit,0.0,1.0,0.0,0
2018-03-23 22:07:16,-0.3818,"Pharma Stock Roundup: ABBV's Rova-T Disappoints, J&J Unit Gets Buyout Offer",0.206,0.794,0.0,-1
2018-03-23 23:07:12,-0.8834,Stocks Suffer Worst Weekly Losses Since 2016,0.72,0.28,0.0,-1
2018-03-23 23:09:19,0.0,GlaxoSmithKline plc (ADR) (GSK) Stock Is Heading Higher Today,0.0,1.0,0.0,0
2018-03-26 02:34:24,0.0,PRESS DIGEST- British Business - March 26,0.0,1.0,0.0,0
2018-03-26 12:04:00,0.6369,Is Pfizer&apos;s Best Option Now a Consumer Healthcare Spinoff?,0.0,0.625,0.375,1
2018-03-26 13:08:52,0.0258,"The Zacks Analyst Blog Highlights: AbbVie, J&J, Heron Therapeutics, Roche and Pfizer",0.0,0.909,0.091,0
2018-03-26 13:09:47,0.6369,Is Pfizer's Best Option Now a Consumer Healthcare Spinoff?,0.0,0.625,0.375,1
2018-03-26 14:02:02,-0.5859,Wall Street Braces for Ugliest March: 5 Ultra-Safe Picks,0.352,0.648,0.0,-1
2018-03-26 14:19:02,0.34,"Glaxo Drops Bid for Pfizer Unit, Shingrix Gains EU/Japan Nod",0.0,0.789,0.211,1
2018-03-26 14:20:02,-0.4215,Pfizer&apos;s Chantix Fails in Phase IV Study in Young Smokers,0.237,0.763,0.0,-1
2018-03-26 14:32:08,0.0,Analysts’ Recommendations for Incyte in March 2018,0.0,1.0,0.0,0
2018-03-26 15:12:47,0.5574,Novartis Gets Positive CHMP Opinion on Biosimilar Remicade,0.0,0.66,0.34,1
2018-03-26 16:11:30,-0.4215,Pfizer's Chantix Fails in Phase IV Study in Young Smokers,0.237,0.763,0.0,-1
2018-03-26 19:44:00,-0.4404,"Don&apos;t Worry, Pfizer Isn&apos;t Out of Options for Its Consumer Health Division Just Yet",0.182,0.818,0.0,-1
2018-03-26 21:09:39,0.3412,"Don't Worry, Pfizer Isn't Out of Options for Its Consumer Health Division Just Yet",0.0,0.844,0.156,1
2018-03-27 00:07:17,-0.6249,5 Ultra-Safe Picks as Wall Street Braces for Worst March Ever,0.313,0.687,0.0,-1
2018-03-27 04:36:28,0.0,[$$] Novartis and GSK CEOs set out diverging strategies,0.0,1.0,0.0,0
2018-03-27 05:04:57,0.0,Glaxo to Buy Novartis Consumer-Venture Stake for $13 Billion,0.0,1.0,0.0,0
2018-03-27 05:54:54,0.0,[$$] GSK to Buy Novartis Stake in Consumer Health JV,0.0,1.0,0.0,0
2018-03-27 08:26:00,0.6597,"GSK, Novartis shares rise on consumer health care deal",0.0,0.565,0.435,1
2018-03-27 08:43:22,0.296,GlaxoSmithKline Is Buying Out Novartis’s Share in Their Consumer Health Joint Venture,0.0,0.833,0.167,1
2018-03-27 10:50:00,0.0516,GSK Shares Surge on $13B Buyout Deal Struck With Novartis,0.164,0.656,0.18,0
2018-03-27 10:57:34,0.0,GSK buys out Novartis in $13bln shake-up,0.0,1.0,0.0,0
2018-03-27 11:06:38,0.0,4 Top-Ranked Drug/Biotech Stocks to Buy as Q1 Nears End,0.0,1.0,0.0,0
2018-03-27 11:37:27,0.0,GSK's $13 Billion Novartis Deal Is Only Just the Start,0.0,1.0,0.0,0
2018-03-27 12:27:56,0.0,[$$] Walmsley still has a lot to do to bring GSK back to health,0.0,1.0,0.0,0
2018-03-27 12:30:12,0.0,[$$] GSK Buys Novartis's Stake in Health-Care Unit for $13 Billion,0.0,1.0,0.0,0
2018-03-27 14:53:09,0.4939,GlaxoSmithKline To Buy Novartis' Stake in Consumer Health Care JV For $13 Billion,0.0,0.789,0.211,1
2018-03-27 17:13:16,0.0,"VYM, WFC, PFE, WMT: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2018-03-27 19:11:41,0.0,10 Biggest Product Recalls of All Time,0.0,1.0,0.0,0
2018-03-28 04:05:10,0.0,[$$] Inside story about the past few weeks of dealmaking at GSK,0.0,1.0,0.0,0
2018-03-28 04:34:30,0.0,[$$] GSK Buys Novartis’s Stake in Health-Care Unit for $13 Billion,0.0,1.0,0.0,0
2018-03-28 13:12:01,0.0,Glaxo (GSK) Buys Novartis&apos; Stake in Consumer Healthcare JV,0.0,1.0,0.0,0
2018-03-28 13:16:01,0.0,Merck KGaA&apos;s Tepotinib Gets Fast Track Designation in Japan,0.0,1.0,0.0,0
2018-03-28 14:03:34,0.6633,AbbVie a Top Ranked SAFE Dividend Stock With 4.2% Yield (ABBV),0.0,0.596,0.404,1
2018-03-28 15:07:01,0.0,Merck KGaA's Tepotinib Gets Fast Track Designation in Japan,0.0,1.0,0.0,0
2018-03-28 15:07:13,0.0,Glaxo (GSK) Buys Novartis' Stake in Consumer Healthcare JV,0.0,1.0,0.0,0
2018-03-28 15:10:27,0.4019,"FDA working on a ""dozen"" policies to boost copycat biotech drugs",0.0,0.769,0.231,1
2018-03-28 17:59:43,0.0,How Did Novartis Perform in 4Q17 and Full-Year 2017?,0.0,1.0,0.0,0
2018-03-28 17:59:50,0.0,How Novartis’s Oncology Segment Drugs Are Performing,0.0,1.0,0.0,0
2018-03-28 18:48:28,0.2006,Tread Very Carefully When Investing in AnaptysBio Inc,0.0,0.796,0.204,1
2018-03-28 21:00:03,0.0,"How Did Novartis’s Gleevec, Tasigna, and Sandostatin Perform in 4Q17?",0.0,1.0,0.0,0
2018-03-28 21:59:00,0.0,"&quot;Fast Money&quot; final trades: TWTR, PFE and more",0.0,1.0,0.0,0
2018-03-29 11:33:52,0.0,Opdivo’s Perfomance in 4Q17,0.0,1.0,0.0,0
2018-03-29 11:34:02,0.0,"How Did Novartis’s Affinitor, Exjade, and Tafinlar+Mekinist Perform in 2017?",0.0,1.0,0.0,0
2018-03-29 11:45:11,0.0258,Is a Recession in the Cards? 4 Safe Bets for Your Portfolio,0.204,0.584,0.212,0
2018-03-29 12:10:33,0.0,How Merck Stock Has Performed Recently,0.0,1.0,0.0,0
2018-03-29 12:54:00,0.5574,Pfizer Reports Positive Results From Phase 3 ATTR-ACT Study Of Tafamidis,0.0,0.714,0.286,1
2018-03-29 13:03:01,0.0,How Novartis’s Ophthalmology Business Performed in 2017,0.0,1.0,0.0,0
2018-03-29 13:11:00,0.0,"Your first trade for Thursday, March 29",0.0,1.0,0.0,0
2018-03-29 13:38:11,0.0,Eli Lilly and Company’s Valuation in March 2018,0.0,1.0,0.0,0
2018-03-29 14:32:47,0.0,A Look at Bristol-Myers Squibb’s Eliquis in 4Q17,0.0,1.0,0.0,0
2018-03-29 15:10:10,0.0,Eli Lilly’s Revenue in 4Q17,0.0,1.0,0.0,0
2018-03-29 15:15:02,0.0,What’s Merck’s Valuation in March 2018?,0.0,1.0,0.0,0
2018-03-29 16:40:10,0.0,Eli Lilly’s Segment-by-Segment Performance in 4Q17,0.0,1.0,0.0,0
2018-03-29 16:45:00,0.5574,Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy,0.0,0.806,0.194,1
2018-03-29 19:32:00,0.296,Pfizer shares rise on late-stage results for cardiomyopathy therapy,0.0,0.784,0.216,1
2018-03-29 20:32:23,0.4939,Pfizer's rare heart disease drug succeeds in late-stage study,0.0,0.714,0.286,1
2018-03-29 20:33:44,-0.34,Tackle Market Uncertainty With These 3 Quality Dividend ETFs,0.255,0.745,0.0,-1
2018-03-29 21:15:04,0.0,"Pfizer Takes On Alnylam, Ionis With Rare Disease Treatment",0.0,1.0,0.0,0
2018-03-30 14:30:34,0.0,Bristol-Myers Squibb’s Developments in March 2018,0.0,1.0,0.0,0
2018-03-30 14:40:57,0.4939,Walmart may make a major splash in the health care industry,0.0,0.738,0.262,1
2018-03-31 12:08:49,0.0258,Drug companies want Supreme Court to take eye drop dispute,0.306,0.382,0.312,0
2018-04-01 12:07:04,0.2023,3 Top Dow Dividend Stocks You Can Buy Right Now,0.0,0.816,0.184,1
2018-04-02 11:30:14,0.0,Analysts’ Recommendations for Bristol-Myers Squibb in March 2018,0.0,1.0,0.0,0
2018-04-02 13:09:00,-0.1027,"The 8 'Dogs Of The Dow' Hit Hard In First Quarter, Here's How To Trade Them Now",0.085,0.915,0.0,-1
2018-04-02 13:37:01,0.0,Pfizer&apos;s Rare Disease Candidate Meets Endpoint in Phase III,0.0,1.0,0.0,0
2018-04-02 13:51:54,0.0,5 Juicy Dividend Stocks to Ride Out a Dicey April,0.0,1.0,0.0,0
2018-04-02 14:30:18,0.0,A Look at the 4Q17 Performance of Eli Lilly’s Elanco,0.0,1.0,0.0,0
2018-04-02 14:55:00,0.0772,Why Pfizer&apos;s Big Win Is Bad News for Alnylam and Ionis,0.215,0.552,0.233,0
2018-04-02 15:52:45,0.0,Shire's Stock Continues to Rise as Takeda Sets Eyes On it,0.0,1.0,0.0,0
2018-04-02 15:53:14,0.0,Amgen's Blincyto Gets FDA Nod for Minimum Residual Disease,0.0,1.0,0.0,0
2018-04-02 15:54:27,0.0,Pfizer's Rare Disease Candidate Meets Endpoint in Phase III,0.0,1.0,0.0,0
2018-04-02 16:14:00,0.0,"Why Alnylam Pharmaceuticals, Inc. Is Tanking Today",0.0,1.0,0.0,0
2018-04-02 18:04:05,0.0,"With Alnylam Pharma Down More Than 15%, Analyst Says Buy The Dip",0.0,1.0,0.0,0
2018-04-02 18:41:25,0.0772,Why Pfizer's Big Win Is Bad News for Alnylam and Ionis,0.215,0.552,0.233,0
2018-04-02 20:16:59,0.0,"How Pfizer Sneaked Into Rare-Disease Market And Hit Alnylam, Ionis",0.0,1.0,0.0,0
2018-04-02 21:43:09,0.5719,Alnylam Falls on Pfizer&apos;s Rare Disease Drug Success,0.0,0.654,0.346,1
2018-04-02 23:12:06,0.0,"Groton (Town of) CT -- Moody's Assigns Aa2 to Town of Groton, CT's $6.7M GO Bonds, 2018",0.0,1.0,0.0,0
2018-04-02 23:40:29,0.5719,Alnylam Falls on Pfizer's Rare Disease Drug Success,0.0,0.654,0.346,1
2018-04-03 07:54:00,0.6124,Will These Drugs Reach Blockbuster Status?,0.0,0.444,0.556,1
2018-04-03 08:14:00,0.0,Pfizer To Hold 25% Ownership Stake In Allogene Therapeutics,0.0,1.0,0.0,0
2018-04-03 08:23:00,-0.6597,"Cellectis, Allogene To Continue Strategic Cancer Immunotherapy Collaboration",0.386,0.614,0.0,-1
2018-04-03 11:30:02,0.3612,What Analysts Recommend for Novartis in March 2018,0.0,0.737,0.263,1
2018-04-03 12:00:00,-0.69,"They're Back! After Selling Kite, Belldegrun And Chang Seek To Change Cancer Treatment Again",0.265,0.735,0.0,-1
2018-04-03 12:00:00,0.6908,Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio,0.0,0.695,0.305,1
2018-04-03 12:00:01,-0.6597,Pfizer signs deal with Allogene to develop cancer cell therapy,0.328,0.672,0.0,-1
2018-04-03 12:13:49,-0.5106,How a failed Pfizer rare-disease drug came back to flatten its rivals,0.248,0.752,0.0,-1
2018-04-03 12:17:12,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Unique Fabricating, Guess&apos;, Nordstrom and Ciner Resources",0.0,1.0,0.0,0
2018-04-03 13:55:39,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Unique Fabricating, Guess', Nordstrom and Ciner Resources",0.0,1.0,0.0,0
2018-04-03 14:32:17,0.4215,"An Update on United Therapeutics’ Remodulin, Tyvaso, and Unituxin",0.0,0.741,0.259,1
2018-04-03 15:09:00,0.0,"Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price: Sources",0.0,1.0,0.0,0
2018-04-03 15:30:00,0.0,Pfizer in talks with P&G on consumer business sale,0.0,1.0,0.0,0
2018-04-03 15:44:54,0.0,Pfizer in talks with P&G for consumer health unit sale: CNBC,0.0,1.0,0.0,0
2018-04-03 15:53:57,0.0,Pfizer in talks with P&G for consumer health unit sale - CNBC,0.0,1.0,0.0,0
2018-04-03 16:12:52,-0.6597,"Pfizer Takes On Gilead, Novartis With New Deal In Cancer Drugs",0.306,0.694,0.0,-1
2018-04-03 16:55:31,0.0,P&G reportedly talking $15B deal with Pfizer,0.0,1.0,0.0,0
2018-04-03 17:14:41,-0.6597,Pfizer in deal with Allogene to develop cancer cell therapies,0.328,0.672,0.0,-1
2018-04-03 19:27:07,0.2023,"Top Research Reports for Facebook, UnitedHealth & Pfizer",0.0,0.769,0.231,1
2018-04-03 19:30:00,-0.296,How Worried Should Alnylam and Ionis Really Be About Pfizer&apos;s New Data?,0.167,0.833,0.0,-1
2018-04-03 20:38:18,0.0,"Johnson & Johnson Stock on March 29, 2018",0.0,1.0,0.0,0
2018-04-03 23:41:00,0.0,Pfizer Reportedly In Talks With P&G On Consumer Business Sale,0.0,1.0,0.0,0
2018-04-04 00:03:00,0.4404,Better Dividend Stock to Buy: AbbVie Inc. vs. Pfizer Inc.,0.0,0.756,0.244,1
2018-04-04 03:49:42,0.4019,[$$] Investors smart at ailing pharma deals,0.0,0.69,0.31,1
2018-04-04 08:07:00,0.2263,Pfizer: FDA Grants Priority Review For Dacomitinib - Quick Facts,0.0,0.808,0.192,1
2018-04-04 10:02:00,-0.1027,Which Big Pharma CEOs Least Deserved Their Big Pay Increases?,0.135,0.865,0.0,-1
2018-04-04 11:34:30,0.0,Analysts’ Recommendations for Johnson & Johnson in March 2018,0.0,1.0,0.0,0
2018-04-04 12:00:00,-0.0258,U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Dacomitinib to Treat Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations,0.148,0.673,0.178,0
2018-04-04 12:10:00,0.0,Today’s Research Reports on Stocks to Watch: Celgene and Pfizer,0.0,1.0,0.0,0
2018-04-04 12:50:55,-0.296,How Worried Should Alnylam and Ionis Really Be About Pfizer's New Data?,0.167,0.833,0.0,-1
2018-04-04 12:55:12,0.0,"The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, Pfizer, McDonald&apos;s and MetLife",0.0,1.0,0.0,0
2018-04-04 13:03:38,0.0,Johnson & Johnson’s Valuation in March 2018,0.0,1.0,0.0,0
2018-04-04 14:01:02,0.0,"Pfizer Inks New CAR-T Deal, In Talks With P&G for Unit Sale",0.0,1.0,0.0,0
2018-04-04 14:33:33,0.0,Johnson & Johnson’s Quarterly Revenue Trend in 2017,0.0,1.0,0.0,0
2018-04-04 14:53:06,0.0,"The Zacks Analyst Blog Highlights: Facebook, UnitedHealth, Pfizer, McDonald's and MetLife",0.0,1.0,0.0,0
2018-04-04 16:50:19,0.0,"VTI, BAC, WFC, PFE: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2018-04-04 20:56:32,0.4576,"After Hours Most Active for Apr 4, 2018 :  CZR, COMT, VCIT, CMCSA, VCSH, ESRX, GE, BAC, LEN, ADM, CHK, PFE",0.0,0.864,0.136,1
2018-04-05 00:00:00,-0.6597,Pfizer Has Big Plans in Treating Lung Cancer,0.386,0.614,0.0,-1
2018-04-05 12:05:00,0.0,Could Orgenesis (ORGS) be the Next Acquisition Target in Cell Therapy Space?,0.0,1.0,0.0,0
2018-04-05 12:47:00,0.0,"Barclays upgrades Merck, downgrades competitor Pfizer",0.0,1.0,0.0,0
2018-04-05 12:47:00,0.5267,"Merck shares rise after Barclays upgrades shares, downgrades competitor Pfizer",0.0,0.645,0.355,1
2018-04-05 13:08:01,0.0,3 Emerging Technologies Set to Transform the Pharma World,0.0,1.0,0.0,0
2018-04-05 15:34:03,-0.6597,Pfizer&apos;s Lung Cancer Candidate Gets FDA&apos;s Priority Review,0.386,0.614,0.0,-1
2018-04-05 18:05:08,-0.6597,Pfizer's Lung Cancer Candidate Gets FDA's Priority Review,0.386,0.614,0.0,-1
2018-04-05 20:49:19,0.0,"Market Close Report: NASDAQ Composite index closes at 7,076.55 up 34.44 points",0.0,1.0,0.0,0
2018-04-05 21:03:23,0.4576,"After Hours Most Active for Apr 5, 2018 :  CZR, MSFT, KEY, JPM, CSCO, CMCSA, MU, MXIM, GE, NUE, ABBV, PFE",0.0,0.864,0.136,1
2018-04-06 10:14:00,0.0,A Glance At Potential Therapies For Sickle Cell Disease,0.0,1.0,0.0,0
2018-04-06 12:45:00,0.0,Can Been-There Biotech Entrepreneur Arie Belldegrun Do It Yet Again?,0.0,1.0,0.0,0
2018-04-06 14:03:00,-0.4767,How To Help Colleagues Suffering From Mental Illness,0.43,0.37,0.2,-1
2018-04-06 14:11:02,-0.6597,"Pharma Stock Roundup: LLY&apos;s Cyramza Shines in Cancer Study, PFE & AZN in Focus",0.268,0.732,0.0,-1
2018-04-06 15:57:15,0.0,"Dow Movers: CAT, PG",0.0,1.0,0.0,0
2018-04-06 16:00:29,-0.6597,"Pharma Stock Roundup: LLY's Cyramza Shines in Cancer Study, PFE & AZN in Focus",0.268,0.732,0.0,-1
2018-04-06 16:56:30,0.0,Biogen Cracks the Case With AbbVie for Humira Biosimilar,0.0,1.0,0.0,0
2018-04-06 23:55:55,0.0,5 Healthcare Stocks To Buy Today,0.0,1.0,0.0,0
2018-04-06 23:56:02,0.4404,10 Safe Dividend Stocks for the Second Quarter,0.0,0.707,0.293,1
2018-04-07 12:34:00,0.0,Is Cellectis SA Stock a Buy Now?,0.0,1.0,0.0,0
2018-04-07 16:08:22,0.0,Venture Capital Deals Of The Week: Alibaba And Instacart Lead The Way,0.0,1.0,0.0,0
2018-04-07 22:07:24,0.0,Will Shire Be Bought Out?,0.0,1.0,0.0,0
2018-04-08 10:31:00,0.8402,1 Chart That Helps Explain Why Pfizer&apos;s Prospects Are the Best They&apos;ve Been in Years,0.0,0.55,0.45,1
2018-04-08 12:35:56,0.8402,1 Chart That Helps Explain Why Pfizer's Prospects Are the Best They've Been in Years,0.0,0.55,0.45,1
2018-04-08 14:35:59,-0.1531,Biotech Fire Sale: 2 Top Stocks to Buy Next Week,0.214,0.625,0.161,-1
2018-04-09 12:08:00,0.7717,Like Dividends? I Bet You&apos;ll Love These 3 Stocks,0.0,0.427,0.573,1
2018-04-09 12:35:08,0.2023,PFE Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.9% Yield,0.0,0.878,0.122,1
2018-04-09 13:24:46,0.7717,Like Dividends? I Bet You'll Love These 3 Stocks,0.0,0.427,0.573,1
2018-04-09 14:21:49,0.2732,Surprising Analyst 12-Month Target For LGLV,0.0,0.704,0.296,1
2018-04-09 16:27:15,0.0,Clovis' (CLVS) Rubraca Gets FDA Nod as Maintainence Therapy,0.0,1.0,0.0,0
2018-04-09 16:37:47,0.0,Exploring Collaboration between Pfizer and Sangamo Therapeutics,0.0,1.0,0.0,0
2018-04-09 16:37:47,0.0,Pfizer and Sangamo Therapeutics: Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2018-04-09 16:37:48,0.4939,Pfizer and Basilea Pharmaceutica: Cresemba Licensing Agreement,0.0,0.652,0.348,1
2018-04-09 18:55:50,0.0,Pharma’s Latest: Mergers and Acquisitions in 1Q18,0.0,1.0,0.0,0
2018-04-09 20:30:02,0.0,How 1Q18 Treated Pharmaceutical ETFs,0.0,1.0,0.0,0
2018-04-09 22:00:02,0.0,How Johnson & Johnson Stock Performed in 1Q18,0.0,1.0,0.0,0
2018-04-09 23:09:27,0.4588,Billionaire Ken Fisher’s Favorite Dividend Stocks,0.0,0.625,0.375,1
2018-04-10 11:33:00,0.0,How Bristol-Myers Squibb Stock Performed in 1Q18,0.0,1.0,0.0,0
2018-04-10 12:30:00,0.0,Pfizer Signs Lease for the Spiral at Hudson Yards in Manhattan,0.0,1.0,0.0,0
2018-04-10 13:02:43,0.0,A Closer Look at Pfizer Stock in 1Q18,0.0,1.0,0.0,0
2018-04-10 13:08:37,0.0,3 Industries to Consider Buying During a Stock Market Correction,0.0,1.0,0.0,0
2018-04-10 14:15:02,-0.5106,vTv Therapeutics Crashes on Alzheimer&apos;s Drug Study Failure,0.32,0.68,0.0,-1
2018-04-10 15:55:15,0.3182,Developer Tishman Speyer secures funds for $3.7 bln New York office tower,0.0,0.827,0.173,1
2018-04-10 16:11:09,-0.5106,vTv Therapeutics Crashes on Alzheimer's Drug Study Failure,0.32,0.68,0.0,-1
2018-04-10 17:07:15,0.296,Agios Pharmaceuticals Shares Rise on Buyout Speculation,0.0,0.732,0.268,1
2018-04-10 18:00:00,-0.2732,Pfizer Provides Update on Phase 3 Trial of Axitinib as Adjuvant Treatment for Patients at High Risk of Renal Cell Carcinoma Recurrence After Surgery,0.087,0.913,0.0,-1
2018-04-10 20:40:08,0.0,AbbVie&apos;s RA Candidate Meets Primary Endpoints in Phase III,0.0,1.0,0.0,0
2018-04-10 22:07:35,0.0,AbbVie's RA Candidate Meets Primary Endpoints in Phase III,0.0,1.0,0.0,0
2018-04-11 00:55:00,0.0772,"AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch",0.0,0.902,0.098,0
2018-04-11 04:04:45,0.5719,[$$] Tishman Speyer Inks Deal With Pfizer and Wins $1.8 Billion Construction Loan,0.0,0.764,0.236,1
2018-04-11 11:31:52,0.0,A Look at Eli Lilly’s 1Q18 Stock Performance,0.0,1.0,0.0,0
2018-04-11 13:55:21,0.0,Why Barclays Upgraded Merck to ‘Overweight’ on April 5,0.0,1.0,0.0,0
2018-04-11 14:37:02,-0.743,Pfizer&apos;s Kidney Cancer Drug Misses Endpoint in Phase III,0.474,0.526,0.0,-1
2018-04-11 15:25:12,-0.296,Barclays Downgrades Pfizer Stock and Cuts Price Target,0.239,0.761,0.0,-1
2018-04-11 15:40:00,-0.2732,This Little-Known Company Should Have Gilead&apos;s and Celgene&apos;s Investors Nervous,0.189,0.811,0.0,-1
2018-04-11 16:21:21,-0.743,Pfizer's Kidney Cancer Drug Misses Endpoint in Phase III,0.474,0.526,0.0,-1
2018-04-11 17:18:29,-0.2732,This Little-Known Company Should Have Gilead's and Celgene's Investors Nervous,0.189,0.811,0.0,-1
2018-04-11 19:11:33,0.0,UAB to receive funding from Pfizer for rheumatoid arthritis study,0.0,1.0,0.0,0
2018-04-12 08:12:00,0.0,Pfizer Begins Clinical Trial With Mini-dystrophin Gene Therapy Candidate,0.0,1.0,0.0,0
2018-04-12 12:00:00,0.0,Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy,0.0,1.0,0.0,0
2018-04-12 13:02:16,0.4019,Olumiant Could Boost Incyte’s Revenues,0.0,0.597,0.403,1
2018-04-12 13:37:44,-0.5267,Pfizer’s Inlyta Expansion Thwarted by Failed Phase III Study,0.386,0.614,0.0,-1
2018-04-12 15:10:02,-0.296,Pfizer Advances in Cancer Cell Therapy with Allogene Agreement,0.301,0.479,0.219,-1
2018-04-12 16:11:21,0.296,"XLV, PFE, MRK, AMGN: ETF Inflow Alert",0.0,0.732,0.268,1
2018-04-12 19:30:55,0.2235,Pfizer's Deal Potential Doesn't Stop at Bristol-Myers,0.0,0.761,0.239,1
2018-04-12 20:11:30,0.2023,Top ETF Picks for Your IRA,0.0,0.735,0.265,1
2018-04-12 20:32:54,0.4019,Dow Jones Component Pfizer Isn&apos;t Interested In Bristol — Yet,0.0,0.748,0.252,1
2018-04-12 20:53:21,0.0,"Technology, industrials and banks lead rally as stocks rise",0.0,1.0,0.0,0
2018-04-12 21:01:10,0.4576,"After Hours Most Active for Apr 12, 2018 :  MU, F, INTC, ORCL, PFE, KMI, ESV, CY, GE, EBAY, FAST, QRTEA",0.0,0.864,0.136,1
2018-04-13 01:20:00,0.0,"FDA Nod For Innovus' Kit, PLSE Soars On SK Data, Keep An Eye On ARNA",0.0,1.0,0.0,0
2018-04-13 03:45:25,0.0,Asian stocks mostly up after Wall Street finishes higher,0.0,1.0,0.0,0
2018-04-13 10:41:10,0.0,Glaxo to Sell Rare Disease Gene Therapies to Private Biotech,0.0,1.0,0.0,0
2018-04-13 12:20:00,0.0,Today’s Research Reports on Stocks to Watch: Novavax and Pfizer,0.0,1.0,0.0,0
2018-04-13 14:36:18,0.4019,Mylan Reportedly Interested Merck KGaA&apos;s Consumer Health Unit,0.0,0.722,0.278,1
2018-04-13 15:37:03,0.0,Pfizer Starts Phase Ib for Duchenne Muscular Dystrophy Drug,0.0,1.0,0.0,0
2018-04-13 16:16:49,0.0,Gene Therapy in Limelight on Novartis Deal: 3 Stocks in Focus,0.0,1.0,0.0,0
2018-04-13 18:02:55,0.0,Pfizer takes big gene therapy step after acquisition in Chapel Hill,0.0,1.0,0.0,0
2018-04-13 19:20:07,0.4939,"Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV&apos;s Drugs Succeed in Phase III",0.0,0.802,0.198,1
2018-04-13 20:52:18,-0.0258,Mylan Denies Report It&apos;s Interested In Buying Merck KGaA&apos;s Consumer Biz,0.193,0.621,0.186,0
2018-04-13 21:12:09,0.4939,"Pharma Stock Roundup: NVS to Buy AveXis, PFE & ABBV's Drugs Succeed in Phase III",0.0,0.802,0.198,1
2018-04-13 22:41:21,0.2263,"EpiPen shortages seen in Canada, UK but U.S. supply intact",0.113,0.696,0.191,1
2018-04-16 11:55:00,0.3818,"Report: Developing Opportunities within Amicus Therapeutics, Rite Aid, Navient, ProPetro Holding, Pfizer, and Sysco — Future Expectations, Projections Moving into 2018",0.0,0.88,0.12,1
2018-04-16 12:06:29,0.0,What to Expect from Johnson & Johnson’s 1Q18 Earnings,0.0,1.0,0.0,0
2018-04-16 12:06:31,0.0,Johnson & Johnson’s Revenue Estimates for 1Q18,0.0,1.0,0.0,0
2018-04-16 12:06:32,0.0,Analysts’ Recommendations for Johnson & Johnson on April 16,0.0,1.0,0.0,0
2018-04-16 17:18:09,-0.4019,Merck to move scientists and money toward promising cancer drug,0.291,0.53,0.179,-1
2018-04-17 10:32:00,0.4404,Pfizer Reportedly Rules Out Bristol-Myers Squibb Deal -- Here Are 3 Better Acquisition Targets,0.0,0.805,0.195,1
2018-04-17 12:02:25,0.3612,What Analysts Recommend for CymaBay Therapeutics,0.0,0.667,0.333,1
2018-04-17 13:40:01,0.5106,"J&J (JNJ) Tops Q1 Earnings Estimates, Raises Sales Guidance",0.0,0.708,0.292,1
2018-04-17 14:32:18,0.0,"Updates on AbbVie’s AndroGel, Lupron, and Kaletra",0.0,1.0,0.0,0
2018-04-17 15:10:02,0.3818,Novartis’s 1Q18: Analysts Expect Revenue Growth,0.0,0.658,0.342,1
2018-04-17 15:16:33,0.0,Shire Sells Oncology Unit Ahead of Takeda's Potential Offer,0.0,1.0,0.0,0
2018-04-17 16:15:57,0.0,What's in Store for Novartis (NVS) This Earnings Season?,0.0,1.0,0.0,0
2018-04-17 17:14:23,0.4404,Bristol-Myers (BMY) Down as Merck NSCLC Study Fares Better,0.0,0.734,0.266,1
2018-04-17 18:29:41,0.0,Coke Versus Pepsi of Drugmakers? Wall Street Doesn't Buy It,0.0,1.0,0.0,0
2018-04-17 19:01:49,0.0,5 Biotech IPOs to Watch in April,0.0,1.0,0.0,0
2018-04-17 20:10:27,0.7506,AbbVie Inc. Is a Clear Value Play in Biotech Stocks,0.0,0.448,0.552,1
2018-04-17 23:10:02,0.3612,Canada seeks U.S. help to solve EpiPen shortage,0.174,0.435,0.391,1
2018-04-17 23:10:38,0.0,7 Stocks on a Long-Term Uptrend,0.0,1.0,0.0,0
2018-04-18 00:10:29,0.25,5 Drug Stocks Poised to Surpass on Earnings This Quarter,0.0,0.8,0.2,1
2018-04-18 12:26:40,0.0,Analysts’ Ratings for Achaogen and Peers in April 2018,0.0,1.0,0.0,0
2018-04-18 12:29:28,0.2263,Analysts’ Ratings for Spark Therapeutics and Its Peers in April 2018,0.0,0.84,0.16,1
2018-04-18 12:29:29,0.2263,A Look at the Financial Performance of Spark Therapeutics,0.0,0.787,0.213,1
2018-04-18 19:32:35,0.0,How Analysts View Tetraphase Pharmaceuticals in April 2018,0.0,1.0,0.0,0
2018-04-18 23:11:42,0.0,3 Dividend ETFs With High Inflows in April,0.0,1.0,0.0,0
2018-04-19 02:10:44,0.0,3 Drugs That Are Moving the Needle at Johnson & Johnson,0.0,1.0,0.0,0
2018-04-19 03:24:00,0.0,P&G To Buy Merck KgaA's Consumer Health Business For EUR 3.4 Bln,0.0,1.0,0.0,0
2018-04-19 11:33:43,0.3818,Vyxeos Could Be Jazz Pharmaceuticals’ Long-Term Growth Driver,0.0,0.729,0.271,1
2018-04-19 15:49:03,0.0,FDA Nods to AstraZeneca&apos;s Tagrisso for First-Line NSCLC,0.0,1.0,0.0,0
2018-04-19 16:38:00,0.0,Pfizer Invites Public to Listen to Webcast of April 26 Annual Meeting of Shareholders,0.0,1.0,0.0,0
2018-04-19 18:12:58,0.0,FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC,0.0,1.0,0.0,0
2018-04-19 21:11:12,0.0,Healthcare ETFs in Focus After Johnson & Johnson Q1 Earnings,0.0,1.0,0.0,0
2018-04-20 11:00:00,0.0,Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business,0.0,1.0,0.0,0
2018-04-20 14:11:02,0.4404,"J&J, Novartis&apos; Q1 Earnings Impress: Will Others Follow Suit?",0.0,0.734,0.266,1
2018-04-20 14:23:54,0.5994,P&G's vitamin boost could signal more to come,0.0,0.55,0.45,1
2018-04-20 16:12:17,0.0,"ITOT, PFE, VZ, KO: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2018-04-20 16:14:39,0.0,Lilly (LLY) to Report Q1 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2018-04-20 18:13:09,0.0,What's in the Cards for Glaxo (GSK) This Earnings Season?,0.0,1.0,0.0,0
2018-04-20 21:00:40,0.4576,"After Hours Most Active for Apr 20, 2018 :  ERIC, ECA, NXPI, PFE, QQQ, MSFT, KMI, BAC, CMCSA, CSCO, WFC, AFL",0.0,0.864,0.136,1
2018-04-20 21:59:34,0.0,Analysts’ Ratings for Sarepta Therapeutics and Peers in April,0.0,1.0,0.0,0
2018-04-22 13:07:34,0.4404,"Better Buy: Gilead Sciences, Inc. (GILD) vs. Pfizer (PFE)",0.0,0.734,0.266,1
2018-04-22 20:08:06,0.296,NMC Health plc -- Moody's assigns first-time Ba1 ratings to NMC Health; outlook stable,0.0,0.855,0.145,1
2018-04-23 07:54:00,0.0,Pfizer Receives CRL On Trastuzumab Biosimilar,0.0,1.0,0.0,0
2018-04-23 07:56:00,0.8893,Pfizer: EU Approves Mylotarg In Combination With Chemotherapy To Treat AML,0.0,0.432,0.568,1
2018-04-23 08:17:00,0.2263,Pfizer: FDA Grants Trumenba Breakthrough Therapy Designation,0.0,0.759,0.241,1
2018-04-23 11:30:00,0.4215,"MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy",0.0,0.877,0.123,1
2018-04-23 11:45:00,0.0,Pfizer Provides Update on Proposed Trastuzumab Biosimilar,0.0,1.0,0.0,0
2018-04-23 11:57:01,-0.6597,FDA declines to approve Pfizer's biosimilar to Roche's cancer drug,0.328,0.672,0.0,-1
2018-04-23 11:58:02,-0.5106,Pfizer says FDA failed to approve Herceptin biosimilar,0.32,0.68,0.0,-1
2018-04-23 12:00:00,0.25,Pfizer Granted FDA Breakthrough Therapy Designation for TRUMENBA® (Meningococcal Group B Vaccine) for the Prevention of Invasive Meningococcal B Disease in Children Ages 1 to 9 Years,0.0,0.917,0.083,1
2018-04-23 12:02:04,0.0,What Analysts Predict for GlaxoSmithKline’s 1Q18 Earnings,0.0,1.0,0.0,0
2018-04-23 12:16:43,0.0,Merck’s Relebactam Met Primary Endpoints in Phase 3 Study,0.0,1.0,0.0,0
2018-04-23 12:25:54,-0.6597,FDA declines to approve Pfizer biosimilar of Roche's cancer drug,0.328,0.672,0.0,-1
2018-04-23 12:47:08,0.4939,"Health Care Sector Update for 04/23/2018: AKRX, PFE, FMS, HUM, BHVN",0.0,0.758,0.242,1
2018-04-23 13:35:02,0.0,Why GlaxoSmithKline’s 1Q18 Revenues Are Expected to Fall,0.0,1.0,0.0,0
2018-04-23 14:00:02,0.0,Is a Beat in Store for Bristol-Myers (BMY) in Q1 Earnings?,0.0,1.0,0.0,0
2018-04-23 15:12:42,0.6369,NYSE to Soon Greet The Fearless Girl Statue,0.0,0.536,0.464,1
2018-04-23 15:39:09,0.0,Analysts’ Estimates for Eli Lilly & Co.’s 1Q18 Earnings,0.0,1.0,0.0,0
2018-04-23 16:13:30,0.2023,Will Midterms Throw Markets Helter-Skelter? 5 Top Picks,0.0,0.769,0.231,1
2018-04-23 17:10:02,0.3818,Eli Lilly’s 1Q18 Estimates: Revenue Growth Expected,0.0,0.698,0.302,1
2018-04-23 17:11:35,0.4939,Q1 Earnings Surprise Well in Cards: Healthcare ETFs to Buy,0.0,0.656,0.344,1
2018-04-23 17:11:51,0.0,FDA Nods to AstraZeneca's Tagrisso for First-Line NSCLC (revised),0.0,1.0,0.0,0
2018-04-23 18:00:00,-0.3182,"Don&apos;t Get Greedy With Novavax, Inc. Stock",0.277,0.723,0.0,-1
2018-04-23 20:56:28,0.4576,"After Hours Most Active for Apr 23, 2018 :  PFE, MRK, APC, BABA, CVS, WFC",0.0,0.813,0.187,1
2018-04-23 23:07:19,0.0,Mylan NV Still Undervalued Despite Unveiling of New Products,0.0,1.0,0.0,0
2018-04-23 23:08:11,0.0,Is a Beat in Store for Alexion (ALXN) This Earnings Season?,0.0,1.0,0.0,0
2018-04-24 02:46:00,-0.1531,"PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA",0.264,0.562,0.174,-1
2018-04-24 09:10:00,0.0,Modern Miracles: America's 10 Best-Selling Drugs,0.0,1.0,0.0,0
2018-04-24 12:51:33,0.5106,"Eli Lilly and Co.’s Strong Q1 Results, Updated 2018 Guidance",0.0,0.732,0.268,1
2018-04-24 13:01:48,0.0,Analyzing Johnson & Johnson’s Segment-Wise Performance in 1Q18,0.0,1.0,0.0,0
2018-04-24 13:28:01,0.0,"The Zacks Analyst Blog Highlights: Aflac, CenterPoint, Guess&apos;, Nordstrom and Pfizer",0.0,1.0,0.0,0
2018-04-24 14:09:50,0.2023,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma,0.0,0.847,0.153,1
2018-04-24 14:11:21,0.5106,"Lilly (LLY) Tops on Q1 Earnings, Raises '18 View, Stock Up",0.0,0.752,0.248,1
2018-04-24 14:31:31,0.0,How Johnson & Johnson’s Pharmaceutical Segment Performed in 1Q18,0.0,1.0,0.0,0
2018-04-24 14:44:09,0.1779,Here’s why Amazon won’t go into pharma: hedge fund billionaire,0.0,0.841,0.159,1
2018-04-24 14:44:10,-0.6369,"NEWS BITES: Police look for motive in deadly Toronto van attack, President George H.W. Bush hospitalized, Prince's family suing hospital that treated him",0.198,0.802,0.0,-1
2018-04-24 15:07:30,-0.6486,"Wegmans EpiPens out of stock, but no U.S. shortage currently seen, FDA says",0.325,0.675,0.0,-1
2018-04-24 15:13:09,0.7003,This Small Biotech Is Building on a Surprising Success,0.0,0.508,0.492,1
2018-04-24 15:17:38,0.0,"The Zacks Analyst Blog Highlights: Aflac, CenterPoint, Guess', Nordstrom and Pfizer",0.0,1.0,0.0,0
2018-04-24 16:13:33,0.3818,Can Allergan (AGN) Keep the Earnings Streak Alive in Q1?,0.0,0.776,0.224,1
2018-04-24 18:10:06,0.0,Is a Beat in the Cards for AbbVie (ABBV) in Q1 Earnings?,0.0,1.0,0.0,0
2018-04-24 19:04:27,0.0,Biktarvy Could Be a Major Driver for Gilead Sciences in 2018,0.0,1.0,0.0,0
2018-04-24 20:56:44,0.4576,"After Hours Most Active for Apr 24, 2018 :  QEP, NWL, CMCSA, BAC, MSFT, QQQ, PFE, SRE, FE, MCHI, FEYE, MU",0.0,0.864,0.136,1
2018-04-24 22:09:33,0.0,Your Guide to Investing in Zinc-Finger (ZFN) Gene Editing,0.0,1.0,0.0,0
2018-04-25 01:41:56,0.5267,[$$] Takeda reaches preliminary agreement to buy Shire for $65bn,0.0,0.645,0.355,1
2018-04-25 09:27:15,-0.3612,[$$] Takeda strikes deal to buy Shire for £46bn,0.238,0.762,0.0,-1
2018-04-25 11:32:56,0.4215,Gilead Sciences’ Inflammation Research Is Seeing Rapid Progress,0.0,0.714,0.286,1
2018-04-25 12:05:41,0.0,Why Incyte Stock Fell ~9% on April 24,0.0,1.0,0.0,0
2018-04-25 12:07:12,0.0,Will Pfizer&apos;s (PFE) Earnings Beat Estimates Again in Q1?,0.0,1.0,0.0,0
2018-04-25 12:14:41,0.0,What Do Analysts Predict for Bristol-Myers Squibb in 1Q18?,0.0,1.0,0.0,0
2018-04-25 13:00:35,0.0,How Did Johnson & Johnson’s Consumer Segment Perform in 1Q18?,0.0,1.0,0.0,0
2018-04-25 13:45:08,0.3818,Analysts Expect Bristol-Myers Squibb to Post Revenue Growth in 1Q18,0.0,0.776,0.224,1
2018-04-25 14:12:05,0.0,Will Pfizer's (PFE) Earnings Beat Estimates Again in Q1?,0.0,1.0,0.0,0
2018-04-25 14:12:19,0.0,What's in the Cards for Merck (MRK) This Earnings Season?,0.0,1.0,0.0,0
2018-04-25 15:26:29,0.0,Analysts’ Estimates for Sanofi’s 1Q18 Earnings,0.0,1.0,0.0,0
2018-04-25 15:35:19,0.0,GlaxoSmithKline: Operating Revenues Up in 1Q18 Earnings,0.0,1.0,0.0,0
2018-04-25 17:00:02,0.0,Sanofi’s 1Q18: Revenue Expected to Fall,0.0,1.0,0.0,0
2018-04-25 20:56:49,0.4576,"After Hours Most Active for Apr 25, 2018 :  FB, GE, PFE, QQQ, ERIC, F, IBM, BAC, T, AAPL, CZR, SBUX",0.0,0.864,0.136,1
2018-04-26 08:00:00,0.0,Pfizer Annual Meeting Of Shareholders At 9:00 AM ET,0.0,1.0,0.0,0
2018-04-26 10:34:00,0.2023,3 Top Dividend Stocks With Yields Over 3%,0.0,0.769,0.231,1
2018-04-26 13:00:52,0.3818,Novo Nordisk’s Hemophilia Segment Could See Steady 2018 Growth,0.0,0.755,0.245,1
2018-04-26 13:01:19,0.0,Analyst Recommendations for Biogen in April,0.0,1.0,0.0,0
2018-04-26 14:12:35,0.0258,Is FlexShares Quality Dividend Defensive Index Fund (QDEF) a Hot ETF Right Now?,0.0,0.909,0.091,0
2018-04-26 15:11:23,0.296,What's in the Cards for Immune Design (IMDZ) in Q1 Earnings?,0.0,0.82,0.18,1
2018-04-26 15:11:38,0.0,What's in the Offing for Keryx (KERX) This Earnings Season?,0.0,1.0,0.0,0
2018-04-26 15:13:20,0.4404,Merck vs. Pfizer: Which Stock is Better Before Q1 Earnings?,0.0,0.756,0.244,1
2018-04-26 16:03:47,-0.4019,"Bristol-Myers raises 2018 forecast, some sales disappoint",0.31,0.69,0.0,-1
2018-04-26 16:14:26,0.4767,"Bristol-Myers (BMY) Beats on Q1 Earnings, Opdivo Impresses",0.0,0.693,0.307,1
2018-04-26 20:57:09,0.4576,"After Hours Most Active for Apr 26, 2018 :  MSFT, INTC, QQQ, PFE, PE, DWDP, CVS, F, T, EBAY, AMZN, SBUX",0.0,0.864,0.136,1
2018-04-27 12:17:00,0.0,Is Bristol-Myers Squibb Stock a Buy After Its Mixed Q1 Results?,0.0,1.0,0.0,0
2018-04-27 14:12:19,0.2732,Why Pfizer (PFE) Might Surprise This Earnings Season,0.0,0.769,0.231,1
2018-04-27 15:28:18,-0.2263,Sanofi Misses Wall Street Estimates for 1Q18 Revenues,0.213,0.787,0.0,-1
2018-04-27 18:10:02,0.0,Analysts’ Recommendations for Allergan on April 27,0.0,1.0,0.0,0
2018-04-27 18:11:12,0.0258,"Amazon (AMZN) Q1 Earnings Crush Estimates, Sales Surge Y/Y",0.155,0.68,0.165,0
2018-04-27 19:30:07,0.5267,"Top Dividend Stock Pfizer Looks Past Lipitor, Xanax, Viagra For Growth",0.0,0.672,0.328,1
2018-04-27 20:04:56,0.0,GlaxoSmithKline’s 1Q18 Earnings: Revenue Trend,0.0,1.0,0.0,0
2018-04-27 20:20:37,0.0,Analyst Recommendations for Pfizer and Peers in April,0.0,1.0,0.0,0
2018-04-27 20:20:45,0.4019,Label Expansion May Boost Pfizer’s Ibrance and Xtandi,0.0,0.722,0.278,1
2018-04-27 20:52:00,0.0,"What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week",0.0,1.0,0.0,0
2018-04-27 20:57:15,0.4576,"After Hours Most Active for Apr 27, 2018 :  BAC, BSX, S, QQQ, AROC, TWTR, INTC, AABA, MSFT, PFE, CZR, DISCK",0.0,0.864,0.136,1
2018-04-27 21:55:07,0.0,Pfizer Expected to Report a Slight Rise in Revenues in 2018,0.0,1.0,0.0,0
2018-04-28 05:07:58,-0.1012,"Q1 Earnings Season Good, But Not Great",0.294,0.447,0.259,-1
2018-04-28 12:59:23,0.0,"As states consider taxing opioids, drugmakers push back",0.0,1.0,0.0,0
2018-04-28 19:41:10,0.0,Drugmakers push back against lawmakers' calls to tax opioids,0.0,1.0,0.0,0
2018-04-28 22:27:00,0.0,Is Biogen Inc. a Buy?,0.0,1.0,0.0,0
2018-04-29 11:17:00,0.0,What to Expect with Pfizer&apos;s Q1 Results,0.0,1.0,0.0,0
2018-04-29 13:07:41,0.0,What to Expect with Pfizer's Q1 Results,0.0,1.0,0.0,0
2018-04-30 11:32:43,0.3818,Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018,0.0,0.776,0.224,1
2018-04-30 11:33:10,0.4404,Pfizer May Witness Fall in Net Profit Margins in 2018,0.0,0.756,0.244,1
2018-04-30 12:10:07,0.0,What Analysts Expect for Pfizer in 1Q18,0.0,1.0,0.0,0
2018-04-30 12:50:12,0.0,"McDonald&apos;s, Apple, Pfizer, MasterCard and Activision-Blizzard are part of Zacks Earnings Preview",0.0,1.0,0.0,0
2018-04-30 13:02:27,-0.0772,Ibrance Could Still Be Leading CDK4/6 Inhibitor in 2018,0.14,0.86,0.0,0
2018-04-30 13:45:02,0.3818,Why Analysts Expect Pfizer to See Revenue Growth in 1Q18,0.0,0.776,0.224,1
2018-04-30 14:11:02,0.0,"Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More",0.0,1.0,0.0,0
2018-04-30 14:11:12,0.0,"McDonald's, Apple, Pfizer, MasterCard and Activision-Blizzard are part of Zacks Earnings Preview",0.0,1.0,0.0,0
2018-04-30 15:15:02,0.3612,What Analysts Recommend for Pfizer ahead of 1Q18 Earnings,0.0,0.762,0.238,1
2018-04-30 15:37:03,0.0,Is a Beat in the Cards for Agios (AGIO) in Q1 Earnings?,0.0,1.0,0.0,0
2018-04-30 15:58:33,0.0,Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning,0.0,1.0,0.0,0
2018-04-30 16:07:04,0.0,"VTI, PFE, CSCO, VZ: Large Outflows Detected at ETF",0.0,1.0,0.0,0
2018-04-30 16:22:18,0.0,Could Teva Exceed Analysts’ Sales Estimates for 1Q18?,0.0,1.0,0.0,0
2018-04-30 16:46:00,0.0,These big pharma names report earnings tomorrow,0.0,1.0,0.0,0
2018-04-30 17:12:41,-0.4019,Will Agenus (AGEN) Disappoint Investors This Earnings Season?,0.278,0.722,0.0,-1
2018-04-30 17:37:01,0.3818,Pfizer Earnings Preview: Ibrance To Drive Q1 Growth,0.0,0.729,0.271,1
2018-04-30 17:55:02,0.0,Analysts Raise Teva’s Earnings Estimates before Its 1Q18 Results,0.0,1.0,0.0,0
2018-04-30 18:08:21,0.0,Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings,0.0,1.0,0.0,0
2018-04-30 18:20:15,-0.1531,The Good and the Bad News With Biogen Inc Earnings Results,0.227,0.584,0.188,-1
2018-04-30 19:25:02,0.0,Teva: ‘Hold’ Ratings from 55% of Analysts before 1Q18 Results,0.0,1.0,0.0,0
2018-04-30 20:08:43,0.0,In Your 60s? 3 Stocks You Should Consider Buying,0.0,1.0,0.0,0
2018-04-30 20:08:51,0.0,3 Small-Cap Biotech Stocks With Big Catalysts in May,0.0,1.0,0.0,0
2018-04-30 20:17:17,0.0,"Pre-Market Earnings Report for May 1, 2018 :  PFE, MRK, AMT, AET, EMR, ECL, BP, MPC, HCA, ETN, JCI, FIS",0.0,1.0,0.0,0
2018-04-30 20:56:50,0.4576,"After Hours Most Active for Apr 30, 2018 :  WPG, OAS, MSFT, PFE, BAC, AUY, T, CMCSA, INTC, RUN, AAPL, CSCO",0.0,0.864,0.136,1
2018-05-01 06:52:00,0.0,Pfizer Inc. Q1 adjusted earnings Beat Estimates,0.0,1.0,0.0,0
2018-05-01 08:34:00,0.6808,"Merck And Pfizer Q1 Adj. Profit Tops View, But Sales Miss",0.101,0.506,0.392,1
2018-05-01 09:00:00,0.0,Pfizer Q1 18 Earnings Conference Call At 10:00 AM ET,0.0,1.0,0.0,0
2018-05-01 10:02:03,0.3612,"Wall Street stocks ready to slip further, with Pfizer earnings ahead",0.0,0.8,0.2,1
2018-05-01 10:45:00,0.0,PFIZER REPORTS FIRST-QUARTER 2018 RESULTS,0.0,1.0,0.0,0
2018-05-01 10:51:23,0.4404,Pfizer's quarterly profit rises 14 percent,0.0,0.633,0.367,1
2018-05-01 10:55:00,0.5106,"Pfizer tops earnings estimates, driven by sales of pneumonia vaccine Prevnar",0.0,0.752,0.248,1
2018-05-01 10:59:59,0.1531,Pfizer shares decline after Q1 sales miss,0.182,0.568,0.25,1
2018-05-01 11:11:00,0.4939,Pfizer New Drug Sales Show Strength as Investors Wait for M&A,0.0,0.758,0.242,1
2018-05-01 11:11:00,-0.4019,Pfizer Sales Disappoint as Investors Wait for Strategic M&A,0.252,0.748,0.0,-1
2018-05-01 11:33:48,-0.5106,[$$] Pfizer blames sales miss on ‘customer buying patterns’,0.381,0.619,0.0,-1
2018-05-01 11:49:06,-0.1531,"Pfizer's Q1 net jumps 14 pct., sales just miss expectations",0.151,0.849,0.0,-1
2018-05-01 11:54:00,-0.4215,"US STOCKS-Futures little changed as trade, inflation worries persist",0.259,0.741,0.0,-1
2018-05-01 12:00:00,0.0,"Stocks making the biggest moves premarket: MRK, PFE, AAPL, UAA, FB, BA & more",0.0,1.0,0.0,0
2018-05-01 12:16:05,-0.3612,"Stock market struggles for direction amid earnings barrage, ahead of Fed meeting",0.185,0.815,0.0,-1
2018-05-01 12:24:12,0.0516,"Pfizer (PFE) Q1 Earnings Beat, Sales Miss, 2018 View Intact",0.14,0.702,0.158,0
2018-05-01 12:45:10,-0.8225,Pfizer sales miss as breast cancer drug disappoints,0.632,0.368,0.0,-1
2018-05-01 12:46:22,-0.34,Dow Jones Component Pfizer Reports Mixed Quarter As Sales Lag,0.211,0.789,0.0,-1
2018-05-01 12:57:59,0.296,Pfizer Shares Deflate After Another Quarter Without a Big Transaction,0.0,0.784,0.216,1
2018-05-01 13:08:20,-0.4215,"US STOCKS-Futures down slightly as trade, inflation worries persist",0.259,0.741,0.0,-1
2018-05-01 13:10:12,0.25,"Stock market poised for flat open amid earnings barrage, ahead of Fed meeting",0.0,0.857,0.143,1
2018-05-01 13:26:56,0.0,"Stocks to Watch: Apple, Boeing, Pfizer, Hasbro, Tapestry",0.0,1.0,0.0,0
2018-05-01 13:41:00,-0.34,"Morning Movers: Under Armour Slumps, Tapestry Tumbles, Pfizer Flops",0.231,0.769,0.0,-1
2018-05-01 13:53:00,0.0,"Merck, Pfizer Report Mixed Results; Market Awaiting Apple, Fed, Jobs Report",0.0,1.0,0.0,0
2018-05-01 13:57:00,-0.296,Stocks - U.S. Futures Point to Lower Open on Wall Street,0.196,0.804,0.0,-1
2018-05-01 14:08:01,-0.296,US stocks edge lower as Pfizer and Under Armour sink,0.196,0.804,0.0,-1
2018-05-01 14:13:02,-0.1531,"Pfizer (PFE) Stock Falls on Q1 Sales Miss, Earnings Beat",0.151,0.849,0.0,-1
2018-05-01 14:20:13,-0.4019,"Pfizer's, Merck's revenue disappoint investors",0.403,0.597,0.0,-1
2018-05-01 14:30:31,0.0,Eli Lilly’s Valuation after Its 1Q18 Earnings,0.0,1.0,0.0,0
2018-05-01 14:47:02,0.0,"ADP Job Data, Q1 Earnings In Focus",0.0,1.0,0.0,0
2018-05-01 15:08:54,0.2732,US stocks slide as industrial and energy companies fall,0.0,0.792,0.208,1
2018-05-01 15:09:34,0.0,Dow drops for third session as caution grows ahead of Fed meeting,0.0,1.0,0.0,0
2018-05-01 15:11:00,-0.4019,"Health-Care Earnings: Merck, Pfizer Disappoint With Q1 Revenue",0.278,0.722,0.0,-1
2018-05-01 15:53:00,0.0,The Five Biggest Acquisitions in History,0.0,1.0,0.0,0
2018-05-01 15:57:03,0.0,Pfizer Pitches Pipeline Over Deals; Investors Aren't Buying,0.0,1.0,0.0,0
2018-05-01 15:57:03,-0.3818,Pfizer Says It Doesn't Need a Major Deal; Investors Unconvinced,0.245,0.755,0.0,-1
2018-05-01 16:02:18,-0.3818,Dow on track for lowest close in a month as caution grows ahead of Fed meeting,0.157,0.843,0.0,-1
2018-05-01 16:09:00,-0.2732,Pfizer falls to session low,0.344,0.656,0.0,-1
2018-05-01 16:09:52,-0.296,Mid-Morning Market Update: Markets Open Lower; Pfizer Posts Mixed Q1 Results,0.18,0.82,0.0,-1
2018-05-01 16:10:12,-0.1531,Pfizer first-quarter results miss estimates as key drug sales fall short,0.138,0.862,0.0,-1
2018-05-01 16:11:16,0.0,PFE Crosses Below Key Moving Average Level,0.0,1.0,0.0,0
2018-05-01 16:14:00,0.0,Pfizer: 7 Secrets You Didn't Know (PFE),0.0,1.0,0.0,0
2018-05-01 16:14:28,0.0772,Jobs Week Shows New Wage Growth (and Lack Thereof),0.193,0.588,0.218,0
2018-05-01 17:47:29,0.4939,"Health Care Sector Update for 05/01/2018: AET,MRK,PFE",0.0,0.652,0.348,1
2018-05-01 18:17:35,0.3182,"Pfizer's 1Q profit up 14 pct., sales just miss expectations",0.128,0.64,0.232,1
2018-05-01 18:32:00,0.0,"With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?",0.0,1.0,0.0,0
2018-05-01 18:34:18,0.2732,US stocks slip as industrial and energy companies fall,0.0,0.792,0.208,1
2018-05-01 19:07:53,0.4215,Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health,0.149,0.584,0.266,1
2018-05-01 19:34:36,-0.4019,US STOCKS-Wall St pares losses after Lighthizer comments on China,0.231,0.769,0.0,-1
2018-05-01 19:36:10,-0.0516,"Stocks recover much of early loss; industrials, energy dip",0.202,0.614,0.184,0
2018-05-01 19:40:30,0.34,"GLOBAL MARKETS-Dollar turns positive for 2018, U.S. stocks mostly lower",0.159,0.58,0.261,1
2018-05-01 19:41:35,0.0,Merck & Co.’s 1Q18 Earnings: Revenues up 6%,0.0,1.0,0.0,0
2018-05-01 20:01:17,0.3818,Pfizer Reports 1Q18 Earnings and Revenue Growth,0.0,0.698,0.302,1
2018-05-01 20:02:22,-0.34,"Pfizer&apos;s Quarterly Sales Brake As Ibrance, Xeljanz Lag Expectations",0.231,0.769,0.0,-1
2018-05-01 20:08:09,0.0,"Amid Mixed News on Earnings, Merck & Co., Inc. (MRK) Stock Remains Steady",0.0,1.0,0.0,0
2018-05-01 20:08:40,-0.4019,"Markets Right Now: Stocks claw back losses, end mostly up",0.231,0.769,0.0,-1
2018-05-01 20:09:41,0.0,Pfizer Q1 Earnings: What You Need to Know,0.0,1.0,0.0,0
2018-05-01 20:11:37,0.0,Dow Jones&apos; Merck Slides On Mixed First Quarter As Keytruda Sales Pop,0.0,1.0,0.0,0
2018-05-01 20:27:39,0.4939,"Health Care Sector Update for 05/01/2018: THC,AET,MRK,PFE",0.0,0.652,0.348,1
2018-05-01 20:33:57,0.0,"Seagate, Pfizer and Cummins skid while AbbVie jumps",0.0,1.0,0.0,0
2018-05-01 20:40:12,0.5423,"S&P, Nasdaq advance on trade optimism",0.0,0.588,0.412,1
2018-05-01 20:47:30,-0.4019,"Close Update: Wall Street Mixed as Measures Pare Losses Before Apple, Fed",0.197,0.803,0.0,-1
2018-05-01 20:49:20,0.0,"Market Close Report: NASDAQ Composite index closes at 7,130.70 up 64.43 points",0.0,1.0,0.0,0
2018-05-01 21:03:29,0.5423,US STOCKS-Wall Street rises on optimism on NAFTA deal and China trade,0.0,0.759,0.241,1
2018-05-01 21:07:53,0.7964,"GLOBAL MARKETS-S&P 500 climbs on trade talk optimism, dollar positive for 2018",0.0,0.585,0.415,1
2018-05-01 21:23:08,-0.3182,Apple leads tech higher as stocks recover from an early loss,0.187,0.813,0.0,-1
2018-05-01 21:58:43,0.0,Analysts’ Recommendations for Eli Lilly and Peers in April,0.0,1.0,0.0,0
2018-05-01 22:07:35,0.34,Dow Slides Before Apple Earnings; Dollar Gains Again,0.0,0.745,0.255,1
2018-05-01 22:08:03,-0.1531,Pfizer Inc. Stock Down on Q1 Revenue Miss,0.186,0.814,0.0,-1
2018-05-02 00:50:43,0.7964,"S&P 500 climbs on trade talk optimism, dollar positive for 2018",0.0,0.559,0.441,1
2018-05-02 02:51:25,-0.5499,Dow Industrials Down but Pare Earlier Losses,0.372,0.628,0.0,-1
2018-05-02 03:59:57,0.3818,[$$] Pfizer Revenue Growth Stalls as Company Mulls OTC Unit’s Future,0.0,0.794,0.206,1
2018-05-02 04:55:42,0.0,Asian shares mostly lower after topsy-turvy day on Wall St,0.177,0.645,0.177,0
2018-05-02 06:07:14,0.0,"Pfizer, Inc. (PFE) Q1 2018 Earnings Conference Call Transcript",0.0,1.0,0.0,0
2018-05-02 11:34:08,0.0,Eli Lilly Expected to Report a Modest Rise in Revenues in 2018,0.0,1.0,0.0,0
2018-05-02 12:00:00,0.6124,"Why You Should Ditch Growth Stocks, Buy Value",0.0,0.545,0.455,1
2018-05-02 13:03:27,0.6486,Eli Lilly Could Report Robust Rise in Net Profit Margins in 2018,0.0,0.654,0.346,1
2018-05-02 13:15:00,0.0,Here&apos;s What Pfizer&apos;s Saying About 2018,0.0,1.0,0.0,0
2018-05-02 13:36:31,0.0,"Merck, Pfizer Deliver Checkup on Pharma Sector",0.0,1.0,0.0,0
2018-05-02 14:17:02,0.0,"Company News for May 2, 2018",0.0,1.0,0.0,0
2018-05-02 15:11:33,0.0,Here's What Pfizer's Saying About 2018,0.0,1.0,0.0,0
2018-05-02 15:28:59,0.0,Are Analysts More Bullish on Pfizer or Merck?,0.0,1.0,0.0,0
2018-05-02 16:07:06,0.1027,Markets Await Confirmation of a June Rate Hike,0.0,0.811,0.189,1
2018-05-02 21:07:45,0.3818,Stagnant Revenues Continue to Hamper the Growth of Pfizer Inc.,0.0,0.776,0.224,1
2018-05-02 22:08:08,0.0,What's in the Cards for Aerie (AERI) This Earnings Season?,0.0,1.0,0.0,0
2018-05-02 23:13:35,0.0,Edited Transcript of PFE earnings conference call or presentation 1-May-18 2:00pm GMT,0.0,1.0,0.0,0
2018-05-03 01:07:00,0.0772,"AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines",0.0,0.902,0.098,0
2018-05-03 15:51:06,-0.5423,Health-care transparency measures fail en masse at Colorado Legislature,0.304,0.696,0.0,-1
2018-05-03 17:07:14,0.4215,How United Therapeutics Performed in 1Q18,0.0,0.641,0.359,1
2018-05-03 17:48:27,0.0,How Much Upside Analysts See in Johnson & Johnson Stock,0.0,1.0,0.0,0
2018-05-03 17:48:29,0.0,Johnson & Johnson’s Financial Performance,0.0,1.0,0.0,0
2018-05-03 19:10:54,-0.25,Pfizer Inc. Is Stuck in a Trading Range – for Now,0.2,0.8,0.0,-1
2018-05-04 01:18:00,-0.6124,"FDA Panel Snubs MNK, Decision On AKCA Drug Delayed, PTLA's Antidote Greenlighted",0.333,0.667,0.0,-1
2018-05-04 10:00:00,0.6249,Eli Lilly Shares Seen Rising 18% as Profits Surge,0.0,0.579,0.421,1
2018-05-04 12:12:34,0.0,How Analysts View Amgen,0.0,1.0,0.0,0
2018-05-04 13:11:27,-0.3818,"This Clinical-Stage Biotech's Tackling a Huge Health Issue, but It Has to Overcome Pessimistic Investors First",0.182,0.726,0.092,-1
2018-05-04 14:13:06,0.0,"Dow 30 Stock Roundup: AAPL, DWDP, CVX, MRK, MCD, PFE Beat on Earnings",0.0,1.0,0.0,0
2018-05-04 15:55:03,-0.2263,Q1 Earnings Drag Pharma ETFs Down,0.275,0.725,0.0,-1
2018-05-04 16:13:00,0.0,Is Trump Willing To Do What It Takes To Reduce High Prescription Drug Prices?,0.0,1.0,0.0,0
2018-05-04 17:15:30,0.0,Analyzing the Cash Flows and Valuation Metrics of Akorn,0.0,1.0,0.0,0
2018-05-04 19:30:02,0.0,Allergan’s Business Segments in 1Q18,0.0,1.0,0.0,0
2018-05-04 20:06:08,0.0,"Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah&apos;s 2nd Indication",0.0,1.0,0.0,0
2018-05-04 21:00:02,0.0,Allergan’s US Specialized Therapeutics Segment in 1Q18,0.0,1.0,0.0,0
2018-05-04 21:55:14,0.0,How Much Upside Does Esperion Therapeutics Offer?,0.0,1.0,0.0,0
2018-05-04 22:07:49,0.0,"Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication",0.0,1.0,0.0,0
2018-05-05 01:30:08,-0.5106,Drug epidemic ensnares 25-year-old pill for nerve pain,0.32,0.68,0.0,-1
2018-05-07 11:32:29,0.6486,Xgeva Could Significantly Boost Amgen’s Revenue Growth in 2018,0.0,0.569,0.431,1
2018-05-07 12:00:00,0.4215,Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer,0.0,0.763,0.237,1
2018-05-07 13:45:03,-0.0772,Verzenio: Major CDK4/6 Inhibitor in the Future,0.178,0.822,0.0,0
2018-05-07 14:32:12,0.0,Allergan’s Valuations after Its 1Q18 Earnings,0.0,1.0,0.0,0
2018-05-07 14:37:09,0.0,"Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More",0.0,1.0,0.0,0
2018-05-08 13:00:22,0.0,"How Amgen’s Aranesp, Epogen and Sensipar Did in 1Q18",0.0,1.0,0.0,0
2018-05-08 13:36:28,0.0,How Much Upside Do Anaysts Expect for Biogen Stock?,0.0,1.0,0.0,0
2018-05-08 13:36:30,0.0,"Biogen’s Key Partnerships: Eisai, Pfizer, AbbVie, and Ionis",0.0,1.0,0.0,0
2018-05-08 13:36:31,0.0,A Look at Biogen’s Cash Flows and Price Performance,0.0,1.0,0.0,0
2018-05-08 14:36:02,0.2023,"Top Analyst Reports for Berkshire Hathaway, Pfizer & U.S. Bancorp",0.0,0.816,0.184,1
2018-05-08 15:33:49,0.0,"Ex-Dividend Reminder: Pfizer, Carlyle Group and South State",0.0,1.0,0.0,0
2018-05-08 15:34:16,0.0,Alnylam Looks Forward,0.0,1.0,0.0,0
2018-05-08 15:47:48,0.0,Analyzing Merck’s Revenue in 1Q18,0.0,1.0,0.0,0
2018-05-08 16:33:20,0.34,iShares Edge MSCI USA Value Factor ETF Experiences Big Inflow,0.0,0.789,0.211,1
2018-05-08 17:20:02,0.0,Merck’s Segment-Wise Performance in 1Q18,0.0,1.0,0.0,0
2018-05-08 17:51:43,-0.25,The U.S. Is Facing an EpiPen Shortage,0.25,0.75,0.0,-1
2018-05-08 18:20:50,0.6597,Jopwell helps track down minority talent,0.0,0.426,0.574,1
2018-05-08 18:38:21,0.4019,FDA Approves JNJ’s Darzalex in Combination with VMP,0.0,0.722,0.278,1
2018-05-08 21:01:27,0.4576,"After Hours Most Active for May 8, 2018 :  PFE, INTC, MBB, CMCSA, T, ABEV, CVX, CSCO, CNP, BMY, AAPL, HBAN",0.0,0.864,0.136,1
2018-05-08 22:04:14,-0.4019,Mylan says U.S. customers may have trouble getting EpiPens,0.252,0.748,0.0,-1
2018-05-09 10:32:54,-0.4588,[$$] Hospitals in US sound alarm on impending chemotherapy shortages,0.333,0.667,0.0,-1
2018-05-09 11:32:50,0.0,How Merck’s Human Vaccines Business Performed in 1Q18,0.0,1.0,0.0,0
2018-05-09 12:33:12,0.0,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, U.S. Bancorp, Tesla and Celgene",0.0,1.0,0.0,0
2018-05-09 12:35:42,0.0,Mylan's EpiPen Added to FDA List of Medications in Short Supply,0.0,1.0,0.0,0
2018-05-09 12:35:42,-0.25,Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results,0.167,0.833,0.0,-1
2018-05-09 12:38:29,0.0,How Valeant Pharmaceuticals Performed in 1Q18,0.0,1.0,0.0,0
2018-05-09 13:02:03,0.0,A Performance Review and Analysts’ Ratings for Celgene in May,0.0,1.0,0.0,0
2018-05-09 13:23:43,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 10, 2018",0.0,1.0,0.0,0
2018-05-09 14:31:32,0.0,Merck’s Immunology and Cardiovascular Products in 1Q18,0.0,1.0,0.0,0
2018-05-09 14:34:37,-0.3182,"Momenta (MNTA) Incurs Wider Y/Y Loss, Glatopa Sales Decline",0.223,0.777,0.0,-1
2018-05-09 15:20:00,0.0,Why Bristol-Myers Squibb Stock Crashed in April,0.0,1.0,0.0,0
2018-05-09 15:25:16,0.0,How Regeneron’s Praluent and Dupixent Performed in 1Q18,0.0,1.0,0.0,0
2018-05-09 19:32:32,-0.4404,Mylan's 1st Quarter Results Are Weaker Than They Might Seem,0.244,0.756,0.0,-1
2018-05-09 20:33:00,-0.25,Epipen shortage should be short term: Mylan,0.25,0.75,0.0,-1
2018-05-09 20:47:13,0.6174,Mylan Flies On Confidence In 2018 Outlook Despite EpiPen Shortage,0.0,0.613,0.387,1
2018-05-10 00:31:24,0.4404,Johnson & Johnson Stock Looks Attractive on the Big Dip,0.0,0.734,0.266,1
2018-05-10 05:15:36,-0.3818,"[$$] EpiPen Emergency Allergy Shot in Short Supply, FDA Says",0.224,0.776,0.0,-1
2018-05-10 11:31:22,0.0,How Merck’s Animal Health Segment Did in 1Q18,0.0,1.0,0.0,0
2018-05-10 12:50:24,0.3612,What Analysts Recommend for Merck and Peers in May,0.0,0.762,0.238,1
2018-05-10 13:00:52,0.0,Merck’s Post-1Q18 Valuation,0.0,1.0,0.0,0
2018-05-10 13:10:00,0.34,Unlocking The Value In Animal Medicine,0.0,0.676,0.324,1
2018-05-10 14:25:02,0.0,Merck Expects to See Modest Rise in Fiscal 2018 Revenues,0.0,1.0,0.0,0
2018-05-10 15:55:02,0.0,Merck Focuses on Vaccines and Hospital Specialty Businesses in 2018,0.0,1.0,0.0,0
2018-05-10 16:42:01,0.0,How Much Upside Do Analysts Expect from AbbVie?,0.0,1.0,0.0,0
2018-05-10 16:42:04,0.0,What’s AbbVie’s Business Strategy for 2018?,0.0,1.0,0.0,0
2018-05-10 19:39:36,0.0,How Much Upside Potential Does Celgene Offer?,0.0,1.0,0.0,0
2018-05-11 12:16:00,0.1779,3 Healthcare Stocks Growing Over 100%,0.0,0.702,0.298,1
2018-05-11 14:13:05,-0.296,Trump to announce ways to lower prescription drug costs,0.216,0.784,0.0,-1
2018-05-11 14:17:35,0.0,US stock indexes edge higher in early trading; oil down,0.0,1.0,0.0,0
2018-05-11 14:31:06,0.0,Merck Focuses on Multiple R&D Programs for Keytruda in 2018,0.0,1.0,0.0,0
2018-05-11 15:15:08,0.0,How Teva Performed in 1Q18,0.0,1.0,0.0,0
2018-05-11 15:35:52,0.4404,Merck vs. Pfizer: Which Stock Looks Better Post Q1 Earnings?,0.0,0.756,0.244,1
2018-05-11 18:07:30,0.4019,Lenvima Is Expected to Boost Merck’s Oncology Portfolio in 2018,0.0,0.769,0.231,1
2018-05-11 21:02:37,0.0,Trump lets drug companies off the hook,0.0,1.0,0.0,0
2018-05-12 02:41:43,0.0,Few teeth in Trump's prescription to reduce drug prices,0.0,1.0,0.0,0
2018-05-12 10:21:14,0.0,Trump's prescription to reduce drug prices takes small steps,0.0,1.0,0.0,0
2018-05-13 11:55:40,0.4404,Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK),0.0,0.707,0.293,1
2018-05-14 16:02:55,0.0,How Much Upside Does Bristol-Myers Squibb Offer?,0.0,1.0,0.0,0
2018-05-14 17:00:32,0.0,What's in the Cards for Merck KGaA (MKGAF) in Q1 Earnings?,0.0,1.0,0.0,0
2018-05-14 17:00:46,0.5859,Will Trump's Surprise Drug Pricing Plan Boost Pharma Stocks?,0.0,0.593,0.407,1
2018-05-14 17:25:00,0.0,The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact,0.0,1.0,0.0,0
2018-05-14 17:43:20,-0.296,Why Trump’s drug-price pitch makes no sense,0.268,0.732,0.0,-1
2018-05-14 18:50:49,0.0,"MARKETS: Alibaba, Baidu jump on Trump tweet; Disney, Walmart, UnitedHealth lead Dow higher; Retail earnings on tap",0.0,1.0,0.0,0
2018-05-14 20:56:18,0.4576,"After Hours Most Active for May 14, 2018 :  F, ENDP, SNCR, INTC, ABEV, MSFT, CMCSA, PFE, CSCO, GE, DHI, CNP",0.0,0.864,0.136,1
2018-05-14 21:06:16,0.296,Close Update: Wall Street Clings to Gains With Dow Up 8th Day as U.S.-China Tensions Ease,0.131,0.631,0.238,1
2018-05-14 23:30:00,0.4767,The Likely 5 Winners Of Canada’s Cannabis Boom,0.0,0.659,0.341,1
2018-05-15 12:00:00,0.5106,Free Stock Performance Review on Pfizer and Three More Drug Makers’ Stocks,0.0,0.769,0.231,1
2018-05-15 13:00:37,0.0,Bristol-Myers Squibb’s Cash Flows and Valuation Metrics,0.0,1.0,0.0,0
2018-05-15 13:29:57,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2018",0.0,1.0,0.0,0
2018-05-15 14:32:02,0.0,Merck KGaA (MKGAF) Q1 Earnings and Revenues Decline Y/Y,0.0,1.0,0.0,0
2018-05-15 15:54:25,0.4019,FDA approves Pfizer's biosimilar of Amgen's Epogen,0.0,0.69,0.31,1
2018-05-15 17:00:12,0.0,AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues,0.0,1.0,0.0,0
2018-05-15 18:07:30,0.0,"Pfizer's biosimilar of Amgen, J&J's anemia treatments gets FDA nod",0.0,1.0,0.0,0
2018-05-15 18:38:00,0.4215,Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA,0.0,0.741,0.259,1
2018-05-15 20:56:43,0.4576,"After Hours Most Active for May 15, 2018 :  QQQ, PPL, GE, KO, EXC, FNSR, PFE, INTC, EPD, CELG, MSFT, FOLD",0.0,0.864,0.136,1
2018-05-15 23:22:00,0.0,Pfizer : FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia,0.0,1.0,0.0,0
2018-05-16 02:48:00,0.7003,"LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim",0.0,0.655,0.345,1
2018-05-16 13:17:34,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for May 17, 2018",0.0,1.0,0.0,0
2018-05-16 14:02:02,0.0,"Pfizer Gets FDA Nod for Amgen, J&J&apos;s Anemia Drug Biosimilar",0.0,1.0,0.0,0
2018-05-16 16:28:08,0.0,"Notable ETF Inflow Detected - VTI, BAC, WFC, PFE",0.0,1.0,0.0,0
2018-05-16 16:31:02,0.0,"Pfizer Gets FDA Nod for Amgen, J&J's Anemia Drug Biosimilar",0.0,1.0,0.0,0
2018-05-16 17:30:53,0.0,Gilead Sciences Stock: How Much Upside Do Analysts Expect?,0.0,1.0,0.0,0
2018-05-16 21:00:00,0.1779,Pfizer Oncology to Showcase Clinical Advances from its Growing Portfolio and Research Pipeline at ASCO,0.0,0.892,0.108,1
2018-05-16 23:30:00,0.0,5 Companies To Watch As Marijuana Legalization Approaches,0.0,1.0,0.0,0
2018-05-17 08:20:00,0.3182,Pfizer: Lyrica Oral Solution CV Phase 3 Trial Meets Primary Endpoint,0.0,0.796,0.204,1
2018-05-17 10:32:00,0.0,"Is Alnylam Pharmaceuticals, Inc. (ALNY) a Buy?",0.0,1.0,0.0,0
2018-05-17 11:32:29,0.7096,Teva’s Fiscal Guidance: Confidence in Its Growth,0.0,0.459,0.541,1
2018-05-17 12:00:00,0.3182,LYRICA® (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint,0.0,0.839,0.161,1
2018-05-17 12:37:12,0.0,Why Exelixis Stock Fell Last Week,0.0,1.0,0.0,0
2018-05-17 13:01:43,0.0,"Gilead Sciences’ Cash Flows, Valuations, and Price Performance",0.0,1.0,0.0,0
2018-05-17 13:35:01,-0.6597,Exelixis&apos; Cabometyx Gets EU Nod for First-Line Kidney Cancer,0.355,0.645,0.0,-1
2018-05-17 14:10:02,0.34,Exelixis Is Expected to Report a Robust Revenue Rise in 2018,0.0,0.789,0.211,1
2018-05-17 14:31:24,0.0,Taking Stock of Gilead Sciences’ Key Developments,0.0,1.0,0.0,0
2018-05-17 14:38:00,0.0,Sangamo Therapeutics Stock History,0.0,1.0,0.0,0
2018-05-17 15:32:57,-0.6597,Exelixis' Cabometyx Gets EU Nod for First-Line Kidney Cancer,0.355,0.645,0.0,-1
2018-05-17 15:40:02,-0.4215,Exelixis Focused on Positioning Cabometyx in Kidney Cancer Space,0.314,0.5,0.186,-1
2018-05-17 16:32:46,0.0,Roche Tecentriq Combo Achieves Longer Overall Survival Rate,0.0,1.0,0.0,0
2018-05-17 20:29:25,0.1779,Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks,0.0,0.866,0.134,1
2018-05-17 20:51:00,0.0,"Invacare Corporation Appoints Petra Danielsohn-Weil, PhD, to Board of Directors",0.0,1.0,0.0,0
2018-05-18 05:35:33,-0.5423,[$$] AstraZeneca chief Pascal Soriot suffers pay revolt,0.429,0.571,0.0,-1
2018-05-18 06:46:46,0.0,[$$] AstraZeneca sales hit by generic competitors to Crestor statin,0.0,1.0,0.0,0
2018-05-18 11:32:00,0.34,Cabometyx Is Expected to Witness a Robust Revenue Rise in 2018,0.0,0.789,0.211,1
2018-05-18 13:00:45,0.4019,Label Expansion May Boost Cabometyx’s Revenue in 2018,0.0,0.722,0.278,1
2018-05-18 14:30:32,0.3818,Exelixis Is Focused on Management of the Cabozantinib Franchise,0.0,0.755,0.245,1
2018-05-18 15:35:04,0.0,"Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat on Earnings",0.0,1.0,0.0,0
2018-05-18 18:35:06,0.0,"Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug",0.0,1.0,0.0,0
2018-05-18 18:58:21,0.0,Eli Lilly’s Valuation on May 17,0.0,1.0,0.0,0
2018-05-18 19:21:07,0.4939,Pfizer&apos;s Epilepsy Drug Lyrica Succeeds in Pediatric Study,0.0,0.686,0.314,1
2018-05-18 21:27:01,0.4939,Pfizer's Epilepsy Drug Lyrica Succeeds in Pediatric Study,0.0,0.686,0.314,1
2018-05-19 01:26:00,0.0,"An Ear To The Pharma: 11 Stocks To Watch (DOVA, SESN, URGNâ€¦)",0.0,1.0,0.0,0
2018-05-21 06:39:00,0.4019,GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV,0.0,0.769,0.231,1
2018-05-21 10:11:00,0.0,"ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV",0.0,1.0,0.0,0
2018-05-21 11:33:22,0.0,A Look into Roche Holding’s Performance in Q1 2018,0.0,1.0,0.0,0
2018-05-22 06:01:01,-0.4767,Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events,0.223,0.706,0.071,-1
2018-05-22 08:07:00,0.0,Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine,0.0,1.0,0.0,0
2018-05-22 12:00:00,0.0,Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine,0.0,1.0,0.0,0
2018-05-22 12:09:57,0.0,What’s Behind the 28% Hike in SCYNEXIS Stock Last Week?,0.0,1.0,0.0,0
2018-05-22 13:41:40,0.0,Gauging the Upside Potential of Vertex Pharmaceuticals Stock,0.0,1.0,0.0,0
2018-05-22 15:07:57,0.0,Wall Street Sees Upside of More than 17% for JNJ in the Next Year,0.0,1.0,0.0,0
2018-05-22 15:43:16,0.5719,"Spark, Pfizer report progress on gene therapy for hemophilia",0.0,0.598,0.402,1
2018-05-22 15:50:00,0.4767,Glaxo and J&J's Two-Drug HIV Regimen Juluca Gets EU Approval,0.0,0.744,0.256,1
2018-05-22 16:40:12,0.0,Why Did JNJ Scrap Its Alzheimer’s Drug Mid-Stage Trial?,0.0,1.0,0.0,0
2018-05-22 17:18:45,0.0,Tesaro Stock: What’s the Upside Potential?,0.0,1.0,0.0,0
2018-05-22 17:18:46,0.0,How Are Tesaro’s Valuations and Cash Flows?,0.0,1.0,0.0,0
2018-05-22 17:30:00,0.0,A Study Analyzing Observational Data Shows Real-World Effectiveness of Prevnar® 13 in Adults Age 65+,0.0,1.0,0.0,0
2018-05-23 08:12:00,0.2263,Pfizer: FDA Grants Breakthrough Therapy Designation For Tafamidis - Quick Facts,0.0,0.826,0.174,1
2018-05-23 12:00:00,0.2263,FDA Grants Breakthrough Therapy Designation for Tafamidis for the Treatment of Patients with Transthyretin Cardiomyopathy,0.0,0.881,0.119,1
2018-05-23 19:54:19,0.0,Pfizer’s Valuation as of May 22,0.0,1.0,0.0,0
2018-05-23 19:54:37,0.0,Analyst Recommendations for Pfizer on May 22,0.0,1.0,0.0,0
2018-05-23 21:25:03,0.0,Pfizer’s Quarterly Revenue Trend in Q1 2018,0.0,1.0,0.0,0
2018-05-23 22:32:00,-0.4767,Trump Administration Ups Dose Of Shame As TV Drug Ad Policy Idea Moves Forward,0.193,0.807,0.0,-1
2018-05-24 02:39:07,0.1027,[$$] Pfizer agrees to pay nearly $24m to settle kickback claims,0.115,0.738,0.148,1
2018-05-24 04:15:26,-0.1531,[$$] Pfizer under pressure to resolve shortage of life-saving EpiPen,0.304,0.507,0.188,-1
2018-05-24 11:15:00,0.6705,Wired News - Spark Therapeutics and Pfizer Announced Positive Data from Phase-1/2 Clinical Trial of SPK-9001 for Haemophilia B Treatment,0.0,0.744,0.256,1
2018-05-24 11:33:46,0.0,Pfizer’s Segment Performances in Q1 2018,0.0,1.0,0.0,0
2018-05-24 13:02:56,0.0,Pfizer’s Performance across Geographies in Q1 2018,0.0,1.0,0.0,0
2018-05-24 13:13:43,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2018",0.0,1.0,0.0,0
2018-05-24 14:18:13,0.2023,3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More,0.0,0.833,0.167,1
2018-05-24 14:19:07,-0.1027,Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks,0.104,0.896,0.0,-1
2018-05-24 14:32:24,0.3818,Pfizer’s Growth Drivers in Q1 2018,0.0,0.658,0.342,1
2018-05-24 14:48:24,0.296,Pfizer to pay $23.85 million to resolve U.S. kickbacks case,0.117,0.667,0.217,1
2018-05-24 14:51:00,0.296,Pfizer To Pay $23.85 Mln To Resolve Kickback Claims: DoJ,0.117,0.667,0.217,1
2018-05-24 15:08:03,0.0,Pfizer&apos;s Tafamadis Gets Breakthrough Therapy Designation,0.0,1.0,0.0,0
2018-05-24 16:12:41,-0.1027,Pfizer to pay $23.85 million to settle kickback allegations,0.149,0.851,0.0,-1
2018-05-24 16:46:33,0.0,Pfizer's Tafamadis Gets Breakthrough Therapy Designation,0.0,1.0,0.0,0
2018-05-24 17:23:41,0.4215,"Pfizer Used Charity to Mask Heart Drug Price Hikes, U.S. Says",0.0,0.781,0.219,1
2018-05-24 17:46:58,0.5994,3 Big Pharma Stocks with Huge Future Growth Potential,0.0,0.55,0.45,1
2018-05-24 20:44:13,0.4767,Novartis Gets Approval for Remicade Biosimilar in Europe,0.0,0.693,0.307,1
2018-05-24 21:03:57,0.4576,"After Hours Most Active for May 24, 2018 :  NWL, TWTR, PFE, KO, VZ, ADM, WDC, MU, TLT, NFLX, MSFT, TVIX",0.0,0.864,0.136,1
2018-05-25 01:17:23,-0.1027,Pfizer to pay $23.85 million to settle U.S. co-payment kickback probe,0.123,0.877,0.0,-1
2018-05-25 03:59:35,0.4215,[$$] Pfizer to Pay $24 Million to Settle Probe Into Copay Assistance Charities,0.09,0.705,0.205,1
2018-05-25 04:30:19,-0.3182,Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales,0.204,0.796,0.0,-1
2018-05-25 11:32:04,0.0,Pfizer’s Products with Declining Revenues in Q1 2018,0.0,1.0,0.0,0
2018-05-25 13:51:01,0.4767,"Dow 30 Stock Roundup: GE&apos;s Transportation Unit to Merge With Wabtec, J&J & Glaxo&apos;s HIV Drug Gets EU Approval",0.0,0.846,0.154,1
2018-05-25 14:47:30,0.4767,"Dow 30 Stock Roundup: GE's Transportation Unit to Merge With Wabtec, J&J & Glaxo's HIV Drug Gets EU Approval",0.0,0.846,0.154,1
2018-05-25 16:04:07,0.0,A Brief Overview of Merck’s First-Quarter Performance,0.0,1.0,0.0,0
2018-05-25 17:35:02,0.6486,This Collaboration Is Expected to Boost Merck’s Long-Term Growth,0.0,0.569,0.431,1
2018-05-25 17:54:31,0.3818,Opdivo Continues to Be Key Growth Driver for Bristol-Myers Squibb,0.0,0.776,0.224,1
2018-05-25 22:32:34,0.0,How to Invest in Diabetes Stocks,0.0,1.0,0.0,0
2018-05-26 18:07:20,0.0,Venture Capital Deals Of The Week: Ant Financial's $200M Motion Sensor Bet,0.0,1.0,0.0,0
2018-05-28 11:34:08,0.3818,Levnima Could Be Merck’s Long-Term Growth Driver,0.0,0.698,0.302,1
2018-05-28 13:03:22,0.0,How Are Merck’s Vaccines Positioned after Q1 2018?,0.0,1.0,0.0,0
2018-05-28 14:33:28,0.3818,What Trends Will Drive Long-Term Growth for Opdivo and Eliquis?,0.0,0.776,0.224,1
2018-05-29 03:52:54,0.0,[$$] The Heated Quest for Opioid Alternatives,0.0,1.0,0.0,0
2018-05-29 08:05:00,0.0,Biotech Stocks Facing FDA Decision In June,0.0,1.0,0.0,0
2018-05-29 08:11:00,0.0,Pfizer: Xalkori Gets FDA Breakthrough Therapy Designation In Two New Indications,0.0,1.0,0.0,0
2018-05-29 12:00:00,0.0,Pfizer’s XALKORI® (crizotinib) Receives FDA Breakthrough Therapy Designation in Two New Indications,0.0,1.0,0.0,0
2018-05-29 22:06:29,0.0,"Europe Drama, Big Banks Cause Stock Sell-Off; VIX Surges",0.0,1.0,0.0,0
2018-05-30 13:00:18,0.4939,How Is Merck’s Hospital Acute Care Segment Positioned?,0.0,0.686,0.314,1
2018-05-30 13:19:00,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 31, 2018",0.0,1.0,0.0,0
2018-05-30 15:29:00,0.5574,The Pfizer Foundation Announces $5 Million in Grants to Support Women and Families,0.0,0.705,0.295,1
2018-05-30 16:08:05,0.6597,FDA approves Pfizer's Xeljanz to treat ulcerative colitis,0.0,0.526,0.474,1
2018-05-30 16:36:54,0.0772,FDA clears Pfizer's Xeljanz for inflammatory bowel disease,0.0,0.843,0.157,0
2018-05-30 19:52:00,0.34,Pfizer Announces U.S. FDA Approves XELJANZ® (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis,0.134,0.625,0.241,1
2018-05-30 20:29:13,0.7906,Dow&apos;s Pfizer Jumps As Its Blockbuster Xeljanz Grabs Another Approval,0.0,0.533,0.467,1
2018-05-30 20:30:02,0.0,Latest Analysts’ Recommendations and Target Price for Sanofi,0.0,1.0,0.0,0
2018-05-30 21:21:09,0.0,Pfizer&apos;s Xalkori Gets Breakthrough Status for New Indications,0.0,1.0,0.0,0
2018-05-30 21:52:39,0.0,A Look at the Upside Potential of AstraZeneca Stock,0.0,1.0,0.0,0
2018-05-30 22:57:00,0.34,Pfizer:FDA Oks XELJANZ To Treat Moderately To Severely Active Ulcerative Colitis,0.183,0.488,0.329,1
2018-05-30 23:08:16,0.0,Pfizer's Xalkori Gets Breakthrough Status for New Indications,0.0,1.0,0.0,0
2018-05-31 00:55:00,0.0,"CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov.",0.0,1.0,0.0,0
2018-05-31 11:30:03,0.5574,Analysts Are Positive on Merck in May,0.0,0.625,0.375,1
2018-05-31 13:02:41,0.3818,Amgen Focused on Advancing Oncology Research Programs in 2018,0.0,0.755,0.245,1
2018-05-31 14:21:02,0.0,Pfizer&apos;s Arthritis Drug Gets FDA Nod for Ulcerative Colitis,0.0,1.0,0.0,0
2018-05-31 15:46:21,0.0,How Novartis’s Valuation Compares,0.0,1.0,0.0,0
2018-05-31 16:09:51,0.0,"Dow Movers: PG, PFE",0.0,1.0,0.0,0
2018-05-31 16:12:37,0.0,Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis,0.0,1.0,0.0,0
2018-05-31 16:12:43,0.0,A Look at GlaxoSmithKline’s Valuation on May 29,0.0,1.0,0.0,0
2018-05-31 16:43:00,0.0,Why investors ponied up $76M for this company&apos;s new approach to Alzheimer&apos;s,0.0,1.0,0.0,0
2018-05-31 17:45:10,0.0,Assessing GlaxoSmithKline’s Quarterly Revenues,0.0,1.0,0.0,0
2018-05-31 18:50:02,0.0,How Novartis’s Business Segments Did in Q1,0.0,1.0,0.0,0
2018-05-31 19:51:00,0.3612,FDA Moves to Ease Way for Generic Drugmakers,0.0,0.737,0.263,1
2018-05-31 20:57:21,0.4576,"After Hours Most Active for May 31, 2018 :  ON, MSFT, CPRT, VZ, INTC, FB, GE, CMCSA, PG, WFC, SFUN, PFE",0.0,0.864,0.136,1
2018-05-31 22:46:00,0.4215,FDA Moves to Make Life Easier for Generic Drug Companies,0.0,0.763,0.237,1
2018-05-31 23:07:55,0.0258,Pfizer Inc. Stock Desperately Needs a Viagra-Like Boost,0.252,0.485,0.262,0
2018-06-01 06:15:00,0.4588,Intelligent Investor - June 1,0.0,0.4,0.6,1
2018-06-01 07:48:00,0.5574,Pfizer Gets Positive CHMP Opinion For Oncology Biosimilar Trazimera,0.0,0.69,0.31,1
2018-06-01 11:30:00,0.5574,"Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, TRAZIMERA™ (trastuzumab)",0.0,0.714,0.286,1
2018-06-01 21:09:37,0.0,"FDA Delays Amgen-Allergan Copycat Herceptin, Gives Roche Breathing Room",0.0,1.0,0.0,0
2018-06-01 23:00:45,0.0,Texas high court rules state must reveal supplier of execution drugs,0.0,1.0,0.0,0
2018-06-01 23:07:32,0.6486,"Kitov (KTOV) Gets Approval from FDA for Consensi, Shares Up",0.0,0.602,0.398,1
2018-06-03 11:35:41,0.0,3 Reasons for Long-Term Investors to Buy Pfizer Stock Right Now,0.0,1.0,0.0,0
2018-06-03 23:27:16,-0.128,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,0.143,0.857,0.0,-1
2018-06-04 12:00:00,0.0,Two-Year Update of Pivotal JAVELIN Merkel 200 Trial Shows Continued Durable Responses with BAVENCIO® (avelumab),0.0,1.0,0.0,0
2018-06-04 12:30:00,0.0,Today's Research Reports on Trending Tickers: Merck & Co. and Pfizer Inc.,0.0,1.0,0.0,0
2018-06-04 13:15:31,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 05, 2018",0.0,1.0,0.0,0
2018-06-04 16:01:00,-0.3182,The 8 'Dogs Of The Dow' Continued To Struggle In May,0.204,0.796,0.0,-1
2018-06-04 21:37:00,0.6444,Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations,0.0,0.774,0.226,1
2018-06-05 12:38:25,0.0,Bristol-Myers (BMY) Reports Data from CheckMate-214 Study,0.0,1.0,0.0,0
2018-06-06 02:35:10,0.0,Is an Acquisition in Portola Pharmaceuticals' Future?,0.0,1.0,0.0,0
2018-06-06 08:35:00,0.5994,Pfizer To Expand Venture Investing With $600 Mln Commitment To Pfizer Venture,0.0,0.671,0.329,1
2018-06-06 12:00:00,0.5994,Pfizer to Expand Venture Investing with $600 Million Commitment to Pfizer Ventures,0.0,0.671,0.329,1
2018-06-06 12:14:11,0.0,Pfizer to invest $600 mln in venture capital arm,0.0,1.0,0.0,0
2018-06-06 12:18:29,0.0,Pfizer pumps $600 million into venture capital arm,0.0,1.0,0.0,0
2018-06-06 12:28:33,0.0,[$$] Pfizer to Invest $600 Million in Its Venture-Capital Arm,0.0,1.0,0.0,0
2018-06-06 14:25:38,0.0,Why Pfizer Stock Rose 2.4% in May,0.0,1.0,0.0,0
2018-06-06 15:36:36,0.0,"Dow Movers: PFE, JPM",0.0,1.0,0.0,0
2018-06-06 15:40:50,0.5574,Abbvie's (ABBV) Upadacitinib Fifth RA Study Data Positive,0.0,0.66,0.34,1
2018-06-06 18:05:23,0.0,Pfizer to pump $600 million in additional funding into biotech startups,0.0,1.0,0.0,0
2018-06-06 21:51:44,-0.1531,Pfizer Recall of Opioid Overdose Drug is the Latest in a Series of Shortages and Backorders,0.103,0.897,0.0,-1
2018-06-06 23:35:24,0.0,[$$] Pfizer Ventures Gets $600 Million for Life Sciences Investments,0.0,1.0,0.0,0
2018-06-07 03:09:52,0.0,[$$] UK tribunal rules against watchdog in Pfizer price-gouging case,0.0,1.0,0.0,0
2018-06-07 03:50:51,0.6705,[$$] Pfizer wins appeal against £84m UK fine over epilepsy drug price,0.0,0.645,0.355,1
2018-06-07 08:16:00,0.25,Pfizer Granted FDA Priority Review For Talazoparib - Quick Facts,0.0,0.8,0.2,1
2018-06-07 12:00:00,-0.4215,U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation,0.157,0.75,0.093,-1
2018-06-07 14:41:02,0.3182,"Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus",0.0,0.753,0.247,1
2018-06-07 15:30:00,0.0,[$$] Big Pharma's Tempting Payouts,0.0,1.0,0.0,0
2018-06-07 16:17:34,0.6705,Pfizer wins appeal against UK fine for epilepsy drug price hike,0.0,0.621,0.379,1
2018-06-07 16:43:58,0.1027,Pfizer Expands Its Investment Portfolio through Pfizer Ventures,0.0,0.833,0.167,1
2018-06-07 18:15:02,0.0,Pfizer’s Highlights from the 54th Annual Meeting of ASCO,0.0,1.0,0.0,0
2018-06-07 19:45:02,0.0,Pfizer Presents the Final Data on Dacomitinib,0.0,1.0,0.0,0
2018-06-07 21:07:35,0.0,"In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection",0.0,1.0,0.0,0
2018-06-07 21:38:03,-0.4019,8 Bitcoin Stocks That You Won’t Lose Your Shirt Over,0.252,0.748,0.0,-1
2018-06-08 00:47:00,0.4404,"FDA Nod For EDAP, AGRX Issues Pink Slips, APHB Turns Heads, MNKD Breathes Easy",0.0,0.818,0.182,1
2018-06-08 14:27:02,0.4767,"Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant",0.0,0.795,0.205,1
2018-06-08 15:48:03,0.3612,Biogen Inks Deal With TMS To Acquire Phase II Stroke Asset,0.0,0.8,0.2,1
2018-06-08 16:20:00,0.3182,"Lilly, Pfizer: Both Unloved but Ready to Grow",0.174,0.536,0.29,1
2018-06-08 17:38:30,0.2023,"Top Stock Reports for Pfizer, Union Pacific & Broadcom",0.0,0.795,0.205,1
2018-06-08 18:16:43,0.0,The FDA and EMA on Pfizer’s Talazoparib,0.0,1.0,0.0,0
2018-06-11 11:32:00,-0.4215,A Story Of Devastation And Rebirth: The Former Pfizer Research Labs In Ann Arbor,0.189,0.811,0.0,-1
2018-06-11 13:06:01,0.5859,"The Zacks Analyst Blog Highlights: Pfizer, Union Pacific, Broadcom, KeyCorp and Ulta Beauty",0.0,0.759,0.241,1
2018-06-11 16:12:16,0.5423,JAK Inhibitors' Prospects Strong: 4 Stocks Ruling the Space,0.16,0.4,0.44,1
2018-06-12 11:00:00,0.4019,Pfizer Announces Extension of Zithromax® Antibiotic Donation Program through 2025 to Help Eliminate World’s Leading Infectious Cause of Blindness,0.0,0.87,0.13,1
2018-06-12 12:11:00,0.4939,Can This Pharma&apos;s $14 Billion Bet Succeed?,0.0,0.652,0.348,1
2018-06-12 14:07:11,0.0,A “Secret” 10.5% Dividend From Pfizer (starting today),0.0,1.0,0.0,0
2018-06-12 14:08:15,0.4939,Can This Pharma's $14 Billion Bet Succeed?,0.0,0.652,0.348,1
2018-06-12 15:10:52,0.0,Alzheimer's Research Stumbles Again: What's the Road Ahead?,0.0,1.0,0.0,0
2018-06-12 21:00:34,0.0,Should You Buy Pfizer Inc (NYSE:PFE) For Its Dividend?,0.0,1.0,0.0,0
2018-06-13 10:33:03,0.5106,Strong Drug Pipeline Bolsters Undervalued Pfizer,0.0,0.602,0.398,1
2018-06-13 12:37:00,0.0,This Rare 10.5% Dividend Won't Be Cheap For Long,0.0,1.0,0.0,0
2018-06-13 13:37:32,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2018",0.0,1.0,0.0,0
2018-06-13 14:37:02,-0.3182,Merck&apos;s (MRK) Keytruda Gets FDA Approval for Cervical Cancer,0.303,0.483,0.214,-1
2018-06-13 17:09:43,-0.3182,Merck's (MRK) Keytruda Gets FDA Approval for Cervical Cancer,0.303,0.483,0.214,-1
2018-06-14 12:20:26,0.5574,ViiV Healthcare reports positive results for late-stage HIV trials,0.0,0.69,0.31,1
2018-06-14 16:11:28,0.0,Sarepta Inks Manufacturing Deal for Gene Therapy Program,0.0,1.0,0.0,0
2018-06-15 17:08:56,0.0,Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III,0.0,1.0,0.0,0
2018-06-15 18:09:23,0.4576,Can Sprout Pharma’s Latest Revival Really Boost VRX Stock?,0.0,0.728,0.272,1
2018-06-15 18:31:00,0.2023,Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers,0.0,0.833,0.167,1
2018-06-15 21:07:13,0.0,"Notable Friday Option Activity: XOM, GERN, PFE",0.0,1.0,0.0,0
2018-06-16 00:36:47,0.6369,25 Blue-Chip Stocks That Mutual Fund Managers Love Most,0.0,0.656,0.344,1
2018-06-16 10:33:04,0.0,Investing Insights: Conference Highlights and Mind the Gap,0.0,1.0,0.0,0
2018-06-18 10:00:00,0.0,5 Drug Stocks With Fat Payouts,0.0,1.0,0.0,0
2018-06-18 11:00:00,0.7184,FOCUS-How U.S. tax reform rewards companies that shift profit to tax havens,0.0,0.625,0.375,1
2018-06-18 13:08:19,0.4767,Why Bristol-Myers Squibb is a Top Socially Responsible Dividend Stock (BMY),0.0,0.661,0.339,1
2018-06-18 20:06:35,0.0,Monday's ETF with Unusual Volume: IXJ,0.0,1.0,0.0,0
2018-06-19 03:00:33,0.0,[$$] Britain’s flawed medicines regime urgently needs reform,0.0,1.0,0.0,0
2018-06-19 12:06:27,0.4767,Myriad Stock Rose on FDA Supplementary Premarket Approval,0.0,0.693,0.307,1
2018-06-19 14:00:00,0.0,Pfizer Invites Public To View And Listen To Webcast Of July 31 Conference Call With Analysts,0.0,1.0,0.0,0
2018-06-19 14:18:00,-0.296,A Gene Therapy Appears To Replace Missing Protein In Muscular Dystrophy Patients,0.18,0.82,0.0,-1
2018-06-19 17:09:31,0.5719,Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx,0.0,0.684,0.316,1
2018-06-20 11:07:36,0.25,Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks,0.176,0.556,0.269,1
2018-06-20 11:45:11,0.5267,Sarepta&apos;s Stock Soars on Encouraging Gene Therapy Results,0.0,0.673,0.327,1
2018-06-20 12:08:00,0.0,There Go Those Drug Companies Inventing New Diseases Again,0.0,1.0,0.0,0
2018-06-20 14:01:16,0.0,A Look at Allergan’s Valuation as of June 19,0.0,1.0,0.0,0
2018-06-20 14:08:02,0.0,Amgen Gets EU Nod to Add Survival Data on Blincyto&apos;s Label,0.0,1.0,0.0,0
2018-06-20 14:09:55,0.5267,Sarepta's Stock Soars on Encouraging Gene Therapy Results,0.0,0.673,0.327,1
2018-06-20 16:11:16,0.0,Amgen Gets EU Nod to Add Survival Data on Blincyto's Label,0.0,1.0,0.0,0
2018-06-20 17:09:46,0.0,"IWD, WFC, PFE, MRK: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2018-06-20 20:13:15,0.0,Should You Buy Pfizer Inc (NYSE:PFE) At This PE Ratio?,0.0,1.0,0.0,0
2018-06-21 01:07:02,0.0,How Long Should You Own a Stock?,0.0,1.0,0.0,0
2018-06-21 06:20:00,0.0,In The Spotlight: Sangamo Therapeutics,0.0,1.0,0.0,0
2018-06-21 09:00:28,-0.6705,[$$] Beijing woos foreign businesses as US trade war looms,0.407,0.593,0.0,-1
2018-06-21 15:27:33,0.0,Investors Are Undervaluing Pfizer Inc (NYSE:PFE) By 43.43%,0.0,1.0,0.0,0
2018-06-21 15:29:14,0.0,"3 Big Stock Charts for Thursday: JPMorgan Chase, Pfizer and Disney",0.0,1.0,0.0,0
2018-06-22 14:11:10,0.0,DMD Research Veers Toward Gene Therapy: 3 Stocks in Focus,0.0,1.0,0.0,0
2018-06-22 16:12:03,0.4019,"Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI",0.0,0.816,0.184,1
2018-06-22 16:13:13,0.34,"Zacks Value Trader Highlights: General Electric, Starbucks, Pfizer and ExxonMobil",0.0,0.789,0.211,1
2018-06-25 06:02:50,-0.6369,Australian watchdog appeals to high court on Pfizer's alleged abuse of market power,0.259,0.741,0.0,-1
2018-06-25 08:30:00,-0.6597,Pfizer Records Overall Survival In Metastatic Breast Cancer Study Using Ibrance,0.306,0.694,0.0,-1
2018-06-25 12:00:00,-0.6597,"Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer",0.206,0.794,0.0,-1
2018-06-25 12:53:54,0.6124,Analyst: Solid Biosciences A Solid Buy On Sarepta's Progress,0.0,0.455,0.545,1
2018-06-25 13:28:19,-0.6597,Pfizer's breast cancer drug combo falls short of survival goal,0.328,0.672,0.0,-1
2018-06-25 15:07:43,0.0,Conviction of SAC's Martoma upheld despite jury instructions,0.0,1.0,0.0,0
2018-06-25 17:09:21,0.7783,Lilly Wins Favorable Ruling From U.S. Court in Alimta Row,0.0,0.541,0.459,1
2018-06-25 18:07:09,0.6369,The 10 Best Stocks to Invest In Right Now,0.0,0.656,0.344,1
2018-06-26 11:00:00,0.0,Stock Performance Review on Pfizer and Three Other Drug Makers Stocks,0.0,1.0,0.0,0
2018-06-26 12:59:12,-0.743,Pfizer&apos;s Breast Cancer Drug Misses Overall Survival in Study,0.474,0.526,0.0,-1
2018-06-26 13:30:00,0.0,"If You&apos;re in Your 70s, Consider Buying These 3 Stocks",0.0,1.0,0.0,0
2018-06-26 13:31:00,-0.0258,Is Pfizer&apos;s Lead Growth Driver in Trouble?,0.262,0.485,0.252,0
2018-06-26 15:01:27,0.5106,WBI Factor Dividend ETF Tops $50M in AUM,0.0,0.68,0.32,1
2018-06-26 15:08:37,-0.0258,Is Pfizer's Lead Growth Driver in Trouble?,0.262,0.485,0.252,0
2018-06-26 15:08:50,0.0,"If You're in Your 70s, Consider Buying These 3 Stocks",0.0,1.0,0.0,0
2018-06-26 15:12:31,-0.743,Pfizer's Breast Cancer Drug Misses Overall Survival in Study,0.474,0.526,0.0,-1
2018-06-26 15:16:03,0.25,Merck&apos;s Keytruda Under FDA Review for Advanced Melanoma,0.0,0.778,0.222,1
2018-06-26 17:08:54,0.25,Merck's Keytruda Under FDA Review for Advanced Melanoma,0.0,0.778,0.222,1
2018-06-26 18:02:04,0.0,How Pfizer’s Valuation Compares,0.0,1.0,0.0,0
2018-06-26 19:35:02,0.0,A Look at Pfizer’s Revenue Trends,0.0,1.0,0.0,0
2018-06-26 20:56:39,0.4576,"After Hours Most Active for Jun 26, 2018 :  PFE, F, QQQ, MSFT, FLNT, ON, BWP, TEVA, GILD, T, INTC, MDT",0.0,0.864,0.136,1
2018-06-26 21:05:02,0.0,How Pfizer’s Business Segments Have Performed,0.0,1.0,0.0,0
2018-06-26 22:06:29,0.5859,Energy Tailwinds Help Stocks Finish Higher,0.0,0.455,0.545,1
2018-06-27 00:39:00,-0.2263,Pfizer Limited (NSE:PFIZER): Commentary On Fundamentals,0.275,0.725,0.0,-1
2018-06-27 08:11:00,0.2263,FDA Grants Priority Review For Pfizer's NDA For Glasdegib - Quick Facts,0.0,0.84,0.16,1
2018-06-27 11:32:54,0.0,Pfizer’s Performance across Geographies,0.0,1.0,0.0,0
2018-06-27 12:00:00,0.2263,U.S. FDA Grants Priority Review for Pfizer’s New Drug Application for Glasdegib in Patients with Previously Untreated Acute Myeloid Leukemia,0.0,0.909,0.091,1
2018-06-27 12:20:19,-0.5994,Pfizer Stock: Trade War Affects Healthcare Products,0.394,0.606,0.0,-1
2018-06-27 13:02:11,0.3818,What Drives Pfizer’s Growth?,0.0,0.536,0.464,1
2018-06-27 13:10:52,-0.25,US hospitals grapple with prolonged injected opioid shortage,0.222,0.778,0.0,-1
2018-06-27 14:31:42,-0.296,Which Pfizer Products Are Seeing Lower Sales,0.268,0.732,0.0,-1
2018-06-27 16:01:00,0.0,Pfizer’s Glasdebig Receives Priority Review Designation,0.0,1.0,0.0,0
2018-06-27 17:10:07,0.7003,Achieve Life Sciences' Shares Rise on Positive Clinical Data,0.0,0.547,0.453,1
2018-06-28 02:03:00,-0.4215,"ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye",0.189,0.811,0.0,-1
2018-06-28 11:30:48,0.0,Analysts’ Estimates and Recommendations for Pfizer,0.0,1.0,0.0,0
2018-06-28 13:00:38,0.0,What’s New for Pfizer This Month,0.0,1.0,0.0,0
2018-06-28 16:20:00,0.0,Pfizer Declares 34-Cent Third-Quarter 2018 Dividend,0.0,1.0,0.0,0
2018-06-28 17:09:33,0.0,"Notable ETF Outflow Detected - IWD, WFC, PFE, VZ",0.0,1.0,0.0,0
2018-06-28 17:49:00,0.4019,XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for Active Psoriatic Arthritis,0.0,0.828,0.172,1
2018-06-28 21:07:21,-0.5106,"Pain, Durect Plunge as FDA Committee Votes Against Remoxy ER",0.268,0.732,0.0,-1
2018-06-29 13:07:33,0.2023,Pfizer a Top 25 Dividend Giant With 3.74% Yield (PFE),0.0,0.816,0.184,1
2018-06-29 13:10:20,0.4404,"Dow 30 Stock Roundup: Nike, Walgreens Earnings Impress",0.0,0.707,0.293,1
2018-06-29 13:57:00,0.4019,Interested In Pharmaceutical Stocks? Try Novartis (ADR),0.0,0.69,0.31,1
2018-06-29 14:09:41,-0.8316,Will a Trade War With China Wreak Havoc in US Healthcare?,0.494,0.506,0.0,-1
2018-06-29 14:13:06,0.0,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's Affirms Four Classes of GCCFC 2005-GG3",0.0,1.0,0.0,0
2018-06-29 15:24:03,0.0,Pfizer&apos;s Leukemia Candidate Gets Priority Review From FDA,0.0,1.0,0.0,0
2018-06-29 17:20:46,0.7003,Pfizer’s EC Approval of Xeljanz for Active Psoriatic Arthritis,0.0,0.547,0.453,1
2018-06-29 22:10:00,0.0,Pfizer's Leukemia Candidate Gets Priority Review From FDA,0.0,1.0,0.0,0
2018-07-01 11:49:12,0.4404,Better Buy: Amgen Inc. vs. Pfizer Inc.,0.0,0.674,0.326,1
2018-07-02 08:23:58,0.0,[$$] US drugmaker Pfizer lifts price of Viagra and 100 other products,0.0,1.0,0.0,0
2018-07-02 16:55:57,-0.0772,Pfizer raises prices; Dan Loeb pressures Nestle; Nordstrom drops on downgrade; bullish call on Wells Fargo,0.126,0.765,0.109,0
2018-07-02 21:42:21,0.3612,Pfizer Raises Prices on Prescription Drugs Like Viagra and Chantix for the Second Time This Year,0.0,0.857,0.143,1
2018-07-02 23:46:46,0.0,[$$] Pfizer Raises Prices for Dozens of Drugs,0.0,1.0,0.0,0
2018-07-03 05:33:00,0.4215,Remember When Was The Last Time A New Alzheimer's Drug Was Approved?,0.0,0.781,0.219,1
2018-07-03 10:01:00,0.8316,"The 5 Biggest Blockbuster Drugs of 2024, and the Companies Poised to Profit From Them",0.0,0.556,0.444,1
2018-07-03 13:20:07,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 05, 2018",0.0,1.0,0.0,0
2018-07-03 13:44:52,0.0,GlaxoSmithKline’s Valuation on June 29,0.0,1.0,0.0,0
2018-07-03 14:13:02,-0.3182,AstraZeneca&apos;s Two New Cancer Drugs Get Approval in Japan,0.303,0.483,0.214,-1
2018-07-03 14:20:31,0.0,"Roku gets upgraded, Pfizer raises prices on dozens of drugs, Alibaba investments into Chinese media giant",0.0,1.0,0.0,0
2018-07-03 14:44:55,0.0,"Roku gets upgraded, Pfizer raises prices on dozens of drugs, Alibaba invests in Chinese media giant",0.0,1.0,0.0,0
2018-07-03 14:51:09,0.0,3 Biotech Stocks With Major Catalysts Incoming,0.0,1.0,0.0,0
2018-07-03 16:48:04,0.2023,"Top Analyst Reports for Pfizer, BHP Billiton & Facebook",0.0,0.795,0.205,1
2018-07-03 16:52:42,-0.3182,AstraZeneca's Two New Cancer Drugs Get Approval in Japan,0.303,0.483,0.214,-1
2018-07-03 17:26:00,0.0516,Drug prices increase despite Trump's plan to cut costs,0.184,0.614,0.202,0
2018-07-03 18:36:00,-0.2924,"Pfizer Hikes Drug Prices Again, Despite President Trump's Promises",0.214,0.786,0.0,-1
2018-07-03 18:56:06,0.0,Is Pfizer&apos;s Price Hike an Effect of Drug Policy on Sector?,0.0,1.0,0.0,0
2018-07-03 20:50:57,0.0,Is Pfizer's Price Hike an Effect of Drug Policy on Sector?,0.0,1.0,0.0,0
2019-01-03 22:08:50,0.34,3 Biopharma Stocks to Buy for Their Robust Dividend Yields,0.0,0.769,0.231,1
2019-01-03 23:09:37,0.4019,Why Johnson & Johnson Stock is Clearly Set to Rise Again,0.0,0.769,0.231,1
2019-01-04 11:50:00,0.0,Today's Research Reports on Trending Tickers: Pfizer and Bristol-Myers Squibb,0.0,1.0,0.0,0
2019-01-04 12:29:12,0.0,Pfizer Begins Pivotal Study on Alopecia Areata Candidate,0.0,1.0,0.0,0
2019-01-04 14:27:19,0.4939,"Health Care Sector Update for 01/04/2019: FLKS, NVAX, ESPR, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-04 15:07:03,0.0,"Pharma Stock Roundup: BMY to Buy CELG for $74B, MRK Gets Rights to NASH Candidate",0.0,1.0,0.0,0
2019-01-04 15:08:51,0.0,"Nektar, ImaginAb Enter Into Immuno-Oncology Collaboration",0.0,1.0,0.0,0
2019-01-04 21:24:40,0.2023,Bristol To Become Top 5 Pharma — And Other Fallout From Celgene Takeover,0.0,0.847,0.153,1
2019-01-07 08:25:00,0.0,Pfizer To Use CytoReason's Machine Learning Model For Drug Discovery,0.0,1.0,0.0,0
2019-01-07 10:30:00,0.0,Pfizer To Present At The J.P. Morgan Conference; Webcast At 11:30 AM ET,0.0,1.0,0.0,0
2019-01-07 11:07:04,0.0,"The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie",0.0,1.0,0.0,0
2019-01-07 14:18:00,0.1779,"J.P. Morgan Healthcare Conference kicks off Monday with focus on Trump, Amazon",0.0,0.866,0.134,1
2019-01-07 14:30:02,0.0,"Company News For Jan 7, 2019",0.0,1.0,0.0,0
2019-01-07 15:56:25,-0.2263,"As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock",0.16,0.84,0.0,-1
2019-01-07 16:12:58,0.0,Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?,0.0,1.0,0.0,0
2019-01-07 16:21:41,0.0,Analysts’ Recommendations for Pfizer in January,0.0,1.0,0.0,0
2019-01-07 16:47:00,0.5423,GSK CEO: Pfizer venture creates value for both our consum...,0.0,0.64,0.36,1
2019-01-07 17:07:01,0.296,"IVV, GOOG, GOOGL, PFE: ETF Inflow Alert",0.0,0.732,0.268,1
2019-01-07 17:55:02,0.0,Analysts’ Recommendations for Eli Lilly in January,0.0,1.0,0.0,0
2019-01-07 18:05:00,0.0,GlaxoSmithKline CEO Emma Walmsley gets &apos;radical&apos; about reshaping portfolio,0.0,1.0,0.0,0
2019-01-07 18:05:00,0.0,GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolio,0.0,1.0,0.0,0
2019-01-07 19:25:02,0.1779,Pfizer or Eli Lilly: Whose Revenue Is Growing More Quickly?,0.0,0.841,0.159,1
2019-01-07 20:51:08,0.0,Biogen Inks Two Deals to Make Drugs for Neurological Diseases,0.0,1.0,0.0,0
2019-01-07 21:09:00,0.0,Why Exact Sciences Soared Today,0.0,1.0,0.0,0
2019-01-07 21:57:09,0.4939,Aerie's Rhopressa Succeeds in Study on Japanese Patients,0.0,0.686,0.314,1
2019-01-07 23:16:28,0.2023,Top Dow Stocks for 2018,0.0,0.69,0.31,1
2019-01-08 01:44:04,0.0,"Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way",0.0,1.0,0.0,0
2019-01-08 03:00:00,0.4588,3 Things Pfizer&apos;s New CEO Just Said That Investors Will be Glad to Hear,0.0,0.8,0.2,1
2019-01-08 04:38:49,0.4588,3 Things Pfizer's New CEO Just Said That Investors Will be Glad to Hear,0.0,0.8,0.2,1
2019-01-08 12:15:00,0.0,3 Companies You Don&apos;t Realize You Rely On Every Day,0.0,1.0,0.0,0
2019-01-08 12:30:40,0.6705,Pfizer or Eli Lilly: Whose Earnings Are Seeing Better Growth?,0.0,0.593,0.407,1
2019-01-08 13:00:01,0.8176,Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?,0.0,0.595,0.405,1
2019-01-08 13:39:51,0.0,3 Companies You Don't Realize You Rely On Every Day,0.0,1.0,0.0,0
2019-01-08 14:00:26,0.4404,Pfizer or Eli Lilly: Which Company Has Better Margins?,0.0,0.734,0.266,1
2019-01-08 14:39:25,0.4939,"Health Care Sector Update for 01/08/2019: AXSM, AKRX, NVS, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-01-08 15:30:34,0.4728,Pfizer or Eli Lilly: Which Company Is More Cost Efficient?,0.0,0.745,0.255,1
2019-01-09 11:36:00,0.0,3 Reasons Buying Celgene Right Now Makes Sense,0.0,1.0,0.0,0
2019-01-09 12:30:26,0.4404,Pfizer or Eli Lilly: Which Company Has the Better Dividend Policy?,0.0,0.775,0.225,1
2019-01-09 14:00:58,0.0,Amarin Expects Expenses to Rise in the Future,0.0,1.0,0.0,0
2019-01-09 14:28:57,0.0,Cell therapy pioneer eyes Bay Area manufacturing,0.0,1.0,0.0,0
2019-01-09 18:29:00,0.4995,"JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon",0.0,0.739,0.261,1
2019-01-09 20:57:07,0.0,7 Dow Jones Stocks Set to Charge Higher,0.0,1.0,0.0,0
2019-01-09 23:45:05,0.0,Pfizer to shut two manufacturing plants in India,0.0,1.0,0.0,0
2019-01-10 03:20:15,0.0,"Morning News Call - India, January 10",0.0,1.0,0.0,0
2019-01-10 14:43:31,0.4939,"Health Care Sector Update for 01/10/2019:  PRPO,CGIX, PHG, JNJ, PFE, MRK, ABT, AMGN",0.0,0.789,0.211,1
2019-01-10 14:56:02,0.368,Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting,0.0,0.798,0.202,1
2019-01-10 18:15:00,0.0,Amarin Corporation&apos;s Stock Heats Up on Buyout Chatter,0.0,1.0,0.0,0
2019-01-10 19:49:42,0.4019,3 Defensive ETFs to Protect Yourself From Another Market Selloff,0.0,0.654,0.346,1
2019-01-10 20:06:41,0.0,Amarin Corporation's Stock Heats Up on Buyout Chatter,0.0,1.0,0.0,0
2019-01-10 20:15:00,0.2023,"6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...)",0.0,0.795,0.205,1
2019-01-10 20:19:08,-0.6597,Athenex Completes Enrollment Target for Breast Cancer Study,0.386,0.614,0.0,-1
2019-01-10 21:13:51,0.296,Will Pfizer Join The Buying Spree With This Small Biotech Stock?,0.0,0.82,0.18,1
2019-01-10 21:23:29,0.4939,"Health Care Sector Update for 01/10/2019: AMRN,PFE,HALO,PRPO,CGIX",0.0,0.652,0.348,1
2019-01-10 21:49:17,0.0,"Market Close Report: NASDAQ Composite index closes at 6,986.07 up 28.99 points",0.0,1.0,0.0,0
2019-01-10 23:03:53,0.5859,Stocks Win 5 In a Row After Dovish Powell,0.0,0.612,0.388,1
2019-01-11 10:03:26,0.0,Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 1/11/2019,0.0,1.0,0.0,0
2019-01-11 11:00:00,0.6249,"For Strong Returns, Try Stock in Top Spenders on R&D",0.0,0.611,0.389,1
2019-01-11 11:22:11,0.0,4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019,0.0,1.0,0.0,0
2019-01-11 12:44:00,0.0,This Market May Just Be in an Uptrend: Market Recon,0.0,1.0,0.0,0
2019-01-11 14:13:25,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019",0.0,1.0,0.0,0
2019-01-11 14:14:01,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 14, 2019",0.0,1.0,0.0,0
2019-01-11 14:25:00,0.0,Pfizer and the Urge to Merge,0.0,1.0,0.0,0
2019-01-11 14:43:50,0.4939,"Health Care Sector Update for 01/11/2019: TLRY, ADXS, APHA, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-11 14:45:02,0.368,"Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet",0.0,0.856,0.144,1
2019-01-11 14:56:02,0.0,Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer,0.0,1.0,0.0,0
2019-01-11 17:09:00,0.0,"For Esperion Therapeutics, 2019 Could Be a Big Year",0.0,1.0,0.0,0
2019-01-11 20:06:57,0.0,7 Pharmaceutical Stocks That Just Raised Prices This Year,0.0,1.0,0.0,0
2019-01-11 21:49:34,0.0,"Market Close Report: NASDAQ Composite index closes at 6,971.48 down -14.59 points",0.0,1.0,0.0,0
2019-01-11 23:04:32,0.4767,Stocks Snap Win Streak as Shutdown Drags On,0.148,0.522,0.33,1
2019-01-11 23:11:11,0.0,NASH Space in Focus in 2019 as Firms Look to Diversify,0.0,1.0,0.0,0
2019-01-12 17:00:00,0.0,3 Biotech Stocks That Soared This Week: Are They Buys?,0.0,1.0,0.0,0
2019-01-13 18:06:45,0.3612,Stock Market Power Rankings: Amazon Back on Top,0.0,0.632,0.368,1
2019-01-14 01:45:00,0.0,Here Are the 2019 Dogs of the Dow,0.0,1.0,0.0,0
2019-01-14 08:07:00,0.3182,Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis,0.0,0.796,0.204,1
2019-01-14 13:00:00,0.6124,US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy,0.0,0.706,0.294,1
2019-01-14 13:56:00,0.2732,Pfizer's new drug applications for tafamidis accepted for filing by FDA,0.0,0.826,0.174,1
2019-01-14 13:56:00,0.2732,Pfizer&apos;s new drug applications for tafamidis accepted for filing by FDA,0.0,0.826,0.174,1
2019-01-14 15:50:09,0.5859,Modern Value Investing: Adding to the Value Investing Toolbox,0.0,0.593,0.407,1
2019-01-14 16:29:34,0.0,How To Approach Q4 Earnings: The Global Perspective,0.0,1.0,0.0,0
2019-01-14 16:48:00,0.0,Why Dow Jones' Pfizer Is Prepped To Rival These 2 Biotech Stocks,0.0,1.0,0.0,0
2019-01-14 16:57:50,0.0,Sell Amarin Stock on the Recent Takeover Rumors Rally,0.0,1.0,0.0,0
2019-01-14 17:09:00,0.0,House Democrats launch drug-pricing probe into a dozen major health-care companies,0.0,1.0,0.0,0
2019-01-14 17:09:00,0.0,House Democrats launch drug pricing probe into a dozen major health-care companies,0.0,1.0,0.0,0
2019-01-14 17:42:09,0.0,House Dems announce sweeping investigation of drug pricing,0.0,1.0,0.0,0
2019-01-14 20:08:00,0.296,What Caused Exact Sciences Shares to Fall 19.1% in December,0.0,0.804,0.196,1
2019-01-14 21:23:00,-0.128,This Biotech Stock Plunged On Its Looming Rivalry With Pfizer,0.143,0.857,0.0,-1
2019-01-14 22:24:31,0.0,Stocks slip as corporate earnings season begins,0.0,1.0,0.0,0
2019-01-14 22:52:16,0.0,Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe,0.0,1.0,0.0,0
2019-01-14 23:00:00,0.0,Democrats target drug prices,0.0,1.0,0.0,0
2019-01-15 01:04:00,0.3818,Here&apos;s How Pfizer Gained 20.5% in 2018,0.0,0.698,0.302,1
2019-01-15 01:06:38,0.3818,8 Dividend Stocks With Growth on the Horizon,0.0,0.698,0.302,1
2019-01-15 01:38:00,-0.34,"First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch",0.179,0.821,0.0,-1
2019-01-15 02:07:29,0.3818,Here's How Pfizer Gained 20.5% in 2018,0.0,0.698,0.302,1
2019-01-15 05:06:38,0.0,Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019,0.0,1.0,0.0,0
2019-01-15 13:00:01,0.0,Pfizer Gets FDA's Priority Review for Rare Disease Candidate,0.0,1.0,0.0,0
2019-01-15 13:00:32,0.0,See what the IHS Markit Score report has to say about Pfizer Inc.,0.0,1.0,0.0,0
2019-01-15 13:09:10,0.0,Why Amarin Is Soaring in First Half of January,0.0,1.0,0.0,0
2019-01-15 14:47:02,0.4939,"Health Care Sector Update for 01/15/2019: BPTH, ALNY, TRXC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-15 17:14:12,-0.6597,Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer,0.355,0.645,0.0,-1
2019-01-15 18:09:26,0.0,"XLV, PFE, UNH, MRK: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2019-01-16 12:35:00,0.0,Fiserv to buy First Data in $22B all-stock deal,0.0,1.0,0.0,0
2019-01-16 13:11:00,0.0,Is Pfizer a Buy?,0.0,1.0,0.0,0
2019-01-16 14:18:56,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019",0.0,1.0,0.0,0
2019-01-16 14:47:12,0.4939,"Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-16 19:57:00,0.2023,"6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...)",0.0,0.795,0.205,1
2019-01-16 20:08:23,0.0,Why Ligand Pharmaceuticals Tanked 25%,0.0,1.0,0.0,0
2019-01-16 20:30:41,0.0,Court rules against Pfizer in religious discrimination suit,0.0,1.0,0.0,0
2019-01-17 14:06:02,0.0,J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect,0.0,1.0,0.0,0
2019-01-17 17:31:48,0.0,"3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group",0.0,1.0,0.0,0
2019-01-17 20:36:37,0.5574,The Stable Value Stock Is Built to Weather Market Storms,0.0,0.635,0.365,1
2019-01-18 13:38:41,0.7783,PFE's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow',0.0,0.506,0.494,1
2019-01-18 15:47:59,0.0516,"Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress",0.185,0.616,0.199,0
2019-01-18 15:49:42,0.7269,Baxter (BAX) Gains From Sharesource's Global Success Rates,0.0,0.496,0.504,1
2019-01-18 16:47:20,0.0,"Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY",0.0,1.0,0.0,0
2019-01-18 17:36:00,0.0,"Bulls bet on this biopharma company. Plus, the update on ...",0.0,1.0,0.0,0
2019-01-18 21:41:15,0.2023,"Top Stock Reports for Pfizer, Biogen & Schwab",0.0,0.769,0.231,1
2019-01-19 21:06:10,0.0,Dogs of the Dow 2019: 10 Dividend Stocks to Watch,0.0,1.0,0.0,0
2019-01-20 14:15:00,0.5859,Would Pfizer Shareholders Win With an Acquisition of Amarin?,0.0,0.678,0.322,1
2019-01-20 15:07:43,-0.7832,Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?,0.408,0.592,0.0,-1
2019-01-21 06:01:26,0.0,[$$] GSK chairman to step down ahead of break-up,0.0,1.0,0.0,0
2019-01-21 07:20:47,0.0,[$$] GlaxoSmithKline chair Philip Hampton to step down,0.0,1.0,0.0,0
2019-01-21 08:12:42,0.0,GSK Chairman Hampton to step down ahead of split,0.0,1.0,0.0,0
2019-01-21 15:14:30,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips",0.0,1.0,0.0,0
2019-01-21 17:07:45,0.4404,3 Stocks That Are Easy to Understand,0.0,0.633,0.367,1
2019-01-21 20:24:45,0.0,The Dogs of the Dow 2019: 10 Dividend Stocks to Watch,0.0,1.0,0.0,0
2019-01-22 00:16:00,0.0,Will AVRO Reverse Course In Run-up To February Event?,0.0,1.0,0.0,0
2019-01-22 13:02:11,0.3612,What Do Analysts Recommend for Pfizer ahead of Its Q4 Results?,0.0,0.8,0.2,1
2019-01-22 13:08:28,0.4404,Better Buy: Pfizer vs. AbbVie,0.0,0.58,0.42,1
2019-01-22 14:35:02,0.4404,Is Pfizer Expected to Impress the Market with Its Q4 Results?,0.0,0.775,0.225,1
2019-01-22 14:45:18,0.5574,All Signals Are Positive for Buying Abbott Laboratories,0.0,0.66,0.34,1
2019-01-22 15:16:51,0.0,Johnson & Johnson Releases Its 2018 Results: Revenue Up 6.7%,0.0,1.0,0.0,0
2019-01-22 16:05:02,0.0,How Pfizer’s Research Pipeline Is Set Up ahead of Its Q4 Results,0.0,1.0,0.0,0
2019-01-23 12:30:02,0.0,Is Pfizer Expecting a Rise in Its Expenses in 2019?,0.0,1.0,0.0,0
2019-01-23 13:34:00,-0.2732,"Pfizer, Merck drop after Wall Street downgrades on &apos;patent cliff&apos; and competition",0.16,0.84,0.0,-1
2019-01-23 13:34:00,-0.2732,"Pfizer, Merck drop after Wall Street downgrades on 'patent cliff' and competition",0.16,0.84,0.0,-1
2019-01-23 14:03:11,0.4767,Merck a Top Socially Responsible Dividend Stock With 2.9% Yield (MRK),0.0,0.661,0.339,1
2019-01-23 16:37:56,0.0,"Dow Movers: MRK, IBM",0.0,1.0,0.0,0
2019-01-23 17:37:19,0.296,"MTUM, MRK, PFE, MA: ETF Outflow Alert",0.0,0.732,0.268,1
2019-01-23 19:04:15,-0.5423,"Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook",0.36,0.64,0.0,-1
2019-01-23 21:25:00,0.0,Big Pharma Stocks Were Downgraded by Analysts Today,0.0,1.0,0.0,0
2019-01-24 08:14:26,-0.4404,[$$] The London Report: Vodafone slides after weak S Africa results,0.244,0.756,0.0,-1
2019-01-24 11:57:03,0.0,Pfizer Falls 3%,0.0,1.0,0.0,0
2019-01-24 14:54:29,0.4939,"Health Care Sector Update for 01/24/2019: URGN, BMY, TTNP, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-01-24 16:59:00,0.4939,Skyrocketing health care costs key topic at Davos,0.0,0.686,0.314,1
2019-01-24 18:40:03,0.0,Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-01-24 18:40:39,0.0,Healthcare ETFs in Focus Ahead of Q4 Earnings,0.0,1.0,0.0,0
2019-01-24 19:37:38,0.0,Stocks waver as chipmakers power tech company rally,0.0,1.0,0.0,0
2019-01-24 19:53:00,0.0,Cost on the rise: Congress to investigate Big Pharma,0.0,1.0,0.0,0
2019-01-24 20:36:21,0.0,Moderna's Hot New mRNA Technology Has Competition,0.0,1.0,0.0,0
2019-01-24 21:48:45,0.0,Stocks waver again as chipmakers jump and drug companies dip,0.0,1.0,0.0,0
2019-01-25 03:47:12,0.5574,Asian shares rise after moderate gains on Wall Street,0.0,0.603,0.397,1
2019-01-25 05:29:03,0.6908,Asian shares rise on optimism over China-US trade talks,0.0,0.551,0.449,1
2019-01-25 12:31:18,0.0,Boeing Is the Second-Best Dow 30 Performer,0.0,1.0,0.0,0
2019-01-25 14:34:52,0.4939,"Health Care Sector Update for 01/25/2019: IDXG, RMD, ABBV, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-01-25 14:37:00,0.0,How to Trade Merck and Pfizer Pre-Earnings - Each Face Deteriorating Charts,0.0,1.0,0.0,0
2019-01-25 15:23:03,-0.4588,"Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV",0.214,0.786,0.0,-1
2019-01-25 16:22:00,0.5574,Stocks Close Firmly Positive After Deal To End Shutdown - U.S. Commentary,0.0,0.735,0.265,1
2019-01-25 17:38:03,0.25,"3 Big Stock Charts for Friday: Merck, Broadcom and Advanced Micro Devices",0.0,0.833,0.167,1
2019-01-25 22:04:57,0.4576,"After Hours Most Active for Jan 25, 2019 :  ENLK, CZR, ENLC, DHI, BAC, PFE, JD, ZNGA, KMI, INTC, FB, QQQ",0.0,0.864,0.136,1
2019-01-27 16:30:00,0.0,3 Things You Should Expect in Pfizer&apos;s Q4 Earnings Update,0.0,1.0,0.0,0
2019-01-27 17:43:40,0.0,3 Things You Should Expect in Pfizer's Q4 Earnings Update,0.0,1.0,0.0,0
2019-01-28 01:29:45,-0.4215,Pfizer Pivots to Cancer Drugs for Growth,0.367,0.417,0.217,-1
2019-01-28 12:02:12,0.0,Clovis' Rubraca Gets Nod as Maintenance Therapy in Europe,0.0,1.0,0.0,0
2019-01-28 14:43:59,0.4939,"Health Care Sector Update for 01/28/2019: TRVN, ARAY, ABBV, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-28 15:19:03,0.0,"Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB & AGN",0.0,1.0,0.0,0
2019-01-28 15:46:21,0.0,Week in Review: U.S. Markets Quiet During Short Week as Government Shutdown Temporarily Ended,0.0,1.0,0.0,0
2019-01-28 16:15:00,-0.6597,Stocks Move Significantly Lower On Disappointing Earnings News - U.S. Commentary,0.403,0.597,0.0,-1
2019-01-28 17:43:12,-0.3182,PFE Makes Notable Cross Below Critical Moving Average,0.247,0.753,0.0,-1
2019-01-28 17:44:59,0.0,"3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte",0.0,1.0,0.0,0
2019-01-28 18:06:00,0.0,"Earnings Preview: Apple, AMD, Verizon, Other Giants to Report Crucial Q4",0.0,1.0,0.0,0
2019-01-28 18:20:13,0.0,Q4 Earnings Outlook For Pfizer,0.0,1.0,0.0,0
2019-01-28 18:39:05,-0.296,5 Dow Jones Stocks Under Pressure,0.355,0.645,0.0,-1
2019-01-28 18:43:02,0.0,Pfizer is Oversold,0.0,1.0,0.0,0
2019-01-28 21:12:46,0.0,"Pre-Market Earnings Report for January 29, 2019 :  PFE, VZ, MMM, LMT, DHR, BIIB, AGN, HCA, GLW, PCAR, ROK, NUE",0.0,1.0,0.0,0
2019-01-28 21:30:35,0.0,The worst-performing Dow stock this year is about to report earnings. Here's what to expect,0.0,1.0,0.0,0
2019-01-28 22:42:41,0.0,Pfizer Stock Is at Do-or-Die Spot Ahead of Earnings,0.0,1.0,0.0,0
2019-01-29 06:39:00,-0.5106,"Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain",0.231,0.769,0.0,-1
2019-01-29 06:47:00,0.1779,Pfizer Shares Slump 2% After Cutting Full-Year Revenue Outlook,0.14,0.654,0.206,1
2019-01-29 07:18:00,-0.3818,Pfizer Q4 Results Beat View; But FY19 Outlook Disappoints,0.245,0.755,0.0,-1
2019-01-29 08:19:00,0.5574,Futures Point To Moderately Positive Opening For Wall Street,0.0,0.69,0.31,1
2019-01-29 08:59:00,0.0,Stocks May Show Initial Move To The Upside - U.S. Commentary,0.0,1.0,0.0,0
2019-01-29 10:47:00,0.0,Major Averages Turning In Mixed Performance In Morning Trading - U.S. Commentary,0.0,1.0,0.0,0
2019-01-29 11:30:00,-0.5106,Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain,0.191,0.809,0.0,-1
2019-01-29 11:45:00,0.0,PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS,0.0,1.0,0.0,0
2019-01-29 11:51:10,-0.5994,Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate,0.29,0.71,0.0,-1
2019-01-29 11:51:10,-0.1531,"Pfizer's earnings beat forecast, but shares fall as company's outlook disappoints",0.224,0.592,0.184,-1
2019-01-29 11:55:47,-0.2263,Pfizer full-year revenue forecast misses estimates,0.275,0.725,0.0,-1
2019-01-29 11:58:00,-0.3818,"Pfizer shares slide 2% premarket after it swings to loss, guidance lags consensus",0.282,0.588,0.129,-1
2019-01-29 12:11:38,-0.0772,"Pfizer Earnings Top, But Dow Jones Drug Giant Guides Low; Allergan Earnings Beat",0.141,0.738,0.121,0
2019-01-29 12:34:48,0.0,"US STOCKS-Wall St futures flat, eyes on China impact",0.0,1.0,0.0,0
2019-01-29 12:46:33,0.5106,[$$] Pfizer sees strong dollar weighing on results in 2019,0.0,0.732,0.268,1
2019-01-29 12:52:54,0.0,"Stocks making the biggest moves premarket: 3M, Pfizer, Verizon, Xerox & more",0.0,1.0,0.0,0
2019-01-29 13:25:34,-0.3818,Pfizer’s Fiscal 2019 Guidance Disappoints Investors,0.342,0.658,0.0,-1
2019-01-29 13:37:36,-0.3818,Pfizer&apos;s Outlook Disappoints as Drugmaker Focuses on Pipeline,0.271,0.729,0.0,-1
2019-01-29 13:53:01,-0.3818,"Pfizer (PFE) Q4 Earnings & Sales Beat, 2019 View Disappoints",0.245,0.755,0.0,-1
2019-01-29 13:54:49,0.0,US STOCKS-Wall St set to open higher after latest batch of earnings,0.0,1.0,0.0,0
2019-01-29 14:03:00,-0.6597,4 Things Exact Sciences Investors Should Know About 23andMe&apos;s New Cancer Test,0.306,0.694,0.0,-1
2019-01-29 14:25:00,0.4019,Dow earnings reporters' stocks would boost Dow's price by 11 points,0.0,0.787,0.213,1
2019-01-29 14:25:00,0.4019,Dow earnings reporters&apos; stocks would boost Dow&apos;s price by 11 points,0.0,0.787,0.213,1
2019-01-29 14:37:43,0.0,"Stocks Mixed Ahead Of Trade Talks, Fed, Apple; Cat Leads Dow Jones",0.0,1.0,0.0,0
2019-01-29 14:41:02,0.0,"Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips",0.0,1.0,0.0,0
2019-01-29 15:03:33,0.0,Pfizer&apos;s Subpar Outlook Embodies Pharma&apos;s Plight,0.0,1.0,0.0,0
2019-01-29 15:15:18,0.0,Dow Leads Despite Mixed Earnings Results; Apple Earnings On Deck,0.0,1.0,0.0,0
2019-01-29 15:16:03,0.0,The Apple (AAPL) of Investors' Eye,0.0,1.0,0.0,0
2019-01-29 15:19:00,0.0772,Dow Gets Lift From 3M as Wall Street Awaits Earnings From Apple,0.0,0.894,0.106,0
2019-01-29 15:40:00,0.0,Pfizer’s ‘Promising Outlook’ Still Shines for Analysts After Earnings Report,0.0,1.0,0.0,0
2019-01-29 16:02:04,0.0,Apple To Report Fiscal Q1 Earnings,0.0,1.0,0.0,0
2019-01-29 17:26:15,0.0,"Stocks making moves midday: PulteGroup, 3M, Harley-Davidson & more",0.0,1.0,0.0,0
2019-01-29 18:01:00,0.0,Major Averages Close Mixed Following Lackluster Session - U.S. Commentary,0.0,1.0,0.0,0
2019-01-29 18:16:00,0.0,South Korea Shares May See Renewed Selling Pressure,0.212,0.577,0.212,0
2019-01-29 18:16:19,0.4215,"Pfizer quarterly profit in line, touts pipeline of future products",0.092,0.667,0.242,1
2019-01-29 18:31:00,-0.2263,Malaysia Bourse May Extend Losing Streak,0.313,0.482,0.205,-1
2019-01-29 18:32:41,0.0516,"Pfizer swings to loss due to restructuring, asset writedowns",0.195,0.593,0.212,0
2019-01-29 18:40:06,0.0,"Apple Earnings Preview & Latest Results from Verizon, 3M, and Pfizer",0.0,1.0,0.0,0
2019-01-29 19:00:00,0.0,Dow Trades Higher and Nasdaq Stumbles Ahead of Apple Earnings,0.0,1.0,0.0,0
2019-01-29 19:01:00,0.0,Continued Consolidation Called For Singapore Stock Market,0.0,1.0,0.0,0
2019-01-29 19:31:00,-0.5563,More Pain Predicted For Taiwan Stock Market,0.375,0.625,0.0,-1
2019-01-29 20:00:00,0.0,Pfizer Q4 Earnings Update: 4 Key Things You Need to Know,0.0,1.0,0.0,0
2019-01-29 20:01:00,-0.296,China Bourse Expected To Open Under Pressure,0.268,0.732,0.0,-1
2019-01-29 20:07:00,0.34,Dow Gives Up Gains as Stocks Falter Ahead of Apple Earnings,0.0,0.806,0.194,1
2019-01-29 20:16:00,-0.128,Losses May Accelerate For Hong Kong Shares,0.273,0.505,0.222,-1
2019-01-29 20:36:00,0.0,Australian Market Modestly Higher,0.0,1.0,0.0,0
2019-01-29 21:01:00,0.4019,"Indonesia Stock Market May Test Support At 6,400 Points",0.0,0.748,0.252,1
2019-01-29 21:20:00,0.0,Dow Closes Modestly Higher Ahead of Apple Earnings,0.0,1.0,0.0,0
2019-01-29 21:26:00,0.1027,Pfizer Tops Q4 Earnings But Guides for Weaker 2019 as Lyrica Exclusivity Ends,0.169,0.64,0.192,1
2019-01-29 21:31:00,0.0,Continued Selling Pressure Predicted For Thai Shares,0.234,0.532,0.234,0
2019-01-29 21:38:00,-0.296,Japanese Market Drifts Lower,0.423,0.577,0.0,-1
2019-01-29 21:42:38,-0.4404,"Pfizer, Allergan Stocks Diverge On Earnings Beat, Weak Sales Outlook",0.244,0.756,0.0,-1
2019-01-29 21:48:50,0.0,"Market Close Report: NASDAQ Composite index closes at 7,028.29 down -57.40 points",0.0,1.0,0.0,0
2019-01-29 21:57:17,0.0,3 Stocks Move Tuesday,0.0,1.0,0.0,0
2019-01-29 22:03:07,0.4576,"After Hours Most Active for Jan 29, 2019 :  ABEV, FCX, PFE, ITUB, PG, TVPT",0.0,0.813,0.187,1
2019-01-29 22:03:25,0.5267,Close Update: Dow Scratches Out Small Gain as Other Major Indexes Slump,0.0,0.764,0.236,1
2019-01-29 22:20:58,0.0,US Market Indexes Close Flat on Tuesday,0.0,1.0,0.0,0
2019-01-29 22:23:00,-0.296,"Asian Markets Mostly Lower Ahead Of Fed Decision, Trade Talks",0.196,0.804,0.0,-1
2019-01-29 22:43:27,0.5859,"Pfizer, 3M Earnings Propel Dow to a Win",0.0,0.612,0.388,1
2019-01-29 23:41:17,-0.296,Here's when an earnings miss isn't really a miss: Jim Cramer,0.286,0.714,0.0,-1
2019-01-30 00:42:40,0.6369,The 5 Best Dow Jones Stocks to Buy Now,0.0,0.625,0.375,1
2019-01-30 01:17:54,-0.4767,[$$] Pfizer Results Hurt by Pricing Challenges,0.351,0.515,0.134,-1
2019-01-30 03:47:30,0.4404,Better Buy: Johnson & Johnson vs. Pfizer,0.0,0.633,0.367,1
2019-01-30 04:45:41,0.0,Pfizer (PFE) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-01-30 05:40:00,0.0,"Pfizer Well-Positioned, Undervalued",0.0,1.0,0.0,0
2019-01-30 12:00:00,0.1779,"New Jersey’s College Savings Plan Bought Up AT&T, Amazon, and GM Stock",0.0,0.866,0.134,1
2019-01-30 12:28:00,-0.6597,A Cure for Cancer Next Year? The Stock Market Says Don&apos;t Believe the Hype,0.268,0.732,0.0,-1
2019-01-30 13:16:00,0.0,3 Big Pharmas Expecting a Softer 2019,0.0,1.0,0.0,0
2019-01-30 13:46:01,0.0,"Amgen (AMGN) Q4 Earnings Beat Estimates, 2019 Guidance Tepid",0.0,1.0,0.0,0
2019-01-30 13:50:26,-0.6597,A Cure for Cancer Next Year? The Stock Market Says Don't Believe the Hype,0.268,0.732,0.0,-1
2019-01-30 13:52:01,-0.0258,Lilly/Pfizer's Osteoarthritis Pain Drug Succeeds in 2nd Study,0.264,0.48,0.256,0
2019-01-30 14:16:50,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for January 31, 2019",0.0,1.0,0.0,0
2019-01-30 14:30:02,0.0,"Company News For Jan 30, 2019",0.0,1.0,0.0,0
2019-01-30 14:47:47,0.4939,"Health Care Sector Update for 01/30/2019: CODX, ANTM, ACIU, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-01-30 16:03:01,0.0,Pfizer Beats Expectations but Reaction Is Muted,0.0,1.0,0.0,0
2019-01-30 17:46:00,0.0,Pfizer's Near-Term Correction Could Be Over,0.0,1.0,0.0,0
2019-01-30 18:23:43,0.0,Pfizer: Analysts’ Recommendations after Its Q4 Results,0.0,1.0,0.0,0
2019-01-30 19:47:33,0.0,What Should Apple Do With Its Cash?,0.0,1.0,0.0,0
2019-01-30 19:55:02,0.0,Pfizer Expects Flat Operational Revenue in Fiscal 2019,0.0,1.0,0.0,0
2019-01-30 21:25:02,0.0,Pfizer: Flat Operational EPS Performance in Fiscal 2019?,0.0,1.0,0.0,0
2019-01-30 21:34:59,0.0,Edited Transcript of PFE earnings conference call or presentation 29-Jan-19 3:00pm GMT,0.0,1.0,0.0,0
2019-01-31 00:01:00,-0.296,Jim Cramer: When Is a Miss Not a Miss?,0.39,0.61,0.0,-1
2019-01-31 04:45:02,-0.128,Why are deep-pocketed biotechs cutting hundreds of jobs?,0.176,0.824,0.0,-1
2019-01-31 12:31:45,0.0,Pfizer’s Expenses Are Expected to Rise in Fiscal 2019,0.0,1.0,0.0,0
2019-01-31 14:01:02,0.3818,Oncology Portfolio: Pfizer’s Key Growth Driver in Fiscal 2018,0.0,0.755,0.245,1
2019-01-31 14:44:22,0.4939,"Health Care Sector Update for 01/31/2019: SCYX, PULM, BAX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-01-31 15:30:45,0.1779,Pfizer: Ibrance and Xtandi Are Key Oncology Assets,0.0,0.805,0.195,1
2019-01-31 16:27:00,0.0,Pfizer Stock’s ‘Dark Period’ Might Finally Be Over,0.0,1.0,0.0,0
2019-01-31 18:43:47,0.0,Merck's Pneumococcal Vaccine Gets Breakthrough Therapy Status,0.0,1.0,0.0,0
2019-01-31 22:43:34,0.6369,Nasdaq Closes Out Best Month Since 2011,0.0,0.588,0.412,1
2019-02-01 09:25:00,0.5574,Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg,0.0,0.69,0.31,1
2019-02-01 12:30:44,0.3612,Xeljanz: Pfizer’s Key Immunology Asset in Fiscal 2019,0.0,0.737,0.263,1
2019-02-01 13:07:36,0.0,Watch These Healthcare Stocks in First Week of February,0.0,1.0,0.0,0
2019-02-01 13:15:01,0.0,"Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",0.0,1.0,0.0,0
2019-02-01 14:17:00,0.0516,Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations,0.129,0.706,0.165,0
2019-02-01 14:44:42,0.4939,"Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-02-01 15:15:45,0.0,Pharma Catches Another Case Of M&A Fever,0.0,1.0,0.0,0
2019-02-01 15:56:29,0.4404,"Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress",0.0,0.775,0.225,1
2019-02-01 21:47:04,0.2023,"Top Analyst Reports for Boeing, Thermo Fisher & Anthem",0.0,0.795,0.205,1
2019-02-02 01:01:00,-0.296,It&apos;s Official: Trump Proposes Plan to Stop Skyrocketing Drug Prices,0.196,0.804,0.0,-1
2019-02-02 02:44:37,-0.296,It's Official: Trump Proposes Plan to Stop Skyrocketing Drug Prices,0.196,0.804,0.0,-1
2019-02-02 19:17:00,-0.3818,Pricing Pressure a Hard Pill for Pharma to Swallow,0.375,0.625,0.0,-1
2019-02-03 14:16:00,0.0,Pfizer&apos;s Next 3 Years: What Investors Can Expect,0.0,1.0,0.0,0
2019-02-03 15:07:35,-0.296,A War on High Drug Prices Could Boost Biosimilars,0.31,0.476,0.214,-1
2019-02-03 16:08:06,0.0,Pfizer's Next 3 Years: What Investors Can Expect,0.0,1.0,0.0,0
2019-02-04 14:46:57,0.4939,"Health Care Sector Update for 02/04/2019: BLRX, EOLS, FENC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-04 15:14:23,0.0,"The Zacks Analyst Blog Highlights: Boeing, Thermo Fisher, Anthem, PayPal and Pfizer",0.0,1.0,0.0,0
2019-02-04 16:16:30,-0.6597,Pfizer's (PFE) New Lung Cancer Drug Vizimpro Gets CHMP Nod,0.328,0.672,0.0,-1
2019-02-04 20:37:06,0.0,What Are Analysts Recommending for Merck after Q4 2018 Results?,0.0,1.0,0.0,0
2019-02-04 20:41:00,0.2023,"7 Top Gainers In Healthcare Sector (ALRN, APHA, INSY...)",0.0,0.795,0.205,1
2019-02-05 02:47:00,0.0,Here&apos;s Why Exact Sciences Soared 42.8% in January,0.0,1.0,0.0,0
2019-02-05 04:07:23,0.0,Here's Why Exact Sciences Soared 42.8% in January,0.0,1.0,0.0,0
2019-02-05 13:03:52,-0.1531,Corporate Profits' New Enemy Is the 'Dollar Vortex',0.282,0.484,0.234,-1
2019-02-05 13:07:01,0.0,Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies,0.0,1.0,0.0,0
2019-02-05 15:07:02,0.4939,"Health Care Sector Update for 02/05/2019: OPGN, CNC, GILD, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-05 16:38:10,0.0,"Pharma execs will testify before Congress 'one way or another,' US senator says",0.0,1.0,0.0,0
2019-02-05 16:38:10,0.0,"Pharma execs will testify before Congress &apos;one way or another,&apos; US senator says",0.0,1.0,0.0,0
2019-02-05 21:06:44,0.0,Merck CEO Frazier to testify at Senate drug pricing hearing,0.0,1.0,0.0,0
2019-02-05 21:49:13,0.0,"Market Close Report: NASDAQ Composite index closes at 7,402.08 up 54.54 points",0.0,1.0,0.0,0
2019-02-05 23:07:11,0.6908,Dow Rallies For Second Straight Triple-Digit Win,0.0,0.467,0.533,1
2019-02-06 12:48:37,0.0,Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.,0.0,1.0,0.0,0
2019-02-06 13:09:03,-0.0772,Winners & Losers from Trump's State of the Union Address,0.252,0.519,0.23,0
2019-02-06 14:44:31,0.0,Pfizer CEO Bourla plans to testify at Senate drug pricing hearing,0.0,1.0,0.0,0
2019-02-06 14:47:08,0.4939,"Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-02-06 17:16:37,-0.3818,Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying,0.148,0.852,0.0,-1
2019-02-06 18:48:00,0.0,Eli Lilly Stock Falls Because 2019 Isn’t 2018,0.0,1.0,0.0,0
2019-02-06 22:52:47,0.0,At least four pharma CEOs to testify at Senate drug pricing hearing,0.0,1.0,0.0,0
2019-02-07 14:00:02,0.0,"Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19",0.0,1.0,0.0,0
2019-02-07 14:47:25,0.4939,"Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-08 04:07:54,-0.4019,What Solid Biosciences' First Failure Means for Sarepta Therapeutics,0.277,0.588,0.134,-1
2019-02-08 10:00:00,0.5267,Buying the Dow Stocks With the Highest Dividends Is a Winning Strategy,0.0,0.746,0.254,1
2019-02-08 12:20:23,-0.296,Pfizer Japan recalls high blood pressure drug Amvalo due to carcinogen,0.18,0.82,0.0,-1
2019-02-08 14:45:22,0.4939,"Health Care Sector Update for 02/08/2019: APOP, SGEN, MBOT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-08 14:53:04,-0.296,Pfizer Japan recalls high blood pressure drug over cancer-causing impurity,0.196,0.804,0.0,-1
2019-02-08 17:07:43,0.0,"Notable ETF Inflow Detected - SPYG, GOOG, GOOGL, PFE",0.0,1.0,0.0,0
2019-02-08 21:14:08,-0.4404,This Gene Therapy Stock Could Soon Hit The Auction Block — Here&apos;s Why,0.209,0.791,0.0,-1
2019-02-10 22:37:42,0.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",0.0,1.0,0.0,0
2019-02-11 13:51:42,0.0,"Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs",0.0,1.0,0.0,0
2019-02-11 13:52:27,-0.3612,"Dow 30 Stock Roundup: Disney Earnings Impress, Pfizer's Cancer Drug Gets CHMP Nod",0.24,0.601,0.158,-1
2019-02-11 14:31:02,0.0,Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake,0.0,1.0,0.0,0
2019-02-11 17:07:14,0.0,"Stocks making the biggest moves midday: Avis Budget Group, Pfizer, Tesla & more",0.0,1.0,0.0,0
2019-02-11 21:07:39,0.0,Stocks Start Week of Trade Talks on Muted Note: Markets Wrap,0.0,1.0,0.0,0
2019-02-11 22:00:00,-0.3182,Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer,0.187,0.681,0.132,-1
2019-02-11 22:05:05,0.4576,"After Hours Most Active for Feb 11, 2019 :  SNAP, BAC, ELAN, FDC, PFE, MGM, FOMX, EMB, FB, EBAY, JBLU, CELG",0.0,0.864,0.136,1
2019-02-11 22:44:00,0.6369,FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma,0.0,0.744,0.256,1
2019-02-12 01:01:26,-0.4767,"Merck, Pfizer combo treatment boosts kidney cancer survival",0.346,0.472,0.181,-1
2019-02-12 14:36:47,0.4939,"Health Care Sector Update for 02/12/2019: KMDA, GILD, MDGS, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-02-12 14:38:35,0.4404,Better Buy: Gilead Sciences vs. Pfizer,0.0,0.633,0.367,1
2019-02-12 15:10:03,-0.6597,Pfizer sBLA for Kidney Cancer Drug Combo Gets Priority Review,0.328,0.672,0.0,-1
2019-02-12 16:36:49,0.4588,Alnylam Pharmaceuticals Is Launched and Ready for More,0.0,0.6,0.4,1
2019-02-12 16:46:23,0.0,"Stock Market News For Feb 12, 2019",0.0,1.0,0.0,0
2019-02-12 18:36:11,0.3612,What Analysts Recommend for Pfizer and Eli Lilly in February,0.0,0.783,0.217,1
2019-02-12 20:10:02,0.6705,Pfizer or Eli Lilly: Who Will Report Better Revenue Growth?,0.0,0.593,0.407,1
2019-02-12 21:40:02,0.3818,Pfizer or Eli Lilly: Who Is Expected to Report Higher EPS Growth?,0.0,0.809,0.191,1
2019-02-13 00:37:38,0.0,Bristol-Myers' Sprycel Gets European Nod for Label Expansion,0.0,1.0,0.0,0
2019-02-13 10:00:00,0.2023,Dogs of the Dow and a 3 Top Dogs Strategy,0.0,0.795,0.205,1
2019-02-13 12:31:52,0.4404,Pfizer or Eli Lilly: Who Is Controlling Expenses Better?,0.0,0.734,0.266,1
2019-02-13 14:00:57,0.0,Pfizer and Eli Lilly: How Dividends and Tax Rates Stack Up,0.0,1.0,0.0,0
2019-02-13 14:19:10,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 14, 2019",0.0,1.0,0.0,0
2019-02-13 14:23:20,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019",0.0,1.0,0.0,0
2019-02-13 14:36:57,0.4939,"Health Care Sector Update for 02/13/2019: BABY, TEVA, EXEL, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-13 15:30:45,0.3818,What Are the Key Growth Drivers for Pfizer in Fiscal 2019?,0.0,0.794,0.206,1
2019-02-13 20:36:08,0.0,Conatus (CNAT) Completes Enrollment in Phase II NASH Study,0.0,1.0,0.0,0
2019-02-13 20:36:54,0.0,"Exelixis (EXEL) Earnings, Revenues Beat Estimates in Q4",0.0,1.0,0.0,0
2019-02-14 10:00:25,-0.4215,Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter,0.167,0.833,0.0,-1
2019-02-14 12:50:18,-0.6486,"The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial",0.275,0.725,0.0,-1
2019-02-14 21:45:00,-0.8126,Bayer stresses drug's tolerability in bid for prostate cancer market,0.481,0.519,0.0,-1
2019-02-15 13:56:01,0.0,Sarepta's NDA for DMD Drug Golodirsen Gets Priority Review,0.0,1.0,0.0,0
2019-02-15 14:56:44,0.4939,"Health Care Sector Update for 02/15/2019: AKAO, ORPN, CGC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-15 15:30:32,0.3818,What Are the Key Growth Drivers for GlaxoSmithKline in 2019?,0.0,0.776,0.224,1
2019-02-15 18:21:01,0.128,Here&apos;s The Dark Horse Contender That Could Break Up Bristol-Celgene,0.0,0.857,0.143,1
2019-02-15 18:21:01,0.0,This Is One Company That Could Break Up Bristol-Celgene Deal,0.0,1.0,0.0,0
2019-02-15 21:18:07,0.0,Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc.,0.0,1.0,0.0,0
2019-02-16 22:10:00,-0.5994,"Merck, Pfizer drug combo extends kidney cancer survival -study",0.341,0.543,0.116,-1
2019-02-18 11:00:00,0.0,Big Pharma Can’t Resist Big Mergers. Here’s Why.,0.0,1.0,0.0,0
2019-02-18 15:12:42,-0.6597,Merck Gets Priority Review for Keytruda Combo in Kidney Cancer,0.328,0.672,0.0,-1
2019-02-19 11:45:00,-0.6597,Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain,0.278,0.722,0.0,-1
2019-02-19 11:56:59,-0.1779,Higher dose of Pfizer-Lilly drug helps reduce back pain in study,0.221,0.604,0.174,-1
2019-02-19 12:17:00,-0.34,Pfizer&apos;s Forgotten Cancer Pill Is About to Become Its Next Blockbuster,0.346,0.44,0.214,-1
2019-02-19 12:22:39,-0.1531,Pfizer-Lilly drug shown to help reduce back pain in late-stage trial,0.22,0.6,0.18,-1
2019-02-19 13:30:00,0.4215,"Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045",0.0,0.865,0.135,1
2019-02-19 14:10:15,-0.34,Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster,0.346,0.44,0.214,-1
2019-02-19 14:32:00,0.4767,"Pfizer Receives European Approval for ZIRABEV™ (bevacizumab), a Biosimilar to Avastin®*",0.0,0.744,0.256,1
2019-02-19 14:47:04,0.4939,"Health Care Sector Update for 02/19/2019: ICPT, MDT, NEO, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-19 15:07:03,0.0,What's in Store for Sangamo (SGMO) This Earnings Season?,0.0,1.0,0.0,0
2019-02-19 15:30:00,0.4404,Ochsner Health System and Pfizer Partner to Develop Innovative Models for Clinical Trials,0.0,0.805,0.195,1
2019-02-19 17:10:53,0.296,"IWB, UNH, V, PFE: ETF Outflow Alert",0.0,0.732,0.268,1
2019-02-19 21:56:58,0.067,"After Hours Most Active for Feb 19, 2019 :  SIRI, PFE, CHK, MO, VER, FDC, ZAYO, WBA, PYPL, AGNC, ADBE, SHY",0.115,0.759,0.126,0
2019-02-19 22:17:20,0.2263,Spark Therapeutics (ONCE) Q4 2018 Earnings Conference Call Transcript,0.0,0.808,0.192,1
2019-02-20 13:42:01,-0.5267,Pfizer & Lilly's Pain Candidate Succeeds in Back Pain Study,0.418,0.38,0.203,-1
2019-02-20 21:48:55,0.0,Market Recap for Wednesday February 20,0.0,1.0,0.0,0
2019-02-20 21:57:09,0.4576,"After Hours Most Active for Feb 20, 2019 :  PFE, ET, TAHO, PRQR, TWTR, XEL, SIRI, QCOM, NWL, XOM, T, AMED",0.0,0.864,0.136,1
2019-02-20 23:10:36,0.4404,Better Buy: Pfizer vs. Eli Lilly,0.0,0.633,0.367,1
2019-02-21 13:33:29,-0.2732,Fears of Amazon appear overblown as companies that fretted competition went on to beat market,0.16,0.743,0.097,-1
2019-02-21 14:47:20,0.4939,"Health Care Sector Update for 02/21/2019: JNJ, A, TFX, PFE, MRK, AMGN, ABT",0.0,0.789,0.211,1
2019-02-22 02:39:00,-0.6249,What Pharma Investors Need to Know About Pfizer&apos;s Latest Disaster,0.313,0.687,0.0,-1
2019-02-22 05:09:46,-0.6249,What Pharma Investors Need to Know About Pfizer's Latest Disaster,0.313,0.687,0.0,-1
2019-02-22 05:52:26,0.0,Icon PLC (ICLR) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-02-22 14:04:02,0.2263,"Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates",0.0,0.863,0.137,1
2019-02-22 14:17:11,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 25, 2019",0.0,1.0,0.0,0
2019-02-22 14:47:35,0.4939,"Health Care Sector Update for 02/22/2019: ZSAN, OBLN, OCUL, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-22 15:19:08,0.0,"Dow 30 Stock Roundup: WMT Earnings Beat, MRK's Keytruda sBLA Gets Priority Review",0.0,1.0,0.0,0
2019-02-22 15:47:03,0.0,Pfizer executive Sally Susman to host 2020 presidential fundraiser for Democrat Kirsten Gillibrand,0.0,1.0,0.0,0
2019-02-22 16:14:13,0.0,"Dow Movers: WBA, INTC",0.0,1.0,0.0,0
2019-02-22 18:01:07,0.0772,"U.S. closes IV solution shortage antitrust probe, Baxter says",0.177,0.619,0.204,0
2019-02-22 18:27:50,0.0,"Intel, Pfizer Lead Dow Jones Rally; 3 Stocks Explode Higher On Earnings",0.0,1.0,0.0,0
2019-02-22 21:57:42,0.4576,"After Hours Most Active for Feb 22, 2019 :  CAR, PFE, FCX, S, CSCO, V, KMI, CVET, FB, SNAP, INTC, Z",0.0,0.857,0.143,1
2019-02-22 23:05:10,0.0,Trump nominates Kelly Craft as UN ambassador,0.0,1.0,0.0,0
2019-02-23 18:07:09,0.0,The Dogs of the Dow Start 2019 Slow,0.0,1.0,0.0,0
2019-02-24 14:00:00,0.0,Exact Sciences Hit a Home Run in Q4. Here&apos;s Why Sales Could Soon Soar Even More.,0.0,1.0,0.0,0
2019-02-24 15:09:19,0.0,Exact Sciences Hit a Home Run in Q4. Here's Why Sales Could Soon Soar Even More.,0.0,1.0,0.0,0
2019-02-25 12:57:12,0.0,What's in the Cards for Nektar (NKTR) This Earnings Season?,0.0,1.0,0.0,0
2019-02-25 15:30:00,0.0,Healthcare Stocks Leading the Sector,0.0,1.0,0.0,0
2019-02-25 17:00:00,0.5106,Dow’s Best-Performing Stock in 2018 Gets Vote of Confidence,0.0,0.708,0.292,1
2019-02-25 17:11:27,0.0,"The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft",0.0,1.0,0.0,0
2019-02-25 18:03:25,0.0,Big Pharma to testify in Senate drug pricing hearing,0.0,1.0,0.0,0
2019-02-25 19:17:19,0.0,Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday,0.0,1.0,0.0,0
2019-02-25 20:18:06,0.4588,"There will be continued interest in gene therapy, says biotech analyst",0.0,0.769,0.231,1
2019-02-25 22:08:01,0.0,Factbox: Pharma company executives to testify at U.S. Senate drug price hearing,0.0,1.0,0.0,0
2019-02-25 22:09:11,-0.128,Pharma CEOs to face tough questions about skyrocketing drug prices,0.143,0.857,0.0,-1
2019-02-25 22:54:07,0.0,Technician says it's time to fade the biotech rally,0.0,1.0,0.0,0
2019-02-26 00:50:46,0.0,[$$] Pharmaceutical Industry CEOs Face Senate Hearing on Drug Prices,0.0,1.0,0.0,0
2019-02-26 14:10:48,0.4404,Better Buy: GlaxoSmithKline vs. Eli Lilly,0.0,0.633,0.367,1
2019-02-26 14:47:03,0.4939,"Health Care Sector Update for 02/26/2019: NVCN, THC, MNK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-02-26 15:34:03,0.2023,"Aerie (AERI) Q4 Earnings Miss, Rhopressa Gains Traction",0.16,0.6,0.24,1
2019-02-26 15:49:53,0.0,Senators grill pharma execs over prescription drug prices,0.0,1.0,0.0,0
2019-02-26 17:07:10,0.4019,Senators say will support Judiciary panel if it looks into drug patents,0.0,0.803,0.197,1
2019-02-26 17:08:10,0.0,The Latest: Pharma CEOs push back on quick fixes for prices,0.0,1.0,0.0,0
2019-02-26 17:41:45,-0.6486,The Latest: Pharma CEOs deny tactics to block competition,0.431,0.569,0.0,-1
2019-02-26 18:42:04,0.0,The Latest: Senators urge pharma CEOs to rein in lobbyists,0.0,1.0,0.0,0
2019-02-26 19:40:07,0.0,"Corcept (CORT) Q4 Earnings Beat Estimates, Revenues In Line",0.0,1.0,0.0,0
2019-02-26 20:19:00,0.0,Congress Grills Drugmakers: 5 Key Takeaways,0.0,1.0,0.0,0
2019-02-26 21:21:19,0.0,Fed Chair Jerome Powell slams ballooning healthcare spending,0.0,1.0,0.0,0
2019-02-26 22:37:44,0.0,Senators grill pharmaceutical executives over rising drug prices,0.0,1.0,0.0,0
2019-02-26 23:16:05,0.2023,Lawmakers grill top pharma execs over high drug costs,0.0,0.816,0.184,1
2019-02-27 14:18:43,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 28, 2019",0.0,1.0,0.0,0
2019-02-27 14:19:31,0.0,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 28, 2019",0.0,1.0,0.0,0
2019-02-27 16:20:02,0.0,The patent system ‘keeps American drug prices so high’,0.0,1.0,0.0,0
2019-02-27 17:08:16,0.296,"IUSG, PFE, USB, ISRG: ETF Inflow Alert",0.0,0.732,0.268,1
2019-02-27 20:49:00,0.0,Big Pharma&apos;s Showdown With Congress Over Drug Pricing: What It Really Means for You,0.0,1.0,0.0,0
2019-02-27 22:09:32,0.0,Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You,0.0,1.0,0.0,0
2019-02-28 13:00:00,0.0,Pfizer Announces Serotypes Included in 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,0.0,1.0,0.0,0
2019-02-28 17:09:22,0.0,"Dow Movers: DWDP, PFE",0.0,1.0,0.0,0
2019-02-28 17:31:49,0.0,Antares Pharma Inc (ATRS) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-02-28 21:57:10,0.4576,"After Hours Most Active for Feb 28, 2019 :  CSCO, ZTO, ABEV, CMCSA, AAPL, MSFT, ATVI, BAC, VALE, KKR, SBUX, PFE",0.0,0.864,0.136,1
2019-02-28 23:02:04,0.7096,Top technician says charts point to healthy gains ahead for this stock,0.0,0.566,0.434,1
2019-03-01 02:40:34,0.0,ICU Medical Inc (ICUI) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-03-01 03:01:48,0.0,Pfizer unit Meridian under civil investigation by U.S. Attorney,0.0,1.0,0.0,0
2019-03-01 13:35:00,0.3182,Pfizer Receives Positive CHMP Opinion for LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer,0.157,0.569,0.274,1
2019-03-01 14:00:37,0.0,Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-03-01 14:17:12,0.0,"Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019",0.0,1.0,0.0,0
2019-03-01 14:29:02,0.0,"Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices",0.0,1.0,0.0,0
2019-03-01 16:17:02,0.0,"Nektar (NKTR) Q4 Earnings Beat, NKTR-181 Review Extended",0.0,1.0,0.0,0
2019-03-01 21:57:15,0.067,"After Hours Most Active for Mar 1, 2019 :  ABEV, GE, XOM, PFE, AR, TSM, SGMS, AAPL, SHY, MSFT, MCHI, INTC",0.115,0.759,0.126,0
2019-03-01 22:06:24,0.0,5 Pharmaceutical Stocks With Big Moats and Bridges,0.0,1.0,0.0,0
2019-03-04 13:00:00,-0.6597,"BioXcel Therapeutics Announces Addition of Merck KGaA, Darmstadt, Germany, and Pfizer to Clinical Collaboration with Nektar for Development of Triple-combination Therapy in Pancreatic Cancer",0.161,0.839,0.0,-1
2019-03-04 13:20:00,0.0,"Market Trends Toward New Normal in Pfizer, Hyatt Hotels, Wipro, Garmin, Ameren, and Qorvo — Emerging Consolidated Expectations, Analyst Ratings",0.0,1.0,0.0,0
2019-03-04 13:48:39,0.3612,What Analysts Recommend for Pfizer and Mylan in March,0.0,0.762,0.238,1
2019-03-04 14:15:32,0.0258,Why Sangamo Therapeutics Lost 22.9% of Its Value in February,0.181,0.63,0.189,0
2019-03-04 14:17:13,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for March 05, 2019",0.0,1.0,0.0,0
2019-03-04 15:05:03,0.0,AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab,0.0,1.0,0.0,0
2019-03-04 15:20:02,0.3818,Pfizer and Mylan: What to Expect from Revenue Growth in 2019,0.0,0.794,0.206,1
2019-03-04 16:25:08,0.296,Pfizer Inc. -- Moody's assigns A1 rating to Pfizer's notes; stable outlook,0.0,0.833,0.167,1
2019-03-04 16:50:02,0.3818,Pfizer or Mylan: Who Is Expected to Report Faster EPS Growth?,0.0,0.794,0.206,1
2019-03-04 17:16:07,0.0,Can This Biotech Puppy Run With the Big Dogs?,0.0,1.0,0.0,0
2019-03-04 17:31:00,0.0,Here&apos;s Why Ascendis Pharma Is Rocketing Higher Today,0.0,1.0,0.0,0
2019-03-04 19:06:27,0.0,Here's Why Ascendis Pharma Is Rocketing Higher Today,0.0,1.0,0.0,0
2019-03-04 21:24:56,0.0,This Biotech Stock Just Flew To A Record After Topping Pfizer In A Study,0.0,1.0,0.0,0
2019-03-05 01:57:00,-0.3612,"Pfizer Prices $5,000,000,000 Debt Offering",0.385,0.615,0.0,-1
2019-03-05 11:47:10,0.0,[$$] Scott Gottlieb to step down as head of FDA,0.0,1.0,0.0,0
2019-03-05 12:24:27,0.5423,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",0.0,0.774,0.226,1
2019-03-05 12:31:07,0.4404,Pfizer or Mylan: Who Is Controlling Expenses Better?,0.0,0.707,0.293,1
2019-03-05 14:00:02,0.4215,Lilly to Bring Half-Priced Version of Popular Humalog Insulin,0.0,0.741,0.259,1
2019-03-05 14:00:18,0.5106,Comparing Dividends and Free Cash Flow for Pfizer and Mylan,0.0,0.732,0.268,1
2019-03-05 14:46:45,0.4939,"Health Care Sector Update for 03/05/2019: ADMS, NNVC, NVTA, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-03-05 15:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,0.0,1.0,0.0,0
2019-03-05 15:05:00,0.5267,AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes,0.0,0.761,0.239,1
2019-03-05 15:30:02,0.128,"Pfizer and Mylan: How Capex, Interest Expenses, and Debt Stack Up",0.172,0.621,0.207,1
2019-03-06 14:46:53,0.4939,"Health Care Sector Update for 03/06/2019: VLRX, OPTN, INFI, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-03-06 16:25:33,0.0,‘Demographics are favorable’ for the healthcare sector,0.0,1.0,0.0,0
2019-03-06 17:56:08,0.0,GlycoMimetics Inc (GLYC) Q4 2018 Earnings Conference Call Transcript,0.0,1.0,0.0,0
2019-03-06 18:19:42,0.2263,The Roche Merger Will Do Wonders for Spark Stock,0.0,0.808,0.192,1
2019-03-06 19:06:57,0.0,Lilly's Emgality Gets FDA Priority Review for Cluster Headache,0.0,1.0,0.0,0
2019-03-07 14:47:05,0.4939,"Health Care Sector Update for 03/07/2019: GTXI, BPTH, CODX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-07 19:47:00,0.2023,5 Top Gene-Editing Stocks for 2019,0.0,0.69,0.31,1
2019-03-07 21:56:49,0.4576,"After Hours Most Active for Mar 7, 2019 :  LTHM, MSFT, S, GE, F, MRO, PFE, GLPI, PTEN, MNST, EBAY, RMBS",0.0,0.864,0.136,1
2019-03-07 22:46:52,-0.6249,"Syndax Pharmaceuticals Sheds 12.5% After Q4 Miss, Studies Fail to Meet Primary Endpoints",0.317,0.683,0.0,-1
2019-03-08 15:07:28,0.4939,"Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-08 18:00:27,0.6369,Exchange Traded Funds: How To Find The Best ETFs,0.0,0.656,0.344,1
2019-03-08 18:45:06,0.2263,"Pharma Stock Roundup: FDA OK's J&J Antidepressant, CHMP Recommends Several Drugs",0.0,0.84,0.16,1
2019-03-08 21:56:55,0.4576,"After Hours Most Active for Mar 8, 2019 :  LLY, PFE, ORCL, MRO, JD, QQQ, EBAY, T, GE, URBN, MSFT, IEF",0.0,0.864,0.136,1
2019-03-11 13:46:48,0.4939,"Health Care Sector Update for 03/11/2019: AXGT, LCI, HRC, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-03-11 14:57:02,0.2023,"Conatus' (CNAT) Q4 Earnings Top Estimates, Emricasan in Focus",0.0,0.816,0.184,1
2019-03-11 16:15:52,0.0,"The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's",0.0,1.0,0.0,0
2019-03-11 20:56:58,0.4019,FDA approves Pfizer's biosimilar to Roche's Herceptin,0.0,0.69,0.31,1
2019-03-11 23:25:57,0.0,Stocks Spike on M&A and Retail Sales,0.0,1.0,0.0,0
2019-03-11 23:37:00,0.4019,"U.S. FDA Approves Pfizer’s Oncology Biosimilar TRAZIMERA™ (trastuzumab-qyyp), a Biosimilar to Herceptin®1",0.0,0.787,0.213,1
2019-03-12 13:06:15,0.6633,Why Novartis is a Top 10 SAFE International Dividend Stock (NVS),0.0,0.596,0.404,1
2019-03-12 13:27:07,0.4939,"Health Care Sector Update for 03/12/2019: ZFGN, AKBA, HEXO, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-12 14:50:02,0.4767,Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval,0.0,0.659,0.341,1
2019-03-12 16:12:58,-0.6597,Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation,0.355,0.645,0.0,-1
2019-03-12 17:20:05,0.3818,Option trading opportunities in Pfizer & Sirius XM,0.0,0.698,0.302,1
2019-03-12 17:29:48,0.2263,Biontech stock offering could be worth as much as $800 million-sources,0.0,0.84,0.16,1
2019-03-12 18:06:17,0.2263,BioNtech hires banks for IPO worth up to $800 million - sources,0.0,0.84,0.16,1
2019-03-12 20:28:42,0.2263,BioNTech hires banks for IPO worth up to $800 million -sources,0.0,0.84,0.16,1
2019-03-13 12:37:57,0.0,FDA medical adviser: 'Congress is owned by pharma',0.0,1.0,0.0,0
2019-03-13 13:38:18,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2019",0.0,1.0,0.0,0
2019-03-13 13:47:12,0.4939,"Health Care Sector Update for 03/13/2019: NVCN, CASI, LXRX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-13 16:50:04,0.4019,Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma,0.0,0.769,0.231,1
2019-03-13 18:27:06,0.0,Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study,0.0,1.0,0.0,0
2019-03-13 19:07:28,0.5859,Lilly's Cyramza Successful in Phase III First-Line NSCLC Study,0.0,0.678,0.322,1
2019-03-13 20:56:56,0.4576,"After Hours Most Active for Mar 13, 2019 :  MSFT, LLY, F, CMCSA, PFE, FOX, CTL, HPQ, PCG, AMD, AAPL, ENDP",0.0,0.864,0.136,1
2019-03-14 09:01:25,0.0,Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades,0.0,1.0,0.0,0
2019-03-14 13:47:20,0.4939,"Health Care Sector Update for 03/14/2019: AXGT, JNJ, BDX, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2019-03-14 17:36:05,0.34,What's the play on Wynn? Plus the trades on Citigroup & Pfizer in #AskHalftime,0.0,0.833,0.167,1
2019-03-14 20:12:29,-0.296,Markets Right Now: Stocks end a wobbly day mostly lower,0.216,0.784,0.0,-1
2019-03-14 20:49:26,0.0,"Market Close Report: NASDAQ Composite index closes at 7,630.91 down -12.50 points",0.0,1.0,0.0,0
2019-03-14 20:57:05,0.4576,"After Hours Most Active for Mar 14, 2019 :  GCP, LLY, HPQ, F, PFE, ACB",0.0,0.813,0.187,1
2019-03-14 22:06:25,0.5859,"S&P, Nasdaq Snap Win Streaks in Down Day for Stocks",0.0,0.703,0.297,1
2019-03-15 14:31:02,0.0,"Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others",0.0,1.0,0.0,0
2019-03-15 14:58:06,-0.3182,Pisani: S&P rebalancing as some companies aggressively buy back stock,0.204,0.796,0.0,-1
2019-03-15 16:09:47,0.0,The Case Against Pfizer Stock and the Rest of the Industry,0.0,1.0,0.0,0
2019-03-15 16:13:44,0.0,"Dow 30 Stock Roundup: PFE's Herceptin Biosimilar Gets FDA Nod, VZ to Launch 5G Soon",0.0,1.0,0.0,0
2019-03-15 17:07:47,0.0,"Notable ETF Inflow Detected - SPYG, PFE, BRK.B, PYPL",0.0,1.0,0.0,0
2019-03-15 20:57:13,0.4576,"After Hours Most Active for Mar 15, 2019 :  PFE, VSTM, ZNGA, GE, CSCO, KO, WFC, DO, MSFT, BAC, INTC, HBAN",0.0,0.864,0.136,1
2019-03-17 15:45:00,0.6597,AUGUSTUS Demonstrates Favorable Safety Results of Eliquis® Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention,0.088,0.649,0.263,1
2019-03-18 07:07:01,0.0,Outside political groups not always what they appear,0.0,1.0,0.0,0
2019-03-18 13:54:46,0.0,Group with consumer-friendly vibe pushes drugmakers' message,0.0,1.0,0.0,0
2019-03-18 15:14:02,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Roche, Merck, Allergan and J&J",0.0,1.0,0.0,0
2019-03-18 15:17:00,0.296,UnitedHealth Shares Finding Their Mojo Again,0.0,0.694,0.306,1
2019-03-18 17:36:00,-0.3412,Big Pharma Earnings Might Not Be as Good as They Look,0.194,0.806,0.0,-1
2019-03-19 01:09:14,0.0,Bristol-Myers & Pfizer Release Phase IV Data on Eliquis,0.0,1.0,0.0,0
2019-03-19 13:46:58,0.4939,"Health Care Sector Update for 03/19/2019: TYHT, ALT, AQB, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-03-19 14:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts,0.0,1.0,0.0,0
2019-03-19 16:09:54,0.0,3 Stocks to Build Your Portfolio Around,0.0,1.0,0.0,0
2019-03-19 16:28:04,0.0,Aerie (AERI) Starts Phase II Study on Eye Candidate AR-1105,0.0,1.0,0.0,0
2019-03-19 18:10:38,0.0,Allergan's Anti-Infective Gets FDA Nod for Pediatric Patients,0.0,1.0,0.0,0
2019-03-19 19:06:27,0.34,Why You Should Buy ABBV Stock for Income and Value,0.0,0.789,0.211,1
2019-03-19 19:17:06,0.0,Analysts Reduce Pfizer’s Target Price in March,0.0,1.0,0.0,0
2019-03-19 20:48:44,0.0,"Market Close Report: NASDAQ Composite index closes at 7,723.95 up 9.47 points",0.0,1.0,0.0,0
2019-03-19 20:56:51,0.4576,"After Hours Most Active for Mar 19, 2019 :  TFCFA, TFCF, LLY, BRX, TWTR, BAC, PFE, EBAY, S, MSFT, CMCSA, INTC",0.0,0.864,0.136,1
2019-03-19 22:06:51,0.5859,Dow Snaps Win Streak on U.S.-China Trade Concerns,0.0,0.648,0.352,1
2019-03-19 23:15:00,-0.5267,"Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer",0.167,0.758,0.076,-1
2019-03-20 08:16:00,0.0,"Stocks -  FedEx, Google Fall in Pre-market; General Mills Jumps",0.0,1.0,0.0,0
2019-03-20 10:00:00,0.0,"5 High-Quality, High-Yielding Stocks",0.0,1.0,0.0,0
2019-03-20 10:45:00,0.4215,Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics,0.0,0.703,0.297,1
2019-03-20 11:20:00,0.0,Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million,0.0,1.0,0.0,0
2019-03-20 11:46:35,-0.5719,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",0.188,0.812,0.0,-1
2019-03-20 11:54:11,0.0,Pfizer Adds to Big Pharma's Gene-Therapy Deal Streak,0.0,1.0,0.0,0
2019-03-20 13:33:00,0.0,Pfizer Acquires Gene Therapy Portfolio in Deal that Could Total $636 Million,0.0,1.0,0.0,0
2019-03-20 14:43:02,-0.25,Glaxo Presents Encouraging Data on Endometrial Cancer Drug,0.319,0.435,0.246,-1
2019-03-20 15:10:03,0.0,Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan,0.0,1.0,0.0,0
2019-03-20 15:30:03,-0.6597,Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study,0.423,0.577,0.0,-1
2019-03-20 17:37:49,0.0,Pfizer buys stake in French gene therapy firm Vivet,0.0,1.0,0.0,0
2019-03-20 19:17:06,0.0,Invest in America’s Rising Healthcare Costs With These Stocks,0.0,1.0,0.0,0
2019-03-20 20:57:04,0.4576,"After Hours Most Active for Mar 20, 2019 :  NLY, XOG, GE, MCHI, ELAN, T, QQQ, MU, NWL, AMD, PFE, DIS",0.0,0.864,0.136,1
2019-03-21 00:06:45,0.7003,5 of the Best Dow Jones Stocks to Buy for Solid Dividends,0.0,0.608,0.392,1
2019-03-21 13:17:31,0.0,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019",0.0,1.0,0.0,0
2019-03-21 13:47:20,0.4939,"Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-21 13:51:36,0.2263,Pfizer buys stake in French gene company in deal worth up to $636M,0.0,0.863,0.137,1
2019-03-21 14:10:02,0.0,Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market,0.0,1.0,0.0,0
2019-03-21 17:00:00,0.0,Boeing&apos;s Lesson About The Dow,0.0,1.0,0.0,0
2019-03-21 17:09:07,0.0,Biogen’s Big Bet in Alzheimer’s Disease Is a Bust,0.0,1.0,0.0,0
2019-03-22 14:17:15,0.5719,"Dow 30 Stock Roundup: AAPL Refreshes Product Lineup, BA Wins $327M Navy Order",0.0,0.764,0.236,1
2019-03-22 15:23:03,0.0,Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan,0.0,1.0,0.0,0
2019-03-22 17:24:06,0.0,"Final Trades: Verizon, XPO, Pfizer, Alphabet and BB&T",0.0,1.0,0.0,0
2019-03-25 13:46:59,0.4939,"Health Care Sector Update for 03/25/2019: NK, MDWD, AIMT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-25 14:53:00,0.0,S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion,0.0,1.0,0.0,0
2019-03-25 16:08:01,0.0,"SPYG, PFE, CRM, MDT: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2019-03-25 20:56:46,0.4576,"After Hours Most Active for Mar 25, 2019 :  XOG, HST, CMCSA, S, CELG, COTY, QQQ, MAT, TGNA, PFE, NEM, UAL",0.0,0.864,0.136,1
2019-03-25 21:10:34,0.7351,Ascendis Pivotal Growth Hormone Deficiency Study Data Positive,0.0,0.492,0.508,1
2019-03-25 22:11:00,0.0,Were Hedge Funds Right About Pfizer Inc. (PFE)?,0.0,1.0,0.0,0
2019-03-26 16:46:27,-0.3612,Cyclacel Drops After Study Supporting Cancer Drug's Mechanism Of Action,0.288,0.523,0.19,-1
2019-03-26 17:09:54,0.4767,AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan,0.0,0.721,0.279,1
2019-03-26 21:32:59,0.0,"Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote",0.0,1.0,0.0,0
2019-03-27 14:25:00,0.6908,"Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says",0.0,0.612,0.388,1
2019-03-27 16:45:40,0.0,6 Gene Therapy M&A Targets On The Radar,0.0,1.0,0.0,0
2019-03-27 20:02:36,0.0,6 Stocks With High Dividend Yields,0.0,1.0,0.0,0
2019-03-27 20:57:03,0.4576,"After Hours Most Active for Mar 27, 2019 :  TAL, V, BILI, COTY, MRK, BZUN, IRBT, PFE, RXN, QQQ, MSFT, MCHI",0.0,0.864,0.136,1
2019-03-27 21:39:09,0.0,Calithera (CALA) Initiates Phase I/II Study of Telaglenastat,0.0,1.0,0.0,0
2019-03-28 00:12:44,0.0,Pfizer (PFE) Dips More Than Broader Markets: What You Should Know,0.0,1.0,0.0,0
2019-03-28 13:47:34,0.4939,"Health Care Sector Update for 03/28/2019: CTST, AMRN, VLRX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-28 13:52:46,0.0,One Key Strategy to Build Your Ultimate Retirement Portfolio,0.0,1.0,0.0,0
2019-03-28 14:11:29,0.4404,Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics,0.0,0.674,0.326,1
2019-03-28 16:11:48,0.3612,"3 Big Stock Charts for Thursday: Pfizer, Coty and Pioneer Natural Resources",0.0,0.8,0.2,1
2019-03-29 14:07:41,0.4939,"Health Care Sector Update for 03/29/2019: SEEL, VTVT, AZN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-03-29 15:20:08,0.0,Global Blood Focuses on Developing Lead Candidate Voxelotor,0.0,1.0,0.0,0
2019-03-29 15:20:24,0.0,Biotech Stocks Outperform During Inversions: 5 Must Watch,0.0,1.0,0.0,0
2019-03-29 15:20:28,0.5574,Sarepta (SRPT) Reports Positive Interim Results for DMD Drug,0.0,0.69,0.31,1
2019-03-29 19:23:00,0.0,Wall Street is buzzing about Gilead’s rheumatoid arthritis drug. Here’s why,0.0,1.0,0.0,0
2019-03-29 20:41:31,-0.6249,These Are The 5 Worst Dow Jones Stocks Of Q1,0.339,0.661,0.0,-1
2019-03-29 22:04:00,0.34,This Dow stock could be a way to play catch-up to the rally,0.0,0.821,0.179,1
2019-04-01 10:00:00,0.1779,Saratoga Springs communications firm growing a year after private-equity acquisition,0.0,0.825,0.175,1
2019-04-01 17:03:24,0.0,"Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts",0.0,1.0,0.0,0
2019-04-01 20:57:08,0.0,Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics,0.0,1.0,0.0,0
2019-04-01 22:19:36,0.6249,"Spero Gets Fast Track Designation for SPR994, Shares Improve",0.0,0.579,0.421,1
2019-04-02 11:00:00,0.0,Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2019-04-02 11:00:00,0.0,Sangamo and Pfizer Announce Phase 1/2 Interim Data For Investigational Hemophilia A Gene Therapy,0.0,1.0,0.0,0
2019-04-02 11:39:00,0.0,Sangamo's stock jumps after upbeat trial data for hemophilia treatment,0.0,1.0,0.0,0
2019-04-02 12:10:00,0.0,Sangamo's stock soars after upbeat trial data for hemophilia treatment,0.0,1.0,0.0,0
2019-04-02 12:10:00,0.0,Sangamo&apos;s stock soars after upbeat trial data for hemophilia treatment,0.0,1.0,0.0,0
2019-04-02 13:38:36,0.4939,"Health Care Sector Update for 04/02/2019: ADMA, EVOK, ANGO, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-02 13:55:00,0.5574,Sangamo Stock Soars on Positive Hemophilia Treatment Trial,0.0,0.66,0.34,1
2019-04-02 14:21:35,0.4939,Trump delays health care vote until after 2020 election,0.0,0.714,0.286,1
2019-04-02 14:54:24,0.0,Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia A,0.0,1.0,0.0,0
2019-04-02 15:33:48,0.0,Why Sangamo Therapeutics Stock Is Soaring Today,0.0,1.0,0.0,0
2019-04-02 15:58:14,0.0,3 Healthcare Stocks to Trade Now,0.0,1.0,0.0,0
2019-04-02 15:59:53,0.0,"Dow Movers: DWDP, AAPL",0.0,1.0,0.0,0
2019-04-02 16:47:06,0.0,Sangamo Soars Amid Multiple Development Pipeline Updates,0.0,1.0,0.0,0
2019-04-02 20:17:24,0.0,Gene-Focused Biotechs Pop After Pfizer Partner Scores In Hemophilia A,0.0,1.0,0.0,0
2019-04-02 21:00:45,0.0,"Noteworthy ETF Inflows: VYM, PFE, IBM, AMGN",0.0,1.0,0.0,0
2019-04-03 08:41:00,0.5046,"Micron Technology, Tencent and two dozen other companies most likely to benefit from a China trade deal",0.0,0.821,0.179,1
2019-04-03 11:37:52,0.0,"3 Big Stock Charts for Wednesday: Twitter, Western Union and Wynn Resorts",0.0,1.0,0.0,0
2019-04-03 13:19:39,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 04, 2019",0.0,1.0,0.0,0
2019-04-03 13:42:00,-0.6597,VIZIMPRO® (dacomitinib) Receives Marketing Authorization in European Union (EU) for the First-Line Treatment of Adult Patients with EGFR-Mutated Non-Small Cell Lung Cancer,0.173,0.827,0.0,-1
2019-04-03 13:59:01,0.4939,"Health Care Sector Update for 04/03/2019: EVGN, ADXS, ACHN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-03 14:02:01,0.6369,Does Sangamo Have the Best Gene Therapy Program Now?,0.0,0.656,0.344,1
2019-04-03 14:10:02,0.2732,Why the Earnings Surprise Streak Could Continue for Pfizer (PFE),0.0,0.811,0.189,1
2019-04-03 14:15:02,0.5574,Sangamo Rises on Positive Phase I/II Hemophilia Study Data,0.0,0.69,0.31,1
2019-04-03 18:51:06,0.2023,"Top Research Reports for Pfizer, Royal Dutch Shell & Celgene",0.0,0.816,0.184,1
2019-04-04 13:38:43,0.4939,"Health Care Sector Update for 04/04/2019: NSPR, REPH, RWLK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-04 14:04:00,0.7783,AM Best Affirms Credit Ratings of Blue Whale Re Ltd.,0.0,0.541,0.459,1
2019-04-04 14:45:19,0.0,"U.S., China key to GSK's consumer venture with Pfizer",0.0,1.0,0.0,0
2019-04-04 16:09:40,0.25,"The Zacks Analyst Blog Highlights: Pfizer, Royal Dutch, Celgene, Advanced Micro and Blackstone",0.0,0.857,0.143,1
2019-04-04 17:05:35,-0.3182,Pfizer's New Lung Cancer Drug Vizimpro Gets EU Approval,0.303,0.483,0.214,-1
2019-04-04 18:57:00,-0.4019,"U.S. FDA Approves IBRANCE® (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer",0.209,0.664,0.128,-1
2019-04-05 00:03:35,0.34,Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know,0.0,0.806,0.194,1
2019-04-05 13:17:01,-0.6124,"Dow 30 Stock Roundup: WBA Q2 Earnings Disappoint, PFE Lung Cancer Drug Gets EU Approval",0.32,0.541,0.14,-1
2019-04-05 13:38:49,0.4939,"Health Care Sector Update for 04/05/2019: SYRS, AQB, MACK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-05 14:20:02,0.0,"Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU",0.0,1.0,0.0,0
2019-04-06 10:01:41,-0.3182,Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men,0.284,0.516,0.2,-1
2019-04-07 16:49:00,0.4404,Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?,0.0,0.791,0.209,1
2019-04-07 20:32:48,0.0,"Bulls & Bears Of The Week: Dow, Lyft, Pfizer, Schlumberger, Tesla And More",0.0,1.0,0.0,0
2019-04-08 13:26:45,0.4939,"Health Care Sector Update for 04/08/2019: MDGL, CTST, QURE, JPM, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-08 14:37:02,0.0,Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym,0.0,1.0,0.0,0
2019-04-08 16:12:02,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca",0.0,1.0,0.0,0
2019-04-08 21:04:39,0.4576,"After Hours Most Active for Apr 8, 2019 :  AMH, FOLD, AABA, PFE, BILI, QQQ, URBN, BAC, EMB, MRK, SCHW, NEM",0.0,0.864,0.136,1
2019-04-09 12:02:12,0.0,Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients,0.0,1.0,0.0,0
2019-04-09 13:24:22,0.4939,"Health Care Sector Update for 04/09/2019: VXRT, ZGNX, NVS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-10 11:13:05,0.296,Who Has Been Selling Pfizer Inc. (NYSE:PFE) Shares?,0.0,0.761,0.239,1
2019-04-10 13:44:29,0.4939,"Health Care Sector Update for 04/10/2019: PTE, PHAS, GH, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-10 17:04:44,0.0,"USMV, V, NEM, PFE: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2019-04-10 19:24:32,0.0,Here's what to expect from the stock market next month,0.0,1.0,0.0,0
2019-04-11 11:30:00,0.0,"A Giant U.K. Pension Fund Is Making Big Bets on Verizon, Home Depot, J&J, and Mastercard Stock",0.0,1.0,0.0,0
2019-04-11 12:25:00,0.0,"Brexit: What it means for U.S. banks, car makers, drug companies",0.0,1.0,0.0,0
2019-04-11 13:15:22,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 12, 2019",0.0,1.0,0.0,0
2019-04-11 13:20:38,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 12, 2019",0.0,1.0,0.0,0
2019-04-11 13:44:31,0.4939,"Health Care Sector Update for 04/11/2019: AVGR, AUTL, NVS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-11 18:57:00,0.0,What ‘Medicare for All’ would do to the health-care sector,0.0,1.0,0.0,0
2019-04-11 19:33:07,0.0,Biotechnology Market on a Tear: 5 ETFs in Spotlight,0.0,1.0,0.0,0
2019-04-11 21:05:07,0.1926,"After Hours Most Active for Apr 11, 2019 :  VEON, PFE, GE, SIRI, NEM, MNST, AMD, EFII, CNP^B, FITB, RIG, ESI",0.096,0.775,0.129,1
2019-04-12 13:42:00,0.0,5 things to know about Hookipa Pharma ahead of its IPO,0.0,1.0,0.0,0
2019-04-12 13:44:37,0.4939,"Health Care Sector Update for 04/12/2019: TCON, XFOR, CGC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-12 15:05:39,0.0,What Are Analysts Recommending for PFE and AZN?,0.0,1.0,0.0,0
2019-04-12 16:15:05,0.0,"Dow 30 Stock Roundup: Procter & Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall",0.0,1.0,0.0,0
2019-04-12 16:40:02,0.3818,PFE or AZN: Comparing Their Revenue Growth in 2019,0.0,0.755,0.245,1
2019-04-12 18:07:37,0.0,Forward Guidance Will Make or Break JNJ Earnings,0.0,1.0,0.0,0
2019-04-12 18:10:02,0.3818,PFE or AZN: Comparing Their Earnings Growth in 2019,0.0,0.755,0.245,1
2019-04-13 08:00:00,0.0,Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older,0.0,1.0,0.0,0
2019-04-14 11:00:00,0.4767,The 3 Greatest Risks Pfizer Faces,0.226,0.323,0.452,1
2019-04-15 11:31:37,0.3818,Why Ibrance Is a Major Growth Driver for Pfizer,0.0,0.729,0.271,1
2019-04-15 13:00:59,0.0,Xtandi: A Key Oncology Pillar in 2019,0.0,1.0,0.0,0
2019-04-15 13:46:41,0.4939,"Health Care Sector Update for 04/15/2019: ASMB, APHA, CLVS, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-04-15 14:07:02,-0.3182,J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer,0.326,0.444,0.23,-1
2019-04-15 14:30:44,0.0,Analyzing Recent Regulatory Approvals for Pfizer’s Oncology Drugs,0.0,1.0,0.0,0
2019-04-15 19:00:46,0.25,"Seeking $86 million IPO, this Peninsula company is betting common bacteria plays role in Alzheimer's",0.0,0.875,0.125,1
2019-04-15 20:06:34,0.0,"These 2 health-care giants could take down the ETFs in their sector, says investor",0.0,1.0,0.0,0
2019-04-15 20:56:41,0.4576,"After Hours Most Active for Apr 15, 2019 :  EMB, VIPS, COTY, TAL, MOMO, PCG, KEY, PFE, YY, EFII, EBAY, AAPL",0.0,0.864,0.136,1
2019-04-16 13:18:43,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 17, 2019",0.0,1.0,0.0,0
2019-04-16 13:46:46,0.4939,"Health Care Sector Update for 04/16/2019: CRSP, VRTX, UNH, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-16 14:58:02,0.3818,"J&J (JNJ) Beats on Q1 Earnings, Ups 2019 Sales Growth View",0.0,0.794,0.206,1
2019-04-16 15:08:15,0.0,Sitting on Cash? 3 Dividends Up to 7.5% That’ll Sail if Markets Sink,0.0,1.0,0.0,0
2019-04-16 19:31:14,0.0,5 Healthcare Stocks to Watch If America Chooses a Single-Payer System,0.0,1.0,0.0,0
2019-04-17 13:47:02,0.4939,"Health Care Sector Update for 04/17/2019: ONCS, TXMD, ABT, JNJ, PFE, MRK, AMGN",0.0,0.789,0.211,1
2019-04-17 15:10:03,0.0,Wave Life Sciences Plunges After DMD Study Data Readout,0.0,1.0,0.0,0
2019-04-17 17:07:40,0.296,RSI Alert: Pfizer Now Oversold,0.0,0.645,0.355,1
2019-04-17 20:08:16,0.0,Major Market Indexes Little Changed in Late Wednesday Trading,0.0,1.0,0.0,0
2019-04-17 21:06:59,-0.6712,Close Update: Healthcare Sector Losses Drag Major Market Indexes Slightly Lower in Wednesday Trading,0.372,0.628,0.0,-1
2019-04-18 11:20:00,0.0,Health-care stocks keep getting hammered — Wall Street says this is why,0.0,1.0,0.0,0
2019-04-18 13:47:07,0.4939,"Health Care Sector Update for 04/18/2019: MBIO, EIGR, CGC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-18 15:08:39,0.0,"Dow Movers: PFE, TRV",0.0,1.0,0.0,0
2019-04-18 15:29:03,0.0,"Clovis Focuses on Rubraca Label Expansion, Competition Stiff",0.0,1.0,0.0,0
2019-04-18 16:03:14,0.0,Markets Right Now: Stocks waver in midday trading,0.0,1.0,0.0,0
2019-04-18 16:25:10,0.0,Here Are the Key Takeaways From J&J's Q1 Earnings Report,0.0,1.0,0.0,0
2019-04-18 17:07:38,0.4588,Mid-Day Report: US Stocks Mixed as Health Care Sector Clouded by Political Rhetoric While US Retail Sales Jump Most in 18 Mths,0.049,0.82,0.131,1
2019-04-18 17:12:39,0.0,Can Q1 Earnings Lift Healthcare ETFs Higher?,0.0,1.0,0.0,0
2019-04-18 18:00:00,0.0,Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders,0.0,1.0,0.0,0
2019-04-18 19:07:03,0.0,"Noteworthy Thursday Option Activity: PFE, SBAC, JEC",0.0,1.0,0.0,0
2019-04-18 20:49:33,0.0,"Market Close Report: NASDAQ Composite index closes at 7,998.06 up 1.98 points",0.0,1.0,0.0,0
2019-04-18 21:00:13,-0.4588,Pharmaceutical ETFs Catch Healthcare Contagion,0.429,0.571,0.0,-1
2019-04-18 21:05:00,0.0,Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis,0.0,1.0,0.0,0
2019-04-18 21:25:28,-0.4588,Worsening Health-Care Rout Wipes Out $150 Billion in Four Days,0.25,0.75,0.0,-1
2019-04-18 22:06:50,0.0,"Dow Closes Higher After Retail Sales, Blue-Chip Earnings",0.0,1.0,0.0,0
2019-04-18 22:14:02,-0.4767,Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study,0.291,0.709,0.0,-1
2019-04-18 22:37:00,0.0772,"Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study",0.145,0.687,0.168,0
2019-04-19 13:27:00,0.0,Health-care drama has now spread to biopharma stocks,0.0,1.0,0.0,0
2019-04-19 18:12:00,0.2023,5 Top Pharmaceutical Stocks to Buy in 2019,0.0,0.769,0.231,1
2019-04-22 11:37:18,0.34,Merck's Keytruda wins FDA approval as combination therapy for kidney cancer,0.229,0.417,0.354,1
2019-04-22 12:12:03,0.3818,JNJ or PFE: Who has a Stronger Revenue Guidance for Fiscal 2019?,0.0,0.794,0.206,1
2019-04-22 12:20:22,-0.1531,What Affected Pfizer’s Stock Price Last Week?,0.211,0.789,0.0,-1
2019-04-22 13:45:11,0.4404,JNJ or PFE: Which Has Better EPS Guidance for 2019?,0.0,0.756,0.244,1
2019-04-22 13:45:11,0.3818,JNJ or PFE: Who has a Stronger EPS Guidance for Fiscal 2019?,0.0,0.794,0.206,1
2019-04-22 13:46:47,0.4939,"Health Care Sector Update for 04/22/2019: ISRG, AXGN, LLY, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-22 13:55:02,0.0,What to Expect from Pfizer’s Revenue and Earnings in Q1,0.0,1.0,0.0,0
2019-04-22 14:09:03,-0.4767,Pfizer Stock Suffers From an Underappreciated Drugs Pipeline,0.307,0.693,0.0,-1
2019-04-22 14:24:22,0.4215,"Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns",0.0,0.714,0.286,1
2019-04-22 15:08:03,0.0,Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?,0.0,1.0,0.0,0
2019-04-22 15:15:10,0.0,JNJ or PFE: Comparing Their Fastest-Growing Immunology Drugs,0.0,1.0,0.0,0
2019-04-22 15:15:10,0.1779,JNJ or PFE: Comparing Fastest Growing Immunology Drugs,0.0,0.805,0.195,1
2019-04-22 16:17:20,0.0,Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-04-22 18:12:04,0.5859,"Monday’s Vital Data: Pfizer, Canopy Growth Corp and Microsoft",0.0,0.593,0.407,1
2019-04-22 19:14:43,0.128,JNJ or PFE: Comparing Legacy and Newly Launched Immunology Drugs,0.0,0.857,0.143,1
2019-04-22 20:42:08,0.0,What's in Store for Bayer (BAYRY) This Earnings Season?,0.0,1.0,0.0,0
2019-04-22 21:34:00,0.0,Exact Sciences Is Near an All-Time High: Here&apos;s Why It Could Go Even Higher,0.0,1.0,0.0,0
2019-04-22 23:09:57,0.0,Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher,0.0,1.0,0.0,0
2019-04-23 13:49:35,0.4939,"Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-23 14:32:02,0.0,Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,0.0,1.0,0.0,0
2019-04-23 16:26:20,0.0,Alexion (ALXN) to Report Q1 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-04-23 17:12:11,0.0,Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-04-23 19:09:27,-0.2023,Why Is Bristol-Myers Near 52-Week Lows?,0.265,0.735,0.0,-1
2019-04-23 19:54:00,0.3612,"Kidney-Cancer Market: Good for Patients, Hard for Investors",0.136,0.583,0.282,1
2019-04-23 21:32:47,0.0,6 Poorly Performing Stocks in Gurus' Portfolios,0.0,1.0,0.0,0
2019-04-24 04:00:52,0.0,AstraZeneca chief claims vindication five years after Pfizer bid,0.0,1.0,0.0,0
2019-04-24 12:17:08,0.0,What Are Analysts Recommending for Merck?,0.0,1.0,0.0,0
2019-04-24 14:10:20,0.4939,"Health Care Sector Update for 04/24/2019: ANTM, RAD, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2019-04-24 20:59:14,0.067,"After Hours Most Active for Apr 24, 2019 :  PCG, MSFT, FB, SNAP, CMCSA, XOG, FOLD, SHY, PFE, RF, CNDT, POL",0.115,0.759,0.126,0
2019-04-24 22:10:16,0.0,Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates?,0.0,1.0,0.0,0
2019-04-24 23:13:30,0.0,Lannett (LCI) to Report Q3 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-04-25 00:12:04,0.0,Why Investors Should Buy the Dip in MRK Stock,0.0,1.0,0.0,0
2019-04-25 00:32:26,0.34,Pfizer (PFE) Gains As Market Dips: What You Should Know,0.0,0.789,0.211,1
2019-04-25 04:00:42,0.0,A deep dive into Tom Barrack’s Colony Capital,0.0,1.0,0.0,0
2019-04-25 11:00:00,0.0,Investec Sells Broadcom Stock and Doubles Down on Alibaba,0.0,1.0,0.0,0
2019-04-25 13:30:14,0.4939,"Health Care Sector Update for 04/25/2019: ABBV, BAX, BMY, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-04-25 18:12:48,0.0,What's in Store for SS&C Technologies (SSNC) in Q1 Earnings?,0.0,1.0,0.0,0
2019-04-25 18:14:16,-0.0258,Pfizer Stock Has Positive and Negative Catalysts Going Into Results,0.242,0.523,0.235,0
2019-04-25 21:15:12,0.5106,"Bristol-Myers Q1 Earnings Beat, Sales Up on Strong Eliquis",0.0,0.708,0.292,1
2019-04-26 13:50:17,0.4939,"Health Care Sector Update for 04/26/2019: AZN, ZBH, UHS, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-04-26 15:00:00,0.0516,Pfizer Receives Positive CHMP Opinion for TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer,0.163,0.63,0.207,0
2019-04-27 12:00:00,0.2263,A tale of two earnings seasons: The stocks hit by weak global growth and those that are immune,0.134,0.645,0.221,1
2019-04-29 03:52:03,0.0,Sangamo (SGMO) Q1 Earnings: What's in Store for the Stock?,0.0,1.0,0.0,0
2019-04-29 13:31:00,0.0,Tomorrow Is Earnings Day for Big Pharma. Here’s What to Watch.,0.0,1.0,0.0,0
2019-04-29 13:46:50,0.4939,"Health Care Sector Update for 04/29/2019: TTNP, DOVA, PHG, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-04-29 16:22:53,0.6249,Why Earnings Season Could Be Great for Pfizer (PFE),0.0,0.661,0.339,1
2019-04-29 17:42:00,0.296,Beaten-down health-care companies join Apple and Google in earnings parade,0.0,0.804,0.196,1
2019-04-29 18:23:13,0.0,"The Funded: New Bay Area IPO filings, $60M in funding deals",0.0,1.0,0.0,0
2019-04-29 20:16:35,0.0,"Pre-Market Earnings Report for April 30, 2019 :  MA, PFE, MRK, MCD, LLY, CHTR, GE, COP, GM, SPG, ECL, HCA",0.0,1.0,0.0,0
2019-04-29 22:07:52,0.0,Is a Beat in Store for Cigna (CI) This Earnings Season?,0.0,1.0,0.0,0
2019-04-29 23:21:24,0.0,Teladoc (TDOC) to Report Q1 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-04-30 06:47:03,0.0,"Pfizer Earnings, Revenue Beat in Q1",0.0,1.0,0.0,0
2019-04-30 09:32:00,0.0,Today Is Earnings Day for Big Pharma. Here’s What to Watch.,0.0,1.0,0.0,0
2019-04-30 10:00:00,-0.5256,Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks,0.207,0.793,0.0,-1
2019-04-30 10:45:00,0.0,PFIZER REPORTS FIRST-QUARTER 2019 RESULTS,0.0,1.0,0.0,0
2019-04-30 10:53:16,0.4404,Pfizer posts 9 pct rise in first-quarter profit,0.0,0.674,0.326,1
2019-04-30 11:06:05,0.0,"Pfizer, Merck both post earnings beats",0.0,1.0,0.0,0
2019-04-30 11:16:06,0.0,"Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly",0.0,1.0,0.0,0
2019-04-30 11:20:40,0.0,Three major pharmaceutical companies just reported earnings — here&apos;s how they did,0.0,1.0,0.0,0
2019-04-30 11:20:40,0.0,Three major pharmaceutical companies just reported earnings — here's how they did,0.0,1.0,0.0,0
2019-04-30 11:35:00,0.0,Pfizer stock up 1.7% after earnings and revenue beat,0.0,1.0,0.0,0
2019-04-30 11:39:22,0.0,US STOCKS-Futures flat as investors parse latest round of earnings,0.0,1.0,0.0,0
2019-04-30 11:41:03,0.0,Pfizer Rises 3%,0.0,1.0,0.0,0
2019-04-30 11:41:19,0.2023,"Pfizer, Merck Earnings Top; Eli Lilly Falls On Revenue",0.0,0.816,0.184,1
2019-04-30 11:45:56,0.0,Taking A Look At Pfizer Inc.'s (NYSE:PFE) ROE,0.0,1.0,0.0,0
2019-04-30 12:13:28,0.0,Biopharmaceuticals power Pfizer in the first quarter,0.0,1.0,0.0,0
2019-04-30 13:06:31,0.0,"US STOCKS-Wall Street set for mixed open, Alphabet to weigh on Nasdaq",0.0,1.0,0.0,0
2019-04-30 13:33:01,0.0,"Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View",0.0,1.0,0.0,0
2019-04-30 13:38:22,0.2023,Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins,0.0,0.833,0.167,1
2019-04-30 13:47:48,0.4939,"Health Care Sector Update for 04/30/2019: LLY, PFE, NVS, JNJ, ABTX, MRK, AMGN",0.0,0.789,0.211,1
2019-04-30 13:52:00,-0.1027,"Fed and tech stocks could crack the market rally, warns Wall Street strategist",0.104,0.896,0.0,-1
2019-04-30 14:18:02,0.0,"Big Day for Q1 Earnings: MCD, PFE, GE & More",0.0,1.0,0.0,0
2019-04-30 14:20:00,0.0,Merck and Pfizer Stock Rise but Eli Lilly Slips as Big Pharma Earnings Roll in,0.0,1.0,0.0,0
2019-04-30 14:30:12,0.0,US STOCKS-Wall Street pauses after record run as Alphabet tumbles,0.0,1.0,0.0,0
2019-04-30 14:46:54,0.0,Big Pharma Puts the Price Squeeze on Itself,0.0,1.0,0.0,0
2019-04-30 15:06:35,0.4019,Will Gilead Stock Get A Needed Boost From This Week’s Earnings Report?,0.0,0.787,0.213,1
2019-04-30 15:07:46,0.0,"Dow Movers: MMM, CVX",0.0,1.0,0.0,0
2019-04-30 15:51:00,0.4404,Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat,0.0,0.791,0.209,1
2019-04-30 16:04:00,0.1531,Stocks slide as Google revenue miss weighs on tech shares,0.136,0.678,0.186,1
2019-04-30 16:22:01,0.0,Q1 Earnings Continue,0.0,1.0,0.0,0
2019-04-30 16:42:17,0.0,"Stocks making the biggest moves midday: Alphabet, GE, McDonald's,Texas Roadhouse & more",0.0,1.0,0.0,0
2019-04-30 16:59:07,0.4019,Vaccine and blood thinner help drive Pfizer to quarterly earnings beat,0.0,0.787,0.213,1
2019-04-30 17:00:00,0.0,What You Need to Know About Pfizer&apos;s Q1 Earnings Beat,0.0,1.0,0.0,0
2019-04-30 17:14:04,-0.2924,Pfizer CEO: Drug prices will not be a growth driver,0.214,0.786,0.0,-1
2019-04-30 17:28:23,0.0,US STOCKS-Wall Street's record run hits snag after Alphabet tumbles,0.0,1.0,0.0,0
2019-04-30 18:12:14,0.0,What You Need to Know About Pfizer's Q1 Earnings Beat,0.0,1.0,0.0,0
2019-04-30 18:48:07,-0.4215,"McDonald's earnings sizzle on its bacon promotions, Alphabet's big miss, Netflix's ad destiny and Pfizer's drug pricing pressure",0.192,0.808,0.0,-1
2019-04-30 18:54:38,-0.3182,U.S. Stock ETFs Stumble as Alphabet Miss Drags,0.355,0.645,0.0,-1
2019-04-30 19:14:07,0.0,US STOCKS-Wall St's recent rally stumbles as Alphabet falls,0.0,1.0,0.0,0
2019-04-30 19:18:43,0.0,"Trump, Democratic leaders to meet on drug prices soon -White House",0.0,1.0,0.0,0
2019-04-30 19:27:57,0.1779,"Pfizer 1Q profit jumps 9% on higher drug sales, lower costs",0.156,0.638,0.206,1
2019-04-30 20:11:19,0.2023,Dow Drug Giants Top First-Quarter Estimates; But Another Pharma Dives,0.0,0.833,0.167,1
2019-04-30 20:22:00,0.0772,S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss,0.103,0.774,0.123,0
2019-04-30 20:50:08,0.0,"Market Close Report: NASDAQ Composite index closes at 8,095.39 down -54 points",0.0,1.0,0.0,0
2019-04-30 20:56:41,0.4576,"After Hours Most Active for Apr 30, 2019 :  AMD, COTY, ZNGA, PFE, VIPS, CVX, T, BKD, ASRT, IXUS, INTC, FB",0.0,0.864,0.136,1
2019-04-30 20:57:57,0.4767,US STOCKS-Nasdaq retreats as Alphabet falls but Apple gains after hours,0.0,0.763,0.237,1
2019-04-30 22:06:44,0.6908,Stocks Snag Fourth Straight Monthly Win,0.0,0.412,0.588,1
2019-04-30 22:25:25,0.6369,US STOCKS-S&P 500 posts best four-month run in nearly 9 years; Apple jumps after hours,0.0,0.756,0.244,1
2019-04-30 23:36:27,0.0,Alphabet Throws a Wet Blanket on Wall Street,0.0,1.0,0.0,0
2019-05-01 01:06:34,0.0,Edited Transcript of PFE earnings conference call or presentation 30-Apr-19 2:00pm GMT,0.0,1.0,0.0,0
2019-05-01 03:12:31,0.0,Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript,0.0,1.0,0.0,0
2019-05-01 13:05:01,-0.5859,"Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure",0.389,0.486,0.125,-1
2019-05-01 13:48:56,0.4939,"Health Care Sector Update for 05/01/2019: NBRV, TNDM, HUM, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-01 21:04:19,0.4576,"After Hours Most Active for May 1, 2019 :  GPRO, MRK, ZNGA, FITB, PFE, SQ, FCX, S, IQ, XOM, QCOM, ODP",0.0,0.864,0.136,1
2019-05-01 22:00:06,0.7506,The top 2 health care names to play for a catch-up: Technician,0.0,0.486,0.514,1
2019-05-02 12:01:28,0.0,What Are Analysts Recommending for PFE after Q1 Results?,0.0,1.0,0.0,0
2019-05-02 13:16:01,0.4767,"Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses",0.0,0.721,0.279,1
2019-05-02 13:35:02,0.0,Pfizer Reiterated Its Fiscal 2019 Revenue Guidance,0.0,1.0,0.0,0
2019-05-02 13:44:37,0.4939,"Health Care Sector Update for 05/02/2019: ABIO, CI, TFX, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-02 15:05:02,0.0,Pfizer Raised Its Fiscal 2019 EPS Guidance,0.0,1.0,0.0,0
2019-05-02 17:10:22,0.0,Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1,0.0,1.0,0.0,0
2019-05-02 17:49:00,-0.0772,Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices,0.115,0.885,0.0,0
2019-05-02 18:18:22,-0.5719,Pfizer Stock Rebounds Under Cloud of Negative Charts,0.346,0.654,0.0,-1
2019-05-02 21:05:26,0.4576,"After Hours Most Active for May 2, 2019 :  PFE, CHK, XOM, ESV, CSTM, SRE",0.0,0.813,0.187,1
2019-05-03 10:10:10,0.0,"Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV  Drugs Get EU Nod",0.0,1.0,0.0,0
2019-05-03 11:13:24,0.4404,"Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress",0.0,0.756,0.244,1
2019-05-03 11:30:29,0.0,Pfizer Reiterated Its Fiscal 2019 Expense Guidance,0.0,1.0,0.0,0
2019-05-03 13:44:39,0.4939,"Health Care Sector Update for 05/03/2019: XRAY, AZN, IMGN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-03 22:06:24,0.2023,"Top Stock Reports for Pfizer, Intel & HCA Healthcare",0.0,0.795,0.205,1
2019-05-04 20:23:38,0.0,GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript,0.0,1.0,0.0,0
2019-05-05 11:30:00,0.6249,5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term,0.0,0.76,0.24,1
2019-05-06 10:45:00,-0.2023,"U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease",0.158,0.721,0.122,-1
2019-05-06 11:07:16,0.4767,"Pfizer gets U.S. approval for $225,000 a year heart drug",0.0,0.721,0.279,1
2019-05-06 13:08:01,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins",0.0,1.0,0.0,0
2019-05-06 13:18:55,0.0,"Sanofi (SNY) Ex-Dividend Date Scheduled for May 07, 2019",0.0,1.0,0.0,0
2019-05-06 13:48:47,0.4939,"Health Care Sector Update for 05/06/2019: ESPR, AXSM, CANF, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-06 15:17:06,0.0,"The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo",0.0,1.0,0.0,0
2019-05-06 16:13:17,0.0,Alnylam Pharmaceuticals Continues Onpattro Launch With More to Come,0.0,1.0,0.0,0
2019-05-06 16:41:00,0.4767,"Pfizer Gets FDA Approval for $225,000 Heart Disease Drug",0.0,0.721,0.279,1
2019-05-06 20:14:03,0.0,How Dow Jones&apos; Pfizer Could Take On New Drugs From 2 Biotech Stocks,0.0,1.0,0.0,0
2019-05-06 21:10:05,0.0,7 Stocks to Buy From the T. Rowe Price Health Sciences Fund,0.0,1.0,0.0,0
2019-05-06 21:10:17,-0.1531,"Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1",0.186,0.814,0.0,-1
2019-05-06 21:12:39,0.1027,Exelixis Expands Its Sales,0.0,0.682,0.318,1
2019-05-07 11:00:00,0.1027,European Commission Approves LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer,0.182,0.537,0.281,1
2019-05-07 13:49:02,0.4939,"Health Care Sector Update for 05/07/2019: CPRX, GWPH, MNK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-07 16:11:47,0.0,"Ex-Dividend Reminder: American Electric Power, Bio-Techne and Pfizer",0.0,1.0,0.0,0
2019-05-07 17:11:32,0.128,Why the politically fueled health care stock crash may be over for now,0.16,0.651,0.189,1
2019-05-07 18:56:00,0.0,Comparing the Relative Valuations of PFE and GSK,0.0,1.0,0.0,0
2019-05-07 20:30:30,0.3818,Comparing the Revenue Growth Trajectories of PFE and GSK,0.0,0.755,0.245,1
2019-05-07 22:00:17,0.0,What Are Analysts Recommending for PFE and GSK in May?,0.0,1.0,0.0,0
2019-05-08 00:21:00,0.5994,Can Pfizer Leap Over the Competition With This Potential Blockbuster?,0.0,0.698,0.302,1
2019-05-08 10:45:00,0.0,Pfizer Acquires Clinical-Stage Biotech Therachon,0.0,1.0,0.0,0
2019-05-08 11:31:23,0.3818,Comparing the EPS Growth Trajectories of PFE and GSK,0.0,0.755,0.245,1
2019-05-08 13:20:56,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 09, 2019",0.0,1.0,0.0,0
2019-05-08 13:49:28,0.4939,"Health Care Sector Update for 05/08/2019: INGN, NVTA, MCK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-08 14:38:02,0.0,"Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More",0.0,1.0,0.0,0
2019-05-08 15:17:51,0.0,Pfizer Buys Rare Disease Biotech Therachon For $340M,0.0,1.0,0.0,0
2019-05-08 15:50:09,0.0,Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates,0.0,1.0,0.0,0
2019-05-08 15:55:34,0.4939,The Health Care Select Sector SPDR Fund Experiences Big Outflow,0.0,0.738,0.262,1
2019-05-08 16:55:12,0.296,"Commit To Buy Pfizer At $30, Earn 4.3% Using Options",0.0,0.804,0.196,1
2019-05-08 18:45:06,-0.2263,"Aerie (AERI) Q1 Earnings Beat, Rhopressa Misses Estimates",0.213,0.787,0.0,-1
2019-05-08 21:03:51,0.4576,"After Hours Most Active for May 8, 2019 :  DWDP, NLY, KDMN, PFE, DIS, TSM",0.0,0.813,0.187,1
2019-05-09 01:02:00,0.0,Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal,0.0,1.0,0.0,0
2019-05-09 01:37:37,0.4767,GSK-Pfizer deal gets approval from Australia's anti-trust watchdog,0.0,0.693,0.307,1
2019-05-09 02:15:00,0.0,What You Need to Know About Sangamo Therapeutics&apos; Q1 Earnings Results,0.0,1.0,0.0,0
2019-05-09 13:00:00,-0.3612,Why Exact Sciences Shrugged Off the Moody Market in April,0.217,0.783,0.0,-1
2019-05-09 13:54:49,0.4939,"Health Care Sector Update for 05/09/2019: ABIO, AGEN, ENDP, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-09 15:58:00,0.0,"Dow Movers: INTC, CVX",0.0,1.0,0.0,0
2019-05-09 17:02:24,0.0,Here's Why Sangamo Therapeutics Fell as Much as 13.6% Today,0.0,1.0,0.0,0
2019-05-10 02:54:01,0.0,"ICU Medical, Inc. (ICUI) Q1 2019 Earnings Call Transcript",0.0,1.0,0.0,0
2019-05-10 10:00:00,0.4019,Buckingham's Bets- Two Values in Healthcare,0.0,0.649,0.351,1
2019-05-10 11:34:11,0.0,"Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug",0.0,1.0,0.0,0
2019-05-10 13:13:58,0.0,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for May 13, 2019",0.0,1.0,0.0,0
2019-05-10 13:54:48,0.4939,"Health Care Sector Update for 05/10/2019: PBYI, TRXC, VSTM, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-10 15:38:05,0.0,"National Mutual Insurance Federation of Agricultur Buys Pfizer Inc, PayPal Holdings Inc, Sells ...",0.0,1.0,0.0,0
2019-05-10 18:13:50,0.4939,"Health Care Sector Update for 05/10/2019: TRXC, PBYI, VSTM, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-10 21:04:04,0.4576,"After Hours Most Active for May 10, 2019 :  COTY, PFE, UBER, HLF, MRK, DOW",0.0,0.813,0.187,1
2019-05-11 12:02:06,0.0,What happened to Viagra after Pfizer's patent for the 'wonder pill' expired,0.0,1.0,0.0,0
2019-05-11 14:30:32,-0.4215,How Viagra revolutionized the erectile dysfunction market,0.318,0.682,0.0,-1
2019-05-12 14:02:05,0.0,The money behind vaccines,0.0,1.0,0.0,0
2019-05-12 15:00:54,0.2023,Top vaccine makers Merck and Pfizer target China and older adults next,0.0,0.859,0.141,1
2019-05-13 02:35:41,0.0,"Fundamentals Of How China Makes Its Money (BABA, PFE)",0.0,1.0,0.0,0
2019-05-13 03:00:58,0.0,US generic drug companies hit by price-fixing claims,0.0,1.0,0.0,0
2019-05-13 10:00:00,-0.3818,FOCUS-TV networks emerge as obstacles on YouTube's hunt for ads,0.224,0.776,0.0,-1
2019-05-13 10:13:10,-0.3818,TV networks emerge as obstacles on YouTube's hunt for ads,0.224,0.776,0.0,-1
2019-05-13 12:40:26,-0.3182,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,0.173,0.827,0.0,-1
2019-05-13 14:07:18,0.4939,"Health Care Sector Update for 05/13/2019: TEVA, NVS, INSY, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-14 13:46:57,0.4939,"Health Care Sector Update for 05/14/2019: CTST, KMDA, MNK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-14 15:17:19,0.0,Generic Drugmakers Face Antitrust Suit Alleging Price Fixing,0.0,1.0,0.0,0
2019-05-14 23:44:00,0.5719,FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma,0.0,0.734,0.266,1
2019-05-15 00:25:00,0.5719,FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma,0.0,0.719,0.281,1
2019-05-15 10:45:00,0.25,"Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis",0.083,0.801,0.115,1
2019-05-15 10:55:16,0.0,Pfizer's dermatitis treatment meets main goals of late-stage study,0.0,1.0,0.0,0
2019-05-15 11:00:00,0.0,Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates,0.0,1.0,0.0,0
2019-05-15 11:12:02,0.0,Pfizer's atopic dermatitis treatment meets goals in late-stage study,0.0,1.0,0.0,0
2019-05-15 11:46:11,-0.2023,AbbVie Settles Humira Litigation With Boehringer Ingelheim,0.231,0.769,0.0,-1
2019-05-15 11:50:08,-0.8271,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",0.355,0.645,0.0,-1
2019-05-15 13:20:43,0.0,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 16, 2019",0.0,1.0,0.0,0
2019-05-15 13:27:01,-0.6597,Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer,0.355,0.645,0.0,-1
2019-05-15 15:14:18,0.0,"The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer",0.0,1.0,0.0,0
2019-05-15 15:47:16,0.2023,Teva Hits Fibonacci Support on Concerns Over Lawsuit,0.179,0.566,0.255,1
2019-05-15 16:09:11,0.0,"Dow Movers: CAT, KO",0.0,1.0,0.0,0
2019-05-15 20:38:39,0.0,This Dow Jones Pharma Giant Is Now A &apos;Top Pick&apos; — Here&apos;s Why,0.0,1.0,0.0,0
2019-05-15 20:56:33,0.4576,"After Hours Most Active for May 15, 2019 :  ARE, NEM, MRC, PFE, SQ, F",0.0,0.8,0.2,1
2019-05-15 21:01:00,0.4404,Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting,0.0,0.854,0.146,1
2019-05-16 12:00:28,-0.4404,Generic Drugs Are Stabilizing — Can They Survive An Antitrust Scandal?,0.244,0.756,0.0,-1
2019-05-16 12:06:08,0.0,"Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more",0.0,1.0,0.0,0
2019-05-16 12:08:32,0.0,"Here are the biggest analyst calls of the day: Macy&apos;s, Pfizer, Owens Corning & more",0.0,1.0,0.0,0
2019-05-16 13:40:00,0.7003,Pfizer Gains After Being Named 'Top Pick' by Credit Suisse,0.0,0.507,0.493,1
2019-05-16 14:21:29,0.0,Pfizer's Eczema Candidate Meets All Goals in Phase III Study,0.0,1.0,0.0,0
2019-05-16 16:07:33,0.0,"XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2019-05-17 12:24:12,0.4404,"Dow 30 Stock Roundup: Walmart, Cisco Earnings Impress",0.0,0.707,0.293,1
2019-05-17 12:35:12,-0.3182,"Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs",0.238,0.595,0.168,-1
2019-05-17 13:47:17,0.4939,"Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-17 20:56:42,0.4576,"After Hours Most Active for May 17, 2019 :  QCOM, VIPS, QQQ, VEON, PFE, WFC, ATI, INTC, WMT, CECO, TEF, IQ",0.0,0.864,0.136,1
2019-05-18 13:08:25,0.0,Where Will Pfizer Be in 5 Years?,0.0,1.0,0.0,0
2019-05-19 14:08:24,0.4404,Better Buy: Eli Lilly vs. Pfizer,0.0,0.633,0.367,1
2019-05-20 13:46:36,0.4939,"Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-20 16:04:42,0.3818,Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock,0.0,0.794,0.206,1
2019-05-20 18:44:17,0.0,Primary Drivers of the Chinese Economy,0.0,1.0,0.0,0
2019-05-21 13:00:00,0.4404,Better Buy: AbbVie vs. Pfizer,0.0,0.58,0.42,1
2019-05-21 15:16:39,-0.802,Merck's Keytruda Fails in Late-Stage Breast Cancer Study,0.545,0.455,0.0,-1
2019-05-22 00:08:55,-0.4215,Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint,0.259,0.741,0.0,-1
2019-05-22 13:46:55,0.4939,"Health Care Sector Update for 05/22/2019: OBLN, CODX, AFMD, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-23 13:08:01,0.0,Lilly (LLY) Launches Half-Priced Version of Humalog Insulin,0.0,1.0,0.0,0
2019-05-23 13:16:42,0.0,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 24, 2019",0.0,1.0,0.0,0
2019-05-23 13:47:08,0.4939,"Health Care Sector Update for 05/23/2019: NVCN, IOVA, MDT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-23 16:16:11,0.0,Alphabet to Aid Pharma Giants Enhance Clinical Trial Process,0.0,1.0,0.0,0
2019-05-23 18:12:07,0.4696,Next level of support for Pioneer? Pfizer or J&J? The viewers #AskHalftime,0.0,0.782,0.218,1
2019-05-23 18:25:10,0.0,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3",0.0,1.0,0.0,0
2019-05-24 15:21:53,-0.4939,3 Stocks to Win Big in the Fight Against Cancer,0.417,0.357,0.226,-1
2019-05-24 17:15:57,0.0,"Barrow, Hanley, Mewhinney & Strauss Trims Multiple Positions in 1st Quarter",0.0,1.0,0.0,0
2019-05-24 20:00:00,0.0,Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures,0.0,1.0,0.0,0
2019-05-24 20:20:00,0.0,Pfizer&apos;s Lyrica doesn&apos;t meet endpoint in epilepsy study,0.0,1.0,0.0,0
2019-05-25 02:50:00,0.0,"PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE",0.0,1.0,0.0,0
2019-05-27 05:24:18,0.0,"3 Peninsula biotech IPOs show off diversity of targets, seek to raise more than $400 million",0.0,1.0,0.0,0
2019-05-27 13:22:01,-0.4215,Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study,0.237,0.763,0.0,-1
2019-05-27 14:05:02,-0.3818,Dow on Longest Losing Streak in 8 Yrs: 5 Stocks Still Up in ETF,0.191,0.809,0.0,-1
2019-05-28 12:32:25,0.0,"Here are the biggest analyst calls of the day: Beyond Meat, Apple, Southwest, Pfizer, Roku & more",0.0,1.0,0.0,0
2019-05-28 12:46:12,0.0,"The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer",0.0,1.0,0.0,0
2019-05-28 13:46:56,0.4939,"Health Care Sector Update for 05/28/2019: TRXC, QTNT, BMRN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-28 15:30:21,0.0,British Columbia to be first Canadian province to switch patients to biosimilars,0.0,1.0,0.0,0
2019-05-28 15:48:03,0.0,Conatus Down More Than 60% in the Past 90 Days: Here's Why,0.0,1.0,0.0,0
2019-05-28 17:07:09,0.0,"Notable ETF Inflow Detected - VLUE, T, PFE, BAC",0.0,1.0,0.0,0
2019-05-28 18:39:44,0.0,4 Drug and Health Stocks Pushing Higher,0.0,1.0,0.0,0
2019-05-28 19:36:50,0.0,This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy,0.0,1.0,0.0,0
2019-05-28 19:56:03,0.875,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns provisional ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,0.0,0.667,0.333,1
2019-05-28 21:35:39,0.7603,"A hemophilia patient hero at zero, BioMarin to seek FDA OK for gene therapy. But will the effect last?",0.0,0.71,0.29,1
2019-05-28 23:06:51,0.0,4 Drug and Health Stocks Pushing Higher &#160;,0.0,1.0,0.0,0
2019-05-29 13:19:41,0.0,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 30, 2019",0.0,1.0,0.0,0
2019-05-29 13:52:00,-0.3182,Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1,0.173,0.827,0.0,-1
2019-05-29 14:07:32,0.4939,"Health Care Sector Update for 05/29/2019: SOLY, CARA, FCSC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-29 17:11:58,-0.5106,Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate,0.355,0.645,0.0,-1
2019-05-29 20:57:15,0.4576,"After Hours Most Active for May 29, 2019 :  ELAN, PFE, QD, LC, TVPT, KO",0.0,0.813,0.187,1
2019-05-29 21:07:40,0.0,Merck (MRK) Up This Year So Far: Will the Momentum Continue?,0.0,1.0,0.0,0
2019-05-29 23:55:06,0.875,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns a provisional rating to One CMBS class of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,0.0,0.667,0.333,1
2019-05-30 01:03:10,-0.296,Pfizer focuses on regional China after price cuts hit sales,0.196,0.804,0.0,-1
2019-05-30 13:47:09,0.4939,"Health Care Sector Update for 05/30/2019: UBX, ACHV, NVS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-05-30 16:15:58,0.0,Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue?,0.0,1.0,0.0,0
2019-05-30 16:59:37,-0.4588,Only five Dow stocks have gained in May as trade war drags on,0.308,0.549,0.143,-1
2019-05-30 17:30:20,-0.4404,Should We Worry About Pfizer Inc.'s (NYSE:PFE) P/E Ratio?,0.266,0.734,0.0,-1
2019-05-30 19:26:23,0.34,Pfizer opens $236M facility as region makes gains in biotech industry,0.0,0.806,0.194,1
2019-05-31 10:32:10,0.0,"Dow 30 Stock Roundup: BA's Dreamliner Order, MSFT LinkedIn's Drawbridge Buyout Plan",0.0,1.0,0.0,0
2019-05-31 12:29:23,0.4019,Drug and Healthcare Stocks to Keep Your Portfolio Healthy,0.0,0.748,0.252,1
2019-05-31 13:47:14,0.4939,"Health Care Sector Update for 05/31/2019: IOVA, MYOV, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2019-06-01 11:30:01,0.8555,Novartis hopes Kisqali data will help narrow gap to blockbuster rival,0.0,0.46,0.54,1
2019-06-01 13:53:51,0.0,Were Hedge Funds Right About Souring On Pfizer Inc. (PFE)?,0.0,1.0,0.0,0
2019-06-03 12:05:00,0.0,Matinas BioPharma to Present at the 9th Annual LD Micro Invitational,0.0,1.0,0.0,0
2019-06-03 13:16:59,0.0,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for June 04, 2019",0.0,1.0,0.0,0
2019-06-03 13:39:01,-0.3818,Merck's Keytruda Improves 5-Year Survival in Lung Cancer,0.333,0.455,0.212,-1
2019-06-03 14:26:02,0.0,Blueprint Medicines' NDA for Avapritinib on Track for GIST,0.0,1.0,0.0,0
2019-06-03 15:06:33,0.0,"XLV, EGPT: Big ETF Outflows",0.0,1.0,0.0,0
2019-06-03 16:07:40,0.0,What Analysts Are Expecting from Pfizer and Merck in June,0.0,1.0,0.0,0
2019-06-03 16:07:40,0.3818,Comparing Pfizer’s and Merck’s 2019 Revenue Growth Trajectories,0.0,0.729,0.271,1
2019-06-03 17:40:11,-0.2263,How Losses of Exclusivity Are Playing Out for PFE and MRK in 2019,0.174,0.71,0.116,-1
2019-06-03 19:10:03,0.0,How Is Pfizer’s Biopharmaceuticals Group Positioned in 2019?,0.0,1.0,0.0,0
2019-06-03 19:10:11,0.0,Comparing Pfizer’s and Merck’s Vaccines Businesses,0.0,1.0,0.0,0
2019-06-03 20:05:11,0.0,6 High-Yield Stocks,0.0,1.0,0.0,0
2019-06-04 10:00:00,0.2023,Ultimate Stock-Pickers' Top 10 Buys and Sells,0.0,0.769,0.231,1
2019-06-04 17:57:05,0.2023,"Top Research Reports for Pfizer, Coca-Cola & VMware",0.0,0.769,0.231,1
2019-06-05 12:15:00,-0.6597,10 Jaw-Dropping Numbers About Cancer Drug Development -- and What They Mean for Investors,0.253,0.747,0.0,-1
2019-06-05 13:05:01,0.0,Pfizer to Launch Several Drugs Despite Generic Headwinds,0.0,1.0,0.0,0
2019-06-05 13:46:59,0.4939,"Health Care Sector Update for 06/05/2019: RWLK, IFRX, SRRA, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-05 15:10:12,0.0,"The Zacks Analyst Blog Highlights: Pfizer, Coca-Cola, VMware, NIKE and AIG",0.0,1.0,0.0,0
2019-06-05 15:44:03,0.0,Blueprint Medicines to File NDA for Avapritinib With FDA,0.0,1.0,0.0,0
2019-06-05 16:21:17,-0.765,How Merck reached new ground in the fight against cancer,0.455,0.455,0.091,-1
2019-06-05 17:07:48,0.2023,Top Tips for Long-Term Stock Investors,0.0,0.735,0.265,1
2019-06-05 17:30:00,0.0,"Jeff Settleman, Ph.D., Joins Pfizer to Lead Oncology Research & Development",0.0,1.0,0.0,0
2019-06-06 12:50:45,0.0,"3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies",0.0,1.0,0.0,0
2019-06-06 13:47:09,0.4939,"Health Care Sector Update for 06/06/2019: MTFB, PLX, SEEL, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-06 14:09:14,0.0,5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug,0.0,1.0,0.0,0
2019-06-06 15:20:34,0.4767,Lilly's Emgality Gets FDA Approval for Cluster Headache,0.0,0.693,0.307,1
2019-06-06 15:20:52,0.0,"Zacks Market Edge Highlights: Pfizer, Vanguard S&P 500 ETF, Global X Social Media ETF, Kraneshares China Internet ETF and Microsoft",0.0,1.0,0.0,0
2019-06-06 21:45:09,0.34,Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know,0.0,0.789,0.211,1
2019-06-07 08:01:22,0.0,"Germany's Stada buys six of GSK's consumer brands, eyes further deals",0.0,1.0,0.0,0
2019-06-07 11:45:00,0.0,Why I&apos;m Sticking With My 3 Worst-Performing Stocks of 2019 So Far,0.0,1.0,0.0,0
2019-06-07 12:50:07,0.0,Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far,0.0,1.0,0.0,0
2019-06-07 13:48:38,0.4939,"Health Care Sector Update for 06/07/2019: LJPC, TXMD, GSK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-10 11:23:18,0.0,"Jim Cramer Weighs In On Tesla, PayPal And More",0.0,1.0,0.0,0
2019-06-10 13:39:01,0.4939,TherapeuticsMD Enters Agreement to Market Drugs Outside US,0.0,0.686,0.314,1
2019-06-10 13:47:01,0.4939,"Health Care Sector Update for 06/10/2019: INSY, TLRY, ONCE, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-10 14:59:22,0.0,9 Hot Stocks to Buy Now,0.0,1.0,0.0,0
2019-06-10 17:35:00,-0.5574,INMB: TNF-α Inhibition Associated with Decreased Risk of Developing Alzheimer’s Disease…,0.338,0.662,0.0,-1
2019-06-11 13:47:12,0.4939,"Health Care Sector Update for 06/11/2019: CBAY, MOTS, PRVB, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-12 12:00:00,-0.0516,"Pfizer Announces Results from XELJANZ® XR (tofacitinib) ORAL Shift Study, The First Phase 3b/4 Study to Evaluate Methotrexate Withdrawal with a JAK Inhibitor",0.058,0.893,0.049,0
2019-06-12 12:28:12,0.4019,Boost Your Portfolio's Health With These 3 Big Drug Stocks,0.0,0.748,0.252,1
2019-06-12 13:47:19,0.4939,"Health Care Sector Update for 06/12/2019: SYBX, CTRV, AXGT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-12 15:18:43,-0.1779,Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer,0.291,0.464,0.245,-1
2019-06-12 17:09:28,0.2023,Top Ranked Income Stocks to Buy for June 12th,0.0,0.816,0.184,1
2019-06-12 22:21:10,0.0,Novartis Reports Data on Cosentyx for Psoriatic Arthritis,0.0,1.0,0.0,0
2019-06-12 22:38:10,0.0,Galapagos Ends Enrollment in Osteoarthritis Study Before Time,0.0,1.0,0.0,0
2019-06-13 13:18:58,0.0,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019",0.0,1.0,0.0,0
2019-06-13 13:47:43,0.4939,"Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-13 14:19:05,0.4767,Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study,0.0,0.721,0.279,1
2019-06-13 17:43:06,0.875,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,0.0,0.667,0.333,1
2019-06-13 20:48:21,0.0,"Market Close Report: NASDAQ Composite index closes at 7,837.13 up 44.41 points",0.0,1.0,0.0,0
2019-06-13 22:06:36,-0.4019,Stocks Bounce Back Amid U.S.-Iran Tanker Tensions,0.31,0.69,0.0,-1
2019-06-14 14:07:00,0.0,Merck Plans Its First Investor Day in 5 Years. Here’s What to Watch.,0.0,1.0,0.0,0
2019-06-14 15:16:43,0.4215,"Dow 30 Stock Roundup: United Technologies-Raytheon Merger, Merck's Tilos Buyout",0.0,0.763,0.237,1
2019-06-14 15:19:20,0.0,Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti,0.0,1.0,0.0,0
2019-06-14 16:09:19,0.0,"Dow Movers: INTC, UTX",0.0,1.0,0.0,0
2019-06-15 14:07:25,0.5994,5 Biggest Blockbuster Drugs of the Future,0.0,0.562,0.438,1
2019-06-17 08:21:00,0.0,"Stocks - Pfizer, Target Fall Premarket; Deutsche Bank, Boeing Rise",0.0,1.0,0.0,0
2019-06-17 09:52:00,0.0,Stocks - Wall Street Mixed as Fed Meeting in Focus,0.0,1.0,0.0,0
2019-06-17 10:54:00,0.0,Pfizer to Acquire Array BioPharma,0.0,1.0,0.0,0
2019-06-17 10:54:13,0.0,Pfizer to buy Array for $10.64 bln,0.0,1.0,0.0,0
2019-06-17 10:56:00,0.0,Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer,0.0,1.0,0.0,0
2019-06-17 10:56:16,-0.6597,Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma,0.286,0.714,0.0,-1
2019-06-17 12:41:00,0.0,U.S. stocks set to rise cautiously as Federal Reserve gathering comes into focus,0.0,1.0,0.0,0
2019-06-17 12:43:00,-0.5719,S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal,0.252,0.748,0.0,-1
2019-06-17 13:06:29,0.0,US STOCKS-Wall St set for muted open; Fed meet in focus,0.0,1.0,0.0,0
2019-06-17 13:26:10,-0.6597,Pfizer buys cancer treatment innovator Array BioPharma for $11 billion,0.328,0.672,0.0,-1
2019-06-17 13:30:02,0.3818,Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth,0.0,0.776,0.224,1
2019-06-17 13:35:00,0.0,Stocks mixed as Fed meeting comes into view,0.0,1.0,0.0,0
2019-06-17 13:35:04,-0.6124,Pfizer Expands in Cancer With $10.6 Billion Deal for Array,0.319,0.58,0.101,-1
2019-06-17 13:52:00,-0.1027,Stocks Mixed in Cautious Trading Ahead of Fed Meeting,0.149,0.851,0.0,-1
2019-06-17 14:29:03,0.0,US STOCKS-Wall Street moves higher; Fed policy meeting on the horizon,0.0,1.0,0.0,0
2019-06-17 14:43:11,0.4466,"ARRAY BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout",0.0,0.789,0.211,1
2019-06-17 14:46:02,0.0,Big Ticket Mergers Are in Focus,0.0,1.0,0.0,0
2019-06-17 15:33:29,-0.34,Why Array BioPharma Stock Is on Fire Today,0.255,0.745,0.0,-1
2019-06-17 15:43:00,-0.6597,Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist,0.286,0.714,0.0,-1
2019-06-17 15:59:41,0.6408,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Array BioPharma Inc. to Pfizer Inc. is Fair to Shareholders",0.0,0.815,0.185,1
2019-06-17 16:10:14,0.0,US STOCKS-Wall Street moves higher; Fed policy meeting eyed,0.0,1.0,0.0,0
2019-06-17 16:11:58,0.0,Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal,0.0,1.0,0.0,0
2019-06-17 16:27:56,0.0,SPDR S&P 500 ETF Experiences Big Inflow,0.0,1.0,0.0,0
2019-06-17 16:32:12,0.0,"&quot;Merger Monday&quot; Returns: Pfizer Buying Array, T-Mobile-Sprint on Ice?",0.0,1.0,0.0,0
2019-06-17 16:40:10,-0.2732,Pfizer Inc. -- Moody's: Pfizer's acquisition of Array is credit negative,0.242,0.588,0.17,-1
2019-06-17 17:20:04,0.34,US STOCKS-Wall Street holds on to gains; Fed policy meeting eyed,0.0,0.806,0.194,1
2019-06-17 17:31:54,0.5267,"Stock Market News: Sotheby's, Array Get Winning Bids on a Big Deal Day",0.0,0.764,0.236,1
2019-06-17 17:58:10,-0.1531,Why Pfizer Is Falling and Array Is Rising on Acquisition News,0.138,0.862,0.0,-1
2019-06-17 18:43:08,0.296,Mid-Day Market Update: Sotheby's Jumps On Acquisition News; Flex Pharma Shares Slide,0.0,0.833,0.167,1
2019-06-17 18:48:05,0.4939,"Health Care Sector Update for 06/17/2019: BPMC,ARRY,PFE,VBIV",0.0,0.652,0.348,1
2019-06-17 18:50:21,0.0,US STOCKS-Faith in the Fed pushes Wall Street higher,0.0,1.0,0.0,0
2019-06-17 18:58:20,-0.6249,The 5 Worst Dow Jones Stocks So Far in 2019,0.339,0.661,0.0,-1
2019-06-17 19:20:00,0.128,Pfizer Is the Latest Drug Company to Put Its Credit Rating at Risk With M&A,0.119,0.734,0.147,1
2019-06-17 19:23:00,-0.6597,"Pfizer Is Buying Array BioPharma, Seeking to Broaden Lineup of Cancer Drugs",0.286,0.714,0.0,-1
2019-06-17 19:28:00,-0.1027,Stocks Rise Modestly in Cautious Trading Ahead of Federal Reserve Meeting,0.123,0.877,0.0,-1
2019-06-17 19:48:16,0.0,Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks?,0.0,1.0,0.0,0
2019-06-17 20:05:26,0.2023,"5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA",0.0,0.816,0.184,1
2019-06-17 20:17:00,0.296,"Stocks close higher as social media, real estate shares lead",0.0,0.804,0.196,1
2019-06-17 20:19:02,0.0,US STOCKS-Faith in the Fed nudges Wall Street higher,0.0,1.0,0.0,0
2019-06-17 20:23:03,0.0,Pfizer acquires Array in 2nd major Boulder bioscience merger this month,0.0,1.0,0.0,0
2019-06-17 20:26:00,-0.0352,Stocks End Slightly Higher in Cautious Trading Ahead of Federal Reserve Meeting,0.094,0.906,0.0,0
2019-06-17 20:28:13,0.4939,"Health Care Sector Update for 06/17/2019: VYGR,SNY,BPMC,ARRY,PFE,VBIV",0.0,0.652,0.348,1
2019-06-17 20:48:37,0.0,How Pfizer&apos;s $11.4 Billion Takeover Of Array Signals More Mergers,0.0,1.0,0.0,0
2019-06-17 20:57:51,0.7598,"After Hours Most Active for Jun 17, 2019 :  VEON, TRUE, CZR, FDC, KR, LC, LXP, PFE, AEG, MSFT, QCOM, INTC",0.0,0.734,0.266,1
2019-06-17 21:00:00,-0.1027,Why Pfizer&apos;s Acquisition of Array BioPharma Won&apos;t Pay Off Anytime Soon,0.123,0.877,0.0,-1
2019-06-17 21:06:21,0.0,What Happened in the Stock Market Today,0.0,1.0,0.0,0
2019-06-17 22:30:22,0.0762,Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon,0.0,0.885,0.115,0
2019-06-18 01:27:56,0.0,Dow Jones Today: Almost a Case of the Mondays,0.0,1.0,0.0,0
2019-06-18 06:07:40,0.0,PRESS DIGEST - Wall Street Journal - June 18,0.0,1.0,0.0,0
2019-06-18 11:01:20,-0.5106,NHS and life sciences sector failing to work together,0.292,0.708,0.0,-1
2019-06-18 11:09:00,0.296,Shares of cancer-therapy companies skyrocket after Pfizer acquisition news,0.0,0.784,0.216,1
2019-06-18 12:00:00,0.2732,3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer&apos;s Surprise Deal,0.0,0.826,0.174,1
2019-06-18 13:35:01,0.0,"Company News For Jun 18, 2019",0.0,1.0,0.0,0
2019-06-18 13:48:23,0.4939,"Health Care Sector Update for 06/18/2019: BHVN, GTHX, PHAS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-18 13:51:01,-0.6597,"Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio",0.386,0.614,0.0,-1
2019-06-18 13:51:14,-0.6597,Cancer Therapy Stocks Soar After Pfizer Deal,0.423,0.577,0.0,-1
2019-06-18 13:55:01,0.0,Pfizer-Array Biopharma Deal Bump Up Biotech ETFs,0.0,1.0,0.0,0
2019-06-18 14:00:00,0.0,Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts,0.0,1.0,0.0,0
2019-06-18 14:27:02,0.0,Protalix (PLX) Completes Enrollment in Fabry Disease Study,0.0,1.0,0.0,0
2019-06-18 21:30:50,-0.3412,Papa John’s Auditor Swap Is Not a Good Look,0.256,0.744,0.0,-1
2019-06-18 21:57:00,0.4466,SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition,0.0,0.705,0.295,1
2019-06-19 11:56:15,0.0,"3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company",0.0,1.0,0.0,0
2019-06-19 13:27:36,0.5106,A Beloved Biotech ETF Could Lure Traders Again,0.0,0.645,0.355,1
2019-06-19 13:48:34,0.4939,"Health Care Sector Update for 06/19/2019: MLNT, CALA, MYOS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-19 14:02:00,0.2263,2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land,0.0,0.853,0.147,1
2019-06-19 15:20:03,0.0,Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal,0.0,1.0,0.0,0
2019-06-19 15:39:39,0.0,Big Drugmakers That May Tread the M&A Path After Pfizer,0.0,1.0,0.0,0
2019-06-19 17:37:30,0.0,GSK kicks off sale of $1.2 billion consumer health drugs: sources,0.0,1.0,0.0,0
2019-06-19 20:49:14,0.34,Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years,0.0,0.769,0.231,1
2019-06-20 08:18:09,0.0,GSK offers concessions to address EU concerns over Pfizer deal,0.0,1.0,0.0,0
2019-06-20 13:48:45,0.4939,"Health Care Sector Update for 06/20/2019: EDSA, GHSI, IDXG, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-20 14:38:59,0.0,Is Pfizer Overpaying for Array Biopharma?,0.0,1.0,0.0,0
2019-06-20 15:37:19,0.0,"Stock Market News For Jun 20, 2019",0.0,1.0,0.0,0
2019-06-20 20:58:19,0.4576,"After Hours Most Active for Jun 20, 2019 :  MSFT, FAST, QQQ, BBVA, AMCR, GE, T, FDC, PFE, CSX, AMD, CMCSA",0.0,0.864,0.136,1
2019-06-21 13:07:01,0.0,"Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod",0.0,1.0,0.0,0
2019-06-21 13:20:01,0.0,"Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up",0.0,1.0,0.0,0
2019-06-21 13:48:55,0.4939,"Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-06-21 14:45:00,-0.1779,European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer,0.19,0.606,0.203,-1
2019-06-21 15:37:36,0.0,"Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma",0.0,1.0,0.0,0
2019-06-21 15:57:54,-0.3182,Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA,0.284,0.516,0.2,-1
2019-06-21 20:29:42,0.0,"Oh, By the Way, This Clinical Trial Didn't Work",0.0,1.0,0.0,0
2019-06-21 20:33:39,0.0,Dow Jones Today: A Typical Summer Friday,0.0,1.0,0.0,0
2019-06-21 21:37:37,0.0,Amag’s plan to bypass female libido drug pitfalls? Social media.,0.0,1.0,0.0,0
2019-06-22 02:50:00,0.0,"PFIZER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE",0.0,1.0,0.0,0
2019-06-22 19:07:43,0.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",0.0,1.0,0.0,0
2019-06-23 12:06:34,0.296,Do Institutions Own Shares In Pfizer Inc. (NYSE:PFE)?,0.0,0.761,0.239,1
2019-06-23 12:09:15,0.4215,Is There An Opportunity With Pfizer Inc.'s (NYSE:PFE) 50% Undervaluation?,0.0,0.763,0.237,1
2019-06-23 13:00:00,0.0,These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?,0.0,1.0,0.0,0
2019-06-24 14:06:02,0.0,"U.S. Senate Takes on Big Tech, Plus &quot;Merger Monday&quot;",0.0,1.0,0.0,0
2019-06-24 15:04:03,0.0,BioMarin Gets $15M From Pfizer on Talzenna's European Nod,0.0,1.0,0.0,0
2019-06-24 15:10:36,-0.6597,Read This Before You Buy Any New Cancer Drug Stocks,0.328,0.672,0.0,-1
2019-06-24 15:18:26,-0.3182,Pfizer's Talzenna Gets Approval in Europe for Breast Cancer,0.303,0.483,0.214,-1
2019-06-24 15:45:24,0.0,Eldorado to Buy Caesars,0.0,1.0,0.0,0
2019-06-24 20:09:04,0.3612,What Analysts Recommend for Pfizer and Bristol-Myers Squibb,0.0,0.737,0.263,1
2019-06-24 20:14:23,0.0,This Biotech Stock Is Facing A 'Whale' As Pfizer Unveils Gene Therapy Data,0.0,1.0,0.0,0
2019-06-24 20:23:08,0.4404,Why These Innovative Biotech ETFs Soaring,0.0,0.633,0.367,1
2019-06-24 21:40:02,0.0,Comparing PFE’s and BMY’s Revenue Trajectory,0.0,1.0,0.0,0
2019-06-25 11:04:20,0.0,Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion deal,0.0,1.0,0.0,0
2019-06-25 11:31:56,0.0,How PFE’s and BMY’s EPS Trends Compare,0.0,1.0,0.0,0
2019-06-25 13:00:33,0.0,Comparing PFE’s and BMY’s Expense Trends,0.0,1.0,0.0,0
2019-06-25 14:14:02,0.0,"AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20",0.0,1.0,0.0,0
2019-06-25 14:30:15,0.3818,Pfizer’s Oncology Treatment Growth Drivers,0.0,0.606,0.394,1
2019-06-25 14:32:02,0.0,Abbvie Decides to Acquire Allergan,0.0,1.0,0.0,0
2019-06-25 15:03:00,0.0,Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015,0.0,1.0,0.0,0
2019-06-25 15:07:50,0.0,"Dow Movers: GS, JNJ",0.0,1.0,0.0,0
2019-06-25 17:07:28,0.0,"Noteworthy ETF Inflows: SPY, BRK.B, DIS, PFE",0.0,1.0,0.0,0
2019-06-25 20:56:49,0.4576,"After Hours Most Active for Jun 25, 2019 :  DIS, TI, LC, PFE, NEM, QD",0.0,0.813,0.187,1
2019-06-25 21:06:51,0.0,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,0.0,1.0,0.0,0
2019-06-25 21:45:09,0.0,Pfizer (PFE) Flat As Market Sinks: What You Should Know,0.0,1.0,0.0,0
2019-06-25 22:07:30,0.0516,Stocks Swing Lower As Rate Cut Optimism Dampens,0.336,0.391,0.273,0
2019-06-26 00:06:49,0.0,3 Biopharma Stocks to Buy for Income,0.0,1.0,0.0,0
2019-06-26 02:08:33,-0.1027,3 Dividend Stocks That Could Pay You the Rest of Your Life,0.123,0.877,0.0,-1
2019-06-26 11:30:02,0.0,Comparing PFE’s and BMY’s Immunology Drugs,0.0,1.0,0.0,0
2019-06-26 12:08:22,-0.3612,Conatus' Emricasan Lags Primary Goal in Liver Function Study,0.238,0.762,0.0,-1
2019-06-27 10:26:09,0.0,Ex-FDA boss joins Pfizer 83 days after leaving US drug regulator,0.0,1.0,0.0,0
2019-06-27 13:37:01,0.2732,Bayer Sets Up Special Committee to Tackle Glyphosate Lawsuits,0.142,0.619,0.239,1
2019-06-27 17:01:38,0.0,Draper laboratory signs 'organ-on-chip' development deal with Bristol-Myers Squibb,0.0,1.0,0.0,0
2019-06-27 17:16:15,0.0,Lilly's Study on Higher Doses of Trulicity Meets Endpoint,0.0,1.0,0.0,0
2019-06-27 20:15:00,0.0,Pfizer Declares Third-Quarter 2019 Dividend,0.0,1.0,0.0,0
2019-06-27 20:17:00,0.0,Scott Gottlieb Elected to Pfizer’s Board of Directors,0.0,1.0,0.0,0
2019-06-27 21:17:59,0.0,Pfizer names former FDA chief Scott Gottlieb to its board,0.0,1.0,0.0,0
2019-06-28 11:32:52,-0.25,"The Daily Biotech Pulse: Chiasma To Join R3K Index, EU Rejects Amgen's Osteoporosis Drug Application, Karuna IPO",0.157,0.735,0.108,-1
2019-06-28 11:33:00,0.4767,"Pfizer Receives U.S. FDA Approval for Its Oncology Biosimilar, ZIRABEV™ (bevacizumab-bvzr)",0.0,0.763,0.237,1
2019-06-28 11:49:00,0.0258,Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer,0.211,0.526,0.263,0
2019-06-28 12:15:36,0.7783,Pfizer's Avastin biosimilar wins FDA approval,0.0,0.37,0.63,1
2019-06-28 13:38:36,0.0,Can Roche's #1 Therapeutic Area With $28 Billion In Revenue Grow Further?,0.0,1.0,0.0,0
2019-06-28 13:44:01,0.0,"Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger",0.0,1.0,0.0,0
2019-06-28 14:15:00,0.0,Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD),0.0,1.0,0.0,0
2019-06-28 14:18:41,0.3182,"Pfizer gene therapy for rare muscle disease shows promise in small, early study",0.0,0.839,0.161,1
2019-06-28 14:34:55,0.4215,Sarepta surges after Pfizer gene therapy data raises safety concerns,0.0,0.763,0.237,1
2019-06-28 15:22:47,-0.5859,"Dow 30 Stock Roundup: Nike Earnings Disappoint, Walgreens Boots Margins Drop",0.348,0.652,0.0,-1
2019-06-28 16:28:55,0.0,Street Crowns Sarepta DMD Gene Therapy King After Pfizer Results,0.0,1.0,0.0,0
2019-06-28 17:35:00,0.0258,Sarepta Therapeutics Soars as Pfizer's Competing Drug Shows Safety Problems,0.2,0.593,0.207,0
2019-06-28 20:05:00,0.0,Pfizer Announces Results from Phase 3 Trial of Revatio® (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension,0.0,1.0,0.0,0
2019-06-28 20:27:00,0.0,Here&apos;s Why Sarepta Therapeutics Is Surging Today,0.0,1.0,0.0,0
2019-06-28 20:28:03,-0.3818,Gene Therapy Battle: Pfizer's Test Results Sent This Biotech Stock Flying,0.206,0.794,0.0,-1
2019-06-28 20:47:05,0.7598,"After Hours Most Active for Jun 27, 2019 :  CZR, UBER, PFE, SYF, AAPL, TRUE, MU, VEON, BAC, NKE, KO, QCOM",0.0,0.734,0.266,1
2019-06-28 21:07:19,0.0,"Daily Dividend Report: FNLC, PFE, T, NYT, BFS",0.0,1.0,0.0,0
2019-06-28 21:08:09,-0.6597,AstraZeneca's Imfinzi Meets Endpoint in Lung Cancer Study,0.386,0.614,0.0,-1
2019-06-28 22:07:38,-0.6249,These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019,0.255,0.745,0.0,-1
2019-06-28 22:08:41,0.0,Here's Why Sarepta Therapeutics Is Surging Today,0.0,1.0,0.0,0
2019-06-29 20:49:15,0.4215,How Mastercard and Other Hedge Fund Favorites Performed in Q2,0.0,0.763,0.237,1
2019-06-30 16:15:00,0.3612,Pfizer&apos;s About to Enter a Sales Slump -- Here&apos;s Why You Should Like the Stock Anyway,0.0,0.848,0.152,1
2019-06-30 17:34:35,0.3612,Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway,0.0,0.848,0.152,1
2019-07-01 12:00:00,0.5574,"Pfizer Announces Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment, 2%, in Children Aged 3 Months to Less Than 24 Months with Mild to Moderate Atopic Dermatitis",0.0,0.878,0.122,1
2019-07-01 12:27:00,0.5574,Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study,0.0,0.783,0.217,1
2019-07-01 13:21:01,-0.3818,Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study,0.224,0.776,0.0,-1
2019-07-01 13:30:01,0.0,"Company News for Jul 1, 2019",0.0,1.0,0.0,0
2019-07-01 13:35:01,0.4215,Sarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues,0.0,0.763,0.237,1
2019-07-01 13:42:00,0.7184,Pfizer Gains on Positive Children-Dermatitis Treatment Results,0.0,0.455,0.545,1
2019-07-01 13:42:53,0.3612,"Futures soar after Trump, Xi agree to hold off on new tariffs",0.0,0.815,0.185,1
2019-07-01 13:43:01,0.4767,Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval,0.0,0.693,0.307,1
2019-07-01 13:54:32,0.4939,"Health Care Sector Update for 07/01/2019: TLSA, BCYC, CERC, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-01 14:00:00,0.0,Pfizer Completes Acquisition of Therachon,0.0,1.0,0.0,0
2019-07-01 14:11:00,0.0,Sarepta Therapeutics Stock Could Capitalize From Pfizer’s Stumble,0.0,1.0,0.0,0
2019-07-01 15:34:06,0.4215,Acquisition Improves the Outlook of Pfizer Stock,0.0,0.682,0.318,1
2019-07-01 16:39:19,0.0,"The Zacks Analyst Blog Highlights: NIKE, Walgreens Boots Alliance, UnitedHealth, Pfizer and Home Depot",0.0,1.0,0.0,0
2019-07-01 18:29:00,0.3182,S&P 500 eases off intraday high sparked by U.S.- China trade truce,0.0,0.827,0.173,1
2019-07-01 20:21:00,0.0,S&P 500 settles below intraday high sparked by U.S.-China trade truce,0.0,1.0,0.0,0
2019-07-01 21:04:14,0.4576,"After Hours Most Active for Jul 1, 2019 :  BX, KO, VZ, BAC, PFE, ET",0.0,0.813,0.187,1
2019-07-02 13:06:29,0.4767,GSK-Pfizer JV gets conditional approval from S.Africa's competition regulator,0.0,0.721,0.279,1
2019-07-02 13:09:26,0.4019,"Pfizer, Sanofi, to boost South African Biovac's vaccine output",0.0,0.748,0.252,1
2019-07-02 13:15:39,0.0,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 03, 2019",0.0,1.0,0.0,0
2019-07-02 13:31:01,0.0,"Company News for Jul 2, 2019",0.0,1.0,0.0,0
2019-07-02 13:54:44,0.4939,"Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-02 15:31:26,0.4019,"CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output",0.0,0.748,0.252,1
2019-07-02 15:32:00,-0.34,Sen. Elizabeth Warren Urges New Pfizer Board Member Gottlieb to Resign,0.194,0.806,0.0,-1
2019-07-02 18:15:15,-0.34,Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board,0.179,0.821,0.0,-1
2019-07-02 18:34:16,-0.6597,GSK hikes price of subsidiary Tesaro's ovarian cancer drug,0.355,0.645,0.0,-1
2019-07-02 19:04:26,-0.296,"Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation",0.155,0.845,0.0,-1
2019-07-02 19:38:28,0.0,3 Dow Jones Stocks to Buy for the Second Half,0.0,1.0,0.0,0
2019-07-02 20:39:00,0.4939,A recession-proof industry you can count on: pet care,0.0,0.686,0.314,1
2019-07-02 22:37:38,0.4215,Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis,0.0,0.741,0.259,1
2019-07-03 12:30:12,-0.6597,Trump's Bully Pulpit Didn’t Stop Drug-Price Hikes,0.519,0.481,0.0,-1
2019-07-03 12:34:13,0.6633,Sanofi a Top Ranked SAFE Dividend Stock With 3.9% Yield (SNY),0.0,0.596,0.404,1
2019-07-03 13:34:01,0.0,Will the Pharma Space Witness More Mega-Merger Deals in 2H?,0.0,1.0,0.0,0
2019-07-03 14:41:45,0.0,Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up,0.0,1.0,0.0,0
2019-07-03 16:34:57,0.0,"3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser",0.0,1.0,0.0,0
2019-07-03 16:35:51,0.0,"Notable ETF Inflow Detected - VOO, BRK.B, PFE, DIS",0.0,1.0,0.0,0
2019-07-03 23:36:07,-0.0258,Pfizer (PFE) Gains But Lags Market: What You Should Know,0.194,0.62,0.186,0
2019-07-04 14:26:02,0.5719,"Glaxo's Dovato Wins EU Nod, RA Candidate Enters Phase III",0.0,0.709,0.291,1
2019-07-05 13:32:01,0.0,"Pharma Stock Roundup: PFE's Regulatory/Pipeline Updates, CHMP Nod for Several Drugs",0.0,1.0,0.0,0
2019-07-05 13:36:01,0.4939,"Health Care Sector Update for 07/05/2019: TYME, CYAD, GRFS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-05 14:45:29,0.0,"Dow 30 Stock Roundup: Visa to Buy Verifi, Goldman May Launch Own Cryptocurrency",0.0,1.0,0.0,0
2019-07-05 18:17:34,0.0,Why Putting the Former Head of the FDA On Pfizer’s Board Is So Fraught,0.0,1.0,0.0,0
2019-07-05 19:21:00,-0.6124,June jobs report crushes expectations as Fed weighs a rate cut,0.385,0.615,0.0,-1
2019-07-06 00:09:15,0.2023,"The Top 10 Biotechnology Companies (JNJ, ROG.VX)",0.0,0.769,0.231,1
2019-07-06 03:15:00,0.2732,Sangamo and Pfizer Announce Updated Phase 1/2 Results for SB-525 Investigational Hemophilia A Gene Therapy Showing Sustained Increased Factor VIII Levels,0.0,0.9,0.1,1
2019-07-07 04:00:24,-0.4939,How private equity overcame its fear of dabbling in drugs,0.262,0.738,0.0,-1
2019-07-07 17:07:51,0.4404,Better Buy: Pfizer vs. Johnson & Johnson,0.0,0.633,0.367,1
2019-07-08 13:34:00,0.7096,Pfizer Is Looking Pretty Smart With Array BioPharma Purchase,0.0,0.543,0.457,1
2019-07-08 13:46:44,0.4939,"Health Care Sector Update for 07/08/2019: SGMO, PFE, ITCI, PRVL, JNJ, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-08 14:07:00,0.3818,Why Exact Sciences Corporation Stock Gained Nearly 14% in June,0.0,0.776,0.224,1
2019-07-08 15:37:40,0.0,Johnson & Johnson: How Does Darzalex Compare To Other Multiple Myeloma Drugs?,0.0,1.0,0.0,0
2019-07-08 15:43:00,0.7096,Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here’s Why.,0.0,0.576,0.424,1
2019-07-08 16:11:15,0.0,Why Bristol-Myers Squibb Stock Plunged in the First Half of 2019,0.0,1.0,0.0,0
2019-07-08 18:06:41,0.4939,"Health Care Sector Update for 07/08/2019: PRVL,SGMO,ITCI",0.0,0.652,0.348,1
2019-07-08 18:08:07,0.0,Here's Why Sangamo Therapeutics Is Surging Today,0.0,1.0,0.0,0
2019-07-08 20:18:09,-0.3818,Gene Therapy Battle: Why Sangamo Therapeutics Is Thrashing Its Rivals,0.224,0.776,0.0,-1
2019-07-08 20:26:33,0.4939,"Health Care Sector Update for 07/08/2019: SOLY,PRVL,SGMO,ITCI",0.0,0.652,0.348,1
2019-07-09 00:08:11,0.0,Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study,0.0,1.0,0.0,0
2019-07-09 13:46:50,0.4939,"Health Care Sector Update for 07/09/2019: CHEK, ALT, IMMP, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-09 14:06:02,0.0,Glaxo's Long-Acting HIV Regimen Gets FDA's Priority Status,0.0,1.0,0.0,0
2019-07-09 14:13:53,0.2023,Women Health a Top Priority Now: 3 Stocks to Watch,0.0,0.795,0.205,1
2019-07-09 14:40:02,0.0,BioMarin (BMRN) to File for Hemophilia A Candidate in Q4,0.0,1.0,0.0,0
2019-07-09 15:07:03,0.3182,Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study,0.0,0.796,0.204,1
2019-07-09 15:40:45,0.0,Amarin Thinks Sales of Its Cardio Drug Could Be in the Billions,0.0,1.0,0.0,0
2019-07-09 15:57:47,0.0,Judge rules against Trump on drug pricing disclosures,0.0,1.0,0.0,0
2019-07-09 16:09:40,0.0,"Dow Movers: MMM, MRK",0.0,1.0,0.0,0
2019-07-09 21:48:09,0.0,Aerie Completes Enrollment Under Rhopressa Study in Japan,0.0,1.0,0.0,0
2019-07-10 12:19:00,0.0,Here&apos;s Why Array BioPharma Soared 75.4% in June,0.0,1.0,0.0,0
2019-07-10 13:46:51,0.4939,"Health Care Sector Update for 07/10/2019: AMRX, OASM, AKTS, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-10 14:08:39,0.0,Here's Why Array BioPharma Soared 75.4% in June,0.0,1.0,0.0,0
2019-07-10 14:14:02,0.0,Merck's Keytruda sBLAs for 6-Week Dosing to be Reviewed by FDA,0.0,1.0,0.0,0
2019-07-10 15:21:56,-0.2263,"Companies to Watch: T-Mobile joins S&P 500, Tesla to ramp up production, Marriott faces lawsuit",0.119,0.881,0.0,-1
2019-07-10 17:16:00,0.0,The 10 Biggest Healthcare Stocks,0.0,1.0,0.0,0
2019-07-10 21:40:09,0.0,Glaxo's Two-Drug HIV Pill Dovato on Par with Three-Drug Pill,0.0,1.0,0.0,0
2019-07-10 21:59:04,0.0,US Indexes Close Higher After Dovish Fed Reports,0.0,1.0,0.0,0
2019-07-11 09:33:09,0.3182,Sangamo Up As Gene Therapy Shows Promise in Hemophilia Study (Revised),0.0,0.813,0.187,1
2019-07-11 12:54:36,-0.1531,UPDATE 2-Walgreens expands epinephrine shot partnership as shortage persists,0.192,0.673,0.135,-1
2019-07-11 13:02:00,0.0,Here&apos;s Why Sangamo Therapeutics Jumped 23% in June,0.0,1.0,0.0,0
2019-07-11 13:17:29,0.0,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2019",0.0,1.0,0.0,0
2019-07-11 13:19:22,0.0,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2019",0.0,1.0,0.0,0
2019-07-11 13:47:18,0.4939,"Health Care Sector Update for 07/11/2019: SNSS, EYEN, BHVN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-11 14:15:25,0.0,Here's Why Sangamo Therapeutics Jumped 23% in June,0.0,1.0,0.0,0
2019-07-11 16:07:10,0.296,"SSO, BRK.B, PFE, CVX: ETF Inflow Alert",0.0,0.732,0.268,1
2019-07-11 16:09:22,0.0,"Dow Movers: MRK, UNH",0.0,1.0,0.0,0
2019-07-11 17:00:00,0.0,Here&apos;s Why CVS Health Stock Is On the Move Today,0.0,1.0,0.0,0
2019-07-11 17:10:00,0.0,"Here are the Dow components driving the  blue-chip stock index to a 27,000 milestone",0.0,1.0,0.0,0
2019-07-11 17:35:00,-0.5106,Drug Stocks Are Falling Because Trump’s Next Move on Pricing Could Be Trouble,0.281,0.719,0.0,-1
2019-07-11 18:08:39,0.0,Here's Why CVS Health Stock Is On the Move Today,0.0,1.0,0.0,0
2019-07-11 19:00:51,0.0,4 Drug Stocks Getting Smashed,0.0,1.0,0.0,0
2019-07-11 20:05:00,0.0,"The Dow components that drove the blue-chip stock index to a 27,000 milestone",0.0,1.0,0.0,0
2019-07-11 20:22:31,0.0,"Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates",0.0,1.0,0.0,0
2019-07-11 21:06:29,0.5267,"US STOCKS-S&P 500, Dow climb as health insurers, financials gain",0.0,0.726,0.274,1
2019-07-12 12:36:12,0.0,"Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY",0.0,1.0,0.0,0
2019-07-12 13:30:01,0.6486,SNY or PFE: Which Is the Better Value Stock Right Now?,0.0,0.629,0.371,1
2019-07-12 13:47:23,0.4939,"Health Care Sector Update for 07/12/2019: MDGS, HOOK, ILMN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-12 14:23:21,0.7096,Health Care stocks help lead Wall Street rally,0.0,0.504,0.496,1
2019-07-12 15:10:15,-0.3804,Why one top exec at this $105 billion drugmaker is 'very disappointed' with Trump,0.197,0.698,0.105,-1
2019-07-12 15:35:03,-0.4404,Drug Pricing Woes Linger on Repealing Drug Rebate Proposal,0.266,0.734,0.0,-1
2019-07-12 16:09:00,0.0,"Dow Movers: PFE, DOW",0.0,1.0,0.0,0
2019-07-12 17:12:08,0.34,AstraZeneca's Imfinzi Gains Orphan Drug Status for SCLC,0.0,0.745,0.255,1
2019-07-12 19:25:00,0.0,Health companies start reporting earnings next week: Here are 3 things to keep in mind,0.0,1.0,0.0,0
2019-07-13 14:08:23,0.0,All Eyes On Biotech M&A,0.0,1.0,0.0,0
2019-07-15 10:00:00,0.5574,"Biden healthcare plan would curb drug prices, raise taxes on rich",0.0,0.735,0.265,1
2019-07-15 20:22:50,-0.1027,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday",0.161,0.714,0.125,-1
2019-07-16 04:00:29,-0.7351,The opioid drugs scandal is depressingly familiar,0.554,0.446,0.0,-1
2019-07-16 13:28:39,0.5106,How Financially Strong Is Pfizer Inc. (NYSE:PFE)?,0.0,0.645,0.355,1
2019-07-16 13:47:00,0.4939,"Health Care Sector Update for 07/16/2019: IMRN, MLNT, JNJ, PFE, ABT, MRK, AMGN",0.0,0.789,0.211,1
2019-07-16 19:05:07,0.2023,"Top Research Reports for Berkshire Hathaway, Pfizer & Danaher",0.0,0.795,0.205,1
2019-07-16 22:05:10,0.0,Should You Pick Up Novartis (NVS) Before Q2 Earnings?,0.0,1.0,0.0,0
2019-07-17 11:43:12,0.0,Sarepta vs Pfizer: Which Stock Should Investors Buy?,0.0,1.0,0.0,0
2019-07-17 11:57:11,0.0,"The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas",0.0,1.0,0.0,0
2019-07-17 13:18:01,0.0,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 18, 2019",0.0,1.0,0.0,0
2019-07-17 13:47:07,0.4939,"Health Care Sector Update for 07/17/2019: GHSI, IMRN, ABT, JNJ, PFE, MRK, AMGN",0.0,0.789,0.211,1
2019-07-18 22:26:10,0.4588,Allergan Announces FDA Acceptance of Glaucoma Candidate NDA,0.0,0.7,0.3,1
2019-07-19 15:36:48,-0.1531,UPDATE 2-Health Canada to keep importing Kaleo's epinephrine shot amid shortages,0.138,0.862,0.0,-1
2019-07-19 16:07:36,0.0,"SPYG, PFE, VZ, MRK: Large Inflows Detected at ETF",0.0,1.0,0.0,0
2019-07-20 16:07:00,-0.0772,8 More Big Pharma Events in 2019 You Don&apos;t Want to Miss,0.134,0.756,0.109,0
2019-07-21 17:53:00,0.0,Amarin: Is a Buyout Really Off the Table?,0.0,1.0,0.0,0
2019-07-22 14:55:02,0.2732,"Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy",0.0,0.811,0.189,1
2019-07-23 13:27:04,0.0,"With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF",0.0,1.0,0.0,0
2019-07-23 14:32:02,0.0,Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for,0.0,1.0,0.0,0
2019-07-23 17:48:00,0.5859,"FDA Approves Pfizer’s Biosimilar, RUXIENCE™ (rituximab-pvvr), for Certain Cancers and Autoimmune Conditions",0.0,0.676,0.324,1
2019-07-23 20:00:00,0.0,How to Invest in Cancer-Fighting Stocks,0.0,1.0,0.0,0
2019-07-23 20:56:44,0.4576,"After Hours Most Active for Jul 23, 2019 :  SNAP, CZR, PFE, QQQ, AVP, BAC, FDC, T, HBAN, INTC, BCRX, IGOV",0.0,0.864,0.136,1
2019-07-24 13:47:27,0.4939,"Health Care Sector Update for 07/24/2019: ANTM, SGEN, TMO, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-24 14:25:22,0.0,"Jim Cramer Gives His Opinion On eBay, Pfizer And More",0.0,1.0,0.0,0
2019-07-24 15:14:36,0.0,Merck (MRK) to Report Q2 Earnings: What's in the Cards?,0.0,1.0,0.0,0
2019-07-24 17:54:05,0.0,What to Expect from Sanofi's (SNY) Q2 Earnings (Revised),0.0,1.0,0.0,0
2019-07-24 20:09:38,0.0,What to Expect from Sanofi's (SNY) Q2 Earnings,0.0,1.0,0.0,0
2019-07-25 01:15:13,0.3818,Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?,0.163,0.523,0.314,1
2019-07-25 13:47:39,0.4939,"Health Care Sector Update for 07/25/2019: GEMP, QGEN, AZN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-25 13:59:01,0.5106,"Glaxo (GSK) Beats on Q2 Earnings, Shingrix Sales Strong",0.0,0.708,0.292,1
2019-07-25 17:13:58,0.0,"Bristol-Myers (BMY) Beats on Q2 Earnings & Sales, Raises View",0.0,1.0,0.0,0
2019-07-26 10:06:41,0.0,Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 7/26/2019,0.0,1.0,0.0,0
2019-07-26 13:55:00,0.7269,"Array Acquisition Could Be a Huge Win for Pfizer, Analyst Says",0.0,0.567,0.433,1
2019-07-26 15:09:17,-0.6597,3 Cancer Treatment Stocks to Buy Right Now,0.423,0.577,0.0,-1
2019-07-26 15:22:45,-0.2732,Senate advances bill to cut the cost of prescriptions,0.208,0.792,0.0,-1
2019-07-26 15:23:58,0.0,"Pharma Stock Roundup: GSK, BMY Q2 Earnings, FDA Nod to LLY's Hypoglycemia Treatment",0.0,1.0,0.0,0
2019-07-26 17:12:53,0.4019,Can Newer Drugs Help Amgen (AMGN) Beat on Earnings in Q2?,0.0,0.787,0.213,1
2019-07-26 18:08:48,0.0,What's in the Cards for Pfizer (PFE) This Earnings Season?,0.0,1.0,0.0,0
2019-07-26 21:51:15,0.4215,AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It?,0.0,0.743,0.257,1
2019-07-27 08:43:36,0.0,Pfizer expected to announce stock deal with Mylan,0.0,1.0,0.0,0
2019-07-27 08:43:36,0.0,Pfizer and Mylan set to merge off-patent drugs businesses,0.0,1.0,0.0,0
2019-07-27 08:43:36,0.1779,Pfizer in talks to merge off-patent assets with Mylan,0.0,0.825,0.175,1
2019-07-27 08:43:36,0.0,Pfizer and Mylan in talks to merge off-patent drugs businesses,0.0,1.0,0.0,0
2019-07-27 12:03:57,0.0,"Pfizer Inc. (NYSE:PFE) Is About To Go Ex-Dividend, And It Pays A 0.8% Yield",0.0,1.0,0.0,0
2019-07-27 12:48:26,0.0,Pfizer in talks to merge off-patent drugs business with Mylan,0.0,1.0,0.0,0
2019-07-27 13:04:02,0.0,Pfizer in talks to merge off-patent drugs business with Mylan: source,0.0,1.0,0.0,0
2019-07-27 13:04:02,0.0,Pfizer in talks to merge off-patent drugs business with Mylan -source,0.0,1.0,0.0,0
2019-07-27 14:42:09,0.0,UPDATE 1-Pfizer in talks to merge off-patent drugs business with Mylan -source,0.0,1.0,0.0,0
2019-07-27 18:06:53,0.0,10 Biggest Cancer-Fighting Stocks,0.0,1.0,0.0,0
2019-07-27 19:00:23,0.0,Pfizer Nears Deal to Combine Off-Patent Drug Unit With Mylan,0.0,1.0,0.0,0
2019-07-27 20:23:01,0.0,"Report: Mylan, Pfizer unit close to merger",0.0,1.0,0.0,0
2019-07-28 13:22:00,0.0,"Pfizer, Mylan Plan to Combine Generic Drug Business: Reports",0.0,1.0,0.0,0
2019-07-29 04:55:58,0.0,PRESS DIGEST- New York Times business news - July 29,0.0,1.0,0.0,0
2019-07-29 06:44:00,0.296,Mylan Shares Surge Amid Reports of Off-Patent Drug Combination with Pfizer,0.0,0.82,0.18,1
2019-07-29 07:04:00,0.1779,"Beyond Meat, Pfizer, Mylan, Amazon, Federal Reserve - 5 Things You Must Know",0.0,0.855,0.145,1
2019-07-29 07:12:00,0.0,Stocks - U.S. Futures Flat as U.S.-China Trade Talks Recommence,0.0,1.0,0.0,0
2019-07-29 07:16:00,0.0,Pfizer to Combine Off-Patent Drug Division With Mylan,0.0,1.0,0.0,0
2019-07-29 10:30:00,0.0,3 Things to Look For in Pfizer&apos;s Q2 Earnings Update,0.0,1.0,0.0,0
2019-07-29 10:45:00,0.8402,"Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World's Need for Medicine",0.0,0.69,0.31,1
2019-07-29 10:45:00,0.8402,"Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine",0.0,0.69,0.31,1
2019-07-29 10:46:00,0.0,PFIZER REPORTS SECOND-QUARTER 2019 RESULTS ,0.0,1.0,0.0,0
2019-07-29 10:50:00,0.0,"Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT",0.0,1.0,0.0,0
2019-07-29 10:59:00,0.0,Mylan's stock soars after merger deal with Pfizer's Upjohn,0.0,1.0,0.0,0
2019-07-29 11:06:05,0.4404,Pfizer posts 30% rise in quarterly profit,0.0,0.674,0.326,1
2019-07-29 11:09:00,0.4404,"Mylan beats adjusted profit, revenue expectations",0.0,0.633,0.367,1
2019-07-29 11:09:57,0.0,"Pfizer to spinoff, merge off-patent drugs unit with Mylan",0.0,1.0,0.0,0
2019-07-29 11:11:50,0.0,Mylan to merge with Upjohn in new company,0.0,1.0,0.0,0
2019-07-29 11:24:16,-0.1531,Pfizer-Mylan Generic Giant Solves Two Problems With One Deal,0.229,0.593,0.178,-1
2019-07-29 11:35:00,0.0,Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes,0.0,1.0,0.0,0
2019-07-29 11:35:03,0.0,Pfizer and Mylan to combine off-patent drugs businesses,0.0,1.0,0.0,0
2019-07-29 11:39:29,0.0,Pfizer and Mylan: Is Mega-Merger on the Horizon?,0.0,1.0,0.0,0
2019-07-29 12:01:01,0.2732,"Mylan, Pfizer's Upjohn To Merge And Create New Company",0.0,0.792,0.208,1
2019-07-29 12:05:12,0.2023,Pfizer (PFE) Q2 Earnings Top Estimates,0.0,0.735,0.265,1
2019-07-29 12:15:56,-0.1531,Futures flat as Fed policy meeting looms,0.211,0.789,0.0,-1
2019-07-29 12:38:00,0.1531,"Mylan Shares Soar on Merger News, but Pfizer’s Stock Is Sagging",0.0,0.862,0.138,1
2019-07-29 12:55:19,0.4576,"Pre-Market Most Active for Jul 29, 2019 :  MYL, TEVA, NOK, PFE, LXRX, AMD, YNDX, AZN, STM, GHDX, TVIX, ABB",0.0,0.857,0.143,1
2019-07-29 12:56:00,-0.1531,"Pfizer stock down after revenue miss, merger announcement",0.186,0.814,0.0,-1
2019-07-29 12:59:46,0.0,3 Things to Look For in Pfizer's Q2 Earnings Update,0.0,1.0,0.0,0
2019-07-29 13:00:53,0.0,"Market Morning: Siri Hears Drug Deals, Sex; Alibaba Banks On Bank, Google Gets Gabbarded, Mylan & Pfizer Unite",0.0,1.0,0.0,0
2019-07-29 13:01:59,-0.1531,US STOCKS-Wall St set to open flat as Fed policy meeting looms,0.127,0.873,0.0,-1
2019-07-29 13:22:00,-0.1531,"The Dow Is Inching Higher, While Pfizer and Starbucks Are Falling",0.138,0.862,0.0,-1
2019-07-29 13:24:00,0.0,Generic drug maker stocks rally after Mylan deal to merge with Pfizer's Upjohn,0.0,1.0,0.0,0
2019-07-29 13:29:17,0.0,"Stocks - Mylan, Uber Rise Premarket; Pfizer, Domino’s Fall",0.0,1.0,0.0,0
2019-07-29 13:35:37,0.4939,"Health Care Sector Update for 07/29/2019: MYL, EXAS, GHDX, SNY, JNJ, PFE, MRK, ABT, AMGN",0.0,0.814,0.186,1
2019-07-29 13:56:55,0.0,"Pfizer to Braid Old Blockbusters Into Mylan, Reshaping Industry",0.0,1.0,0.0,0
2019-07-29 14:12:02,0.0,What's in Store for Array BioPharma (ARRY) in Q4 Earnings?,0.0,1.0,0.0,0
2019-07-29 14:19:00,0.0,S&P downgrades Pfizer by one notch to AA-minus after Upjohn/Mylan deal,0.0,1.0,0.0,0
2019-07-29 14:36:34,-0.1779,US STOCKS-Wall Street falls as tech drags; Fed meeting eyed,0.159,0.841,0.0,-1
2019-07-29 14:52:00,-0.4404,"It's Market Madness: Jim Cramer on Earnings Season, Pfizer and Mylan, Starbucks",0.209,0.791,0.0,-1
2019-07-29 14:58:15,-0.3612,"For Mylan, it's bye-bye Netherlands, but Canonsburg's future role still unclear",0.2,0.8,0.0,-1
2019-07-29 14:58:57,-0.128,"Pfizer Reports Mixed Q2 Earnings, Lowers Guidance",0.2,0.8,0.0,-1
2019-07-29 15:35:59,0.0,Pfizer in talks to transition EpiPen manufacturing into generics spinoff,0.0,1.0,0.0,0
2019-07-29 15:38:15,0.1531,US STOCKS-Wall St eases from record highs as tech drags; Fed meeting eyed,0.113,0.733,0.153,1
2019-07-29 15:40:59,0.0,"Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan",0.0,1.0,0.0,0
2019-07-29 15:47:00,0.0516,"While No Magic Pill, Mylan Deal Might Just Revive Drugmaker",0.175,0.635,0.19,0
2019-07-29 15:55:33,0.0,Buy Pfizer Stock Before this Week’s Earnings Report Gives It a Bump Up,0.0,1.0,0.0,0
2019-07-29 15:58:08,0.0,"Dow Movers: PFE, MRK",0.0,1.0,0.0,0
2019-07-29 16:00:52,0.0,Pfizer Closes in on a Major Spinoff,0.0,1.0,0.0,0
2019-07-29 16:04:16,0.0,UPDATE 1-Pfizer in talks to transition EpiPen maker into generics spinoff -spokeswoman,0.0,1.0,0.0,0
2019-07-29 16:09:00,-0.3724,Wall Street is not exactly impressed with the Pfizer-Mylan deal,0.221,0.779,0.0,-1
2019-07-29 16:24:00,0.0,Why Mylan Stock Is Jumping Today,0.0,1.0,0.0,0
2019-07-29 16:58:03,0.0,Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty,0.0,1.0,0.0,0
2019-07-29 17:03:28,0.0,Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger,0.0,1.0,0.0,0
2019-07-29 17:06:44,0.1779,"US STOCKS-Wall Street mixed as Amazon, Facebook weigh",0.0,0.805,0.195,1
2019-07-29 17:17:09,0.0,Pharmacia Corporation (Old Monsanto) -- Moody's reviews Pfizer's A1 rating for downgrade; affirms P-1 rating,0.0,1.0,0.0,0
2019-07-29 17:31:29,0.0,Meet the CEO-in-waiting of the Mylan-Upjohn company,0.0,1.0,0.0,0
2019-07-29 17:32:19,0.0,Pfizer Stock Is The Biggest Pharma — But Should You Buy It?,0.0,1.0,0.0,0
2019-07-29 17:40:57,0.0,Mylan’s Mastermind Clutches the Reins as Pfizer Makes Its Move,0.0,1.0,0.0,0
2019-07-29 18:09:56,0.0772,What You'll Want to Know About Pfizer's Q2 Earnings Results,0.0,0.874,0.126,0
2019-07-29 18:35:30,0.4939,"Health Care Sector Update for 07/29/2019: RDY,MYL,PFE,EXAS,GHDX",0.0,0.652,0.348,1
2019-07-29 18:42:08,0.296,Mylan N.V. -- Moody's affirms Mylan's Baa3 ratings; outlook stable,0.0,0.804,0.196,1
2019-07-29 18:45:06,0.296,Mylan Inc. -- Moody's affirms Mylan's Baa3 ratings; outlook stable,0.0,0.804,0.196,1
2019-07-29 19:05:00,0.0,Pfizer to Combine Off-Patent Drug Business With Mylan,0.0,1.0,0.0,0
2019-07-29 19:19:00,0.0,Why Is Pfizer Stock Down Despite the Deal With Mylan? Look at the Numbers.,0.0,1.0,0.0,0
2019-07-29 19:28:37,0.5267,"Bresch would stand to gain a lot with Mylan's change in control, according to proxy",0.0,0.793,0.207,1
2019-07-29 19:29:07,0.0,"Mylan (MYL) Beats on Q2 Earnings, Inks Deal with Pfizer",0.0,1.0,0.0,0
2019-07-29 20:07:01,0.0,US Stock Market Overview &#8211; Stock Trade Mixed Ahead Central Bank Decisions,0.0,1.0,0.0,0
2019-07-29 20:11:59,0.0,"Merger Fever Runs Hot In Pharma: Viagra, Epipen Sellers Announce Matchup",0.0,1.0,0.0,0
2019-07-29 20:15:14,0.0,"Pre-Market Earnings Report for July 30, 2019 :  PG, MA, PFE, MRK, LLY, MO, COP, ECL, MMC, HCA, ETN, PEG",0.0,1.0,0.0,0
2019-07-29 20:17:03,0.34,"Dow Jones Leads Stock Market As Apple, Disney Score Gains",0.0,0.789,0.211,1
2019-07-29 20:33:17,0.0,US STOCKS-U.S. stocks back off record highs ahead of Fed meeting,0.0,1.0,0.0,0
2019-07-29 20:35:20,0.0,Dow Jones Today: Fed Watch Begins,0.0,1.0,0.0,0
2019-07-29 20:58:15,0.0,Mylan's Mixed 2nd-Quarter Results Overshadowed by News of Its Upjohn Merger,0.0,1.0,0.0,0
2019-07-29 21:34:16,0.34,"GRAPHIC-Mylan stock boost follows long share struggles for company, generics industry",0.162,0.519,0.318,1
2019-07-29 21:55:21,0.3818,UPDATE 2-J&J says FTC probing efforts to protect arthritis drug Remicade,0.0,0.794,0.206,1
2019-07-29 22:04:33,-0.296,US Indexes Close Mostly Lower on Monday,0.268,0.732,0.0,-1
2019-07-29 22:53:29,0.0,"Pfizer-Mylan Deal 'Well-Valued' for Mylan, Says Raffat",0.0,1.0,0.0,0
2019-07-30 00:01:00,0.4466,SHAREHOLDER ALERT: WeissLaw LLP Investigates Mylan N.V.,0.0,0.672,0.328,1
2019-07-30 04:00:28,0.0,Prey turns predator as LSE goes for Refinitiv,0.0,1.0,0.0,0
2019-07-30 06:09:33,0.0,Mylan deal puts future of its beleaguered EpiPen in spotlight,0.0,1.0,0.0,0
2019-07-30 10:00:00,0.0,3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders,0.0,1.0,0.0,0
2019-07-30 11:56:52,0.0772,Challenges remain for Mylan despite merger with Upjohn,0.0,0.843,0.157,0
2019-07-30 12:00:42,-0.6249,The 5 Worst S&P 500 Stocks Are Costing You $22.3 Billion; Here's Why,0.272,0.728,0.0,-1
2019-07-30 12:16:00,0.0,Pfizer Completes Acquisition of Array Biopharma,0.0,1.0,0.0,0
2019-07-30 13:01:49,0.0,"3 Big Stock Charts for Tuesday: Hanesbrands, Tapestry and Travelers Companies",0.0,1.0,0.0,0
2019-07-30 13:08:46,-0.296,"US STOCKS-Wall St set to open lower as focus shifts to Fed meeting, Apple earnings",0.136,0.864,0.0,-1
2019-07-30 13:25:30,0.34,"RPT-GRAPHIC-Mylan stock boost follows long share struggles for company, generics industry",0.162,0.519,0.318,1
2019-07-30 13:35:49,0.4939,"Health Care Sector Update for 07/30/2019: FMS, MRK, LLY, JNJ, PFE, ABT, AMGN",0.0,0.789,0.211,1
2019-07-30 14:15:00,-0.6249,Pfizer's stock tumbles toward worst 2-day stretch in 10 1/2-years,0.313,0.687,0.0,-1
2019-07-30 14:32:00,0.0,Pfizer Stock Falls for the Second Day After Mylan Deal,0.0,1.0,0.0,0
2019-07-30 14:34:02,0.0,"Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More",0.0,1.0,0.0,0
2019-07-30 14:44:58,0.0516,Mylan reaches $30 million settlement in SEC's EpiPen probe,0.0,0.87,0.13,0
2019-07-30 15:12:00,0.0,Pfizer Falls 7%,0.0,1.0,0.0,0
2019-07-30 15:58:47,0.0,"Dow Movers: PFE, PG",0.0,1.0,0.0,0
2019-07-30 16:12:40,0.0,"Stock Market News For Jul 30, 2019",0.0,1.0,0.0,0
2019-07-30 16:14:41,0.0,Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger,0.0,1.0,0.0,0
2019-07-30 16:22:49,0.0,FTC investigating Johnson & Johnson's Remicade contracting practices,0.0,1.0,0.0,0
2019-07-30 16:25:59,0.0,How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?,0.0,1.0,0.0,0
2019-07-30 16:55:41,0.6597,Relative Strength Alert For Pfizer,0.0,0.357,0.643,1
2019-07-30 16:58:01,0.0,"DGRO, VZ, PFE, MRK: Large Outflows Detected at ETF",0.0,1.0,0.0,0
2019-07-30 16:58:18,0.2732,"Ex-Dividend Reminder: CMS Energy, Pfizer and Atlantic Union Bankshares",0.0,0.792,0.208,1
2019-07-30 17:02:46,0.0,Economic and Earnings Date Deluge,0.0,1.0,0.0,0
2019-07-30 17:14:27,0.7964,Merck Shares Rise on Strong Sales Growth,0.0,0.331,0.669,1
2019-07-30 17:39:42,0.0,Dow Still Underwater As Pfizer Stock Slammed; Will Apple Earnings Beat?,0.0,1.0,0.0,0
2019-07-30 17:41:23,-0.1531,Pfizer Becomes a Falling Knife After Monday's Earnings,0.211,0.789,0.0,-1
2019-07-30 18:55:15,0.0,"Notable Tuesday Option Activity: LEG, PFE, DIS",0.0,1.0,0.0,0
2019-07-30 18:56:24,0.0,Tuesday's ETF with Unusual Volume: SIZE,0.0,1.0,0.0,0
2019-07-30 18:58:42,0.0258,Stock Market Pares Losses; Apple Improves Ahead Of Earnings,0.216,0.56,0.224,0
2019-07-30 19:00:49,-0.4215,"US STOCKS-Wall Street drops on new trade worries, Fed; Apple eyed",0.219,0.781,0.0,-1
2019-07-30 20:20:14,0.0,Dow Jones Today: Trump Trade Tweets at It Again,0.0,1.0,0.0,0
2019-07-30 20:38:53,0.0,"Why Beyond Meat, McDermott International, and Pfizer Slumped Today",0.0,1.0,0.0,0
2019-07-30 20:39:24,-0.5574,US STOCKS-Tech pulls Wall Street lower on Trump trade warning,0.365,0.635,0.0,-1
2019-07-30 20:49:46,0.0,"Market Close Report: NASDAQ Composite index closes at 8,273.61 down -19.72 points",0.0,1.0,0.0,0
2019-07-30 21:55:35,-0.2263,"Trade Tweets, Pfizer Drag On Dow",0.275,0.725,0.0,-1
2019-07-30 22:21:54,-0.296,US Indexes Close Mostly Lower Tuesday,0.306,0.694,0.0,-1
2019-07-30 22:39:18,0.0,Edited Transcript of PFE earnings conference call or presentation 29-Jul-19 2:30pm GMT,0.0,1.0,0.0,0
2019-07-31 09:39:44,0.0,Pfizer: Downgrade Double-Whammy On Mylan Deal,0.0,1.0,0.0,0
2019-07-31 13:15:47,0.0,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 01, 2019",0.0,1.0,0.0,0
2019-07-31 13:35:58,0.4939,"Health Care Sector Update for 07/31/2019: HUM, TTOO, AMRN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-07-31 13:55:41,0.4588,Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal,0.0,0.786,0.214,1
2019-07-31 15:18:00,0.5859,Stocks - Stocks Dive as Fed's Powell Sinks Future Easing Hopes,0.0,0.625,0.375,1
2019-07-31 15:55:51,0.0,"3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco",0.0,1.0,0.0,0
2019-07-31 18:56:31,0.4939,"Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple",0.0,0.625,0.375,1
2019-07-31 19:23:46,0.0,Why Pfizer Stock Continues to Tank after Mylan Deal,0.0,1.0,0.0,0
2019-07-31 22:55:32,0.0,5 Stocks to Buy and Keep an Eye on Come Fall,0.0,1.0,0.0,0
2019-08-01 01:58:57,0.0,Pfizer Inc (PFE) Q2 2019 Earnings Call Transcript,0.0,1.0,0.0,0
2019-08-01 08:00:00,0.0772,"Cover story: After years of challenges, Mylan looks to chart a different course",0.0,0.894,0.106,0
2019-08-01 12:54:12,0.0,Is a Beat in Store for Nektar (NKTR) This Earnings Season?,0.0,1.0,0.0,0
2019-08-01 13:57:45,0.4939,"Health Care Sector Update for 08/01/2019: ABMD, CFMS, ABC, JNJ, PFE, MRK, ABT, AMGN",0.0,0.802,0.198,1
2019-08-01 14:50:02,0.0,"Exelixis (EXEL) Q2 Earnings & Sales Beat, Cabometyx Shines",0.0,1.0,0.0,0
2019-08-01 15:17:42,0.0,"GSK, Pfizer complete deal to combine consumer health brands",0.0,1.0,0.0,0
2019-08-01 15:59:41,0.0,"Dow Movers: PFE, CSCO",0.0,1.0,0.0,0
2019-08-02 04:27:45,0.6369,Best of Lex: your weekly round-up,0.0,0.543,0.457,1
2019-08-02 11:24:29,0.0,GlycoMimetics (GLYC) Q2 2019 Earnings Call Transcript,0.0,1.0,0.0,0
2019-08-02 13:29:30,0.0,Waiting game: Will Mylan merger change local employment?,0.0,1.0,0.0,0
2019-08-02 13:32:00,-0.5719,Fitch Ratings downgrades Pfizer to A vs. A-plus with negative outlook,0.291,0.709,0.0,-1
2019-08-02 13:54:01,0.0,"Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger",0.0,1.0,0.0,0
2019-08-02 13:57:16,0.4939,"Health Care Sector Update for 08/02/2019: APHA, TNDM, IMGN, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-08-02 14:52:02,0.1531,BioMarin (BMRN) Shares Down on Q1 Earnings & Sales Miss,0.148,0.648,0.204,1
2019-08-02 14:59:10,-0.0258,Undercover Yields Up to 8.3% That the Computers Overlooked,0.121,0.879,0.0,0
2019-08-02 17:09:36,0.0,"After Mylan Gets Acquired, Could Teva Be Next?",0.0,1.0,0.0,0
2019-08-02 20:14:56,0.7184,10 Stock Picks That Should Love Lower Interest Rates,0.143,0.39,0.468,1
2019-08-02 21:56:31,0.2023,"Top Analyst Reports for Caterpillar, Walmart & McDonald's",0.0,0.769,0.231,1
2019-08-02 22:49:00,-0.6249,Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis,0.215,0.785,0.0,-1
2019-08-03 05:00:00,-0.4939,"Weekly Wrap: Bond-Fund Picks, Reducing Portfolio Risk, and a Rate Cut",0.344,0.656,0.0,-1
2019-08-03 14:25:57,0.0,"Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More",0.0,1.0,0.0,0
2019-08-03 16:52:11,0.2023,The Top Pharma Stocks for 2019,0.0,0.735,0.265,1
2019-08-04 13:00:00,0.0,These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024,0.0,1.0,0.0,0
2019-08-05 10:34:00,-0.4215,GlycoMimetics Plummets After Phase 3 Trial of Sickle Cell Treatment Fails,0.237,0.763,0.0,-1
2019-08-05 12:56:00,-0.5106,GlycoMimetics stock down 53% after Phase 3 trial failure,0.32,0.68,0.0,-1
2019-08-05 13:46:40,0.4939,"Health Care Sector Update for 08/05/2019: GLYC, PRVB, ZYME, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-08-05 16:29:14,-0.2023,52-Week Company Lows,0.474,0.526,0.0,-1
2019-08-05 18:08:53,0.0,"The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan",0.0,1.0,0.0,0
2019-08-05 18:09:00,0.3612,Investors Don’t Like Mylan’s Deal With Pfizer,0.0,0.706,0.294,1
2019-08-05 19:26:33,0.4939,"The Vanguard Health Care Fund Buys Pfizer, Humana",0.0,0.686,0.314,1
2019-08-06 06:29:21,-0.4939,Fear Around Bristol-Myers Squibb Stock is Starting to Fade,0.286,0.714,0.0,-1
2019-08-06 12:19:40,0.0,"3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink",0.0,1.0,0.0,0
2019-08-06 13:30:01,0.6486,SNY vs. PFE: Which Stock Is the Better Value Option?,0.0,0.602,0.398,1
2019-08-06 13:46:44,0.4939,"Health Care Sector Update for 08/06/2019: BDX, BHC, MNK, JNJ, PFE, ABT, MRK, AMGN",0.0,0.802,0.198,1
2019-08-06 21:10:45,-0.296,Here's What's Pushing Teva Pharmaceutical Industries Stock Even Lower Today,0.196,0.804,0.0,-1
2019-08-07 15:00:03,-0.1531,"Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies",0.167,0.833,0.0,-1
